0000081362-21-000016.txt : 20211104 0000081362-21-000016.hdr.sgml : 20211104 20211104165320 ACCESSION NUMBER: 0000081362-21-000016 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 102 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211104 DATE AS OF CHANGE: 20211104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUAKER CHEMICAL CORP CENTRAL INDEX KEY: 0000081362 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS PRODUCTS OF PETROLEUM & COAL [2990] IRS NUMBER: 230993790 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-12019 FILM NUMBER: 211380824 BUSINESS ADDRESS: STREET 1: ONE QUAKER PARK STREET 2: 901 HECTOR STREET CITY: CONSHOHOCKEN STATE: PA ZIP: 19428 BUSINESS PHONE: 6108324000 MAIL ADDRESS: STREET 1: ONE QUAKER PARK STREET 2: 901 HECTOR ST CITY: CONSHOHOCKEN STATE: PA ZIP: 19428 10-Q 1 kwr20210930.htm QUAKER CHEMICAL CORPORATION kwr20210930
FALSE --12-31 3 2021 1 30000000 Q3 0000081362 17888577 17850616 ☒ 0000081362 2021-01-01 2021-09-30 0000081362 kwr:StockOptionsCompensationExpenseMember 2021-01-01 2021-09-30 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2021-01-01 2021-09-30 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2021-01-01 2021-09-30 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2021-01-01 2021-09-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-09-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-09-30 0000081362 us-gaap:EMEAMember 2021-01-01 2021-09-30 0000081362 srt:AsiaPacificMember 2021-01-01 2021-09-30 0000081362 2021-10-31 0000081362 2020-07-01 2020-09-30 0000081362 2020-01-01 2020-09-30 0000081362 2021-09-30 0000081362 2020-12-31 0000081362 2019-12-31 0000081362 2020-09-30 0000081362 us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-09-30 0000081362 us-gaap:TransferredAtPointInTimeMember srt:AmericasMember 2020-01-01 2020-09-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-09-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-09-30 0000081362 us-gaap:TransferredOverTimeMember 2020-01-01 2020-09-30 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-09-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-09-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-09-30 0000081362 kwr:StockOptionsCompensationExpenseMember 2020-07-01 2020-09-30 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2020-07-01 2020-09-30 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2020-07-01 2020-09-30 0000081362 kwr:StockOptionsCompensationExpenseMember 2020-01-01 2020-09-30 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2020-01-01 2020-09-30 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2020-01-01 2020-09-30 0000081362 us-gaap:RestrictedStockMember 2021-09-30 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2021-09-30 0000081362 us-gaap:RestrictedStockMember 2021-01-01 2021-09-30 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-09-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2021-07-01 2021-09-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-07-01 2021-09-30 0000081362 us-gaap:CustomerListsMember 2020-12-31 0000081362 us-gaap:OtherIntangibleAssetsMember 2020-12-31 0000081362 us-gaap:CustomerListsMember 2021-09-30 0000081362 us-gaap:OtherIntangibleAssetsMember 2021-09-30 0000081362 us-gaap:FairValueInputsLevel1Member 2021-09-30 0000081362 us-gaap:FairValueInputsLevel2Member 2021-09-30 0000081362 us-gaap:FairValueInputsLevel3Member 2021-09-30 0000081362 us-gaap:FairValueInputsLevel1Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member 2020-12-31 0000081362 srt:MinimumMember kwr:AcpMember 2021-09-30 0000081362 kwr:AcpMember srt:MaximumMember 2021-09-30 0000081362 kwr:SbDeckingMember 2021-09-30 0000081362 us-gaap:CommonStockMember 2020-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000081362 us-gaap:RetainedEarningsMember 2020-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2020-12-31 0000081362 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0000081362 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-09-30 0000081362 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-09-30 0000081362 us-gaap:CommonStockMember 2021-09-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0000081362 us-gaap:RetainedEarningsMember 2021-09-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0000081362 us-gaap:NoncontrollingInterestMember 2021-09-30 0000081362 us-gaap:CommonStockMember 2019-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000081362 us-gaap:RetainedEarningsMember 2019-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2019-12-31 0000081362 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0000081362 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0000081362 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-09-30 0000081362 us-gaap:CommonStockMember 2020-09-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0000081362 us-gaap:RetainedEarningsMember 2020-09-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0000081362 us-gaap:NoncontrollingInterestMember 2020-09-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-09-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-09-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-09-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-09-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-09-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-07-01 2020-09-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-07-01 2020-09-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-07-01 2020-09-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-09-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-09-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-01-01 2021-09-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-09-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-09-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-09-30 0000081362 us-gaap:OtherNoncurrentLiabilitiesMember 2020-12-31 0000081362 us-gaap:OtherNoncurrentLiabilitiesMember 2021-09-30 0000081362 us-gaap:InterestExpenseMember 2020-07-01 2020-09-30 0000081362 us-gaap:InterestExpenseMember 2021-01-01 2021-09-30 0000081362 us-gaap:InterestExpenseMember 2020-01-01 2020-09-30 0000081362 2020-01-01 2020-12-31 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2020-07-01 2020-09-30 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2020-01-01 2020-09-30 0000081362 kwr:HoughtonCombinationMember 2021-09-30 0000081362 kwr:HoughtonCombinationMember 2020-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-09-30 0000081362 2021-07-01 2021-09-30 0000081362 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-09-30 0000081362 us-gaap:EmployeeStockOptionMember 2021-09-30 0000081362 srt:MaximumMember kwr:HoughtonEnvironmentalMattersMember 2021-09-30 0000081362 srt:MinimumMember kwr:HoughtonEnvironmentalMattersMember 2021-09-30 0000081362 kwr:DefinedContributionPlanMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember kwr:MetalsMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember us-gaap:EMEAMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AsiaPacificMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember kwr:MetalworkingMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember kwr:MetalworkingMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember kwr:MetalworkingMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember srt:AmericasMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember us-gaap:EMEAMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember srt:AsiaPacificMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember kwr:MetalsMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember us-gaap:EMEAMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AsiaPacificMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember kwr:MetalworkingMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember kwr:MetalworkingMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember kwr:MetalworkingMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember srt:AmericasMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember us-gaap:EMEAMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember srt:AsiaPacificMember 2020-07-01 2020-09-30 0000081362 srt:ScenarioPreviouslyReportedMember kwr:CoralChemicalCompanyMember 2020-12-22 0000081362 kwr:CoralChemicalCompanyMember srt:RestatementAdjustmentMember 2020-12-22 0000081362 kwr:CoralChemicalCompanyMember 2020-12-22 0000081362 kwr:CoralChemicalCompanyMember srt:RestatementAdjustmentMember 2020-12-22 2020-12-22 0000081362 srt:ScenarioPreviouslyReportedMember kwr:CoralChemicalCompanyMember 2020-12-22 2020-12-22 0000081362 kwr:CoralChemicalCompanyMember 2020-12-22 2020-12-22 0000081362 kwr:TinplatingsolutionsMember 2021-02-01 2021-02-28 0000081362 kwr:TinplatingsolutionsMember 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:CustomerListsMember 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:PatentedTechnologyMember 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:TrademarksMember 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:CustomerListsMember 2021-02-01 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:PatentedTechnologyMember 2021-02-01 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:TrademarksMember 2021-02-01 2021-02-28 0000081362 kwr:TinplatingsolutionsMember 2021-01-01 2021-09-30 0000081362 kwr:CoralChemicalCompanyMember 2020-01-01 2020-12-31 0000081362 kwr:CoralChemicalCompanyMember 2021-01-01 2021-09-30 0000081362 kwr:TelnordicMember 2020-05-01 2020-05-31 0000081362 kwr:TelnordicMember 2020-07-01 2020-09-30 0000081362 kwr:TelnordicMember 2020-09-30 0000081362 kwr:TelnordicMember 2021-01-01 2021-09-30 0000081362 kwr:SouthAfricaEquityAffiliateMember 2020-03-31 0000081362 kwr:SouthAfricaEquityAffiliateMember 2020-03-01 2020-03-31 0000081362 kwr:NormanHayMember 2019-10-01 2019-10-31 0000081362 kwr:NormanHayMember 2020-01-01 2020-03-31 0000081362 srt:AmericasMember us-gaap:IntersegmentEliminationMember 2021-07-01 2021-09-30 0000081362 srt:AmericasMember us-gaap:IntersegmentEliminationMember 2021-01-01 2021-09-30 0000081362 us-gaap:EMEAMember us-gaap:IntersegmentEliminationMember 2021-07-01 2021-09-30 0000081362 us-gaap:EMEAMember us-gaap:IntersegmentEliminationMember 2021-01-01 2021-09-30 0000081362 srt:AsiaPacificMember us-gaap:IntersegmentEliminationMember 2021-07-01 2021-09-30 0000081362 srt:AsiaPacificMember us-gaap:IntersegmentEliminationMember 2021-01-01 2021-09-30 0000081362 kwr:GlobalSpecialtyBusinessesMember us-gaap:IntersegmentEliminationMember 2021-07-01 2021-09-30 0000081362 kwr:GlobalSpecialtyBusinessesMember us-gaap:IntersegmentEliminationMember 2021-01-01 2021-09-30 0000081362 srt:AmericasMember us-gaap:IntersegmentEliminationMember 2020-07-01 2020-09-30 0000081362 srt:AmericasMember us-gaap:IntersegmentEliminationMember 2020-01-01 2020-09-30 0000081362 us-gaap:EMEAMember us-gaap:IntersegmentEliminationMember 2020-07-01 2020-09-30 0000081362 us-gaap:EMEAMember us-gaap:IntersegmentEliminationMember 2020-01-01 2020-09-30 0000081362 srt:AsiaPacificMember us-gaap:IntersegmentEliminationMember 2020-07-01 2020-09-30 0000081362 srt:AsiaPacificMember us-gaap:IntersegmentEliminationMember 2020-01-01 2020-09-30 0000081362 kwr:GlobalSpecialtyBusinessesMember us-gaap:IntersegmentEliminationMember 2020-07-01 2020-09-30 0000081362 kwr:GlobalSpecialtyBusinessesMember us-gaap:IntersegmentEliminationMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember kwr:MetalsMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember us-gaap:EMEAMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AsiaPacificMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember kwr:MetalworkingMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember kwr:MetalworkingMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember kwr:MetalworkingMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2021-07-01 2021-09-30 0000081362 srt:AmericasMember 2021-07-01 2021-09-30 0000081362 us-gaap:EMEAMember 2021-07-01 2021-09-30 0000081362 srt:AsiaPacificMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2020-07-01 2020-09-30 0000081362 srt:AmericasMember 2020-07-01 2020-09-30 0000081362 us-gaap:EMEAMember 2020-07-01 2020-09-30 0000081362 srt:AsiaPacificMember 2020-07-01 2020-09-30 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2020-07-01 2020-09-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2020-07-01 2020-09-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2020-07-01 2020-09-30 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember 2020-07-01 2020-09-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2020-07-01 2020-09-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2020-07-01 2020-09-30 0000081362 us-gaap:TransferredAtPointInTimeMember 2020-07-01 2020-09-30 0000081362 us-gaap:TransferredOverTimeMember 2020-07-01 2020-09-30 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2021-07-01 2021-09-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2021-07-01 2021-09-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2021-07-01 2021-09-30 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember 2021-07-01 2021-09-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2021-07-01 2021-09-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember srt:AmericasMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember us-gaap:EMEAMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember srt:AsiaPacificMember 2021-01-01 2021-09-30 0000081362 srt:AmericasMember 2021-01-01 2021-09-30 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-09-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-09-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-09-30 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-09-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-09-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-09-30 0000081362 us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-09-30 0000081362 us-gaap:TransferredOverTimeMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember kwr:MetalsMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember us-gaap:EMEAMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AsiaPacificMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember kwr:MetalworkingMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember kwr:MetalworkingMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember kwr:MetalworkingMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember srt:AmericasMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember us-gaap:EMEAMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember srt:AsiaPacificMember 2020-01-01 2020-09-30 0000081362 srt:AmericasMember 2020-01-01 2020-09-30 0000081362 us-gaap:EMEAMember 2020-01-01 2020-09-30 0000081362 srt:AsiaPacificMember 2020-01-01 2020-09-30 0000081362 kwr:QhProgramMember 2020-12-31 0000081362 kwr:QhProgramMember 2021-01-01 2021-09-30 0000081362 kwr:QhProgramMember 2021-09-30 0000081362 kwr:StockOptionsCompensationExpenseMember 2021-07-01 2021-09-30 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2021-07-01 2021-09-30 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2021-07-01 2021-09-30 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2021-07-01 2021-09-30 0000081362 us-gaap:PerformanceSharesMember 2021-07-01 2021-09-30 0000081362 us-gaap:PerformanceSharesMember 2020-07-01 2020-09-30 0000081362 us-gaap:PerformanceSharesMember 2021-01-01 2021-09-30 0000081362 us-gaap:PerformanceSharesMember 2020-01-01 2020-09-30 0000081362 us-gaap:StockCompensationPlanMember 2021-07-01 2021-09-30 0000081362 us-gaap:StockCompensationPlanMember 2020-07-01 2020-09-30 0000081362 us-gaap:StockCompensationPlanMember 2021-01-01 2021-09-30 0000081362 us-gaap:StockCompensationPlanMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-09-30 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember 2021-09-30 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember 2020-12-31 0000081362 us-gaap:LineOfCreditMember 2021-09-30 0000081362 us-gaap:DomesticLineOfCreditMember 2021-09-30 0000081362 us-gaap:ForeignLineOfCreditMember 2021-09-30 0000081362 kwr:IndustrialDevelopmentBondsMember 2021-09-30 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2021-09-30 0000081362 us-gaap:LineOfCreditMember 2020-12-31 0000081362 us-gaap:DomesticLineOfCreditMember 2020-12-31 0000081362 us-gaap:ForeignLineOfCreditMember 2020-12-31 0000081362 kwr:IndustrialDevelopmentBondsMember 2020-12-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2020-12-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2021-01-01 2021-09-30 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2020-01-01 2020-12-31 0000081362 us-gaap:RevolvingCreditFacilityMember 2021-09-30 0000081362 us-gaap:RevolvingCreditFacilityMember srt:MaximumMember 2021-01-01 2021-09-30 0000081362 us-gaap:RevolvingCreditFacilityMember srt:MinimumMember 2021-01-01 2021-09-30 0000081362 srt:MinimumMember 2021-09-30 0000081362 srt:MaximumMember 2021-09-30 0000081362 kwr:TermLoanMember 2021-01-01 2021-09-30 0000081362 kwr:TermLoanMember 2021-09-30 0000081362 kwr:TermLoanMember 2019-11-30 0000081362 us-gaap:OtherAssetsMember 2021-09-30 0000081362 us-gaap:OtherAssetsMember 2020-12-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2021-09-30 0000081362 us-gaap:CorporateBondSecuritiesMember 2020-12-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2021-01-01 2021-09-30 0000081362 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0000081362 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000081362 us-gaap:NoncontrollingInterestMember 2020-07-01 2020-09-30 0000081362 2020-06-30 0000081362 us-gaap:CommonStockMember 2020-06-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0000081362 us-gaap:RetainedEarningsMember 2020-06-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0000081362 us-gaap:NoncontrollingInterestMember 2020-06-30 0000081362 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0000081362 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0000081362 us-gaap:NoncontrollingInterestMember 2021-07-01 2021-09-30 0000081362 us-gaap:CommonStockMember 2021-06-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000081362 us-gaap:RetainedEarningsMember 2021-06-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0000081362 us-gaap:NoncontrollingInterestMember 2021-06-30 0000081362 2021-06-30 0000081362 us-gaap:CommonStockMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 us-gaap:NoncontrollingInterestMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 us-gaap:CommonStockMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 us-gaap:NoncontrollingInterestMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-01-01 2021-09-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-09-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-01-01 2020-09-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-09-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-06-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-06-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-06-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-07-01 2021-09-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-07-01 2021-09-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-07-01 2021-09-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-06-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-06-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-06-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-06-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-07-01 2021-09-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-06-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-07-01 2020-09-30 0000081362 2020-01-01 2020-03-31 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2021-07-01 2021-09-30 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2021-01-01 2021-09-30 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2020-07-01 2020-09-30 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2020-01-01 2020-09-30 0000081362 kwr:DefinedbenefitplansettlementMember 2020-07-01 2020-09-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2021-09-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-09-30 0000081362 country:IT 2021-01-01 2021-09-30 0000081362 country:IT us-gaap:ForeignCountryMember kwr:HoughtonMember 2021-09-30 0000081362 country:DE 2021-09-30 0000081362 us-gaap:ForeignCountryMember kwr:NetherlandsAndSpainMember 2021-09-30 0000081362 country:IT us-gaap:ForeignCountryMember 2021-09-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2020-07-01 2020-09-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-07-01 2020-09-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-09-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-09-30 0000081362 us-gaap:InterestExpenseMember 2021-07-01 2021-09-30 0000081362 kwr:BrazilianIndirectTaxesMember 2021-01-01 2021-09-30 0000081362 us-gaap:InterestRateSwapMember 2019-11-30 0000081362 us-gaap:InterestRateSwapMember 2021-01-01 2021-09-30 0000081362 srt:ScenarioForecastMember 2021-12-31 0000081362 srt:MaximumMember kwr:FacilitiesVehiclesAndMachineryAndEquipmentMember 2021-09-30 0000081362 srt:MaximumMember us-gaap:LandMember 2021-09-30 0000081362 srt:MinimumMember country:IT us-gaap:ForeignCountryMember kwr:HoughtonMember 2021-01-01 2021-09-30 0000081362 srt:MaximumMember country:IT us-gaap:ForeignCountryMember kwr:HoughtonMember 2021-01-01 2021-09-30 0000081362 srt:MinimumMember us-gaap:ForeignCountryMember kwr:HoughtonMember country:DE 2021-01-01 2021-09-30 0000081362 srt:MaximumMember us-gaap:ForeignCountryMember kwr:HoughtonMember country:DE 2021-01-01 2021-09-30 0000081362 srt:SubsidiariesMember country:AR 2020-07-01 2020-09-30 0000081362 srt:SubsidiariesMember country:AR 2020-01-01 2020-09-30 0000081362 kwr:GlobalSpecialtyBusinessesMember kwr:ChemicalMaskantsProductLineMember 2021-01-01 2021-09-30 0000081362 kwr:HoughtonMember country:DE 2021-09-30 0000081362 srt:SubsidiariesMember country:AR us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2021-07-01 2021-09-30 0000081362 srt:SubsidiariesMember country:AR us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-09-30 0000081362 us-gaap:PerformanceSharesMember 2021-09-30 0000081362 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember kwr:LargestCustomerMember 2020-01-01 2020-12-31 0000081362 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember kwr:TopFiveMember 2020-01-01 2020-12-31 0000081362 srt:SubsidiariesMember country:AR us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2021-01-01 2021-09-30 0000081362 srt:SubsidiariesMember country:AR us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2020-01-01 2020-09-30 0000081362 srt:SubsidiariesMember country:AR us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-09-30 0000081362 srt:SubsidiariesMember country:AR us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2021-07-01 2021-09-30 0000081362 srt:SubsidiariesMember country:AR us-gaap:GeographicConcentrationRiskMember us-gaap:SalesRevenueNetMember 2020-07-01 2020-09-30 0000081362 srt:SubsidiariesMember country:AR us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2020-07-01 2020-09-30 0000081362 kwr:DefinedContributionPlanMember 2021-07-01 2021-09-30 0000081362 kwr:HoughtonCombinationMember 2021-01-01 2021-03-31 0000081362 kwr:HoughtonCombinationMember 2020-12-31 0000081362 kwr:HoughtonCombinationMember 2021-09-30 0000081362 srt:MaximumMember us-gaap:ForeignCountryMember country:IT 2021-01-01 2021-09-30 0000081362 srt:MinimumMember us-gaap:ForeignCountryMember country:IT 2021-01-01 2021-09-30 0000081362 us-gaap:ForeignCountryMember country:IT 2021-01-01 2021-09-30 0000081362 us-gaap:ForeignCountryMember country:BR 2021-01-01 2021-09-30 0000081362 us-gaap:ForeignCountryMember country:NL 2021-01-01 2021-09-30 0000081362 us-gaap:ForeignCountryMember country:CN 2021-01-01 2021-09-30 0000081362 us-gaap:ForeignCountryMember country:MX 2021-01-01 2021-09-30 0000081362 us-gaap:ForeignCountryMember country:GB 2021-01-01 2021-09-30 0000081362 country:CA us-gaap:StateAndLocalJurisdictionMember 2021-01-01 2021-09-30 0000081362 us-gaap:InternalRevenueServiceIRSMember 2021-01-01 2021-09-30 0000081362 us-gaap:StateAndLocalJurisdictionMember 2021-01-01 2021-09-30 0000081362 us-gaap:ForeignCountryMember country:IN 2021-01-01 2021-09-30 0000081362 kwr:DefinedContributionPlanMember 2020-07-01 2020-09-30 0000081362 kwr:DefinedContributionPlanMember 2020-01-01 2020-09-30 0000081362 kwr:ForeignconsumptiontaxMember 2021-07-01 2021-09-30 0000081362 kwr:GlobalSpecialtyBusinessesMember kwr:GrindaixGmbhMember 2021-09-01 2021-09-30 0000081362 kwr:GlobalSpecialtyBusinessesMember kwr:GrindaixGmbhMember 2021-02-28 0000081362 kwr:GlobalSpecialtyBusinessesMember kwr:GrindaixGmbhMember 2021-02-01 2021-02-28 0000081362 us-gaap:InsuranceClaimsMember 2021-09-30 0000081362 us-gaap:InsuranceClaimsMember 2021-01-01 2021-09-30 0000081362 us-gaap:InterestRateSwapMember 2020-01-01 2020-12-31 0000081362 us-gaap:ErrorCorrectionOtherMember 2020-07-01 2020-09-30 0000081362 us-gaap:ErrorCorrectionOtherMember 2020-01-01 2020-09-30 0000081362 us-gaap:ErrorCorrectionOtherMember 2020-01-01 2020-03-31 0000081362 us-gaap:ErrorCorrectionOtherMember 2020-04-01 2020-06-30 0000081362 us-gaap:TransferredAtPointInTimeMember 2021-07-01 2021-09-30 0000081362 us-gaap:TransferredOverTimeMember 2021-07-01 2021-09-30 0000081362 us-gaap:SubsequentEventMember kwr:TwentyTwentyOneAcquisitionMember 2021-11-01 2021-11-30 0000081362 us-gaap:SubsequentEventMember kwr:TwentyTwentyOneAcquisitionMember 2021-11-30 0000081362 kwr:DefinedbenefitplansettlementMember 2020-01-01 2020-09-30 0000081362 srt:SubsidiariesMember country:AR 2021-07-01 2021-09-30 0000081362 srt:SubsidiariesMember us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-09-30 iso4217:BRL iso4217:DKK iso4217:EUR iso4217:GBP iso4217:USD iso4217:ZAR xbrli:pure xbrli:shares iso4217:USD xbrli:shares dummy:People dummy:Segments dummy:Countries
 
 
 
 
 
 
 
 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
 
FORM
10-Q
 
 
☒
QUARTERLY
 
REPORT PURSUANT TO SECTION 13
 
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
September 30, 2021
OR
 
☐
TRANSITION REPORT PURSUANT TO
 
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
 
OF 1934
For the transition period from
 
to
 
Commission file number
001-12019
QUAKER CHEMICAL CORPORATION
(Exact name of Registrant as specified in its charter)
 
 
Pennsylvania
 
23-0993790
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
901 E. Hector Street
,
Conshohocken
,
Pennsylvania
 
19428 – 2380
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code:
610
-
832-4000
Not Applicable
Former name, former address and former fiscal year,
 
if changed since last report.
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $1 par value
KWR
New York Stock Exchange
Indicate by check mark whether the Registrant (1) has filed
 
all reports required to be filed by Section 13 or 15(d)
 
of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant
 
was required to file such reports), and (2) has been subject
 
to such filing requirements for the past 90
days.
 
Yes
 
☒
 
No
 
☐
 
Indicate by check mark whether the Registrant has submitted
 
electronically, every Interactive Data File required to be submitted pursuant to Rule
 
405 of Regulation S-T
(§232.405 of this chapter) during the preceding 12 months (or for
 
such shorter period that the registrant was required
 
to submit such files) .
 
Yes
 
☒
 
No
 
☐
 
Indicate by check mark whether the Registrant is a large accelerated
 
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging
growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”,
 
and “emerging growth company” in Rule 12b-2 of
the Exchange Act.
Large accelerated filer
 
☒
Accelerated filer
 
☐
 
Non-accelerated filer
 
☐
 
Smaller reporting company
☐
Emerging growth company
 
☐
 
If an emerging growth company, indicate by check mark if the Registrant has elected not to
 
use the extended transition period for complying with any new
 
or revised
financial accounting standards provided pursuant to Section 13(a)
 
of the Exchange Act.
 
☐
Indicate by check mark whether the Registrant is a shell
 
company (as defined in Rule 12b-2 of the Exchange Act).
 
Yes
 
☐
 
No
 
☒
Indicate the number of shares outstanding of each of the
 
issuer’s classes of common stock, as of the latest practicable date.
Number of Shares of Common Stock
Outstanding on October 31, 2021
 
17,894,480
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2
PART
 
I
FINANCIAL INFORMATION
Item 1.
 
Financial Statements (Unaudited).
Quaker Chemical Corporation
Condensed Consolidated Statements of Operations
(Dollars in thousands, except per share data)
Unaudited
Three Months Ended
Nine Months Ended
September 30,
 
September 30,
 
2021
2020
2021
2020
Net sales
$
449,072
$
367,224
$
1,314,117
$
1,031,825
Cost of goods sold (
excluding amortization expense - See Note 14
)
 
303,941
 
227,032
 
858,341
 
660,396
Gross profit
 
145,131
 
140,192
 
455,776
 
371,429
Selling, general and administrative expenses
 
104,215
 
97,037
 
317,204
 
282,405
Indefinite-lived intangible asset impairment
—
—
—
38,000
Restructuring and related charges
(880)
1,383
593
3,585
Combination, integration and other acquisition-related expenses
5,786
6,913
18,259
22,786
Operating income
 
36,010
34,859
 
119,720
 
24,653
Other income (expense), net
 
647
 
(239)
 
19,344
 
(22,407)
Interest expense, net
(5,637)
(6,837)
(16,725)
(22,109)
Income (loss) before taxes and equity in net income of
associated companies
 
31,020
 
27,783
 
122,339
 
(19,863)
Taxes on income (loss)
 
before equity in net income of associated
companies
 
795
 
2,245
 
26,702
 
(7,603)
Income (loss) before equity in net income of associated
companies
 
30,225
 
25,538
 
95,637
 
(12,260)
Equity in net income of associated companies
 
848
 
1,804
 
7,668
 
3,536
Net income (loss)
31,073
27,342
103,305
(8,724)
Less: Net income attributable to noncontrolling interest
15
38
62
88
Net income (loss) attributable to Quaker Chemical Corporation
$
31,058
$
27,304
$
103,243
$
(8,812)
Per share data:
 
 
 
 
Net income (loss) attributable to Quaker Chemical Corporation
common shareholders – basic
$
1.74
$
1.53
$
5.78
$
(0.50)
Net income (loss) attributable to Quaker Chemical Corporation
 
common shareholders – diluted
$
1.73
$
1.53
$
5.76
$
(0.50)
Dividends declared
$
0.415
$
0.395
$
1.205
$
1.165
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3
Quaker Chemical Corporation
Condensed Consolidated Statements of Comprehensive Income (Loss)
 
(Dollars in thousands)
Unaudited
Three Months Ended
Nine Months Ended
September 30,
 
September 30,
 
2021
2020
2021
2020
Net income (loss)
 
$
31,073
$
27,342
$
103,305
$
(8,724)
Other comprehensive (loss) income, net of tax
Currency translation adjustments
(19,905)
33,618
(29,201)
(10,582)
Defined benefit retirement plans
904
(257)
2,593
16,913
Current period change in fair value of derivatives
436
354
1,450
(3,738)
Unrealized (loss) gain on available-for-sale securities
(215)
556
(2,961)
453
Other comprehensive (loss) income
(18,780)
34,271
(28,119)
3,046
Comprehensive income (loss)
12,293
61,613
75,186
(5,678)
Less: Comprehensive (income) loss attributable to
noncontrolling interest
(15)
(56)
(68)
25
Comprehensive income (loss) attributable to Quaker Chemical
Corporation
$
12,278
$
61,557
$
75,118
$
(5,653)
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4
Quaker Chemical Corporation
Condensed Consolidated Balance Sheets
(Dollars in thousands, except par value)
Unaudited
September 30,
December 31,
2021
2020
ASSETS
 
 
 
 
Current assets
 
 
 
 
Cash and cash equivalents
$
141,393
$
181,833
Accounts receivable, net
 
433,631
 
372,974
Inventories
 
 
Raw materials and supplies
 
121,951
 
86,148
Work-in-process
 
and finished goods
 
132,943
 
101,616
Prepaid expenses and other current assets
 
63,278
 
50,156
Total current
 
assets
 
893,196
 
792,727
Property, plant and equipment,
 
at cost
 
423,469
 
423,253
Less accumulated depreciation
 
(232,636)
 
(219,370)
Property, plant and equipment,
 
net
 
190,833
 
203,883
Right of use lease assets
34,314
38,507
Goodwill
 
630,669
 
631,212
Other intangible assets, net
 
1,048,688
 
1,081,358
Investments in associated companies
 
94,110
 
95,785
Deferred tax assets
 
18,409
 
16,566
Other non-current assets
 
31,608
 
31,796
Total assets
$
2,941,827
$
2,891,834
LIABILITIES AND EQUITY
 
 
Current liabilities
 
 
Short-term borrowings and current portion of long-term debt
$
52,611
$
38,967
Accounts and other payables
 
219,601
 
198,872
Accrued compensation
 
40,655
 
43,300
Accrued restructuring
4,050
8,248
Other current liabilities
 
93,042
 
93,573
Total current
 
liabilities
 
409,959
 
382,960
Long-term debt
 
839,275
 
849,068
Long-term lease liabilities
24,599
27,070
Deferred tax liabilities
 
174,405
 
192,763
Other non-current liabilities
 
109,893
 
119,059
Total liabilities
 
1,558,131
 
1,570,920
Commitments and contingencies (Note 19)
Equity
 
 
Common stock $
1
 
par value; authorized
30,000,000
 
shares; issued and
 
 
outstanding 2021 –
17,888,577
 
shares; 2020 –
17,850,616
 
shares
17,889
17,851
Capital in excess of par value
 
914,277
 
905,171
Retained earnings
 
505,635
 
423,940
Accumulated other comprehensive loss
 
(54,723)
 
(26,598)
Total Quaker
 
shareholders’ equity
 
1,383,078
 
1,320,364
Noncontrolling interest
 
618
550
Total equity
1,383,696
1,320,914
Total liabilities and equity
$
2,941,827
$
2,891,834
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5
Quaker Chemical Corporation
Condensed Consolidated Statements of Cash Flows
(Dollars in thousands)
Unaudited
Nine Months Ended
September 30,
2021
2020
Cash flows from operating activities
 
 
 
 
 
Net income (loss)
 
$
103,305
$
(8,724)
Adjustments to reconcile net income (loss) to net cash provided by operating
 
activities:
 
 
Amortization of debt issuance costs
 
3,562
 
3,562
Depreciation and amortization
 
65,440
 
62,818
Equity in undistributed earnings of associated companies, net of dividends
 
(7,563)
 
1,415
Acquisition-related fair value adjustments related to inventory
801
229
Deferred compensation, deferred taxes and other,
 
net
 
(21,865)
 
(30,657)
Share-based compensation
 
8,441
 
17,820
(Gain) loss on disposal of property,
 
plant, equipment and other assets
 
(4,819)
 
105
Insurance settlement realized
 
—
 
(818)
Indefinite-lived intangible asset impairment
—
38,000
Combination and other acquisition-related expenses, net of payments
(1,705)
2,498
Restructuring and related charges
593
3,585
Pension and other postretirement benefits
 
(5,638)
 
16,219
(Decrease) increase in cash from changes in current assets and current
 
 
liabilities, net of acquisitions:
Accounts receivable
 
(68,664)
 
30,225
Inventories
 
(72,962)
 
2,137
Prepaid expenses and other current assets
 
(24,512)
 
(113)
Change in restructuring liabilities
(4,557)
(12,772)
Accounts payable and accrued liabilities
 
32,652
 
(13,481)
 
Net cash provided by operating activities
 
2,509
 
112,048
Cash flows from investing activities
 
 
Investments in property,
 
plant and equipment
 
(12,823)
 
(12,184)
Payments related to acquisitions, net of cash acquired
 
(31,975)
 
(3,132)
Proceeds from disposition of assets
14,744
11
Insurance settlement interest earned
 
—
 
41
 
Net cash used in investing activities
 
(30,054)
 
(15,264)
Cash flows from financing activities
 
 
Payments of term loan debt
 
(28,558)
 
(28,132)
Borrowings (repayments) on revolving credit facilities, net
 
39,143
 
(16,485)
Repayments on other debt, net
(585)
 
(527)
Dividends paid
 
(21,175)
 
(20,520)
Stock options exercised, other
 
704
 
2,385
Purchase of noncontrolling interest in affiliates
—
(1,047)
Distributions to noncontrolling affiliate shareholders
—
(751)
 
Net cash used in financing activities
 
(10,471)
 
(65,077)
 
Effect of foreign exchange rate changes on cash
 
(2,486)
 
(529)
Net (decrease) increase in cash, cash equivalents and restricted cash
 
(40,502)
 
31,178
Cash, cash equivalents and restricted cash at the beginning of the period
 
181,895
 
143,555
Cash, cash equivalents and restricted cash at the end of the period
$
141,393
$
174,733
The accompanying notes are an integral part of these condensed consolidated financial
 
statements.
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
(Dollars in thousands, except per share amounts,
 
unless otherwise stated)
(Unaudited)
6
Note 1 – Basis of Presentation and Description of Business
 
Basis of Presentation
As used in these Notes to Condensed Consolidated Financial Statements of
 
this Quarterly Report on Form 10-Q for the period
ended September 30, 2021 (the “Report”),
 
the terms “Quaker,”
 
“Quaker Houghton,”
 
the “Company,”
 
“we,” and “our” refer to Quaker
Chemical Corporation (doing business as Quaker Houghton), its subsidiaries, and
 
associated companies, unless the context otherwise
requires.
 
As used in these Notes to Condensed Consolidated Financial Statements,
 
the term Legacy Quaker refers to the Company
prior to the closing of its combination with Houghton International, Inc. (“Houghton”)
 
(herein referred to as the “Combination”).
 
The
condensed consolidated financial statements included herein are
 
unaudited and have been prepared in accordance with generally
accepted accounting principles in the United States (“U.S. GAAP”) for interim
 
financial reporting and the United States Securities and
Exchange Commission (“SEC”) regulations.
 
Certain information and footnote disclosures normally included in financial statements
prepared in accordance with U.S. GAAP have been condensed or omitted
 
pursuant to such rules and regulations.
 
In the opinion of
management, the financial statements reflect all adjustments consisting
 
only of normal recurring adjustments which are necessary for a
fair statement of the financial position, results of operations and cash
 
flows for the interim periods.
 
The results for the nine months
ended September 30, 2021 are not necessarily indicative of the results to be expected
 
for the full year.
 
These financial statements
should be read in conjunction with the Company’s
 
Annual Report filed on Form 10-K for the year ended December
 
31, 2020 (the
“2020 Form 10-K”).
 
During the three months ended September 30, 2020, the Company
 
identified and corrected certain immaterial adjustments relating
to the three months ended March 31, 2020 as well as the three and six months
 
ended June 30, 2020.
 
These adjustments related to the
Company’s over-recognition
 
of cost of goods sold (“COGS”) and corresponding under-recognition
 
of inventory, as well as the
associated tax impact of these adjustments, in the Company’s
 
previously issued interim financial statements for the three months
ended March 31, 2020 and the three and six months ended June 30, 2020.
 
These adjustments impact the Company’s
 
Americas
reportable segment.
 
The cumulative amount of reduction to COGS recorded in the three and nine months ended
 
September 30, 2020
was approximately $
1.7
 
million, with approximately $
0.7
 
million related to the three months ended March 31, 2020 and
approximately $
1.0
 
million related to the three months ended June 30, 2020.
Description of Business
The Company was organized in 1918, incorporated as a Pennsylvania
 
business corporation in 1930, and in August 2019
completed the Combination with Houghton to form Quaker Houghton.
 
Quaker Houghton is the global leader in industrial process
fluids.
 
With a presence around the world, including
 
operations in over
25
 
countries, the Company’s customers
 
include thousands of
the world’s most advanced and specialized
 
steel, aluminum, automotive, aerospace, offshore, can,
 
mining, and metalworking
companies.
 
Quaker Houghton develops, produces, and markets a broad range of formulated
 
chemical specialty products and offers
chemical management services (which the Company refers to as “Fluidcare”)
 
for various heavy industrial and manufacturing
applications throughout its
four
 
segments: Americas; Europe, Middle East and Africa (“EMEA”); Asia/Pacific; and
 
Global Specialty
Businesses.
Hyper-inflationary economies
Based on various indices or index compilations being used to monitor inflation
 
in Argentina as well as economic instability,
effective July 1, 2018, Argentina’s
 
economy was considered hyper-inflationary under U.S. GAAP.
 
As of, and for the three and nine
months ended September 30, 2021, the Company's Argentine
 
subsidiaries represented less than
1
% of the Company’s consolidated
total assets and net sales, respectively.
 
During the three and nine months ended September 30, 2021, the Company
 
recorded less than
$
0.1
 
million and $
0.3
 
million, respectively,
 
of remeasurement losses associated with the applicable currency conversions
 
related to
Argentina.
 
Comparatively, during the
 
three and nine months ended September 30, 2020, the Company recorded $
0.2
 
million and $
0.3
million, respectively,
 
of remeasurement losses associated with the applicable currency conversions
 
related to Argentina.
 
These losses
were recorded within foreign exchange losses, net, which is a component
 
of other income (expense), net, in the Company’s
Condensed Consolidated Statements of Operations.
COVID-19
Management continues to monitor the impact that the COVID-19 pandemic
 
is having on the Company, the overall
 
specialty
chemical industry, and
 
the economies and markets in which the Company operates.
 
The full extent of the COVID-19 pandemic
related business and travel restrictions and changes to business and consumer behavior
 
intended to reduce its spread are uncertain as of
the date of the Report as COVID-19 and the responses of governmental
 
authorities continue to evolve globally.
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts, unless otherwise stated)
(Unaudited)
7
Further, management continues to evaluate
 
how COVID-19-related circumstances, such as remote work arrangements, affect
financial reporting processes, internal control over financial reporting,
 
and disclosure controls and procedures.
 
While the
circumstances have presented and are expected to continue to present challenges,
 
at this time, Management does not believe that
COVID-19 has had a material impact on financial reporting processes, internal
 
control over financial reporting, and disclosure
controls and procedures.
The Company cannot reasonably estimate the magnitude of the effects
 
these conditions will have on the Company’s
 
operations in
the future as they are subject to significant uncertainties relating to the ultimate
 
geographic spread of the virus, the incidence and
severity of the symptoms, the duration or resurgences
 
of the outbreak including the impact of new variants, the global availability,
acceptance and efficacy of vaccines, the length of the travel restrictions
 
and business closures imposed by governments of impacted
countries, and the economic response by governments of impacted countries,
 
all of which continue to evolve.
To the extent
 
that the Company’s customers and suppliers continue
 
to be significantly and adversely impacted by COVID-19, this
could reduce the availability,
 
or result in delays, of materials or supplies to or from the Company,
 
which in turn could significantly
interrupt the Company’s business operations.
 
Such impacts could grow and become more significant to the Company’s
 
operations
and the Company’s liquidity
 
or financial position.
 
Therefore, given the continuously evolving global developments with respect to
this pandemic, the Company cannot reasonably estimate the magnitude or
 
the full extent to which COVID-19 may impact the
Company’s results of operations,
 
liquidity or financial position.
Note 2 – Business Acquisitions
2021 Acquisitions
In September 2021, the Company acquired the remaining interest in Grindaix-GmbH
 
(“Grindaix”), a Germany-based, high-tech
provider of coolant control and delivery systems for approximately
2.4
 
million EUR or approximately $
2.9
 
million for its Global
Specialty Businesses reportable segment.
 
Previously, in February 2021,
 
the Company acquired a
38
% ownership interest in Grindaix
for approximately
1.4
 
million EUR or approximately $
1.7
 
million.
 
The Company recorded its initial investment as an equity method
investment within the Condensed Consolidated Financial Statements and
 
accounted for the purchase of the remaining interest as a step
acquisition whereby the Company remeasured the previously held
 
equity method investment to its fair value.
In June 2021, the Company acquired certain assets for its chemical maskants
 
product line in the Global Specialty Businesses
reportable segment for
2.3
 
million EUR or approximately $
2.8
 
million.
 
The Company accounted for the acquisition using the asset
acquisition method under ASC 805,
Business Combinations
.
 
In February 2021, the Company acquired a tin-plating solutions business
 
for the steel end market for approximately $
25
 
million.
 
This acquisition is part of each of the Company’s
 
geographic reportable segments.
 
The Company allocated $
19.6
 
million of the
purchase price to intangible assets, comprised of $
18.3
 
million of customer relationships, to be amortized over
19 years
; $
0.9
 
million
of existing product technology to be amortized over
14 years
; and $
0.4
 
million of a licensed trademark to be amortized over
3 years
.
 
In addition, the Company recorded $
5.0
 
million of goodwill related to expected value not allocated to other acquired
 
assets, all of
which is expected to be tax deductible in various jurisdictions in which we
 
operate.
 
As of September 30, 2021, the allocation of the
purchase price has not been finalized and the
one year
 
measurement period has not ended.
 
Further adjustments may be necessary as a
result of the Company’s on-going
 
assessment of additional information related to the fair value of assets acquired
 
and liabilities
assumed.
The results of operations of the acquired assets and businesses subsequent to the
 
respective acquisition dates are included in the
Condensed Consolidated Statements of Operations as of September 30, 2021.
 
Applicable transaction expenses associated with these
acquisitions are included in Combination, integration and other acquisition
 
-related expenses in the Company’s Condensed
Consolidated Statements of Operations.
 
Certain pro forma and other information is not presented, as the operations of the acquired
assets and businesses are not considered material to the overall operations of the
 
Company for the periods presented.
In November 2021, the Company closed two additional acquisitions that expand
 
its strategic product offerings and increase the
Company’s presence in its core metalworking
 
industries.
 
The total initial purchase price for these acquisitions was approximately $
10
million, subject to post-closing adjustments as well as certain earn-out
 
provisions that could total approximately $
4
 
million.
 
Transaction expenses associated with these
 
acquisitions are included in Combination, integration and other acquisition-related
expenses in the Condensed Consolidated Statements of Operations.
 
The results of operations of these two acquisitions are not
included in the Consolidated Statements of Operations because the date of
 
closing for each was subsequent to September 30, 2021.
 
Preliminary purchase price allocation of assets acquired and liabilities assumed
 
have not been presented as that information is not
available as of the date of these Condensed Consolidated Financial Statements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts, unless otherwise stated)
(Unaudited)
8
Previous Acquisitions
In December 2020, the Company completed its acquisition of Coral Chemical
 
Company (“Coral”), a privately held, U.S.-based
provider of metal finishing fluid solutions.
 
The acquisition provides technical expertise and product solutions for pre-treatment,
metalworking and wastewater treatment applications to the beverage
 
cans and general industrial end markets.
 
The original purchase
price was approximately $
54.1
 
million, subject to routine and customary post-closing adjustments related to working
 
capital and net
indebtedness levels.
 
The Company anticipates finalizing its post-closing adjustments for the Coral acquisition
 
during the fourth
quarter of 2021.
The following table presents the preliminary estimated fair values of
 
Coral net assets acquired:
Measurement
December 22,
December 22,
Period
2020
2020 (1)
Adjustments
(as adjusted)
Cash and cash equivalents
$
958
$
—
$
958
Accounts receivable
8,473
—
8,473
Inventories
4,527
—
4,527
Prepaid expenses and other assets
181
—
181
Property, plant and equipment
10,467
652
11,119
Intangible assets
30,300
(500)
29,800
Goodwill
2,814
270
3,084
Total assets purchased
57,720
422
58,142
Long-term debt including current portions and finance leases
183
556
739
Accounts payable, accrued expenses and other accrued liabilities
3,482
—
3,482
Total liabilities assumed
3,665
556
4,221
Total consideration
 
paid for Coral
54,055
(134)
53,921
Less: estimated purchase price settlement
—
(134)
(134)
Less: cash acquired
958
—
958
Net cash paid for Coral
$
53,097
$
—
$
53,097
(1) As previously disclosed in the Company’s
 
2020 Form 10-K
.
Measurement period adjustments recorded during the first nine months of
 
2021 include certain adjustments related to refining
original estimates for assets and liabilities for certain acquired finance
 
leases, as well the adjustment to reflect the expected settlement
of post-closing working capital and net indebtedness true ups to the original purchase
 
price.
 
As of September 30, 2021, the allocation
of the purchase price for Coral has not been finalized and the
one year
 
measurement period has not ended.
 
Further adjustments may
be necessary as a result of the Company’s
 
on-going assessment of additional information related to the fair value of assets acquired
and liabilities assumed.
 
In May 2020, the Company acquired Tel
 
Nordic ApS (“TEL”), a company that specializes in lubricants and engineering primarily
in high pressure aluminum die casting for its EMEA reportable segment.
 
Consideration paid was in the form of a convertible
promissory note in the amount of
20.0
 
million DKK, or approximately $
2.9
 
million, which was subsequently converted into shares of
the Company’s common stock.
 
An adjustment to the purchase price of approximately
0.4
 
million DKK, or less than $
0.1
 
million, was
made as a result of finalizing a post-closing settlement in the second
 
quarter of 2020.
 
The Company allocated approximately $
2.4
million of the purchase price to intangible assets to be amortized over
17 years
.
 
In addition, the Company recorded approximately
$
0.5
 
million of goodwill, related to expected value not allocated to other acquired
 
assets, none of which will be tax deductible.
 
As of
September 30, 2021, the allocation of the purchase price of TEL was finalized
 
and the
one year
 
measurement period ended.
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts, unless otherwise stated)
(Unaudited)
9
In March 2020, the Company acquired the remaining
49
% ownership interest in one of its South African affiliates, Quaker
Chemical South Africa Limited (“QSA”) for
16.7
 
million ZAR, or approximately $
1.0
 
million, from its joint venture partner PQ
Holdings South Africa.
 
QSA is a part of the Company’s EMEA
 
reportable segment.
 
As this acquisition was a change in an existing
controlling ownership, the Company recorded $
0.7
 
million of excess purchase price over the carrying value of the noncontrolling
interest in Capital in excess of par value.
 
In October 2019, the Company completed its acquisition of the operating
 
divisions of Norman Hay plc (“Norman Hay”), a private
U.K. company that provides specialty chemicals, operating equipment, and
 
services to industrial end markets.
 
The original purchase
price was
80.0
 
million GBP,
 
on a cash-free and debt-free basis, subject to routine and customary post-closing
 
adjustments related to
working capital and net indebtedness levels.
 
The Company finalized its post-closing adjustments for the
 
Norman Hay acquisition and
paid approximately
2.5
 
million GBP during the first quarter of 2020 to settle such adjustments.
 
Note 3 – Recently Issued Accounting Standards
 
Recently Issued Accounting Standards
 
Adopted
The Financial Accounting Standards Board (“FASB”)
 
issued Account Standards Update (“ASU”)
ASU 2019-12
, Income Taxes
(Topic
 
740): Simplifying the Accounting for Income Taxes
 
in December 2019 to simplify the accounting for income taxes.
 
The
guidance within this accounting standard update removes
 
certain exceptions, including the exception to the incremental approach for
certain intra-period tax allocations, to the requirement to recognize
 
or not recognize certain deferred tax liabilities for equity method
investments and foreign subsidiaries, and to the general methodology for
 
calculating income taxes in an interim period when a year-to-
date loss exceeds the anticipated loss for the year.
 
Further, the guidance simplifies the accounting related
 
to franchise taxes, the step
up in tax basis for goodwill, current and deferred tax expense, and codification
 
improvements for income taxes related to employee
stock ownership plans.
 
The guidance is effective for annual and interim periods beginning
 
after December 15, 2020.
 
The Company
adopted this standard on a prospective basis, effective January
 
1, 2021.
 
There was no cumulative effect of adoption recorded within
retained earnings on January 1, 2021.
The FASB issued ASU 2020
 
-04,
Reference Rate Reform (Topic
 
848): Facilitation of the Effects of Reference Rate Reform
 
on
Financial Reporting
 
in March 2020.
 
The FASB subsequently
 
issued ASU 2021-01,
Reference Rate Reform (Topic
 
848): Scope
 
in
January 2021 which clarified the guidance but did not materially change
 
the guidance or its applicability to the Company.
 
The
amendments provide temporary optional expedients and exceptions
 
for applying U.S. GAAP to contract modifications, hedging
relationships and other transactions to ease the potential accounting
 
and financial reporting burden associated with transitioning away
from reference rates that are expected to be discontinued, including
 
the London Interbank Offered Rate (“LIBOR”).
 
ASU 2020-04 is
effective for the Company as of March 12, 2020 and generally can
 
be applied through December 31, 2022.
 
As of September 30, 2021,
the expedients provided in ASU 2020-04 do not presently impact
 
the Company; however, the Company will continue
 
to monitor for
potential impacts on its consolidated financial statements.
Note 4 – Business Segments
The Company’s operating
 
segments, which are consistent with its reportable segments, reflect the structure of the
 
Company’s
internal organization, the method by which the Company’s
 
resources are allocated and the manner by which the chief operating
decision maker assesses the Company’s
 
performance.
 
The Company has
four
 
reportable segments: (i) Americas; (ii) EMEA; (iii)
Asia/Pacific; and (iv) Global Specialty Businesses.
 
The three geographic segments are composed of the net sales and operations in
each respective region, excluding net sales and operations managed globally
 
by the Global Specialty Businesses segment, which
includes the Company’s container,
 
metal finishing, mining, offshore, specialty coatings, specialty grease
 
and Norman Hay businesses.
Segment operating earnings for each of the Company’s
 
reportable segments are comprised of the segment’s
 
net sales less directly
related COGS and selling, general and administrative expenses (“SG&A”).
 
Operating expenses not directly attributable to the net
sales of each respective segment, such as certain corporate and administrative costs, Combination,
 
integration and other acquisition-
related expenses, and Restructuring and related charges,
 
are not included in segment operating earnings.
 
Other items not specifically
identified with the Company’s reportable
 
segments include interest expense, net and other income (expense), net.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts, unless otherwise stated)
(Unaudited)
10
The following table presents information about the performance of the Company’s
 
reportable segments for the three and nine
months ended September 30, 2021 and 2020.
Three Months Ended
Nine Months Ended
September 30,
September 30,
2021
2020
2021
2020
Net sales
 
 
 
 
 
 
 
 
 
 
Americas
$
150,799
$
119,540
$
425,343
$
330,012
EMEA
 
122,241
 
94,005
 
365,491
 
276,546
Asia/Pacific
 
98,659
 
84,877
 
286,924
 
226,850
Global Specialty Businesses
 
77,373
 
68,802
 
236,359
 
198,417
Total net sales
$
449,072
$
367,224
$
1,314,117
$
1,031,825
Segment operating earnings
Americas
$
31,273
$
31,099
$
97,155
$
70,590
EMEA
20,153
17,439
68,802
46,269
Asia/Pacific
23,285
27,304
73,990
66,106
Global Specialty Businesses
 
20,663
 
21,161
 
69,041
 
58,114
Total segment operating
 
earnings
 
95,374
 
97,003
 
308,988
 
241,079
Combination, integration and other acquisition-related expenses
(5,786)
(6,913)
(18,259)
(22,786)
Restructuring and related charges
880
(1,383)
(593)
(3,585)
Fair value step up of acquired inventory sold
 
—
—
(801)
(226)
Indefinite-lived intangible asset impairment
—
—
—
(38,000)
Non-operating and administrative expenses
(38,691)
(39,786)
(122,760)
(110,282)
Depreciation
 
of corporate assets and amortization
 
(15,767)
 
(14,062)
 
(46,855)
 
(41,547)
Operating income
36,010
34,859
119,720
24,653
Other income (expense), net
647
(239)
19,344
(22,407)
Interest expense, net
 
(5,637)
 
(6,837)
 
(16,725)
 
(22,109)
Income (loss) before taxes and equity in net income of
associated companies
$
31,020
$
27,783
$
122,339
$
(19,863)
Inter-segment revenues for the three and nine months ended September
 
30, 2021 were $
3.6
 
million and $
9.3
 
million for Americas,
$
6.8
 
million and $
21.9
 
million for EMEA, $
0.8
 
million and $
1.3
 
million for Asia/Pacific, and $
1.8
 
million and $
5.9
 
million for Global
Specialty Businesses, respectively.
 
Inter-segment revenues for the three and nine months ended
 
September 30, 2020 were $
1.7
million and $
7.0
 
million for Americas, $
5.3
 
million and $
16.1
 
million for EMEA, $
0.2
 
million and $
0.5
 
million for Asia/Pacific, and
$
1.1
 
million and $
3.4
 
million for Global Specialty Businesses, respectively.
 
However, all inter-segment
 
transactions have been
eliminated from each reportable operating segment’s
 
net sales and earnings for all periods presented in the above tables.
Note 5 – Net Sales and Revenue Recognition
Business Description
The Company develops, produces, and markets a broad range of formulated
 
chemical specialty products and offers chemical
management services (“Fluidcare”) for various heavy industrial and
 
manufacturing applications throughout its four segments.
 
A
significant portion of the Company’s
 
revenues are realized from the sale of process fluids and services made directly
 
to manufacturers
through its own employees and its Fluidcare programs, with the balance
 
being handled through distributors and agents.
As part of the Company’s Fluidcare
 
business, certain third-party product sales to customers are managed by
 
the Company.
 
Where
the Company acts as a principal, revenues are recognized on a gross reporting
 
basis at the selling price negotiated with its customers.
Where the Company acts as an agent, revenue is recognized on a net reporting
 
basis at the amount of the administrative fee earned by
the Company for ordering the goods.
 
The Company transferred third-party products under arrangements recognized
 
on a net reporting
basis of $
18.9
 
million and $
53.4
 
million for the three and nine months ended September 30, 2021, respectively,
 
and $
11.1
 
million and
$
29.9
 
million for the three and nine months ended September 30, 2020, respectively.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts, unless otherwise stated)
(Unaudited)
11
As previously disclosed in the Company’s
 
2020 Form 10-K, during 2020, the Company’s
 
five largest customers (each composed
of multiple subsidiaries or divisions with semiautonomous purchasing
 
authority) accounted for approximately
10
% of consolidated net
sales, with its largest customer accounting for approximately
3
% of consolidated net sales.
Revenue Recognition Model
The Company applies the five-step model in the FASB’s
 
guidance, which requires the Company to: (i) identify the
 
contract with a
customer; (ii) identify the performance obligations in the contract; (iii)
 
determine the transaction price; (iv) allocate the transaction
price to the performance obligations in the contract; and (v) recognize
 
revenue when, or as, the Company satisfies a performance
obligation.
 
Refer to the Company’s 2020 Form 10-K
 
for additional information on the Company’s
 
revenue recognition policies,
including its practical expedients and accounting policy elections.
 
Allowance for Doubtful Accounts
As previously disclosed in the Company’s
 
2020 Form 10-K, during 2020, the Company adopted, as required, an accounting
standard update related to the accounting and disclosure of credit losses effective
 
January 1, 2020.
 
The Company recognizes an
allowance for credit losses, which represents the portion of its trade accounts
 
receivable that the Company does not expect to collect
over the contractual life, considering past events and reasonable and
 
supportable forecasts of future economic conditions.
 
The
Company’s allowance for
 
credit losses on its trade accounts receivables is based on specific collectability facts and circumstances
 
for
each outstanding receivable and customer,
 
the aging of outstanding receivables, and the associated collection risk the
 
Company
estimates for certain past due aging categories, and also, the general risk
 
to all outstanding accounts receivable based on historical
amounts determined to be uncollectible.
 
The Company does not have any off-balance-sheet credit exposure
 
related to its customers.
Contract Assets and Liabilities
The Company recognizes a contract asset or receivable on its Condensed
 
Consolidated Balance Sheet when the Company
performs a service or transfers a good in advance of receiving consideration.
 
A receivable is the Company’s right to
 
consideration that
is unconditional and only the passage of time is required before payment
 
of that consideration is due.
 
A contract asset is the
Company’s right to consideration
 
in exchange for goods or services that the Company has transferred to a customer.
 
The Company
had no material contract assets recorded on its Condensed Consolidated
 
Balance Sheets as of September 30, 2021 or December 31,
2020.
A contract liability is recognized when the Company receives consideration,
 
or if it has the unconditional right to receive
consideration, in advance of performance.
 
A contract liability is the Company’s
 
obligation to transfer goods or services to a customer
for which the Company has received consideration, or a specified amount
 
of consideration is due, from the customer.
 
The Company’s
contract liabilities primarily represent deferred revenue recorded
 
for customer payments received by the Company prior to the
Company satisfying the associated performance obligation.
 
Deferred revenues are presented within other current liabilities in the
Company’s Condensed Consolidated
 
Balance Sheets.
 
The Company had approximately $
4.4
 
million and $
4.0
 
million of deferred
revenue as of September 30, 2021 and December 31, 2020, respectively.
 
For the nine months ended September 30, 2021, the
Company satisfied all of the associated performance obligations
 
and recognized into revenue the advance payments received and
recorded as of December 31, 2020.
Disaggregated Revenue
The following tables disaggregate the Company’s
 
net sales by segment, geographic region, customer industry,
 
and timing of
revenue recognized for the three and nine months ended September 30, 2021
 
and 2020.
Three Months Ended September 30, 2021
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
56,954
$
38,483
$
53,994
$
149,431
Metalworking and other
93,845
83,758
44,665
222,268
150,799
122,241
98,659
371,699
Global Specialty Businesses
46,008
19,253
12,112
77,373
$
196,807
$
141,494
$
110,771
$
449,072
Timing of Revenue Recognized
Product sales at a point in time
$
188,340
$
131,982
$
108,559
$
428,881
Services transferred over time
8,467
9,512
2,212
20,191
$
196,807
$
141,494
$
110,771
$
449,072
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts, unless otherwise stated)
(Unaudited)
12
Three Months Ended September 30, 2020
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
42,098
$
25,362
$
45,001
$
112,461
Metalworking and other
77,442
68,643
39,876
185,961
119,540
94,005
84,877
298,422
Global Specialty Businesses
39,197
17,429
12,176
68,802
$
158,737
$
111,434
$
97,053
$
367,224
Timing of Revenue Recognized
Product sales at a point in time
$
153,820
$
107,093
$
94,660
$
355,573
Services transferred over time
4,917
4,341
2,393
11,651
$
158,737
$
111,434
$
97,053
$
367,224
Nine Months Ended September 30, 2021
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
155,546
$
108,391
$
151,944
$
415,881
Metalworking and other
269,797
257,100
134,980
661,877
425,343
365,491
286,924
1,077,758
Global Specialty Businesses
137,447
61,203
37,709
236,359
$
562,790
$
426,694
$
324,633
$
1,314,117
Timing of Revenue Recognized
Product sales at a point in time
$
537,161
$
400,982
$
316,222
$
1,254,365
Services transferred over time
25,629
25,712
8,411
59,752
$
562,790
$
426,694
$
324,633
$
1,314,117
Nine Months Ended September 30, 2020
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
121,458
$
80,174
$
122,006
$
323,638
Metalworking and other
208,554
196,372
104,844
509,770
330,012
276,546
226,850
833,408
Global Specialty Businesses
115,722
49,603
33,092
198,417
$
445,734
$
326,149
$
259,942
$
1,031,825
Timing of Revenue Recognized
Product sales at a point in time
$
431,266
$
313,511
$
254,011
$
998,788
Services transferred over time
14,468
12,638
5,931
33,037
$
445,734
$
326,149
$
259,942
$
1,031,825
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts, unless otherwise stated)
(Unaudited)
13
Note 6 – Leases
The Company determines if an arrangement is a lease at its inception.
 
This determination generally depends on whether the
arrangement conveys the right to control the use of an identified fixed asset explicitly
 
or implicitly for a period of time in exchange for
consideration.
 
Control of an underlying asset is conveyed if the Company obtains the rights to direct the
 
use of, and obtains
substantially all of the economic benefits from the use of, the underlying
 
asset.
 
Lease expense for variable leases and short-term
leases is recognized when the obligation is incurred.
The Company has operating leases for certain facilities, vehicles and machinery
 
and equipment with remaining lease terms up to
10 years
.
 
In addition, the Company has certain land use leases with remaining lease terms up
 
to
94 years
.
 
The lease term for all of the
Company’s leases includes the non
 
-cancellable period of the lease plus any additional periods covered by an option
 
to extend the lease
that the Company is reasonably certain it will exercise.
 
Operating leases are included in right of use lease assets, other current
liabilities and long-term lease liabilities on the Condensed Consolidated
 
Balance Sheet.
 
Right of use lease assets and liabilities are
recognized at each lease’s commencement
 
date based on the present value of its lease payments over its respective lease term.
 
The
Company uses the stated borrowing rate for a lease when readily determinable.
 
When a stated borrowing rate is not available in a
lease agreement, the Company uses its incremental borrowing rate based on
 
information available at the lease’s commencement
 
date
to determine the present value of its lease payments.
 
In determining the incremental borrowing rate used to present value each of its
leases, the Company considers certain information including fully
 
secured borrowing rates readily available to the Company and its
subsidiaries.
 
The Company has immaterial finance leases, which are included in property,
 
plant and equipment, current portion of
long-term debt and long-term debt on the Condensed Consolidated Balance
 
Sheet.
Operating lease expense is recognized on a straight-line basis over the
 
lease term.
 
Operating lease expense for the three and nine
months ended September 30, 2021 was $
3.4
 
million and $
10.6
 
million, respectively.
 
Comparatively, operating
 
lease expense for the
three and nine months ended September 30, 2020 was $
3.7
 
million and $
10.6
 
million, respectively.
 
Short-term lease expense for the
three and nine months ended September 30, 2021 was $
0.2
 
million and $
0.8
 
million, respectively.
 
Comparatively, short-term
 
lease
expense for the three and nine months ended September 30, 2020
 
was $
0.2
 
million and $
1.1
 
million, respectively.
 
The Company has
no
 
material variable lease costs or sublease income for the three or nine months ended September
 
30, 2021 and 2020.
 
Cash paid for operating leases during the nine months ended September 30, 2021
 
and 2020 was $
10.4
 
million and $
10.5
 
million,
respectively.
 
The Company recorded new right of use lease assets and associated lease liabilities of $
5.6
 
million during the nine
months ended September 30, 2021.
 
Supplemental balance sheet information related to the Company’s
 
leases is as follows:
September 30,
December 31,
2021
2020
Right of use lease assets
$
34,314
$
38,507
Other current liabilities
9,356
10,901
Long-term lease liabilities
24,599
27,070
Total operating lease liabilities
$
33,955
$
37,971
Weighted average
 
remaining lease term (years)
5.7
6.0
Weighted average
 
discount rate
4.26%
4.20%
Maturities of operating lease liabilities as of September 30, 2021 were
 
as follows:
September 30,
2021
For the remainder of 2021
$
2,978
For the year ended December 31, 2022
9,695
For the year ended December 31, 2023
7,564
For the year ended December 31, 2024
5,623
For the year ended December 31, 2025
4,340
For the year ended December 31, 2026 and beyond
8,104
Total lease payments
38,304
Less: imputed interest
(4,349)
Present value of lease liabilities
$
33,955
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts, unless otherwise stated)
(Unaudited)
14
Note 7 – Restructuring and Related Activities
The Company’s management approved a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost
synergies associated with the Combination in the third quarter of 2019. The QH Program includes restructuring and associated
severance costs to reduce total headcount by approximately 400 people globally, as well as plans for the closure of certain
manufacturing and non-manufacturing facilities. The exact timing and total costs associated with the QH Program will depend on a
number of factors and is subject to change; however, the Company currently expects reduction in headcount and site closures to
continue to occur throughout 2021 and into 2022 under the QH Program and estimates that anticipated cost synergies realized from the
QH Program will approximate one-times the restructuring costs incurred. Employee separation benefits will vary depending on local
regulations within certain foreign countries and will include severance and other benefits.
All costs incurred to date relate to severance costs to reduce headcount,
 
including customary and routine adjustments to initial
estimates for employee separation costs, as well as costs to close certain facilities and
 
are recorded in Restructuring and related
charges in the Company’s
 
Condensed Statements of Operations.
 
As described in Note 4 of Notes to Condensed Consolidated
Financial Statements, restructuring and related charges
 
are not included in the Company’s calculation of
 
reportable segments’ measure
of operating earnings and therefore these costs are not reviewed by
 
or recorded to reportable segments.
Activity in the Company’s accrual
 
for restructuring under the QH Program for the nine months ended September 30, 2021
 
is as
follows:
QH Program
Accrued restructuring as of December 31, 2020
$
8,248
Restructuring and related charges
593
Cash payments
(4,557)
Currency translation adjustments
 
(234)
Accrued restructuring as of September 30, 2021
$
4,050
Note 8 – Share-Based Compensation
The Company recognized the following share-based compensation expense
 
in its Condensed Consolidated Statements of
Operations for the three and nine months ended September 30, 2021
 
and 2020:
 
Three Months Ended
Nine Months Ended
September 30,
 
September 30,
 
2021
2020
2021
2020
Stock options
$
298
$
353
$
938
$
1,138
Non-vested stock awards and restricted stock units
1,277
1,259
3,963
3,782
Non-elective and elective 401(k) matching contribution in stock
—
910
1,553
2,072
Director stock ownership plan
241
243
660
337
Performance stock units
491
280
1,327
560
Annual incentive plan
—
7,102
—
9,931
Total share-based
 
compensation expense
$
2,307
$
10,147
$
8,441
$
17,820
Share-based compensation expense is recorded in SG&A, except for $
0.2
 
million and $
0.7
 
million for the three and nine months
ended September 30, 2021, respectively,
 
and $
0.4
 
million and $
1.2
 
million for the three and nine months ended September 30, 2020,
respectively, recorded
 
within Combination, integration and other acquisition-related expenses.
Stock Options
During the first nine months of 2021, the Company granted stock options
 
under its long-term incentive plan (“LTIP”)
 
that are
subject only to time-based vesting over a
three
 
year period.
 
For the purposes of determining the fair value of stock option awards,
 
the
Company used a Black-Scholes option pricing model and which primarily used
 
the assumptions set forth in the table below:
Number of options granted
25,250
Dividend yield
0.85
%
Expected volatility
37.33
%
Risk-free interest rate
0.60
%
Expected term (years)
4.0
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts, unless otherwise stated)
(Unaudited)
15
The fair value of these options is amortized on a straight-line basis over the
 
vesting period.
 
As of September 30, 2021,
unrecognized compensation expense related to all stock options granted was $
2.1
 
million, to be recognized over a weighted average
remaining period of
 
2.1
 
years.
 
Restricted Stock Awards
 
and Restricted Stock Units
During the nine months ended September 30, 2021, the Company granted
17,692
 
non-vested restricted shares and
2,791
 
non-
vested restricted stock units under its LTIP,
 
which are subject to time-based vesting, generally over a
three year
 
period.
 
The fair value
of these grants is based on the trading price of the Company’s
 
common stock on the date of grant.
 
The Company adjusts the grant
date fair value of these awards for expected forfeitures based on historical experience.
 
As of September 30, 2021, unrecognized
compensation expense related to the non-vested restricted
 
shares was $
5.1
 
million, to be recognized over a weighted average
remaining period of
1.7
 
years, and unrecognized compensation expense related to non-vested restricted
 
stock units was $
0.9
 
million,
to be recognized over a weighted average remaining period of
2.0
 
years.
Performance Stock Units
During the first nine months of 2021, the Company granted performance
 
-dependent stock awards (“PSUs”) as a component of its
LTIP,
 
which will be settled in a certain number of shares subject to market-based and
 
time-based vesting conditions.
 
The number of
fully vested shares that may ultimately be issued as settlement for each award
 
may range from
0
% up to
200
% of the target award,
subject to the achievement of the Company’s
 
total shareholder return (“TSR”) relative to the performance of the Company’s
 
peer
group, the S&P Midcap 400 Materials group.
 
The service period required for the PSUs is three years and the TSR measurement
period for the PSUs is from January 1 of the year of grant through December 31 of the year prior
 
to issuance of the shares upon
settlement.
Compensation expense for PSUs is measured based on their grant date fair value
 
and is recognized on a straight-line basis over
the
three year
 
vesting period.
 
The grant-date fair value of the PSUs granted during the first nine months
 
of 2021 was estimated using
a Monte Carlo simulation on the grant date and using the following assumptions:
 
(i) a risk-free rate of
 
0.29
%; (ii) an expected term of
3.0
 
years; and (iii) a three year daily historical volatility for each of the companies in the peer group,
 
including Quaker Houghton.
 
As of September 30, 2021, the Company estimates that it will issue approximately
23,756
 
fully vested shares as of the applicable
settlement date of all outstanding PSUs awards based on the conditions
 
of the PSUs and performance to date for each award.
 
As of
September 30, 2021, there was approximately $
3.7
 
million of total unrecognized compensation cost related to PSUs, which the
Company expects to recognize over a weighted-average period of
 
2.1
 
years.
Annual Incentive Plan
The Company maintains an Annual Incentive Plan (“AIP”), which may be
 
settled in cash or a certain number of shares subject to
performance-based and time-based vesting conditions.
 
As of September 30, 2020, it had been the Company’s
 
intention to settle the
2020 AIP in shares, and therefore, expense associated with the AIP in 2020
 
was recorded as a component of share-based
compensation expense.
 
In the fourth quarter of 2020, the Company determined that it would settle the 2020
 
AIP in cash.
 
Therefore,
the share-based compensation associated with the AIP during the
 
year ended December 31, 2020 was reclassified from a component
of share-based compensation expense to incentive compensation.
 
This determination and conclusion had no impact on the
classification of AIP expense within the Company’s
 
Condensed Consolidated Statement of Operations for the periods as both are
 
a
component of SG&A.
 
As of September 30, 2021, it is the Company’s
 
intention to settle the 2021 AIP in cash.
 
Defined Contribution Plan
 
The Company has a 401(k) plan with an employer match covering
 
a majority of its U.S. employees.
 
The Company matches
50
%
of the first
6
% of compensation that is contributed to the plan, with a maximum matching contribution of
3
% of compensation.
 
Additionally,
 
the plan provides for non-elective nondiscretionary contributions on behalf
 
of participants who have completed one year
of service equal to
3
% of the eligible participants’ compensation.
 
Beginning in April 2020 and continuing through March 2021, the
Company matched both non-elective and elective 401(k) contributions
 
in fully vested shares of the Company’s common
 
stock rather
than cash.
 
For the three months ended September 30, 2021, there were
no
 
matching contributions in stock.
 
For the nine months ended
September 30, 2021, total contributions were $
1.5
 
million. Comparatively,
 
total contributions for the three and nine months ended
September 30, 2020 were $
0.9
 
million and $
2.1
 
million, respectively.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts, unless otherwise stated)
(Unaudited)
16
Note 9 – Pension and Other Postretirement
 
Benefits
The components of net periodic benefit cost for the three and nine months
 
ended September 30, 2021 and 2020 are as follows:
Three Months Ended September 30,
Nine Months Ended September 30,
Other
Other
Postretirement
Postretirement
Pension Benefits
Benefits
Pension Benefits
Benefits
2021
2020
2021
2020
2021
2020
2021
2020
Service cost
$
289
$
1,227
$
(2)
$
2
$
921
$
3,565
$
1
$
5
Interest cost
1,078
1,527
(1)
25
3,262
4,782
20
77
Expected return on plan assets
(2,075)
(3,526)
—
—
(6,250)
(7,246)
—
—
Settlement charge
—
—
—
—
—
22,667
—
—
Actuarial loss amortization
737
626
(85)
15
2,449
2,288
(85)
46
Prior service cost amortization
3
(42)
—
—
8
(123)
—
—
Net periodic benefit cost
$
32
$
(188)
$
(88)
$
42
$
390
$
25,933
$
(64)
$
128
As disclosed in the Company’s 2020
 
Form 10-K, in the fourth quarter of 2018, the Company began the process of terminating
 
its
legacy Quaker non-contributory U.S. pension plan (“Legacy Quaker
 
U.S. Pension Plan”).
 
During the third quarter of 2019, the
Company received a favorable termination determination letter from the
 
Internal Revenue Service (“I.R.S.”) and completed the
Legacy Quaker U.S. Pension Plan termination during the first quarter of 2020.
 
In order to terminate the Legacy Quaker U.S. Pension
Plan in accordance with I.R.S. and Pension Benefit Guaranty Corporation requirements,
 
the Company was required to fully fund the
Legacy Quaker U.S. Pension Plan on a termination basis and the amount
 
necessary to do so was approximately $
1.8
 
million, subject to
final true up adjustments,
 
which were completed in the third quarter of 2020 resulting in a refund in premium received
 
in the third
quarter of 2020 of approximately $
1.6
 
million.
 
In addition, the Company recorded a non-cash pension settlement charge
 
at plan
termination of approximately $
22.7
 
million.
 
This settlement charge included the immediate recognition into expense
 
of the related
unrecognized losses within accumulated other comprehensive (loss) income
 
(“AOCI”) on the balance sheet as of the plan termination
date.
 
Employer Contributions
As of September 30, 2021, $
5.7
 
million and $
0.2
 
million of contributions have been made to the Company’s
 
U.S. and foreign
pension plans and its other postretirement benefit plans, respectively
 
.
 
Taking into consideration
 
current minimum cash contribution
requirements, the Company expects to make full year cash contributions
 
of approximately $
6
 
million to its U.S. and foreign pension
plans and less than $
1
 
million to its other postretirement benefit plans in 2021
.
Note 10 – Other Income (Expense), Net
The components of other income (expense), net, for the three and nine months
 
ended September 30, 2021 and 2020 are as
follows:
Three Months Ended
Nine Months Ended
September 30,
 
September 30,
 
2021
2020
2021
2020
Income from third party license fees
$
314
$
190
$
1,026
$
702
Foreign exchange gains (losses), net
368
(1,897)
(1,948)
(3,080)
(Loss) gain on disposals of property,
 
plant, equipment and other
assets, net
(537)
(24)
4,819
(105)
Non-income tax refunds and other related credits
3
—
14,395
2,131
Pension and postretirement benefit income (costs),
 
non-service components
343
1,375
596
(22,491)
Other non-operating income, net
156
117
456
436
Total other income
 
(expense), net
$
647
$
(239)
$
19,344
$
(22,407)
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts, unless otherwise stated)
(Unaudited)
17
The (Loss) gain on disposals of property,
 
plant, equipment and other assets, net, during the three months ended
 
September 30,
2021,
 
includes losses related to certain fixed asset disposals resulting from the
 
property damage caused by flooding of the Company’s
Conshohocken, Pennsylvania headquarters, described in Note 19 of Notes
 
to Condensed Consolidated Financial Statements, and
during the nine months ended September 30, 2021, includes the gain on the
 
sale of certain held-for-sale real property assets related to
the Combination.
 
Non-income tax refunds and other related credits during the nine months ended September
 
30, 2021 includes
certain non-income tax credits for the Company’s
 
Brazilian subsidiaries described in Note 19 of Notes to Condensed Consolidated
Financial Statements.
 
Pension and postretirement benefit income (costs), non-service
 
components during both the three and nine
months ended September 30, 2020 includes the refund in premium described
 
in Note 9 of Notes to Condensed Consolidated Financial
Statements.
 
In addition, this line also includes the Legacy Quaker U.S. Pension Plan non
 
-cash settlement charge during the nine
months ended September 30, 2020, also described in Note 9 of Notes to
 
Condensed Consolidated Financial Statements.
Note 11 – Income Taxes
 
and Uncertain Income Tax
 
Positions
The Company’s effective
 
tax rates for the three and nine months ended September 30, 2021 were an expense
 
of
2.6
% and
21.8
%,
respectively, compared
 
to an expense of
8.1
% and a benefit of
38.3
% for the three and nine months ended September 30, 2020,
respectively.
 
The Company’s current year
 
effective tax rates were largely impacted by changes in permanent
 
reinvestment assertions,
changes in foreign tax credit valuation allowances, tax law changes in a foreign
 
jurisdiction, deferred tax benefits related to an
intercompany intangible asset transfer and the income tax impacts of certain
 
non-income tax credits recorded by the Company’s
Brazilian subsidiaries described in Note 19 of Notes to Condensed Consolidated
 
Financial Statements.
 
Comparatively,
 
the prior year
effective tax rates were impacted by the tax effect
 
of certain one-time pre-tax losses as well as certain tax charges and benefits
 
in the
prior year period including those related to changes in tax regulations and
 
other changes in foreign tax credit valuation allowances, tax
law changes in foreign jurisdictions and the tax impacts of the Company’s
 
termination of its Legacy Quaker U.S. Pension Plan.
As of December 31, 2020, the Company had a deferred tax liability of $
5.9
 
million, which primarily represents the Company’s
estimate of non-U.S. taxes it will incur to repatriate certain foreign earnings to
 
the U.S.
 
The balance as of September 30, 2021 was
$
5.8
 
million. As of September 30, 2021, the Company’s
 
cumulative liability for gross unrecognized tax benefits was $
24.0
 
million, an
increase of $
1.9
 
million from the cumulative liability accrued as of December 31, 2020.
 
The Company continues to recognize interest and penalties associated with uncertain
 
tax positions as a component of taxes on
income (loss) before equity in net income of associated companies
 
in its Condensed Consolidated Statements of Operations.
 
The
Company recognized an expense for interest of approximately $
0.2
 
million and $
0.4
 
million and a benefit of less than $
0.1
 
million and
$
0.2
 
million for penalties in its Condensed Consolidated Statement of Operations for the
 
three and nine months ended September 30,
2021, respectively,
 
and recognized a credit for interest of $
0.2
 
million and an expense of $
0.4
 
million and an expense for penalties of
less than $
0.1
 
million and $
0.5
 
million in its Condensed Consolidated Statement of Operations for the
 
three and nine months ended
September 30, 2020, respectively.
 
As of September 30, 2021, the Company had accrued $
3.3
 
million for cumulative interest and $
3.5
million for cumulative penalties in its Condensed Consolidated
 
Balance Sheets, compared to $
3.0
 
million for cumulative interest and
$
3.9
 
million for cumulative penalties accrued at December 31, 2020.
 
During the nine months ended September 30, 2021 and 2020,
the Company recognized decreases of $
1.2
 
million and $
1.9
 
million, respectively,
 
in its cumulative liability for gross unrecognized tax
benefits due to the expiration of the applicable statutes of limitations for
 
certain tax years.
The Company estimates that during the year ending December 31, 2021
 
it will reduce its cumulative liability for gross
unrecognized tax benefits by approximately $
1.5
 
million due to the expiration of the statute of limitations with regard to certain tax
positions.
 
This estimated reduction in the cumulative liability for unrecognized tax
 
benefits does not consider any increase in liability
for unrecognized tax benefits with regard to existing tax positions or any increase
 
in cumulative liability for unrecognized tax benefits
with regard to new tax positions for the year ending December 31, 2021.
The Company and its subsidiaries are subject to U.S. Federal income tax,
 
as well as the income tax of various state and foreign
tax jurisdictions.
 
Tax years that remain subject
 
to examination by major tax jurisdictions include Italy from
2006
, Brazil from
2011
,
the Netherlands and China from
2015
, Mexico, Spain, Germany and the United Kingdom from
2016
, Canada and the U.S. from
2018
,
India from fiscal year beginning April 1, 2018 and ending March 31,
2019
, and various U.S. state tax jurisdictions from
2011
.
 
As previously reported, the Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia
S.r.l., relating to the tax years 2007 through 2015. The Company has filed for competent authority relief from these assessments under
the Mutual Agreement Procedures (“MAP”) of the Organization for Economic Co-Operation and Development for all years except
2007. In 2020, the respective tax authorities in Italy, Spain and the Netherlands reached agreement with respect to the MAP
proceedings which the Company has accepted.
 
As of September 30, 2021, the Company has received $
1.6
 
million in refunds from the
Netherlands and Spain and currently expects to pay $
2.6
 
million due to Italy in the fourth quarter of 2021.
 
As of September 30, 2021,
the Company believes it has adequate reserves for the remaining uncertain
 
tax positions related to 2007.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts, unless otherwise stated)
(Unaudited)
18
Houghton Italia, S.r.l is also involved
 
in a corporate income tax audit with the Italian tax authorities covering tax years
2014
through
2018
.
 
As of September 30, 2021, the Company has a $
6.0
 
million reserve for uncertain tax positions relating to matters
related to this audit.
 
Because the reserve relates to the tax periods prior to August 1, 2019, the tax liability was established
 
through
purchase accounting related to the Combination.
 
The Company has also submitted an indemnification claim against funds held in
escrow by Houghton’s former
 
owners and as a result, a corresponding $
5.4
 
million indemnification receivable has also been
established through purchase accounting.
 
In October 2021, the Company settled a portion of the Houghton Italia
 
S.r.l corporate
income tax audit with the Italian tax authorities for the tax year 2015.
 
The Company remains under audit for tax years 2014 and 2016
through 2018 and believes it has adequate reserves for the remaining uncertain
 
tax positions.
Houghton Deutschland GmbH is also under audit by the German tax authorities for
 
the tax years
2015
 
through
2017
.
 
Based on
preliminary audit findings, primarily related to transfer pricing,
 
the Company has recorded reserves for $
0.9
 
million as of September
30, 2021.
 
Of this amount, $
0.8
 
million relates to tax periods prior to the Combination and therefore
 
the Company has submitted an
indemnification claim with Houghton’s
 
former owners for any tax liabilities arising pre-Combination.
 
As a result, a corresponding
$
0.8
 
million indemnification receivable has also been established to offset
 
the $
0.8
 
million tax liability.
 
In October 2021 the
Company received a settlement proposal from the German
 
tax authorities and is currently reviewing the proposal with Houghton’s
former owners.
Note 12 – Earnings Per Share
The following table summarizes earnings per share calculations for
 
the three and nine months ended September 30, 2021 and
2020:
Three Months Ended
 
Nine Months Ended
September 30,
September 30,
2021
2020
2021
2020
Basic earnings (loss) per common share
 
 
 
Net income (loss) attributable to Quaker Chemical Corporation
$
31,058
$
27,304
$
103,243
$
(8,812)
Less: (income) loss allocated to participating securities
 
(119)
 
(113)
 
(413)
 
44
Net income (loss) available to common shareholders
$
30,939
$
27,191
$
102,830
$
(8,768)
Basic weighted average common shares outstanding
17,812,216
17,743,538
17,800,082
17,704,662
Basic earnings (loss) per common share
$
1.74
$
1.53
$
5.78
$
(0.50)
Diluted earnings (loss) per common share
Net income (loss) attributable to Quaker Chemical Corporation
$
31,058
$
27,304
$
103,243
$
(8,812)
Less: (income) loss allocated to participating securities
(119)
 
(113)
 
(412)
 
44
Net income (loss) available to common shareholders
$
30,939
$
27,191
$
102,831
$
(8,768)
Basic weighted average common shares outstanding
17,812,216
17,743,538
17,800,082
17,704,662
Effect of dilutive securities
58,176
57,327
59,986
—
Diluted weighted average common shares outstanding
17,870,392
17,800,865
17,860,068
17,704,662
Diluted earnings (loss) per common share
$
1.73
$
1.53
$
5.76
$
(0.50)
Certain stock options and restricted stock units are not included in the diluted
 
earnings (loss) per share calculation when the effect
would have been anti-dilutive.
 
The calculated amount of anti-diluted shares not included was
5,531
 
and
3,722
 
for the three and nine
months ended September 30, 2021,
 
respectively.
 
All of the Company’s potentially
 
dilutive shares for the nine months ended
September 30, 2020 are anti-dilutive and not included in the dilutive loss per
 
share calculations because of the Company’s net
 
loss
during the period.
 
There were
no
 
anti-dilutive shares excluded from the diluted earnings per share calculation for the three months
ended September 30, 2020.
Note 13 – Restricted Cash
Prior to December 2020, the Company had restricted cash recorded in other assets related to proceeds from an inactive subsidiary
of the Company which previously executed separate settlement and release agreements with two of its insurance carriers for an
original total value of $35.0 million.
 
The proceeds of both settlements were restricted and could only be used
 
to pay claims and costs
of defense associated with the subsidiary’s
 
asbestos litigation.
 
The proceeds of the settlement and release agreements were deposited
into interest bearing accounts that earned less than $
0.1
 
million offset by $
0.8
 
million of net payments during the nine months ended
September 30, 2020.
 
Due to the restricted nature of the proceeds, a corresponding deferred credit was established
 
in other non-current
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts, unless otherwise stated)
(Unaudited)
19
liabilities for an equal and offsetting amount that continued
 
until the restrictions lapsed.
 
As disclosed in the Company’s 2020
 
Form
10-K, during December 2020, the restrictions ended on these previously
 
received insurance settlements and the Company transferred
the cash into an operating account.
The following table provides a reconciliation of cash, cash equivalents
 
and restricted cash as of September 30, 2021 and 2020,
 
as
well as December 31, 2020 and 2019:
September 30,
December 31,
2021
2020
2020
2019
Cash and cash equivalents
$
141,393
$
155,750
$
181,833
$
123,524
Restricted cash included in other current assets
—
82
62
353
Restricted cash included in other assets
—
18,901
—
19,678
Cash, cash equivalents and restricted cash
$
141,393
$
174,733
$
181,895
$
143,555
Note 14 – Goodwill and Other Intangible Assets
Changes in the carrying amount of goodwill for the nine months ended
 
September 30, 2021 were as follows:
Global
Specialty
Americas
EMEA
Asia/Pacific
Businesses
Total
Balance as of December 31, 2020
$
213,242
$
140,162
$
158,090
$
119,718
 
$
631,212
Goodwill additions
1,208
2,626
1,308
1,951
7,093
Currency translation and other adjustments
 
(621)
(5,530)
1,109
(2,594)
(7,636)
Balance as of September 30, 2021
$
213,829
$
137,258
$
160,507
$
119,075
 
$
630,669
Gross carrying amounts and accumulated amortization for definite-lived
 
intangible assets as of September 30, 2021 and
December 31, 2020 were as follows:
Gross Carrying
Accumulated
Amount
Amortization
2021
2020
2021
2020
Customer lists and rights to sell
$
847,909
 
$
839,551
 
$
135,571
 
$
99,806
Trademarks, formulations and product
 
technology
 
167,682
 
 
166,448
 
 
36,871
 
 
30,483
Other
 
6,325
 
 
6,372
 
 
5,886
 
 
5,824
Total definite-lived
 
intangible assets
$
1,021,916
 
$
1,012,371
 
$
178,328
 
$
136,113
The Company amortizes definite-lived intangible assets on a straight-line basis over
 
their useful lives.
 
The Company recorded
$
14.9
 
million and $
44.7
 
million of amortization expense for the three and nine months ended September
 
30, 2021, respectively.
 
Comparatively,
 
the Company recorded $
14.0
 
million and $
41.7
 
million of amortization expense for the three and nine months ended
September 30, 2020, respectively.
 
Estimated annual aggregate amortization expense for the current year
 
and subsequent five years is as follows:
For the year ended December 31, 2021
$
58,852
For the year ended December 31, 2022
59,173
For the year ended December 31, 2023
59,005
For the year ended December 31, 2024
58,338
For the year ended December 31, 2025
57,653
For the year ended December 31, 2026
57,346
The Company has four indefinite-lived intangible assets totaling $
205.1
 
million as of both September 30, 2021 and December 31,
2020, including $
204.0
 
million of indefinite-lived intangible assets for trademarks and tradename associated
 
with the Combination.
Goodwill and intangible assets that have indefinite lives are not amortized and
 
are required to be assessed at least annually for
impairment.
 
The Company completes its annual goodwill and indefinite-lived intangible asset impairment
 
test during the fourth
quarter of each year.
 
The Company continuously evaluates if triggering events indicate a possible impairment
 
in one or more of its
reporting units or indefinite-lived or long-lived assets.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts, unless otherwise stated)
(Unaudited)
20
The Company previously disclosed in its 2020 Form 10-K that as of March 31, 2020,
 
the Company concluded that the impact of
COVID-19 did not represent a triggering event with regards to the Company’s
 
reporting units or indefinite-lived and long-lived assets,
except for the Company’s Houghton
 
and Fluidcare trademarks and tradename indefinite-lived intangible assets.
 
The determination of
estimated fair value of the Houghton and Fluidcare trademarks and tradename
 
indefinite-lived assets was based on a relief from
royalty valuation method, which requires management’s
 
judgment and often involves the use of significant estimates and assumptions,
including assumptions with respect to the weighted average cost of capital
 
(“WACC”)
 
and royalty rates, as well as revenue growth
rates and terminal growth rates.
 
In the first quarter of 2020, as a result of the impact of COVID-19 driving
 
a decrease in projected
legacy Houghton net sales during that year and the impact of the sales decline on
 
projected future legacy Houghton net sales as well as
an increase in the WACC
 
assumption utilized in the quantitative impairment assessment, the
 
Company concluded that the estimated
fair values of the Houghton and Fluidcare trademarks and tradename
 
intangible assets were less than their carrying values.
 
As a
result, an impairment charge of $
38.0
 
million was recorded in the first quarter of 2020 to write down the carrying values of
 
these
intangible assets to their estimated fair values.
As of September 30, 2021, the Company continued to evaluate all potential triggering
 
events, including the on-going impact of
COVID-19 on the Company’s operations,
 
and the volatility and uncertainty in the economic outlook as a result of COVID-19,
 
to
determine if this indicated it was more likely than not that the carrying value
 
of any of the Company’s reporting
 
units or indefinite-
lived or long-lived intangible assets were not recoverable.
 
The Company concluded that the impact of COVID-19 did not represent
 
a
triggering event as of September 30, 2021.
 
While the Company concluded that the impact of COVID-19 did not represent a
 
triggering
event as of September 30, 2021, the Company will continue to evaluate the
 
impact of COVID-19 on the Company’s
 
current and
projected results. If the current economic conditions worsen or projections
 
of the timeline for recovery are significantly extended, then
the Company may conclude in the future that the impact from COVID-19
 
requires the need to perform further interim quantitative
impairment tests, which could result in additional impairment charges
 
in the future.
Note 15 – Debt
 
Debt as of September 30, 2021 and December 31, 2020 includes the following:
As of September 30, 2021
As of December 31, 2020
Interest
Outstanding
 
Interest
Outstanding
 
Rate
Balance
Rate
Balance
Credit Facilities:
Revolver
1.58%
$
198,543
1.65%
$
160,000
U.S. Term Loan
1.58%
547,500
1.65%
570,000
EURO Term Loan
1.50%
142,559
1.50%
157,062
Industrial development bonds
5.26%
10,000
5.26%
10,000
Bank lines of credit and other debt obligations
Various
2,060
Various
2,072
Total debt
$
900,662
$
899,134
Less: debt issuance costs
(8,776)
(11,099)
Less: short-term and current portion of long-term debts
(52,611)
(38,967)
Total long-term debt
$
839,275
$
849,068
Credit facilities
The Company’s primary credit facility
 
(as amended, the “Credit Facility”) is comprised of a $
400.0
 
million multicurrency
revolver (the “Revolver”), a $
600.0
 
million term loan (the “U.S. Term
 
Loan”), each with the Company as borrower,
 
and a $
150.0
million (as of August 1, 2019) Euro equivalent term loan (the “EURO Term
 
Loan” and together with the “U.S. Term
 
Loan”, the
“Term Loans”)
 
with Quaker Chemical B.V.,
 
a Dutch subsidiary of the Company as borrower, each
 
with a
five year
 
term maturing in
August 2024.
 
Subject to the consent of the administrative agent and certain other conditions, the Company
 
may designate additional
borrowers.
 
The maximum amount available under the Credit Facility can be increased by up
 
to $
300.0
 
million at the Company’s
request if there are lenders who agree to accept additional commitments and
 
the Company has satisfied certain other conditions.
 
Borrowings under the Credit Facility bear interest at a base rate or LIBOR plus an
 
applicable margin based upon the Company’s
consolidated net leverage ratio.
 
There are LIBOR replacement provisions that contemplate a further amendment
 
when LIBOR ceases
to be reported.
 
The variable interest rate incurred on the outstanding borrowings under
 
the Credit Facility as of and during the nine
months ended September 30, 2021 was approximately
1.6
%.
 
In addition to paying interest on outstanding principal under the Credit
Facility, the Company
 
is required to pay a commitment fee ranging from
0.2
% to
0.3
% depending on the Company’s consolidated
 
net
leverage ratio to the lenders under the Revolver in respect of the unutilized
 
commitments thereunder.
 
The Company has unused
capacity under the Revolver of approximately $
197
 
million, net of bank letters of credit of approximately $
4
 
million, as of September
30, 2021.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts, unless otherwise stated)
(Unaudited)
21
The Credit Facility is subject to certain financial and other covenants. The Company’s initial consolidated net debt to
consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit
Facility.
 
As of September 30, 2021, the consolidated net debt to adjusted EBITDA
 
may not exceed
4.00
 
to 1.
 
The Company’s
consolidated adjusted EBITDA to interest expense ratio cannot be less than
3.0
 
to 1 over the term of the agreement.
 
The Credit
Facility also prohibits the payment of cash dividends if the Company
 
is in default or if the amount of the dividend paid annually
exceeds the greater of $
50.0
 
million and
20
% of consolidated adjusted EBITDA unless the ratio of consolidated net debt
 
to
consolidated adjusted EBITDA is less than
2.0
 
to 1, in which case there is no such limitation on amount.
 
As of September 30, 2021
and December 31, 2020, the Company was in compliance with all of the Credit Facility covenants.
 
The Term Loans have quarterly
principal amortization during their
five year
 
terms, with
5.0
% amortization of the principal balance due in years 1 and 2,
7.5
% in year
3, and
10.0
% in years 4 and 5, with the remaining principal amount due at maturity.
 
During the nine months ended September 30,
2021, the Company made quarterly amortization payments related to the
 
Term Loans totaling $
28.6
 
million.
 
The Credit Facility is
guaranteed by certain of the Company’s
 
domestic subsidiaries and is secured by first priority liens on substantially all of the assets of
the Company and the domestic subsidiary guarantors, subject to certain
 
customary exclusions.
 
The obligations of the Dutch borrower
are guaranteed only by certain foreign subsidiaries on an unsecured basis.
The Credit Facility required the Company to fix its variable interest rates on at least
20
% of its total Term Loans.
 
In order to
satisfy this requirement as well as to manage the Company’s
 
exposure to variable interest rate risk associated with the Credit Facility,
in November 2019, the Company entered into $
170.0
 
million notional amounts of three year interest rate swaps at a base rate of
1.64
%
plus an applicable margin as provided in the Credit Facility,
 
based on the Company’s consolidated
 
net leverage ratio.
 
At the time the
Company entered into the swaps, and as of September 30, 2021, the
 
aggregate interest rate on the swaps, including the fixed base rate
plus an applicable margin, was
3.1
%.
 
See Note 18 of Notes to Condensed Consolidated Financial Statements.
The Company capitalized $
23.7
 
million of certain third-party debt issuance costs in connection with executing
 
the Credit Facility.
 
Approximately $
15.5
 
million of the capitalized costs were attributed to the Term
 
Loans and recorded as a direct reduction of long-
term debt on the Company’s Condensed
 
Consolidated Balance Sheet.
 
Approximately $
8.3
 
million of the capitalized costs were
attributed to the Revolver and recorded within other assets on the Company’s
 
Condensed Consolidated Balance Sheet.
 
These
capitalized costs are being amortized into interest expense over the
 
five year term of the Credit Facility.
 
As of September 30, 2021
and December 31, 2020, the Company had $
8.8
 
million and $
11.1
 
million, respectively, of debt
 
issuance costs recorded as a reduction
of long-term debt.
 
As of September 30, 2021 and December 31, 2020, the Company had $
4.7
 
million and $
5.9
 
million, respectively,
of debt issuance costs recorded within other assets.
 
Industrial development bonds
As of September 30, 2021 and December 31, 2020, the Company had fixed
 
rate, industrial development authority bonds totaling
$
10.0
 
million in principal amount due in
2028
.
 
These bonds have similar covenants to the Credit Facility noted above.
Bank lines of credit and other debt obligations
The Company has certain unsecured bank lines of credit and discounting
 
facilities in one of its foreign subsidiaries, which are not
collateralized.
 
The Company’s other debt obligat
 
ions primarily consist of certain domestic and foreign low interest rate or interest-
free municipality-related loans, local credit facilities of certain foreign subsidiaries
 
and capital lease obligations.
 
Total unused
capacity under these arrangements as of September 30, 2021 was approximately
 
$
39
 
million.
In addition to the bank letters of credit described in the “Credit facilities” subsection above, the Company’s only other off-balance
sheet arrangements include certain financial and other guarantees. The Company’s total bank letters of credit and guarantees
outstanding as of September 30, 2021 were approximately $7 million.
The Company incurred the following debt related expenses included
 
within Interest expense, net, in the Condensed Consolidated
Statements of Operations:
Three Months Ended
Nine Months Ended
September 30,
September 30,
2021
2020
2021
2020
Interest expense
$
4,779
$
5,957
$
14,242
$
19,621
Amortization of debt issuance costs
1,187
1,188
3,562
3,562
Total
$
5,966
$
7,145
$
17,804
$
23,183
Based on the variable interest rates associated with the Credit Facility,
 
as of September 30, 2021 and December 31, 2020, the
amounts at which the Company’s
 
total debt were recorded are not materially different from
 
their fair market value.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts, unless otherwise stated)
(Unaudited)
22
Note 16 – Equity
The following tables present the changes in equity,
 
net of tax, for the three and nine months ended September 30, 2021 and 2020:
Accumulated
Capital in
Other
Common
Excess of
Retained
Comprehensive
Noncontrolling
Stock
Par Value
Earnings
Loss
Interest
Total
Balance at June 30, 2021
$
17,878
$
910,862
$
482,001
$
(35,943)
$
603
$
1,375,401
Net income
—
—
31,058
—
15
31,073
Amounts reported in other comprehensive
 
loss
—
—
—
(18,780)
—
(18,780)
Dividends ($
0.415
 
per share)
—
—
(7,424)
—
—
(7,424)
Share issuance and equity-based
compensation plans
11
3,415
—
—
—
3,426
Balance at September 30, 2021
$
17,889
$
914,277
$
505,635
$
(54,723)
$
618
$
1,383,696
Balance at June 30, 2020
$
17,800
$
896,108
$
362,265
$
(109,264)
$
432
$
1,167,341
Net income
—
—
27,304
—
38
27,342
Amounts reported in other comprehensive
 
income
—
—
—
34,254
17
34,271
Dividends ($
0.395
 
per share)
—
—
(7,048)
—
—
(7,048)
Share issuance and equity-based
compensation plans
31
4,494
—
—
—
4,525
Balance at September 30, 2020
$
17,831
$
900,602
$
382,521
$
(75,010)
$
487
$
1,226,431
Accumulated
Capital in
Other
Common
Excess of
Retained
Comprehensive
Noncontrolling
Stock
Par Value
Earnings
Loss
Interest
Total
Balance at December 31, 2020
$
17,851
$
905,171
$
423,940
$
(26,598)
$
550
$
1,320,914
Net income
—
—
103,243
—
62
103,305
Amounts reported in other comprehensive
 
(loss) income
—
—
—
(28,125)
6
(28,119)
Dividends ($
1.205
 
per share)
—
—
(21,548)
—
—
(21,548)
Share issuance and equity-based
compensation plans
38
9,106
—
—
—
9,144
Balance at September 30, 2021
$
17,889
$
914,277
$
505,635
$
(54,723)
$
618
$
1,383,696
Balance at December 31, 2019
$
17,735
$
888,218
$
412,979
$
(78,170)
$
1,604
$
1,242,366
Cumulative effect of an accounting change
—
—
(911)
—
—
(911)
Balance at January 1, 2020
17,735
888,218
412,068
(78,170)
1,604
1,241,455
Net (loss) income
—
—
(8,812)
—
88
(8,724)
Amounts reported in other comprehensive
 
income (loss)
—
—
—
3,160
(114)
3,046
Dividends ($
1.165
 
per share)
—
—
(20,735)
—
—
(20,735)
Acquisition of noncontrolling interest
—
(707)
—
—
(340)
(1,047)
Distributions to noncontrolling affiliate
shareholders
—
—
—
—
(751)
(751)
Share issuance and equity-based
compensation plans
96
13,091
—
—
—
13,187
Balance at September 30, 2020
$
17,831
$
900,602
$
382,521
$
(75,010)
$
487
$
1,226,431
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts, unless otherwise stated)
(Unaudited)
23
The following tables show the reclassifications from and resulting balances
 
of AOCI for the three and nine months ended
September 30, 2021 and 2020:
Defined
Unrealized
Currency
Benefit
Gain (Loss) in
Translation
Pension
Available-for-
Derivative
Adjustments
Plans
Sale Securities
Instruments
Total
Balance at June 30, 2021
$
(12,177)
$
(21,778)
$
596
$
(2,584)
$
(35,943)
Other comprehensive (loss) income before
 
reclassifications
(19,905)
488
(85)
567
(18,935)
Amounts reclassified from AOCI
—
709
(176)
—
533
Related tax amounts
—
(293)
46
(131)
(378)
Balance at September 30, 2021
$
(32,082)
$
(20,874)
$
381
$
(2,148)
$
(54,723)
Balance at June 30, 2020
$
(88,637)
$
(17,363)
$
1,148
$
(4,412)
$
(109,264)
Other comprehensive income (loss) before
reclassifications
33,601
(901)
810
460
33,970
Amounts reclassified from AOCI
—
584
(104)
—
480
Related tax amounts
—
60
(150)
(106)
(196)
Balance at September 30, 2020
$
(55,036)
$
(17,620)
$
1,704
$
(4,058)
$
(75,010)
Defined
Unrealized
Currency
Benefit
Gain (Loss) in
Translation
Pension
Available-for-
Derivative
Adjustments
Plans
Sale Securities
Instruments
Total
Balance at December 31, 2020
$
(2,875)
$
(23,467)
$
3,342
$
(3,598)
$
(26,598)
Other comprehensive (loss) income before
reclassifications
(29,207)
1,009
(489)
1,883
(26,804)
Amounts reclassified from AOCI
—
2,423
(3,259)
—
(836)
Related tax amounts
—
(839)
787
(433)
(485)
Balance at September 30, 2021
$
(32,082)
$
(20,874)
$
381
$
(2,148)
$
(54,723)
Balance at December 31, 2019
$
(44,568)
$
(34,533)
$
1,251
$
(320)
$
(78,170)
Other comprehensive (loss) income before
 
reclassifications
(10,468)
(409)
802
(4,855)
(14,930)
Amounts reclassified from AOCI
—
25,550
(229)
—
25,321
Related tax amounts
—
(8,228)
(120)
1,117
(7,231)
Balance at September 30, 2020
$
(55,036)
$
(17,620)
$
1,704
$
(4,058)
$
(75,010)
All reclassifications related to unrealized gain (loss) in available-for-sale securities relate
 
to the Company’s equity
 
interest in a
captive insurance company and are recorded in equity in net income
 
of associated companies.
 
The amounts reported in other
comprehensive income for noncontrolling interest are related to currency
 
translation adjustments.
Note 17 – Fair Value
 
Measurements
The Company has valued its company-owned life insurance policies at fair value.
 
These assets are subject to fair value
measurement as follows:
Fair Value
 
Measurements at September 30, 2021
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
$
2,135
$
—
$
2,135
$
—
Total
$
2,135
$
—
$
2,135
$
—
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts, unless otherwise stated)
(Unaudited)
24
Fair Value
 
Measurements at December 31, 2020
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
 
$
1,961
$
—
$
1,961
$
—
Total
$
1,961
$
—
$
1,961
$
—
The fair values of Company-owned life insurance assets are based on quotes
 
for like instruments with similar credit ratings and
terms.
 
The Company did not hold any Level 3 investments as of September 30,
 
2021 or December 31, 2020, respectively,
 
so related
disclosures have not been included.
Note 18 – Hedging Activities
In order to satisfy certain requirements of the Credit Facility as well as to manage
 
the Company’s exposure to variable
 
interest
rate risk associated with the Credit Facility,
 
in November 2019, the Company entered into $
170.0
 
million notional amounts of
three
year
 
interest rate swaps.
 
See Note 15 of Notes to Condensed Consolidated Financial Statements.
 
These interest rate swaps are
designated as cash flow hedges and, as such, the contracts are marked-to-market
 
at each reporting date and any unrealized gains or
losses are included in AOCI to the extent effective and reclassified to interest
 
expense in the period during which the transaction
affects earnings or it becomes probable that the forecasted
 
transaction will not occur.
 
The balance sheet classification and fair values of the Company’s
 
derivative instruments, which are Level 2 measurements, are as
follows:
Fair Value
Condensed Consolidated
September 30,
 
December 31,
Balance Sheet Location
2021
2020
Derivatives designated as cash flow hedges:
Interest rate swaps
Other non-current liabilities
$
2,789
$
4,672
$
2,789
$
4,672
The following table presents the net unrealized loss deferred to AOCI:
September 30,
 
December 31,
2021
2020
Derivatives designated as cash flow hedges:
Interest rate swaps
AOCI
$
2,148
$
3,598
$
2,148
$
3,598
The following table presents the net loss reclassified from AOCI to earnings:
Three Months Ended
Nine Months Ended
September 30,
 
September 30,
 
2021
2020
2021
2020
Amount and location of expense reclassified
from AOCI into expense (effective portion)
Interest expense, net
$
(672)
$
(640)
$
(1,974)
$
(1,105)
Interest rate swaps are entered into with a limited number of counterparties,
 
each of which allows for net settlement of all
contracts through a single payment in a single currency in the event of a default
 
on or termination of any one contract.
 
As such, in
accordance with the Company’s accounting
 
policy, these derivative instruments
 
are recorded on a net basis within the Condensed
Consolidated Balance Sheets.
Note 19 – Commitments and Contingencies
The Company previously disclosed in its 2020 Form 10-K that AC Products, Inc.
 
(“ACP”), a wholly owned subsidiary,
 
has been
operating a groundwater treatment system to hydraulically contain groundwater
 
contamination emanating from ACP’s site,
 
the
principal contaminant of which is perchloroethylene.
 
As of September 30, 2021, ACP believes it is close to meeting the conditions
 
for
closure of the groundwater treatment system, but continues to operate
 
this system while in discussions with the relevant authorities.
 
As of September 30, 2021, the Company believes that the range of potential
 
-known liabilities associated with the balance of the ACP
water remediation program is approximately $
0.1
 
million to $
1.0
 
million.
 
The low and high ends of the range are based on the length
of operation of the treatment system as determined by groundwater modeling.
 
Costs of operation include the operation and
maintenance of the extraction well, groundwater monitoring and
 
program management.
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts, unless otherwise stated)
(Unaudited)
25
The Company previously disclosed in its 2020 Form 10-K that an inactive
 
subsidiary of the Company that was acquired in 1978
sold certain products containing asbestos, primarily on an installed basis, and
 
is among the defendants in numerous lawsuits alleging
injury due to exposure to asbestos.
 
During the three and nine months ended September 30, 2021, there have been
 
no significant
changes to the facts or circumstances of this previously disclosed matter,
 
aside from on-going claims and routine payments associated
with this litigation.
 
Based on a continued analysis of the existing and anticipated future claims against this subsidiary,
 
it is currently
projected that the subsidiary’s total
 
liability over the next 50 years for these claims is approximately $
0.4
 
million (excluding costs of
defense).
The Company previously disclosed in its 2020 Form 10-K that it is party to certain environmental
 
matters related to certain
domestic and foreign properties currently or previously owned by Houghton.
 
These environmental matters primarily require the
Company to perform long-term monitoring as well as operating and
 
maintenance at each of the applicable sites.
 
During the three and
nine months ended September 30, 2021, there have been no significant
 
changes to the facts or circumstances of these previously
disclosed matters, aside from on-going monitoring and maintenance
 
activities and routine payments associated with each of the sites.
 
The Company continually evaluates its obligations related to such matters,
 
and based on historical costs incurred and projected costs
to be incurred over the next 28 years, has estimated the present value
 
range of costs for all of the Houghton environmental matters,
 
on
a discounted basis, to be between approximately $
5.5
 
million and $
6.5
 
million as of September 30, 2021, for which $
5.7
 
million was
accrued within other accrued liabilities and other non-current liabilities on
 
the Company’s Condensed
 
Consolidated Balance Sheet as
of September 30, 2021.
 
Comparatively, as of December
 
31, 2020, the Company had $
6.0
 
million accrued for with respect to these
matters.
The Company believes, although there can be no assurance regarding the outcome
 
of other unrelated environmental matters, that
it has made adequate accruals for costs associated with other environmental
 
problems of which it is aware.
 
Approximately $
0.3
million and $
0.1
 
million was accrued as of September 30, 2021 and December 31, 2020,
 
respectively, to provide for
 
such anticipated
future environmental assessments and remediation costs.
 
The Company previously disclosed in its 2020 Form 10-K that during the fourth
 
quarter of 2020, one of the Company’s
subsidiaries received a notice of inspection from a taxing authority
 
in a country where certain of its subsidiaries operate which related
to a non-income (indirect) tax that may be applicable to certain products the
 
subsidiary sells.
 
During the third quarter of 2021, the
Company’s subsidiary received
 
notice from the taxing authority that the inspection was closed, with no tax
 
assessment issued.
 
Based
on this development, during the third quarter of 2021, the Company reversed
 
its previously recorded $
1.8
 
million liability related to
this matter.
 
The Company also reversed the associated $
1.1
 
million indemnification receivable, as the asserted tax liability in
 
part
related to a Houghton entity acquired in the Combination and for
 
the periods prior to the Combination, for which the Company would
be indemnified by Houghton’s
 
former owners.
 
Based on all available information as of the date of this Report, the Company does not
anticipate further tax inspection or liabilities related to this matter to be
 
asserted by the taxing authority.
 
During the first half of 2021, one of the Company’s
 
Brazilian subsidiaries received a notice that it had prevailed on an existing
legal claim in regard to certain non-income (indirect) taxes that had been
 
previously charged and paid.
 
The matter specifically relates
to companies’ rights to exclude the state tax on goods circulation (a valued-added-tax
 
or
VAT
equivalent, known in Brazil as “ICMS”)
from the calculation of certain additional indirect taxes (specifically the program
 
of social integration (“PIS”) and contribution for the
financing of social security (“COFINS”)) levied by the Brazilian States on the sale of
 
goods.
 
In May 2021, the Brazilian Supreme
Court concluded that ICMS should not be included in the tax base of PIS
 
and COFINS, and confirmed the methodology for
calculating the PIS and COFINS tax credit claims to which taxpayers are
 
entitled.
 
The Company’s Brazilian entities had
 
previously
filed legal or administrative disputes on this matter and are entitled to receive
 
tax credits and interest dating back to five years
preceding the date of their legal claims.
 
As a result of these court rulings, during the second quarter of 2021, the
 
Company recognized
non-income tax credits of
67.0
 
million BRL or approximately $
13.3
 
million, which included approximately $
8.4
 
million for the PIS
and COFINS tax credits as well as interest on these tax credits of $
4.9
 
million.
 
The tax credits to which the Company’s Brazilian
subsidiaries are entitled are claimable once registered with the
 
Brazilian tax authorities.
 
The Company submitted its formal claim for
tax credits in October 2021.
 
These tax credits can be used to offset future Brazilian federal taxes and
 
the Company currently
anticipates using the full amount of credits during the five year period of
 
time permitted.
 
During the third quarter of 2021, the
Brazilian Supreme Court ruled that interest income to which companies are
 
entitled for matters such as this claim should not be
taxable, which resulted in a reduction to the estimated income tax expense
 
associated with the tax credits recorded.
 
In connection with obtaining regulatory approvals for the Combination,
 
certain steel and aluminum related product lines of
Houghton were divested on August 1, 2019. In July 2021, the entity that acquired
 
these divested product lines submitted an
indemnification claim for certain alleged breaches of representation made
 
by Houghton in the agreement pursuant to which such assets
had been divested.
 
The Company and the acquirer have agreed to extend the period for
 
a possible negotiated resolution of this claim
through November 30, 2021 so that both parties can evaluate the other’s
 
positions with respect to the subject matters of the claim.
 
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts, unless otherwise stated)
(Unaudited)
26
The Company is evaluating the merits of the alleged losses in the indemnification
 
claim received.
 
As of the date of this Report, the
Company does not believe it is reasonably possible to determine or quantify
 
any possible exposure.
 
During the third quarter of 2021, two of the Company’s
 
locations suffered property damages as a result of flooding and fire.
 
The
Company maintains property insurance for all of its facilities globally.
 
In Conshohocken, Pennsylvania, the Company’s
 
global
headquarters as well as its laboratory experienced property damages
 
as a result of flooding from Hurricane Ida.
 
Also, one of the
Company’s North American
 
production facilities in its Global Specialty Businesses segment experienced an
 
electrical fire that
resulted in damage and the temporary shutdown of production,
 
and also required remediation, cleaning and subsequent restoration.
 
The Company, its insurance
 
adjuster and insurance carrier are actively managing the remediation and restoration
 
activities associated
with these events and at this time the Company has concluded, based on all available
 
information and discussions with its insurance
adjuster and insurance carrier, that the losses incurred
 
during the third quarter of 2021 will be covered under the Company’s
 
property
insurance coverage, net of an aggregate deductible of $
2.0
 
million.
 
The Company has received advance payments from its insurers of
$
1.0
 
million and has recorded an insurance receivable associated with these events
 
(and a gain on insurance recoveries for losses
incurred) of $
1.7
 
million as of September 30, 2021.
 
The Company and its insurance carrier are in early stages of reviewing the impact
of the electrical fire on the production facility’s
 
operations as it relates to a potential business interruption insurance claim; however,
as of the date of this Report, the Company cannot reasonably estimate any
 
probable amount of business interruption insurance claim
recoverable, therefore the Company has not recorded a gain contingency
 
for a possible business interruption insurance claim as of
September 30, 2021.
The Company is party to other litigation which management currently
 
believes will not have a material adverse effect on the
Company’s results of operations,
 
cash flows or financial condition.
 
In addition, the Company has an immaterial amount of contractual
purchase obligations.
Quaker Chemical Corporation
Management’s Discussion and Analysis
27
Item 2.
 
Management’s Discussion and Analysis
 
of Financial Condition and Results of Operations
.
As used in this Report, the terms “Quaker Houghton,”
 
the “Company,”
 
“we” and “our” refer to Quaker Chemical Corporation
(doing business as Quaker Houghton), its subsidiaries, and associated companies,
 
unless the context otherwise requires.
 
As used in
this Report, the term Legacy Quaker refers to the Company prior to the closing of
 
its combination with Houghton International, Inc.
(“Houghton”) (herein referred to as the “Combination”) on August 1, 2019.
 
Throughout the Report, all figures presented, unless
otherwise stated, reflect the results of operations of the combined company for the
 
three and nine months ended September 30, 2021
and 2020.
Executive Summary
Quaker Houghton is the global leader in industrial process fluids.
 
With a presence around the world, including operations
 
in over
25 countries, our customers include thousands of the world’s
 
most advanced and specialized steel, aluminum, automotive, aerospace,
offshore, can, mining, and metalworking companies.
 
Our high-performing, innovative and sustainable solutions are backed by best-
in-class technology,
 
deep process knowledge, and customized services.
 
Quaker Houghton is headquartered in Conshohocken,
Pennsylvania, located near Philadelphia in the United States.
The Company’s third quarter
 
results were highlighted by record net sales as well as the on-going execution of
 
integration
activities and synergy realization, but these positive
 
financial impacts were partially offset by continued raw material
 
cost headwinds
and global supply chain pressures.
 
Specifically, net sales of $449.1
 
million in the third quarter of 2021 increased 22% compared to
$367.2 million in the third quarter of 2020, primarily due to higher volumes
 
of approximately 10%, including additional net sales from
acquisitions of 4%, increases from selling price and product mix of
 
approximately 10% and the positive impact from foreign currency
translation of 2%.
 
The increase in sales volumes compared to the third quarter of 2020 was primarily a
 
result of continued market
share gains and the year-over-year improvement
 
in end market conditions since the beginning of the COVID-19 pandemic.
 
The
increase in selling price and product mix is primarily the result of
 
the Company’s price increases implemented
 
during 2021 to help
offset the unprecedented increases in raw material
 
costs the Company has experienced throughout 2021.
 
The Company’s current
quarter gross margin of 32.3% declined sequentially
 
compared to 35.5% in the second quarter of 2021
 
which, as the Company had
expected,
 
was lower than the 38.2% in the prior year third quarter,
 
driven by the continued increase in raw material costs and logistics
pressures.
The Company had net income in the third quarter of 2021 of $31.1 million, or $1.73 per diluted
 
share, compared to a third quarter
of 2020 net income of $27.3 million, or $1.53 per diluted share.
 
The current quarter results reflect the gross margin headwinds noted
above while the prior year third quarter net income was affected by
 
the COVID-19 pandemic and its impact on the global economy,
including most of the Company’s
 
end customers.
 
Excluding non-recurring items including costs associated with the Combination
 
and
other non-core items in each period, the Company’s
 
third quarter of 2021 non-GAAP earnings per diluted share were $1.63 compared
to $1.56 in the prior year third quarter.
 
The Company’s current quarter adjusted
 
EBITDA of $66.2 million increased 3% compared to
$63.9 million in the third quarter of 2020 primarily due to the significant
 
increase in net sales quarter-over-quarter as well as higher
realized cost synergies from the Combination and foreign
 
currency transaction gains in the current quarter compared to foreign
currency transaction losses in the third quarter of 2020, partially offset
 
by lower gross margins driven by higher raw material costs and
the impacts of disruptions in the global supply chain experienced in 2021
 
as well as higher selling, general and administrative
expenses (“SG&A”) including the impact
 
of higher sales on direct selling expenses and additional SG&A from recent acquisitions.
 
The Company estimates that it realized cost synergies associated
 
with the Combination of approximately $19 million during the
 
third
quarter of 2021 compared to approximately $17 million during
 
the third quarter of 2020.
 
See the Non-GAAP Measures section of this
Item below, as well as other
 
items discussed in the Company’s
 
Consolidated Operations Review in the Operations section of this Item,
below.
The Company’s third quarter
 
of 2021 operating performance in each of its four reportable segments: (i) Americas;
 
(ii) Europe,
Middle East and Africa (“EMEA”); (iii) Asia/Pacific; and (iv) Global Specialty
 
Businesses, reflect similar drivers to that of its
consolidated performance.
 
All four segments had higher net sales compared to the third quarter of 2020 reflecting
 
the continued
rebound in 2021 from the negative impacts
 
of COVID-19 on the Company’s
 
end markets during 2020 as well as continued success of
taking market share in each of the Company’s
 
segments during the third quarter of 2021.
 
All of the Company’s segments benefited
from higher organic sales volumes,
 
which excludes the benefits of recent acquisitions, as compared
 
to the prior year quarter, additional
net sales from acquisitions, the positive impact from foreign currency
 
translation due to the strengthening of most major currencies
against the U.S. dollar, and from increases in
 
selling price and product mix.
 
As reported, the Company’s Americas and
 
EMEA
segment operating earnings were higher compared to the third quarter of 2020
 
reflecting the increase in net sales including the benefits
of acquisitions; however, all of the Company’s
 
segment’s operating earnings were negatively
 
impacted by the unprecedented raw
material cost increases and the impacts of disruptions in the global supply
 
chain that continued throughout the third quarter of 2021 as
well as higher SG&A which were a result of an increase in direct selling expenses
 
associated with year-over-year inflation increases
and increases due to the increase in net sales as well as the lower levels of prior year SG&A
 
as a result of temporary cost saving
measures implemented in response to COVID-19.
Quaker Chemical Corporation
Management’s Discussion and Analysis
28
The Company had a net operating cash flow of $2.5 million in the first nine
 
months of 2021 as compared to net operating cash
flow of $112.0 million in the first nine
 
months of 2020.
 
The decrease in net operating cash flow year-over-year was primarily driven
by a significant change in working capital compared to the prior year,
 
mainly increases in accounts receivable, due to higher net sales
and inventory, due to
 
higher costs as well as building inventories in response to global supply chain
 
and logistics pressures.
 
The key
drivers of the Company’s operating
 
cash flow and working capital are further discussed in the Company’s
 
Liquidity and Capital
Resources section of this Item, below.
Overall, the Company’s third
 
quarter results were good, despite being negatively impacted by
 
the automotive semiconductor
shortage and continued supply chain challenges.
 
Increases in net sales in all segments were driven by the continued year-over
 
-year
improvement in the Company’s
 
end-markets and increased customer demand from lower levels experienced
 
during 2020 as a result of
COVID-19; however, each segment was negatively
 
impacted by the significant escalation of raw material costs as well as higher
SG&A.
 
While sequential operating performance as compared to the second
 
quarter of 2021 was slightly lower, continued strong
customer demand in the third quarter of 2021 coupled with on-going
 
market share gains and the execution of integration activities and
synergy realization helped offset the negative
 
impacts from the continued escalation of raw material costs and continued supply
 
chain
pressures.
 
As the Company looks to the rest of 2021, it expects gross margins
 
to continue to be challenged by increased raw material costs
and supply chain headwinds, although it also expects to have sequential improvement
 
in product margins from current quarter levels
as it continues to implement price increases.
 
In addition, although the Company expects customer demand for most of its businesses
to remain strong, it also anticipates some near-term headwinds
 
due to the power restrictions in China, the global semiconductor
shortages in the automotive industry,
 
and some seasonality trends which the Company typically experiences in the last quarter
 
of the
year.
 
Looking ahead to 2022, the Company expects another strong year with net sales and earnings
 
growth to be above normal long-
term trends as the Company expects good growth in end markets, continued
 
market share gains and higher gross margins as pricing
initiatives catch up from the lag experienced in 2021 due to significant raw
 
material inflation.
On-going impact of COVID-19
The global outbreak of COVID-19 has negatively impacted all locations where
 
the Company does business.
 
Although the
Company has now operated in this COVID-19 environment for
 
over a year, the full extent of the outbreak and related
 
business
impacts continue to remain uncertain and volatile, and therefore
 
the full extent to which COVID-19 may impact the Company’s
 
future
results of operations or financial condition is uncertain.
 
This outbreak has significantly disrupted the operations of the Company
 
and
those of its suppliers and customers.
 
During the pandemic, the Company has experienced volume declines and
 
lower net sales as
compared to pre-COVID-19 levels, as further described in this section.
 
Management continues to monitor the impact that the
COVID-19 pandemic is having on the Company,
 
the overall specialty chemical industry and the economies and markets in which
 
the
Company operates.
 
Given the continuously evolving global developments with respect to this pandemic,
 
the Company cannot, as of
the date of this Report, reasonably estimate the magnitude or the full extent of
 
the impact to its future results of operations or to the
ability of it or its customers to resume more normal operations, even as certain restrictions
 
are lifted.
 
The prolonged pandemic and
resurgences
 
of the outbreak including as new variants continue to emerge,
 
and continued restrictions on day-to-day life and business
operations may result in volume declines and lower net sales in future periods.
 
To the extent that the Company’s
 
customers and
suppliers continue to be significantly and adversely impacted by
 
COVID-19, this could reduce the availability,
 
or result in delays, of
materials or supplies to or from the Company,
 
which in turn could significantly interrupt the Company’s
 
business operations.
 
Given
this ongoing uncertainty,
 
the Company cautions that its future results of operations could be significantly adversely
 
impacted by
COVID-19.
 
Further, management continues to evaluate
 
how COVID-19-related circumstances, such as remote work arrangements,
illness or staffing shortages and travel restrictions have affected
 
financial reporting processes and systems, internal control over
financial reporting, and disclosure controls and procedures.
 
While the circumstances have presented and are expected to continue
 
to
present challenges, and have necessitated additional time and resources
 
to be deployed to sufficiently address the challenges brought
on by the pandemic, at this time, management does not believe that COVID-19
 
has had a material impact on financial reporting
processes, internal controls over financial reporting, or disclosure controls
 
and procedures.
 
The Company’s top priority,
 
especially during this pandemic, is to protect the health and safety of its employees
 
and customers,
while working to ensure business continuity to meet customers’ needs.
 
The Company continues to take steps to protect the health and
wellbeing of its people in affected areas through various
 
actions, including enabling work at home where needed and possible, and
employing social distancing standards, implementing
 
travel restrictions where applicable, enhancing onsite hygiene practices, and
instituting visitation restrictions at the Company’s
 
facilities.
 
The Company has not and does not expect that it will incur material
expenses implementing these health and safety policies.
 
All of the Company’s 31 production
 
facilities worldwide are open and
operating and are deemed as essential businesses in the jurisdictions where
 
they are operating.
 
The Company believes that to date it
has been able to meet the needs of all its customers across the globe despite the
 
current economic challenges.
 
The Company’s third
quarter of 2021 showed year-over-year
 
improvement from the prior year third quarter and continued a trend of gradual
 
volume
improvement which began in the second half of 2020.
 
The Company continues to expect that the impact from COVID-19 will
gradually improve subject to the effective containment
 
of the virus and its variants and successful distribution and acceptance of the
Quaker Chemical Corporation
Management’s Discussion and Analysis
29
available vaccines.
 
However, the incidence of reported cases of COVID-19
 
or a variant in several geographies where the Company
has significant operations remains high and continues to evolve and it remains
 
highly uncertain as to how long the global pandemic
and related economic challenges will last and when our customers’ businesses
 
will recover to pre-COVID-19 levels.
 
The Company
took various actions to temporarily conserve cash and reduce costs since the
 
onset of the pandemic and these temporary initiatives
were designed and implemented so that the Company could successfully manage
 
through the challenging COVID-19 situation while
continuing to protect the health of its employees, meet customers’ needs,
 
maintain the Company’s long-term competitive
 
advantages
and above-market growth, and enable it to continue to effec
 
tively integrate Houghton.
 
While the actions taken to date to protect our
workforce, to continue to serve our customers with excellence and to conserve
 
cash and reduce costs, have been effective thus far,
further actions to respond to the pandemic and its effects may
 
be necessary as conditions continue to evolve.
Liquidity and Capital Resources
At September 30, 2021, the Company had cash, cash equivalents and restricted
 
cash of $141.4 million.
 
Total cash, cash
equivalents and restricted cash was $181.9 million at December
 
31, 2020.
 
The $40.5 million decrease in cash, cash equivalents and
restricted cash was the net result of approximately $30.1 million of
 
cash used in investing activities, $10.5 million of cash used in
financing activities, and a $2.5 million negative impact due to the effect
 
of foreign currency translation,
 
partially offset by $2.5 million
of cash provided by operating activities.
Net cash flows provided by operating activities were $2.5 million in the
 
first nine months of 2021 compared to $112.0 million in
the first nine months of 2020.
 
The decrease in net operating cash flows of $109.5 million was primarily
 
driven by a significant change
in working capital.
 
The significant increase in current year net sales resulted in a large increase in
 
accounts receivable in the first nine
months of 2021 as compared to accounts receivable being a cash inflow in
 
the prior year as sales and the associated accounts
receivables significantly declined during the first nine months of 2020
 
due to the negative impact from COVID-19.
 
In addition, the
Company has experienced an increase in inventory in the first nine months
 
of 2021 as a result of continued rising raw material costs as
well as a build in inventory to ensure the Company has appropriate stock
 
to meet customer demands in response to ongoing stress on
the global supply chain.
 
In addition, the Company had higher cash dividends received from its associated companies
 
in the first nine
months of 2020, primarily due to $5.0 million received from the Company’s
 
joint venture in Korea with no similar dividend received
in the first nine months of 2021 related to the timing of dividends received.
Net cash flows used in investing activities were $30.1 million in the
 
first nine months of 2021 compared to $15.3 million in the
first nine months of 2020.
 
This increase in cash outflows was driven by higher cash payments related to acquisitions
 
during the first
nine months of 2021, including $25.0 million for certain assets related to tin-plating
 
solutions primarily for steel end markets.
 
These
higher cash outflows were partially offset by cash proceeds
 
of approximately $14.7 million from the disposition of assets, which
includes the sale of certain held-for-sale real property assets related to the Combination.
 
Capital expenditures were relatively
consistent at $12.8 million in the first nine months of 2021 compared to $12.2
 
million in the first nine months of 2020.
 
Net cash flows used in financing activities were $10.5 million in the first nine
 
months of 2021 compared to $65.1 million in the
first nine months of 2020.
 
The decrease in net cash flows used in financing activities of $54.6 million
 
was primarily driven an
increase in borrowings in the current year under the Company’s
 
revolving credit facility compared to repayments in the prior year
which was primarily driven by the significant working capital investment
 
in the current year described above.
 
In addition, the
Company paid $21.2 million of cash dividends during the first nine months
 
of 2021, a $0.7 million or 3% increase in cash dividends
compared to the prior year.
 
Finally, during the first nine
 
months of 2020, the Company used $1.0 million to purchase the remaining
noncontrolling interest in a South Africa affiliate.
 
Prior to this buyout,
 
this South Africa affiliate made a distribution to the prior
noncontrolling affiliate shareholder of approximately
 
$0.8 million in the first nine months of 2020.
 
There were no similar
noncontrolling interest activities in the first nine months of 2021.
The Company’s primary credit facility
 
(the “Credit Facility”) is comprised of a $400.0 million multicurrency
 
revolver (the
“Revolver”), a $600.0 million term loan (the “U.S. Term
 
Loan”), each with the Company as borrower, and
 
a $150.0 million (as of
August 1, 2019) Euro equivalent term loan (the “Euro Term
 
Loan” and together with the U.S. Term
 
Loan”, the “Term Loans”)
 
with
Quaker Chemical B.V.,
 
a Dutch subsidiary of the Company as borrower,
 
each with a five year term maturing in August 2024.
 
Subject
to the consent of the administrative agent and certain other conditions,
 
the Company may designate additional borrowers.
 
The
maximum amount available under the Credit Facility can be increased by
 
up to $300.0 million at the Company’s request
 
if there are
lenders who agree to accept additional commitments and the Company has
 
satisfied certain other conditions.
 
Borrowings under the
Credit Facility bear interest at a base rate or LIBOR plus an applicable margin
 
based on the Company’s consolidated
 
net leverage
ratio.
 
There are LIBOR replacement provisions that contemplate a further amendment
 
when LIBOR ceases to be reported.
 
The
weighted average interest rate incurred on the outstanding borrowings
 
under the Credit Facility during both the first nine months of
2021 and as of September 30, 2021 was approximately 1.6%.
 
In addition to paying interest on outstanding principal under the Credit
Facility, the Company
 
is required to pay a commitment fee ranging from 0.2% to 0.3% depending on
 
the Company’s consolidated net
leverage ratio to the lenders under the Revolver in respect of the unutilized
 
commitments thereunder.
Quaker Chemical Corporation
Management’s Discussion and Analysis
30
The Credit Facility is subject to certain financial and other covenants.
 
The Company’s initial consolidated net
 
debt to
consolidated adjusted EBITDA ratio could not exceed 4.25 to 1,
 
with step downs in the permitted ratio over the term of the Credit
Facility.
 
As of September 30, 2021,
 
the consolidated net debt to consolidated adjusted EBITDA ratio may
 
not exceed 4.00 to 1.
 
The
Company’s consolidated
 
adjusted EBITDA to interest expense ratio may not be less than 3.0 to 1 over the
 
term of the agreement.
 
The
Credit Facility also prohibits the payment of cash dividends if the Company
 
is in default or if the amount of the dividends paid
annually exceeds the greater of $50.0 million and 20% of consolidated adjusted
 
EBITDA unless the ratio of consolidated net debt to
consolidated adjusted EBITDA is less than 2.0 to 1, in which case there is no such limitation
 
on amount.
 
As of September 30, 2021,
and December 31, 2020, the Company was in compliance with all of the
 
Credit Facility covenants.
 
The Term Loans have quarterly
principal amortization during their five year terms, with 5.0% amortization
 
of the principal balance due in years 1 and 2, 7.5% in year
3, and 10.0% in years 4 and 5, with the remaining principal amount due
 
at maturity.
 
The Credit Facility is guaranteed by certain of the
Company’s domestic subsidiaries and
 
is secured by first priority liens on substantially all of the assets of the Company
 
and the
domestic subsidiary guarantors, subject to certain customary exclusions.
 
The obligations of the Dutch borrower are guaranteed only
by certain foreign subsidiaries on an unsecured basis.
The Credit Facility required the Company to fix its variable interest rates on
 
at least 20% of its total Term
 
Loans.
 
In order to
satisfy this requirement as well as to manage the Company’s
 
exposure to variable interest rate risk associated with the Credit Facility,
in November 2019, the Company entered into $170.0 million notional
 
amounts of three year interest rate swaps at a base rate of 1.64%
plus an applicable margin as provided in the Credit Facility,
 
based on the Company’s consolidated
 
net leverage ratio.
 
At the time the
Company entered into the swaps, and as of September 30, 2021, the
 
aggregate interest rate on the swaps, including the fixed base rate
plus an applicable margin, was 3.1%.
 
The Company capitalized $23.7 million of certain third-party debt issuance
 
costs in connection with executing the Credit Facility.
 
Approximately $15.5 million of the capitalized costs were attributed to the Term
 
Loans and recorded as a direct reduction of long-
term debt on the Company’s Consolidated
 
Balance Sheet.
 
Approximately $8.3 million of the capitalized costs were attributed
 
to the
Revolver and recorded within other assets on the Company’s
 
Condensed Consolidated Balance Sheet.
 
These capitalized costs are
being amortized into interest expense over the five year term of the Credit
 
Facility.
 
As of September 30, 2021, the Company had Credit Facility borrowings
 
outstanding of $888.6 million.
 
As of December 31,
2020, the Company had Credit Facility borrowings outstanding of $887.1
 
million.
 
The Company has unused capacity under the
Revolver of approximately $197 million, net of bank letters of credit
 
of approximately $4 million, as September 30, 2021.
 
The
Company’s other debt obligations
 
are primarily industrial development bonds, bank lines of credit and municipality-related
 
loans,
which totaled $12.1 million as of both September 30, 2021 and December
 
31, 2020.
 
Total unused capacity under
 
these arrangements
as of September 30, 2021 was approximately $39 million.
 
The Company’s total net debt as of September
 
30, 2021 was $759.3
million.
The Company estimates that it realized cost synergies in the first nine
 
months of 2021 of approximately $56 million compared to
approximately $40 million in the first nine months of 2020.
 
The Company continues to expect to realize Combination cost synergies
of approximately $75 million in 2021 and $80 million in 2022.
 
The Company continues to expect to incur additional costs and make
associated cash payments to integrate Quaker and Houghton and continue
 
realizing the Combination’s total anticipated
 
cost synergies.
 
The Company expects total cash payments, including those pursuant
 
to the QH Program, described below,
 
but excluding incremental
capital expenditures related to the Combination, will be approximately
 
1.3 times its total anticipated 2022 cost synergies of $80
million.
 
A significant portion of these costs were already incurred in 2019, 2020 and the
 
first nine months of 2021, but the Company
expects to continue to incur such costs throughout the remainder
 
of 2021 and into 2022.
 
The Company incurred $13.6 million of total
Combination, integration and other acquisition-related expenses in the first
 
nine months of 2021, which includes $0.7 million of
accelerated depreciation and is net of a $5.4 million gain on the sale of
 
certain held-for-sale real property assets, described in the
 
Non-
GAAP Measures section of this Item below.
 
Comparatively, in the first nine months
 
of 2020, the Company incurred $23.4 million of
total Combination, integration and other acquisition-related expenses
 
,
 
including $0.8 million of accelerated depreciation, described in
the Non-GAAP Measures section of this Item below.
 
The Company had aggregate net cash outflows of approximately $20.0
 
million
related to the Combination, integration and other acquisition-related
 
expenses during the first nine months of 2021 as compared to
$20.9 million during the first nine months of 2020.
 
Quaker Houghton’s management
 
approved, and the Company initiated, a global restructuring plan (the
 
“QH Program”) in the
third quarter of 2019 as part of its planned cost synergies associated
 
with the Combination.
 
The QH Program includes restructuring
and associated severance costs to reduce total headcount by approximately
 
400 people globally and plans for the closure of certain
manufacturing and non-manufacturing facilities.
 
In connection with the plans for closure of certain manufacturing and non-
manufacturing facilities, the Company made a decision to make available
 
for sale certain facilities during the second quarter of 2020.
 
During the first quarter of 2021, certain of these facilities were sold
 
and the Company recognized a gain on disposal of $5.4 million
included within other income (expense), net on the Condensed
 
Consolidated Statement of Operations.
 
The exact timing and total
costs associated with the QH Program will depend on a number of factors
 
and is subject to change; however, reductions in headcount
and site closures have continued into 2021.
 
The Company currently expects additional headcount reductions and site closures
 
to occur
Quaker Chemical Corporation
Management’s Discussion and Analysis
31
into 2022 and estimates that the anticipated cost synergies
 
realized under the QH Program will approximate one-times restructuring
costs incurred.
 
The Company made cash payments related to the settlement of restructuring liabilities under
 
the QH Program during
the first nine months of 2021 of approximately $4.6 million compared
 
to $12.8 million in the first nine months of 2020.
In
 
the fourth quarter of 2018, the Company began the process of terminating
 
its non-contributory U.S. pension plan (“the Legacy
Quaker U.S. Pension Plan”) and in this process, which was completed
 
during the first quarter of 2020, the Company was required to
fully fund the Legacy Quaker U.S. Pension Plan on a termination basis in the
 
amount of approximately $1.8 million, subject to final
true up adjustments.
 
In the third quarter of 2020, the Company finalized the amount of liability and related
 
annuity payments and
received a refund in premium of $1.6 million.
 
In addition, the Company recorded
 
a non-cash pension settlement charge at plan
termination of approximately $22.7 million in the first quarter of 2020.
As of September 30, 2021, the Company’s
 
gross liability for uncertain tax positions, including interest and penalties,
 
was $30.8
million.
 
The Company cannot determine a reliable estimate of the timing of cash flows
 
by period related to its uncertain tax position
liability.
 
However, should the entire liability be
 
paid, the amount of the payment may be reduced by up to $7.6 million as a result of
offsetting benefits in other tax jurisdictions.
 
During the first nine months of 2021, the Company recorded $13.3 million of non-
income tax credits for certain of its Brazilian subsidiaries.
 
The Company expects to utilize these credits to offset
 
certain Brazilian
federal tax payments over approximately two years beginning in the
 
fourth quarter of 2021.
 
See Note 19 of Notes to Condensed
Consolidated Financial Statements in Item 1 of this Report.
During the third quarter of 2021, two of the Company’s
 
locations suffered property damage as a result of flooding and fire.
 
The
Company maintains property insurance for all of its facilities globally.
 
The Company, its insurance
 
adjuster and insurance carrier are
actively managing the remediation and restoration activities associated
 
with both of these events and at this time the Company has
concluded, based on all available information and discussions with its insurance
 
adjuster and insurance carrier, that the losses incurred
during the third quarter of 2021 will be covered under the Company’s
 
property insurance coverage, net of an aggregate deductible
 
of
$2.0 million.
 
The Company has received advance payments from its insurers of $1.0 million and
 
has recorded an insurance receivable
associated with these events of $1.7 million as of September 30, 2021.
 
The Company and its insurance carrier are in early stages of
reviewing the impact on operations as it relates to a potential business interruption
 
insurance claim; however, as of the date of
 
this
report, the Company cannot reasonably estimate any probable amount
 
of business interruption insurance claim recoverable, therefore
the Company has not recorded a gain contingency for a possible business interruption
 
insurance claim as of September 30, 2021.
 
See
Note 19 of Notes to Condensed Consolidated Financial Statements in Item
 
1 of this Report.
 
The Company believes that its existing cash, anticipated cash flows from
 
operations and available additional liquidity will be
sufficient to support its operating requirements and fund
 
its business objectives for at least the next twelve months, including but not
limited to, payments of dividends to shareholders, costs related to the
 
Combination and integration, pension plan contributions, capital
expenditures, other business opportunities (including potential acquisitions)
 
and other potential contingencies.
 
The Company’s
liquidity is affected by many factors, some based on normal operations
 
of our business and others related to the impact of the
pandemic
 
on our business and on global economic conditions as well as industry uncertainties,
 
which we cannot predict.
 
We also
cannot predict economic conditions and industry downturns or the
 
timing, strength or duration of recoveries.
 
We may seek,
 
as we
believe appropriate, additional debt or equity financing which would
 
provide capital for corporate purposes, working capital funding,
additional liquidity needs or to fund future growth opportunities, including
 
possible acquisitions and investments.
 
The timing and
amount of potential capital requirements cannot be determined at this time
 
and will depend on a number of factors, including the
actual and projected demand for our products, specialty chemical industry
 
conditions, competitive factors, and the condition of
financial markets, among others.
Non-GAAP Measures
The information in this Form 10-Q includes non-GAAP (unaudited)
 
financial information that includes EBITDA, adjusted
EBITDA, adjusted EBITDA margin, non-GAAP operating
 
income, non-GAAP operating margin, non-GAAP
 
net income and non-
GAAP earnings per diluted share.
 
The Company believes these non-GAAP financial measures provide meani
 
ngful supplemental
information as they enhance a reader’s understanding
 
of the financial performance of the Company,
 
are indicative of future operating
performance of the Company,
 
and facilitate a comparison among fiscal periods, as the non-GAAP financial
 
measures exclude items
that are not considered indicative of future operating performance or not
 
considered core to the Company’s operations.
 
Non-GAAP
results are presented for supplemental informational purposes only
 
and should not be considered a substitute for the financial
information presented in accordance with GAAP.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
32
The Company presents EBITDA which is calculated as net income (loss)
 
attributable to the Company before depreciation and
amortization, interest expense, net, and taxes on income (loss) before
 
equity in net income of associated companies.
 
The Company
also presents adjusted EBITDA which is calculated as EBITDA plus or
 
minus certain items that are not considered indicative of future
operating performance or not considered core to the Company’s
 
operations.
 
In addition, the Company presents non-GAAP operating
income which is calculated as operating income plus or minus certain items that
 
are not considered indicative of future operating
performance or not considered core to the Company’s
 
operations.
 
Adjusted EBITDA margin and non-GAAP operating margin
 
are
calculated as the percentage of adjusted EBITDA and non-GAAP operating
 
income to consolidated net sales, respectively.
 
The
Company believes these non-GAAP measures provide transparent
 
and useful information and are widely used by analysts, investors,
and competitors in our industry as well as by management in assessing the
 
operating performance of the Company on a consistent
basis.
Additionally, the
 
Company presents non-GAAP net income and non-GAAP earnings per diluted share
 
as additional performance
measures.
 
Non-GAAP net income is calculated as adjusted EBITDA, defined above,
 
less depreciation and amortization, interest
expense, net, and taxes on income before equity in net income of associated
 
companies, in each case adjusted, as applicable, for any
depreciation, amortization, interest or tax impacts resulting from the non
 
-core items identified in the reconciliation of net income
attributable to the Company to adjusted EBITDA.
 
Non-GAAP earnings per diluted share is calculated as non-GAAP net income
 
per
diluted share as accounted for under the “two-class share method.”
 
The Company believes that non-GAAP net income and non-
GAAP earnings per diluted share provide transparent and useful information
 
and are widely used by analysts, investors, and
competitors in our industry as well as by management in assessing the operating
 
performance of the Company on a consistent basis.
The following tables reconcile the Company’s
 
non-GAAP financial measures (unaudited) to their most directly
 
comparable
GAAP (unaudited) financial measures (dollars in thousands unless otherwise
 
noted, except per share amounts):
Non-GAAP Operating Income and Margin Reconciliations
Three Months Ended
Nine Months Ended
September 30,
September 30,
2021
2020
2021
2020
Operating income
$
36,010
$
34,859
$
119,720
$
24,653
Houghton combination, integration and other
 
 
acquisition-related expenses (a)
5,963
6,913
18,977
23,442
Restructuring and related charges (b)
(880)
1,383
593
3,585
Fair value step up of acquired inventory sold (c)
—
—
801
226
CEO transition costs (d)
285
—
1,097
—
Inactive subsidiary's non-operating litigation costs (e)
320
—
613
—
Customer bankruptcy costs (f)
—
—
—
463
Facility remediation costs, net (g)
1,490
—
1,490
—
Indefinite-lived intangible asset impairment (h)
—
—
—
38,000
Non-GAAP operating income
$
43,188
$
43,155
$
143,291
$
90,369
Non-GAAP operating margin (%) (p)
9.6%
11.8%
10.9%
8.8%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
33
EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin
and Non-GAAP Net Income Reconciliations
Three Months Ended
Nine Months Ended
September 30,
September 30,
2021
2020
2021
2020
Net income (loss) attributable to Quaker Chemical Corporation
$
31,058
$
27,304
$
103,243
$
(8,812)
Depreciation and amortization (a)(m)
21,542
21,022
66,334
63,764
Interest expense, net
5,637
6,837
16,725
22,109
Taxes on income (loss)
 
before equity in net income
 
of associated companies
795
2,245
26,702
(7,603)
EBITDA
59,032
57,408
213,004
69,458
Equity income in a captive insurance company (i)
(108)
(542)
(4,071)
(697)
Houghton combination, integration and other
 
acquisition-related expenses (a)
5,786
6,913
12,871
22,679
Restructuring and related charges (b)
(880)
1,383
593
3,585
Fair value step up of acquired inventory sold (c)
—
—
801
226
CEO transition costs (d)
285
—
1,097
—
Inactive subsidiary's non-operating litigation costs (e)
320
—
613
—
Customer bankruptcy costs (f)
—
—
—
463
Facility remediation costs, net (g)
2,019
—
2,019
—
Indefinite-lived intangible asset impairment (h)
—
—
—
38,000
Pension and postretirement benefit (income) costs,
 
non-service components (j)
(343)
(1,375)
(596)
22,491
Brazilian non-income tax credits (k)
—
—
(13,293)
—
Currency conversion impacts of hyper-inflationary economies (l)
58
154
336
278
Adjusted EBITDA
$
66,169
$
63,941
$
213,374
$
156,483
Adjusted EBITDA margin (%) (p)
14.7%
17.4%
16.2%
15.2%
Adjusted EBITDA
$
66,169
$
63,941
$
213,374
$
156,483
Less: Depreciation and amortization - adjusted (a)
21,365
21,022
65,616
63,002
Less: Interest expense, net
5,637
6,837
16,725
22,109
Less: Taxes on income
 
before equity in net income
 
of associated companies - adjusted (a)(o)
9,765
8,337
31,277
15,473
Non-GAAP net income
$
29,402
$
27,745
$
99,756
$
55,899
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
34
Non-GAAP Earnings per Diluted Share Reconciliations
Three Months Ended
Nine Months Ended
September 30,
September 30,
2021
2020
2021
2020
GAAP earnings (loss) per diluted share attributable to
Quaker Chemical Corporation common shareholders
$
1.73
$
1.53
$
5.76
$
(0.50)
Equity income in a captive insurance company
 
per diluted share (i)
(0.01)
(0.03)
(0.23)
(0.04)
Houghton combination, integration and other
 
 
acquisition-related expenses per diluted share (a)
0.26
0.30
0.58
1.03
Restructuring and related charges per diluted share (b)
(0.04)
0.06
0.03
0.15
Fair value step up of acquired inventory sold per diluted share (c)
—
—
0.03
0.01
CEO transition costs per diluted share (d)
0.01
—
0.05
—
Inactive subsidiary's non-operating litigation costs per
 
 
diluted share (e)
0.02
—
0.03
—
Customer bankruptcy costs per diluted share (f)
—
—
—
0.02
Facility remediation costs, net, per diluted share (g)
0.09
—
0.09
—
Indefinite-lived intangible asset impairment per diluted share (h)
—
—
—
1.65
Pension and postretirement benefit (income) costs,
 
non-service components per diluted share (j)
(0.02)
(0.06)
(0.03)
0.83
Brazilian non-income tax credits per diluted share (k)
(0.04)
—
(0.48)
—
Currency conversion impacts of hyper-inflationary
 
 
economies per diluted share (l)
0.00
 
0.01
0.02
0.02
Impact of certain discrete tax items per diluted share (m)
(0.37)
(0.25)
(0.29)
(0.02)
Non-GAAP earnings per diluted share (q)
$
1.63
$
1.56
$
5.56
$
3.15
(a)
Houghton combination, integration and other acquisition-related
 
expenses include certain legal, financial, and other advisory and
consultant costs incurred in connection with post-closing integration
 
activities including internal control readiness and
remediation.
 
These
 
costs are not indicative of the future operating performance of the Company.
 
Approximately $0.2 million
and $0.7 million in the three and nine months ended September 30, 2021, respectively,
 
and approximately $0.3 million and $1.5
million in the three and nine months ended September 30, 2020, respectively,
 
of these pre-tax costs were considered non-
deductible for the purpose of determining the Company’s
 
effective tax rate, and, therefore, taxes on income before equity in
 
net
income of associated companies - adjusted reflects the impact of these
 
items.
 
During the three and nine months ended September
30, 2021, the Company recorded $0.2 million and $0.7 million, respectively,
 
of accelerated depreciation related to certain of the
Company’s facilities compared
 
to $0.8 million during the nine months ended September 30, 2020, which is included
 
in the
caption “Houghton combination, integration and other acquisition-related
 
expenses” in the reconciliation of operating income to
non-GAAP operating income and included in the caption “Depreciation
 
and amortization” in the reconciliation of net income
(loss) attributable to the Company to EBITDA, but excluded from the caption
 
“Depreciation and amortization - adjusted” in the
reconciliation of adjusted EBITDA to non-GAAP net income attributable
 
to the Company.
 
During the nine months ended
September 30, 2021, the Company recorded a $5.4 million gain on the sale of
 
certain held-for-sale real property assets related to
the Combination which is included in the caption “Houghton combination,
 
integration and other acquisition-related expenses” in
the reconciliation of GAAP earnings (loss) per diluted share attributed
 
to Quaker Chemical Corporation common shareholders to
Non-GAAP earnings per diluted share as well as the reconciliation of net
 
income (loss) attributable to Quaker Chemical
Corporation to Adjusted EBITDA and Non-GAAP net income.
 
See Note 2 of Notes to Condensed Consolidated Financial
Statements, which appears in Item 1 of this Report.
(b)
Restructuring and related charges represent the
 
costs incurred by the Company associated with the QH restructuring program
which was initiated in the third quarter of 2019 as part of the Company’s
 
plan to realize cost synergies associated with the
Combination.
 
These costs are not indicative of the future operating performance of the Company.
 
See Note 7 of Notes to
Condensed Consolidated Financial Statements, which appears in Item
 
1 of this Report.
 
(c)
Fair value step up of acquired inventory sold relates to expense associated with
 
selling inventory of acquired businesses which
was adjusted to fair value as a part of purchase accounting.
 
This increase to COGS is not indicative of the future operating
performance of the Company.
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
35
(d)
CEO transition costs represent the costs related to the Company’s
 
search and hiring of a new CEO in connection with the
previously announced executive transition planned for the end of 2021.
 
These expenses are not indicative of the future operating
performance of the Company.
 
(e)
Inactive subsidiary’s non
 
-operating litigation costs represents the charges incurred by
 
an inactive subsidiary of the Company and
are a result of the termination of restrictions on insurance settlement reserves as previously
 
disclosed in the Company’s 2020
Form 10-K.
 
These charges are not indicative of the future operating performance
 
of the Company.
 
See Note 9 of Notes to
Condensed Consolidated Financial Statements, which appears in Item
 
1 of this Report.
(f)
Customer bankruptcy costs represent the cost associated with a specific
 
reserve for trade accounts receivable related to a customer
who filed for bankruptcy protection.
 
These expenses are not indicative of the future operating performance
 
of the Company.
(g)
Facility remediation costs, net, presents the gross costs associated with remediation,
 
cleaning and subsequent restoration costs
associated with the property damages to certain of the Company’s
 
facilities, net of insurance recoveries received.
 
These charges
are non-recurring and are not indicative of the future operating performance
 
of the Company.
 
See Note 19 of Notes to Condensed
Consolidated Financial Statements, which appears in Item 1 of this Report.
(h)
Indefinite-lived intangible asset impairment represents the non-cash
 
charge taken to write down the value of certain indefinite-
lived intangible assets associated with the Houghton Combination.
 
The Company has no prior history of goodwill or intangible
asset impairments and this charge is not indicative of the future
 
operating performance of the Company.
 
See Note 14 of Notes to
Condensed Consolidated Financial Statements, which appears in Item
 
1 of this Report.
(i)
Equity income in a captive insurance company represents the after-tax
 
income attributable to the Company’s
 
interest in Primex,
Ltd. (“Primex”), a captive insurance company.
 
The Company holds a 32% investment in and has significant influence over
Primex, and therefore accounts for this interest under the equity method
 
of accounting.
 
The income attributable to Primex is not
indicative of the future operating performance of the Company
 
and is not considered core to the Company’s
 
operations.
(j)
Pension and postretirement benefit (income) costs, non-service components
 
represent the pre-tax, non-service component of the
Company’s pension and postretirement
 
net periodic benefit cost in each period.
 
These costs are not indicative of the future
operating performance of the Company.
 
The amount in the nine months ended September 30, 2020 includes the $22.7
 
million
settlement charge for the Company’s
 
termination of the Legacy Quaker U.S. Pension Plan.
 
See Note 9 of Notes to Condensed
Consolidated Financial Statements, which appears in Item 1 of this Report.
(k)
Brazilian non-income tax credits represent indirect tax credits related to certain
 
of the Company’s Brazilian subsidiaries
prevailing in a legal claim as well as the Brazilian Supreme Court ruling
 
on these non-income tax matters.
 
The third quarter of
2021 impact to Non-GAAP earnings per diluted share reflects the tax only
 
adjustment related to the Brazilian Supreme Court
ruling on the taxability of interest income.
 
The non-income tax credit is non-recurring and not indicative of the future operating
performance of the Company.
 
See Note 19 of Notes to Condensed Consolidated Financial Statements, which
 
appears in Item 1 of
this Report.
(l)
Currency conversion impacts of hyper-inflationary economies represents
 
the foreign currency remeasurement impacts associated
with the Company’s affiliates
 
whose local economies are designated as hyper-inflationary under
 
U.S. GAAP.
 
During the three
and nine months ended September 30, 2021 and 2020, the Company
 
incurred non-deductible, pre-tax charges related to the
Company’s Argentine
 
affiliates.
 
These charges related to the immediate recognition of
 
foreign currency remeasurement in the
Condensed Consolidated Statements of Operations associated with these entities are
 
not indicative of the future operating
performance of the Company.
 
See Note 1 of Notes to Condensed Consolidated Financial Statements, which
 
appears in Item 1 of
this Report.
(m)
The impact of certain discrete tax items includes the impact of changes
 
in certain valuation allowance recorded on certain of the
Company’s foreign
 
tax credits, tax law changes in a foreign jurisdiction, changes in withholding rates,
 
the tax impacts of non-
income tax credits associated with certain of the Company’s
 
Brazilian subsidiaries and the associated impact on previously
accrued for distributions at certain of the Company’s
 
Asia/Pacific subsidiaries, the one-time deferred tax benefit recorded on the
transfer of additional intangible assets between the Company’s
 
subsidiaries as well as the offsetting impact and amortization
 
of a
deferred tax benefit the Company recorded in the fourth quarters of
 
2019 and 2020 related to a similar intercompany intangible
asset transfer.
 
See Note 11 of Notes to Condensed Consolidated Financial
 
Statements, which appears in Item 1 of this Report.
 
(n)
Depreciation and amortization for the three and nine months ended
 
September 30, 2021 includes approximately $0.3 million and
$0.9 million, respectively,
 
and for the three and nine months ended September 30, 2020 includes $0.2 million
 
and $0.9 million,
respectively, of
 
amortization expense recorded within equity in net income of associated companies
 
in the Company’s Condensed
Consolidated Statements of Operations, which is attributable to
 
the amortization of the fair value step up for the Company’s
 
50%
interest in a Houghton joint venture in Korea as a result of required purchase accounting.
 
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
36
(o)
Taxes on income
 
before equity in net income of associated companies – adjusted presents the impact
 
of any current and deferred
income tax expense (benefit), as applicable, of the reconciling items presented
 
in the reconciliation of net income (loss)
attributable to Quaker Chemical Corporation to adjusted EBITDA, and
 
was determined utilizing the applicable rates in the taxing
jurisdictions in which these adjustments occurred, subject to deductibility.
 
Houghton combination, integration and other
acquisition-related expenses described in (a) resulted in incremental taxes of $1.4 million
 
and $3.1 million during the three and
nine months ended September 30, 2021, and $1.7
 
million and $5.1 million during the three and nine months ended September 30,
2020,
 
respectively.
 
Restructuring and related charges described in (b) resulted in
 
a tax benefit of $0.2 million and incremental
taxes of $0.1 million during the three and nine months ended September
 
30, 2021, respectively, and
 
$0.4 million and $0.9
 
million
for the three and nine months ended September 30, 2020, respectively.
 
Fair value step up of acquired inventory sold described in
(c) resulted in incremental taxes of $0.2 million during the nine months
 
ended September 30, 2021 and less than $0.1 million
during
 
the nine months ended September 30, 2020.
 
CEO transition expenses described in (d) resulted in incremental taxes of $0.1
million and $0.3 million during the three and nine months ended September
 
30, 2021, respectively.
 
Inactive subsidiary litigation
described in (e) resulted in incremental taxes of $0.1 million and approximately
 
$0.2 million during the three and nine months
ended September 30, 2021, respectively.
 
Customer bankruptcy costs described in (f) resulted in incremental taxes of $0.1 million
during the nine months ended September 30, 2020.
 
Facility fire and flood remediation costs described in (g) resulted in
incremental taxes of $0.5 million in each of the three and nine months
 
ended September 30, 2021.
 
Indefinite-lived intangible
asset impairment described in (h) resulted in incremental taxes of $8.7 million
 
during the nine months ended September 30, 2020.
 
Pension and postretirement benefit (income) costs, non-service components
 
described in (j) resulted in a tax benefit of
approximately $0.1 million during each of the three and nine months
 
ended September 30, 2021,
 
and a reduction of taxes of $0.3
million and incremental taxes of $7.7 million for the three and nine months
 
ended September 30, 2020, respectively.
 
Brazilian
non-income tax credits described in (k) resulted in incremental taxes of
 
approximately $0.6 million and a tax benefit of $4.7
million during the three and nine months ended September 30, 2021.
 
Tax impact of certain discrete
 
items described in (m) above
resulted in a tax benefit of approximately $6.5 million and $5.1 million
 
during three and nine months ended September 30, 2021,
respectively, and resulted
 
in a tax benefit of $4.5 million and $0.4 million for the three and nine months ended
 
September 30,
2020,
 
respectively.
(p)
The Company calculates adjusted EBITDA margin
 
and non-GAAP operating margin as the percentage of adjusted EBITDA
 
and
non-GAAP operating income to consolidated net sales.
(q)
The Company calculates non-GAAP earnings per diluted share as non
 
-GAAP net income attributable to the Company per
weighted average diluted shares outstanding using the “two-class share method”
 
to calculate such in each given period.
 
Off-Balance Sheet Arrangements
The Company had no material off-balance sheet items, as defined
 
under Item 303(a)(4) of Regulation S-K as of September 30,
2021.
 
The Company’s only off-balance
 
sheet items outstanding as of September 30, 2021 represented approximately
 
$7 million of
total bank letters of credit and guarantees.
 
The bank letters of credit and guarantees are not significant to the Company’s
 
liquidity or
capital resources.
 
See Note 15 of Notes to Condensed Consolidated Financial Statements in Item 1 of
 
this Report.
 
Operations
Consolidated Operations Review – Comparison of the Third
 
Quarter of 2021 with the Third Quarter of 2020
Net sales were $449.1 million in the third quarter
 
of 2021
 
compared to $367.2 million in the third quarter of 2020.
 
The net sales
increase of approximately $81.8 million or 22% quarter-over-quarter
 
was primarily due to higher sales volumes of 10%, which
includes additional net sales from recent acquisitions of 4%, increases
 
from selling price and product mix of 10% and the positive
impact of foreign currency translation of 2%.
 
The increase in organic sales volumes compared to the third quarter
 
of 2020 was
primarily the result of the continued year-over-year
 
improvement in end market conditions and continued market share gains realized
in the current quarter.
 
Sales from acquisitions is driven by the Company’s
 
acquisition of Coral Chemical Company (“Coral”) in
December 2020 as well as the tin-plating solutions business acquired
 
in February 2021.
 
The increase from selling price and product
mix includes the impact of current year selling price increases implemented
 
in response to the increases in raw material costs
experienced in 2021.
 
The positive impact from foreign currency translation is primarily the result of the
 
strengthening of the Chinese
renminbi,
 
euro, and Mexican peso against the U.S. dollar quarter-over-quarter.
COGS were $303.9 million in the third quarter of 2021 compared to
 
$227.0 million in the third quarter of 2020.
 
The increase in
COGS of 34% was driven by the associated COGS on the increase in net
 
sales described above and continued increases in the
Company’s global raw material costs compared
 
to the prior year quarter and the impacts of supply constraints in the current year.
Gross profit in the third quarter of 2021 of $145.1 million increased $4.9 million
 
or approximately 4% from the third quarter of
2020, due primarily to the increase in net sales noted above.
 
The Company’s reported
 
gross margin in the third quarter of 2021 was
32.3%
 
compared to 38.2% in the third quarter of 2020.
 
The lower current quarter gross margin is driven by significant raw material
cost increases that began in the fourth quarter of 2020 and have continued throughout
 
2021 and the impacts of constraints on the
world’s global supply
 
chain.
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
37
SG&A in the third quarter of 2021 increased $7.2 million compared
 
to the third quarter of 2020 due primarily to the impact of
sales increases on direct selling costs, year-over-year
 
inflation increases,
 
additional SG&A from recent acquisitions and higher SG&A
due to foreign currency translation, partially offset by
 
lower incentive compensation quarter-over-quarter as well as the benefits of
additional realized cost savings associated with the Combination quarter-over-quarter.
 
In addition, SG&A was lower in the prior year
period as a result of temporary cost saving measures the Company
 
implemented in response to COVID-19.
 
While the Company
continues to manage costs during the on-going pandemic, it has incurred
 
higher SG&A quarter-over-quarter as the
 
global economy
continues to gradually rebound.
 
The Company estimates that it realized cost synergies associated with the
 
Combination of
approximately $19 million during the third quarter of 2021 compared
 
to approximately $17 million during the third quarter of 2020.
During the third quarter of 2021 and 2020, the Company incurred $5.8
 
million and $6.9 million, respectively,
 
of Combination,
integration and other acquisition-related expenses primarily for professional
 
fees related to Houghton integration and other
acquisition-related activities.
 
See the Non-GAAP Measures section of this Item, above.
The Company initiated a restructuring program during the third quarter
 
of 2019 as part of its global plan to realize cost synergies
associated with the Combination.
 
The Company incurred restructuring and related charges for reductions
 
in headcount and site
closures under this program,
 
net of adjustments to initial estimates for severance, of a credit of $0.8 million
 
and expense $1.4 million
during the third quarters of 2021 and 2020, respectively.
 
See the Non-GAAP Measures section of this Item, above.
Operating income in the third quarter of 2021 was $36.0 million compared
 
to $34.9 million in the third quarter of 2020.
 
Excluding Combination, integration and other acquisition-related expenses,
 
restructuring and related charges and other non-core
items, the Company’s current quarter
 
non-GAAP operating income was consistent at $43.2 million in each of the current quarter
 
and
the prior year quarter primarily due to the increase in net sales described
 
above and the benefits from cost savings related to the
Combination offset by an increase in SG&A as well as the significant
 
increases in raw material costs quarter-over-quarter.
The Company had other income, net, of $0.6 million in the third quarter
 
of 2021 compared to other expense, net, of $0.2 million
in the third quarter of 2020.
 
The third quarter of 2021 included foreign currency transaction gains compared
 
to foreign currency
transaction losses incurred in the prior year quarter.
 
In addition, the Company had lower non-service components of pension and
postretirement benefit costs in the current quarter,
 
partially offset by higher losses on fixed asset disposals related to the events
mentioned as facility remediation activities above.
 
See the Non-GAAP Measures section of this Item, above.
Interest expense, net, decreased $1.2 million compared to the third
 
quarter of 2020 driven by lower current quarter borrowings
outstanding as a result of the additional revolver borrowings drawn
 
down in March 2020 at the onset of the pandemic which were
subsequently repaid in September 2020 and, to a lesser extent, a slight decline
 
in overall interest rates quarter-over-quarter.
The Company’s effective
 
tax rates for the third quarters of 2021 and 2020 were 2.6% and 8.1%, respectively.
 
The Company’s
lower current quarter effective tax rate is primarily driven
 
by a one-time deferred tax benefit related to an intercompany intangible
asset transfer, described in the Non-GAAP
 
measures section of this Item, above.
 
Comparatively, the prior
 
year third quarter effective
tax rate was impacted by the tax effect of certain one-time
 
items including benefits related to the impact of tax regulations and other
changes in foreign tax credit valuation allowances, a change in a foreign
 
subsidiary’s statutory rate and impacts related
 
to the
Combination.
 
Excluding the impact of these items as well as all other non-core items in each quarter,
 
described in the Non-GAAP
Measures section of this Item, above, the Company estimates that its third quarters
 
of 2021 and 2020 effective tax rates would have
been approximately 25% and 24%, respectively.
 
The higher estimated current quarter tax rate was primarily driven by the impact
 
of
changes in mix of earnings and provision to return adjustments in the prior period,
 
partially offset with a change in permanent
reinvestment assertions.
Equity in net income of associated companies decreased $1.0 million
 
in the third quarter of 2021 compared to the third quarter of
2020, primarily due to lower current year quarter income from the Company’s
 
interest in a captive insurance company as well as from
its 50% interest in a joint venture in Korea compared to the prior year quarter.
 
See the Non-GAAP Measures section of this Item,
above.
 
Net income attributable to noncontrolling interest was less than $0.1 million
 
in both the third quarters of 2021 and 2020.
Foreign exchange positively impacted the Company’s
 
third quarter results by approximately 10% driven by the positive impact
from foreign currency translation on earnings as well as foreign exchange
 
transaction gains in the current year quarter as compared to
foreign exchange transaction losses in the prior year third quarter.
 
Consolidated Operations Review – Comparison of the First Nine Months of 202
 
1
 
with the First Nine Months of 2020
Net sales were $1,314.1 million in the first nine months of 2021 compared to $1,031.8
 
million in the first nine months of 2020.
 
The net sales increase of $282.3 million or 27% period-over-period
 
reflects a benefit from higher sales volumes of 18%, which
includes additional net sales from recent acquisitions of 4%, increases
 
in selling price and product mix of 5%, and the positive impact
from foreign currency translation of 4%.
 
The increase in sales volumes compared to the first nine months of 2020 was primarily
 
due
to improved end market conditions from the prior year impacts of COVID-19 and
 
continued market share gains.
 
Additional net sales
Quaker Chemical Corporation
Management’s Discussion and Analysis
38
from acquisitions relate primarily to the acquisitions of a tin-plating solutions
 
business and Coral, acquired in February 2021 and
December 2020, respectively.
 
The increase from selling price and product mix includes the benefits of
 
current year selling price
increases implemented to date to help offset the rising
 
raw material and input costs.
 
The positive impact from foreign currency
translation is primarily the result of the strengthening of the euro
 
and Chinese Renminbi against the U.S. dollar year-over-year.
 
COGS were $858.3 million in the first nine months of 2021 compared to
 
$660.4 million in the first nine months of 2020.
 
The
increase in COGS of 30% was driven by the associated COGS on the increase
 
in net sales as described above, and the higher raw
material costs noted in the quarterly discussion.
Gross profit in the first nine months of 2021 increased $84.3 million
 
or 23% from the first nine months of 2020, due primarily to
the increase in net sales described above.
 
The Company’s reported gross margin
 
in the first nine months of 2021 was 34.7%
compared to 36.0% in the first nine months of 2020.
 
The Company’s lower current year gross margin
 
was primarily due to the
significant raw material increases described in the third quarter discussion
 
above.
 
SG&A in the first nine months of 2021 increased $34.8 million compared
 
to the first nine months of 2020 due primarily to the
same drivers described in the third quarter discussion above.
During the first nine months of 2021 and 2020, the Company incurred
 
$18.3 million and $22.8 million, respectively,
 
of
Combination, integration and other acquisition-related expenses primarily
 
for professional fees related to Houghton integration and
other acquisition-related activities.
 
See the Non-GAAP Measures section of this Item, above.
As described above, the Company initiated a restructuring program
 
during the third quarter of 2019 as part of its global plan to
realize cost synergies associated with the Combination.
 
The Company recorded restructuring and related charges of $0.6 million
during the first nine months of 2021 compared to $3.6 million during the first nine
 
months of 2020 under this program.
 
See the Non-
GAAP Measures section of this Item, above.
During the first quarter of 2020, the Company recorded a $38.0 million
 
non-cash impairment charge to write down the value of
certain indefinite-lived intangible assets associated with the Combination.
 
This non-cash impairment charge is related to certain
acquired Houghton trademarks and tradenames and was primarily
 
the result of the projected negative impacts of COVID-19 as of
March 31, 2020 on their estimated fair values.
 
There was no similar impairment charges recorded during the first nine
 
months of
2021.
 
Operating income in the first nine months of 2021 was $119.7
 
million compared to $24.7 million in the first nine months of 2020.
 
Excluding Combination, integration and other acquisition-related expenses,
 
restructuring and related charges, the non-cash indefinite-
lived intangible asset impairment charge, and other non
 
-core items, the Company’s
 
current year non-GAAP operating income of
$143.3 million increased compared to $90.4 million in the prior
 
year period, primarily due to the increase in net sales described above
and the continued benefits from cost savings related to the Combination
 
,
 
partially offset by higher SG&A and the negative impact of
significant increases in raw material costs due to constraints on the overall
 
global supply chain.
The Company’s other
 
income, net, was $19.3 million in the first nine months of 2021 compared to other
 
expense, net of $22.4
million in the prior year period.
 
The year-over-year change was primarily due to other income related to certain non-income
 
tax
credits recorded by the Company’s
 
Brazilian subsidiaries during the second quarter of 2021 as well as the gain on
 
the sale of certain
held-for-sale real property assets during the first quarter of 2021
 
compared to a first quarter of 2020 pension plan settlement charge
associated with the termination of the Legacy Quaker U.S. Pension Plan.
 
See the Non-GAAP Measures section of this Item, above.
Interest expense, net, decreased $5.4 million in the first nine months
 
of 2021 compared to the first nine months of 2020 driven by
lower current year borrowings outstanding as a result of the additional
 
revolver borrowings drawn down in March 2020 at the onset of
the pandemic as well as a decline in overall interest rates year-over-year,
 
as the weighted average interest rate incurred on borrowings
under the Company’s credit
 
facility was approximately 1.6% during the first nine months of 2021 compared to approximately
 
2.2%
during the first nine months of 2020.
The Company’s effective
 
tax rates for the first nine months of 2021 and 2020 were an expense of 21.8% compared to a benefit of
38.3%, respectively.
 
The Company’s effective
 
tax rate for the nine months ended September 30, 2021 was impacted by certain
 
U.S.
tax law changes, the tax impact of certain non-income tax credits recorded by
 
the Company’s Brazilian subsidiaries, and a deferred
 
tax
benefit related to an intercompany intangible asset transfer.
 
Comparatively,
 
the prior year first nine months effective tax rate was
impacted by the tax effect of certain one-time pre-tax losses as well as certain tax
 
charges and benefits in the period including those
related to changes in foreign tax credit valuation allowances, tax law changes
 
in a foreign jurisdiction, the tax impacts of the
Company’s termination
 
of its Legacy Quaker U.S. Pension Plan and the Houghton indefinite-lived trademarks
 
and tradename
intangible asset impairment.
 
Excluding the impact of these items as well as all other non-core items in each
 
year, described in the
Non-GAAP Measures section of this Item, above, the Company estimates that
 
its first nine months of 2021 and 2020 effective tax
rates were relatively consistent at approximately 25% and 23%, respectively.
 
The year-over-year increase was largely
 
driven by the
impact of changes in pre-tax income levels on certain tax adjustments in each
 
period and the mix of earnings,
 
as well as withholding
taxes on repatriations and provision to return adjustments in the prior
 
period, partially offset with a change in permanent reinvestment
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
39
assertions.
 
The Company may experience continued volatility in its effective
 
tax rates due to several factors, including the timing of
tax audits and the expiration of applicable statutes of limitations as they
 
relate to uncertain tax positions, the unpredictability of the
timing and amount of certain incentives in various tax jurisdictions, the treatment
 
of certain acquisition-related costs and the timing
and amount of certain share-based compensation-related tax benefits, among
 
other factors.
 
In addition, the foreign tax credit valuation
allowance is based on a number of variables, including forecasted earnings,
 
which may vary.
Equity in net income of associated companies increased $4.1 million in
 
the first nine months of 2021 compared to the first nine
months of 2020, primarily due to higher current year earnings from the
 
Company’s interest in a captive insurance
 
company.
 
See the
Non-GAAP Measures section of this Item, above.
 
In addition, the Company had slightly higher earnings year-over-year
 
from the
Company’s 50% interest in its joint
 
venture in Korea.
Net income attributable to noncontrolling interest was less than $0.1 million
 
in both the first nine months of 2021 and 2020.
Foreign exchange positively impacted the Company’s
 
first nine months of 2021 results by approximately 6% driven by the
positive impact from foreign currency translation on earnings as well as lower foreign
 
exchange transaction losses in the current year
as compared to the prior year period.
Reportable Segments Review - Comparison of the Third
 
Quarter of 2021
 
with the Third Quarter of 2020
The Company’s reportable
 
segments reflect the structure of the Company’s
 
internal organization, the method by which the
Company’s resources are allocated
 
and the manner by which the chief operating decision maker of the Company
 
assesses its
performance.
 
The Company has four reportable segments: (i) Americas; (ii) EMEA; (iii)
 
Asia/Pacific; and (iv) Global Specialty
Businesses.
 
The three geographic segments are composed of the net sales and operations
 
in each respective region, excluding net
sales and operations managed globally by the Global Specialty Businesses
 
segment, which includes the Company’s
 
container, metal
finishing, mining, offshore, specialty coatings, specialty
 
grease and Norman Hay businesses.
 
Segment operating earnings for the Company’s
 
reportable segments are comprised of net sales less COGS and SG&A directly
related to the respective segment’s product
 
sales.
 
Operating expenses not directly attributable to the net sales of each respective
segment,
 
such as certain corporate and administrative costs, Combination,
 
integration and other acquisition-related expenses,
Restructuring and related charges, and COGS related
 
to acquired inventory sold, which is adjusted to fair value as part of purchase
accounting,
 
are not included in segment operating earnings.
 
Other items not specifically identified with the Company’s
 
reportable
segments include interest expense, net, and other income (expense),
 
net.
Americas
Americas represented approximately 34% of the Company’s
 
consolidated net sales in the third quarter of 2021.
 
The segment’s
net sales were $150.8 million, an increase of $31.3 million or 26% compared
 
to the third quarter of 2020.
 
Excluding sales from
acquisitions, the segment’s
 
net sales increase quarter-over-quarter of approximately 21% was driven
 
by higher volumes of 9%, a
benefit in selling price and product mix of 10% and the positive impact
 
of foreign currency translation of 2%.
 
The current quarter
organic volume increase was driven by the
 
continued improvement in end market conditions compared to the prior year quarter
 
which
was impacted by COVID-19.
 
The increase in selling price and product mix is primarily driven by price
 
increases implemented to help
offset the significant increases in raw material
 
and other input costs incurred during 2021.
 
The foreign exchange impact was primarily
driven by the strengthening of the Mexican peso against the U.S. dollar,
 
as this exchange rate averaged 20.02 in the third quarter of
2021 compared to 22.06 during the third quarter of 2020.
 
This segment’s operating earnings were
 
$31.3 million, an increase of $0.2
million or 1% compared to the third quarter of 2020.
 
The relatively consistent segment operating earnings quarter-over-quarter
 
is the
net result of increases in net sales, described above, offset by lower
 
gross margins driven by the continued raw material cost increases
and global supply chain and logistics pressures coupled with higher
 
SG&A including an increase in direct selling costs associated with
higher net sales, SG&A from acquisitions and an increase in SG&A as the prior
 
year third quarter included temporary cost savings
measures implemented in response to the onset of the COVID-19 pandemic.
EMEA
EMEA represented approximately 27% of the Company’s
 
consolidated net sales in the third quarter of 2021.
 
The segment’s net
sales were $122.2 million, an increase of $28.3 million or 30% compared
 
to the third quarter of 2020.
 
The increase in net sales was
driven by a benefit from selling price and product mix of 19%, increases in organic
 
volumes of approximately 9%, the positive impact
of foreign currency translation of 1%, and additional net sales from acquisitions of
 
1%.
 
The increase in selling price and product mix
is primarily driven by price increases implemented to offset
 
the significant increase in raw material and other input costs incurred
during 2021.
 
The current quarter volume increase was driven by the continued improvement in end market
 
conditions compared to
the prior year quarter which was heavily impacted by COVID-19.
 
The foreign exchange impact was primarily driven by the
strengthening of the euro against the U.S. dollar as this exchange rate averaged
 
1.18 in the third quarter of 2021 compared to 1.17 in
the third quarter of 2020.
 
This segment’s operating earnings were $20.2
 
million, an increase of $2.7 million or 16% compared to the
third quarter of 2020.
 
The increase in segment operating earnings reflects the higher net
 
sales described above, partially offset by
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
40
lower current quarter gross margins driven by the continued
 
raw material cost increases and global supply chain and logistics
pressures as well as higher SG&A including increases in direct selling costs associated with
 
higher net sales as well as increases as the
prior year third quarter included temporary cost savings measures implemented
 
in response to the onset of the COVID-19 pandemic.
Asia/Pacific
Asia/Pacific represented approximately 22% of the Company’s
 
consolidated net sales in the third quarter of 2021.
 
The segment’s
net sales were $98.7 million, an increase of approximately $13.8 million
 
or 16% compared to the third quarter of 2020.
 
The increase
in net sales quarter-over-quarter was driven by increases in volumes
 
of 7%, the positive impact of foreign currency translation of 5%,
increases from selling price and product mix of 3% and additional net sales from
 
acquisitions of 1%.
 
The current quarter volume
increase was driven by the continued improvement in end market conditions
 
compared to the prior year quarter which was impacted
by COVID-19.
 
The foreign exchange impact was primarily due to the strengthening of the Chinese renminbi
 
against the U.S. dollar as
this exchange rate averaged 6.47 in the third quarter of 2021 compared
 
to 6.92 in the third quarter of 2020.
 
This segment’s operating
earnings were $23.3 million, a decrease of $4.0 million or 15% compared
 
to the third quarter of 2020.
 
The decrease in segment
operating earnings was largely driven by the continued
 
raw material cost increases and global supply chain and logistics pressures as
well as higher direct selling costs associated with higher net sales.
Global Specialty Businesses
Global Specialty Businesses represented approximately 17% of the
 
Company’s consolidated net sales in the
 
third quarter of 2021.
 
The segment’s net sales were $77.4
 
million, an increase of $8.6 million or 12% compared to the third quarter of 2020.
 
Excluding net
sales from acquisitions, the segment’s
 
net sales would have increased 5% quarter-over-quarter
 
driven by increases in selling price and
product mix, including Norman Hay,
 
of 13% and the positive impact of foreign currency translation of 2% partially offset
 
by volume
declines of 10%.
 
Both the changes in selling price and product mix and sales volumes were primarily
 
driven by higher amounts of
shipments of a lower priced product in the Company’s
 
mining business in the prior year period.
 
The foreign exchange impact was a
result of similar strengthening of certain currencies in EMEA and
 
Americas as described above.
 
This segment’s operating earnings
were $20.7 million, a decrease of $0.5 million or 2% compared to the third quarter
 
of 2020.
 
The decrease in segment operating
earnings was driven by the continued raw material cost increases and global
 
supply chain and logistics pressures as well as higher
SG&A, including SG&A from acquisitions in the current year quarter.
Reportable Segments Review - Comparison of the First Nine months of 2021
 
with the First Nine months of 2020
Americas
Americas represented approximately 32% of the Company’s
 
consolidated net sales in the first nine months of 2021.
 
The
segment’s net sales were $425.3
 
million, an increase of $95.3 million or 29% compared to the first nine months of 2020.
 
The increase
in net sales was due to higher sales volumes of approximately
 
16%, additional net sales from acquisitions of 6% primarily resulting
from Coral, benefits from selling price and product mix of 6%, and
 
the positive impact of foreign currency translation of 1%.
 
The
current year volume increase was driven by the continued economic
 
rebound from the COVID-19 slowdown that began in late March
and continued throughout the third quarter of 2020.
 
This segment’s operating earnings were $97.2
 
million, an increase of $26.6
million or 38% compared to the first nine months of 2020.
 
The increase in segment operating earnings reflects the higher net
 
sales
described above, partially offset by lower gross margins
 
in the current year period coupled with higher SG&A, including SG&A from
acquisitions primarily due to the same drivers as described in the third quarter
 
discussion above.
EMEA
EMEA represented approximately 28% of the Company’s
 
consolidated net sales in the first nine months of 2021.
 
The segment’s
net sales were $365.5 million, an increase of $88.9 million or 32% compared
 
to the first nine months of 2020.
 
The increase in net
sales was due to higher sales volumes of 15%, increases in selling price and product
 
mix of 8%, the positive impacts from foreign
exchange translation of 7% and additional net sales from acquisitions of
 
2%.
 
The current year volume increase was driven by the
continued economic rebound from the COVID-19 slowdown.
 
The foreign exchange impact was primarily due to the strengthening of
the euro and British pound against the U.S. dollar as these exchange rates averaged
 
1.20 and 1.39, respectively,
 
during the first nine
months of 2021 compared to 1.12 and 1.27, respectively,
 
during the first nine months of 2020.
 
This segment’s operating earnings
were $68.8 million, an increase of $22.5 million or 49% compared
 
to the first nine months of 2020.
 
The increase in segment operating
earnings reflect the higher net sales described above partially offset
 
lower gross margins in the current year period coupled with
 
higher
direct selling expenses on the increase in net sales primarily due to the same
 
drivers as described in the third quarter discussion above.
Asia/Pacific
Asia/Pacific represented approximately 22% of the Company’s
 
consolidated net sales in the first nine months of 2021.
 
The
segment’s net sales were $286.9
 
million, an increase of $60.1 million or 26% compared to the first nine months of 2020.
 
The increase
in net sales was driven by higher sales volumes of approximately 19% and
 
the positive impact of foreign currency translation of 7%.
 
The current year volume increase was driven by the
 
continued gradual economic rebound from the COVID-19 slowdown as the
pandemic notably impacted China beginning in the first quarter of 2020 and then
 
the rest of the region through the third quarter of
Quaker Chemical Corporation
Management’s Discussion and Analysis
41
2020.
 
The foreign exchange impact was primarily due to the strengthening
 
of the Chinese renminbi against the U.S. dollar as this
exchange rate averaged 6.47 during the first nine months of 2021
 
compared to 6.99 during the first nine months of 2020.
 
This
segment’s operating earnings were
 
$74.0 million, an increase of $7.9 million or 12% compared to the first nine
 
months of 2020.
 
The
increase in segment operating earnings reflect the higher net sales described
 
above partially offset lower gross margins
 
in the current
year period coupled with higher direct selling expenses on the increase
 
in net sales primarily due to the same drivers as described in
the third quarter discussion above.
Global Specialty Businesses
Global Specialty Businesses represented 18% of the Company’s
 
consolidated net sales in the first nine months of 2021.
 
The
segment’s net sales were $236.4
 
million, an increase of $37.9 million or 19% compared to the first nine months of 2020.
 
The increase
in net sales was driven by benefits from selling price and product mix, including
 
Norman Hay, of 16%, additional
 
net sales from
acquisitions of 7% primarily driven by Coral, and the positive impact of
 
foreign currency transaction of 3%, partially offset by
decreases in volumes of 7%.
 
The foreign exchange impact was a result of similar strengthening of
 
certain currencies in EMEA and
Americas as described above.
 
Both the changes in selling price and product mix and sales volumes were
 
primarily driven by higher
shipments of a lower priced product in the Company’s
 
mining business in the period year period.
 
This segment’s operating earnings
were $69.0 million, an increase of $10.9 million or 19% compared
 
to the first nine months of 2020.
 
The increase in segment operating
earnings reflects the higher net sales described above, partially offset
 
by lower gross margins in the current year period coupled with
higher SG&A, including SG&A from acquisitions primarily due
 
to the same drivers as described in the third quarter discussion above.
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
42
Factors That May Affect Our Future Results
(Cautionary Statements Under the Private Securities Litigation Reform
 
Act of 1995)
Certain information included in this Report and other materials filed or
 
to be filed by Quaker Chemical Corporation with the
Securities and Exchange Commission (“SEC”) (as well as information
 
included in oral statements or other written statements made or
to be made by us) contain or may contain forward-looking statements within the
 
meaning of Section 27A of the Securities Act of
1933, as amended, and Section 21E of the Securities Exchange Act of 1934,
 
as amended.
 
These statements can be identified by the
fact that they do not relate strictly to historical or current facts.
 
We have based
 
these forward-looking statements, including statements
regarding the potential effects of the COVID-19 pandemic
 
and global supply chain constraints on the Company’s
 
business, results of
operations, and financial condition, our expectation that we will maintain sufficient
 
liquidity and remediate any of our material
weaknesses in internal control over financial reporting, and statements regarding
 
the impact of increased raw material costs and
pricing initiatives on our current expectations about future
 
events.
 
These forward-looking statements include statements with respect to
 
our beliefs, plans, objectives, goals, expectations,
anticipations, intentions, financial condition, results of operations, future
 
performance, and business, including:
 
•
 
the potential benefits of the Combination and other acquisitions;
 
•
 
the impacts on our business as a result of the COVID-19 pandemic and
 
any projected global economic rebound or
anticipated positive results due to Company actions taken in response;
•
 
cost increases in prices of raw materials and the impacts of constraints and
 
disruptions in the global supply chain;
 
•
our current and future results and plans; and
 
•
 
statements that include the words “may,”
 
“could,” “should,” “would,” “believe,” “expect,” “anticipate,” “estimate,”
“intend,” “plan” or similar expressions.
Such statements include information relating to current and future business activities,
 
operational matters, capital spending, and
financing sources.
 
From time to time, forward-looking statements are also included in the Company’s
 
other periodic reports on Forms
10-K, 10-Q and 8-K, press releases, and other materials released to,
 
or statements made to, the public.
Any or all of the forward-looking statements in this Report, in the Company’s
 
Annual Report to Shareholders for 2020 and in any
other public statements we make may turn out to be wrong.
 
This can occur as a result of inaccurate assumptions or as a consequence
of known or unknown risks and uncertainties.
 
Many factors discussed in this Report will be important in determining our future
performance.
 
Consequently, actual results may
 
differ materially from those that might be anticipated from our forward-looking
statements.
We undertake
 
no obligation to publicly update any forward-looking statements, whether
 
as a result of new information, future
events or otherwise.
 
However, any further disclosures made on
 
related subjects in the Company’s subsequent
 
reports on Forms 10-K,
10-Q, 8-K and other related filings should be consulted.
 
A major risk is that demand for the Company’s
 
products and services is
largely derived from the demand for our customers’ products,
 
which subjects the Company to uncertainties related to downturns in a
customer’s business and unanticipated customer production
 
slowdowns and shutdowns, including as is currently being experienced by
many automotive industry companies as a result of supply chain disruption.
 
Other major risks and uncertainties include, but are not
limited to, the primary and secondary impacts of the COVID-19 pandemic,
 
including actions taken in response to the pandemic by
various governments, which could exacerbate some or all of the other
 
risks and uncertainties faced by the Company,
 
as well as the
potential for significant increases in raw material costs, supply chain
 
disruptions, customer financial instability,
 
worldwide economic
and political disruptions, foreign currency fluctuations,
 
significant changes in applicable tax rates and regulations, future terrorist
attacks and other acts of violence.
 
Furthermore, the Company is subject to the same business cycles as those experienced
 
by our
customers in the steel, automobile, aircraft, industrial equipment, and durable
 
goods industries.
 
The ultimate impact of COVID-19 on
our business will depend on, among other things, the extent and duration of
 
the pandemic, the severity of the disease and the number
of people infected with the virus including as new variants emerge,
 
the continued uncertainty regarding global availability,
administration, acceptance and long-term efficacy
 
of vaccines, or other treatments for COVID-19 or its variants, the longer-term
effects on the economy of the pandemic, including the
 
resulting market volatility,
 
and by the measures taken by governmental
authorities and other third parties restricting day-to-day life and
 
business operations and the length of time that such measures remain
in place, as well as laws and other governmental programs implemented
 
to address the pandemic or assist impacted businesses, such
as fiscal stimulus and other legislation designed to deliver monetary
 
aid and other relief.
 
Other factors could also adversely affect us,
including those related to the Combination and other acquisitions and the
 
integration of acquired businesses.
 
Our forward-looking
statements are subject to risks, uncertainties and assumptions about
 
the Company and its operations that are subject to change based
on various important
 
factors, some of which are beyond our control.
 
These risks, uncertainties, and possible inaccurate assumptions
relevant to our business could cause our actual results to differ
 
materially from expected and historical results.
 
 
Quaker Chemical Corporation
Management’s Discussion and Analysis
43
Therefore, we caution you not to place undue reliance on our forward-looking
 
statements.
 
For more information regarding these
risks and uncertainties as well as certain additional risks that we face,
 
refer to the Risk Factors section, which appears in Item 1A in
our 2020 Form 10-K and in our quarterly and other reports filed from time to
 
time with the SEC.
 
This discussion is provided as
permitted by the Private Securities Litigation Reform Act of 1995
 
.
Quaker Houghton on the Internet
 
Financial results, news and other information about Quaker Houghton
 
can be accessed from the Company’s
 
website at
https://www.quakerhoughton.com.
 
This site includes important information on the Company’s
 
locations, products and services,
financial reports, news releases and career opportunities.
 
The Company’s periodic and current reports
 
on Forms 10-K, 10-Q, 8-K, and
other filings, including exhibits and supplemental schedules filed therewith,
 
and amendments to those reports, filed with the SEC are
available on the Company’s website,
 
free of charge, as soon as reasonably practicable after they
 
are electronically filed with or
furnished to the SEC.
 
Information contained on, or that may be accessed through,
 
the Company’s website is not incorporated
 
by
reference in this Report and, accordingly,
 
you should not consider that information part of this Report.
44
Item 3.
 
Quantitative and Qualitative Disclosures About Market
 
Risk.
We have evaluated
 
the information required under this Item that was disclosed in Part II, Item 7A, of our Annual Report on
 
Form
10-K for the year ended December 31, 2020, and we believe there has been no material
 
change to that information.
 
45
Item 4.
 
Controls and Procedures.
Evaluation of disclosure controls
 
and procedures.
 
As required by Rule 13a-15(b) under the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), our management, including our
 
principal executive officer and principal financial officer,
 
has
evaluated the effectiveness of our disclosure controls
 
and procedures (as defined in Rule 13a-15(e) under the Exchange Act ) as of the
end of the period covered by this Report.
 
Based on that evaluation, our principal executive officer and our principal
 
financial officer
have concluded that, as of the end of the period covered by this Report, our disclosure
 
controls and procedures (as defined in Rule
13a-15(e) under the Exchange Act) were not effective
 
as of September 30, 2021 because of the material weaknesses in our internal
control over financial reporting, as described below.
As previously disclosed in “Item 9A. Controls and Procedures.” in the Company’s
 
2020 Form 10-K, through the process of
evaluating risks and corresponding changes to the design of existing or the
 
implementation of new controls in light of the significant
non-recurring transactions that occurred during 2019, including the Combination,
 
the Company identified certain deficiencies in its
application of the principles associated with the
Committee of Sponsoring Organization of
 
the Treadway Commission
 
in Internal
Control – Integrated Framework (2013)
 
that management has concluded in the aggregate constitute a material weakness.
 
A material
weakness is a deficiency,
 
or combination of deficiencies, in internal control over financial reporting, such
 
that there is a reasonable
possibility that a material misstatement of annual or interim financial statements will not
 
be prevented or detected on a timely basis.
 
We did not
 
design and maintain effective controls in response to the risks of material
 
misstatement.
 
Specifically, changes to existing
controls or the implementation of new controls were not sufficient
 
to respond to changes to the risks of material misstatement in
financial reporting as a result of becoming a larger,
 
more complex global organization due to the Combination.
 
This material
weakness also contributed to an additional material weakness as we did not design
 
and maintain effective controls over the review of
pricing, quantity and customer data to verify that revenue recognized was complete
 
and accurate.
 
These material weaknesses did not
result in material misstatements to the interim or annual consolidated financial
 
statements.
 
However, these material weaknesses could
result in misstatements to our account balances and disclosures that could
 
result in a material misstatement to the interim or annual
consolidated financial statements that would not be prevented or detected.
Notwithstanding these material weaknesses, the Company has concluded
 
that the unaudited condensed consolidated financial
statements included in this Report present fairly,
 
in all material respects, the financial position of the Company as of September 30,
2021 and December 31, 2020, and that the results of its operations and its cash flows
 
and changes in equity for both the three and nine
month periods ended September 30, 2021 and 2020, are in conformity with
 
accounting principles generally accepted in the United
States of America.
 
Progress on Remediation
 
of Material Weaknesses
The Company and its Board of Directors, including the Audit Committee of the Board
 
of Directors, are committed to maintaining
a strong internal control environment.
 
Since identifying the material weaknesses, the Company has dedicated
 
a significant amount of
time and resources to remediate all of the previously identified material weaknesses as quickly
 
and effectively as possible. During
2020 and into 2021, the Company dedicated multiple internal resources and
 
supplemented those internal resources with various third-
party specialists to assist with the formalization of a robust and detailed
 
remediation plan.
 
In undertaking remediation activities, the
Company has hired additional personnel dedicated to financial and information
 
technology compliance to further supplement its
internal resources.
 
In addition, the Company has established a global network of personnel to assist local management
 
in
understanding control performance and documentation requirements.
 
In order to sustain this network, the Company conducts periodic
trainings and hosts discussions to address questions on a current basis.
 
However, the impact of COVID-19,
 
including travel
restrictions and remote work arrangements required the Company
 
to adapt and make changes to its internal controls integration plans
as well as its remediation plans, and has presented and is expected to continue
 
to present challenges with regards to the timing of the
Company’s remediation
 
and integration plan activities.
Despite the challenges brought on by COVID-19 and driven by the
 
Company’s priority of creating a
 
long-term sustainable control
structure to ensure stability for a company that has more than doubled in
 
size since August 2019, the Company continues to make
substantial strides towards remediating the underlying causes of the
 
previously disclosed material weaknesses in our risk assessment
process and within our revenue process, as further discussed below.
Risk Assessment –
 
We previously determined
 
that our risk assessment process was not designed adequately to respond
 
to changes
to the risks of material misstatement to financial reporting.
 
In order to remediate this material weakness, we have designed and
implemented an improved risk assessment process, including identifying
 
and assessing those risks attendant to the significant changes
within the Company as a result of becoming a larger,
 
more complex global organization due to the Combination.
 
During 2020, a full
review was performed of our processes and controls across significant
 
locations in order to identify and address potential design gaps.
 
In addition to individual transactional-level control enhancements, this review
 
resulted in (i) an enhanced financial statement risk
assessment, (ii) the standardization of existing legal entity and newly
 
implemented segment quarterly analytics and quarterly closing
packages completed by key financial reporting personnel, (iii) a global
 
account reconciliation review program and (iv) enhancements
to our quarterly identification and reassessment of new and existing business
 
and information technology risks that could affect our
financial reporting.
 
Monitoring is also performed through our enhanced quarterly controls certification
 
process, whereby changes in
business or information technology processes or control owners are identified
 
and addressed timely.
 
Although we have implemented
46
and tested the additional controls as noted in our remediation plan and found them
 
to be effective, this material weakness will not be
considered remediated due to the Revenue – Price and Quantity material weakness,
 
discussed below.
 
Once the Revenue – Price and
Quantity material weakness is remediated, we expect the Risk Assessment material
 
weakness will also be remediated.
Revenue – Price and Quantity –
We previously determined
 
that we did not design and maintain effective controls over the review
of pricing, quantity and customer data to verify that revenue recognized
 
was complete and accurate.
 
In order to remediate this
material weakness, the Company made significant progress in its redesign
 
of certain aspects of its revenue process and related
controls.
 
The Company has identified and agreed upon design enhancements and requirements for
 
each revenue sub-process.
 
The
design includes enhancements to entity-level and transactional-level
 
manual controls as well as IT general and application controls.
 
During the third quarter of 2021 and through the date of this Form 10-Q filing
 
for the period ended September 30, 2021, the Company
has implemented these design changes.
 
While the Company believes that the enhancements to these entity-level, transactional
 
and IT
general and application controls will sufficiently address the material
 
weakness previously identified, because the additional controls
have not been fully tested, this material weakness is not yet remediated.
 
The existing material weakness will not be considered
remediated until the applicable remedial controls have been operat
 
ing for a sufficient period of time and management has concluded,
through testing, that the controls are operating effectively.
 
Given the significant resources the Company has dedicated to remediation
 
of its material weaknesses, the Company is committed
to remediation and expects that in 2021 it will successfully remediate its price
 
and quantity and its risk assessment material
weaknesses.
 
Changes in internal control over financial reporting.
 
As required by Rule 13a-15(d) under the Exchange Act, our
management, including our principal executive officer
 
and principal financial officer, has evaluated
 
our internal control over
financial reporting to determine whether any changes to our internal control
 
over financial reporting occurred during the
quarter ended September 30, 2021 that have materially affected,
 
or are reasonably likely to materially affect, our internal
control over financial reporting.
 
Based on that evaluation, as described above, there were changes that have materially
affected, or are reasonably likely to materially affect,
 
our internal control over financial reporting during the quarter ended
September 30, 2021.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
47
PART
 
II.
 
OTHER INFORMATION
Items 3, 4 and 5 of Part II are inapplicable and have been omitted.
Item 1.
 
Legal Proceedings.
Incorporated by reference is the information in Note 19 of the Notes to
 
the Condensed Consolidated Financial Statements in Part
I, Item 1, of this Report.
Item 1A. Risk Factors.
The Company’s business, financial
 
conditions, results of operations and cash flows are subject to various risks
 
that could cause
actual results to vary materially from recent results or from anticipated future
 
results.
 
In addition to the other information set forth in
this Report, you should carefully consider the risk factors previously disclosed
 
in Part I, Item 1A of our 2020 Form 10-K.
 
There have
been no material changes to the risk factors described therein.
Item 2.
 
Unregistered Sales of Equity Securities and Use of Proceeds.
The following table sets forth information concerning shares of the
 
Company’s common stock acquired
 
by the Company during
the period covered by this Report:
(c)
(d)
Total
 
Number of
Approximate Dollar
(a)
(b)
Shares Purchased
 
Value of
 
Shares that
Total
 
Number
Average
as part of
May Yet
 
be
of Shares
Price Paid
Publicly Announced
Purchased Under the
Period
Purchased (1)
Per Share (2)
Plans or Programs
Plans or Programs (3)
July 1 - July 31
—
$
—
—
$
86,865,026
 
August 1 - August 31
491
 
$
251.74
 
—
$
86,865,026
 
September 1 - September 30
34
 
$
240.64
 
—
$
86,865,026
 
Total
525
 
$
251.02
 
—
$
86,865,026
 
(1)
All of these shares were acquired from employees upon their surrender
 
of Quaker Chemical Corporation shares in payment of
the exercise price of employee stock options exercised or for the payment
 
of taxes upon exercise of employee stock options
or the vesting of restricted stock awards or units.
 
(2)
The price paid for shares acquired from employees pursuant to employee
 
benefit and share-based compensation plans is, in
each case, based on the closing price of the Company’s
 
common stock on the date of exercise or vesting as specified by the
plan pursuant to which the applicable option, restricted stock award, or
 
restricted stock unit was granted.
 
(3)
On May 6, 2015, the Board of Directors of the Company approved, and the
 
Company announced, a share repurchase
program, pursuant to which the Company is authorized to repurchase up to
 
$100,000,000 of Quaker Chemical Corporation
common stock (the “2015 Share Repurchase Program”), and it has no expiration
 
date.
 
There were no shares acquired by the
Company pursuant to the 2015 Share Repurchase Program during the
 
quarter ended September 30, 2021.
Limitation on the Payment of Dividends
The Credit Facility has certain limitations on the payment of dividends
 
and other so-called restricted payments.
 
See Note 15 of
Notes to Condensed Consolidated Financial Statements, in Part I, Item
 
1, of this Report.
 
48
Item 6.
 
Exhibits.
(a) Exhibits
3.1
–
3.2
–
10.1
–
10.2
–
10.3
–
31.1
–
31.2
–
32.1
–
32.2
–
101.INS
Inline XBRL Instance Document*
101.SCH
Inline XBRL Taxonomy
 
Extension Schema Document*
101.CAL
Inline XBRL Taxonomy
 
Extension Calculation Linkbase Document*
101.DEF
Inline XBRL Taxonomy
 
Extension Definition Linkbase Document*
101.LAB
Inline XBRL Taxonomy
 
Extension Label Linkbase Document*
101.PRE
Inline XBRL Taxonomy
 
Extension Presentation Linkbase Document*
104
Cover Page Interactive Data File (formatted as Inline XBRL and contained
 
in Exhibit 101.INS)*
* Filed herewith.
** Furnished herewith.
† Management contract or compensatory plan.
*********
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has
 
duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.
 
 
 
 
 
QUAKER CHEMICAL CORPORATION
 
(Registrant)
 
 
 
 
/s/ Shane W. Hostetter
Date: November 4, 2021
 
 
 
Shane W. Hostetter,
 
Senior Vice President, Chief Financial
Officer (officer duly authorized on behalf of, and principal
financial officer of, the Registrant)
EX-10.1 2 exhibit101.htm EMPLOYMENT AGREEMENT - A. TOMETICH exhibit101
exhibit101p1i0.jpg
 
 
 
EXHIBIT 10.1
1
EMPLOYMENT AGREEMENT
September 2, 2021
NAME:
Andrew Tometich
[ REDACTED ]
[ REDACTED ]
The parties to this Employment Agreement (“Agreement”) are
 
Andrew Tometich (“You”
 
or the “Executive”) and
Quaker
 
Chemical
 
Corporation,
 
d/b/a
 
Quaker
 
Houghton,
 
a
 
Pennsylvania
 
corporation
 
(“Quaker
 
Houghton”
 
or
 
the
“Company”).
You
 
are hereby
 
appointed as
 
the Company’s
 
Chief Executive
 
Officer and
 
President effective
 
December 1,
 
2021
with an anticipated start date of on or about October 11, 2021.
 
 
NOW THEREFORE in consideration
 
of the mutual
 
promises and covenants herein contained
 
and intending to be
legally bound hereby the parties hereto agree as follows:
1.
Duties
 
Quaker Houghton agrees
 
to employ you
 
and you agree
 
to serve as
 
Quaker Houghton’s Chief Executive
 
Officer and
President.
 
You
 
shall perform all
 
duties consistent with
 
such position as
 
well as any
 
other duties that
 
are assigned to
 
you
from time
 
to
 
time by
 
Quaker Houghton’s
 
Board of
 
Directors. You
 
agree that
 
during the
 
term
 
of your
 
employment with
Quaker Houghton to devote your knowledge,
 
skill, and working time solely
 
and exclusively to the business
 
and interests of
Quaker Houghton and its subsidiaries.
 
2.
 
Compensation
 
Your
 
base salary
 
will be
 
determined from
 
time to
 
time by
 
the Quaker
 
Houghton Board of
 
Directors. In addition,
you will be entitled to
 
participate, to the extent
 
eligible, in any of Quaker
 
Houghton’s annual and long term incentive
 
plans,
retirement savings plan (401k plan),
 
and will be entitled to vacations,
 
paid holidays, and medical, dental,
 
and other benefits
as are
 
made generally
 
available by
 
Quaker Houghton
 
to its
 
full-time U.S.
 
employees.
 
During your
 
employment with
 
Quaker
Houghton,
 
your
 
salary
 
will
 
not
 
be
 
reduced
 
by
 
Quaker
 
Houghton
 
without
 
your
 
prior
 
written
 
consent.
 
Your
 
initial
compensation and benefits are outlined on Addendum 1, which is attached
 
hereto and made a part hereof.
 
3.
 
Term
 
of Employment
.
Your
 
employment with
 
Quaker Houghton
 
may be
 
terminated on
 
ninety (90)
 
days' written
 
notice by
 
either party,
with or
 
without cause
 
or reason
 
whatsoever.
 
Within ninety
 
(90) days
 
after termination
 
of your
 
employment, you will
 
be
given an accounting
 
of all
 
monies due you.
 
Notwithstanding the
 
foregoing, Quaker Houghton
 
has the right
 
to terminate your
employment upon less than ninety (90) days’ notice for Cause (as defined
 
below).
 
 
2
4.
 
Covenant Not to Disclose
a.
 
As Chief Executive Officer,
 
you acknowledge that the identity
 
of Quaker Houghton's (and any
 
of Quaker
Houghton's affiliates’)
 
customers, the
 
requirements of such
 
customers, pricing and
 
payment terms
 
quoted and charged
 
to
such customers,
 
the identity
 
of Quaker
 
Houghton's suppliers
 
and terms
 
of supply
 
(and the
 
suppliers and
 
related terms
 
of
supply of
 
any of
 
Quaker Houghton's
 
customers for
 
which chemical
 
and other
 
management services
 
are being
 
provided),
information
 
concerning the
 
method
 
and
 
conduct
 
of
 
Quaker
 
Houghton's
 
(and
 
any
 
affiliate’s)
 
business
 
such
 
as
 
formulae,
formulation
 
information,
 
application
 
technology,
 
manufacturing
 
information,
 
marketing
 
information,
 
strategic
 
and
marketing
 
plans,
 
financial
 
information,
 
financial
 
statements
 
(audited
 
and
 
unaudited),
 
budgets,
 
corporate
 
practices
 
and
procedures, research and
 
development efforts, and laboratory
 
test methods and all
 
of Quaker Houghton's (and
 
its affiliates’)
manuals,
 
documents,
 
notes,
 
letters,
 
records,
 
and
 
computer
 
programs
 
are
 
Quaker
 
Houghton's
 
confidential
 
information
("Confidential Information")
 
and are
 
Quaker Houghton’s (and/or
 
any of
 
its affiliates’, as
 
the case
 
may be)
 
sole and
 
exclusive
property.
 
You
 
agree that at no time during or following your employment with Quaker Houghton will you appropriate for
your
 
own
 
use,
 
divulge
 
or
 
pass
 
on,
 
directly
 
or
 
through
 
any
 
other
 
individual
 
or
 
entity
 
or
 
to
 
any
 
third
 
party,
 
any
 
Quaker
Houghton
 
Confidential
 
Information.
 
Upon
 
termination
 
of
 
your
 
employment
 
with
 
Quaker
 
Houghton
 
and
 
prior
 
to
 
final
payment
 
of
 
all
 
monies
 
due
 
to
 
you
 
under
 
Section 2
 
or
 
at
 
any
 
other time
 
upon
 
Quaker Houghton's
 
request, you
 
agree
 
to
surrender immediately
 
to Quaker
 
Houghton any
 
and all
 
materials in
 
your possession
 
or control
 
which include
 
or contain
any Quaker Houghton Confidential Information.
b.
 
You
 
acknowledge that, by this
 
Section 4(b), you have been
 
notified in accordance with the
 
Defend Trade
Secrets Act that, notwithstanding the foregoing:
(i)
You
 
will not be
 
held criminally or civilly
 
liable under any federal
 
or state trade secret
 
law or this
Agreement for the disclosure
 
of Confidential Information that: (A)
 
you make (1) in
 
confidence to a federal, state,
 
or local
government
 
official,
 
either
 
directly
 
or
 
indirectly,
 
or
 
to
 
your
 
attorney;
 
and
 
(2)
 
solely
 
for
 
the
 
purpose
 
of
 
reporting
 
or
investigating a suspected
 
violation of law;
 
or (B) you
 
make in a
 
complaint or other
 
document that is
 
filed under seal
 
in a
lawsuit or other proceeding.
(ii)
If you file a lawsuit for retaliation by Quaker Houghton for reporting a suspected violation of
 
law,
you may disclose Confidential Information
 
to your attorney and use the
 
Confidential Information in the court
 
proceeding if
you: (A)
 
file any
 
document containing
 
Confidential Information
 
under seal
 
and (B)
 
do not
 
disclose Confidential
 
Information,
except pursuant to court order.
 
c.
 
Additionally, Quaker Houghton confirms that nothing in this Agreement is intended to or shall prevent,
impede or interfere with your right, without prior notice to Quaker Houghton,
 
to provide information to the government,
participate in any government investigations, file a court or administrative
 
complaint, testify in proceedings regarding
Quaker Houghton’s past or future conduct, or engage in any future activities protected under any statute
 
administered by
any government agency.
5.
 
Covenant Not to Compete
In consideration of
 
your position of
 
Chief Executive Officer
 
for Quaker Houghton
 
and the training
 
and Confidential
Information you are to receive
 
from Quaker Houghton,
 
you agree that during your
 
employment with Quaker Houghton
 
and
for a period of eighteen (18) months thereafter, regardless of the reason for your termination, you will
 
not:
a.
 
directly or
 
indirectly,
 
together or
 
separately or
 
with any
 
third party,
 
whether as
 
an employee,
 
individual
proprietor, partner, stockholder, officer, director, or investor, or in
 
a joint venture
 
or any other
 
capacity whatsoever, actively
engage in
 
business or
 
assist anyone
 
or any
 
firm in
 
business as a
 
manufacturer, seller,
 
or distributor of
 
specialty chemical
products which are the same, like, similar to, or which compete with Quaker Houghton’s (or any of its affiliates’) products
or services; and
 
b.
 
directly or indirectly recruit, solicit or encourage any Quaker Houghton (or any
 
of its affiliates’) employee
or otherwise induce
 
such employee to
 
leave Quaker Houghton’s (or
 
any of its
 
affiliates’) employ, or to
 
become an employee
or otherwise be associated with
 
you or any firm, corporation, business,
 
or other entity with which
 
you are or may become
associated; and
 
 
 
3
c.
 
solicit or induce any of Quaker Houghton's suppliers of products and/or services (or a supplier of
 
products
and/or services of
 
a customer who
 
is being provided
 
or solicited for
 
the provision of
 
chemical management or
 
other services
by Quaker Houghton)
 
to terminate or alter its contractual relationship with Quaker
 
Houghton (and/or any such customer).
The parties
 
consider these
 
restrictions reasonable,
 
including the
 
period of
 
time during
 
which the
 
restrictions are
effective.
 
However,
 
if
 
any
 
restriction
 
or
 
the
 
period
 
of
 
time
 
specified
 
should
 
be
 
found
 
to
 
be
 
unreasonable
 
in
 
any
 
court
proceeding, then such restriction shall be modified or
 
the period of time shall be shortened as
 
is found to be reasonable so
that the foregoing covenant not to compete may be enforced.
 
You
 
agree that in the event of a breach or
 
threatened breach
by you of
 
the provisions of
 
the restrictive covenants
 
contained in Section
 
4 or in
 
this Section 5,
 
Quaker Houghton
 
will suffer
irreparable harm, and monetary
 
damages may not be
 
an adequate remedy.
 
Therefore, if any
 
breach occurs, or is
 
threatened,
in addition to all other remedies available to Quaker Houghton,
 
at law or in equity, Quaker Houghton shall be entitled as a
matter of
 
right to
 
specific performance
 
of the
 
covenants contained
 
herein by
 
way of
 
temporary or
 
permanent injunctive
relief.
 
In the event of any breach of
 
the restrictive covenant contained in
 
this Section 5, the term of the restrictive
 
covenant
shall be extended
 
by a period
 
of time equal
 
to that period
 
beginning on the
 
date such violation
 
commenced and
 
ending when
the activities constituting such violation cease.
6.
 
Contractual Restrictions
 
You
 
represent and warrant to Quaker Houghton that:
 
(a) there are no restrictions, agreements, or understandings
 
to
which
 
you
 
are
 
a
 
party
 
that
 
would
 
prevent
 
or
 
make
 
unlawful
 
your
 
employment
 
with
 
Quaker
 
Houghton
 
and
 
(b)
 
your
employment by Quaker
 
Houghton shall
 
not constitute
 
a breach of
 
any contract,
 
agreement, or
 
understanding, oral
 
or written,
to which you
 
are a party
 
or by which
 
you are bound.
 
You further represent that you
 
will not use
 
any trade secret,
 
proprietary
or otherwise
 
confidential information
 
belonging to
 
a prior
 
employer or
 
other third
 
party in
 
connection with
 
your employment
with Quaker Houghton.
7.
 
Inventions
All improvements, modifications, formulations,
 
processes, discoveries or inventions
 
("Inventions"), whether or not
patentable, which
 
were originated,
 
conceived or
 
developed by
 
you solely
 
or jointly
 
with others
 
(a) during
 
your working
hours or at
 
Quaker Houghton’s
 
expense or at Quaker
 
Houghton's premises or at
 
a customer’s premises
 
or (b) during your
employment with
 
Quaker Houghton
 
and additionally
 
for
 
a period
 
of one
 
year thereafter,
 
and which
 
relate to
 
(i)
 
Quaker
Houghton’s business or (ii)
 
any research, products,
 
processes, devices,
 
or machines
 
under actual or
 
anticipated development
or investigation by Quaker Houghton at the earlier of (i) that
 
time or (ii) as the date of termination of employment, shall be
Quaker Houghton’s
 
sole property.
 
You
 
shall promptly
 
disclose to
 
Quaker Houghton
 
all Inventions
 
that you
 
conceive or
become
 
aware
 
of
 
at
 
any
 
time
 
during
 
your
 
employment
 
with
 
Quaker
 
Houghton
 
and
 
shall
 
keep
 
complete,
 
accurate,
 
and
authentic notes, data and records of all Inventions and of
 
all work done by you solely or jointly with
 
others, in the manner
directed by
 
Quaker Houghton.
 
You
 
hereby transfer and
 
assign to
 
Quaker Houghton all
 
of your right,
 
title, and interest
 
in
and
 
to
 
any
 
and
 
all
 
Inventions
 
which
 
may
 
be
 
conceived
 
or
 
developed
 
by
 
you
 
solely
 
or
 
jointly
 
with
 
others
 
during
 
your
employment with Quaker Houghton.
 
You
 
shall assist Quaker Houghton in applying, obtaining, and
 
enforcing any United
States Letters Patent and Foreign Letters Patent on any such Inventions and to take such other actions as may be necessary
or
 
desirable
 
to
 
protect
 
Quaker
 
Houghton's
 
interests
 
therein.
 
Upon
 
request,
 
you
 
shall
 
execute
 
any
 
and
 
all
 
applications,
assignments,
 
or
 
other
 
documents
 
that
 
Quaker
 
Houghton
 
deems
 
necessary
 
and
 
desirable
 
for
 
such
 
purposes.
 
You
 
have
attached hereto
 
a list
 
of unpatented
 
inventions that
 
you have
 
made or
 
conceived prior
 
to your
 
employment with
 
Quaker
Houghton, and it is agreed that those inventions shall be excluded
 
from the terms of this Agreement.
8.
Termination
.
 
(a)
Either party may terminate this Agreement per the terms of Section 3 hereof and Quaker Houghton, in its sole
discretion, may terminate
 
your employment
 
at any time
 
for Cause (as
 
defined herein).
 
If you incur
 
a Separation
from Service (as defined
 
below) by decision and
 
action of Quaker Houghton
 
for any reason
 
other than Cause
or death Quaker Houghton agrees to:
 
4
1.
 
Provide you with reasonable
 
outplacement assistance, either by providing
 
the services in-kind, or
by reimbursing reasonable
 
expenses actually incurred
 
by you in connection
 
with your Separation
 
from Service.
 
The
 
outplacement
 
services
 
must
 
be
 
provided
 
during
 
the
 
one-year
 
period
 
following
 
your
 
Separation
 
from
Service.
 
If any expenses are to be reimbursed, you must request
 
the reimbursement within eighteen months of
your Separation from
 
Service and reimbursement
 
will be made
 
within 30 days
 
of the
 
receipt of your
 
request;
and
2.
 
Pay you a severance consisting
 
of 18 months of salary
 
and bonus at target paid biweekly
 
over such
eighteen months commencing on the
 
Payment Date (as defined below) and
 
continuing on Quaker Houghton's
normal payroll dates thereafter;
 
provided you sign a Release within 45 days of the later of the date
 
you receive
the Release
 
or your
 
Separation from
 
Service. Continuation
 
of all
 
medical and
 
dental coverage’s
 
will also
 
be
available for 18 months at a level equal to the coverage provided before
 
your Separation from Service.
(b)
If the Executive dies during
 
the Term
 
of Employment, the Company shall not
 
thereafter be obligated to make
any further payments under this
 
Agreement except for amounts
 
accrued as of the date
 
of the Executive’s death,
and except that the Company shall pay a death benefit equal to 100%
 
of base salary in effect on the day before
your death
 
and 50%
 
of base
 
salary in
 
each of
 
the four
 
years thereafter.
 
“Beneficiary” shall
 
mean the
 
person
designated by the Executive to
 
receive benefits under this Agreement in
 
a writing filed by the
 
Executive with
the Company’s human resources department before
 
the Executive’s death or, if the Executive fails
 
to designate
a beneficiary or the designated beneficiary predeceases the Executive, the Executive’s Beneficiary shall be his
surviving spouse or, if the Executive has no surviving spouse, his estate.
“Separation from Service”
 
means your separation
 
from service with
 
Quaker Houghton and
 
its affiliates within
 
the
meaning of Treas. Reg. §1.409A-1(h) or any successor thereto.
 
“Cause”
 
means your
 
employment with
 
Quaker Houghton
 
has been
 
terminated by
 
reason of
 
(i) your
 
willful and
material breach of this Agreement (after having received notice thereof and a reasonable opportunity to
 
cure or correct) or
the Company’s
 
policies, (ii)
 
dishonesty,
 
fraud, willful
 
malfeasance, gross
 
negligence, or
 
other gross
 
misconduct, in
 
each
case
 
relating
 
to
 
the
 
performance
 
of
 
your
 
duties
 
hereunder
 
which
 
is
 
materially
 
injurious
 
to
 
Quaker
 
Houghton,
 
or
 
(iii)
conviction of or plea of guilty or nolo contendere to a felony.
“Payment Date”
 
means (x) the 60th day after your Separation from Service
 
or (y) if you are a specified employee
(as defined
 
in
 
Treas.
 
Reg. §1.409A-1(i))
 
as of
 
the date
 
of your
 
Separation from
 
Service, and
 
the severance
 
described in
subsection (b) is
 
deferred compensation subject
 
to section
 
409A of the
 
Code, the
 
first business day
 
of the
 
seventh month
following the
 
month in
 
which your
 
Separation from
 
Service occurs.
 
If the
 
Payment Date
 
is described
 
in clause
 
(y), the
amount paid on
 
the Payment Date
 
shall include all
 
monthly installments that
 
would have been
 
paid earlier had
 
clause (y)
not been applicable, plus interest at the
 
Wall
 
Street Journal Prime Rate published in the
 
Wall
 
Street Journal on the date of
your Separation from Service (or the previous business day if
 
such day is not a business day), for the
 
period from the date
payment would have been made had clause (y) not been applicable through
 
the date payment is made.
“Release”
 
means
 
a
 
release
 
(in
 
a
 
form
 
satisfactory
 
to
 
Quaker
 
Houghton)
 
of
 
any
 
and
 
all
 
claims
 
against
 
Quaker
Houghton and all related parties
 
with respect to all matters arising
 
out of your employment with Quaker
 
Houghton, or the
termination thereof (other than for claims for any entitlements under the terms of this Agreement or any plans or programs
of Quaker Houghton under which you
 
have accrued a benefit) that Quaker
 
Houghton provides to you no
 
later than ten days
after your Separation from Service.
 
If a release is not provided to
 
you within this time period, the
 
severance shall be paid
even if you do not sign a release.
9.
 
Indemnification
Quaker
 
Houghton
 
shall
 
defend
 
you
 
and
 
hold
 
you
 
harmless
 
to
 
the
 
fullest
 
extent
 
permitted
 
by
 
applicable
 
law
 
in
connection
 
with
 
any claim,
 
action,
 
suit, investigation
 
or
 
proceeding arising
 
out
 
of
 
or
 
relating to
 
performance by
 
you
 
of
 
 
 
 
 
 
5
services for, or actions of you
 
as a director, officer,
 
or employee of Quaker Houghton or any parent, subsidiary or affiliate
of
 
Quaker Houghton,
 
or
 
of
 
any other
 
person or
 
enterprise at
 
Quaker Houghton’s
 
request.
 
Expenses incurred
 
by you
 
in
defending such a claim, action,
 
suit or investigation or
 
criminal proceeding shall be paid
 
by Quaker Houghton in
 
advance
of
 
the
 
final
 
disposition thereof
 
upon
 
the
 
receipt
 
by
 
the
 
Company
 
of
 
an
 
undertaking
 
by
 
or
 
on
 
your
 
behalf
 
to
 
repay
 
said
amounts unless it shall ultimately be determined that you are entitled
 
to be indemnified hereunder; provided, however, that
this shall not apply to a nonderivative action commenced by Quaker Houghton
 
against you.
 
10.
 
Governing Law.
 
The provisions of this Agreement shall be construed in accordance with
 
the laws of the Commonwealth of
Pennsylvania without reference to principles of conflicts of laws.
11.
 
Miscellaneous
This Agreement
 
and the
 
Change in
 
Control Agreement
 
to which
 
you are
 
a party,
 
constitute the
 
entire integrated
agreement concerning
 
the subjects
 
covered herein.
 
In case
 
any provision
 
of
 
this Agreement
 
shall be
 
invalid, illegal,
 
or
otherwise unenforceable, the validity, legality,
 
and enforceability of the remaining provisions shall not thereby be affected
or impaired.
 
You may not assign any of your rights or obligations under this Agreement without Quaker Houghton’s prior
written consent.
 
Quaker Houghton may assign this Agreement in its discretion, including to any affiliate or upon a sale of
assets
 
or
 
equity,
 
merger
 
or
 
other
 
corporate
 
transaction;
 
provided
 
that
 
Quaker
 
Houghton
 
obtains
 
the
 
assignee’s
 
written
commitment to honor the
 
terms and conditions contained herein.
 
This Agreement shall be
 
governed by,
 
and construed in
accordance with, the laws of the Commonwealth of
 
Pennsylvania without regard to any conflict of laws.
 
This Agreement
shall be binding upon
 
you, your heirs, executors,
 
and administrators and shall
 
inure to the benefit
 
of Quaker Houghton as
well as
 
its successors
 
and assigns.
 
In the
 
event of
 
any overlap
 
in the
 
restrictions contained
 
herein, including
 
Sections 4
and/or 5 above, with similar restrictions
 
contained in any other agreement, such
 
restrictions shall be read together so
 
as to
provide the broadest restriction possible.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement the day and year first above written.
WITNESS:
QUAKER CHEMICAL CORPORATION
DBA QUAKER HOUGHTON
/s/ Robert T. Traub
/s/ Michael F. Barry
WITNESS:
/s/ Danielle R. Tometich
/s/ Andrew E. Tometich
ANDREW TOMETICH
 
6
ADDENDUM 1
Base Salary:
Your
 
salary will be payable on a bi-weekly basis at the rate of
 
$30,769.23, which
 
is annualized
 
at $800,000.
 
You
 
will be
 
eligible for
 
your
next salary increase in 2023.
Annual and Long-
Term
 
Bonuses:
For your position, you are eligible to participate in the Annual Incentive Plan
(“AIP”) with
 
a target
 
award percentage for
 
2022 year of
 
100% of
 
your base
salary,
 
dependent
 
upon
 
Quaker
 
Houghton’s
 
financial
 
results
 
and
 
personal
objectives to be determined.
You will be eligible
 
to participate
 
in the 2022-2024
 
Long-Term Incentive Plan
(“LTIP”).
 
Your
 
award for the 2022-2024 performance period includes a mix
of
 
time-based
 
restricted
 
stock,
 
stock
 
options,
 
and
 
target
 
performance
 
stock
units (PSU’s)
 
,
 
such mix
 
to be
 
determined by
 
the Company’s
 
Compensation
and Human Resources
 
Committee.
 
The value, at
 
a target level, is
 
$1,680,000.
 
All incentive compensation
 
awards are made
 
at the Company’s discretion, are
subject to change, and
 
require the approval of the
 
Company’s Compensation
and Human Resources Committee.
Special One-time Grants:
You
 
will be provided a one-time cash payment
 
$550,000
to offset the annual
incentive
 
at
 
your
 
current
 
employment
 
and
 
in
 
lieu
 
of
 
any
 
potential
 
annual
incentive
 
earned
 
in
 
2021
 
at
 
Quaker
 
Houghton.
 
This
 
cash
 
payment
 
will
 
be
payable
 
in
 
the
 
first
 
quarter
 
of
 
2022
 
at
 
the
 
time
 
the
 
Quaker
 
Houghton
 
AIP
payments
 
are
 
made
 
to
 
AIP
 
participants
 
generally.
 
Such
 
cash
 
payment
 
is
subject to
 
a claw-back
 
and must
 
be repaid
 
to the
 
Company if
 
you terminate
your employment with Quaker Houghton for any reason
 
other than for cause
or if
 
a change
 
a control
 
occurs within
 
the first
 
two (2)
 
years of
 
your tenure
with Quaker Houghton.
 
You
 
will also
 
be provided a
 
one-time equity
 
award equaling
 
a cash
 
value at
time of grant of $1,750,000 in order to offset
 
the equity that will expire upon
your
 
accepting
 
employment
 
with
 
Quaker
 
Houghton.
 
Such
 
award
 
will
 
be
provided as
 
a mix
 
of 50%
 
time-based restricted
 
stock and
 
50% PSU’s.
 
The
time based
 
restricted stock
 
will vest
 
one year
 
from the
 
date of
 
grant, which
will
 
be
 
on
 
your
 
first
 
day
 
of
 
employment
 
with
 
Quaker
 
Houghton
 
(currently
anticipated
 
to
 
be
 
October
 
11,
 
2021).
 
However,
 
in
 
the
 
event
 
that
 
your
employment is
 
terminated for
 
any reason
 
(other than
 
cause) within
 
the first
twelve (12) months of your start date, then the
 
vesting date of the time based
restricted stock described
 
in this paragraph
 
will be accelerated
 
to the date
 
of
termination.
 
The grant
 
of 50%
 
PSUs will
 
also be
 
made on
 
your first
 
day of
employment
 
and
 
will
 
be
 
based
 
on
 
the
 
three
 
year
 
period starting
 
October
 
1,
2021 and ending September 30, 2024.
 
Relocation:
You
 
will receive, as
 
soon as administratively possible after
 
your start date, a
lump
 
sum
 
payment of
 
$150,000.00
 
to
 
cover
 
all
 
relocation
 
expenses,
 
which
will be
 
grossed up
 
for taxes.
 
If you
 
should voluntarily
 
leave Quaker
 
within
7
one year of
 
receipt of these
 
funds, all financial relocation
 
assistance must be
reimbursed to Quaker Houghton.
Financial Planning:
You
 
will be eligible to be reimbursed for up to $8,000 per calendar year for
expenses incurred for financial planning and/or tax preparation.
Benefits:
Quaker Houghton
 
offers a Flexible
 
Benefits Program
 
that is
 
subject to change.
 
This gives you the opportunity to choose from
 
a variety of options creating a
customized benefits package.
 
The following benefits are currently
 
part of the
program.
 
In each
 
of these
 
areas, you
 
are offered
 
a range
 
of options
 
so you
may choose the ones that make the most sense for your personal situation.
●
Medical
 
●
Dental
 
●
Life & AD&D Insurance
●
Long-term Disability
●
Health Care and Dependent Care Flexible Spending Accounts (FSAs)
●
Retirement Savings Plan (401K)
●
The
 
Company
 
is
 
reviewing
 
a
 
non-qualified
 
deferred
 
compensation
(excess)
 
plan,
 
which
 
if
 
adopted
 
will
 
be
 
part
 
of
 
your
 
overall
 
benefits
package
 
 
Vacation
 
/ Holidays:
You
 
will be eligible for 25 PTO days per calendar year while you are
working in the U.S. You will begin to accrue an additional 5 days of PTO
per calendar year when you meet the next service level as defined in
 
the
plan.
 
In addition, you will be eligible to be paid for regional holidays.
 
Unused vacation days will not roll over from year to year, unless applicable
law requires otherwise.
GRAPHIC 3 exhibit101p1i0.jpg LOGO begin 644 exhibit101p1i0.jpg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exhibit102.htm CHANGE IN CONTROL AGREEMENT - A. TOMETICH exhibit102
 
 
1
EXHIBIT 10.2
CHANGE IN CONTROL AGREEMENT
 
THIS AGREEMENT, dated September
 
2, 2021 between QUAKER CHEMICAL CORPORATION,
d/b/a QUAKER HOUGHTON, a Pennsylvania corporation (the “Company”), and Andrew Tometich
 
(the
“Executive”).
 
W I T N E S S E T H
 
T H A T
 
WHEREAS, the Executive and the Company entered into an employment agreement dated September 2,
2021; and
 
WHEREAS, the Executive and the Company wish to enter into this Change in Control Agreement (the
“Agreement”);
 
 
NOW,
 
THEREFORE, IN CONSIDERATION
 
of the mutual obligations and agreements contained
herein and intending to be legally bound hereby, the Executive and the Company agree as follows:
 
1.
Term
 
of Agreement.
 
 
This Agreement shall become effective on October 11,
 
2021 (the “Effective Date”), and shall continue
in effect through December 31, 2022; provided, however, that the term of this Agreement shall automatically be
extended for successive one-year periods thereafter, unless, not later than eighteen (18) months preceding the
calendar year for which the term would otherwise automatically extend, the Company shall have given written
notice to the Executive of intention not to extend this Agreement for an additional year, in which event this
Agreement shall continue in effect until December 31 of the calendar year immediately preceding the calendar
year for which the term would have otherwise automatically extended. Notwithstanding any such notice not to
extend, if a Change in Control (as defined in Section 2) occurs during the original or extended term of this
Agreement, this Agreement shall remain in effect after a Change in Control until all obligations of the parties
hereto under this Agreement shall have been satisfied.
 
2.
Change in Control.
 
 
As used in this Agreement, a “Change in Control” of the Company shall be deemed to have occurred if:
 
(a)
Any person (a “Person”), as such term is used in Sections 13(d) and 14(d) of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”) (other than (i) the Company and/or its wholly owned
subsidiaries; (ii) any ESOP or other employee benefit plan of the Company and any trustee or other fiduciary in
such capacity holding securities under such plan; (iii) any corporation owned, directly or indirectly, by the
shareholders of the Company in substantially the same proportions as their ownership of stock of the Company;
or (iv) any other Person who, within the one year prior to the event which would otherwise be a Change in
Control, is an executive officer of the Company or any group of Persons of which he voluntarily is a part), is or
becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of
securities of the Company representing 30% or more of the combined voting power of the Company’s then
outstanding securities or such lesser percentage of voting power, but not less than 15%, as determined by the
members of the Board of Directors of the Company who are independent directors (as defined in the New York
Stock Exchange, Inc. Listed Company Manual);
 
(b)
During any two-year period after the Effective Date, Directors of the Company in office at the
beginning of such period plus any new Director (other than a Director designated by a Person who has entered
 
 
 
2
into an agreement with the Company to effect a transaction within the purview of subsections (a) or (c)) whose
election by the Board of Directors of the Company or whose nomination for election by the Company’s
shareholders was approved by a vote of at least two-thirds of the Directors then still in office who either were
Directors at the beginning of the period or whose election or nomination for election was previously so
approved shall cease for any reason to constitute at least a majority of the Board;
 
(c)
The consummation of (i) any consolidation or merger of the Company in which the Company is
not the continuing or surviving corporation or pursuant to which the Company’s voting common shares (the
“Common Shares”) would be converted into cash, securities, and/or other property, other than a merger
 
of the
Company in which holders of Common Shares immediately prior to the merger have the same proportionate
ownership of voting shares of the surviving corporation immediately after the merger as they had in the
Common Shares immediately before; or (ii) any sale, lease, exchange, or other transfer (in one transaction or a
series of related transactions) of all or substantially all the assets or earning power of the Company; or
 
(d)
The Company’s shareholders or the Company’s
 
Board of Directors shall approve the liquidation
or dissolution of the Company.
 
3.
Entitlement to Change in Control Benefits; Certain Definitions.
 
 
The Executive shall be entitled to the benefits provided in this Agreement in the event the Executive has
a Separation from Service under the circumstances described in (a) below (a “Covered Termination”), provided
the Executive executes and does not revoke a Release (as defined below), if any, provided by the Company.
 
(a)
A Covered Termination shall have occurred in the event the Executive’s
 
employment with the
Company or its affiliates is terminated within two (2) years following a Change in Control by:
 
(i)
The Company or its affiliates without Cause (as defined below); or
 
(ii)
Resignation of the Executive for Good Reason (as defined below).
 
 
The Executive shall have no rights to any payments or benefits under this Agreement in the event the
Executive’s employment with the Company and its affiliates is terminated (i) as a result of death or Disability
(as defined below), or (ii) by the Company or its affiliates for Cause. In the event the Executive’s employment
is terminated for any reason prior to a Change in Control, the Executive shall have no rights to any payments or
benefits under this Agreement and, after any such termination, this Agreement shall be of no further force or
effect.
 
 
“Cause” shall mean (i) the Executive’s willful and material breach of the employment agreement
between the Executive and the Company (after having received notice thereof and a reasonable opportunity to
cure or correct), (ii) dishonesty, fraud, willful malfeasance, gross negligence, or other gross misconduct, in each
case relating to the performance of the Executive’s employment with the Company or its affiliates which
 
is
materially injurious to the Company, or (iii) conviction of or plea of guilty to a felony,
 
such Cause to be
determined, in each case, by a resolution approved by at least two-thirds of the Directors of the Company after
having afforded the Executive a reasonable opportunity to appear before the Board of Directors of the Company
and present his position.
 
 
“Code” shall mean the Internal Revenue Code of 1986, as amended, together with any applicable
regulations thereunder.
 
 
 
 
 
 
 
 
3
 
“Disability” shall mean covered total and permanent disability as defined in the long-term disability plan
maintained by the Company for employees generally or, if the Company does not maintain such a plan, the
long-term disability plan most recently maintained by the Company for employees generally.
 
“Good Reason” shall mean any of the following actions without the Executive’s consent, other than due
to the Executive’s death or Disability: (i) any reduction in the Executive’s
 
base salary from that provided
immediately before the Covered Termination or,
 
if higher, immediately before the Change in Control; (ii) any
reduction in the Executive’s bonus opportunity (including cash and noncash incentives) or increase in the goals
or standards required to accrue that opportunity, as compared to the opportunity and goals or standards in effect
immediately before the Change in Control; (iii) a material adverse change in the nature or scope of the
Executive’s authorities, powers, functions, or duties from those in effect immediately before the Change in
Control; (iv) a reduction in the Executive’s benefits from those provided immediately before the Change in
Control, disregarding any reduction under a plan or program covering employees generally that applies to all
employees covered by the plan or program; (or (v) the Executive being required to accept a primary
employment location which is more than twenty-five (25) miles from the location at which he primarily was
employed during the ninety (90) day period prior to a Change in Control.
 
 
“Payment Date” shall mean the 60
th
 
day after the Executive’s Separation from Service, subject to
Section 9.
 
“Release” shall mean a release (in a form satisfactory to the Company) of any and all claims against the
Company and all related parties with respect to all matters arising out of the Executive’s employment by the
Company and its affiliates, or the termination thereof (other than claims for any entitlements under the terms of
this Agreement, under the employment agreement between the Executive and the Company, or under any plans
or programs of the Company under which the Executive has accrued a benefit) that the Company provides to
the Executive no later than three days after the date of the Executive’s Covered Termination.
 
Notwithstanding
any provision of this Agreement to the contrary, if the Company provides a Release to the Executive, the
Executive shall not be entitled to any payments or benefits under this Agreement unless the Executive executes
the Release within 45 days of the later of the date he receives the Release or the date of his Covered
Termination, and the Executive does not revoke the Release.
 
“Separation from Service” shall mean the Executive’s separation from service with the Company and its
affiliates within the meaning of Treas. Reg. §1.409A-1(h) or any successor thereto.
 
“Specified Employee”
 
shall mean the Executive if he is a specified employee as defined in Section 409A
of the Code as of the date of his Separation from Service.
4.
Severance Allowance.
 
(a)
Amount of Severance Allowance. In the event of a Covered Termination, the Company shall pay
or cause to be paid to the Executive in cash a severance allowance (the “Severance Allowance”) equal to two
times the sum of the amounts determined in accordance with the following paragraphs (i) and (ii):
 
(i)
An amount equivalent to the highest annualized base salary which the Executive was
entitled to receive from the Company and its subsidiaries at any time during his
employment prior to the Covered Termination; and
 
(ii)
An amount equal to the average of the aggregate annual amounts paid to the Executive in
the Applicable Three-Year
 
Period under all applicable annual incentive compensation
plans maintained by the Company and its affiliates (other than compensation relating to
relocation expense; the grant, exercise, or settlement of stock options, restricted stock or
 
 
 
 
4
performance incentive units or the sale or other disposition of shares received upon
exercise or settlement of such awards); provided, however, that (x) in determining the
average amount paid under the annual incentive plan during the Applicable Three-Year
Period there shall be excluded any year in which no amounts were paid to the Executive
under that plan; (y) there shall be excluded from such calculation any amounts paid to the
Executive under any such incentive compensation plan as a result of the acceleration of
such payments under such plan due to termination of the plan, a Change in Control, or a
similar occurrence; and (z) in no event shall the amount under this paragraph (ii) be less
than the amount of the mid/target bonus which would otherwise have been payable to the
Executive under the annual incentive compensation plans for the calendar year in which
the Change in Control occurred.
 
The Applicable Three-Year
 
Period shall be (A) if the
Executive has received an annual incentive compensation plan payment in the calendar
year of his Covered Termination, the calendar year in which such Covered Termination
occurs and the two preceding calendar years, or (B) in any other case, the three calendar
years preceding the calendar year in which the Executive’s Covered Termination
 
occurs;
provided, however, that the Applicable Three-Year
 
Period shall be determined by
substituting “ Change In Control” for “Covered Termination” if such substitution
 
results
in a higher amount under this subsection (ii).
 
 
In no event shall any retention bonus or change in control or success fee be taken into account when
determining the amount of the Severance Allowance hereunder.
 
(b)
Payment of Severance Allowance.
 
The Severance Allowance shall be paid to the Executive in a
lump sum on the Payment Date if the applicable Change in Control is also a change in control event as defined
in Treas. Reg. §1.409A-3(i)(5) (or any successor thereto).
 
In any other case, the Severance Allowance shall be
paid in twenty-four monthly installments commencing on the Payment Date, each of which is equal to one-
twenty-fourth (1/24th) of the amount of the Severance Allowance determined under Section 4(a), which are
treated as a right to a series of separate payments for purposes of Section 409A of the Code.
5.
Outplacement and Welfare Benefits.
 
(a)
Outplacement.
 
Subject to Section 6, for a period of one year following a Covered Termination of
the Executive, the Company shall make or cause to be made available to the Executive, at its expense,
outplacement counseling and other outplacement services comparable to those available for the Company’s
senior executives prior to the Change in Control.
 
(b)
Welfare Benefits. Subject to Section 6, for a period of 24 months following a Covered
Termination of the Executive,
 
the Executive and the Executive’s dependents shall be entitled to participate in
the Company’s life, medical, and dental insurance plans at the Company’s
 
expense, in accordance with the
terms of such plans at the time of such Covered Termination as if the Executive were still employed by the
Company or its affiliates under this Agreement. If, however, life, medical, or dental insurance benefits are not
paid or provided under any such plan to the Executive or his dependents because the Executive is no longer an
employee of the Company or its subsidiaries, the Company itself shall, to the extent necessary, pay or otherwise
provide for such benefits to the Executive and his dependents.
 
 
5
6.
Effect of Other Employment.
 
 
In the event the Executive becomes employed (as defined below) during the period with respect to
which benefits are continuing pursuant to Section 5: (a) the Executive shall notify the Company not later than
the day such employment commences; and (b) the benefits provided for in Section 5 shall terminate as of the
date of such employment. For the purposes of this Section 6, the Executive shall be deemed to have become
“employed” by another entity or person only if the Executive becomes essentially a full-time employee of a
person or an entity (not more than 30% of which is owned by the Executive and/or members of his family); and
the Executive’s “family” shall mean his parents, his siblings and their spouses, his children and their spouses,
and the Executive’s spouse and her parents and siblings. Nothing herein shall relieve the Company of its
obligations for compensation or benefits accrued up to the time of termination provided for herein.
 
 
6
7.
Other Payments and Benefits.
 
 
On the Payment Date, the Company shall pay or cause to be paid to the Executive the aggregate of: (a)
the Executive’s earned but unpaid base salary through the Covered Termination
 
at the rate in effect on the date
of the Covered Termination, or if higher,
 
at the rate in effect at any time during the 90-day period preceding the
Change in Control; (b) any unpaid bonus or annual incentive payable to the Executive in respect of the calendar
year ending prior to the Covered Termination; (c) the pro rata portion of any and all unpaid bonuses and annual
incentive awards for the calendar year in which the Covered Termination occurs, said pro rata portion to
 
be
calculated on the fractional portion (the numerator of said fraction being the number of days between January 1
and the date of the Covered Termination, and the denominator of which is 365) of the mid/target
 
bonuses or
annual incentive awards for such calendar year; and (d) the pro rata portion of any and all awards under the
Company’s long term incentive plan for the performance period(s) in which the Covered Termination
 
occurs,
said pro rata portion to be calculated on the fractional portion (the numerator of said fraction being the number
of days between the first day of the applicable performance period and the date of the Covered Termination, and
the denominator of which is the total number of days in the applicable performance period) of the amount of the
award which would have been payable had (i) the Covered Termination not occurred, and (ii) the
 
mid/target
level of performance been achieved for the applicable performance period. The Executive shall be entitled to
receive any other payments or benefits that the Executive is entitled to pursuant to the express terms of any
compensation or benefit plan or arrangement of the Company or any of its affiliates; provided that: (x) the
Severance Allowance (i) shall be in lieu of any severance payments to which the Executive might otherwise be
entitled under the terms of any severance pay plan, policy, or arrangement maintained by the Company or the
employment agreement between the Executive and the Company, and (ii) shall be credited against any
severance payments to which the Executive may be entitled by statute; (y) any annual incentive described in
subsection (b) or (c) shall decrease (or shall be decreased by), but not below zero, the amount of the annual
incentive payable (or paid) with respect to the same calendar year under the Company's annual incentive plan;
and (z) any amount described in (d) shall decrease (or shall be decreased by), but not below zero, the amount of
the analogous performance award payable (or paid) with respect to the same performance period(s) under the
Company’s long term incentive plan(s).
8.
Death After Covered Termination
 
.
 
 
In the event the Executive dies after a Covered Termination occurs, (a) any payments due to the
Executive under Section 4 and the first sentence of Section 7 and not paid prior to the Executive’s death shall be
made to the person or persons who may be designated by the Executive in writing or, in the event he fails to so
designate, to the Executive’s personal representatives, (b) the Executive’s
 
spouse and dependents shall be
eligible for the welfare benefits described in Section 5(b).
 
Payments pursuant to subsection (a) shall be made
on the later of (i) the date payment would have been made to the Executive without regard to Section 9, or (ii)
the date of the Executive’s death.
 
 
 
 
 
 
7
9.
Certain Section 409A Rules.
 
(a)
Specified Employee.
 
Notwithstanding any provision of this Agreement to the contrary, if the
Executive is a Specified Employee, any payment or benefit under this Agreement that constitutes deferred
compensation subject to Section 409A of the Code and for which the payment event is Separation from Service
shall be not be made or provided before the date that is six months after the date of the Executive’s Separation
from Service.
 
Any payment or benefit that is delayed pursuant to this Section 9 shall be made or provided on
the first business day of the seventh month following the month in which the Executive’s Separation from
Service occurs.
 
With respect to any cash payment delayed pursuant to this Section 9, the first payment shall
include interest, at the Wall Street Journal Prime Rate published in the Wall
 
Street Journal on the date of the
Executive’s Covered Termination
 
(or the previous business day if such date is not a business day), for the
period from the date the payment would have been made but for this Section 9 through the date payment is
made.
 
The provisions of this Section 9 shall apply only to the extent required to avoid the Executive’s
incurrence of any additional tax or interest under Section 409A of the Code.
(b)
Reimbursement and In-Kind Benefits.
 
Notwithstanding any provision of this Agreement to the
contrary, with respect to in-kind benefits provided or expenses eligible for reimbursement under this Agreement
which are subject to Section 409A of the Code, (i) the benefits provided or the amount of expenses eligible for
reimbursement during any calendar year shall not affect the benefits provided or expenses eligible for
reimbursement in any other calendar year, except as otherwise provided in Treas. Reg. §1.409A-3(i)(1)(iv)(B),
and (ii) the reimbursement of an eligible expense shall be made as soon as practicable after the Executive
requests such reimbursement (subject to Section 9(a)),
 
but not later than the December 31 following the
calendar year in which the expense was incurred.
(c)
Interpretation and Construction.
 
This Agreement is intended to comply with Section 409A of the
Code and shall be administered, interpreted and construed in accordance therewith to avoid the imposition of
additional tax under Section 409A of the Code.
10.
Confidentiality and Noncompetition.
 
(a)
Confidential Information.
 
The Executive acknowledges that information concerning the method
and conduct of the Company’s (and any affiliate’s)
 
business, including, without limitation, strategic and
marketing plans, budgets, corporate practices and procedures, financial statements, customer and supplier
information, formulae, formulation information, application technology, manufacturing information, and
laboratory test methods and all of the Company’s (and any affiliate’s)
 
manuals, documents, notes, letters,
records, and computer programs (“Proprietary Business Information”), are the sole and exclusive property of
the Company (and/or the Company’s affiliates, as the case may be) and are likely to constitute, contain or reveal
trade secrets (“Trade Secrets”) of the Company (and/or the Company’s
 
affiliate’s, as the case may be). The term
“Trade Secrets” as used herein does not include Proprietary Business Information that is known or becomes
known to the public through no act or failure to act on the part of the Executive, or which can be clearly shown
by written records to have been known by the Executive prior to the commencement of his employment with
the Company.
 
(i)
The Executive agrees that at no time during or following his employment with the
Company will he use, divulge, or pass on, directly or through any other individual or
entity, any Trade
 
Secrets.
 
(ii)
Upon termination of the Executive’s employment with the Company regardless of the
reason for the termination of the Executive’s employment hereunder,
 
or at any other time
 
 
 
8
upon the Company’s request, the Executive agrees to forthwith surrender to the Company
any and all materials in his possession or control which constitute or contain any
Proprietary Business Information.
 
(b)
Noncompetition. The Executive agrees that during his employment and for a period of two (2)
years thereafter, regardless of the reason for the termination of the Executive’s
 
employment, he will not:
 
(i)
directly or indirectly, together or separately or with any third party,
 
whether as an
individual proprietor, partner, stockholder,
 
officer, director,
 
joint venturer, investor,
 
or in
any other capacity whatsoever actively engage in business or assist anyone or any firm in
business as a manufacturer, seller, or distributor of specialty chemical products or
chemical management services which are the same, like, similar to, or which compete
with the products and services offered by the Company (or any of its affiliates);
 
(ii)
directly or indirectly recruit, solicit or encourage any employee of the Company (or any
of its affiliates) or otherwise induce such employee to leave the employ of the Company
(or any of its affiliates) or to become an employee or otherwise be associated with his or
any firm, corporation, business or other entity with which he is or may become
associated; or
 
(iii)
solicit, directly or indirectly, for himself or as agent or employee of any person,
partnership, corporation, or other entity (other than for the Company), any then or former
customer, supplier, or client of the Company with the intent of actively engaging in
business which would cause competitive harm to the Company (or any of its affiliates).
 
(c)
Severability.
 
The Executive acknowledges and agrees that all of the foregoing restrictions are
reasonable as to the period of time and scope. However, if any paragraph, sentence, clause, or other provision is
held invalid or unenforceable by a court of competent and relevant jurisdiction, such provision shall be deemed
to be modified in a manner consistent with the intent of such original provision so as to make it valid and
enforceable, and this Agreement and the application of such provision to persons and circumstances other than
those with respect to which it would be invalid or unenforceable shall not be affected thereby.
 
(d)
Remedies.
 
The Executive agrees and recognizes that in the event of a breach or threatened
breach of the provisions of the restrictive covenants contained in this Section 10, the Company may suffer
irreparable harm, and monetary damages may not be an adequate remedy. Therefore, if any breach occurs or is
threatened, the Company shall be entitled to seek equitable remedies, including injunctive relief in any court of
applicable jurisdiction notwithstanding the provisions of Section 12. In the event of any breach of the restrictive
covenant contained in this Section 10, the term of the restrictive covenant specified herein shall be extended by
a period of time equal to that period beginning on the date such violation commenced and ending when the
activities constituting such violation cease. Furthermore, if a court or arbitration panel determines that the
Executive has breached any of the provisions of this Section 10, the Company’s obligations to pay amounts and
continue the benefits under this Agreement to the Executive (and his dependents) shall immediately terminate.
 
 
 
 
 
 
 
 
9
11.
Set-Off Mitigation.
 
 
Except as provided in Section 6, the Company’s obligation to make the payments provided for in this
Agreement and otherwise to perform its obligations hereunder shall not be affected by any set-off,
counterclaim, recoupment, defense, or other claim, right, or action which the Company may have against the
Executive or others. In no event shall the Executive be obligated to seek other employment or take any other
action by way of mitigation of the amounts payable to the Executive under any of the provisions of this
Agreement.
 
12.
Arbitration: Costs and Expenses of Enforcement.
 
(a)
Arbitration.
 
Except as otherwise provided in Sections 10(d) and 13, any controversy or claim
arising out of or relating to this Agreement or the breach thereof which cannot promptly be resolved by the
parties shall be promptly submitted to and settled exclusively by arbitration in the City of Philadelphia,
Pennsylvania, in accordance with the laws of the Commonwealth of Pennsylvania by three arbitrators, one of
whom shall be appointed by the Company, one by the Executive, and the third of whom shall be appointed by
the first two arbitrators. The arbitration shall be conducted in accordance with the rules of the American
Arbitration Association, except with respect to the selection of arbitrators which shall be as provided in this
Section 12. Judgment upon the award rendered by the arbitrators may be entered in any court having
jurisdiction thereof.
 
(b)
Costs and Expenses.
 
In the event that it shall be necessary or desirable for the Executive to
retain legal counsel and/or incur other costs and expenses in connection with the enforcement of any and all of
his rights under this Agreement at any time during his lifetime, the Company shall pay (or the Executive shall
be entitled to recover from the Company, as the case may be) his reasonable attorneys’ fees and costs
 
and
expenses in connection with the enforcement of his said rights (including those incurred in or related to any
arbitration proceedings provided for in subsection (a) and the enforcement of any arbitration award in court),
regardless of the final outcome.
 
13.
Limitation on Payment Obligation.
 
(a)
Definitions.
 
For purposes of this Section 13, all terms capitalized but not otherwise defined
herein shall have the meanings as set forth in Section 280G of the Code.
 
In addition:
 
(i)
the term “Parachute Payment” shall mean a payment described in Section 280G(b)(2)(A)
or Section 280G(b)(2)(B) of the Code (including, but not limited to, any stock option
rights, stock grants, and other cash and noncash compensation amounts that are treated as
payments under either such section) and not excluded under Section 280G(b)(4)(A) or
Section 280G(b)(6) of the Code;
 
(ii)
the term “Reasonable Compensation” shall mean reasonable compensation for prior
personal services as defined in Section 280G(b)(4)(B) of the Code and subject to the
requirement that any such reasonable compensation must be established by clear and
convincing evidence; and
 
(iii)
the portion of the “Base Amount” and the amount of “Reasonable Compensation”
allocable to any “Parachute Payment” shall be determined in accordance with Section
280G(b)(3) and (4) of the Code.
 
(b)
Limitation.
 
Notwithstanding any other provision of this Agreement, Parachute Payments to be
made to or for the benefit of the Executive but for this subsection (b), whether pursuant to this Agreement or
otherwise, shall be reduced if and to the extent necessary so that the aggregate Present Value
 
of all such
 
 
 
 
10
Parachute Payments shall be at least one dollar ($1.00) less than the greater of (i) three times the Executive’s
Base Amount and (ii) the aggregate Reasonable Compensation allocable to such Parachute Payments.
 
Any
reduction in Parachute Payments caused by reason of this subsection (b) shall be applied in the manner least
economically detrimental to the Executive.
 
In the event reduction of two or more types of payments would be
economically equivalent, the reduction shall be applied pro-rata to such types of payments.
 
This subsection (b) shall be interpreted and applied to limit the amounts otherwise payable to the
Executive under this Agreement or otherwise only to the extent required to avoid any material risk of the
imposition of excise taxes on the Executive under Section 4999 of the Code or the disallowance of a deduction
to the Company under Section 280G(a) of the Code. In the making of any such interpretation and application,
the Executive shall be presumed to be a disqualified individual for purposes of applying the limitations set forth
in this subsection (b) without regard to whether or not the Executive meets the definition of disqualified
individual set forth in Section 280G(c) of the Code. In the event that the Executive and the Company are unable
to agree as to the application of this subsection (b), the Company’s independent auditors shall select
independent tax counsel to determine the amount of such limits. Such selection of tax counsel shall be subject to
the Executive’s consent, provided that the Executive shall not unreasonably withhold his consent. The
determination of such tax counsel under this Section 13 shall be final and binding upon the Executive and the
Company.
 
(c)
Illegal Payments.
 
Notwithstanding any other provision of this Agreement, no payment shall be
made hereunder to or for the benefit of the Executive if and to the extent that such payments are determined to
be illegal.
 
14.
Notices.
 
 
Any notices, requests, demands, and other communications provided for by this Agreement shall be
sufficient if in writing, and if hand delivered or if sent by registered or certified mail, if to the Executive, at the
last address he had filed in writing with the Company or if to the Company, at its principal executive offices.
Notices, requests, etc. shall be effective when actually received by the addressee or at such address.
 
15.
Withholding.
 
 
Notwithstanding any provision of this Agreement to the contrary, the Company may,
 
to the extent
required by law, withhold applicable Federal, state and local income and other taxes from any payments due to
the Executive hereunder.
 
16.
Assignment and Benefit.
 
(a)
This Agreement is personal to the Executive and shall not be assignable by the Executive, by
operation of law, or otherwise without the prior written consent of the Company otherwise than by will or the
laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by the
Executive’s heirs and legal representatives.
 
(b)
This Agreement shall inure to the benefit of and be binding upon the Company and its successors
and assigns, including, without limitation, any subsidiary of the Company to which the Company may assign
any of its rights hereunder; provided, however, that no assignment of this Agreement by the Company,
 
by
operation of law, or otherwise shall relieve it of its obligations hereunder except an assignment of this
Agreement to, and its assumption by, a successor pursuant to subsection (c).
 
(c)
The Company shall require any successor (whether direct or indirect, by purchase, merger,
consolidation, operation of law, or otherwise) to all or substantially all of the business and/or assets of the
 
 
 
 
 
11
Company to assume expressly and agree to perform this Agreement in the same manner and to the same extent
that the Company would be required to perform it if no such succession had taken place, but, irrespective of any
such assignment or assumption, this Agreement shall inure to the benefit of and be binding upon such a
successor. As used in this Agreement, “Company” shall mean the Company as hereinbefore defined and any
successor to its business and/or assets as aforesaid.
 
17.
Governing Law.
 
 
The provisions of this Agreement shall be construed in accordance with the laws of the Commonwealth
of Pennsylvania without reference to principles of conflicts of laws.
 
18.
Entire Agreement;
 
Amendment.
(a)
Except for the change in control provisions set forth in the Company’s annual incentive plan and
long term incentive plan, this Agreement represents the entire agreement and understanding of the parties with
respect to the subject matter hereof.
 
The Executive understands and acknowledges that the Company’s
severance plan, annual incentive plan and long term incentive plans are hereby amended with respect to the
Executive to avoid duplication of benefits, as provided in Section 7.
(b)
The Company reserves the right to unilaterally amend this Agreement without the consent of the
Executive to the extent the Compensation and Human Resources Committee of the Company’s Board of
Directors (in its sole discretion) determines is necessary or appropriate to avoid the additional tax under Section
409A(a)(1)(B) of the Code; otherwise, this Agreement may not be altered or amended except by an agreement
in writing executed by the Company and the Executive.
19.
No Waiver.
 
 
The failure to insist upon strict compliance with any provision of this Agreement by any party shall not
be deemed to be a waiver of any future noncompliance with such provision or of noncompliance with any other
provision.
 
20.
Severability.
 
 
In the event that any provision or portion of this Agreement shall be determined to be invalid or
unenforceable for any reason, the remaining provisions of this Agreement shall be unaffected thereby and shall
remain in full force and effect.
 
21.
Indemnification.
 
 
The Company shall defend and hold the Executive harmless to the fullest extent permitted by applicable
law in connection with any claim, action, suit, investigation or proceeding arising out of or relating to
performance by the Executive of services for, or action of the Executive as a director, officer
 
or employee of the
Company or any parent, subsidiary or affiliate of the Company, or of any other person or enterprise at the
Company’s request. Expenses incurred by the Executive in defending such a claim, action, suit or investigation
or criminal proceeding shall be paid by the Company in advance of the final disposition thereof upon the receipt
by the Company of an undertaking by or on behalf of the Executive to repay said amount unless it shall
ultimately be determined that the Executive is entitled to be indemnified hereunder; provided, however, that this
shall not apply to a nonderivative action commenced by the Company against the Executive.
 
 
 
 
12
IN WITNESS WHEREOF, the Executive has hereunto
 
set his hand and, pursuant to the authorization from its
Board of Directors, the Company has caused these presents to be executed in its name and on its behalf and
attested by its Secretary or Assistant Secretary, all as of the day and year first above written.
 
 
QUAKER CHEMICAL CORPORATION
DBA QUAKER HOUGHTON
By:
/s/ Michael F. Barry
EXECUTIVE
/s/ Andrew E Tometich
Andrew Tometich
EX-10.3 5 exhibit103.htm EMPLOYMENT AGREEMENT - J. BERQUIST exhibit103
exhibit103p1i0.jpg
EXHIBIT 10.3
1
August 18, 2021
Joe Berquist
 
Quaker Houghton
Dear Joe:
Congratulations!
 
I am pleased to offer you this promotion to the EVP, Chief Strategy Officer and MD, Global Specialty Businesses.
 
In
addition
 
to
 
your
 
current
 
responsibilities
 
for
 
directing
 
the
 
Company’s
 
strategic
 
priorities
 
and
 
leading
 
the
 
Global
 
Specialty
 
Business
segment,
 
you
 
will
 
be
 
responsible
 
for
 
directing
 
the
 
Company’s
 
global
 
merger
 
&
 
acquisition
 
process
 
and
 
organization,
 
leading
 
our
Corporate
 
Sustainability
 
efforts,
 
directing
 
our
 
strategic
 
and
 
operational
 
approach
 
for
 
supporting
 
our
 
information
 
technology
infrastructure,
 
and our plan and execution for digitization by leading our Information Technology
 
organization.
 
Your
 
tentative start date for this position is September 9, 2021.
 
We believe you can
 
make significant contributions in this role and will
find this opportunity engaging and rewarding.
 
Please review the details of the offer below.
 
Salary
Your
 
new annualized
 
salary is
 
$500,000,
 
effective on
 
September 9,
 
2021.
 
You
 
will be
 
eligible for
 
your next
 
merit increase
 
in April
2022,
 
reflective of performance year 2021.
Annual Incentive Plan
 
You
 
will continue to participate in our 2021 Annual Incentive Plan (AIP), with an annual bonus target of 65% of your base salary.
 
This
is inclusive of the full 2021 annual performance for your responsibility areas
 
and based on your revised base salary.
 
Long Term
 
Incentive Plan
You
 
will be eligible to participate in our Long
 
Term Incentive Plan (LTIP)
 
at a target value of 100% of your
 
base salary.
 
For the 2021
plan
 
year,
 
you received
 
a grant
 
on March
 
15
th
 
valued
 
at $270,000.
 
You
 
will receive
 
an additional
 
Restricted
 
Stock grant
 
valued
 
at
$230,000 in October 2021 to reflect the difference from the grant provided
 
in March of 2021.
 
The Restricted Stock grant is time based
and will vest in accordance with the LTIP
 
rules.
 
The terms and
 
conditions of your
 
employment remain in
 
effect, except
 
as specifically set
 
forth above.
 
Quaker Houghton reserves
 
the
right to modify your job title, duties and compensation, as well as all company
 
rules, practices and other terms of employment.
We are
 
excited about this opportunity for
 
you Joe and look forward
 
to you accepting this expanded role
 
with Quaker Houghton.
 
After
your review of this offer,
 
please sign below to confirm your acceptance and return to me with a copy to Rob Traub
 
and Kym Johnson.
Sincerely,
/s/ Michael F. Barry
Mike Barry
CEO, President and Chairman of the Board
Quaker Chemical Corporation
A Quaker Houghton Company
901 E. Hector Street
Conshohocken, PA 19428-2380
T: 610.832.4000
quakerhoughton.com
 
 
2
Employee Offer Acceptance
I accept the terms and conditions outlined above:
/s/ Joseph C. Berquist
18-August-2021
Joseph Berquist
Date
GRAPHIC 6 exhibit103p1i0.jpg LOGO begin 644 exhibit103p1i0.jpg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exhibit311.htm SECTION 302 CEO CERTIFICATION exhibit311
 
1
EXHIBIT 31.1
CERTIFICATION
 
OF CHIEF EXECUTIVE OFFICER OF THE COMPANY
 
PURSUANT TO RULE 13a-14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934
I, Michael F.
 
Barry, certify that:
 
1.
I have reviewed this quarterly report on Form 10-Q of Quaker Chemical
 
Corporation;
 
2.
Based on my knowledge, this report does not contain any untrue statement of
 
a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under
 
which such statements were made, not misleading with
respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information
 
included in this report, fairly present in all
material respects the financial condition, results of operations and cash flows
 
of the registrant as of, and for, the periods presented
in this report;
 
4.
The registrant’s other certifying
 
officer and I are responsible for establishing and maintaining
 
disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
 
control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
 
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls
 
and procedures to be designed
under our supervision, to ensure that material information relating to the
 
registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
 
during the period in which this report is
being prepared;
 
 
(b)
Designed such internal control over financial reporting, or caused such
 
internal control over financial reporting to be
designed under our supervision, to provide reasonable assurance regarding
 
the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance with
 
generally accepted accounting
principles;
 
 
(c)
Evaluated the effectiveness of the registrant’s
 
disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures,
 
as of the end of the period covered by
this report based on such evaluation; and
 
 
(d)
Disclosed in this report any change in the registrant’s
 
internal control over financial reporting that occurred during
the registrant’s most recent fiscal quarter
 
(the registrant’s fourth fiscal quarter in the
 
case of an annual report) that
has materially affected, or is reasonably likely to materially affect,
 
the registrant’s internal control over financial
reporting; and
 
5.
The registrant’s other certifying
 
officer and I have disclosed, based on our most recent evaluation
 
of internal control over financial
reporting, to the registrant’s
 
auditors and the audit committee of the registrant’s
 
board of directors (or persons performing the
equivalent functions):
 
 
(a)
All significant deficiencies and material weaknesses in the design or operation
 
of internal control over financial
reporting which are reasonably likely to adversely affect the registrant’s
 
ability to record, process, summarize and
report financial information; and
 
 
(b)
Any fraud, whether or not material, that involves management or other
 
employees who have a significant role in the
registrant’s internal control
 
over financial reporting.
Date: November 4, 2021
 
/s/ Michael F. Barry
Michael F. Barry
Chief Executive Officer
EX-31.2 8 exhibit312.htm SECTION 302 CFO CERTIFICATION exhibit312
 
1
EXHIBIT 31.2
CERTIFICATION
 
OF CHIEF FINANCIAL OFFICER OF THE COMPANY
 
PURSUANT TO RULE 13a-14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934
I, Shane Hostetter, certify that:
 
1.
I have reviewed this quarterly report on Form 10-Q of Quaker Chemical
 
Corporation;
 
2.
Based on my knowledge, this report does not contain any untrue statement of
 
a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under
 
which such statements were made, not misleading with
respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial
 
information included in this report, fairly present in all
material respects the financial condition, results of operations and cash flows
 
of the registrant as of, and for, the periods presented
in this report;
 
4.
The registrant’s other certifying
 
officer and I are responsible for establishing and maintaining
 
disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
 
control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
 
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls
 
and procedures to be designed
under our supervision, to ensure that material information relating to the
 
registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
 
during the period in which this report is
being prepared;
 
 
(b)
Designed such internal control over financial reporting, or caused such
 
internal control over financial reporting to be
designed under our supervision, to provide reasonable assurance regarding
 
the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance
 
with generally accepted accounting
principles;
 
 
(c)
Evaluated the effectiveness of the registrant’s
 
disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures,
 
as of the end of the period covered by
this report based on such evaluation; and
 
 
(d)
Disclosed in this report any change in the registrant’s
 
internal control over financial reporting that occurred during
the registrant’s most recent fiscal quarter
 
(the registrant’s fourth fiscal quarter in the
 
case of an annual report) that
has materially affected, or is reasonably likely to materially affect,
 
the registrant’s internal control over financial
reporting; and
 
5.
The registrant’s other certifying
 
officer and I have disclosed, based on our most recent evaluation
 
of internal control over financial
reporting, to the registrant’s auditors
 
and the audit committee of the registrant’s
 
board of directors (or persons performing the
equivalent functions):
 
 
(a)
All significant deficiencies and material weaknesses in the design or operation
 
of internal control over financial
reporting which are reasonably likely to adversely affect the registrant’s
 
ability to record, process, summarize and
report financial information; and
 
 
(b)
Any fraud, whether or not material, that involves management or other
 
employees who have a significant role in the
registrant’s internal control
 
over financial reporting.
Date: November 4, 2021
 
/s/ Shane W. Hostetter
Shane W.
 
Hostetter
Chief Financial Officer
EX-32.1 9 exhibit321.htm SECTION 906 CEO CERTIFICATION exhibit321
 
1
EXHIBIT 32.1
CERTIFICATION
 
PURSUANT TO 18 U.S.C. SECTION 1350
The undersigned hereby certifies that the Form 10-Q Quarterly Report
 
of Quaker Chemical Corporation (the “Company”) for the
quarterly period ended September 30, 2021 filed with the Securities and Exchange
 
Commission (the “Report”) fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange
 
Act of 1934 and that the information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations
 
of the Company.
 
Dated: November 4, 2021
 
 
/s/ Michael F. Barry
 
 
Michael F. Barry
 
 
Chief Executive Officer of Quaker Chemical Corporation
EX-32.2 10 exhibit322.htm SECTION 906 CFO CERTIFICATION exhibit322
 
1
EXHIBIT 32.2
CERTIFICATION
 
PURSUANT TO 18 U.S.C. SECTION 1350
The undersigned hereby certifies that the Form 10-Q Quarterly Report
 
of Quaker Chemical Corporation (the “Company”) for the
quarterly period ended September 30, 2021 filed with the Securities and Exchange
 
Commission (the “Report”) fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange
 
Act of 1934 and that the information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations
 
of the Company.
 
Dated: November 4, 2021
 
 
/s/ Shane W. Hostetter
 
 
Shane W.
 
Hostetter
 
 
Chief Financial Officer of Quaker Chemical Corporation
EX-101.SCH 11 kwr-20210930.xsd XBRL EXTENSION SCHEMA DOCUMENT 000100 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 000200 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 000400 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 000450 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 000500 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 012410 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 012415 - Disclosure - Hedging Activities link:presentationLink link:definitionLink link:calculationLink 010710 - Disclosure - Share-Based Compensation link:presentationLink link:definitionLink link:calculationLink 011010 - Disclosure - Earnings Per Share link:presentationLink link:definitionLink link:calculationLink 010409 - Disclosure - Business Segments link:presentationLink link:definitionLink link:calculationLink 011510 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:definitionLink link:calculationLink 010750 - Disclosure - Pension and Postretirement Benefits link:presentationLink link:definitionLink link:calculationLink 012510 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 010910 - Disclosure - Income Taxes and Uncertain Income Tax Positions link:presentationLink link:definitionLink link:calculationLink 011910 - Disclosure - Debt link:presentationLink link:definitionLink link:calculationLink 042211 - Disclosure - Equity - Changes in Equity (Details) link:presentationLink link:definitionLink link:calculationLink 042212 - Disclosure - Equity - Changes in Equity (Parentheticals) (Details) link:presentationLink link:definitionLink link:calculationLink 000300 - Statement - Condensed Consolidated Statements of Comprehensive Income link:presentationLink link:definitionLink link:calculationLink 041010 - Disclosure - Earnings Per Share - Earnings per Share Calculations Basic (Details) link:presentationLink link:definitionLink link:calculationLink 041020 - Disclosure - Earnings Per Share - Earnings per Share Calculations Diluted (Details) link:presentationLink link:definitionLink link:calculationLink 041030 - Disclosure - Earnings Per Share - Earnings per Share Calculations Antidilutive Shares (Details) link:presentationLink link:definitionLink link:calculationLink 042510 - Disclosure - Commitments and Contingencies - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 042520 - Disclosure - Commitments and Contingencies - Operating Leases (Details) link:presentationLink link:definitionLink link:calculationLink 040960 - Disclosure - Income Taxes and Uncertain Income Tax Positions - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 040970 - Disclosure - Income Taxes and Uncertain Income Tax Positions 2 - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 042410 - Disclosure - Fair Value Measurements - Assets Subject to Fair Value Measurement (Details) link:presentationLink link:definitionLink link:calculationLink 042504 - Disclosure - Hedging Activities - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 042505 - Disclosure - Hedging Activities - Balance Sheet Classification and Fair Values (Details) link:presentationLink link:definitionLink link:calculationLink 041910 - Disclosure - Debt - Table (Details) link:presentationLink link:definitionLink link:calculationLink 041940 - Disclosure - Debt - Maturity Schedules (Details) link:presentationLink link:definitionLink link:calculationLink 041960 - Disclosure - Debt - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 040315 - Disclosure - Business Segments - Performance of reportable segments (Details) link:presentationLink link:definitionLink link:calculationLink 041510 - Disclosure - Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details) link:presentationLink link:definitionLink link:calculationLink 041520 - Disclosure - Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details) link:presentationLink link:definitionLink link:calculationLink 040710 - Disclosure - Share-Based Compensation - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 040720 - Disclosure - Share-Based Compensation - Share-based Compensation Expense (Details) link:presentationLink link:definitionLink link:calculationLink 040760 - Disclosure - Share-Based Compensation - Black-Scholes Option Pricing Model (Details) link:presentationLink link:definitionLink link:calculationLink 032410 - Disclosure - Fair Value Measurements (Table) link:presentationLink link:definitionLink link:calculationLink 032411 - Disclosure - Hedging Activities (Tables) link:presentationLink link:definitionLink link:calculationLink 031750 - Disclosure - Debt (Tables) link:presentationLink link:definitionLink link:calculationLink 030710 - Disclosure - Share Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 030410 - Disclosure - Business Segments (Tables) link:presentationLink link:definitionLink link:calculationLink 030303 - Disclosure - Business Acquisitions (Tables) link:presentationLink link:definitionLink link:calculationLink 031510 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 030910 - Disclosure - Taxes on Income and Uncertain Positions (Tables) link:presentationLink link:definitionLink link:calculationLink 030750 - Disclosure - Pension and Other Post Retirement Benefits (Tables) link:presentationLink link:definitionLink link:calculationLink 031010 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 032510 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 040815 - Disclosure - Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details) link:presentationLink link:definitionLink link:calculationLink 040860 - Disclosure - Pension and Other Postretirement Benefits - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 042220 - Disclosure - Equity - AOCI Reclassifications (Details) link:presentationLink link:definitionLink link:calculationLink 012210 - Disclosure - Equity link:presentationLink link:definitionLink link:calculationLink 032211 - Disclosure - Equity (Tables) link:presentationLink link:definitionLink link:calculationLink 042210 - Disclosure - Equity - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 010810 - Disclosure - Other Income (Expense) link:presentationLink link:definitionLink link:calculationLink 030810 - Disclosure - Other Income (Expense) (Tables) link:presentationLink link:definitionLink link:calculationLink 040900 - Disclosure - Other Income (Expense) (Details) link:presentationLink link:definitionLink link:calculationLink 010310 - Disclosure - Recently Issued Accounting Standards link:presentationLink link:definitionLink link:calculationLink 010640 - Disclosure - Restructuring and Related Activities link:presentationLink link:definitionLink link:calculationLink 030610 - Disclosure - Restructuring and Related Activities (Tables) link:presentationLink link:definitionLink link:calculationLink 040650 - Disclosure - Restructuring and Related Activities (Details) link:presentationLink link:definitionLink link:calculationLink 041540 - Disclosure - Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details) link:presentationLink link:definitionLink link:calculationLink 041550 - Disclosure - Intangible Assets - Indefinite Lived (Details) link:presentationLink link:definitionLink link:calculationLink 040640 - Disclosure - Restructuring and Related Activities - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 040310 - Disclosure - Recently Issued Accounting Standards - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 010210 - Disclosure - Business Acquisitions link:presentationLink link:definitionLink link:calculationLink 011118 - Disclosure - Restricted Cash link:presentationLink link:definitionLink link:calculationLink 010410 - Disclosure - Net Sales and Revenue Recognition link:presentationLink link:definitionLink link:calculationLink 031110 - Disclosure - Restricted Cash (Tables) link:presentationLink link:definitionLink link:calculationLink 030510 - Disclosure - Net Sales and Revenue Recognition (Tables) link:presentationLink link:definitionLink link:calculationLink 041110 - Disclosure - Restricted Cash (Details) link:presentationLink link:definitionLink link:calculationLink 040412 - Disclosure - Net Sales and Revenue Recognition (Details) link:presentationLink link:definitionLink link:calculationLink 040410 - Disclosure - Net Sales and Revenue Recognition - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 010508 - Disclosure - Leases link:presentationLink link:definitionLink link:calculationLink 030609 - Disclosure - Leases (Tables) link:presentationLink link:definitionLink link:calculationLink 040415 - Disclosure - Leases - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 040416 - Disclosure - Leases - Supplemental Balance Sheet Information (Details) link:presentationLink link:definitionLink link:calculationLink 040417 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 041950 - Disclosure - Debt - Debt related expenses included within Interest expense (Details) link:presentationLink link:definitionLink link:calculationLink 040214 - Disclosure - Business Acquisitions - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 040314 - Disclosure - Business Segments - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 040215 - Disclosure - Business Acquisitions - Preliminary Estimated Fair Values of Coral Net Assets Acquired (Details) link:presentationLink link:definitionLink link:calculationLink 040216 - Disclosure - Business Acquisitions - Coral - Narrative (Details) link:presentationLink link:definitionLink link:calculationLink 010110 - Disclosure - Basis of Presentation and Description of Business link:presentationLink link:definitionLink link:calculationLink 040010 - Disclosure - Basis of Presentation and Description of Business (Details) link:presentationLink link:definitionLink link:calculationLink 020001 - Disclosure - Basis of Presentation and Description of Business (Policies) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 12 kwr-20210930_cal.xml XBRL CALCULATION LINKBASE DOCUMENT EX-101.DEF 13 kwr-20210930_def.xml XBRL DEFINITION LINKBASE DOCUMENT EX-101.LAB 14 kwr-20210930_lab.xml XBRL LABEL LINKBASE DOCUMENT EX-101.PRE 15 kwr-20210930_pre.xml XBRL PRESENTATION LINKBASE DOCUMENT XML 16 kwr20210930_htm.xml IDEA: XBRL DOCUMENT 0000081362 2021-01-01 2021-09-30 0000081362 kwr:StockOptionsCompensationExpenseMember 2021-01-01 2021-09-30 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2021-01-01 2021-09-30 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2021-01-01 2021-09-30 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2021-01-01 2021-09-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-09-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-09-30 0000081362 us-gaap:EMEAMember 2021-01-01 2021-09-30 0000081362 srt:AsiaPacificMember 2021-01-01 2021-09-30 0000081362 2021-10-31 0000081362 2020-07-01 2020-09-30 0000081362 2020-01-01 2020-09-30 0000081362 2021-09-30 0000081362 2020-12-31 0000081362 2019-12-31 0000081362 2020-09-30 0000081362 us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-09-30 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-09-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-09-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-09-30 0000081362 us-gaap:TransferredOverTimeMember 2020-01-01 2020-09-30 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-09-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-09-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-09-30 0000081362 kwr:StockOptionsCompensationExpenseMember 2020-07-01 2020-09-30 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2020-07-01 2020-09-30 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2020-07-01 2020-09-30 0000081362 kwr:StockOptionsCompensationExpenseMember 2020-01-01 2020-09-30 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2020-01-01 2020-09-30 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2020-01-01 2020-09-30 0000081362 us-gaap:RestrictedStockMember 2021-09-30 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2021-09-30 0000081362 us-gaap:RestrictedStockMember 2021-01-01 2021-09-30 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-09-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2021-07-01 2021-09-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-07-01 2021-09-30 0000081362 us-gaap:CustomerListsMember 2020-12-31 0000081362 us-gaap:OtherIntangibleAssetsMember 2020-12-31 0000081362 us-gaap:CustomerListsMember 2021-09-30 0000081362 us-gaap:OtherIntangibleAssetsMember 2021-09-30 0000081362 us-gaap:FairValueInputsLevel1Member 2021-09-30 0000081362 us-gaap:FairValueInputsLevel2Member 2021-09-30 0000081362 us-gaap:FairValueInputsLevel3Member 2021-09-30 0000081362 us-gaap:FairValueInputsLevel1Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel2Member 2020-12-31 0000081362 us-gaap:FairValueInputsLevel3Member 2020-12-31 0000081362 srt:MinimumMember kwr:AcpMember 2021-09-30 0000081362 srt:MaximumMember kwr:AcpMember 2021-09-30 0000081362 kwr:SbDeckingMember 2021-09-30 0000081362 us-gaap:CommonStockMember 2020-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000081362 us-gaap:RetainedEarningsMember 2020-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2020-12-31 0000081362 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0000081362 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-09-30 0000081362 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-09-30 0000081362 us-gaap:CommonStockMember 2021-09-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0000081362 us-gaap:RetainedEarningsMember 2021-09-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0000081362 us-gaap:NoncontrollingInterestMember 2021-09-30 0000081362 us-gaap:CommonStockMember 2019-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000081362 us-gaap:RetainedEarningsMember 2019-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2019-12-31 0000081362 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0000081362 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0000081362 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-09-30 0000081362 us-gaap:CommonStockMember 2020-09-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0000081362 us-gaap:RetainedEarningsMember 2020-09-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0000081362 us-gaap:NoncontrollingInterestMember 2020-09-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-09-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-09-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-09-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-09-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-09-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-07-01 2020-09-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-07-01 2020-09-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-07-01 2020-09-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-09-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-09-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-01-01 2021-09-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-09-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-09-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-09-30 0000081362 us-gaap:OtherNoncurrentLiabilitiesMember 2020-12-31 0000081362 us-gaap:OtherNoncurrentLiabilitiesMember 2021-09-30 0000081362 us-gaap:InterestExpenseMember 2020-07-01 2020-09-30 0000081362 us-gaap:InterestExpenseMember 2021-01-01 2021-09-30 0000081362 us-gaap:InterestExpenseMember 2020-01-01 2020-09-30 0000081362 2020-01-01 2020-12-31 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2020-07-01 2020-09-30 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2020-01-01 2020-09-30 0000081362 kwr:HoughtonCombinationMember 2021-09-30 0000081362 kwr:HoughtonCombinationMember 2020-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-09-30 0000081362 2021-07-01 2021-09-30 0000081362 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-09-30 0000081362 us-gaap:EmployeeStockOptionMember 2021-09-30 0000081362 srt:MaximumMember kwr:HoughtonEnvironmentalMattersMember 2021-09-30 0000081362 srt:MinimumMember kwr:HoughtonEnvironmentalMattersMember 2021-09-30 0000081362 kwr:DefinedContributionPlanMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AmericasMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember us-gaap:EMEAMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AsiaPacificMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember srt:AmericasMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember us-gaap:EMEAMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember srt:AsiaPacificMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember kwr:GlobalSpecialtyBusinessesMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember kwr:GlobalSpecialtyBusinessesMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember kwr:GlobalSpecialtyBusinessesMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AmericasMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember us-gaap:EMEAMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AsiaPacificMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember srt:AmericasMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember us-gaap:EMEAMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember srt:AsiaPacificMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember kwr:GlobalSpecialtyBusinessesMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember kwr:GlobalSpecialtyBusinessesMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember kwr:GlobalSpecialtyBusinessesMember 2020-07-01 2020-09-30 0000081362 srt:ScenarioPreviouslyReportedMember kwr:CoralChemicalCompanyMember 2020-12-22 0000081362 srt:RestatementAdjustmentMember kwr:CoralChemicalCompanyMember 2020-12-22 0000081362 kwr:CoralChemicalCompanyMember 2020-12-22 0000081362 srt:RestatementAdjustmentMember kwr:CoralChemicalCompanyMember 2020-12-22 2020-12-22 0000081362 srt:ScenarioPreviouslyReportedMember kwr:CoralChemicalCompanyMember 2020-12-22 2020-12-22 0000081362 kwr:CoralChemicalCompanyMember 2020-12-22 2020-12-22 0000081362 kwr:TinplatingsolutionsMember 2021-02-01 2021-02-28 0000081362 kwr:TinplatingsolutionsMember 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:CustomerListsMember 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:PatentedTechnologyMember 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:TrademarksMember 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:CustomerListsMember 2021-02-01 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:PatentedTechnologyMember 2021-02-01 2021-02-28 0000081362 kwr:TinplatingsolutionsMember us-gaap:TrademarksMember 2021-02-01 2021-02-28 0000081362 kwr:TinplatingsolutionsMember 2021-01-01 2021-09-30 0000081362 kwr:CoralChemicalCompanyMember 2020-01-01 2020-12-31 0000081362 kwr:CoralChemicalCompanyMember 2021-01-01 2021-09-30 0000081362 kwr:TelnordicMember 2020-05-01 2020-05-31 0000081362 kwr:TelnordicMember 2020-07-01 2020-09-30 0000081362 kwr:TelnordicMember 2020-09-30 0000081362 kwr:TelnordicMember 2021-01-01 2021-09-30 0000081362 kwr:SouthAfricaEquityAffiliateMember 2020-03-31 0000081362 kwr:SouthAfricaEquityAffiliateMember 2020-03-01 2020-03-31 0000081362 kwr:NormanHayMember 2019-10-01 2019-10-31 0000081362 kwr:NormanHayMember 2020-01-01 2020-03-31 0000081362 us-gaap:IntersegmentEliminationMember srt:AmericasMember 2021-07-01 2021-09-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AmericasMember 2021-01-01 2021-09-30 0000081362 us-gaap:IntersegmentEliminationMember us-gaap:EMEAMember 2021-07-01 2021-09-30 0000081362 us-gaap:IntersegmentEliminationMember us-gaap:EMEAMember 2021-01-01 2021-09-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2021-07-01 2021-09-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2021-01-01 2021-09-30 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2021-07-01 2021-09-30 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-09-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AmericasMember 2020-07-01 2020-09-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AmericasMember 2020-01-01 2020-09-30 0000081362 us-gaap:IntersegmentEliminationMember us-gaap:EMEAMember 2020-07-01 2020-09-30 0000081362 us-gaap:IntersegmentEliminationMember us-gaap:EMEAMember 2020-01-01 2020-09-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2020-07-01 2020-09-30 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2020-01-01 2020-09-30 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2020-07-01 2020-09-30 0000081362 us-gaap:IntersegmentEliminationMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AmericasMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember us-gaap:EMEAMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AsiaPacificMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember srt:AmericasMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember us-gaap:EMEAMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember srt:AsiaPacificMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2021-07-01 2021-09-30 0000081362 srt:AmericasMember 2021-07-01 2021-09-30 0000081362 us-gaap:EMEAMember 2021-07-01 2021-09-30 0000081362 srt:AsiaPacificMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2020-07-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2020-07-01 2020-09-30 0000081362 srt:AmericasMember 2020-07-01 2020-09-30 0000081362 us-gaap:EMEAMember 2020-07-01 2020-09-30 0000081362 srt:AsiaPacificMember 2020-07-01 2020-09-30 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2020-07-01 2020-09-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2020-07-01 2020-09-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2020-07-01 2020-09-30 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember 2020-07-01 2020-09-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2020-07-01 2020-09-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2020-07-01 2020-09-30 0000081362 us-gaap:TransferredAtPointInTimeMember 2020-07-01 2020-09-30 0000081362 us-gaap:TransferredOverTimeMember 2020-07-01 2020-09-30 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2021-07-01 2021-09-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2021-07-01 2021-09-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2021-07-01 2021-09-30 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember 2021-07-01 2021-09-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2021-07-01 2021-09-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2021-07-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-09-30 0000081362 srt:AmericasMember 2021-01-01 2021-09-30 0000081362 srt:AmericasMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-09-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-09-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-09-30 0000081362 srt:AmericasMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-09-30 0000081362 us-gaap:EMEAMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-09-30 0000081362 srt:AsiaPacificMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-09-30 0000081362 us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-09-30 0000081362 us-gaap:TransferredOverTimeMember 2021-01-01 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AmericasMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember us-gaap:EMEAMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AsiaPacificMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember srt:AmericasMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember us-gaap:EMEAMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember srt:AsiaPacificMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember kwr:GlobalSpecialtyBusinessesMember 2020-01-01 2020-09-30 0000081362 srt:AmericasMember 2020-01-01 2020-09-30 0000081362 us-gaap:EMEAMember 2020-01-01 2020-09-30 0000081362 srt:AsiaPacificMember 2020-01-01 2020-09-30 0000081362 kwr:QhProgramMember 2020-12-31 0000081362 kwr:QhProgramMember 2021-01-01 2021-09-30 0000081362 kwr:QhProgramMember 2021-09-30 0000081362 kwr:StockOptionsCompensationExpenseMember 2021-07-01 2021-09-30 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2021-07-01 2021-09-30 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2021-07-01 2021-09-30 0000081362 kwr:MatchingStockContribution401KPlanCompensationExpenseMember 2021-07-01 2021-09-30 0000081362 us-gaap:PerformanceSharesMember 2021-07-01 2021-09-30 0000081362 us-gaap:PerformanceSharesMember 2020-07-01 2020-09-30 0000081362 us-gaap:PerformanceSharesMember 2021-01-01 2021-09-30 0000081362 us-gaap:PerformanceSharesMember 2020-01-01 2020-09-30 0000081362 us-gaap:StockCompensationPlanMember 2021-07-01 2021-09-30 0000081362 us-gaap:StockCompensationPlanMember 2020-07-01 2020-09-30 0000081362 us-gaap:StockCompensationPlanMember 2021-01-01 2021-09-30 0000081362 us-gaap:StockCompensationPlanMember 2020-01-01 2020-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2021-09-30 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2020-12-31 0000081362 us-gaap:OperatingSegmentsMember kwr:GlobalSpecialtyBusinessesMember 2021-09-30 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember 2021-09-30 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember 2020-12-31 0000081362 us-gaap:LineOfCreditMember 2021-09-30 0000081362 us-gaap:DomesticLineOfCreditMember 2021-09-30 0000081362 us-gaap:ForeignLineOfCreditMember 2021-09-30 0000081362 kwr:IndustrialDevelopmentBondsMember 2021-09-30 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2021-09-30 0000081362 us-gaap:LineOfCreditMember 2020-12-31 0000081362 us-gaap:DomesticLineOfCreditMember 2020-12-31 0000081362 us-gaap:ForeignLineOfCreditMember 2020-12-31 0000081362 kwr:IndustrialDevelopmentBondsMember 2020-12-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2020-12-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2021-01-01 2021-09-30 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2020-01-01 2020-12-31 0000081362 us-gaap:RevolvingCreditFacilityMember 2021-09-30 0000081362 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember 2021-01-01 2021-09-30 0000081362 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember 2021-01-01 2021-09-30 0000081362 srt:MinimumMember 2021-09-30 0000081362 srt:MaximumMember 2021-09-30 0000081362 kwr:TermLoanMember 2021-01-01 2021-09-30 0000081362 kwr:TermLoanMember 2021-09-30 0000081362 kwr:TermLoanMember 2019-11-30 0000081362 us-gaap:OtherAssetsMember 2021-09-30 0000081362 us-gaap:OtherAssetsMember 2020-12-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2021-09-30 0000081362 us-gaap:CorporateBondSecuritiesMember 2020-12-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2021-01-01 2021-09-30 0000081362 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0000081362 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000081362 us-gaap:NoncontrollingInterestMember 2020-07-01 2020-09-30 0000081362 2020-06-30 0000081362 us-gaap:CommonStockMember 2020-06-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0000081362 us-gaap:RetainedEarningsMember 2020-06-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0000081362 us-gaap:NoncontrollingInterestMember 2020-06-30 0000081362 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0000081362 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0000081362 us-gaap:NoncontrollingInterestMember 2021-07-01 2021-09-30 0000081362 us-gaap:CommonStockMember 2021-06-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000081362 us-gaap:RetainedEarningsMember 2021-06-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0000081362 us-gaap:NoncontrollingInterestMember 2021-06-30 0000081362 2021-06-30 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:CommonStockMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:NoncontrollingInterestMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:CommonStockMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:RetainedEarningsMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:NoncontrollingInterestMember 2019-12-31 0000081362 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-01-01 2021-09-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-09-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-12-31 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-01-01 2020-09-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-09-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-06-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-06-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-06-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-07-01 2021-09-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-07-01 2021-09-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2021-07-01 2021-09-30 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2020-06-30 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-06-30 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-06-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-06-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-07-01 2021-09-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-06-30 0000081362 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-07-01 2020-09-30 0000081362 2020-01-01 2020-03-31 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2021-07-01 2021-09-30 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2021-01-01 2021-09-30 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2020-07-01 2020-09-30 0000081362 kwr:CombinationAndOtherAcquisitionRelatedMember 2020-01-01 2020-09-30 0000081362 kwr:DefinedbenefitplansettlementMember 2020-07-01 2020-09-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2021-09-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-09-30 0000081362 country:IT 2021-01-01 2021-09-30 0000081362 country:IT kwr:HoughtonMember us-gaap:ForeignCountryMember 2021-09-30 0000081362 country:DE 2021-09-30 0000081362 kwr:NetherlandsAndSpainMember us-gaap:ForeignCountryMember 2021-09-30 0000081362 country:IT us-gaap:ForeignCountryMember 2021-09-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2020-07-01 2020-09-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-07-01 2020-09-30 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-09-30 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-09-30 0000081362 us-gaap:InterestExpenseMember 2021-07-01 2021-09-30 0000081362 kwr:BrazilianIndirectTaxesMember 2021-01-01 2021-09-30 0000081362 us-gaap:InterestRateSwapMember 2019-11-30 0000081362 us-gaap:InterestRateSwapMember 2021-01-01 2021-09-30 0000081362 srt:ScenarioForecastMember 2021-12-31 0000081362 srt:MaximumMember kwr:FacilitiesVehiclesAndMachineryAndEquipmentMember 2021-09-30 0000081362 srt:MaximumMember us-gaap:LandMember 2021-09-30 0000081362 srt:MinimumMember country:IT kwr:HoughtonMember us-gaap:ForeignCountryMember 2021-01-01 2021-09-30 0000081362 srt:MaximumMember country:IT kwr:HoughtonMember us-gaap:ForeignCountryMember 2021-01-01 2021-09-30 0000081362 srt:MinimumMember country:DE kwr:HoughtonMember us-gaap:ForeignCountryMember 2021-01-01 2021-09-30 0000081362 srt:MaximumMember country:DE kwr:HoughtonMember us-gaap:ForeignCountryMember 2021-01-01 2021-09-30 0000081362 srt:SubsidiariesMember country:AR 2020-07-01 2020-09-30 0000081362 srt:SubsidiariesMember country:AR 2020-01-01 2020-09-30 0000081362 kwr:ChemicalMaskantsProductLineMember kwr:GlobalSpecialtyBusinessesMember 2021-01-01 2021-09-30 0000081362 country:DE kwr:HoughtonMember 2021-09-30 0000081362 srt:SubsidiariesMember country:AR us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2021-07-01 2021-09-30 0000081362 srt:SubsidiariesMember country:AR us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-09-30 0000081362 us-gaap:PerformanceSharesMember 2021-09-30 0000081362 kwr:LargestCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000081362 kwr:TopFiveMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000081362 srt:SubsidiariesMember country:AR us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-09-30 0000081362 srt:SubsidiariesMember country:AR us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-09-30 0000081362 srt:SubsidiariesMember country:AR us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-09-30 0000081362 srt:SubsidiariesMember country:AR us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2021-07-01 2021-09-30 0000081362 srt:SubsidiariesMember country:AR us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2020-07-01 2020-09-30 0000081362 srt:SubsidiariesMember country:AR us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2020-07-01 2020-09-30 0000081362 kwr:DefinedContributionPlanMember 2021-07-01 2021-09-30 0000081362 kwr:HoughtonCombinationMember 2021-01-01 2021-03-31 0000081362 kwr:HoughtonCombinationMember 2020-12-31 0000081362 kwr:HoughtonCombinationMember 2021-09-30 0000081362 srt:MaximumMember country:IT us-gaap:ForeignCountryMember 2021-01-01 2021-09-30 0000081362 srt:MinimumMember country:IT us-gaap:ForeignCountryMember 2021-01-01 2021-09-30 0000081362 country:IT us-gaap:ForeignCountryMember 2021-01-01 2021-09-30 0000081362 country:BR us-gaap:ForeignCountryMember 2021-01-01 2021-09-30 0000081362 country:NL us-gaap:ForeignCountryMember 2021-01-01 2021-09-30 0000081362 country:CN us-gaap:ForeignCountryMember 2021-01-01 2021-09-30 0000081362 country:MX us-gaap:ForeignCountryMember 2021-01-01 2021-09-30 0000081362 country:GB us-gaap:ForeignCountryMember 2021-01-01 2021-09-30 0000081362 country:CA us-gaap:StateAndLocalJurisdictionMember 2021-01-01 2021-09-30 0000081362 us-gaap:InternalRevenueServiceIRSMember 2021-01-01 2021-09-30 0000081362 us-gaap:StateAndLocalJurisdictionMember 2021-01-01 2021-09-30 0000081362 country:IN us-gaap:ForeignCountryMember 2021-01-01 2021-09-30 0000081362 kwr:DefinedContributionPlanMember 2020-07-01 2020-09-30 0000081362 kwr:DefinedContributionPlanMember 2020-01-01 2020-09-30 0000081362 kwr:ForeignconsumptiontaxMember 2021-07-01 2021-09-30 0000081362 kwr:GrindaixGmbhMember kwr:GlobalSpecialtyBusinessesMember 2021-09-01 2021-09-30 0000081362 kwr:GrindaixGmbhMember kwr:GlobalSpecialtyBusinessesMember 2021-02-28 0000081362 kwr:GrindaixGmbhMember kwr:GlobalSpecialtyBusinessesMember 2021-02-01 2021-02-28 0000081362 us-gaap:InsuranceClaimsMember 2021-09-30 0000081362 us-gaap:InsuranceClaimsMember 2021-01-01 2021-09-30 0000081362 us-gaap:InterestRateSwapMember 2020-01-01 2020-12-31 0000081362 us-gaap:ErrorCorrectionOtherMember 2020-07-01 2020-09-30 0000081362 us-gaap:ErrorCorrectionOtherMember 2020-01-01 2020-09-30 0000081362 us-gaap:ErrorCorrectionOtherMember 2020-01-01 2020-03-31 0000081362 us-gaap:ErrorCorrectionOtherMember 2020-04-01 2020-06-30 0000081362 us-gaap:TransferredAtPointInTimeMember 2021-07-01 2021-09-30 0000081362 us-gaap:TransferredOverTimeMember 2021-07-01 2021-09-30 0000081362 kwr:TwentyTwentyOneAcquisitionMember us-gaap:SubsequentEventMember 2021-11-01 2021-11-30 0000081362 kwr:TwentyTwentyOneAcquisitionMember us-gaap:SubsequentEventMember 2021-11-30 0000081362 kwr:DefinedbenefitplansettlementMember 2020-01-01 2020-09-30 0000081362 srt:SubsidiariesMember country:AR 2021-07-01 2021-09-30 0000081362 srt:SubsidiariesMember us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-09-30 iso4217:BRL iso4217:DKK iso4217:EUR iso4217:GBP iso4217:USD iso4217:ZAR pure shares iso4217:USD shares dummy:People dummy:Segments dummy:Countries false --12-31 P3Y 2021 1 30000000 Q3 0000081362 17888577 17850616 false 10-Q true 2021-09-30 false 001-12019 QUAKER CHEMICAL CORPORATION PA 23-0993790 901 E. Hector Street Conshohocken PA 19428 – 2380 610 832-4000 Common Stock, $1 par value KWR NYSE Yes Yes Large Accelerated Filer false false 17894480 449072000 367224000 1314117000 1031825000 303941000 227032000 858341000 660396000 145131000 140192000 455776000 371429000 104215000 97037000 317204000 282405000 0 0 0 38000000 -880000 1383000 593000 3585000 5786000 6913000 18259000 22786000 36010000 34859000 119720000 24653000 647000 -239000 19344000 -22407000 -5637000 -6837000 -16725000 -22109000 31020000 27783000 122339000 -19863000 795000 2245000 26702000 -7603000 30225000 25538000 95637000 -12260000 848000 1804000 7668000 3536000 31073000 27342000 103305000 -8724000 15000 38000 62000 88000 31058000 27304000 103243000 -8812000 1.74 1.53 5.78 -0.50 1.73 1.53 5.76 -0.50 0.415 0.395 1.205 1.165 31073000 27342000 103305000 -8724000 -19905000 33618000 -29201000 -10582000 904000 -257000 2593000 16913000 436000 354000 1450000 -3738000 -215000 556000 -2961000 453000 -18780000 34271000 -28119000 3046000 12293000 61613000 75186000 -5678000 15000 56000 68000 -25000 12278000 61557000 75118000 -5653000 141393000 181833000 433631000 372974000 121951000 86148000 132943000 101616000 63278000 50156000 893196000 792727000 423469000 423253000 232636000 219370000 190833000 203883000 34314000 38507000 630669000 631212000 1048688000 1081358000 94110000 95785000 18409000 16566000 31608000 31796000 2941827000 2891834000 52611000 38967000 219601000 198872000 40655000 43300000 4050000 8248000 93042000 93573000 409959000 382960000 839275000 849068000 24599000 27070000 174405000 192763000 109893000 119059000 1558131000 1570920000 1 30000000 17888577 17850616 17889000 17851000 914277000 905171000 505635000 423940000 -54723000 -26598000 1383078000 1320364000 618000 550000 1383696000 1320914000 2941827000 2891834000 103305000 -8724000 3562000 3562000 65440000 62818000 7563000 -1415000 801000 229000 -21865000 -30657000 8441000 17820000 4819000 -105000 0 818000 0 38000000 -1705000 2498000 593000 3585000 -5638000 16219000 68664000 -30225000 72962000 -2137000 24512000 113000 -4557000 -12772000 32652000 -13481000 2509000 112048000 12823000 12184000 31975000 3132000 14744000 11000 0 41000 -30054000 -15264000 28558000 28132000 39143000 -16485000 -585000 -527000 21175000 20520000 704000 2385000 0 1047000 0 751000 -10471000 -65077000 -2486000 -529000 -40502000 31178000 181895000 143555000 141393000 174733000 <div id="TextBlockContainer534" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:809px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2559" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 1 – Basis of Presentation and Description of Business<div style="display:inline-block;width:5px"> </div></div><div id="div_530_XBRL_TS_eb3f996fb8514e3e9a7d1174839ecbb8" style="position:absolute;left:0px;top:23px;float:left;"><div id="TextBlockContainer531" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:239px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2569" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Basis of Presentation </div><div id="a2572" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">As used in these Notes to Condensed Consolidated Financial Statements of<div style="display:inline-block;width:5px"> </div>this Quarterly Report on Form 10-Q for the period </div><div id="a2581" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">ended September 30, 2021 (the “Report”),<div style="display:inline-block;width:4px"> </div>the terms “Quaker,”<div style="display:inline-block;width:4px"> </div>“Quaker Houghton,”<div style="display:inline-block;width:4px"> </div>the “Company,”<div style="display:inline-block;width:4px"> </div>“we,” and “our” refer to Quaker </div><div id="a2603" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">Chemical Corporation (doing business as Quaker Houghton), its subsidiaries, and<div style="display:inline-block;width:5px"> </div>associated companies, unless the context otherwise </div><div id="a2605" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">requires.<div style="display:inline-block;width:7px"> </div>As used in these Notes to Condensed Consolidated Financial Statements,<div style="display:inline-block;width:5px"> </div>the term Legacy Quaker refers to the Company </div><div id="a2610" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">prior to the closing of its combination with Houghton International, Inc. (“Houghton”)<div style="display:inline-block;width:5px"> </div>(herein referred to as the “Combination”).<div style="display:inline-block;width:7px"> </div>The </div><div id="a2613" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">condensed consolidated financial statements included herein are<div style="display:inline-block;width:5px"> </div>unaudited and have been prepared in accordance with generally </div><div id="a2615" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">accepted accounting principles in the United States (“U.S. GAAP”) for interim<div style="display:inline-block;width:5px"> </div>financial reporting and the United States Securities and </div><div id="a2617" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:131px;">Exchange Commission (“SEC”) regulations.<div style="display:inline-block;width:8px"> </div>Certain information and footnote disclosures normally included in financial statements </div><div id="a2622" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:146px;">prepared in accordance with U.S. GAAP have been condensed or omitted<div style="display:inline-block;width:5px"> </div>pursuant to such rules and regulations.<div style="display:inline-block;width:7px"> </div>In the opinion of </div><div id="a2624" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:161px;">management, the financial statements reflect all adjustments consisting<div style="display:inline-block;width:5px"> </div>only of normal recurring adjustments which are necessary for a </div><div id="a2631" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:177px;">fair statement of the financial position, results of operations and cash<div style="display:inline-block;width:5px"> </div>flows for the interim periods.<div style="display:inline-block;width:7px"> </div>The results for the nine months </div><div id="a2634" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:192px;">ended September 30, 2021 are not necessarily indicative of the results to be expected<div style="display:inline-block;width:5px"> </div>for the full year.<div style="display:inline-block;width:8px"> </div>These financial statements </div><div id="a2637" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:207px;">should be read in conjunction with the Company’s<div style="display:inline-block;width:5px"> </div>Annual Report filed on Form 10-K for the year ended December<div style="display:inline-block;width:5px"> </div>31, 2020 (the </div><div id="a2645" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:223px;">“2020 Form 10-K”).</div></div></div><div id="a2645_18_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:114px;top:246px;"><div style="display:inline-block;width:6px"> </div></div><div id="div_532_XBRL_TS_42d9b6c08f3448fab67fdd25a6bb3d6d" style="position:absolute;left:0px;top:269px;float:left;"><div id="TextBlockContainer533" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:124px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2654" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">During the three months ended September 30, 2020, the Company<div style="display:inline-block;width:5px"> </div>identified and corrected certain immaterial adjustments relating </div><div id="a2688" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">to the three months ended March 31, 2020 as well as the three and six months<div style="display:inline-block;width:5px"> </div>ended June 30, 2020.<div style="display:inline-block;width:7px"> </div>These adjustments related to the </div><div id="a2739" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Company’s over-recognition<div style="display:inline-block;width:5px"> </div>of cost of goods sold (“COGS”) and corresponding under-recognition<div style="display:inline-block;width:5px"> </div>of inventory, as well as the </div><div id="a2777" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">associated tax impact of these adjustments, in the Company’s<div style="display:inline-block;width:5px"> </div>previously issued interim financial statements for the three months </div><div id="a2814" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">ended March 31, 2020 and the three and six months ended June 30, 2020.<div style="display:inline-block;width:8px"> </div>These adjustments impact the Company’s<div style="display:inline-block;width:5px"> </div>Americas </div><div id="a2855" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">reportable segment.<div style="display:inline-block;width:7px"> </div>The cumulative amount of reduction to COGS recorded in the three and nine months ended<div style="display:inline-block;width:5px"> </div>September 30, 2020 </div><div id="a2896" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:92px;">was approximately $</div><div id="a2896_19_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:116px;top:92px;">1.7</div><div id="a2896_22_30" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:132px;top:92px;"><div style="display:inline-block;width:3px"> </div>million, with approximately $</div><div id="a2896_52_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:295px;top:92px;">0.7</div><div id="a2896_55_62" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:312px;top:92px;"><div style="display:inline-block;width:3px"> </div>million related to the three months ended March 31, 2020 and </div><div id="a2933" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:107px;">approximately $</div><div id="a2933_15_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:92px;top:107px;">1.0</div><div id="a2933_18_57" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:108px;top:107px;"><div style="display:inline-block;width:3px"> </div>million related to the three months ended June 30, 2020.</div></div></div><div id="a2957" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:400px;">Description of Business </div><div id="a2959" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:423px;">The Company was organized in 1918, incorporated as a Pennsylvania<div style="display:inline-block;width:5px"> </div>business corporation in 1930, and in August 2019 </div><div id="a2962" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:439px;">completed the Combination with Houghton to form Quaker Houghton.<div style="display:inline-block;width:8px"> </div>Quaker Houghton is the global leader in industrial process </div><div id="a2970" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:454px;">fluids.<div style="display:inline-block;width:7px"> </div>With a presence around the world, including<div style="display:inline-block;width:5px"> </div>operations in over </div><div id="a2970_72_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:385px;top:454px;">25</div><div id="a2970_74_57" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:399px;top:454px;"><div style="display:inline-block;width:3px"> </div>countries, the Company’s customers<div style="display:inline-block;width:5px"> </div>include thousands of </div><div id="a2972" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:469px;">the world’s most advanced and specialized<div style="display:inline-block;width:5px"> </div>steel, aluminum, automotive, aerospace, offshore, can,<div style="display:inline-block;width:5px"> </div>mining, and metalworking </div><div id="a2974" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:485px;">companies.<div style="display:inline-block;width:7px"> </div>Quaker Houghton develops, produces, and markets a broad range of formulated<div style="display:inline-block;width:5px"> </div>chemical specialty products and offers </div><div id="a2978" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:500px;">chemical management services (which the Company refers to as “Fluidcare”)<div style="display:inline-block;width:5px"> </div>for various heavy industrial and manufacturing </div><div id="a2985" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:515px;">applications throughout its </div><div id="a2985_28_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:150px;top:515px;">four</div><div id="a2985_32_97" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:172px;top:515px;"><div style="display:inline-block;width:3px"> </div>segments: Americas; Europe, Middle East and Africa (“EMEA”); Asia/Pacific; and<div style="display:inline-block;width:5px"> </div>Global Specialty </div><div id="a2987" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:531px;">Businesses. </div><div id="a2989" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:554px;">Hyper-inflationary economies</div><div id="a2993" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:577px;">Based on various indices or index compilations being used to monitor inflation<div style="display:inline-block;width:5px"> </div>in Argentina as well as economic instability, </div><div id="a2994" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:593px;">effective July 1, 2018, Argentina’s<div style="display:inline-block;width:5px"> </div>economy was considered hyper-inflationary under U.S. GAAP.<div style="display:inline-block;width:9px"> </div>As of, and for the three and nine </div><div id="a3001" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:608px;">months ended September 30, 2021, the Company's Argentine<div style="display:inline-block;width:5px"> </div>subsidiaries represented less than </div><div id="a3001_92_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:516px;top:608px;">1</div><div id="a3001_93_32" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:523px;top:608px;">% of the Company’s consolidated </div><div id="a3011" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:623px;">total assets and net sales, respectively.<div style="display:inline-block;width:7px"> </div>During the three and nine months ended September 30, 2021, the Company<div style="display:inline-block;width:5px"> </div>recorded less than </div><div id="a3025" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:639px;">$</div><div id="a3025_1_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:11px;top:639px;">0.1</div><div id="a3025_4_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:639px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a3025_18_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:102px;top:639px;">0.3</div><div id="a3025_21_111" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:119px;top:639px;"><div style="display:inline-block;width:3px"> </div>million, respectively,<div style="display:inline-block;width:5px"> </div>of remeasurement losses associated with the applicable currency conversions<div style="display:inline-block;width:5px"> </div>related to </div><div id="a3039" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:654px;">Argentina.<div style="display:inline-block;width:7px"> </div>Comparatively, during the<div style="display:inline-block;width:5px"> </div>three and nine months ended September 30, 2020, the Company recorded $</div><div id="a3039_108_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:613px;top:654px;">0.2</div><div id="a3039_111_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:654px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a3039_125_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:705px;top:654px;">0.3</div><div id="a3053" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:669px;">million, respectively,<div style="display:inline-block;width:5px"> </div>of remeasurement losses associated with the applicable currency conversions<div style="display:inline-block;width:5px"> </div>related to Argentina.<div style="display:inline-block;width:7px"> </div>These losses </div><div id="a3062" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:685px;">were recorded within foreign exchange losses, net, which is a component<div style="display:inline-block;width:5px"> </div>of other income (expense), net, in the Company’s </div><div id="a3066" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:700px;">Condensed Consolidated Statements of Operations. </div><div id="a3069" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:723px;">COVID-19 </div><div id="a3073" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:747px;">Management continues to monitor the impact that the COVID-19 pandemic<div style="display:inline-block;width:5px"> </div>is having on the Company, the overall<div style="display:inline-block;width:5px"> </div>specialty </div><div id="a3076" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:762px;">chemical industry, and<div style="display:inline-block;width:5px"> </div>the economies and markets in which the Company operates.<div style="display:inline-block;width:8px"> </div>The full extent of the COVID-19 pandemic </div><div id="a3083" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:777px;">related business and travel restrictions and changes to business and consumer behavior<div style="display:inline-block;width:5px"> </div>intended to reduce its spread are uncertain as of </div><div id="a3085" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:793px;">the date of the Report as COVID-19 and the responses of governmental<div style="display:inline-block;width:5px"> </div>authorities continue to evolve globally.</div></div><div id="TextBlockContainer536" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:262px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3110" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Further, management continues to evaluate<div style="display:inline-block;width:5px"> </div>how COVID-19-related circumstances, such as remote work arrangements, affect </div><div id="a3115" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">financial reporting processes, internal control over financial reporting,<div style="display:inline-block;width:5px"> </div>and disclosure controls and procedures.<div style="display:inline-block;width:8px"> </div>While the </div><div id="a3117" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">circumstances have presented and are expected to continue to present challenges,<div style="display:inline-block;width:5px"> </div>at this time, Management does not believe that </div><div id="a3119" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">COVID-19 has had a material impact on financial reporting processes, internal<div style="display:inline-block;width:5px"> </div>control over financial reporting, and disclosure </div><div id="a3123" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">controls and procedures. </div><div id="a3125" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:85px;">The Company cannot reasonably estimate the magnitude of the effects<div style="display:inline-block;width:5px"> </div>these conditions will have on the Company’s<div style="display:inline-block;width:5px"> </div>operations in </div><div id="a3127" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">the future as they are subject to significant uncertainties relating to the ultimate<div style="display:inline-block;width:5px"> </div>geographic spread of the virus, the incidence and </div><div id="a3129" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">severity of the symptoms, the duration or resurgences<div style="display:inline-block;width:5px"> </div>of the outbreak including the impact of new variants, the global availability, </div><div id="a3131" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:131px;">acceptance and efficacy of vaccines, the length of the travel restrictions<div style="display:inline-block;width:5px"> </div>and business closures imposed by governments of impacted </div><div id="a3133" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:146px;">countries, and the economic response by governments of impacted countries,<div style="display:inline-block;width:5px"> </div>all of which continue to evolve. </div><div id="a3136" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:169px;">To the extent<div style="display:inline-block;width:5px"> </div>that the Company’s customers and suppliers continue<div style="display:inline-block;width:5px"> </div>to be significantly and adversely impacted by COVID-19, this </div><div id="a3139" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:185px;">could reduce the availability,<div style="display:inline-block;width:5px"> </div>or result in delays, of materials or supplies to or from the Company,<div style="display:inline-block;width:5px"> </div>which in turn could significantly </div><div id="a3141" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:200px;">interrupt the Company’s business operations.<div style="display:inline-block;width:8px"> </div>Such impacts could grow and become more significant to the Company’s<div style="display:inline-block;width:5px"> </div>operations </div><div id="a3143" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:215px;">and the Company’s liquidity<div style="display:inline-block;width:5px"> </div>or financial position.<div style="display:inline-block;width:7px"> </div>Therefore, given the continuously evolving global developments with respect to </div><div id="a3145" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:231px;">this pandemic, the Company cannot reasonably estimate the magnitude or<div style="display:inline-block;width:5px"> </div>the full extent to which COVID-19 may impact the </div><div id="a3148" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:246px;">Company’s results of operations,<div style="display:inline-block;width:5px"> </div>liquidity or financial position.</div></div> <div id="TextBlockContainer531" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:239px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2569" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Basis of Presentation </div><div id="a2572" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">As used in these Notes to Condensed Consolidated Financial Statements of<div style="display:inline-block;width:5px"> </div>this Quarterly Report on Form 10-Q for the period </div><div id="a2581" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">ended September 30, 2021 (the “Report”),<div style="display:inline-block;width:4px"> </div>the terms “Quaker,”<div style="display:inline-block;width:4px"> </div>“Quaker Houghton,”<div style="display:inline-block;width:4px"> </div>the “Company,”<div style="display:inline-block;width:4px"> </div>“we,” and “our” refer to Quaker </div><div id="a2603" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">Chemical Corporation (doing business as Quaker Houghton), its subsidiaries, and<div style="display:inline-block;width:5px"> </div>associated companies, unless the context otherwise </div><div id="a2605" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">requires.<div style="display:inline-block;width:7px"> </div>As used in these Notes to Condensed Consolidated Financial Statements,<div style="display:inline-block;width:5px"> </div>the term Legacy Quaker refers to the Company </div><div id="a2610" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">prior to the closing of its combination with Houghton International, Inc. (“Houghton”)<div style="display:inline-block;width:5px"> </div>(herein referred to as the “Combination”).<div style="display:inline-block;width:7px"> </div>The </div><div id="a2613" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">condensed consolidated financial statements included herein are<div style="display:inline-block;width:5px"> </div>unaudited and have been prepared in accordance with generally </div><div id="a2615" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">accepted accounting principles in the United States (“U.S. GAAP”) for interim<div style="display:inline-block;width:5px"> </div>financial reporting and the United States Securities and </div><div id="a2617" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:131px;">Exchange Commission (“SEC”) regulations.<div style="display:inline-block;width:8px"> </div>Certain information and footnote disclosures normally included in financial statements </div><div id="a2622" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:146px;">prepared in accordance with U.S. GAAP have been condensed or omitted<div style="display:inline-block;width:5px"> </div>pursuant to such rules and regulations.<div style="display:inline-block;width:7px"> </div>In the opinion of </div><div id="a2624" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:161px;">management, the financial statements reflect all adjustments consisting<div style="display:inline-block;width:5px"> </div>only of normal recurring adjustments which are necessary for a </div><div id="a2631" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:177px;">fair statement of the financial position, results of operations and cash<div style="display:inline-block;width:5px"> </div>flows for the interim periods.<div style="display:inline-block;width:7px"> </div>The results for the nine months </div><div id="a2634" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:192px;">ended September 30, 2021 are not necessarily indicative of the results to be expected<div style="display:inline-block;width:5px"> </div>for the full year.<div style="display:inline-block;width:8px"> </div>These financial statements </div><div id="a2637" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:207px;">should be read in conjunction with the Company’s<div style="display:inline-block;width:5px"> </div>Annual Report filed on Form 10-K for the year ended December<div style="display:inline-block;width:5px"> </div>31, 2020 (the </div><div id="a2645" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:223px;">“2020 Form 10-K”).</div></div><div id="TextBlockContainer533" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:124px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2654" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">During the three months ended September 30, 2020, the Company<div style="display:inline-block;width:5px"> </div>identified and corrected certain immaterial adjustments relating </div><div id="a2688" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">to the three months ended March 31, 2020 as well as the three and six months<div style="display:inline-block;width:5px"> </div>ended June 30, 2020.<div style="display:inline-block;width:7px"> </div>These adjustments related to the </div><div id="a2739" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Company’s over-recognition<div style="display:inline-block;width:5px"> </div>of cost of goods sold (“COGS”) and corresponding under-recognition<div style="display:inline-block;width:5px"> </div>of inventory, as well as the </div><div id="a2777" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">associated tax impact of these adjustments, in the Company’s<div style="display:inline-block;width:5px"> </div>previously issued interim financial statements for the three months </div><div id="a2814" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">ended March 31, 2020 and the three and six months ended June 30, 2020.<div style="display:inline-block;width:8px"> </div>These adjustments impact the Company’s<div style="display:inline-block;width:5px"> </div>Americas </div><div id="a2855" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">reportable segment.<div style="display:inline-block;width:7px"> </div>The cumulative amount of reduction to COGS recorded in the three and nine months ended<div style="display:inline-block;width:5px"> </div>September 30, 2020 </div><div id="a2896" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:92px;">was approximately $</div><div id="a2896_19_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:116px;top:92px;">1.7</div><div id="a2896_22_30" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:132px;top:92px;"><div style="display:inline-block;width:3px"> </div>million, with approximately $</div><div id="a2896_52_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:295px;top:92px;">0.7</div><div id="a2896_55_62" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:312px;top:92px;"><div style="display:inline-block;width:3px"> </div>million related to the three months ended March 31, 2020 and </div><div id="a2933" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:107px;">approximately $</div><div id="a2933_15_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:92px;top:107px;">1.0</div><div id="a2933_18_57" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:108px;top:107px;"><div style="display:inline-block;width:3px"> </div>million related to the three months ended June 30, 2020.</div></div> 1700000 1700000 700000 1000000.0 25 4 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 100000 300000 200000 300000 <div id="TextBlockContainer538" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:732px;height:554px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3151" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 2 – Business Acquisitions </div><div id="a3156" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:23px;">2021 Acquisitions </div><div id="a3158" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:47px;">In September 2021, the Company acquired the remaining interest in Grindaix-GmbH<div style="display:inline-block;width:5px"> </div>(“Grindaix”), a Germany-based, high-tech </div><div id="a3165" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:62px;">provider of coolant control and delivery systems for approximately </div><div id="a3165_67_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:366px;top:62px;">2.4</div><div id="a3165_70_31" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:62px;"><div style="display:inline-block;width:3px"> </div>million EUR or approximately $</div><div id="a3165_101_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:559px;top:62px;">2.9</div><div id="a3165_104_24" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:576px;top:62px;"><div style="display:inline-block;width:3px"> </div>million for its Global </div><div id="a3180" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">Specialty Businesses reportable segment.<div style="display:inline-block;width:8px"> </div>Previously, in February 2021,<div style="display:inline-block;width:5px"> </div>the Company acquired a </div><div id="a3180_95_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:527px;top:77px;">38</div><div id="a3180_97_33" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:540px;top:77px;">% ownership interest in Grindaix </div><div id="a3185" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:93px;">for approximately </div><div id="a3185_18_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:104px;top:93px;">1.4</div><div id="a3185_21_31" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:120px;top:93px;"><div style="display:inline-block;width:3px"> </div>million EUR or approximately $</div><div id="a3185_52_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:297px;top:93px;">1.7</div><div id="a3185_55_75" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:93px;"><div style="display:inline-block;width:3px"> </div>million.<div style="display:inline-block;width:7px"> </div>The Company recorded its initial investment as an equity method </div><div id="a3188" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:108px;">investment within the Condensed Consolidated Financial Statements and<div style="display:inline-block;width:5px"> </div>accounted for the purchase of the remaining interest as a step </div><div id="a3191" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:123px;">acquisition whereby the Company remeasured the previously held<div style="display:inline-block;width:5px"> </div>equity method investment to its fair value. </div><div id="a3193" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:147px;">In June 2021, the Company acquired certain assets for its chemical maskants<div style="display:inline-block;width:5px"> </div>product line in the Global Specialty Businesses </div><div id="a3231" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:162px;">reportable segment for </div><div id="a3231_23_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:129px;top:162px;">2.3</div><div id="a3231_26_31" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:145px;top:162px;"><div style="display:inline-block;width:3px"> </div>million EUR or approximately $</div><div id="a3231_57_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:322px;top:162px;">2.8</div><div id="a3231_60_69" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:339px;top:162px;"><div style="display:inline-block;width:3px"> </div>million.<div style="display:inline-block;width:7px"> </div>The Company accounted for the acquisition using the asset </div><div id="a3269" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:177px;">acquisition method under ASC 805, </div><div id="a3279" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:199px;top:177px;">Business Combinations</div><div id="a3283" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:324px;top:177px;">.<div style="display:inline-block;width:7px"> </div></div><div id="a3286" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:201px;">In February 2021, the Company acquired a tin-plating solutions business<div style="display:inline-block;width:5px"> </div>for the steel end market for approximately $</div><div id="a3286_116_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:655px;top:201px;">25</div><div id="a3286_118_11" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:669px;top:201px;"><div style="display:inline-block;width:3px"> </div>million.<div style="display:inline-block;width:4px"> </div></div><div id="a3327" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:216px;">This acquisition is part of each of the Company’s<div style="display:inline-block;width:5px"> </div>geographic reportable segments.<div style="display:inline-block;width:7px"> </div>The Company allocated $</div><div id="a3327_106_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:588px;top:216px;">19.6</div><div id="a3327_110_16" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:611px;top:216px;"><div style="display:inline-block;width:3px"> </div>million of the </div><div id="a3365" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:231px;">purchase price to intangible assets, comprised of $</div><div id="a3365_51_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:273px;top:231px;">18.3</div><div id="a3365_55_57" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:297px;top:231px;"><div style="display:inline-block;width:3px"> </div>million of customer relationships, to be amortized over </div><div id="a3365_112_8" style="position:absolute;font-family:'Times New Roman';left:597px;top:231px;">19 years</div><div id="a3365_120_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:642px;top:231px;">; $</div><div id="a3365_123_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:655px;top:231px;">0.9</div><div id="a3365_126_9" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:231px;"><div style="display:inline-block;width:3px"> </div>million </div><div id="a3406" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:247px;">of existing product technology to be amortized over </div><div id="a3406_52_8" style="position:absolute;font-family:'Times New Roman';left:285px;top:247px;">14 years</div><div id="a3406_60_7" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:329px;top:247px;">; and $</div><div id="a3406_67_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:366px;top:247px;">0.4</div><div id="a3406_70_54" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:247px;"><div style="display:inline-block;width:3px"> </div>million of a licensed trademark to be amortized over </div><div id="a3406_124_7" style="position:absolute;font-family:'Times New Roman';left:669px;top:247px;">3 years</div><div id="a3406_131_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:707px;top:247px;">.<div style="display:inline-block;width:3px"> </div></div><div id="a3452" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:262px;">In addition, the Company recorded $</div><div id="a3452_35_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:201px;top:262px;">5.0</div><div id="a3452_38_94" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:218px;top:262px;"><div style="display:inline-block;width:3px"> </div>million of goodwill related to expected value not allocated to other acquired<div style="display:inline-block;width:5px"> </div>assets, all of </div><div id="a3495" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:277px;">which is expected to be tax deductible in various jurisdictions in which we<div style="display:inline-block;width:5px"> </div>operate.<div style="display:inline-block;width:7px"> </div>As of September 30, 2021, the allocation of the </div><div id="a3542" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:293px;">purchase price has not been finalized and the </div><div id="a3542_46_8" style="position:absolute;font-family:'Times New Roman';left:248px;top:293px;">one year</div><div id="a3542_54_78" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:293px;top:293px;"><div style="display:inline-block;width:3px"> </div>measurement period has not ended.<div style="display:inline-block;width:7px"> </div>Further adjustments may be necessary as a </div><div id="a3587" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:308px;">result of the Company’s on-going<div style="display:inline-block;width:5px"> </div>assessment of additional information related to the fair value of assets acquired<div style="display:inline-block;width:5px"> </div>and liabilities </div><div id="a3627" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:323px;">assumed. </div><div id="a3629" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:347px;">The results of operations of the acquired assets and businesses subsequent to the<div style="display:inline-block;width:5px"> </div>respective acquisition dates are included in the </div><div id="a3632" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:362px;">Condensed Consolidated Statements of Operations as of September 30, 2021.<div style="display:inline-block;width:8px"> </div>Applicable transaction expenses associated with these </div><div id="a3635" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:377px;">acquisitions are included in Combination, integration and other acquisition<div style="display:inline-block;width:1px"> </div>-related expenses in the Company’s Condensed </div><div id="a3639" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:393px;">Consolidated Statements of Operations.<div style="display:inline-block;width:8px"> </div>Certain pro forma and other information is not presented, as the operations of the acquired </div><div id="a3641" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:408px;">assets and businesses are not considered material to the overall operations of the<div style="display:inline-block;width:5px"> </div>Company for the periods presented. </div><div id="a3644" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:431px;">In November 2021, the Company closed two additional acquisitions that expand<div style="display:inline-block;width:5px"> </div>its strategic product offerings and increase the </div><div id="a3646" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:447px;">Company’s presence in its core metalworking<div style="display:inline-block;width:5px"> </div>industries.<div style="display:inline-block;width:7px"> </div>The total initial purchase price for these acquisitions was approximately $</div><div id="a3646_132_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:709px;top:447px;">10</div><div id="a3649" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:462px;">million, subject to post-closing adjustments as well as certain earn-out<div style="display:inline-block;width:5px"> </div>provisions that could total approximately $</div><div id="a3649_116_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:612px;top:462px;">4</div><div id="a3649_117_11" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:462px;"><div style="display:inline-block;width:3px"> </div>million.<div style="display:inline-block;width:3px"> </div></div><div id="a3657" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:477px;">Transaction expenses associated with these<div style="display:inline-block;width:5px"> </div>acquisitions are included in Combination, integration and other acquisition-related </div><div id="a3661" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:493px;">expenses in the Condensed Consolidated Statements of Operations.<div style="display:inline-block;width:8px"> </div>The results of operations of these two acquisitions are not </div><div id="a3663" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:508px;">included in the Consolidated Statements of Operations because the date of<div style="display:inline-block;width:5px"> </div>closing for each was subsequent to September 30, 2021.<div style="display:inline-block;width:4px"> </div></div><div id="a3667" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:523px;">Preliminary purchase price allocation of assets acquired and liabilities assumed<div style="display:inline-block;width:5px"> </div>have not been presented as that information is not </div><div id="a3669" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:539px;">available as of the date of these Condensed Consolidated Financial Statements.</div></div><div id="TextBlockContainer540" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:720px;height:116px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3689" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Previous Acquisitions </div><div id="a3692" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">In December 2020, the Company completed its acquisition of Coral Chemical<div style="display:inline-block;width:5px"> </div>Company (“Coral”), a privately held, U.S.-based </div><div id="a3704" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">provider of metal finishing fluid solutions.<div style="display:inline-block;width:8px"> </div>The acquisition provides technical expertise and product solutions for pre-treatment, </div><div id="a3711" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">metalworking and wastewater treatment applications to the beverage<div style="display:inline-block;width:5px"> </div>cans and general industrial end markets.<div style="display:inline-block;width:7px"> </div>The original purchase </div><div id="a3715" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">price was approximately $</div><div id="a3715_25_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:146px;top:69px;">54.1</div><div id="a3715_29_103" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:169px;top:69px;"><div style="display:inline-block;width:3px"> </div>million, subject to routine and customary post-closing adjustments related to working<div style="display:inline-block;width:5px"> </div>capital and net </div><div id="a3723" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">indebtedness levels.<div style="display:inline-block;width:7px"> </div>The Company anticipates finalizing its post-closing adjustments for the Coral acquisition<div style="display:inline-block;width:5px"> </div>during the fourth </div><div id="a3730" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">quarter of 2021.</div></div><div id="TextBlockContainer542" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:519px;height:16px;display:inline-block;"><div id="a3733" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">The following table presents the preliminary estimated fair values of<div style="display:inline-block;width:5px"> </div>Coral net assets acquired:</div></div><div id="TextBlockContainer545" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:703px;height:287px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3743" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:508px;top:0px;">Measurement </div><div id="a3746" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:611px;top:0px;">December 22, </div><div id="a3752" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:407px;top:18px;">December 22, </div><div id="a3755" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:529px;top:18px;">Period </div><div id="a3758" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:636px;top:18px;">2020 </div><div id="a3764" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:423px;top:35px;">2020 (1) </div><div id="a3767" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:511px;top:35px;">Adjustments </div><div id="a3770" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:613px;top:35px;">(as adjusted) </div><div id="a3774" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:52px;">Cash and cash equivalents </div><div id="a3776" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:52px;">$ </div><div id="a3778" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:467px;top:52px;">958</div><div id="a3781" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:503px;top:52px;">$ </div><div id="a3783" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:52px;">—</div><div id="a3786" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:605px;top:52px;">$ </div><div id="a3788" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:671px;top:52px;">958</div><div id="a3792" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:67px;">Accounts receivable </div><div id="a3795" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:67px;">8,473</div><div id="a3799" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:67px;">—</div><div id="a3803" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:661px;top:67px;">8,473</div><div id="a3807" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:82px;">Inventories </div><div id="a3811" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:82px;">4,527</div><div id="a3815" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:82px;">—</div><div id="a3819" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:661px;top:82px;">4,527</div><div id="a3823" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:97px;">Prepaid expenses and other assets </div><div id="a3826" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:467px;top:97px;">181</div><div id="a3830" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:97px;">—</div><div id="a3834" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:671px;top:97px;">181</div><div id="a3838" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:112px;">Property, plant and equipment </div><div id="a3842" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:112px;">10,467</div><div id="a3846" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:112px;">652</div><div id="a3850" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:112px;">11,119</div><div id="a3854" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:127px;">Intangible assets </div><div id="a3857" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:127px;">30,300</div><div id="a3861" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:564px;top:127px;display:flex;">(500)</div><div id="a3865" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:127px;">29,800</div><div id="a3869" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:142px;">Goodwill </div><div id="a3873" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:142px;">2,814</div><div id="a3877" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:142px;">270</div><div id="a3881" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:661px;top:142px;">3,084</div><div id="a3886" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:157px;">Total assets purchased </div><div id="a3889" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:157px;">57,720</div><div id="a3893" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:157px;">422</div><div id="a3897" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:157px;">58,142</div><div id="a3901" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:172px;">Long-term debt including current portions and finance leases </div><div id="a3906" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:467px;top:172px;">183</div><div id="a3910" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:172px;">556</div><div id="a3914" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:671px;top:172px;">739</div><div id="a3918" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:187px;">Accounts payable, accrued expenses and other accrued liabilities </div><div id="a3922" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:187px;">3,482</div><div id="a3926" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:187px;">—</div><div id="a3930" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:661px;top:187px;">3,482</div><div id="a3935" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:203px;">Total liabilities assumed </div><div id="a3938" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:203px;">3,665</div><div id="a3942" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:203px;">556</div><div id="a3946" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:661px;top:203px;">4,221</div><div id="a3951" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:220px;">Total consideration<div style="display:inline-block;width:5px"> </div>paid for Coral </div><div id="a3954" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:220px;">54,055</div><div id="a3958" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:564px;top:220px;display:flex;">(134)</div><div id="a3962" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:220px;">53,921</div><div id="a3967" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:237px;">Less: estimated purchase price settlement </div><div id="a3970" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:473px;top:237px;">—</div><div id="a3974" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:564px;top:237px;display:flex;">(134)</div><div id="a3978" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:237px;display:flex;">(134)</div><div id="a3983" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:254px;">Less: cash acquired </div><div id="a3986" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:467px;top:254px;">958</div><div id="a3990" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:254px;">—</div><div id="a3994" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:671px;top:254px;">958</div><div id="a3999" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:271px;">Net cash paid for Coral </div><div id="a4001" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:271px;">$ </div><div id="a4003" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:271px;">53,097</div><div id="a4006" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:503px;top:271px;">$ </div><div id="a4008" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:271px;">—</div><div id="a4011" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:605px;top:271px;">$ </div><div id="a4013" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:271px;">53,097</div></div><div id="TextBlockContainer550" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:727px;height:116px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_548_XBRL_TS_4dfca22478d748028f5d6a5c543fe326" style="position:absolute;left:24px;top:0px;float:left;"><div id="TextBlockContainer549" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:351px;height:16px;display:inline-block;"><div id="a4016" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">(1) As previously disclosed in the Company’s<div style="display:inline-block;width:5px"> </div>2020 Form 10-K</div></div></div><div id="a4016_59_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:366px;top:0px;">. </div><div id="a4039" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">Measurement period adjustments recorded during the first nine months of<div style="display:inline-block;width:5px"> </div>2021 include certain adjustments related to refining </div><div id="a4045" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">original estimates for assets and liabilities for certain acquired finance<div style="display:inline-block;width:5px"> </div>leases, as well the adjustment to reflect the expected settlement </div><div id="a4048" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">of post-closing working capital and net indebtedness true ups to the original purchase<div style="display:inline-block;width:5px"> </div>price.<div style="display:inline-block;width:7px"> </div>As of September 30, 2021, the allocation </div><div id="a4055" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">of the purchase price for Coral has not been finalized and the </div><div id="a4055_63_8" style="position:absolute;font-family:'Times New Roman';left:333px;top:69px;">one year</div><div id="a4055_71_60" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:379px;top:69px;"><div style="display:inline-block;width:3px"> </div>measurement period has not ended.<div style="display:inline-block;width:7px"> </div>Further adjustments may </div><div id="a4062" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">be necessary as a result of the Company’s<div style="display:inline-block;width:5px"> </div>on-going assessment of additional information related to the fair value of assets acquired </div><div id="a4066" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">and liabilities assumed.</div></div><div id="TextBlockContainer552" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:123px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a4069" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">In May 2020, the Company acquired Tel<div style="display:inline-block;width:5px"> </div>Nordic ApS (“TEL”), a company that specializes in lubricants and engineering primarily </div><div id="a4108" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">in high pressure aluminum die casting for its EMEA reportable segment.<div style="display:inline-block;width:8px"> </div>Consideration paid was in the form of a convertible </div><div id="a4149" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">promissory note in the amount of </div><div id="a4149_33_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:185px;top:31px;">20.0</div><div id="a4149_37_32" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:209px;top:31px;"><div style="display:inline-block;width:3px"> </div>million DKK, or approximately $</div><div id="a4149_69_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:391px;top:31px;">2.9</div><div id="a4149_72_58" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:408px;top:31px;"><div style="display:inline-block;width:3px"> </div>million, which was subsequently converted into shares of </div><div id="a4189" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">the Company’s common stock.<div style="display:inline-block;width:8px"> </div>An adjustment to the purchase price of approximately </div><div id="a4189_82_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:468px;top:46px;">0.4</div><div id="a4189_85_28" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:484px;top:46px;"><div style="display:inline-block;width:3px"> </div>million DKK, or less than $</div><div id="a4189_113_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:636px;top:46px;">0.1</div><div id="a4189_116_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:652px;top:46px;"><div style="display:inline-block;width:3px"> </div>million, was </div><div id="a4232" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">made as a result of finalizing a post-closing settlement in the second<div style="display:inline-block;width:5px"> </div>quarter of 2020.<div style="display:inline-block;width:7px"> </div>The Company allocated approximately $</div><div id="a4232_126_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:61px;">2.4</div><div id="a4274" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">million of the purchase price to intangible assets to be amortized over </div><div id="a4274_72_8" style="position:absolute;font-family:'Times New Roman';left:379px;top:77px;">17 years</div><div id="a4274_80_51" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:424px;top:77px;">.<div style="display:inline-block;width:7px"> </div>In addition, the Company recorded approximately </div><div id="a4315" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:92px;">$</div><div id="a4315_1_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:11px;top:92px;">0.5</div><div id="a4315_4_133" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:92px;"><div style="display:inline-block;width:3px"> </div>million of goodwill, related to expected value not allocated to other acquired<div style="display:inline-block;width:5px"> </div>assets, none of which will be tax deductible.<div style="display:inline-block;width:7px"> </div>As of </div><div id="a4361" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:107px;">September 30, 2021, the allocation of the purchase price of TEL was finalized<div style="display:inline-block;width:5px"> </div>and the </div><div id="a4361_86_8" style="position:absolute;font-family:'Times New Roman';left:467px;top:107px;">one year</div><div id="a4361_94_28" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:107px;"><div style="display:inline-block;width:3px"> </div>measurement period ended.<div style="display:inline-block;width:4px"> </div></div></div><div id="TextBlockContainer554" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:732px;height:162px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a4416" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">In March 2020, the Company acquired the remaining </div><div id="a4416_50_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:0px;">49</div><div id="a4416_52_68" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:329px;top:0px;">% ownership interest in one of its South African affiliates, Quaker </div><div id="a4421" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">Chemical South Africa Limited (“QSA”) for </div><div id="a4421_42_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:246px;top:15px;">16.7</div><div id="a4421_46_32" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:269px;top:15px;"><div style="display:inline-block;width:3px"> </div>million ZAR, or approximately $</div><div id="a4421_78_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:449px;top:15px;">1.0</div><div id="a4421_81_44" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:466px;top:15px;"><div style="display:inline-block;width:3px"> </div>million, from its joint venture partner PQ </div><div id="a4422" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Holdings South Africa.<div style="display:inline-block;width:7px"> </div>QSA is a part of the Company’s EMEA<div style="display:inline-block;width:5px"> </div>reportable segment.<div style="display:inline-block;width:7px"> </div>As this acquisition was a change in an existing </div><div id="a4426" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">controlling ownership, the Company recorded $</div><div id="a4426_45_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:260px;top:46px;">0.7</div><div id="a4426_48_80" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:277px;top:46px;"><div style="display:inline-block;width:3px"> </div>million of excess purchase price over the carrying value of the noncontrolling </div><div id="a4428" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">interest in Capital in excess of par value.<div style="display:inline-block;width:7px"> </div></div><div id="a4431" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:85px;">In October 2019, the Company completed its acquisition of the operating<div style="display:inline-block;width:5px"> </div>divisions of Norman Hay plc (“Norman Hay”), a private </div><div id="a4433" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">U.K. company that provides specialty chemicals, operating equipment, and<div style="display:inline-block;width:5px"> </div>services to industrial end markets.<div style="display:inline-block;width:7px"> </div>The original purchase </div><div id="a4435" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">price was </div><div id="a4435_10_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:59px;top:115px;">80.0</div><div id="a4435_14_119" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:82px;top:115px;"><div style="display:inline-block;width:3px"> </div>million GBP,<div style="display:inline-block;width:5px"> </div>on a cash-free and debt-free basis, subject to routine and customary post-closing<div style="display:inline-block;width:5px"> </div>adjustments related to </div><div id="a4442" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:131px;">working capital and net indebtedness levels.<div style="display:inline-block;width:8px"> </div>The Company finalized its post-closing adjustments for the<div style="display:inline-block;width:5px"> </div>Norman Hay acquisition and </div><div id="a4446" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:146px;">paid approximately </div><div id="a4446_19_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:111px;top:146px;">2.5</div><div id="a4446_22_73" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:128px;top:146px;"><div style="display:inline-block;width:3px"> </div>million GBP during the first quarter of 2020 to settle such adjustments.</div></div> 2400000 2900000 0.38 1400000 1700000 2300000 2800000 25000000 19600000 18300000 P19Y 900000 P14Y 400000 P3Y 5000000.0 P1Y 10000000 4000000 54100000 <div id="TextBlockContainer546" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:703px;height:287px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_544_XBRL_TS_063f2606415d4b358eb6d37079f1fdf7" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer545" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:703px;height:287px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a3743" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:508px;top:0px;">Measurement </div><div id="a3746" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:611px;top:0px;">December 22, </div><div id="a3752" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:407px;top:18px;">December 22, </div><div id="a3755" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:529px;top:18px;">Period </div><div id="a3758" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:636px;top:18px;">2020 </div><div id="a3764" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:423px;top:35px;">2020 (1) </div><div id="a3767" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:511px;top:35px;">Adjustments </div><div id="a3770" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:613px;top:35px;">(as adjusted) </div><div id="a3774" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:52px;">Cash and cash equivalents </div><div id="a3776" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:52px;">$ </div><div id="a3778" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:467px;top:52px;">958</div><div id="a3781" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:503px;top:52px;">$ </div><div id="a3783" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:52px;">—</div><div id="a3786" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:605px;top:52px;">$ </div><div id="a3788" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:671px;top:52px;">958</div><div id="a3792" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:67px;">Accounts receivable </div><div id="a3795" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:67px;">8,473</div><div id="a3799" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:67px;">—</div><div id="a3803" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:661px;top:67px;">8,473</div><div id="a3807" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:82px;">Inventories </div><div id="a3811" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:82px;">4,527</div><div id="a3815" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:82px;">—</div><div id="a3819" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:661px;top:82px;">4,527</div><div id="a3823" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:97px;">Prepaid expenses and other assets </div><div id="a3826" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:467px;top:97px;">181</div><div id="a3830" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:97px;">—</div><div id="a3834" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:671px;top:97px;">181</div><div id="a3838" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:112px;">Property, plant and equipment </div><div id="a3842" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:112px;">10,467</div><div id="a3846" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:112px;">652</div><div id="a3850" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:112px;">11,119</div><div id="a3854" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:127px;">Intangible assets </div><div id="a3857" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:127px;">30,300</div><div id="a3861" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:564px;top:127px;display:flex;">(500)</div><div id="a3865" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:127px;">29,800</div><div id="a3869" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:142px;">Goodwill </div><div id="a3873" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:142px;">2,814</div><div id="a3877" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:142px;">270</div><div id="a3881" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:661px;top:142px;">3,084</div><div id="a3886" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:157px;">Total assets purchased </div><div id="a3889" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:157px;">57,720</div><div id="a3893" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:157px;">422</div><div id="a3897" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:157px;">58,142</div><div id="a3901" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:172px;">Long-term debt including current portions and finance leases </div><div id="a3906" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:467px;top:172px;">183</div><div id="a3910" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:172px;">556</div><div id="a3914" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:671px;top:172px;">739</div><div id="a3918" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:187px;">Accounts payable, accrued expenses and other accrued liabilities </div><div id="a3922" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:187px;">3,482</div><div id="a3926" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:187px;">—</div><div id="a3930" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:661px;top:187px;">3,482</div><div id="a3935" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:203px;">Total liabilities assumed </div><div id="a3938" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:203px;">3,665</div><div id="a3942" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:203px;">556</div><div id="a3946" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:661px;top:203px;">4,221</div><div id="a3951" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:220px;">Total consideration<div style="display:inline-block;width:5px"> </div>paid for Coral </div><div id="a3954" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:220px;">54,055</div><div id="a3958" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:564px;top:220px;display:flex;">(134)</div><div id="a3962" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:220px;">53,921</div><div id="a3967" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:237px;">Less: estimated purchase price settlement </div><div id="a3970" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:473px;top:237px;">—</div><div id="a3974" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:564px;top:237px;display:flex;">(134)</div><div id="a3978" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:237px;display:flex;">(134)</div><div id="a3983" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:254px;">Less: cash acquired </div><div id="a3986" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:467px;top:254px;">958</div><div id="a3990" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:254px;">—</div><div id="a3994" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:671px;top:254px;">958</div><div id="a3999" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:271px;">Net cash paid for Coral </div><div id="a4001" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:271px;">$ </div><div id="a4003" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:271px;">53,097</div><div id="a4006" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:503px;top:271px;">$ </div><div id="a4008" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:271px;">—</div><div id="a4011" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:605px;top:271px;">$ </div><div id="a4013" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:271px;">53,097</div></div></div></div><div id="TextBlockContainer549" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:351px;height:16px;display:inline-block;"><div id="a4016" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">(1) As previously disclosed in the Company’s<div style="display:inline-block;width:5px"> </div>2020 Form 10-K</div></div> 958000 0 958000 8473000 0 8473000 4527000 0 4527000 181000 0 181000 10467000 652000 11119000 30300000 -500000 29800000 2814000 270000 3084000 57720000 422000 58142000 183000 556000 739000 3482000 0 3482000 3665000 556000 4221000 54055000 -134000 53921000 0 -134000 -134000 958000 0 958000 53097000 0 53097000 P1Y 20000000.0 2900000 400000 100000 2400000 P17Y 500000 P1Y 0.49 16700000 1000000.0 700000 80000000.0 2500000 <div id="TextBlockContainer556" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:732px;height:349px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a4448" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 3 – Recently Issued Accounting Standards<div style="display:inline-block;width:4px"> </div></div><div id="a4455" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:26px;">Recently Issued Accounting Standards<div style="display:inline-block;width:5px"> </div>Adopted </div><div id="a4465" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:49px;">The Financial Accounting Standards Board (“FASB”)<div style="display:inline-block;width:5px"> </div>issued Account Standards Update (“ASU”)</div><div id="a4487" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:554px;top:49px;">ASU 2019-12</div><div id="a4490" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:629px;top:49px;">, Income Taxes </div><div id="a4492" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:64px;">(Topic<div style="display:inline-block;width:5px"> </div>740): Simplifying the Accounting for Income Taxes</div><div id="a4493" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:315px;top:64px;"><div style="display:inline-block;width:3px"> </div>in December 2019 to simplify the accounting for income taxes.<div style="display:inline-block;width:8px"> </div>The </div><div id="a4516" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:80px;">guidance within this accounting standard update removes<div style="display:inline-block;width:5px"> </div>certain exceptions, including the exception to the incremental approach for </div><div id="a4551" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:95px;">certain intra-period tax allocations, to the requirement to recognize<div style="display:inline-block;width:5px"> </div>or not recognize certain deferred tax liabilities for equity method </div><div id="a4591" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:110px;">investments and foreign subsidiaries, and to the general methodology for<div style="display:inline-block;width:5px"> </div>calculating income taxes in an interim period when a year-to-</div><div id="a4634" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:126px;">date loss exceeds the anticipated loss for the year.<div style="display:inline-block;width:8px"> </div>Further, the guidance simplifies the accounting related<div style="display:inline-block;width:5px"> </div>to franchise taxes, the step </div><div id="a4676" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:141px;">up in tax basis for goodwill, current and deferred tax expense, and codification<div style="display:inline-block;width:5px"> </div>improvements for income taxes related to employee </div><div id="a4717" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:156px;">stock ownership plans.<div style="display:inline-block;width:7px"> </div>The guidance is effective for annual and interim periods beginning<div style="display:inline-block;width:5px"> </div>after December 15, 2020.<div style="display:inline-block;width:7px"> </div>The Company </div><div id="a4755" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:172px;">adopted this standard on a prospective basis, effective January<div style="display:inline-block;width:5px"> </div>1, 2021.<div style="display:inline-block;width:7px"> </div>There was no cumulative effect of adoption recorded within </div><div id="a4797" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:187px;">retained earnings on January 1, 2021. </div><div id="a4811" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:210px;">The FASB issued ASU 2020<div style="display:inline-block;width:2px"> </div>-04, </div><div id="a4823" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:207px;top:210px;">Reference Rate Reform (Topic<div style="display:inline-block;width:6px"> </div>848): Facilitation of the Effects of Reference Rate Reform<div style="display:inline-block;width:5px"> </div>on </div><div id="a4851" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:226px;">Financial Reporting</div><div id="a4854" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:113px;top:226px;"><div style="display:inline-block;width:3px"> </div>in March 2020.<div style="display:inline-block;width:7px"> </div>The FASB subsequently<div style="display:inline-block;width:5px"> </div>issued ASU 2021-01, </div><div id="a4876" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:457px;top:226px;">Reference Rate Reform (Topic<div style="display:inline-block;width:5px"> </div>848): Scope</div><div id="a4887" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:686px;top:226px;"><div style="display:inline-block;width:3px"> </div>in </div><div id="a4890" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:241px;">January 2021 which clarified the guidance but did not materially change<div style="display:inline-block;width:5px"> </div>the guidance or its applicability to the Company.<div style="display:inline-block;width:8px"> </div>The </div><div id="a4931" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:256px;">amendments provide temporary optional expedients and exceptions<div style="display:inline-block;width:5px"> </div>for applying U.S. GAAP to contract modifications, hedging </div><div id="a4962" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:272px;">relationships and other transactions to ease the potential accounting<div style="display:inline-block;width:5px"> </div>and financial reporting burden associated with transitioning away </div><div id="a4996" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:287px;">from reference rates that are expected to be discontinued, including<div style="display:inline-block;width:5px"> </div>the London Interbank Offered Rate (“LIBOR”).<div style="display:inline-block;width:8px"> </div>ASU 2020-04 is </div><div id="a5037" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:302px;">effective for the Company as of March 12, 2020 and generally can<div style="display:inline-block;width:5px"> </div>be applied through December 31, 2022.<div style="display:inline-block;width:7px"> </div>As of September 30, 2021, </div><div id="a5084" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:318px;">the expedients provided in ASU 2020-04 do not presently impact<div style="display:inline-block;width:5px"> </div>the Company; however, the Company will continue<div style="display:inline-block;width:5px"> </div>to monitor for </div><div id="a5126" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:333px;">potential impacts on its consolidated financial statements.</div></div> <div id="TextBlockContainer560" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:729px;height:200px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5140" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 4 – Business Segments </div><div id="div_558_XBRL_TS_2d4a2c3dfae3439ebf761d2e8084c05f" style="position:absolute;left:0px;top:23px;float:left;"><div id="TextBlockContainer559" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:729px;height:92px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5145" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The Company’s operating<div style="display:inline-block;width:5px"> </div>segments, which are consistent with its reportable segments, reflect the structure of the<div style="display:inline-block;width:5px"> </div>Company’s </div><div id="a5148" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">internal organization, the method by which the Company’s<div style="display:inline-block;width:5px"> </div>resources are allocated and the manner by which the chief operating </div><div id="a5149" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">decision maker assesses the Company’s<div style="display:inline-block;width:5px"> </div>performance.<div style="display:inline-block;width:7px"> </div>The Company has </div><div id="a5149_68_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:398px;top:31px;">four</div><div id="a5149_72_53" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:420px;top:31px;"><div style="display:inline-block;width:3px"> </div>reportable segments: (i) Americas; (ii) EMEA; (iii) </div><div id="a5153" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">Asia/Pacific; and (iv) Global Specialty Businesses.<div style="display:inline-block;width:8px"> </div>The three geographic segments are composed of the net sales and operations in </div><div id="a5155" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">each respective region, excluding net sales and operations managed globally<div style="display:inline-block;width:5px"> </div>by the Global Specialty Businesses segment, which </div><div id="a5157" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">includes the Company’s container,<div style="display:inline-block;width:5px"> </div>metal finishing, mining, offshore, specialty coatings, specialty grease<div style="display:inline-block;width:5px"> </div>and Norman Hay businesses.</div></div></div><div id="a5165" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:123px;">Segment operating earnings for each of the Company’s<div style="display:inline-block;width:5px"> </div>reportable segments are comprised of the segment’s<div style="display:inline-block;width:5px"> </div>net sales less directly </div><div id="a5176" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:139px;">related COGS and selling, general and administrative expenses (“SG&amp;A”).<div style="display:inline-block;width:8px"> </div>Operating expenses not directly attributable to the net </div><div id="a5180" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:154px;">sales of each respective segment, such as certain corporate and administrative costs, Combination,<div style="display:inline-block;width:5px"> </div>integration and other acquisition-</div><div id="a5183" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:169px;">related expenses, and Restructuring and related charges,<div style="display:inline-block;width:5px"> </div>are not included in segment operating earnings.<div style="display:inline-block;width:7px"> </div>Other items not specifically </div><div id="a5188" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:185px;">identified with the Company’s reportable<div style="display:inline-block;width:5px"> </div>segments include interest expense, net and other income (expense), net.</div></div><div id="TextBlockContainer562" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:706px;height:32px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5209" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The following table presents information about the performance of the Company’s<div style="display:inline-block;width:6px"> </div>reportable segments for the three and nine </div><div id="a5211" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">months ended September 30, 2021 and 2020.</div></div><div id="TextBlockContainer565" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:460px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5220" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:387px;top:0px;">Three Months Ended </div><div id="a5223" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:578px;top:0px;">Nine Months Ended </div><div id="a5227" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:407px;top:17px;">September 30, </div><div id="a5230" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:594px;top:17px;">September 30, </div><div id="a5234" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:387px;top:34px;">2021 </div><div id="a5237" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:482px;top:34px;">2020 </div><div id="a5240" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:575px;top:34px;">2021 </div><div id="a5243" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:668px;top:34px;">2020 </div><div id="a5245" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:51px;">Net sales </div><div id="a5247" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:51px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5250" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:51px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5252" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:51px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5254" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:464px;top:51px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5256" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:538px;top:51px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5258" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:51px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5260" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:557px;top:51px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5262" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:51px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5264" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:51px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5266" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:51px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5269" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:68px;">Americas </div><div id="a5271" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:68px;">$ </div><div id="a5273" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:68px;">150,799</div><div id="a5276" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:68px;">$ </div><div id="a5278" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:68px;">119,540</div><div id="a5281" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:68px;">$ </div><div id="a5283" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:68px;">425,343</div><div id="a5286" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:68px;">$ </div><div id="a5288" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:68px;">330,012</div><div id="a5291" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:85px;">EMEA </div><div id="a5293" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:85px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5295" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:85px;">122,241</div><div id="a5298" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:85px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5300" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:85px;">94,005</div><div id="a5303" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:85px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5305" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:85px;">365,491</div><div id="a5308" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:85px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5310" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:85px;">276,546</div><div id="a5313" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:102px;">Asia/Pacific </div><div id="a5315" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:102px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5317" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:102px;">98,659</div><div id="a5320" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:102px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5322" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:102px;">84,877</div><div id="a5325" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:102px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5327" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:102px;">286,924</div><div id="a5330" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:102px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5332" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:102px;">226,850</div><div id="a5335" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:119px;">Global Specialty Businesses </div><div id="a5337" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:119px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5339" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:119px;">77,373</div><div id="a5342" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:119px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5344" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:119px;">68,802</div><div id="a5347" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:119px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5349" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:119px;">236,359</div><div id="a5352" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:119px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5354" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:119px;">198,417</div><div id="a5356" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:137px;">Total net sales </div><div id="a5358" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:137px;">$ </div><div id="a5360" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:137px;">449,072</div><div id="a5363" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:137px;">$ </div><div id="a5365" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:137px;">367,224</div><div id="a5368" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:137px;">$ </div><div id="a5370" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:137px;">1,314,117</div><div id="a5373" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:137px;">$ </div><div id="a5375" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:665px;top:137px;">1,031,825</div><div id="a5390" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:172px;">Segment operating earnings </div><div id="a5404" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:189px;">Americas </div><div id="a5406" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:189px;">$ </div><div id="a5408" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:189px;">31,273</div><div id="a5411" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:189px;">$ </div><div id="a5413" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:189px;">31,099</div><div id="a5416" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:189px;">$ </div><div id="a5418" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:589px;top:189px;">97,155</div><div id="a5421" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:189px;">$ </div><div id="a5423" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:189px;">70,590</div><div id="a5426" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:206px;">EMEA </div><div id="a5429" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:206px;">20,153</div><div id="a5433" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:206px;">17,439</div><div id="a5437" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:589px;top:206px;">68,802</div><div id="a5441" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:206px;">46,269</div><div id="a5444" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:223px;">Asia/Pacific </div><div id="a5447" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:223px;">23,285</div><div id="a5451" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:223px;">27,304</div><div id="a5455" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:589px;top:223px;">73,990</div><div id="a5459" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:223px;">66,106</div><div id="a5462" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:240px;">Global Specialty Businesses </div><div id="a5464" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:240px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5466" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:240px;">20,663</div><div id="a5469" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:240px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5471" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:240px;">21,161</div><div id="a5474" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:240px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5476" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:589px;top:240px;">69,041</div><div id="a5479" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:240px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5481" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:240px;">58,114</div><div id="a5483" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:257px;">Total segment operating<div style="display:inline-block;width:5px"> </div>earnings </div><div id="a5485" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:257px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5487" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:257px;">95,374</div><div id="a5490" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:257px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5492" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:257px;">97,003</div><div id="a5495" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:257px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5497" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:257px;">308,988</div><div id="a5500" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:257px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5502" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:257px;">241,079</div><div id="a5504" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:274px;">Combination, integration and other acquisition-related expenses </div><div id="a5510" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:403px;top:274px;display:flex;">(5,786)</div><div id="a5514" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:498px;top:274px;display:flex;">(6,913)</div><div id="a5518" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:584px;top:274px;display:flex;">(18,259)</div><div id="a5522" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:274px;display:flex;">(22,786)</div><div id="a5524" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:291px;">Restructuring and related charges </div><div id="a5528" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:418px;top:291px;">880</div><div id="a5532" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:498px;top:291px;display:flex;">(1,383)</div><div id="a5536" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:291px;display:flex;">(593)</div><div id="a5540" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:684px;top:291px;display:flex;">(3,585)</div><div id="a5542" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:308px;">Fair value step up of acquired inventory sold<div style="display:inline-block;width:2px"> </div></div><div id="a5546" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:424px;top:308px;">—</div><div id="a5550" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:308px;">—</div><div id="a5554" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:308px;display:flex;">(801)</div><div id="a5558" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:694px;top:308px;display:flex;">(226)</div><div id="a5560" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:325px;">Indefinite-lived intangible asset impairment </div><div id="a5566" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:424px;top:325px;">—</div><div id="a5570" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:325px;">—</div><div id="a5574" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:612px;top:325px;">—</div><div id="a5578" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:325px;display:flex;">(38,000)</div><div id="a5580" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:342px;">Non-operating and administrative expenses </div><div id="a5585" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:342px;display:flex;">(38,691)</div><div id="a5589" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:491px;top:342px;display:flex;">(39,786)</div><div id="a5593" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:578px;top:342px;display:flex;">(122,760)</div><div id="a5597" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:342px;display:flex;">(110,282)</div><div id="a5599" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:359px;">Depreciation<div style="display:inline-block;width:4px"> </div>of corporate assets and amortization </div><div id="a5602" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:359px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5604" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:359px;display:flex;">(15,767)</div><div id="a5607" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:359px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5609" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:491px;top:359px;display:flex;">(14,062)</div><div id="a5612" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:359px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5614" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:584px;top:359px;display:flex;">(46,855)</div><div id="a5617" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:359px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5619" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:359px;display:flex;">(41,547)</div><div id="a5621" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:376px;">Operating income </div><div id="a5624" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:376px;">36,010</div><div id="a5628" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:376px;">34,859</div><div id="a5632" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:376px;">119,720</div><div id="a5636" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:376px;">24,653</div><div id="a5638" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:393px;">Other income (expense), net </div><div id="a5641" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:418px;top:393px;">647</div><div id="a5645" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:508px;top:393px;display:flex;">(239)</div><div id="a5649" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:589px;top:393px;">19,344</div><div id="a5653" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:393px;display:flex;">(22,407)</div><div id="a5655" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:410px;">Interest expense, net </div><div id="a5657" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:410px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5659" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:403px;top:410px;display:flex;">(5,637)</div><div id="a5663" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:410px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5665" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:498px;top:410px;display:flex;">(6,837)</div><div id="a5668" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:410px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5670" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:584px;top:410px;display:flex;">(16,725)</div><div id="a5673" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:410px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5675" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:410px;display:flex;">(22,109)</div><div id="a5677" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:427px;">Income (loss) before taxes and equity in net income of </div><div id="a5691" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:444px;">associated companies </div><div id="a5693" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:444px;">$ </div><div id="a5695" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:444px;">31,020</div><div id="a5698" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:444px;">$ </div><div id="a5700" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:444px;">27,783</div><div id="a5703" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:444px;">$ </div><div id="a5705" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:444px;">122,339</div><div id="a5708" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:444px;">$ </div><div id="a5710" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:444px;display:flex;">(19,863)</div></div><div id="TextBlockContainer568" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:93px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5712" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Inter-segment revenues for the three and nine months ended September<div style="display:inline-block;width:5px"> </div>30, 2021 were $</div><div id="a5712_84_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:498px;top:0px;">3.6</div><div id="a5712_87_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:515px;top:0px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a5712_101_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:589px;top:0px;">9.3</div><div id="a5712_104_23" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:606px;top:0px;"><div style="display:inline-block;width:3px"> </div>million for Americas, </div><div id="a5735" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">$</div><div id="a5735_1_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:11px;top:15px;">6.8</div><div id="a5735_4_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:15px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a5735_18_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:102px;top:15px;">21.9</div><div id="a5735_22_20" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:126px;top:15px;"><div style="display:inline-block;width:3px"> </div>million for EMEA, $</div><div id="a5735_42_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:241px;top:15px;">0.8</div><div id="a5735_45_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:258px;top:15px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a5735_59_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:332px;top:15px;">1.3</div><div id="a5735_62_32" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:349px;top:15px;"><div style="display:inline-block;width:3px"> </div>million for Asia/Pacific, and $</div><div id="a5735_94_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:514px;top:15px;">1.8</div><div id="a5735_97_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:531px;top:15px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a5735_111_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:605px;top:15px;">5.9</div><div id="a5735_114_20" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:622px;top:15px;"><div style="display:inline-block;width:3px"> </div>million for Global </div><div id="a5744" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Specialty Businesses, respectively.<div style="display:inline-block;width:8px"> </div>Inter-segment revenues for the three and nine months ended<div style="display:inline-block;width:5px"> </div>September 30, 2020 were $</div><div id="a5744_121_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:667px;top:31px;">1.7</div><div id="a5759" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">million and $</div><div id="a5759_13_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:76px;top:46px;">7.0</div><div id="a5759_16_24" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:92px;top:46px;"><div style="display:inline-block;width:3px"> </div>million for Americas, $</div><div id="a5759_40_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:221px;top:46px;">5.3</div><div id="a5759_43_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:237px;top:46px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a5759_57_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:312px;top:46px;">16.1</div><div id="a5759_61_20" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:335px;top:46px;"><div style="display:inline-block;width:3px"> </div>million for EMEA, $</div><div id="a5759_81_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:46px;">0.2</div><div id="a5759_84_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:467px;top:46px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a5759_98_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:46px;">0.5</div><div id="a5759_101_31" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:558px;top:46px;"><div style="display:inline-block;width:3px"> </div>million for Asia/Pacific, and </div><div id="a5785" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">$</div><div id="a5785_1_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:11px;top:61px;">1.1</div><div id="a5785_4_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:61px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a5785_18_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:102px;top:61px;">3.4</div><div id="a5785_21_107" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:119px;top:61px;"><div style="display:inline-block;width:3px"> </div>million for Global Specialty Businesses, respectively.<div style="display:inline-block;width:9px"> </div>However, all inter-segment<div style="display:inline-block;width:5px"> </div>transactions have been </div><div id="a5791" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">eliminated from each reportable operating segment’s<div style="display:inline-block;width:5px"> </div>net sales and earnings for all periods presented in the above tables.</div></div> <div id="TextBlockContainer559" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:729px;height:92px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5145" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The Company’s operating<div style="display:inline-block;width:5px"> </div>segments, which are consistent with its reportable segments, reflect the structure of the<div style="display:inline-block;width:5px"> </div>Company’s </div><div id="a5148" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">internal organization, the method by which the Company’s<div style="display:inline-block;width:5px"> </div>resources are allocated and the manner by which the chief operating </div><div id="a5149" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">decision maker assesses the Company’s<div style="display:inline-block;width:5px"> </div>performance.<div style="display:inline-block;width:7px"> </div>The Company has </div><div id="a5149_68_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:398px;top:31px;">four</div><div id="a5149_72_53" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:420px;top:31px;"><div style="display:inline-block;width:3px"> </div>reportable segments: (i) Americas; (ii) EMEA; (iii) </div><div id="a5153" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">Asia/Pacific; and (iv) Global Specialty Businesses.<div style="display:inline-block;width:8px"> </div>The three geographic segments are composed of the net sales and operations in </div><div id="a5155" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">each respective region, excluding net sales and operations managed globally<div style="display:inline-block;width:5px"> </div>by the Global Specialty Businesses segment, which </div><div id="a5157" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">includes the Company’s container,<div style="display:inline-block;width:5px"> </div>metal finishing, mining, offshore, specialty coatings, specialty grease<div style="display:inline-block;width:5px"> </div>and Norman Hay businesses.</div></div> 4 <div id="TextBlockContainer566" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:460px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_564_XBRL_TS_d064a6ad78bf47a78fd8b64142fe0633" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer565" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:460px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5220" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:387px;top:0px;">Three Months Ended </div><div id="a5223" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:578px;top:0px;">Nine Months Ended </div><div id="a5227" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:407px;top:17px;">September 30, </div><div id="a5230" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:594px;top:17px;">September 30, </div><div id="a5234" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:387px;top:34px;">2021 </div><div id="a5237" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:482px;top:34px;">2020 </div><div id="a5240" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:575px;top:34px;">2021 </div><div id="a5243" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:668px;top:34px;">2020 </div><div id="a5245" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:51px;">Net sales </div><div id="a5247" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:51px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5250" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:51px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5252" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:51px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5254" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:464px;top:51px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5256" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:538px;top:51px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5258" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:51px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5260" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:557px;top:51px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5262" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:51px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5264" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:51px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5266" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:51px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5269" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:68px;">Americas </div><div id="a5271" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:68px;">$ </div><div id="a5273" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:68px;">150,799</div><div id="a5276" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:68px;">$ </div><div id="a5278" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:68px;">119,540</div><div id="a5281" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:68px;">$ </div><div id="a5283" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:68px;">425,343</div><div id="a5286" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:68px;">$ </div><div id="a5288" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:68px;">330,012</div><div id="a5291" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:85px;">EMEA </div><div id="a5293" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:85px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5295" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:85px;">122,241</div><div id="a5298" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:85px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5300" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:85px;">94,005</div><div id="a5303" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:85px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5305" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:85px;">365,491</div><div id="a5308" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:85px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5310" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:85px;">276,546</div><div id="a5313" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:102px;">Asia/Pacific </div><div id="a5315" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:102px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5317" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:102px;">98,659</div><div id="a5320" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:102px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5322" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:102px;">84,877</div><div id="a5325" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:102px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5327" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:102px;">286,924</div><div id="a5330" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:102px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5332" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:102px;">226,850</div><div id="a5335" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:119px;">Global Specialty Businesses </div><div id="a5337" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:119px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5339" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:119px;">77,373</div><div id="a5342" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:119px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5344" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:119px;">68,802</div><div id="a5347" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:119px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5349" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:119px;">236,359</div><div id="a5352" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:119px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5354" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:119px;">198,417</div><div id="a5356" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:137px;">Total net sales </div><div id="a5358" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:137px;">$ </div><div id="a5360" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:137px;">449,072</div><div id="a5363" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:137px;">$ </div><div id="a5365" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:137px;">367,224</div><div id="a5368" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:137px;">$ </div><div id="a5370" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:137px;">1,314,117</div><div id="a5373" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:137px;">$ </div><div id="a5375" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:665px;top:137px;">1,031,825</div><div id="a5390" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:172px;">Segment operating earnings </div><div id="a5404" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:189px;">Americas </div><div id="a5406" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:189px;">$ </div><div id="a5408" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:189px;">31,273</div><div id="a5411" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:189px;">$ </div><div id="a5413" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:189px;">31,099</div><div id="a5416" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:189px;">$ </div><div id="a5418" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:589px;top:189px;">97,155</div><div id="a5421" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:189px;">$ </div><div id="a5423" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:189px;">70,590</div><div id="a5426" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:206px;">EMEA </div><div id="a5429" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:206px;">20,153</div><div id="a5433" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:206px;">17,439</div><div id="a5437" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:589px;top:206px;">68,802</div><div id="a5441" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:206px;">46,269</div><div id="a5444" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:223px;">Asia/Pacific </div><div id="a5447" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:223px;">23,285</div><div id="a5451" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:223px;">27,304</div><div id="a5455" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:589px;top:223px;">73,990</div><div id="a5459" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:223px;">66,106</div><div id="a5462" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:240px;">Global Specialty Businesses </div><div id="a5464" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:240px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5466" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:240px;">20,663</div><div id="a5469" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:240px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5471" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:240px;">21,161</div><div id="a5474" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:240px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5476" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:589px;top:240px;">69,041</div><div id="a5479" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:240px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5481" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:240px;">58,114</div><div id="a5483" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:257px;">Total segment operating<div style="display:inline-block;width:5px"> </div>earnings </div><div id="a5485" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:257px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5487" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:257px;">95,374</div><div id="a5490" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:257px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5492" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:257px;">97,003</div><div id="a5495" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:257px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5497" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:257px;">308,988</div><div id="a5500" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:257px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5502" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:257px;">241,079</div><div id="a5504" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:274px;">Combination, integration and other acquisition-related expenses </div><div id="a5510" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:403px;top:274px;display:flex;">(5,786)</div><div id="a5514" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:498px;top:274px;display:flex;">(6,913)</div><div id="a5518" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:584px;top:274px;display:flex;">(18,259)</div><div id="a5522" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:274px;display:flex;">(22,786)</div><div id="a5524" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:291px;">Restructuring and related charges </div><div id="a5528" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:418px;top:291px;">880</div><div id="a5532" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:498px;top:291px;display:flex;">(1,383)</div><div id="a5536" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:291px;display:flex;">(593)</div><div id="a5540" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:684px;top:291px;display:flex;">(3,585)</div><div id="a5542" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:308px;">Fair value step up of acquired inventory sold<div style="display:inline-block;width:2px"> </div></div><div id="a5546" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:424px;top:308px;">—</div><div id="a5550" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:308px;">—</div><div id="a5554" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:308px;display:flex;">(801)</div><div id="a5558" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:694px;top:308px;display:flex;">(226)</div><div id="a5560" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:325px;">Indefinite-lived intangible asset impairment </div><div id="a5566" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:424px;top:325px;">—</div><div id="a5570" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:325px;">—</div><div id="a5574" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:612px;top:325px;">—</div><div id="a5578" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:325px;display:flex;">(38,000)</div><div id="a5580" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:342px;">Non-operating and administrative expenses </div><div id="a5585" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:342px;display:flex;">(38,691)</div><div id="a5589" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:491px;top:342px;display:flex;">(39,786)</div><div id="a5593" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:578px;top:342px;display:flex;">(122,760)</div><div id="a5597" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:342px;display:flex;">(110,282)</div><div id="a5599" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:359px;">Depreciation<div style="display:inline-block;width:4px"> </div>of corporate assets and amortization </div><div id="a5602" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:359px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5604" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:359px;display:flex;">(15,767)</div><div id="a5607" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:359px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5609" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:491px;top:359px;display:flex;">(14,062)</div><div id="a5612" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:359px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5614" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:584px;top:359px;display:flex;">(46,855)</div><div id="a5617" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:359px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5619" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:359px;display:flex;">(41,547)</div><div id="a5621" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:376px;">Operating income </div><div id="a5624" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:376px;">36,010</div><div id="a5628" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:376px;">34,859</div><div id="a5632" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:376px;">119,720</div><div id="a5636" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:376px;">24,653</div><div id="a5638" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:393px;">Other income (expense), net </div><div id="a5641" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:418px;top:393px;">647</div><div id="a5645" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:508px;top:393px;display:flex;">(239)</div><div id="a5649" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:589px;top:393px;">19,344</div><div id="a5653" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:393px;display:flex;">(22,407)</div><div id="a5655" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:410px;">Interest expense, net </div><div id="a5657" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:410px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5659" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:403px;top:410px;display:flex;">(5,637)</div><div id="a5663" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:410px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5665" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:498px;top:410px;display:flex;">(6,837)</div><div id="a5668" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:410px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5670" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:584px;top:410px;display:flex;">(16,725)</div><div id="a5673" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:410px;"><div style="display:inline-block;width:3px"> </div></div><div id="a5675" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:410px;display:flex;">(22,109)</div><div id="a5677" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:427px;">Income (loss) before taxes and equity in net income of </div><div id="a5691" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:444px;">associated companies </div><div id="a5693" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:444px;">$ </div><div id="a5695" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:444px;">31,020</div><div id="a5698" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:444px;">$ </div><div id="a5700" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:444px;">27,783</div><div id="a5703" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:444px;">$ </div><div id="a5705" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:444px;">122,339</div><div id="a5708" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:444px;">$ </div><div id="a5710" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:444px;display:flex;">(19,863)</div></div></div></div> 150799000 119540000 425343000 330012000 122241000 94005000 365491000 276546000 98659000 84877000 286924000 226850000 77373000 68802000 236359000 198417000 449072000 367224000 1314117000 1031825000 31273000 31099000 97155000 70590000 20153000 17439000 68802000 46269000 23285000 27304000 73990000 66106000 20663000 21161000 69041000 58114000 95374000 97003000 308988000 241079000 5786000 6913000 18259000 22786000 -880000 1383000 593000 3585000 0 0 801000 226000 0 0 0 38000000 38691000 39786000 122760000 110282000 15767000 14062000 46855000 41547000 36010000 34859000 119720000 24653000 647000 -239000 19344000 -22407000 -5637000 -6837000 -16725000 -22109000 31020000 27783000 122339000 -19863000 3600000 9300000 6800000 21900000 800000 1300000 1800000 5900000 1700000 7000000.0 5300000 16100000 200000 500000 1100000 3400000 <div id="TextBlockContainer572" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:213px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5800" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 5 – Net Sales and Revenue Recognition </div><div id="a5805" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:26px;">Business Description </div><div id="a5809" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:51px;">The Company develops, produces, and markets a broad range of formulated<div style="display:inline-block;width:5px"> </div>chemical specialty products and offers chemical </div><div id="a5843" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:67px;">management services (“Fluidcare”) for various heavy industrial and<div style="display:inline-block;width:5px"> </div>manufacturing applications throughout its four segments.<div style="display:inline-block;width:8px"> </div>A </div><div id="a5873" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:82px;">significant portion of the Company’s<div style="display:inline-block;width:5px"> </div>revenues are realized from the sale of process fluids and services made directly<div style="display:inline-block;width:5px"> </div>to manufacturers </div><div id="a5914" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:97px;">through its own employees and its Fluidcare programs, with the balance<div style="display:inline-block;width:5px"> </div>being handled through distributors and agents. </div><div id="div_570_XBRL_TS_d17e07890735413b9ed379261b113b27" style="position:absolute;left:0px;top:121px;float:left;"><div id="TextBlockContainer571" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5948" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">As part of the Company’s Fluidcare<div style="display:inline-block;width:5px"> </div>business, certain third-party product sales to customers are managed by<div style="display:inline-block;width:5px"> </div>the Company.<div style="display:inline-block;width:8px"> </div>Where </div><div id="a5988" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">the Company acts as a principal, revenues are recognized on a gross reporting<div style="display:inline-block;width:5px"> </div>basis at the selling price negotiated with its customers. </div><div id="a6032" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Where the Company acts as an agent, revenue is recognized on a net reporting<div style="display:inline-block;width:5px"> </div>basis at the amount of the administrative fee earned by </div><div id="a6081" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">the Company for ordering the goods.</div></div></div><div id="a6081_35_96" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:202px;top:167px;"><div style="display:inline-block;width:7px"> </div>The Company transferred third-party products under arrangements recognized<div style="display:inline-block;width:5px"> </div>on a net reporting </div><div id="a6119" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:182px;">basis of $</div><div id="a6119_10_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:56px;top:182px;">18.9</div><div id="a6119_14_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:79px;top:182px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a6119_28_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:153px;top:182px;">53.4</div><div id="a6119_32_84" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:177px;top:182px;"><div style="display:inline-block;width:3px"> </div>million for the three and nine months ended September 30, 2021, respectively,<div style="display:inline-block;width:6px"> </div>and $</div><div id="a6119_116_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:631px;top:182px;">11.1</div><div id="a6119_120_13" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:182px;"><div style="display:inline-block;width:3px"> </div>million and </div><div id="a6166" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:197px;">$</div><div id="a6166_1_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:11px;top:197px;">29.9</div><div id="a6166_5_78" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:35px;top:197px;"><div style="display:inline-block;width:3px"> </div>million for the three and nine months ended September 30, 2020, respectively.</div></div><div id="TextBlockContainer582" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:559px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a6211" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">As previously disclosed in the Company’s<div style="display:inline-block;width:5px"> </div>2020 Form 10-K, during 2020, the Company’s<div style="display:inline-block;width:5px"> </div>five largest customers (each composed </div><div id="a6249" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">of multiple subsidiaries or divisions with semiautonomous purchasing<div style="display:inline-block;width:5px"> </div>authority) accounted for approximately </div><div id="a6249_108_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:594px;top:15px;">10</div><div id="a6249_110_22" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:608px;top:15px;">% of consolidated net </div><div id="a6281" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">sales, with its largest customer accounting for approximately </div><div id="a6281_62_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:332px;top:31px;">3</div><div id="a6281_63_28" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:339px;top:31px;">% of consolidated net sales.</div><div id="a6309" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:51px;">Revenue Recognition Model </div><div id="div_574_XBRL_TS_7f1b69d053e84e68863a7323eefc10a6" style="position:absolute;left:0px;top:72px;float:left;"><div id="TextBlockContainer575" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:732px;height:77px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a6315" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The Company applies the five-step model in the FASB’s<div style="display:inline-block;width:6px"> </div>guidance, which requires the Company to: (i) identify the<div style="display:inline-block;width:5px"> </div>contract with a </div><div id="a6360" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">customer; (ii) identify the performance obligations in the contract; (iii)<div style="display:inline-block;width:5px"> </div>determine the transaction price; (iv) allocate the transaction </div><div id="a6396" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">price to the performance obligations in the contract; and (v) recognize<div style="display:inline-block;width:5px"> </div>revenue when, or as, the Company satisfies a performance </div><div id="a6437" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">obligation.<div style="display:inline-block;width:7px"> </div>Refer to the Company’s 2020 Form 10-K<div style="display:inline-block;width:5px"> </div>for additional information on the Company’s<div style="display:inline-block;width:5px"> </div>revenue recognition policies, </div><div id="a6473" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">including its practical expedients and accounting policy elections.</div></div></div><div id="a6473_67_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:356px;top:133px;"><div style="display:inline-block;width:7px"> </div></div><div id="a6490" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:154px;">Allowance for Doubtful Accounts </div><div id="a6498" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:175px;">As previously disclosed in the Company’s<div style="display:inline-block;width:5px"> </div>2020 Form 10-K, during 2020, the Company adopted, as required, an accounting </div><div id="a6537" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:190px;">standard update related to the accounting and disclosure of credit losses effective<div style="display:inline-block;width:5px"> </div>January 1, 2020.<div style="display:inline-block;width:7px"> </div></div><div id="div_576_XBRL_TS_009a771f8de1409ca2878f0dba49ffff" style="position:absolute;left:0px;top:190px;float:left;"><div id="TextBlockContainer577" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:725px;height:108px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a6537_102_26" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:535px;top:0px;">The Company recognizes an </div><div id="a6575" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">allowance for credit losses, which represents the portion of its trade accounts<div style="display:inline-block;width:5px"> </div>receivable that the Company does not expect to collect </div><div id="a6618" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">over the contractual life, considering past events and reasonable and<div style="display:inline-block;width:5px"> </div>supportable forecasts of future economic conditions.<div style="display:inline-block;width:8px"> </div>The </div><div id="a6652" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">Company’s allowance for<div style="display:inline-block;width:5px"> </div>credit losses on its trade accounts receivables is based on specific collectability facts and circumstances<div style="display:inline-block;width:5px"> </div>for </div><div id="a6691" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">each outstanding receivable and customer,<div style="display:inline-block;width:5px"> </div>the aging of outstanding receivables, and the associated collection risk the<div style="display:inline-block;width:5px"> </div>Company </div><div id="a6725" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">estimates for certain past due aging categories, and also, the general risk<div style="display:inline-block;width:5px"> </div>to all outstanding accounts receivable based on historical </div><div id="a6766" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:92px;">amounts determined to be uncollectible.<div style="display:inline-block;width:7px"> </div>The Company does not have any off-balance-sheet credit exposure<div style="display:inline-block;width:5px"> </div>related to its customers.</div></div></div><div id="a6806" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:303px;">Contract Assets and Liabilities </div><div id="div_578_XBRL_TS_fe9af32a63e14009b4c828997777e961" style="position:absolute;left:0px;top:323px;float:left;"><div id="TextBlockContainer579" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a6814" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The Company recognizes a contract asset or receivable on its Condensed<div style="display:inline-block;width:5px"> </div>Consolidated Balance Sheet when the Company </div><div id="a6848" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">performs a service or transfers a good in advance of receiving consideration.<div style="display:inline-block;width:8px"> </div>A receivable is the Company’s right to<div style="display:inline-block;width:5px"> </div>consideration that </div><div id="a6891" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">is unconditional and only the passage of time is required before payment<div style="display:inline-block;width:5px"> </div>of that consideration is due.<div style="display:inline-block;width:7px"> </div>A contract asset is the </div><div id="a6935" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">Company’s right to consideration<div style="display:inline-block;width:5px"> </div>in exchange for goods or services that the Company has transferred to a customer.</div></div></div><div id="a6935_114_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:624px;top:369px;"><div style="display:inline-block;width:7px"> </div>The Company </div><div id="a6976" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:385px;">had no material contract assets recorded on its Condensed Consolidated<div style="display:inline-block;width:5px"> </div>Balance Sheets as of September 30, 2021 or December 31, </div><div id="a7016" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:400px;">2020. </div><div id="div_580_XBRL_TS_503fa992adb44a1a87eed7ffcb482bc1" style="position:absolute;left:0px;top:421px;float:left;"><div id="TextBlockContainer581" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:92px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a7018" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">A contract liability is recognized when the Company receives consideration,<div style="display:inline-block;width:5px"> </div>or if it has the unconditional right to receive </div><div id="a7056" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">consideration, in advance of performance.<div style="display:inline-block;width:8px"> </div>A contract liability is the Company’s<div style="display:inline-block;width:5px"> </div>obligation to transfer goods or services to a customer </div><div id="a7097" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">for which the Company has received consideration, or a specified amount<div style="display:inline-block;width:5px"> </div>of consideration is due, from the customer.<div style="display:inline-block;width:8px"> </div>The Company’s </div><div id="a7137" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">contract liabilities primarily represent deferred revenue recorded<div style="display:inline-block;width:5px"> </div>for customer payments received by the Company prior to the </div><div id="a7171" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">Company satisfying the associated performance obligation.<div style="display:inline-block;width:8px"> </div>Deferred revenues are presented within other current liabilities in the </div><div id="a7203" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">Company’s Condensed Consolidated<div style="display:inline-block;width:5px"> </div>Balance Sheets.</div></div></div><div id="a7203_48_33" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:290px;top:497px;"><div style="display:inline-block;width:7px"> </div>The Company had approximately $</div><div id="a7203_81_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:486px;top:497px;">4.4</div><div id="a7203_84_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:502px;top:497px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a7203_98_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:577px;top:497px;">4.0</div><div id="a7203_101_21" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:594px;top:497px;"><div style="display:inline-block;width:3px"> </div>million of deferred </div><div id="a7237" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:513px;">revenue as of September 30, 2021 and December 31, 2020, respectively.<div style="display:inline-block;width:9px"> </div>For the nine months ended September 30, 2021, the </div><div id="a7277" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:528px;">Company satisfied all of the associated performance obligations<div style="display:inline-block;width:5px"> </div>and recognized into revenue the advance payments received and </div><div id="a7311" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:543px;">recorded as of December 31, 2020.</div></div><div id="TextBlockContainer584" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:701px;height:54px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a7324" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Disaggregated Revenue </div><div id="a7328" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The following tables disaggregate the Company’s<div style="display:inline-block;width:5px"> </div>net sales by segment, geographic region, customer industry,<div style="display:inline-block;width:5px"> </div>and timing of </div><div id="a7331" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">revenue recognized for the three and nine months ended September 30, 2021<div style="display:inline-block;width:5px"> </div>and 2020.</div></div><div id="TextBlockContainer588" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:724px;height:237px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_586_XBRL_TS_43f51b4a4250448299c1a96d9b13264b" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer587" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:724px;height:237px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a7335" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:374px;top:0px;">Three Months Ended September 30, 2021 </div><div id="a7346" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:630px;top:17px;">Consolidated </div><div id="a7349" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:289px;top:31px;">Americas </div><div id="a7352" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:414px;top:31px;">EMEA </div><div id="a7355" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:518px;top:31px;">Asia/Pacific </div><div id="a7358" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:653px;top:31px;">Total </div><div id="a7360" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:48px;">Customer Industries </div><div id="a7373" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:65px;">Metals </div><div id="a7375" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:66px;">$</div><div id="a7377" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:66px;">56,954</div><div id="a7380" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:66px;">$ </div><div id="a7382" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:66px;">38,483</div><div id="a7385" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:66px;">$</div><div id="a7387" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:66px;">53,994</div><div id="a7390" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:66px;">$</div><div id="a7392" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:66px;">149,431</div><div id="a7394" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:82px;">Metalworking and other </div><div id="a7397" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:83px;">93,845</div><div id="a7401" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:83px;">83,758</div><div id="a7405" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:83px;">44,665</div><div id="a7409" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:83px;">222,268</div><div id="a7413" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:100px;">150,799</div><div id="a7417" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:100px;">122,241</div><div id="a7421" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:100px;">98,659</div><div id="a7425" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:100px;">371,699</div><div id="a7427" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:117px;">Global Specialty Businesses </div><div id="a7430" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:117px;">46,008</div><div id="a7434" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:117px;">19,253</div><div id="a7438" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:117px;">12,112</div><div id="a7442" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:678px;top:117px;">77,373</div><div id="a7445" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:135px;">$</div><div id="a7447" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:135px;">196,807</div><div id="a7450" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:135px;">$ </div><div id="a7452" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:135px;">141,494</div><div id="a7455" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:135px;">$</div><div id="a7457" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:135px;">110,771</div><div id="a7460" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:135px;">$</div><div id="a7462" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:135px;">449,072</div><div id="a7476" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:169px;">Timing of Revenue Recognized </div><div id="a7489" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:186px;">Product sales at a point in time </div><div id="a7491" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:187px;">$</div><div id="a7493" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:187px;">188,340</div><div id="a7496" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:187px;">$ </div><div id="a7498" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:187px;">131,982</div><div id="a7501" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:187px;">$</div><div id="a7503" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:187px;">108,559</div><div id="a7506" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:187px;">$</div><div id="a7508" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:187px;">428,881</div><div id="a7510" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:203px;">Services transferred over time </div><div id="a7513" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:204px;">8,467</div><div id="a7517" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:451px;top:204px;">9,512</div><div id="a7521" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:204px;">2,212</div><div id="a7525" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:678px;top:204px;">20,191</div><div id="a7528" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:222px;">$</div><div id="a7530" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:222px;">196,807</div><div id="a7533" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:222px;">$ </div><div id="a7535" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:222px;">141,494</div><div id="a7538" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:222px;">$</div><div id="a7540" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:222px;">110,771</div><div id="a7543" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:222px;">$</div><div id="a7545" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:222px;">449,072</div></div></div></div><div id="TextBlockContainer592" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:724px;height:238px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_590_XBRL_TS_e827bdefc5814e158d311304bd3850f2" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer591" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:724px;height:238px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a7566" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:374px;top:0px;">Three Months Ended September 30, 2020 </div><div id="a7577" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:630px;top:17px;">Consolidated </div><div id="a7580" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:289px;top:31px;">Americas </div><div id="a7583" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:414px;top:31px;">EMEA </div><div id="a7586" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:518px;top:31px;">Asia/Pacific </div><div id="a7589" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:653px;top:31px;">Total </div><div id="a7591" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:48px;">Customer Industries </div><div id="a7604" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:65px;">Metals </div><div id="a7606" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:66px;">$</div><div id="a7608" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:66px;">42,098</div><div id="a7611" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:66px;">$ </div><div id="a7613" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:66px;">25,362</div><div id="a7616" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:66px;">$</div><div id="a7618" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:66px;">45,001</div><div id="a7621" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:66px;">$</div><div id="a7623" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:66px;">112,461</div><div id="a7625" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:82px;">Metalworking and other </div><div id="a7628" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:83px;">77,442</div><div id="a7632" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:83px;">68,643</div><div id="a7636" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:83px;">39,876</div><div id="a7640" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:83px;">185,961</div><div id="a7644" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:100px;">119,540</div><div id="a7648" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:100px;">94,005</div><div id="a7652" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:100px;">84,877</div><div id="a7656" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:100px;">298,422</div><div id="a7658" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:116px;">Global Specialty Businesses </div><div id="a7661" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:116px;">39,197</div><div id="a7665" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:116px;">17,429</div><div id="a7669" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:116px;">12,176</div><div id="a7673" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:678px;top:116px;">68,802</div><div id="a7676" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:135px;">$</div><div id="a7678" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:134px;">158,737</div><div id="a7681" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:135px;">$ </div><div id="a7683" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:134px;">111,434</div><div id="a7686" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:135px;">$</div><div id="a7688" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:134px;">97,053</div><div id="a7691" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:135px;">$</div><div id="a7693" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:134px;">367,224</div><div id="a7707" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:169px;">Timing of Revenue Recognized </div><div id="a7720" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:186px;">Product sales at a point in time </div><div id="a7722" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:187px;">$</div><div id="a7724" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:187px;">153,820</div><div id="a7727" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:187px;">$ </div><div id="a7729" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:187px;">107,093</div><div id="a7732" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:187px;">$</div><div id="a7734" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:187px;">94,660</div><div id="a7737" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:187px;">$</div><div id="a7739" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:187px;">355,573</div><div id="a7741" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:203px;">Services transferred over time </div><div id="a7744" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:204px;">4,917</div><div id="a7748" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:451px;top:204px;">4,341</div><div id="a7752" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:204px;">2,393</div><div id="a7756" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:678px;top:204px;">11,651</div><div id="a7759" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:222px;">$</div><div id="a7761" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:221px;">158,737</div><div id="a7764" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:222px;">$ </div><div id="a7766" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:221px;">111,434</div><div id="a7769" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:222px;">$</div><div id="a7771" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:221px;">97,053</div><div id="a7774" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:222px;">$</div><div id="a7776" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:221px;">367,224</div></div></div></div><div id="TextBlockContainer596" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:724px;height:236px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_594_XBRL_TS_7fe1438acf704b80a13dec2774db7b64" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer595" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:724px;height:236px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a7780" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:377px;top:0px;">Nine Months Ended September 30, 2021 </div><div id="a7792" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:630px;top:17px;">Consolidated </div><div id="a7795" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:289px;top:31px;">Americas </div><div id="a7798" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:414px;top:31px;">EMEA </div><div id="a7801" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:518px;top:31px;">Asia/Pacific </div><div id="a7804" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:653px;top:31px;">Total </div><div id="a7806" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:47px;">Customer Industries </div><div id="a7819" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:64px;">Metals </div><div id="a7821" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:65px;">$</div><div id="a7823" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:65px;">155,546</div><div id="a7826" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:65px;">$ </div><div id="a7828" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:65px;">108,391</div><div id="a7831" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:65px;">$</div><div id="a7833" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:65px;">151,944</div><div id="a7836" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:65px;">$</div><div id="a7838" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:65px;">415,881</div><div id="a7840" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:81px;">Metalworking and other </div><div id="a7843" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:82px;">269,797</div><div id="a7847" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:82px;">257,100</div><div id="a7851" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:82px;">134,980</div><div id="a7855" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:82px;">661,877</div><div id="a7859" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:99px;">425,343</div><div id="a7863" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:99px;">365,491</div><div id="a7867" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:99px;">286,924</div><div id="a7871" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:99px;">1,077,758</div><div id="a7873" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:116px;">Global Specialty Businesses </div><div id="a7876" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:116px;">137,447</div><div id="a7880" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:116px;">61,203</div><div id="a7884" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:116px;">37,709</div><div id="a7888" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:116px;">236,359</div><div id="a7891" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:134px;">$</div><div id="a7893" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:134px;">562,790</div><div id="a7896" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:134px;">$ </div><div id="a7898" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:134px;">426,694</div><div id="a7901" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:134px;">$</div><div id="a7903" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:134px;">324,633</div><div id="a7906" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:134px;">$</div><div id="a7908" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:134px;">1,314,117</div><div id="a7922" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:168px;">Timing of Revenue Recognized </div><div id="a7935" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:185px;">Product sales at a point in time </div><div id="a7937" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:186px;">$</div><div id="a7939" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:186px;">537,161</div><div id="a7942" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:186px;">$ </div><div id="a7944" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:186px;">400,982</div><div id="a7947" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:186px;">$</div><div id="a7949" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:186px;">316,222</div><div id="a7952" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:186px;">$</div><div id="a7954" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:186px;">1,254,365</div><div id="a7956" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:202px;">Services transferred over time </div><div id="a7959" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:203px;">25,629</div><div id="a7963" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:203px;">25,712</div><div id="a7967" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:203px;">8,411</div><div id="a7971" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:678px;top:203px;">59,752</div><div id="a7974" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:221px;">$</div><div id="a7976" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:221px;">562,790</div><div id="a7979" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:221px;">$ </div><div id="a7981" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:221px;">426,694</div><div id="a7984" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:221px;">$</div><div id="a7986" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:221px;">324,633</div><div id="a7989" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:221px;">$</div><div id="a7991" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:221px;">1,314,117</div></div></div></div><div id="TextBlockContainer600" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:724px;height:237px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_598_XBRL_TS_c1b98bcf933f4ce6931137ba3813180d" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer599" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:724px;height:237px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a7995" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:377px;top:0px;">Nine Months Ended September 30, 2020 </div><div id="a8007" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:630px;top:17px;">Consolidated </div><div id="a8010" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:289px;top:31px;">Americas </div><div id="a8013" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:414px;top:31px;">EMEA </div><div id="a8016" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:518px;top:31px;">Asia/Pacific </div><div id="a8019" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:653px;top:31px;">Total </div><div id="a8021" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:48px;">Customer Industries </div><div id="a8034" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:65px;">Metals </div><div id="a8036" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:66px;">$</div><div id="a8038" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:65px;">121,458</div><div id="a8041" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:66px;">$ </div><div id="a8043" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:65px;">80,174</div><div id="a8046" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:66px;">$</div><div id="a8048" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:65px;">122,006</div><div id="a8051" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:66px;">$</div><div id="a8053" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:65px;">323,638</div><div id="a8055" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:82px;">Metalworking and other </div><div id="a8058" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:82px;">208,554</div><div id="a8062" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:82px;">196,372</div><div id="a8066" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:82px;">104,844</div><div id="a8070" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:82px;">509,770</div><div id="a8074" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:99px;">330,012</div><div id="a8078" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:99px;">276,546</div><div id="a8082" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:99px;">226,850</div><div id="a8086" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:99px;">833,408</div><div id="a8088" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:117px;">Global Specialty Businesses </div><div id="a8091" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:116px;">115,722</div><div id="a8095" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:116px;">49,603</div><div id="a8099" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:116px;">33,092</div><div id="a8103" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:116px;">198,417</div><div id="a8106" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:135px;">$</div><div id="a8108" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:134px;">445,734</div><div id="a8111" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:135px;">$ </div><div id="a8113" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:134px;">326,149</div><div id="a8116" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:135px;">$</div><div id="a8118" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:134px;">259,942</div><div id="a8121" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:135px;">$</div><div id="a8123" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:134px;">1,031,825</div><div id="a8137" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:169px;">Timing of Revenue Recognized </div><div id="a8150" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:186px;">Product sales at a point in time </div><div id="a8152" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:187px;">$</div><div id="a8154" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:186px;">431,266</div><div id="a8157" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:187px;">$ </div><div id="a8159" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:186px;">313,511</div><div id="a8162" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:187px;">$</div><div id="a8164" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:186px;">254,011</div><div id="a8167" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:187px;">$</div><div id="a8169" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:186px;">998,788</div><div id="a8171" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:203px;">Services transferred over time </div><div id="a8174" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:203px;">14,468</div><div id="a8178" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:203px;">12,638</div><div id="a8182" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:203px;">5,931</div><div id="a8186" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:678px;top:203px;">33,037</div><div id="a8189" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:222px;">$</div><div id="a8191" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:221px;">445,734</div><div id="a8194" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:222px;">$ </div><div id="a8196" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:221px;">326,149</div><div id="a8199" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:222px;">$</div><div id="a8201" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:221px;">259,942</div><div id="a8204" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:222px;">$</div><div id="a8206" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:221px;">1,031,825</div></div></div></div> <div id="TextBlockContainer571" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a5948" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">As part of the Company’s Fluidcare<div style="display:inline-block;width:5px"> </div>business, certain third-party product sales to customers are managed by<div style="display:inline-block;width:5px"> </div>the Company.<div style="display:inline-block;width:8px"> </div>Where </div><div id="a5988" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">the Company acts as a principal, revenues are recognized on a gross reporting<div style="display:inline-block;width:5px"> </div>basis at the selling price negotiated with its customers. </div><div id="a6032" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Where the Company acts as an agent, revenue is recognized on a net reporting<div style="display:inline-block;width:5px"> </div>basis at the amount of the administrative fee earned by </div><div id="a6081" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">the Company for ordering the goods.</div></div> 18900000 53400000 11100000 29900000 0.10 0.03 <div id="TextBlockContainer575" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:732px;height:77px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a6315" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The Company applies the five-step model in the FASB’s<div style="display:inline-block;width:6px"> </div>guidance, which requires the Company to: (i) identify the<div style="display:inline-block;width:5px"> </div>contract with a </div><div id="a6360" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">customer; (ii) identify the performance obligations in the contract; (iii)<div style="display:inline-block;width:5px"> </div>determine the transaction price; (iv) allocate the transaction </div><div id="a6396" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">price to the performance obligations in the contract; and (v) recognize<div style="display:inline-block;width:5px"> </div>revenue when, or as, the Company satisfies a performance </div><div id="a6437" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">obligation.<div style="display:inline-block;width:7px"> </div>Refer to the Company’s 2020 Form 10-K<div style="display:inline-block;width:5px"> </div>for additional information on the Company’s<div style="display:inline-block;width:5px"> </div>revenue recognition policies, </div><div id="a6473" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">including its practical expedients and accounting policy elections.</div></div><div id="TextBlockContainer579" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a6814" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The Company recognizes a contract asset or receivable on its Condensed<div style="display:inline-block;width:5px"> </div>Consolidated Balance Sheet when the Company </div><div id="a6848" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">performs a service or transfers a good in advance of receiving consideration.<div style="display:inline-block;width:8px"> </div>A receivable is the Company’s right to<div style="display:inline-block;width:5px"> </div>consideration that </div><div id="a6891" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">is unconditional and only the passage of time is required before payment<div style="display:inline-block;width:5px"> </div>of that consideration is due.<div style="display:inline-block;width:7px"> </div>A contract asset is the </div><div id="a6935" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">Company’s right to consideration<div style="display:inline-block;width:5px"> </div>in exchange for goods or services that the Company has transferred to a customer.</div></div><div id="TextBlockContainer581" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:92px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a7018" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">A contract liability is recognized when the Company receives consideration,<div style="display:inline-block;width:5px"> </div>or if it has the unconditional right to receive </div><div id="a7056" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">consideration, in advance of performance.<div style="display:inline-block;width:8px"> </div>A contract liability is the Company’s<div style="display:inline-block;width:5px"> </div>obligation to transfer goods or services to a customer </div><div id="a7097" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">for which the Company has received consideration, or a specified amount<div style="display:inline-block;width:5px"> </div>of consideration is due, from the customer.<div style="display:inline-block;width:8px"> </div>The Company’s </div><div id="a7137" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">contract liabilities primarily represent deferred revenue recorded<div style="display:inline-block;width:5px"> </div>for customer payments received by the Company prior to the </div><div id="a7171" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">Company satisfying the associated performance obligation.<div style="display:inline-block;width:8px"> </div>Deferred revenues are presented within other current liabilities in the </div><div id="a7203" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">Company’s Condensed Consolidated<div style="display:inline-block;width:5px"> </div>Balance Sheets.</div></div> <div id="TextBlockContainer577" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:725px;height:108px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a6537_102_26" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:535px;top:0px;">The Company recognizes an </div><div id="a6575" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">allowance for credit losses, which represents the portion of its trade accounts<div style="display:inline-block;width:5px"> </div>receivable that the Company does not expect to collect </div><div id="a6618" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">over the contractual life, considering past events and reasonable and<div style="display:inline-block;width:5px"> </div>supportable forecasts of future economic conditions.<div style="display:inline-block;width:8px"> </div>The </div><div id="a6652" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">Company’s allowance for<div style="display:inline-block;width:5px"> </div>credit losses on its trade accounts receivables is based on specific collectability facts and circumstances<div style="display:inline-block;width:5px"> </div>for </div><div id="a6691" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">each outstanding receivable and customer,<div style="display:inline-block;width:5px"> </div>the aging of outstanding receivables, and the associated collection risk the<div style="display:inline-block;width:5px"> </div>Company </div><div id="a6725" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">estimates for certain past due aging categories, and also, the general risk<div style="display:inline-block;width:5px"> </div>to all outstanding accounts receivable based on historical </div><div id="a6766" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:92px;">amounts determined to be uncollectible.<div style="display:inline-block;width:7px"> </div>The Company does not have any off-balance-sheet credit exposure<div style="display:inline-block;width:5px"> </div>related to its customers.</div></div> 4400000 4000000.0 <div id="TextBlockContainer587" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:724px;height:237px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a7335" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:374px;top:0px;">Three Months Ended September 30, 2021 </div><div id="a7346" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:630px;top:17px;">Consolidated </div><div id="a7349" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:289px;top:31px;">Americas </div><div id="a7352" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:414px;top:31px;">EMEA </div><div id="a7355" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:518px;top:31px;">Asia/Pacific </div><div id="a7358" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:653px;top:31px;">Total </div><div id="a7360" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:48px;">Customer Industries </div><div id="a7373" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:65px;">Metals </div><div id="a7375" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:66px;">$</div><div id="a7377" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:66px;">56,954</div><div id="a7380" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:66px;">$ </div><div id="a7382" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:66px;">38,483</div><div id="a7385" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:66px;">$</div><div id="a7387" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:66px;">53,994</div><div id="a7390" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:66px;">$</div><div id="a7392" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:66px;">149,431</div><div id="a7394" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:82px;">Metalworking and other </div><div id="a7397" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:83px;">93,845</div><div id="a7401" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:83px;">83,758</div><div id="a7405" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:83px;">44,665</div><div id="a7409" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:83px;">222,268</div><div id="a7413" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:100px;">150,799</div><div id="a7417" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:100px;">122,241</div><div id="a7421" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:100px;">98,659</div><div id="a7425" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:100px;">371,699</div><div id="a7427" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:117px;">Global Specialty Businesses </div><div id="a7430" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:117px;">46,008</div><div id="a7434" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:117px;">19,253</div><div id="a7438" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:117px;">12,112</div><div id="a7442" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:678px;top:117px;">77,373</div><div id="a7445" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:135px;">$</div><div id="a7447" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:135px;">196,807</div><div id="a7450" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:135px;">$ </div><div id="a7452" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:135px;">141,494</div><div id="a7455" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:135px;">$</div><div id="a7457" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:135px;">110,771</div><div id="a7460" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:135px;">$</div><div id="a7462" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:135px;">449,072</div><div id="a7476" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:169px;">Timing of Revenue Recognized </div><div id="a7489" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:186px;">Product sales at a point in time </div><div id="a7491" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:187px;">$</div><div id="a7493" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:187px;">188,340</div><div id="a7496" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:187px;">$ </div><div id="a7498" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:187px;">131,982</div><div id="a7501" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:187px;">$</div><div id="a7503" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:187px;">108,559</div><div id="a7506" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:187px;">$</div><div id="a7508" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:187px;">428,881</div><div id="a7510" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:203px;">Services transferred over time </div><div id="a7513" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:204px;">8,467</div><div id="a7517" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:451px;top:204px;">9,512</div><div id="a7521" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:204px;">2,212</div><div id="a7525" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:678px;top:204px;">20,191</div><div id="a7528" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:222px;">$</div><div id="a7530" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:222px;">196,807</div><div id="a7533" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:222px;">$ </div><div id="a7535" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:222px;">141,494</div><div id="a7538" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:222px;">$</div><div id="a7540" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:222px;">110,771</div><div id="a7543" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:222px;">$</div><div id="a7545" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:222px;">449,072</div></div><div id="TextBlockContainer591" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:724px;height:238px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a7566" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:374px;top:0px;">Three Months Ended September 30, 2020 </div><div id="a7577" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:630px;top:17px;">Consolidated </div><div id="a7580" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:289px;top:31px;">Americas </div><div id="a7583" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:414px;top:31px;">EMEA </div><div id="a7586" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:518px;top:31px;">Asia/Pacific </div><div id="a7589" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:653px;top:31px;">Total </div><div id="a7591" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:48px;">Customer Industries </div><div id="a7604" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:65px;">Metals </div><div id="a7606" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:66px;">$</div><div id="a7608" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:66px;">42,098</div><div id="a7611" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:66px;">$ </div><div id="a7613" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:66px;">25,362</div><div id="a7616" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:66px;">$</div><div id="a7618" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:66px;">45,001</div><div id="a7621" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:66px;">$</div><div id="a7623" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:66px;">112,461</div><div id="a7625" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:82px;">Metalworking and other </div><div id="a7628" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:83px;">77,442</div><div id="a7632" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:83px;">68,643</div><div id="a7636" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:83px;">39,876</div><div id="a7640" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:83px;">185,961</div><div id="a7644" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:100px;">119,540</div><div id="a7648" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:100px;">94,005</div><div id="a7652" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:100px;">84,877</div><div id="a7656" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:100px;">298,422</div><div id="a7658" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:116px;">Global Specialty Businesses </div><div id="a7661" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:116px;">39,197</div><div id="a7665" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:116px;">17,429</div><div id="a7669" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:116px;">12,176</div><div id="a7673" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:678px;top:116px;">68,802</div><div id="a7676" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:135px;">$</div><div id="a7678" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:134px;">158,737</div><div id="a7681" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:135px;">$ </div><div id="a7683" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:134px;">111,434</div><div id="a7686" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:135px;">$</div><div id="a7688" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:134px;">97,053</div><div id="a7691" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:135px;">$</div><div id="a7693" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:134px;">367,224</div><div id="a7707" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:169px;">Timing of Revenue Recognized </div><div id="a7720" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:186px;">Product sales at a point in time </div><div id="a7722" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:187px;">$</div><div id="a7724" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:187px;">153,820</div><div id="a7727" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:187px;">$ </div><div id="a7729" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:187px;">107,093</div><div id="a7732" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:187px;">$</div><div id="a7734" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:187px;">94,660</div><div id="a7737" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:187px;">$</div><div id="a7739" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:187px;">355,573</div><div id="a7741" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:203px;">Services transferred over time </div><div id="a7744" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:204px;">4,917</div><div id="a7748" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:451px;top:204px;">4,341</div><div id="a7752" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:204px;">2,393</div><div id="a7756" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:678px;top:204px;">11,651</div><div id="a7759" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:222px;">$</div><div id="a7761" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:221px;">158,737</div><div id="a7764" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:222px;">$ </div><div id="a7766" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:221px;">111,434</div><div id="a7769" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:222px;">$</div><div id="a7771" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:221px;">97,053</div><div id="a7774" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:222px;">$</div><div id="a7776" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:221px;">367,224</div></div><div id="TextBlockContainer595" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:724px;height:236px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a7780" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:377px;top:0px;">Nine Months Ended September 30, 2021 </div><div id="a7792" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:630px;top:17px;">Consolidated </div><div id="a7795" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:289px;top:31px;">Americas </div><div id="a7798" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:414px;top:31px;">EMEA </div><div id="a7801" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:518px;top:31px;">Asia/Pacific </div><div id="a7804" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:653px;top:31px;">Total </div><div id="a7806" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:47px;">Customer Industries </div><div id="a7819" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:64px;">Metals </div><div id="a7821" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:65px;">$</div><div id="a7823" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:65px;">155,546</div><div id="a7826" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:65px;">$ </div><div id="a7828" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:65px;">108,391</div><div id="a7831" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:65px;">$</div><div id="a7833" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:65px;">151,944</div><div id="a7836" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:65px;">$</div><div id="a7838" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:65px;">415,881</div><div id="a7840" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:81px;">Metalworking and other </div><div id="a7843" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:82px;">269,797</div><div id="a7847" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:82px;">257,100</div><div id="a7851" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:82px;">134,980</div><div id="a7855" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:82px;">661,877</div><div id="a7859" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:99px;">425,343</div><div id="a7863" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:99px;">365,491</div><div id="a7867" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:99px;">286,924</div><div id="a7871" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:99px;">1,077,758</div><div id="a7873" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:116px;">Global Specialty Businesses </div><div id="a7876" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:116px;">137,447</div><div id="a7880" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:116px;">61,203</div><div id="a7884" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:116px;">37,709</div><div id="a7888" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:116px;">236,359</div><div id="a7891" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:134px;">$</div><div id="a7893" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:134px;">562,790</div><div id="a7896" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:134px;">$ </div><div id="a7898" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:134px;">426,694</div><div id="a7901" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:134px;">$</div><div id="a7903" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:134px;">324,633</div><div id="a7906" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:134px;">$</div><div id="a7908" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:134px;">1,314,117</div><div id="a7922" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:168px;">Timing of Revenue Recognized </div><div id="a7935" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:185px;">Product sales at a point in time </div><div id="a7937" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:186px;">$</div><div id="a7939" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:186px;">537,161</div><div id="a7942" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:186px;">$ </div><div id="a7944" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:186px;">400,982</div><div id="a7947" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:186px;">$</div><div id="a7949" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:186px;">316,222</div><div id="a7952" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:186px;">$</div><div id="a7954" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:186px;">1,254,365</div><div id="a7956" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:202px;">Services transferred over time </div><div id="a7959" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:203px;">25,629</div><div id="a7963" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:203px;">25,712</div><div id="a7967" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:203px;">8,411</div><div id="a7971" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:678px;top:203px;">59,752</div><div id="a7974" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:221px;">$</div><div id="a7976" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:221px;">562,790</div><div id="a7979" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:221px;">$ </div><div id="a7981" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:221px;">426,694</div><div id="a7984" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:221px;">$</div><div id="a7986" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:221px;">324,633</div><div id="a7989" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:221px;">$</div><div id="a7991" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:221px;">1,314,117</div></div><div id="TextBlockContainer599" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:724px;height:237px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a7995" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:377px;top:0px;">Nine Months Ended September 30, 2020 </div><div id="a8007" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:630px;top:17px;">Consolidated </div><div id="a8010" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:289px;top:31px;">Americas </div><div id="a8013" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:414px;top:31px;">EMEA </div><div id="a8016" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:518px;top:31px;">Asia/Pacific </div><div id="a8019" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:653px;top:31px;">Total </div><div id="a8021" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:48px;">Customer Industries </div><div id="a8034" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:65px;">Metals </div><div id="a8036" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:66px;">$</div><div id="a8038" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:65px;">121,458</div><div id="a8041" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:66px;">$ </div><div id="a8043" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:65px;">80,174</div><div id="a8046" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:66px;">$</div><div id="a8048" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:65px;">122,006</div><div id="a8051" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:66px;">$</div><div id="a8053" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:65px;">323,638</div><div id="a8055" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:82px;">Metalworking and other </div><div id="a8058" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:82px;">208,554</div><div id="a8062" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:82px;">196,372</div><div id="a8066" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:82px;">104,844</div><div id="a8070" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:82px;">509,770</div><div id="a8074" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:99px;">330,012</div><div id="a8078" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:99px;">276,546</div><div id="a8082" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:99px;">226,850</div><div id="a8086" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:99px;">833,408</div><div id="a8088" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:117px;">Global Specialty Businesses </div><div id="a8091" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:116px;">115,722</div><div id="a8095" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:116px;">49,603</div><div id="a8099" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:116px;">33,092</div><div id="a8103" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:116px;">198,417</div><div id="a8106" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:135px;">$</div><div id="a8108" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:134px;">445,734</div><div id="a8111" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:135px;">$ </div><div id="a8113" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:134px;">326,149</div><div id="a8116" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:135px;">$</div><div id="a8118" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:134px;">259,942</div><div id="a8121" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:135px;">$</div><div id="a8123" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:134px;">1,031,825</div><div id="a8137" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:169px;">Timing of Revenue Recognized </div><div id="a8150" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:186px;">Product sales at a point in time </div><div id="a8152" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:187px;">$</div><div id="a8154" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:186px;">431,266</div><div id="a8157" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:187px;">$ </div><div id="a8159" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:186px;">313,511</div><div id="a8162" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:187px;">$</div><div id="a8164" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:186px;">254,011</div><div id="a8167" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:187px;">$</div><div id="a8169" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:186px;">998,788</div><div id="a8171" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:203px;">Services transferred over time </div><div id="a8174" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:203px;">14,468</div><div id="a8178" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:203px;">12,638</div><div id="a8182" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:203px;">5,931</div><div id="a8186" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:678px;top:203px;">33,037</div><div id="a8189" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:222px;">$</div><div id="a8191" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:221px;">445,734</div><div id="a8194" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:222px;">$ </div><div id="a8196" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:221px;">326,149</div><div id="a8199" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:222px;">$</div><div id="a8201" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:221px;">259,942</div><div id="a8204" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:222px;">$</div><div id="a8206" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:221px;">1,031,825</div></div> 56954000 38483000 53994000 149431000 93845000 83758000 44665000 222268000 150799000 122241000 98659000 371699000 46008000 19253000 12112000 77373000 196807000 141494000 110771000 449072000 188340000 131982000 108559000 428881000 8467000 9512000 2212000 20191000 196807000 141494000 110771000 449072000 42098000 25362000 45001000 112461000 77442000 68643000 39876000 185961000 119540000 94005000 84877000 298422000 39197000 17429000 12176000 68802000 158737000 111434000 97053000 367224000 153820000 107093000 94660000 355573000 4917000 4341000 2393000 11651000 158737000 111434000 97053000 367224000 155546000 108391000 151944000 415881000 269797000 257100000 134980000 661877000 425343000 365491000 286924000 1077758000 137447000 61203000 37709000 236359000 562790000 426694000 324633000 1314117000 537161000 400982000 316222000 1254365000 25629000 25712000 8411000 59752000 562790000 426694000 324633000 1314117000 121458000 80174000 122006000 323638000 208554000 196372000 104844000 509770000 330012000 276546000 226850000 833408000 115722000 49603000 33092000 198417000 445734000 326149000 259942000 1031825000 431266000 313511000 254011000 998788000 14468000 12638000 5931000 33037000 445734000 326149000 259942000 1031825000 <div id="TextBlockContainer604" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:732px;height:293px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8225" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 6 – Leases </div><div id="div_602_XBRL_TS_8c06c8e1621448c4813235577e1c3604" style="position:absolute;left:0px;top:23px;float:left;"><div id="TextBlockContainer603" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:732px;height:78px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8230" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The Company determines if an arrangement is a lease at its inception.<div style="display:inline-block;width:8px"> </div>This determination generally depends on whether the </div><div id="a8268" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">arrangement conveys the right to control the use of an identified fixed asset explicitly<div style="display:inline-block;width:5px"> </div>or implicitly for a period of time in exchange for </div><div id="a8317" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">consideration.<div style="display:inline-block;width:7px"> </div>Control of an underlying asset is conveyed if the Company obtains the rights to direct the<div style="display:inline-block;width:5px"> </div>use of, and obtains </div><div id="a8360" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">substantially all of the economic benefits from the use of, the underlying<div style="display:inline-block;width:5px"> </div>asset.<div style="display:inline-block;width:7px"> </div>Lease expense for variable leases and short-term </div><div id="a8402" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">leases is recognized when the obligation is incurred.</div></div></div><div id="a8419" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:108px;">The Company has operating leases for certain facilities, vehicles and machinery<div style="display:inline-block;width:5px"> </div>and equipment with remaining lease terms up to </div><div id="a8457" style="position:absolute;font-family:'Times New Roman';left:4px;top:123px;">10 years</div><div id="a8457_8_89" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:49px;top:123px;">.<div style="display:inline-block;width:7px"> </div>In addition, the Company has certain land use leases with remaining lease terms up<div style="display:inline-block;width:5px"> </div>to </div><div id="a8457_97_8" style="position:absolute;font-family:'Times New Roman';left:520px;top:123px;">94 years</div><div id="a8457_105_33" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:565px;top:123px;">.<div style="display:inline-block;width:7px"> </div>The lease term for all of the </div><div id="a8510" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:139px;">Company’s leases includes the non<div style="display:inline-block;width:1px"> </div>-cancellable period of the lease plus any additional periods covered by an option<div style="display:inline-block;width:5px"> </div>to extend the lease </div><div id="a8554" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:154px;">that the Company is reasonably certain it will exercise.<div style="display:inline-block;width:8px"> </div>Operating leases are included in right of use lease assets, other current </div><div id="a8596" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:169px;">liabilities and long-term lease liabilities on the Condensed Consolidated<div style="display:inline-block;width:5px"> </div>Balance Sheet.<div style="display:inline-block;width:7px"> </div>Right of use lease assets and liabilities are </div><div id="a8636" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:185px;">recognized at each lease’s commencement<div style="display:inline-block;width:5px"> </div>date based on the present value of its lease payments over its respective lease term.<div style="display:inline-block;width:8px"> </div>The </div><div id="a8679" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:200px;">Company uses the stated borrowing rate for a lease when readily determinable.<div style="display:inline-block;width:8px"> </div>When a stated borrowing rate is not available in a </div><div id="a8723" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:215px;">lease agreement, the Company uses its incremental borrowing rate based on<div style="display:inline-block;width:5px"> </div>information available at the lease’s commencement<div style="display:inline-block;width:5px"> </div>date </div><div id="a8759" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:231px;">to determine the present value of its lease payments.<div style="display:inline-block;width:8px"> </div>In determining the incremental borrowing rate used to present value each of its </div><div id="a8804" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:246px;">leases, the Company considers certain information including fully<div style="display:inline-block;width:5px"> </div>secured borrowing rates readily available to the Company and its </div><div id="a8840" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:261px;">subsidiaries.<div style="display:inline-block;width:7px"> </div>The Company has immaterial finance leases, which are included in property,<div style="display:inline-block;width:6px"> </div>plant and equipment, current portion of </div><div id="a8878" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:277px;">long-term debt and long-term debt on the Condensed Consolidated Balance<div style="display:inline-block;width:5px"> </div>Sheet.</div></div><div id="TextBlockContainer606" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:726px;height:170px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8905" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Operating lease expense is recognized on a straight-line basis over the<div style="display:inline-block;width:5px"> </div>lease term.<div style="display:inline-block;width:7px"> </div>Operating lease expense for the three and nine </div><div id="a8949" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">months ended September 30, 2021 was $</div><div id="a8949_37_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:223px;top:15px;">3.4</div><div id="a8949_40_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:240px;top:15px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a8949_54_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:315px;top:15px;">10.6</div><div id="a8949_58_72" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:338px;top:15px;"><div style="display:inline-block;width:3px"> </div>million, respectively.<div style="display:inline-block;width:8px"> </div>Comparatively, operating<div style="display:inline-block;width:5px"> </div>lease expense for the </div><div id="a8991" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">three and nine months ended September 30, 2020 was $</div><div id="a8991_52_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:302px;top:31px;">3.7</div><div id="a8991_55_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:319px;top:31px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a8991_69_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:393px;top:31px;">10.6</div><div id="a8991_73_58" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:417px;top:31px;"><div style="display:inline-block;width:3px"> </div>million, respectively.<div style="display:inline-block;width:8px"> </div>Short-term lease expense for the </div><div id="a9035" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">three and nine months ended September 30, 2021 was $</div><div id="a9035_52_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:302px;top:46px;">0.2</div><div id="a9035_55_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:319px;top:46px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a9035_69_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:393px;top:46px;">0.8</div><div id="a9035_72_57" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:46px;"><div style="display:inline-block;width:3px"> </div>million, respectively.<div style="display:inline-block;width:8px"> </div>Comparatively, short-term<div style="display:inline-block;width:5px"> </div>lease </div><div id="a9077" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">expense for the three and nine months ended September 30, 2020<div style="display:inline-block;width:5px"> </div>was $</div><div id="a9077_68_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:387px;top:61px;">0.2</div><div id="a9077_71_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:61px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a9077_85_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:478px;top:61px;">1.1</div><div id="a9077_88_41" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:495px;top:61px;"><div style="display:inline-block;width:3px"> </div>million, respectively.<div style="display:inline-block;width:8px"> </div>The Company has </div><div id="a9121" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">no</div><div id="a9121_2_116" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:18px;top:77px;"><div style="display:inline-block;width:3px"> </div>material variable lease costs or sublease income for the three or nine months ended September<div style="display:inline-block;width:5px"> </div>30, 2021 and 2020.<div style="display:inline-block;width:7px"> </div></div><div id="a9163" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:100px;">Cash paid for operating leases during the nine months ended September 30, 2021<div style="display:inline-block;width:5px"> </div>and 2020 was $</div><div id="a9163_93_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:548px;top:100px;">10.4</div><div id="a9163_97_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:571px;top:100px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a9163_111_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:646px;top:100px;">10.5</div><div id="a9163_115_10" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:669px;top:100px;"><div style="display:inline-block;width:3px"> </div>million, </div><div id="a9206" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">respectively.<div style="display:inline-block;width:8px"> </div>The Company recorded new right of use lease assets and associated lease liabilities of $</div><div id="a9206_103_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:115px;">5.6</div><div id="a9206_106_25" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:564px;top:115px;"><div style="display:inline-block;width:3px"> </div>million during the nine </div><div id="a9250" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:131px;">months ended September 30, 2021.<div style="display:inline-block;width:7px"> </div></div><div id="a9262" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:154px;">Supplemental balance sheet information related to the Company’s<div style="display:inline-block;width:5px"> </div>leases is as follows:</div></div><div id="TextBlockContainer609" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:667px;height:169px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9289" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:476px;top:0px;">September 30, </div><div id="a9293" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:577px;top:0px;">December 31, </div><div id="a9297" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:504px;top:17px;">2021 </div><div id="a9300" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:603px;top:17px;">2020 </div><div id="a9303" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:35px;">Right of use lease assets </div><div id="a9305" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:35px;">$ </div><div id="a9307" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:35px;">34,314</div><div id="a9310" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:35px;">$ </div><div id="a9312" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:35px;">38,507</div><div id="a9322" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">Other current liabilities </div><div id="a9325" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:69px;">9,356</div><div id="a9329" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:69px;">10,901</div><div id="a9332" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:86px;">Long-term lease liabilities </div><div id="a9337" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:86px;">24,599</div><div id="a9341" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:86px;">27,070</div><div id="a9344" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:103px;">Total operating lease liabilities </div><div id="a9347" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:103px;">$ </div><div id="a9349" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:103px;">33,955</div><div id="a9352" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:103px;">$ </div><div id="a9354" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:103px;">37,971</div><div id="a9365" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:137px;">Weighted average<div style="display:inline-block;width:5px"> </div>remaining lease term (years) </div><div id="a9368" style="position:absolute;font-family:'Times New Roman';left:539px;top:137px;">5.7</div><div id="a9372" style="position:absolute;font-family:'Times New Roman';left:638px;top:137px;">6.0</div><div id="a9375" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:154px;">Weighted average<div style="display:inline-block;width:5px"> </div>discount rate </div><div id="a9378" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:154px;display:flex;">4.26%</div><div id="a9382" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:624px;top:154px;display:flex;">4.20%</div></div><div id="TextBlockContainer612" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:449px;height:16px;display:inline-block;"><div id="a9384" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">Maturities of operating lease liabilities as of September 30, 2021 were<div style="display:inline-block;width:5px"> </div>as follows:</div></div><div id="TextBlockContainer616" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:667px;height:183px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_614_XBRL_TS_0d579ae1d84049168fd116dbaa5385b9" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer615" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:667px;height:183px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9407" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:575px;top:0px;">September 30, </div><div id="a9411" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:603px;top:17px;">2021 </div><div id="a9414" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:33px;">For the remainder of 2021 </div><div id="a9416" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:33px;">$ </div><div id="a9418" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:33px;">2,978</div><div id="a9421" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:49px;">For the year ended December 31, 2022 </div><div id="a9424" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:48px;">9,695</div><div id="a9427" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:66px;">For the year ended December 31, 2023 </div><div id="a9430" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:65px;">7,564</div><div id="a9433" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:83px;">For the year ended December 31, 2024 </div><div id="a9436" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:82px;">5,623</div><div id="a9439" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">For the year ended December 31, 2025 </div><div id="a9442" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:99px;">4,340</div><div id="a9445" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:117px;">For the year ended December 31, 2026 and beyond </div><div id="a9448" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:116px;">8,104</div><div id="a9451" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:134px;">Total lease payments </div><div id="a9454" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:133px;">38,304</div><div id="a9457" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:151px;">Less: imputed interest </div><div id="a9460" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:620px;top:150px;display:flex;">(4,349)</div><div id="a9463" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:168px;">Present value of lease liabilities </div><div id="a9465" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:168px;">$ </div><div id="a9467" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:168px;">33,955</div></div></div></div> <div id="TextBlockContainer603" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:732px;height:78px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a8230" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The Company determines if an arrangement is a lease at its inception.<div style="display:inline-block;width:8px"> </div>This determination generally depends on whether the </div><div id="a8268" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">arrangement conveys the right to control the use of an identified fixed asset explicitly<div style="display:inline-block;width:5px"> </div>or implicitly for a period of time in exchange for </div><div id="a8317" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">consideration.<div style="display:inline-block;width:7px"> </div>Control of an underlying asset is conveyed if the Company obtains the rights to direct the<div style="display:inline-block;width:5px"> </div>use of, and obtains </div><div id="a8360" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">substantially all of the economic benefits from the use of, the underlying<div style="display:inline-block;width:5px"> </div>asset.<div style="display:inline-block;width:7px"> </div>Lease expense for variable leases and short-term </div><div id="a8402" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">leases is recognized when the obligation is incurred.</div></div> P10Y P94Y 3400000 10600000 3700000 10600000 200000 800000 200000 1100000 0 0 0 0 0 0 0 0 10400000 10500000 5600000 <div id="TextBlockContainer610" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:667px;height:169px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_608_XBRL_TS_28a22557745b422a8997cc4e07903877" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer609" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:667px;height:169px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9289" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:476px;top:0px;">September 30, </div><div id="a9293" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:577px;top:0px;">December 31, </div><div id="a9297" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:504px;top:17px;">2021 </div><div id="a9300" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:603px;top:17px;">2020 </div><div id="a9303" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:35px;">Right of use lease assets </div><div id="a9305" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:35px;">$ </div><div id="a9307" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:35px;">34,314</div><div id="a9310" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:35px;">$ </div><div id="a9312" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:35px;">38,507</div><div id="a9322" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">Other current liabilities </div><div id="a9325" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:69px;">9,356</div><div id="a9329" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:69px;">10,901</div><div id="a9332" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:86px;">Long-term lease liabilities </div><div id="a9337" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:86px;">24,599</div><div id="a9341" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:86px;">27,070</div><div id="a9344" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:103px;">Total operating lease liabilities </div><div id="a9347" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:103px;">$ </div><div id="a9349" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:103px;">33,955</div><div id="a9352" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:103px;">$ </div><div id="a9354" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:103px;">37,971</div><div id="a9365" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:137px;">Weighted average<div style="display:inline-block;width:5px"> </div>remaining lease term (years) </div><div id="a9368" style="position:absolute;font-family:'Times New Roman';left:539px;top:137px;">5.7</div><div id="a9372" style="position:absolute;font-family:'Times New Roman';left:638px;top:137px;">6.0</div><div id="a9375" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:154px;">Weighted average<div style="display:inline-block;width:5px"> </div>discount rate </div><div id="a9378" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:154px;display:flex;">4.26%</div><div id="a9382" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:624px;top:154px;display:flex;">4.20%</div></div></div></div> 34314000 38507000 9356000 10901000 24599000 27070000 33955000 37971000 P5Y8M12D P6Y 0.0426 0.0420 <div id="TextBlockContainer615" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:667px;height:183px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9407" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:575px;top:0px;">September 30, </div><div id="a9411" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:603px;top:17px;">2021 </div><div id="a9414" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:33px;">For the remainder of 2021 </div><div id="a9416" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:33px;">$ </div><div id="a9418" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:33px;">2,978</div><div id="a9421" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:49px;">For the year ended December 31, 2022 </div><div id="a9424" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:48px;">9,695</div><div id="a9427" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:66px;">For the year ended December 31, 2023 </div><div id="a9430" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:65px;">7,564</div><div id="a9433" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:83px;">For the year ended December 31, 2024 </div><div id="a9436" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:82px;">5,623</div><div id="a9439" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">For the year ended December 31, 2025 </div><div id="a9442" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:99px;">4,340</div><div id="a9445" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:117px;">For the year ended December 31, 2026 and beyond </div><div id="a9448" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:116px;">8,104</div><div id="a9451" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:134px;">Total lease payments </div><div id="a9454" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:133px;">38,304</div><div id="a9457" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:151px;">Less: imputed interest </div><div id="a9460" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:620px;top:150px;display:flex;">(4,349)</div><div id="a9463" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:168px;">Present value of lease liabilities </div><div id="a9465" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:168px;">$ </div><div id="a9467" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:168px;">33,955</div></div> 2978000 9695000 7564000 5623000 4340000 8104000 38304000 4349000 33955000 <div id="TextBlockContainer618" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:231px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9486" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 7 – Restructuring and Related Activities </div><div id="a9491" style="position:absolute;font-family:'Times New Roman';left:28px;top:23px;">The Company’s management approved a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost </div><div id="a9532" style="position:absolute;font-family:'Times New Roman';left:4px;top:39px;">synergies associated with the Combination in the third quarter of 2019. The QH Program includes restructuring and associated </div><div id="a9569" style="position:absolute;font-family:'Times New Roman';left:4px;top:54px;">severance costs to reduce total headcount by approximately 400 people globally, as well as plans for the closure of certain </div><div id="a9609" style="position:absolute;font-family:'Times New Roman';left:4px;top:69px;">manufacturing and non-manufacturing facilities. The exact timing and total costs associated with the QH Program will depend on a </div><div id="a9649" style="position:absolute;font-family:'Times New Roman';left:4px;top:85px;">number of factors and is subject to change; however, the Company currently expects reduction in headcount and site closures to </div><div id="a9689" style="position:absolute;font-family:'Times New Roman';left:4px;top:100px;">continue to occur throughout 2021 and into 2022 under the QH Program and estimates that anticipated cost synergies realized from the </div><div id="a9731" style="position:absolute;font-family:'Times New Roman';left:4px;top:115px;">QH Program will approximate one-times the restructuring costs incurred. Employee separation benefits will vary depending on local </div><div id="a9768" style="position:absolute;font-family:'Times New Roman';left:4px;top:131px;">regulations within certain foreign countries and will include severance and other benefits.</div><div id="a9792" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:154px;">All costs incurred to date relate to severance costs to reduce headcount,<div style="display:inline-block;width:5px"> </div>including customary and routine adjustments to initial </div><div id="a9794" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:169px;">estimates for employee separation costs, as well as costs to close certain facilities and<div style="display:inline-block;width:5px"> </div>are recorded in Restructuring and related </div><div id="a9796" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:185px;">charges in the Company’s<div style="display:inline-block;width:5px"> </div>Condensed Statements of Operations.<div style="display:inline-block;width:8px"> </div>As described in Note 4 of Notes to Condensed Consolidated </div><div id="a9800" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:200px;">Financial Statements, restructuring and related charges<div style="display:inline-block;width:5px"> </div>are not included in the Company’s calculation of<div style="display:inline-block;width:5px"> </div>reportable segments’ measure </div><div id="a9803" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:215px;">of operating earnings and therefore these costs are not reviewed by<div style="display:inline-block;width:5px"> </div>or recorded to reportable segments.</div></div><div id="TextBlockContainer620" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:716px;height:31px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9806" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Activity in the Company’s accrual<div style="display:inline-block;width:5px"> </div>for restructuring under the QH Program for the nine months ended September 30, 2021<div style="display:inline-block;width:5px"> </div>is as </div><div id="a9838" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">follows:</div></div><div id="TextBlockContainer624" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:664px;height:101px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_622_XBRL_TS_98558c94639649bc8d7319250ef31c9e" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer623" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:664px;height:101px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9843" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:577px;top:0px;">QH Program </div><div id="a9846" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:16px;">Accrued restructuring as of December 31, 2020 </div><div id="a9848" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:17px;">$ </div><div id="a9850" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:622px;top:17px;">8,248</div><div id="a9854" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:34px;">Restructuring and related charges </div><div id="a9857" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:631px;top:34px;">593</div><div id="a9861" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:51px;">Cash payments </div><div id="a9864" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:616px;top:51px;display:flex;">(4,557)</div><div id="a9868" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:68px;">Currency translation adjustments </div><div id="a9871" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:68px;"><div style="display:inline-block;width:3px"> </div></div><div id="a9873" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:68px;display:flex;">(234)</div><div id="a9876" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">Accrued restructuring as of September 30, 2021 </div><div id="a9878" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:86px;">$ </div><div id="a9880" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:621px;top:86px;">4,050</div></div></div></div> The Company’s management approved a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost synergies associated with the Combination in the third quarter of 2019. The QH Program includes restructuring and associated severance costs to reduce total headcount by approximately 400 people globally, as well as plans for the closure of certain manufacturing and non-manufacturing facilities. The exact timing and total costs associated with the QH Program will depend on a number of factors and is subject to change; however, the Company currently expects reduction in headcount and site closures to continue to occur throughout 2021 and into 2022 under the QH Program and estimates that anticipated cost synergies realized from the QH Program will approximate one-times the restructuring costs incurred. Employee separation benefits will vary depending on local regulations within certain foreign countries and will include severance and other benefits. 400 <div id="TextBlockContainer623" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:664px;height:101px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9843" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:577px;top:0px;">QH Program </div><div id="a9846" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:16px;">Accrued restructuring as of December 31, 2020 </div><div id="a9848" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:17px;">$ </div><div id="a9850" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:622px;top:17px;">8,248</div><div id="a9854" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:34px;">Restructuring and related charges </div><div id="a9857" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:631px;top:34px;">593</div><div id="a9861" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:51px;">Cash payments </div><div id="a9864" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:616px;top:51px;display:flex;">(4,557)</div><div id="a9868" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:16px;top:68px;">Currency translation adjustments </div><div id="a9871" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:68px;"><div style="display:inline-block;width:3px"> </div></div><div id="a9873" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:68px;display:flex;">(234)</div><div id="a9876" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">Accrued restructuring as of September 30, 2021 </div><div id="a9878" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:86px;">$ </div><div id="a9880" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:621px;top:86px;">4,050</div></div> 8248000 593000 4557000 234000 4050000 <div id="TextBlockContainer626" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:682px;height:54px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9882" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 8 – Share-Based Compensation </div><div id="a9889" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The Company recognized the following share-based compensation expense<div style="display:inline-block;width:5px"> </div>in its Condensed Consolidated Statements of </div><div id="a9894" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">Operations for the three and nine months ended September 30, 2021<div style="display:inline-block;width:5px"> </div>and 2020:</div></div><div id="TextBlockContainer630" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:727px;height:175px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_628_XBRL_TS_0ff0571e7d5d412983e1d5ea6802dcea" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer629" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:727px;height:175px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9906" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:387px;top:0px;">Three Months Ended </div><div id="a9909" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:578px;top:0px;">Nine Months Ended </div><div id="a9913" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:407px;top:18px;">September 30,<div style="display:inline-block;width:4px"> </div></div><div id="a9916" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:594px;top:18px;">September 30,<div style="display:inline-block;width:4px"> </div></div><div id="a9920" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:387px;top:35px;">2021 </div><div id="a9923" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:482px;top:35px;">2020 </div><div id="a9926" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:575px;top:35px;">2021 </div><div id="a9929" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:668px;top:35px;">2020 </div><div id="a9931" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:53px;">Stock options </div><div id="a9933" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:53px;">$ </div><div id="a9935" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:418px;top:53px;">298</div><div id="a9938" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:53px;">$ </div><div id="a9940" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:53px;">353</div><div id="a9943" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:53px;">$ </div><div id="a9945" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:606px;top:53px;">938</div><div id="a9948" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:53px;">$ </div><div id="a9950" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:689px;top:53px;">1,138</div><div id="a9952" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:70px;">Non-vested stock awards and restricted stock units </div><div id="a9957" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:408px;top:70px;">1,277</div><div id="a9961" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:503px;top:70px;">1,259</div><div id="a9965" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:596px;top:70px;">3,963</div><div id="a9969" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:689px;top:70px;">3,782</div><div id="a9971" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:88px;">Non-elective and elective 401(k) matching contribution in stock </div><div id="a9976" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:424px;top:88px;">—</div><div id="a9980" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:88px;">910</div><div id="a9984" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:596px;top:88px;">1,553</div><div id="a9988" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:689px;top:88px;">2,072</div><div id="a9990" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:106px;">Director stock ownership plan </div><div id="a9993" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:418px;top:106px;">241</div><div id="a9997" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:106px;">243</div><div id="a10001" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:606px;top:106px;">660</div><div id="a10005" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:699px;top:106px;">337</div><div id="a10007" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:123px;">Performance stock units </div><div id="a10010" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:418px;top:123px;">491</div><div id="a10014" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:123px;">280</div><div id="a10018" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:596px;top:123px;">1,327</div><div id="a10022" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:699px;top:123px;">560</div><div id="a10024" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:141px;">Annual incentive plan </div><div id="a10027" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:424px;top:141px;">—</div><div id="a10031" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:503px;top:141px;">7,102</div><div id="a10035" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:612px;top:141px;">—</div><div id="a10039" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:689px;top:141px;">9,931</div><div id="a10041" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:159px;">Total share-based<div style="display:inline-block;width:5px"> </div>compensation expense </div><div id="a10045" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:159px;">$ </div><div id="a10047" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:408px;top:159px;">2,307</div><div id="a10050" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:159px;">$ </div><div id="a10052" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:159px;">10,147</div><div id="a10055" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:159px;">$ </div><div id="a10057" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:596px;top:159px;">8,441</div><div id="a10060" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:159px;">$ </div><div id="a10062" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:159px;">17,820</div></div></div></div><div id="TextBlockContainer632" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:728px;height:124px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10064" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Share-based compensation expense is recorded in SG&amp;A, except for $</div><div id="a10064_66_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:0px;">0.2</div><div id="a10064_69_15" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:421px;top:0px;"><div style="display:inline-block;width:7px"> </div>million and $</div><div id="a10064_84_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:498px;top:0px;">0.7</div><div id="a10064_87_39" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:515px;top:0px;"><div style="display:inline-block;width:3px"> </div>million for the three and nine months </div><div id="a10107" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">ended September 30, 2021, respectively,<div style="display:inline-block;width:5px"> </div>and $</div><div id="a10107_45_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:15px;">0.4</div><div id="a10107_48_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:270px;top:15px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a10107_62_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:15px;">1.2</div><div id="a10107_65_65" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:362px;top:15px;"><div style="display:inline-block;width:3px"> </div>million for the three and nine months ended September 30, 2020, </div><div id="a10151" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">respectively, recorded<div style="display:inline-block;width:5px"> </div>within Combination, integration and other acquisition-related expenses. </div><div id="a10171" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:54px;">Stock Options</div><div id="a10175" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:77px;">During the first nine months of 2021, the Company granted stock options<div style="display:inline-block;width:5px"> </div>under its long-term incentive plan (“LTIP”)<div style="display:inline-block;width:5px"> </div>that are </div><div id="a10218" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:93px;">subject only to time-based vesting over a </div><div id="a10218_42_5" style="position:absolute;font-family:'Times New Roman';left:226px;top:93px;-sec-ix-hidden:ID_441;">three</div><div id="a10218_47_90" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:253px;top:93px;"><div style="display:inline-block;width:3px"> </div>year period.<div style="display:inline-block;width:7px"> </div>For the purposes of determining the fair value of stock option awards,<div style="display:inline-block;width:5px"> </div>the </div><div id="a10266" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:108px;">Company used a Black-Scholes option pricing model and which primarily used<div style="display:inline-block;width:5px"> </div>the assumptions set forth in the table below:</div></div><div id="TextBlockContainer635" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:436px;height:86px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10308" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">Number of options granted </div><div id="a10310" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:374px;top:0px;">25,250</div><div id="a10315" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:18px;">Dividend yield </div><div id="a10317" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:388px;top:18px;">0.85</div><div id="a10319" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:417px;top:18px;">% </div><div id="a10323" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:35px;">Expected volatility </div><div id="a10325" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:35px;">37.33</div><div id="a10327" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:417px;top:35px;">% </div><div id="a10331" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:53px;">Risk-free interest rate </div><div id="a10335" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:388px;top:53px;">0.60</div><div id="a10337" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:417px;top:53px;">% </div><div id="a10341" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:70px;">Expected term (years) </div><div id="a10343" style="position:absolute;font-family:'Times New Roman';left:395px;top:70px;">4.0</div></div><div id="TextBlockContainer638" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:717px;height:47px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10364" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The fair value of these options is amortized on a straight-line basis over the<div style="display:inline-block;width:5px"> </div>vesting period.<div style="display:inline-block;width:7px"> </div>As of September 30, 2021, </div><div id="a10405" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">unrecognized compensation expense related to all stock options granted was $</div><div id="a10405_76_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:421px;top:15px;">2.1</div><div id="a10405_79_51" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:15px;"><div style="display:inline-block;width:3px"> </div>million, to be recognized over a weighted average </div><div id="a10443" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">remaining period of<div style="display:inline-block;width:7px"> </div></div><div id="a10443_21_3" style="position:absolute;font-family:'Times New Roman';left:117px;top:31px;">2.1</div><div id="a10443_24_7" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:134px;top:31px;"><div style="display:inline-block;width:3px"> </div>years.</div></div><div id="TextBlockContainer640" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:131px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10455" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Restricted Stock Awards<div style="display:inline-block;width:5px"> </div>and Restricted Stock Units</div><div id="a10457" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">During the nine months ended September 30, 2021, the Company granted </div><div id="a10457_69_6" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:23px;">17,692</div><div id="a10457_75_34" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:462px;top:23px;"><div style="display:inline-block;width:3px"> </div>non-vested restricted shares and </div><div id="a10457_109_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:639px;top:23px;">2,791</div><div id="a10457_114_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:669px;top:23px;"><div style="display:inline-block;width:3px"> </div>non-</div><div id="a10486" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">vested restricted stock units under its LTIP,<div style="display:inline-block;width:7px"> </div>which are subject to time-based vesting, generally over a </div><div id="a10486_104_10" style="position:absolute;font-family:'Times New Roman';left:547px;top:39px;">three year</div><div id="a10486_114_25" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:600px;top:39px;"><div style="display:inline-block;width:3px"> </div>period.<div style="display:inline-block;width:7px"> </div>The fair value </div><div id="a10528" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">of these grants is based on the trading price of the Company’s<div style="display:inline-block;width:5px"> </div>common stock on the date of grant.<div style="display:inline-block;width:7px"> </div>The Company adjusts the grant </div><div id="a10531" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">date fair value of these awards for expected forfeitures based on historical experience.<div style="display:inline-block;width:8px"> </div>As of September 30, 2021, unrecognized </div><div id="a10542" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">compensation expense related to the non-vested restricted<div style="display:inline-block;width:5px"> </div>shares was $</div><div id="a10542_70_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:383px;top:85px;">5.1</div><div id="a10542_73_51" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:400px;top:85px;"><div style="display:inline-block;width:3px"> </div>million, to be recognized over a weighted average </div><div id="a10580" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">remaining period of </div><div id="a10580_20_3" style="position:absolute;font-family:'Times New Roman';left:114px;top:100px;">1.7</div><div id="a10580_23_96" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:131px;top:100px;"><div style="display:inline-block;width:3px"> </div>years, and unrecognized compensation expense related to non-vested restricted<div style="display:inline-block;width:5px"> </div>stock units was $</div><div id="a10580_119_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:100px;">0.9</div><div id="a10580_122_10" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:100px;"><div style="display:inline-block;width:3px"> </div>million, </div><div id="a10618" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">to be recognized over a weighted average remaining period of </div><div id="a10618_61_3" style="position:absolute;font-family:'Times New Roman';left:339px;top:115px;">2.0</div><div id="a10618_64_7" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:355px;top:115px;"><div style="display:inline-block;width:3px"> </div>years.</div></div><div id="TextBlockContainer642" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:727px;height:131px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10643" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Performance Stock Units </div><div id="a10645" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">During the first nine months of 2021, the Company granted performance<div style="display:inline-block;width:1px"> </div>-dependent stock awards (“PSUs”) as a component of its </div><div id="a10653" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">LTIP,<div style="display:inline-block;width:6px"> </div>which will be settled in a certain number of shares subject to market-based and<div style="display:inline-block;width:5px"> </div>time-based vesting conditions.<div style="display:inline-block;width:7px"> </div>The number of </div><div id="a10661" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">fully vested shares that may ultimately be issued as settlement for each award<div style="display:inline-block;width:5px"> </div>may range from </div><div id="a10661_94_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:511px;top:54px;">0</div><div id="a10661_95_8" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:517px;top:54px;">% up to </div><div id="a10661_103_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:54px;">200</div><div id="a10661_106_23" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:54px;">% of the target award, </div><div id="a10663" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">subject to the achievement of the Company’s<div style="display:inline-block;width:5px"> </div>total shareholder return (“TSR”) relative to the performance of the Company’s<div style="display:inline-block;width:5px"> </div>peer </div><div id="a10665" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">group, the S&amp;P Midcap 400 Materials group.<div style="display:inline-block;width:8px"> </div>The service period required for the PSUs is three years and the TSR measurement </div><div id="a10668" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">period for the PSUs is from January 1 of the year of grant through December 31 of the year prior<div style="display:inline-block;width:5px"> </div>to issuance of the shares upon </div><div id="a10672" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">settlement.</div></div><div id="TextBlockContainer644" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:730px;height:132px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10674" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Compensation expense for PSUs is measured based on their grant date fair value<div style="display:inline-block;width:5px"> </div>and is recognized on a straight-line basis over </div><div id="a10677" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">the </div><div id="a10677_4_10" style="position:absolute;font-family:'Times New Roman';left:24px;top:15px;">three year</div><div id="a10677_14_121" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:77px;top:15px;"><div style="display:inline-block;width:3px"> </div>vesting period.<div style="display:inline-block;width:7px"> </div>The grant-date fair value of the PSUs granted during the first nine months<div style="display:inline-block;width:5px"> </div>of 2021 was estimated using </div><div id="a10689" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">a Monte Carlo simulation on the grant date and using the following assumptions:<div style="display:inline-block;width:5px"> </div>(i) a risk-free rate of<div style="display:inline-block;width:7px"> </div></div><div id="a10689_105_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:31px;">0.29</div><div id="a10689_109_28" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:578px;top:31px;">%; (ii) an expected term of </div><div id="a10692" style="position:absolute;font-family:'Times New Roman';left:4px;top:46px;">3.0</div><div id="a10692_3_132" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:21px;top:46px;"><div style="display:inline-block;width:3px"> </div>years; and (iii) a three year daily historical volatility for each of the companies in the peer group,<div style="display:inline-block;width:5px"> </div>including Quaker Houghton.<div style="display:inline-block;width:4px"> </div></div><div id="a10697" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:69px;">As of September 30, 2021, the Company estimates that it will issue approximately </div><div id="a10697_81_6" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:471px;top:69px;">23,756</div><div id="a10697_87_42" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:508px;top:69px;"><div style="display:inline-block;width:3px"> </div>fully vested shares as of the applicable </div><div id="a10705" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">settlement date of all outstanding PSUs awards based on the conditions<div style="display:inline-block;width:5px"> </div>of the PSUs and performance to date for each award.<div style="display:inline-block;width:7px"> </div>As of </div><div id="a10707" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">September 30, 2021, there was approximately $</div><div id="a10707_45_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:259px;top:100px;">3.7</div><div id="a10707_48_76" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:276px;top:100px;"><div style="display:inline-block;width:3px"> </div>million of total unrecognized compensation cost related to PSUs, which the </div><div id="a10709" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">Company expects to recognize over a weighted-average period of<div style="display:inline-block;width:8px"> </div></div><div id="a10709_64_3" style="position:absolute;font-family:'Times New Roman';left:361px;top:115px;">2.1</div><div id="a10709_67_7" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:378px;top:115px;"><div style="display:inline-block;width:3px"> </div>years.</div></div><div id="TextBlockContainer646" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:726px;height:147px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10713" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Annual Incentive Plan </div><div id="a10715" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The Company maintains an Annual Incentive Plan (“AIP”), which may be<div style="display:inline-block;width:5px"> </div>settled in cash or a certain number of shares subject to </div><div id="a10717" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">performance-based and time-based vesting conditions.<div style="display:inline-block;width:8px"> </div>As of September 30, 2020, it had been the Company’s<div style="display:inline-block;width:5px"> </div>intention to settle the </div><div id="a10723" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">2020 AIP in shares, and therefore, expense associated with the AIP in 2020<div style="display:inline-block;width:5px"> </div>was recorded as a component of share-based </div><div id="a10726" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">compensation expense.<div style="display:inline-block;width:7px"> </div>In the fourth quarter of 2020, the Company determined that it would settle the 2020<div style="display:inline-block;width:5px"> </div>AIP in cash.<div style="display:inline-block;width:7px"> </div>Therefore, </div><div id="a10728" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">the share-based compensation associated with the AIP during the<div style="display:inline-block;width:5px"> </div>year ended December 31, 2020 was reclassified from a component </div><div id="a10731" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">of share-based compensation expense to incentive compensation.<div style="display:inline-block;width:8px"> </div>This determination and conclusion had no impact on the </div><div id="a10735" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">classification of AIP expense within the Company’s<div style="display:inline-block;width:5px"> </div>Condensed Consolidated Statement of Operations for the periods as both are<div style="display:inline-block;width:5px"> </div>a </div><div id="a10738" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:131px;">component of SG&amp;A.<div style="display:inline-block;width:7px"> </div>As of September 30, 2021, it is the Company’s<div style="display:inline-block;width:5px"> </div>intention to settle the 2021 AIP in cash.</div></div><div id="TextBlockContainer648" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:147px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10741" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Defined Contribution Plan<div style="display:inline-block;width:4px"> </div></div><div id="a10743" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The Company has a 401(k) plan with an employer match covering<div style="display:inline-block;width:5px"> </div>a majority of its U.S. employees.<div style="display:inline-block;width:7px"> </div>The Company matches </div><div id="a10743_117_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:694px;top:23px;">50</div><div id="a10743_119_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:708px;top:23px;">% </div><div id="a10746" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">of the first </div><div id="a10746_13_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:63px;top:39px;">6</div><div id="a10746_14_91" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:70px;top:39px;">% of compensation that is contributed to the plan, with a maximum matching contribution of </div><div id="a10746_105_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:568px;top:39px;">3</div><div id="a10746_106_20" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:39px;">% of compensation.<div style="display:inline-block;width:4px"> </div></div><div id="a10748" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">Additionally,<div style="display:inline-block;width:4px"> </div>the plan provides for non-elective nondiscretionary contributions on behalf<div style="display:inline-block;width:5px"> </div>of participants who have completed one year </div><div id="a10752" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">of service equal to </div><div id="a10752_20_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:106px;top:69px;">3</div><div id="a10752_21_110" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:113px;top:69px;">% of the eligible participants’ compensation.<div style="display:inline-block;width:7px"> </div>Beginning in April 2020 and continuing through March 2021, the </div><div id="a10757" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">Company matched both non-elective and elective 401(k) contributions<div style="display:inline-block;width:5px"> </div>in fully vested shares of the Company’s common<div style="display:inline-block;width:5px"> </div>stock rather </div><div id="a10760" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">than cash.<div style="display:inline-block;width:7px"> </div>For the three months ended September 30, 2021, there were </div><div id="a10760_70_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:387px;top:100px;">no</div><div id="a10760_72_61" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:400px;top:100px;"><div style="display:inline-block;width:3px"> </div>matching contributions in stock.<div style="display:inline-block;width:7px"> </div>For the nine months ended </div><div id="a10770" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">September 30, 2021, total contributions were $</div><div id="a10770_46_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:255px;top:115px;">1.5</div><div id="a10770_49_81" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:272px;top:115px;"><div style="display:inline-block;width:3px"> </div>million. Comparatively,<div style="display:inline-block;width:5px"> </div>total contributions for the three and nine months ended </div><div id="a10783" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:131px;">September 30, 2020 were $</div><div id="a10783_25_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:151px;top:131px;">0.9</div><div id="a10783_28_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:167px;top:131px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a10783_42_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:242px;top:131px;">2.1</div><div id="a10783_45_23" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:259px;top:131px;"><div style="display:inline-block;width:3px"> </div>million, respectively.</div></div> <div id="TextBlockContainer629" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:727px;height:175px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a9906" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:387px;top:0px;">Three Months Ended </div><div id="a9909" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:578px;top:0px;">Nine Months Ended </div><div id="a9913" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:407px;top:18px;">September 30,<div style="display:inline-block;width:4px"> </div></div><div id="a9916" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:594px;top:18px;">September 30,<div style="display:inline-block;width:4px"> </div></div><div id="a9920" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:387px;top:35px;">2021 </div><div id="a9923" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:482px;top:35px;">2020 </div><div id="a9926" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:575px;top:35px;">2021 </div><div id="a9929" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:668px;top:35px;">2020 </div><div id="a9931" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:53px;">Stock options </div><div id="a9933" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:53px;">$ </div><div id="a9935" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:418px;top:53px;">298</div><div id="a9938" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:53px;">$ </div><div id="a9940" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:53px;">353</div><div id="a9943" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:53px;">$ </div><div id="a9945" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:606px;top:53px;">938</div><div id="a9948" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:53px;">$ </div><div id="a9950" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:689px;top:53px;">1,138</div><div id="a9952" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:70px;">Non-vested stock awards and restricted stock units </div><div id="a9957" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:408px;top:70px;">1,277</div><div id="a9961" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:503px;top:70px;">1,259</div><div id="a9965" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:596px;top:70px;">3,963</div><div id="a9969" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:689px;top:70px;">3,782</div><div id="a9971" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:88px;">Non-elective and elective 401(k) matching contribution in stock </div><div id="a9976" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:424px;top:88px;">—</div><div id="a9980" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:88px;">910</div><div id="a9984" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:596px;top:88px;">1,553</div><div id="a9988" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:689px;top:88px;">2,072</div><div id="a9990" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:106px;">Director stock ownership plan </div><div id="a9993" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:418px;top:106px;">241</div><div id="a9997" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:106px;">243</div><div id="a10001" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:606px;top:106px;">660</div><div id="a10005" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:699px;top:106px;">337</div><div id="a10007" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:123px;">Performance stock units </div><div id="a10010" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:418px;top:123px;">491</div><div id="a10014" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:123px;">280</div><div id="a10018" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:596px;top:123px;">1,327</div><div id="a10022" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:699px;top:123px;">560</div><div id="a10024" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:141px;">Annual incentive plan </div><div id="a10027" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:424px;top:141px;">—</div><div id="a10031" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:503px;top:141px;">7,102</div><div id="a10035" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:612px;top:141px;">—</div><div id="a10039" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:689px;top:141px;">9,931</div><div id="a10041" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:159px;">Total share-based<div style="display:inline-block;width:5px"> </div>compensation expense </div><div id="a10045" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:159px;">$ </div><div id="a10047" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:408px;top:159px;">2,307</div><div id="a10050" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:159px;">$ </div><div id="a10052" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:159px;">10,147</div><div id="a10055" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:159px;">$ </div><div id="a10057" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:596px;top:159px;">8,441</div><div id="a10060" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:159px;">$ </div><div id="a10062" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:159px;">17,820</div></div> 298000 353000 938000 1138000 1277000 1259000 3963000 3782000 0 910000 1553000 2072000 241000 243000 660000 337000 491000 280000 1327000 560000 0 7102000 0 9931000 2307000 10147000 8441000 17820000 200000 700000 400000 1200000 <div id="TextBlockContainer636" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:436px;height:86px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_634_XBRL_TS_cd75c0bafa2e4402a459e4591de4676c" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer635" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:436px;height:86px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10308" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">Number of options granted </div><div id="a10310" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:374px;top:0px;">25,250</div><div id="a10315" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:18px;">Dividend yield </div><div id="a10317" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:388px;top:18px;">0.85</div><div id="a10319" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:417px;top:18px;">% </div><div id="a10323" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:35px;">Expected volatility </div><div id="a10325" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:35px;">37.33</div><div id="a10327" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:417px;top:35px;">% </div><div id="a10331" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:53px;">Risk-free interest rate </div><div id="a10335" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:388px;top:53px;">0.60</div><div id="a10337" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:417px;top:53px;">% </div><div id="a10341" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:70px;">Expected term (years) </div><div id="a10343" style="position:absolute;font-family:'Times New Roman';left:395px;top:70px;">4.0</div></div></div></div> 25250 0.0085 0.3733 0.60 P4Y 2100000 P2Y1M6D 17692 2791 P3Y 5100000 P1Y8M12D 900000 P2Y 0 2 P3Y 0.0029 P3Y 23756 3700000 P2Y1M6D 0.50 0.06 0.03 0.03 0 1500000 900000 2100000 <div id="TextBlockContainer650" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:711px;height:39px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10807" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 9 – Pension and Other Postretirement<div style="display:inline-block;width:5px"> </div>Benefits </div><div id="a10812" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The components of net periodic benefit cost for the three and nine months<div style="display:inline-block;width:5px"> </div>ended September 30, 2021 and 2020 are as follows:</div></div><div id="TextBlockContainer653" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:727px;height:204px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10819" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:205px;top:0px;">Three Months Ended September 30, </div><div id="a10822" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:489px;top:0px;">Nine Months Ended September 30, </div><div id="a10832" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:361px;top:17px;">Other </div><div id="a10841" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:642px;top:17px;">Other </div><div id="a10851" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:336px;top:34px;">Postretirement </div><div id="a10860" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:616px;top:34px;">Postretirement </div><div id="a10864" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:191px;top:51px;">Pension Benefits </div><div id="a10867" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:356px;top:51px;">Benefits </div><div id="a10870" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:472px;top:51px;">Pension Benefits </div><div id="a10873" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:636px;top:51px;">Benefits </div><div id="a10878" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:195px;top:68px;">2021 </div><div id="a10882" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:265px;top:68px;">2020 </div><div id="a10886" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:335px;top:68px;">2021 </div><div id="a10890" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:405px;top:68px;">2020 </div><div id="a10894" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:475px;top:68px;">2021 </div><div id="a10898" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:545px;top:68px;">2020 </div><div id="a10902" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:615px;top:68px;">2021 </div><div id="a10906" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:685px;top:68px;">2020 </div><div id="a10908" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">Service cost </div><div id="a10910" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:174px;top:85px;">$ </div><div id="a10912" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:209px;top:85px;">289</div><div id="a10915" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:244px;top:85px;">$ </div><div id="a10917" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:85px;">1,227</div><div id="a10920" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:85px;">$ </div><div id="a10922" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:357px;top:85px;display:flex;">(2)</div><div id="a10925" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:384px;top:85px;">$ </div><div id="a10927" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:432px;top:85px;">2</div><div id="a10930" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:454px;top:85px;">$ </div><div id="a10932" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:85px;">921</div><div id="a10935" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:85px;">$ </div><div id="a10937" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:549px;top:85px;">3,565</div><div id="a10940" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:594px;top:85px;">$ </div><div id="a10942" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:642px;top:85px;">1</div><div id="a10945" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:665px;top:85px;">$ </div><div id="a10947" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:712px;top:85px;">5</div><div id="a10949" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:102px;">Interest cost </div><div id="a10952" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:199px;top:102px;">1,078</div><div id="a10956" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:102px;">1,527</div><div id="a10960" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:357px;top:102px;display:flex;">(1)</div><div id="a10964" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:102px;">25</div><div id="a10968" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:479px;top:102px;">3,262</div><div id="a10972" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:549px;top:102px;">4,782</div><div id="a10976" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:102px;">20</div><div id="a10980" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:705px;top:102px;">77</div><div id="a10982" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:119px;">Expected return on plan assets </div><div id="a10985" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:194px;top:119px;display:flex;">(2,075)</div><div id="a10989" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:119px;display:flex;">(3,526)</div><div id="a10993" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:355px;top:119px;">—</div><div id="a10997" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:119px;">—</div><div id="a11001" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:119px;display:flex;">(6,250)</div><div id="a11005" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:544px;top:119px;display:flex;">(7,246)</div><div id="a11009" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:119px;">—</div><div id="a11013" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:705px;top:119px;">—</div><div id="a11015" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:136px;">Settlement charge </div><div id="a11018" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:215px;top:136px;">—</div><div id="a11022" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:285px;top:136px;">—</div><div id="a11026" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:355px;top:136px;">—</div><div id="a11030" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:136px;">—</div><div id="a11034" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:495px;top:136px;">—</div><div id="a11038" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:136px;">22,667</div><div id="a11042" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:136px;">—</div><div id="a11046" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:705px;top:136px;">—</div><div id="a11048" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:153px;">Actuarial loss amortization </div><div id="a11051" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:209px;top:153px;">737</div><div id="a11055" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:279px;top:153px;">626</div><div id="a11059" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:350px;top:153px;display:flex;">(85)</div><div id="a11063" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:153px;">15</div><div id="a11067" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:479px;top:153px;">2,449</div><div id="a11071" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:549px;top:153px;">2,288</div><div id="a11075" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:153px;display:flex;">(85)</div><div id="a11079" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:705px;top:153px;">46</div><div id="a11081" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:170px;">Prior service cost amortization </div><div id="a11084" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:222px;top:170px;">3</div><div id="a11088" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:280px;top:170px;display:flex;">(42)</div><div id="a11092" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:355px;top:170px;">—</div><div id="a11096" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:170px;">—</div><div id="a11100" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:502px;top:170px;">8</div><div id="a11104" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:554px;top:170px;display:flex;">(123)</div><div id="a11108" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:170px;">—</div><div id="a11112" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:705px;top:170px;">—</div><div id="a11114" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:189px;">Net periodic benefit cost </div><div id="a11116" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:174px;top:189px;">$ </div><div id="a11118" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:215px;top:189px;">32</div><div id="a11121" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:244px;top:189px;">$ </div><div id="a11123" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:274px;top:189px;display:flex;">(188)</div><div id="a11126" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:189px;">$ </div><div id="a11128" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:350px;top:189px;display:flex;">(88)</div><div id="a11131" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:384px;top:189px;">$ </div><div id="a11133" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:189px;">42</div><div id="a11136" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:454px;top:189px;">$ </div><div id="a11138" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:189px;">390</div><div id="a11141" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:189px;">$ </div><div id="a11143" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:189px;">25,933</div><div id="a11146" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:594px;top:189px;">$ </div><div id="a11148" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:189px;display:flex;">(64)</div><div id="a11151" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:665px;top:189px;">$ </div><div id="a11153" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:699px;top:189px;">128</div></div><div id="TextBlockContainer656" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:170px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11155" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">As disclosed in the Company’s 2020<div style="display:inline-block;width:5px"> </div>Form 10-K, in the fourth quarter of 2018, the Company began the process of terminating<div style="display:inline-block;width:5px"> </div>its </div><div id="a11160" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">legacy Quaker non-contributory U.S. pension plan (“Legacy Quaker<div style="display:inline-block;width:5px"> </div>U.S. Pension Plan”).<div style="display:inline-block;width:7px"> </div>During the third quarter of 2019, the </div><div id="a11169" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Company received a favorable termination determination letter from the<div style="display:inline-block;width:5px"> </div>Internal Revenue Service (“I.R.S.”) and completed the </div><div id="a11171" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">Legacy Quaker U.S. Pension Plan termination during the first quarter of 2020.<div style="display:inline-block;width:8px"> </div>In order to terminate the Legacy Quaker U.S. Pension </div><div id="a11174" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">Plan in accordance with I.R.S. and Pension Benefit Guaranty Corporation requirements,<div style="display:inline-block;width:5px"> </div>the Company was required to fully fund the </div><div id="a11178" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">Legacy Quaker U.S. Pension Plan on a termination basis and the amount<div style="display:inline-block;width:5px"> </div>necessary to do so was approximately $</div><div id="a11178_108_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:607px;top:77px;">1.8</div><div id="a11178_111_21" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:624px;top:77px;"><div style="display:inline-block;width:3px"> </div>million, subject to </div><div id="a11186" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:92px;">final true up adjustments,<div style="display:inline-block;width:4px"> </div>which were completed in the third quarter of 2020 resulting in a refund in premium received<div style="display:inline-block;width:5px"> </div>in the third </div><div id="a11190" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:107px;">quarter of 2020 of approximately $</div><div id="a11190_34_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:191px;top:107px;">1.6</div><div id="a11190_37_90" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:208px;top:107px;"><div style="display:inline-block;width:3px"> </div>million.<div style="display:inline-block;width:7px"> </div>In addition, the Company recorded a non-cash pension settlement charge<div style="display:inline-block;width:5px"> </div>at plan </div><div id="a11200" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:123px;">termination of approximately $</div><div id="a11200_30_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:171px;top:123px;">22.7</div><div id="a11200_34_97" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:194px;top:123px;"><div style="display:inline-block;width:3px"> </div>million.<div style="display:inline-block;width:7px"> </div>This settlement charge included the immediate recognition into expense<div style="display:inline-block;width:5px"> </div>of the related </div><div id="a11209" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:138px;">unrecognized losses within accumulated other comprehensive (loss) income<div style="display:inline-block;width:5px"> </div>(“AOCI”) on the balance sheet as of the plan termination </div><div id="a11211" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:153px;">date.</div></div><div id="TextBlockContainer658" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:719px;height:85px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11214" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Employer Contributions </div><div id="a11218" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">As of September 30, 2021, $</div><div id="a11218_27_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:182px;top:23px;">5.7</div><div id="a11218_30_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:198px;top:23px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a11218_44_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:273px;top:23px;">0.2</div><div id="a11218_47_75" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:289px;top:23px;"><div style="display:inline-block;width:3px"> </div>million of contributions have been made to the Company’s<div style="display:inline-block;width:5px"> </div>U.S. and foreign </div><div id="a11254" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">pension plans and its other postretirement benefit plans, respectively<div style="display:inline-block;width:1px"> </div>.<div style="display:inline-block;width:7px"> </div>Taking into consideration<div style="display:inline-block;width:5px"> </div>current minimum cash contribution </div><div id="a11287" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">requirements, the Company expects to make full year cash contributions<div style="display:inline-block;width:5px"> </div>of approximately $</div><div id="a11287_89_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:495px;top:54px;">6</div><div id="a11287_90_41" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:502px;top:54px;"><div style="display:inline-block;width:3px"> </div>million to its U.S. and foreign pension </div><div id="a11328" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">plans and less than $</div><div id="a11328_21_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:115px;top:69px;">1</div><div id="a11328_22_58" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:122px;top:69px;"><div style="display:inline-block;width:3px"> </div>million to its other postretirement benefit plans in 2021</div></div> <div id="TextBlockContainer654" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:727px;height:204px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_652_XBRL_TS_538c7687e35a42a7ae9d6c4ac3774b02" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer653" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:727px;height:204px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a10819" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:205px;top:0px;">Three Months Ended September 30, </div><div id="a10822" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:489px;top:0px;">Nine Months Ended September 30, </div><div id="a10832" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:361px;top:17px;">Other </div><div id="a10841" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:642px;top:17px;">Other </div><div id="a10851" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:336px;top:34px;">Postretirement </div><div id="a10860" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:616px;top:34px;">Postretirement </div><div id="a10864" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:191px;top:51px;">Pension Benefits </div><div id="a10867" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:356px;top:51px;">Benefits </div><div id="a10870" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:472px;top:51px;">Pension Benefits </div><div id="a10873" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:636px;top:51px;">Benefits </div><div id="a10878" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:195px;top:68px;">2021 </div><div id="a10882" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:265px;top:68px;">2020 </div><div id="a10886" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:335px;top:68px;">2021 </div><div id="a10890" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:405px;top:68px;">2020 </div><div id="a10894" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:475px;top:68px;">2021 </div><div id="a10898" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:545px;top:68px;">2020 </div><div id="a10902" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:615px;top:68px;">2021 </div><div id="a10906" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:685px;top:68px;">2020 </div><div id="a10908" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">Service cost </div><div id="a10910" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:174px;top:85px;">$ </div><div id="a10912" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:209px;top:85px;">289</div><div id="a10915" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:244px;top:85px;">$ </div><div id="a10917" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:85px;">1,227</div><div id="a10920" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:85px;">$ </div><div id="a10922" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:357px;top:85px;display:flex;">(2)</div><div id="a10925" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:384px;top:85px;">$ </div><div id="a10927" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:432px;top:85px;">2</div><div id="a10930" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:454px;top:85px;">$ </div><div id="a10932" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:85px;">921</div><div id="a10935" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:85px;">$ </div><div id="a10937" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:549px;top:85px;">3,565</div><div id="a10940" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:594px;top:85px;">$ </div><div id="a10942" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:642px;top:85px;">1</div><div id="a10945" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:665px;top:85px;">$ </div><div id="a10947" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:712px;top:85px;">5</div><div id="a10949" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:102px;">Interest cost </div><div id="a10952" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:199px;top:102px;">1,078</div><div id="a10956" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:102px;">1,527</div><div id="a10960" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:357px;top:102px;display:flex;">(1)</div><div id="a10964" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:102px;">25</div><div id="a10968" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:479px;top:102px;">3,262</div><div id="a10972" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:549px;top:102px;">4,782</div><div id="a10976" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:102px;">20</div><div id="a10980" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:705px;top:102px;">77</div><div id="a10982" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:119px;">Expected return on plan assets </div><div id="a10985" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:194px;top:119px;display:flex;">(2,075)</div><div id="a10989" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:119px;display:flex;">(3,526)</div><div id="a10993" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:355px;top:119px;">—</div><div id="a10997" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:119px;">—</div><div id="a11001" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:474px;top:119px;display:flex;">(6,250)</div><div id="a11005" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:544px;top:119px;display:flex;">(7,246)</div><div id="a11009" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:119px;">—</div><div id="a11013" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:705px;top:119px;">—</div><div id="a11015" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:136px;">Settlement charge </div><div id="a11018" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:215px;top:136px;">—</div><div id="a11022" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:285px;top:136px;">—</div><div id="a11026" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:355px;top:136px;">—</div><div id="a11030" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:136px;">—</div><div id="a11034" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:495px;top:136px;">—</div><div id="a11038" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:136px;">22,667</div><div id="a11042" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:136px;">—</div><div id="a11046" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:705px;top:136px;">—</div><div id="a11048" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:153px;">Actuarial loss amortization </div><div id="a11051" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:209px;top:153px;">737</div><div id="a11055" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:279px;top:153px;">626</div><div id="a11059" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:350px;top:153px;display:flex;">(85)</div><div id="a11063" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:153px;">15</div><div id="a11067" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:479px;top:153px;">2,449</div><div id="a11071" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:549px;top:153px;">2,288</div><div id="a11075" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:153px;display:flex;">(85)</div><div id="a11079" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:705px;top:153px;">46</div><div id="a11081" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:170px;">Prior service cost amortization </div><div id="a11084" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:222px;top:170px;">3</div><div id="a11088" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:280px;top:170px;display:flex;">(42)</div><div id="a11092" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:355px;top:170px;">—</div><div id="a11096" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:170px;">—</div><div id="a11100" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:502px;top:170px;">8</div><div id="a11104" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:554px;top:170px;display:flex;">(123)</div><div id="a11108" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:635px;top:170px;">—</div><div id="a11112" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:705px;top:170px;">—</div><div id="a11114" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:189px;">Net periodic benefit cost </div><div id="a11116" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:174px;top:189px;">$ </div><div id="a11118" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:215px;top:189px;">32</div><div id="a11121" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:244px;top:189px;">$ </div><div id="a11123" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:274px;top:189px;display:flex;">(188)</div><div id="a11126" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:189px;">$ </div><div id="a11128" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:350px;top:189px;display:flex;">(88)</div><div id="a11131" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:384px;top:189px;">$ </div><div id="a11133" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:189px;">42</div><div id="a11136" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:454px;top:189px;">$ </div><div id="a11138" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:189px;">390</div><div id="a11141" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:189px;">$ </div><div id="a11143" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:189px;">25,933</div><div id="a11146" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:594px;top:189px;">$ </div><div id="a11148" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:189px;display:flex;">(64)</div><div id="a11151" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:665px;top:189px;">$ </div><div id="a11153" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:699px;top:189px;">128</div></div></div></div> 289000 1227000 -2000 2000 921000 3565000 1000 5000 1078000 1527000 -1000 25000 3262000 4782000 20000 77000 2075000 3526000 0 0 6250000 7246000 0 0 0 0 0 0 0 -22667000 0 0 -737000 -626000 85000 -15000 -2449000 -2288000 85000 -46000 3000 -42000 0 0 8000 -123000 0 0 32000 -188000 -88000 42000 390000 25933000 -64000 128000 1800000 1600000 22700000 5700000 200000 6000000 1000000 <div id="TextBlockContainer660" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:687px;height:54px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11358" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 10 – Other Income (Expense), Net</div><div id="a11363" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The components of other income (expense), net, for the three and nine months<div style="display:inline-block;width:5px"> </div>ended September 30, 2021 and 2020 are as </div><div id="a11365" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">follows:</div></div><div id="TextBlockContainer664" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:205px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_662_XBRL_TS_0140e58fa29b426da51e6803a5fe8267" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer663" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:205px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11369" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:388px;top:0px;">Three Months Ended </div><div id="a11372" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:579px;top:0px;">Nine Months Ended </div><div id="a11376" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:408px;top:17px;">September 30,<div style="display:inline-block;width:4px"> </div></div><div id="a11379" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:595px;top:17px;">September 30,<div style="display:inline-block;width:4px"> </div></div><div id="a11383" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:388px;top:34px;">2021 </div><div id="a11386" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:483px;top:34px;">2020 </div><div id="a11389" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:576px;top:34px;">2021 </div><div id="a11392" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:669px;top:34px;">2020 </div><div id="a11394" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:51px;">Income from third party license fees </div><div id="a11396" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:361px;top:51px;">$ </div><div id="a11398" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:417px;top:51px;">314</div><div id="a11401" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:51px;">$</div><div id="a11403" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:512px;top:51px;">190</div><div id="a11406" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:549px;top:51px;">$ </div><div id="a11408" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:595px;top:51px;">1,026</div><div id="a11411" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:642px;top:51px;">$ </div><div id="a11413" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:698px;top:51px;">702</div><div id="a11415" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:68px;">Foreign exchange gains (losses), net </div><div id="a11418" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:417px;top:68px;">368</div><div id="a11422" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:497px;top:68px;display:flex;">(1,897)</div><div id="a11426" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:590px;top:68px;display:flex;">(1,948)</div><div id="a11430" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:683px;top:68px;display:flex;">(3,080)</div><div id="a11432" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:87px;">(Loss) gain on disposals of property,<div style="display:inline-block;width:5px"> </div>plant, equipment and other </div><div id="a11447" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:13px;top:104px;">assets, net </div><div id="a11450" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:412px;top:104px;display:flex;">(537)</div><div id="a11454" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:514px;top:104px;display:flex;">(24)</div><div id="a11458" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:595px;top:104px;">4,819</div><div id="a11462" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:693px;top:104px;display:flex;">(105)</div><div id="a11464" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:121px;">Non-income tax refunds and other related credits </div><div id="a11470" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:430px;top:121px;">3</div><div id="a11474" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:121px;">—</div><div id="a11478" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:588px;top:121px;">14,395</div><div id="a11482" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:688px;top:121px;">2,131</div><div id="a11484" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:138px;">Pension and postretirement benefit income (costs),<div style="display:inline-block;width:4px"> </div></div><div id="a11497" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:13px;top:155px;">non-service components </div><div id="a11502" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:417px;top:155px;">343</div><div id="a11506" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:502px;top:155px;">1,375</div><div id="a11510" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:605px;top:155px;">596</div><div id="a11514" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:155px;display:flex;">(22,491)</div><div id="a11516" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:172px;">Other non-operating income, net </div><div id="a11521" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:417px;top:172px;">156</div><div id="a11525" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:512px;top:172px;">117</div><div id="a11529" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:605px;top:172px;">456</div><div id="a11533" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:698px;top:172px;">436</div><div id="a11535" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:189px;">Total other income<div style="display:inline-block;width:5px"> </div>(expense), net </div><div id="a11538" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:361px;top:189px;">$ </div><div id="a11540" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:417px;top:189px;">647</div><div id="a11543" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:189px;">$</div><div id="a11545" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:507px;top:189px;display:flex;">(239)</div><div id="a11548" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:549px;top:189px;">$ </div><div id="a11550" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:588px;top:189px;">19,344</div><div id="a11553" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:642px;top:189px;">$ </div><div id="a11555" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:189px;display:flex;">(22,407)</div></div></div></div><div id="TextBlockContainer666" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:728px;height:154px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11574" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The (Loss) gain on disposals of property,<div style="display:inline-block;width:5px"> </div>plant, equipment and other assets, net, during the three months ended<div style="display:inline-block;width:5px"> </div>September 30, </div><div id="a11580" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">2021,<div style="display:inline-block;width:3px"> </div>includes losses related to certain fixed asset disposals resulting from the<div style="display:inline-block;width:5px"> </div>property damage caused by flooding of the Company’s </div><div id="a11589" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Conshohocken, Pennsylvania headquarters, described in Note 19 of Notes<div style="display:inline-block;width:5px"> </div>to Condensed Consolidated Financial Statements, and </div><div id="a11595" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">during the nine months ended September 30, 2021, includes the gain on the<div style="display:inline-block;width:5px"> </div>sale of certain held-for-sale real property assets related to </div><div id="a11606" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">the Combination.<div style="display:inline-block;width:7px"> </div>Non-income tax refunds and other related credits during the nine months ended September<div style="display:inline-block;width:5px"> </div>30, 2021 includes </div><div id="a11618" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">certain non-income tax credits for the Company’s<div style="display:inline-block;width:5px"> </div>Brazilian subsidiaries described in Note 19 of Notes to Condensed Consolidated </div><div id="a11628" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:92px;">Financial Statements.<div style="display:inline-block;width:7px"> </div>Pension and postretirement benefit income (costs), non-service<div style="display:inline-block;width:5px"> </div>components during both the three and nine </div><div id="a11641" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:107px;">months ended September 30, 2020 includes the refund in premium described<div style="display:inline-block;width:5px"> </div>in Note 9 of Notes to Condensed Consolidated Financial </div><div id="a11643" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:123px;">Statements.<div style="display:inline-block;width:7px"> </div>In addition, this line also includes the Legacy Quaker U.S. Pension Plan non<div style="display:inline-block;width:1px"> </div>-cash settlement charge during the nine </div><div id="a11650" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:138px;">months ended September 30, 2020, also described in Note 9 of Notes to<div style="display:inline-block;width:5px"> </div>Condensed Consolidated Financial Statements.</div></div> <div id="TextBlockContainer663" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:205px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11369" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:388px;top:0px;">Three Months Ended </div><div id="a11372" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:579px;top:0px;">Nine Months Ended </div><div id="a11376" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:408px;top:17px;">September 30,<div style="display:inline-block;width:4px"> </div></div><div id="a11379" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:595px;top:17px;">September 30,<div style="display:inline-block;width:4px"> </div></div><div id="a11383" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:388px;top:34px;">2021 </div><div id="a11386" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:483px;top:34px;">2020 </div><div id="a11389" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:576px;top:34px;">2021 </div><div id="a11392" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:669px;top:34px;">2020 </div><div id="a11394" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:51px;">Income from third party license fees </div><div id="a11396" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:361px;top:51px;">$ </div><div id="a11398" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:417px;top:51px;">314</div><div id="a11401" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:51px;">$</div><div id="a11403" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:512px;top:51px;">190</div><div id="a11406" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:549px;top:51px;">$ </div><div id="a11408" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:595px;top:51px;">1,026</div><div id="a11411" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:642px;top:51px;">$ </div><div id="a11413" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:698px;top:51px;">702</div><div id="a11415" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:68px;">Foreign exchange gains (losses), net </div><div id="a11418" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:417px;top:68px;">368</div><div id="a11422" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:497px;top:68px;display:flex;">(1,897)</div><div id="a11426" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:590px;top:68px;display:flex;">(1,948)</div><div id="a11430" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:683px;top:68px;display:flex;">(3,080)</div><div id="a11432" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:87px;">(Loss) gain on disposals of property,<div style="display:inline-block;width:5px"> </div>plant, equipment and other </div><div id="a11447" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:13px;top:104px;">assets, net </div><div id="a11450" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:412px;top:104px;display:flex;">(537)</div><div id="a11454" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:514px;top:104px;display:flex;">(24)</div><div id="a11458" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:595px;top:104px;">4,819</div><div id="a11462" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:693px;top:104px;display:flex;">(105)</div><div id="a11464" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:121px;">Non-income tax refunds and other related credits </div><div id="a11470" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:430px;top:121px;">3</div><div id="a11474" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:121px;">—</div><div id="a11478" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:588px;top:121px;">14,395</div><div id="a11482" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:688px;top:121px;">2,131</div><div id="a11484" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:138px;">Pension and postretirement benefit income (costs),<div style="display:inline-block;width:4px"> </div></div><div id="a11497" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:13px;top:155px;">non-service components </div><div id="a11502" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:417px;top:155px;">343</div><div id="a11506" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:502px;top:155px;">1,375</div><div id="a11510" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:605px;top:155px;">596</div><div id="a11514" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:155px;display:flex;">(22,491)</div><div id="a11516" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:172px;">Other non-operating income, net </div><div id="a11521" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:417px;top:172px;">156</div><div id="a11525" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:512px;top:172px;">117</div><div id="a11529" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:605px;top:172px;">456</div><div id="a11533" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:698px;top:172px;">436</div><div id="a11535" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:189px;">Total other income<div style="display:inline-block;width:5px"> </div>(expense), net </div><div id="a11538" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:361px;top:189px;">$ </div><div id="a11540" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:417px;top:189px;">647</div><div id="a11543" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:189px;">$</div><div id="a11545" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:507px;top:189px;display:flex;">(239)</div><div id="a11548" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:549px;top:189px;">$ </div><div id="a11550" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:588px;top:189px;">19,344</div><div id="a11553" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:642px;top:189px;">$ </div><div id="a11555" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:189px;display:flex;">(22,407)</div></div> 314000 190000 1026000 702000 368000 -1897000 -1948000 -3080000 -537000 -24000 4819000 -105000 3000 0 14395000 2131000 343000 1375000 596000 -22491000 156000 117000 456000 436000 647000 -239000 19344000 -22407000 <div id="TextBlockContainer668" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:677px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a11656" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 11 – Income Taxes<div style="display:inline-block;width:6px"> </div>and Uncertain Income Tax<div style="display:inline-block;width:5px"> </div>Positions </div><div id="a11661" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The Company’s effective<div style="display:inline-block;width:5px"> </div>tax rates for the three and nine months ended September 30, 2021 were an expense<div style="display:inline-block;width:5px"> </div>of </div><div id="a11661_108_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:627px;top:23px;">2.6</div><div id="a11661_111_6" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:644px;top:23px;">% and </div><div id="a11661_117_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:681px;top:23px;">21.8</div><div id="a11661_121_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:704px;top:23px;">%, </div><div id="a11705" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">respectively, compared<div style="display:inline-block;width:5px"> </div>to an expense of </div><div id="a11705_40_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:222px;top:39px;">8.1</div><div id="a11705_43_19" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:239px;top:39px;">% and a benefit of </div><div id="a11705_62_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:340px;top:39px;">38.3</div><div id="a11705_66_58" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:363px;top:39px;">% for the three and nine months ended September 30, 2020, </div><div id="a11754" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">respectively.<div style="display:inline-block;width:7px"> </div>The Company’s current year<div style="display:inline-block;width:5px"> </div>effective tax rates were largely impacted by changes in permanent<div style="display:inline-block;width:5px"> </div>reinvestment assertions, </div><div id="a11791" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">changes in foreign tax credit valuation allowances, tax law changes in a foreign<div style="display:inline-block;width:5px"> </div>jurisdiction, deferred tax benefits related to an </div><div id="a11832" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">intercompany intangible asset transfer and the income tax impacts of certain<div style="display:inline-block;width:5px"> </div>non-income tax credits recorded by the Company’s </div><div id="a11870" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">Brazilian subsidiaries described in Note 19 of Notes to Condensed Consolidated<div style="display:inline-block;width:5px"> </div>Financial Statements.<div style="display:inline-block;width:7px"> </div>Comparatively,<div style="display:inline-block;width:5px"> </div>the prior year </div><div id="a11904" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">effective tax rates were impacted by the tax effect<div style="display:inline-block;width:5px"> </div>of certain one-time pre-tax losses as well as certain tax charges and benefits<div style="display:inline-block;width:5px"> </div>in the </div><div id="a11957" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:131px;">prior year period including those related to changes in tax regulations and<div style="display:inline-block;width:5px"> </div>other changes in foreign tax credit valuation allowances, tax </div><div id="a11999" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:146px;">law changes in foreign jurisdictions and the tax impacts of the Company’s<div style="display:inline-block;width:5px"> </div>termination of its Legacy Quaker U.S. Pension Plan. </div><div id="a12041" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:169px;">As of December 31, 2020, the Company had a deferred tax liability of $</div><div id="a12041_70_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:413px;top:169px;">5.9</div><div id="a12041_73_51" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:429px;top:169px;"><div style="display:inline-block;width:3px"> </div>million, which primarily represents the Company’s </div><div id="a12082" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:185px;">estimate of non-U.S. taxes it will incur to repatriate certain foreign earnings to<div style="display:inline-block;width:5px"> </div>the U.S.<div style="display:inline-block;width:7px"> </div>The balance as of September 30, 2021 was </div><div id="a12130" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:200px;">$</div><div id="a12130_1_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:11px;top:200px;">5.8</div><div id="a12130_4_112" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:200px;"><div style="display:inline-block;width:3px"> </div>million. As of September 30, 2021, the Company’s<div style="display:inline-block;width:5px"> </div>cumulative liability for gross unrecognized tax benefits was $</div><div id="a12130_116_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:636px;top:200px;">24.0</div><div id="a12130_120_13" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:659px;top:200px;"><div style="display:inline-block;width:3px"> </div>million, an </div><div id="a12174" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:215px;">increase of $</div><div id="a12174_13_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:73px;top:215px;">1.9</div><div id="a12174_16_73" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:89px;top:215px;"><div style="display:inline-block;width:3px"> </div>million from the cumulative liability accrued as of December 31, 2020.<div style="display:inline-block;width:4px"> </div></div><div id="a12206" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:239px;">The Company continues to recognize interest and penalties associated with uncertain<div style="display:inline-block;width:5px"> </div>tax positions as a component of taxes on </div><div id="a12244" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:254px;">income (loss) before equity in net income of associated companies<div style="display:inline-block;width:5px"> </div>in its Condensed Consolidated Statements of Operations.<div style="display:inline-block;width:8px"> </div>The </div><div id="a12280" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:269px;">Company recognized an expense for interest of approximately $</div><div id="a12280_61_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:347px;top:269px;">0.2</div><div id="a12280_64_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:363px;top:269px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a12280_78_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:269px;">0.4</div><div id="a12280_81_37" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:455px;top:269px;"><div style="display:inline-block;width:3px"> </div>million and a benefit of less than $</div><div id="a12280_118_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:643px;top:269px;">0.1</div><div id="a12280_121_13" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:659px;top:269px;"><div style="display:inline-block;width:3px"> </div>million and </div><div id="a12329" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:285px;">$</div><div id="a12329_1_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:11px;top:285px;">0.2</div><div id="a12329_4_127" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:285px;"><div style="display:inline-block;width:3px"> </div>million for penalties in its Condensed Consolidated Statement of Operations for the<div style="display:inline-block;width:5px"> </div>three and nine months ended September 30, </div><div id="a12371" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:300px;">2021, respectively,<div style="display:inline-block;width:5px"> </div>and recognized a credit for interest of $</div><div id="a12371_61_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:319px;top:300px;">0.2</div><div id="a12371_64_28" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:336px;top:300px;"><div style="display:inline-block;width:3px"> </div>million and an expense of $</div><div id="a12371_92_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:487px;top:300px;">0.4</div><div id="a12371_95_41" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:504px;top:300px;"><div style="display:inline-block;width:3px"> </div>million and an expense for penalties of </div><div id="a12422" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:315px;">less than $</div><div id="a12422_11_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:61px;top:315px;">0.1</div><div id="a12422_14_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:78px;top:315px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a12422_28_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:152px;top:315px;">0.5</div><div id="a12422_31_99" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:169px;top:315px;"><div style="display:inline-block;width:3px"> </div>million in its Condensed Consolidated Statement of Operations for the<div style="display:inline-block;width:5px"> </div>three and nine months ended </div><div id="a12467" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:331px;">September 30, 2020, respectively.<div style="display:inline-block;width:8px"> </div>As of September 30, 2021, the Company had accrued $</div><div id="a12467_86_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:488px;top:331px;">3.3</div><div id="a12467_89_38" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:331px;"><div style="display:inline-block;width:3px"> </div>million for cumulative interest and $</div><div id="a12467_127_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:703px;top:331px;">3.5</div><div id="a12517" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:346px;">million for cumulative penalties in its Condensed Consolidated<div style="display:inline-block;width:5px"> </div>Balance Sheets, compared to $</div><div id="a12517_92_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:509px;top:346px;">3.0</div><div id="a12517_95_37" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:346px;"><div style="display:inline-block;width:3px"> </div>million for cumulative interest and </div><div id="a12553" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:361px;">$</div><div id="a12553_1_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:11px;top:361px;">3.9</div><div id="a12553_4_123" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:361px;"><div style="display:inline-block;width:3px"> </div>million for cumulative penalties accrued at December 31, 2020.<div style="display:inline-block;width:8px"> </div>During the nine months ended September 30, 2021 and 2020, </div><div id="a12594" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:377px;">the Company recognized decreases of $</div><div id="a12594_37_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:217px;top:377px;">1.2</div><div id="a12594_40_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:233px;top:377px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a12594_54_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:308px;top:377px;">1.9</div><div id="a12594_57_79" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:324px;top:377px;"><div style="display:inline-block;width:3px"> </div>million, respectively,<div style="display:inline-block;width:5px"> </div>in its cumulative liability for gross unrecognized tax </div><div id="a12638" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:392px;">benefits due to the expiration of the applicable statutes of limitations for<div style="display:inline-block;width:5px"> </div>certain tax years. </div><div id="a12668" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:415px;">The Company estimates that during the year ending December 31, 2021<div style="display:inline-block;width:5px"> </div>it will reduce its cumulative liability for gross </div><div id="a12706" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:431px;">unrecognized tax benefits by approximately $</div><div id="a12706_44_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:249px;top:431px;">1.5</div><div id="a12706_47_88" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:265px;top:431px;"><div style="display:inline-block;width:3px"> </div>million due to the expiration of the statute of limitations with regard to certain tax </div><div id="a12751" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:446px;">positions.<div style="display:inline-block;width:7px"> </div>This estimated reduction in the cumulative liability for unrecognized tax<div style="display:inline-block;width:5px"> </div>benefits does not consider any increase in liability </div><div id="a12790" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:461px;">for unrecognized tax benefits with regard to existing tax positions or any increase<div style="display:inline-block;width:5px"> </div>in cumulative liability for unrecognized tax benefits </div><div id="a12830" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:477px;">with regard to new tax positions for the year ending December 31, 2021. </div><div id="a12856" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:500px;">The Company and its subsidiaries are subject to U.S. Federal income tax,<div style="display:inline-block;width:5px"> </div>as well as the income tax of various state and foreign </div><div id="a12902" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:515px;">tax jurisdictions.<div style="display:inline-block;width:7px"> </div>Tax years that remain subject<div style="display:inline-block;width:5px"> </div>to examination by major tax jurisdictions include Italy from </div><div id="a12902_111_4" style="position:absolute;font-family:'Times New Roman';left:583px;top:515px;">2006</div><div id="a12902_115_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:610px;top:515px;">, Brazil from </div><div id="a12902_129_4" style="position:absolute;font-family:'Times New Roman';left:681px;top:515px;">2011</div><div id="a12902_133_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:708px;top:515px;">, </div><div id="a12942" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:531px;">the Netherlands and China from </div><div id="a12942_31_4" style="position:absolute;font-family:'Times New Roman';left:179px;top:531px;">2015</div><div id="a12942_35_53" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:206px;top:531px;">, Mexico, Spain, Germany and the United Kingdom from </div><div id="a12942_88_4" style="position:absolute;font-family:'Times New Roman';left:515px;top:531px;">2016</div><div id="a12942_92_27" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:531px;">, Canada and the U.S. from </div><div id="a12942_119_4" style="position:absolute;font-family:'Times New Roman';left:690px;top:531px;">2018</div><div id="a12942_123_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:716px;top:531px;">, </div><div id="a12987" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:546px;">India from fiscal year beginning April 1, 2018 and ending March 31, </div><div id="a12987_68_4" style="position:absolute;font-family:'Times New Roman';left:375px;top:546px;">2019</div><div id="a12987_72_48" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:546px;">, and various U.S. state tax jurisdictions from </div><div id="a12987_120_4" style="position:absolute;font-family:'Times New Roman';left:646px;top:546px;">2011</div><div id="a12987_124_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:673px;top:546px;">.<div style="display:inline-block;width:7px"> </div></div><div id="a13031" style="position:absolute;font-family:'Times New Roman';left:28px;top:569px;">As previously reported, the Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia </div><div id="a13067" style="position:absolute;font-family:'Times New Roman';left:4px;top:585px;">S.r.l., relating to the tax years 2007 through 2015. The Company has filed for competent authority relief from these assessments under </div><div id="a13110" style="position:absolute;font-family:'Times New Roman';left:4px;top:600px;">the Mutual Agreement Procedures (“MAP”) of the Organization for Economic Co-Operation and Development for all years except </div><div id="a13146" style="position:absolute;font-family:'Times New Roman';left:4px;top:615px;">2007. In 2020, the respective tax authorities in Italy, Spain and the Netherlands reached agreement with respect to the MAP </div><div id="a13186" style="position:absolute;font-family:'Times New Roman';left:4px;top:631px;">proceedings which the Company has accepted.</div><div id="a13186_43_54" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:631px;"><div style="display:inline-block;width:7px"> </div>As of September 30, 2021, the Company has received $</div><div id="a13186_97_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:558px;top:631px;">1.6</div><div id="a13186_100_29" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:631px;"><div style="display:inline-block;width:3px"> </div>million in refunds from the </div><div id="a13232" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:646px;">Netherlands and Spain and currently expects to pay $</div><div id="a13232_52_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:289px;top:646px;">2.6</div><div id="a13232_55_80" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:306px;top:646px;"><div style="display:inline-block;width:3px"> </div>million due to Italy in the fourth quarter of 2021.<div style="display:inline-block;width:8px"> </div>As of September 30, 2021, </div><div id="a13284" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:661px;">the Company believes it has adequate reserves for the remaining uncertain<div style="display:inline-block;width:5px"> </div>tax positions related to 2007. </div></div><div id="TextBlockContainer670" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:728px;height:239px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a13333" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Houghton Italia, S.r.l is also involved<div style="display:inline-block;width:5px"> </div>in a corporate income tax audit with the Italian tax authorities covering tax years </div><div id="a13333_124_4" style="position:absolute;font-family:'Times New Roman';left:665px;top:0px;">2014</div><div id="a13375" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">through </div><div id="a13375_8_4" style="position:absolute;font-family:'Times New Roman';left:49px;top:15px;">2018</div><div id="a13375_12_48" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:76px;top:15px;">.<div style="display:inline-block;width:7px"> </div>As of September 30, 2021, the Company has a $</div><div id="a13375_60_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:344px;top:15px;">6.0</div><div id="a13375_63_65" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:361px;top:15px;"><div style="display:inline-block;width:3px"> </div>million reserve for uncertain tax positions relating to matters </div><div id="a13421" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">related to this audit.<div style="display:inline-block;width:7px"> </div>Because the reserve relates to the tax periods prior to August 1, 2019, the tax liability was established<div style="display:inline-block;width:5px"> </div>through </div><div id="a13467" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">purchase accounting related to the Combination.<div style="display:inline-block;width:8px"> </div>The Company has also submitted an indemnification claim against funds held in </div><div id="a13504" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">escrow by Houghton’s former<div style="display:inline-block;width:5px"> </div>owners and as a result, a corresponding $</div><div id="a13504_69_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:388px;top:61px;">5.4</div><div id="a13504_72_50" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:405px;top:61px;"><div style="display:inline-block;width:3px"> </div>million indemnification receivable has also been </div><div id="a13544" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">established through purchase accounting.<div style="display:inline-block;width:8px"> </div>In October 2021, the Company settled a portion of the Houghton Italia<div style="display:inline-block;width:5px"> </div>S.r.l corporate </div><div id="a13581" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:92px;">income tax audit with the Italian tax authorities for the tax year 2015.<div style="display:inline-block;width:8px"> </div>The Company remains under audit for tax years 2014 and 2016 </div><div id="a13630" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:107px;">through 2018 and believes it has adequate reserves for the remaining uncertain<div style="display:inline-block;width:5px"> </div>tax positions. </div><div id="a13659" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:131px;">Houghton Deutschland GmbH is also under audit by the German tax authorities for<div style="display:inline-block;width:5px"> </div>the tax years </div><div id="a13659_94_4" style="position:absolute;font-family:'Times New Roman';left:547px;top:131px;">2015</div><div id="a13659_98_9" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:131px;"><div style="display:inline-block;width:3px"> </div>through </div><div id="a13659_107_4" style="position:absolute;font-family:'Times New Roman';left:622px;top:131px;">2017</div><div id="a13659_111_12" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:649px;top:131px;">.<div style="display:inline-block;width:7px"> </div>Based on </div><div id="a13701" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:146px;">preliminary audit findings, primarily related to transfer pricing,<div style="display:inline-block;width:5px"> </div>the Company has recorded reserves for $</div><div id="a13701_106_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:564px;top:146px;">0.9</div><div id="a13701_109_25" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:581px;top:146px;"><div style="display:inline-block;width:3px"> </div>million as of September </div><div id="a13740" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:161px;">30, 2021.<div style="display:inline-block;width:7px"> </div>Of this amount, $</div><div id="a13740_28_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:155px;top:161px;">0.8</div><div id="a13740_31_100" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:171px;top:161px;"><div style="display:inline-block;width:3px"> </div>million relates to tax periods prior to the Combination and therefore<div style="display:inline-block;width:5px"> </div>the Company has submitted an </div><div id="a13786" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:177px;">indemnification claim with Houghton’s<div style="display:inline-block;width:5px"> </div>former owners for any tax liabilities arising pre-Combination.<div style="display:inline-block;width:8px"> </div>As a result, a corresponding </div><div id="a13822" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:192px;">$</div><div id="a13822_1_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:11px;top:192px;">0.8</div><div id="a13822_4_77" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:192px;"><div style="display:inline-block;width:3px"> </div>million indemnification receivable has also been established to offset<div style="display:inline-block;width:5px"> </div>the $</div><div id="a13822_81_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:430px;top:192px;">0.8</div><div id="a13822_84_45" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:446px;top:192px;"><div style="display:inline-block;width:3px"> </div>million tax liability.<div style="display:inline-block;width:8px"> </div>In October 2021 the </div><div id="a13863" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:207px;">Company received a settlement proposal from the German<div style="display:inline-block;width:5px"> </div>tax authorities and is currently reviewing the proposal with Houghton’s </div><div id="a13900" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:223px;">former owners.</div></div> 0.026 0.218 0.081 -0.383 5900000 5800000 24000000.0 1900000 200000 400000 -100000 200000 200000 400000 100000 500000 3300000 3500000 3000000.0 3900000 1200000 1900000 1500000 2006 2011 2015 2015 2016 2016 2018 2018 2019 2011 As previously reported, the Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia S.r.l., relating to the tax years 2007 through 2015. The Company has filed for competent authority relief from these assessments under the Mutual Agreement Procedures (“MAP”) of the Organization for Economic Co-Operation and Development for all years except 2007. In 2020, the respective tax authorities in Italy, Spain and the Netherlands reached agreement with respect to the MAP proceedings which the Company has accepted. 2007 2015 -1600000 2600000 2014 2018 6000000.0 5400000 2015 2017 900000 800000 800000 800000 <div id="TextBlockContainer672" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:705px;height:55px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a13905" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 12 – Earnings Per Share </div><div id="a13911" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The following table summarizes earnings per share calculations for<div style="display:inline-block;width:5px"> </div>the three and nine months ended September 30, 2021 and </div><div id="a13912" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">2020:</div></div><div id="TextBlockContainer676" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:730px;height:317px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_674_XBRL_TS_4cf63bc0fd11463a81eb486457c9ef6b" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer675" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:730px;height:317px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a13916" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:388px;top:0px;">Three Months Ended<div style="display:inline-block;width:4px"> </div></div><div id="a13919" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:579px;top:0px;">Nine Months Ended </div><div id="a13923" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:408px;top:18px;">September 30, </div><div id="a13926" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:595px;top:18px;">September 30, </div><div id="a13930" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:388px;top:36px;">2021 </div><div id="a13933" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:483px;top:36px;">2020 </div><div id="a13936" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:576px;top:36px;">2021 </div><div id="a13939" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:669px;top:36px;">2020 </div><div id="a13941" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:54px;">Basic earnings (loss) per common share </div><div id="a13944" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:368px;top:54px;"><div style="display:inline-block;width:7px"> </div></div><div id="a13948" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:464px;top:54px;"><div style="display:inline-block;width:7px"> </div></div><div id="a13952" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:557px;top:54px;"><div style="display:inline-block;width:7px"> </div></div><div id="a13958" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:72px;">Net income (loss) attributable to Quaker Chemical Corporation </div><div id="a13961" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:71px;">$ </div><div id="a13963" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:403px;top:72px;">31,058</div><div id="a13966" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:71px;">$ </div><div id="a13968" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:498px;top:72px;">27,304</div><div id="a13971" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:71px;">$ </div><div id="a13973" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:584px;top:72px;">103,243</div><div id="a13976" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:71px;">$ </div><div id="a13978" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:686px;top:72px;display:flex;">(8,812)</div><div id="a13981" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:89px;">Less: (income) loss allocated to participating securities </div><div id="a13983" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:88px;"><div style="display:inline-block;width:3px"> </div></div><div id="a13985" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:415px;top:89px;display:flex;">(119)</div><div id="a13988" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:88px;"><div style="display:inline-block;width:3px"> </div></div><div id="a13990" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:510px;top:89px;display:flex;">(113)</div><div id="a13993" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:88px;"><div style="display:inline-block;width:3px"> </div></div><div id="a13995" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:603px;top:89px;display:flex;">(413)</div><div id="a13998" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:88px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14000" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:707px;top:89px;">44</div><div id="a14003" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:107px;">Net income (loss) available to common shareholders </div><div id="a14005" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:106px;">$ </div><div id="a14007" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:403px;top:107px;">30,939</div><div id="a14010" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:106px;">$ </div><div id="a14012" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:498px;top:107px;">27,191</div><div id="a14015" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:106px;">$ </div><div id="a14017" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:584px;top:107px;">102,830</div><div id="a14020" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:106px;">$ </div><div id="a14022" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:686px;top:107px;display:flex;">(8,768)</div><div id="a14025" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:125px;">Basic weighted average common shares outstanding </div><div id="a14028" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:380px;top:125px;">17,812,216</div><div id="a14033" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:125px;">17,743,538</div><div id="a14037" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:125px;">17,800,082</div><div id="a14041" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:125px;">17,704,662</div><div id="a14043" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:142px;">Basic earnings (loss) per common share </div><div id="a14045" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:141px;">$ </div><div id="a14047" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:416px;top:142px;">1.74</div><div id="a14050" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:141px;">$ </div><div id="a14052" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:511px;top:142px;">1.53</div><div id="a14055" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:141px;">$ </div><div id="a14057" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:604px;top:142px;">5.78</div><div id="a14060" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:141px;">$ </div><div id="a14062" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:692px;top:142px;display:flex;">(0.50)</div><div id="a14077" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:177px;">Diluted earnings (loss) per common share </div><div id="a14092" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:195px;">Net income (loss) attributable to Quaker Chemical Corporation </div><div id="a14094" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:194px;">$ </div><div id="a14096" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:403px;top:195px;">31,058</div><div id="a14099" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:194px;">$ </div><div id="a14101" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:498px;top:195px;">27,304</div><div id="a14104" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:194px;">$ </div><div id="a14106" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:584px;top:195px;">103,243</div><div id="a14109" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:194px;">$ </div><div id="a14111" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:686px;top:195px;display:flex;">(8,812)</div><div id="a14114" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:213px;">Less: (income) loss allocated to participating securities </div><div id="a14117" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:415px;top:213px;display:flex;">(119)</div><div id="a14120" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:212px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14122" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:510px;top:213px;display:flex;">(113)</div><div id="a14125" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:212px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14127" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:603px;top:213px;display:flex;">(412)</div><div id="a14130" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:212px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14132" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:707px;top:213px;">44</div><div id="a14135" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:230px;">Net income (loss) available to common shareholders </div><div id="a14137" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:229px;">$ </div><div id="a14139" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:403px;top:230px;">30,939</div><div id="a14142" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:229px;">$ </div><div id="a14144" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:498px;top:230px;">27,191</div><div id="a14147" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:229px;">$ </div><div id="a14149" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:584px;top:230px;">102,831</div><div id="a14152" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:229px;">$ </div><div id="a14154" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:686px;top:230px;display:flex;">(8,768)</div><div id="a14157" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:247px;">Basic weighted average common shares outstanding </div><div id="a14160" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:380px;top:248px;">17,812,216</div><div id="a14164" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:248px;">17,743,538</div><div id="a14169" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:248px;">17,800,082</div><div id="a14173" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:248px;">17,704,662</div><div id="a14176" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:264px;">Effect of dilutive securities </div><div id="a14179" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:403px;top:264px;">58,176</div><div id="a14183" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:498px;top:264px;">57,327</div><div id="a14187" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:591px;top:264px;">59,986</div><div id="a14191" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:707px;top:264px;">—</div><div id="a14194" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:282px;">Diluted weighted average common shares outstanding </div><div id="a14197" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:380px;top:282px;">17,870,392</div><div id="a14201" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:282px;">17,800,865</div><div id="a14205" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:282px;">17,860,068</div><div id="a14209" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:282px;">17,704,662</div><div id="a14211" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:301px;">Diluted earnings (loss) per common share </div><div id="a14213" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:300px;">$ </div><div id="a14215" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:416px;top:301px;">1.73</div><div id="a14218" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:300px;">$ </div><div id="a14220" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:511px;top:301px;">1.53</div><div id="a14223" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:300px;">$ </div><div id="a14225" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:604px;top:301px;">5.76</div><div id="a14228" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:300px;">$ </div><div id="a14230" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:692px;top:301px;display:flex;">(0.50)</div></div></div></div><div id="TextBlockContainer678" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:93px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14232" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Certain stock options and restricted stock units are not included in the diluted<div style="display:inline-block;width:5px"> </div>earnings (loss) per share calculation when the effect </div><div id="a14234" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">would have been anti-dilutive.<div style="display:inline-block;width:7px"> </div>The calculated amount of anti-diluted shares not included was </div><div id="a14234_94_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:508px;top:15px;">5,531</div><div id="a14234_99_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:538px;top:15px;"><div style="display:inline-block;width:3px"> </div>and </div><div id="a14234_104_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:564px;top:15px;">3,722</div><div id="a14234_109_24" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:594px;top:15px;"><div style="display:inline-block;width:3px"> </div>for the three and nine </div><div id="a14247" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">months ended September 30, 2021,<div style="display:inline-block;width:4px"> </div>respectively.<div style="display:inline-block;width:7px"> </div>All of the Company’s potentially<div style="display:inline-block;width:5px"> </div>dilutive shares for the nine months ended </div><div id="a14262" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">September 30, 2020 are anti-dilutive and not included in the dilutive loss per<div style="display:inline-block;width:5px"> </div>share calculations because of the Company’s net<div style="display:inline-block;width:5px"> </div>loss </div><div id="a14265" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">during the period.<div style="display:inline-block;width:7px"> </div>There were </div><div id="a14265_31_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:170px;top:61px;">no</div><div id="a14265_33_100" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:183px;top:61px;"><div style="display:inline-block;width:3px"> </div>anti-dilutive shares excluded from the diluted earnings per share calculation for the three months </div><div id="a14269" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">ended September 30, 2020.</div></div> <div id="TextBlockContainer675" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:730px;height:317px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a13916" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:388px;top:0px;">Three Months Ended<div style="display:inline-block;width:4px"> </div></div><div id="a13919" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:579px;top:0px;">Nine Months Ended </div><div id="a13923" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:408px;top:18px;">September 30, </div><div id="a13926" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:595px;top:18px;">September 30, </div><div id="a13930" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:388px;top:36px;">2021 </div><div id="a13933" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:483px;top:36px;">2020 </div><div id="a13936" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:576px;top:36px;">2021 </div><div id="a13939" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:669px;top:36px;">2020 </div><div id="a13941" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:54px;">Basic earnings (loss) per common share </div><div id="a13944" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:368px;top:54px;"><div style="display:inline-block;width:7px"> </div></div><div id="a13948" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:464px;top:54px;"><div style="display:inline-block;width:7px"> </div></div><div id="a13952" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:557px;top:54px;"><div style="display:inline-block;width:7px"> </div></div><div id="a13958" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:72px;">Net income (loss) attributable to Quaker Chemical Corporation </div><div id="a13961" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:71px;">$ </div><div id="a13963" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:403px;top:72px;">31,058</div><div id="a13966" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:71px;">$ </div><div id="a13968" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:498px;top:72px;">27,304</div><div id="a13971" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:71px;">$ </div><div id="a13973" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:584px;top:72px;">103,243</div><div id="a13976" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:71px;">$ </div><div id="a13978" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:686px;top:72px;display:flex;">(8,812)</div><div id="a13981" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:89px;">Less: (income) loss allocated to participating securities </div><div id="a13983" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:88px;"><div style="display:inline-block;width:3px"> </div></div><div id="a13985" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:415px;top:89px;display:flex;">(119)</div><div id="a13988" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:88px;"><div style="display:inline-block;width:3px"> </div></div><div id="a13990" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:510px;top:89px;display:flex;">(113)</div><div id="a13993" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:88px;"><div style="display:inline-block;width:3px"> </div></div><div id="a13995" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:603px;top:89px;display:flex;">(413)</div><div id="a13998" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:88px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14000" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:707px;top:89px;">44</div><div id="a14003" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:107px;">Net income (loss) available to common shareholders </div><div id="a14005" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:106px;">$ </div><div id="a14007" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:403px;top:107px;">30,939</div><div id="a14010" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:106px;">$ </div><div id="a14012" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:498px;top:107px;">27,191</div><div id="a14015" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:106px;">$ </div><div id="a14017" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:584px;top:107px;">102,830</div><div id="a14020" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:106px;">$ </div><div id="a14022" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:686px;top:107px;display:flex;">(8,768)</div><div id="a14025" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:125px;">Basic weighted average common shares outstanding </div><div id="a14028" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:380px;top:125px;">17,812,216</div><div id="a14033" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:125px;">17,743,538</div><div id="a14037" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:125px;">17,800,082</div><div id="a14041" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:125px;">17,704,662</div><div id="a14043" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:142px;">Basic earnings (loss) per common share </div><div id="a14045" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:141px;">$ </div><div id="a14047" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:416px;top:142px;">1.74</div><div id="a14050" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:141px;">$ </div><div id="a14052" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:511px;top:142px;">1.53</div><div id="a14055" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:141px;">$ </div><div id="a14057" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:604px;top:142px;">5.78</div><div id="a14060" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:141px;">$ </div><div id="a14062" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:692px;top:142px;display:flex;">(0.50)</div><div id="a14077" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:177px;">Diluted earnings (loss) per common share </div><div id="a14092" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:195px;">Net income (loss) attributable to Quaker Chemical Corporation </div><div id="a14094" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:194px;">$ </div><div id="a14096" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:403px;top:195px;">31,058</div><div id="a14099" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:194px;">$ </div><div id="a14101" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:498px;top:195px;">27,304</div><div id="a14104" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:194px;">$ </div><div id="a14106" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:584px;top:195px;">103,243</div><div id="a14109" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:194px;">$ </div><div id="a14111" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:686px;top:195px;display:flex;">(8,812)</div><div id="a14114" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:213px;">Less: (income) loss allocated to participating securities </div><div id="a14117" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:415px;top:213px;display:flex;">(119)</div><div id="a14120" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:212px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14122" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:510px;top:213px;display:flex;">(113)</div><div id="a14125" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:212px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14127" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:603px;top:213px;display:flex;">(412)</div><div id="a14130" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:212px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14132" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:707px;top:213px;">44</div><div id="a14135" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:230px;">Net income (loss) available to common shareholders </div><div id="a14137" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:229px;">$ </div><div id="a14139" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:403px;top:230px;">30,939</div><div id="a14142" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:229px;">$ </div><div id="a14144" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:498px;top:230px;">27,191</div><div id="a14147" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:229px;">$ </div><div id="a14149" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:584px;top:230px;">102,831</div><div id="a14152" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:229px;">$ </div><div id="a14154" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:686px;top:230px;display:flex;">(8,768)</div><div id="a14157" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:247px;">Basic weighted average common shares outstanding </div><div id="a14160" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:380px;top:248px;">17,812,216</div><div id="a14164" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:248px;">17,743,538</div><div id="a14169" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:248px;">17,800,082</div><div id="a14173" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:248px;">17,704,662</div><div id="a14176" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:264px;">Effect of dilutive securities </div><div id="a14179" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:403px;top:264px;">58,176</div><div id="a14183" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:498px;top:264px;">57,327</div><div id="a14187" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:591px;top:264px;">59,986</div><div id="a14191" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:707px;top:264px;">—</div><div id="a14194" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:282px;">Diluted weighted average common shares outstanding </div><div id="a14197" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:380px;top:282px;">17,870,392</div><div id="a14201" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:282px;">17,800,865</div><div id="a14205" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:282px;">17,860,068</div><div id="a14209" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:282px;">17,704,662</div><div id="a14211" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:301px;">Diluted earnings (loss) per common share </div><div id="a14213" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:300px;">$ </div><div id="a14215" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:416px;top:301px;">1.73</div><div id="a14218" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:300px;">$ </div><div id="a14220" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:511px;top:301px;">1.53</div><div id="a14223" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:300px;">$ </div><div id="a14225" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:604px;top:301px;">5.76</div><div id="a14228" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:300px;">$ </div><div id="a14230" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:692px;top:301px;display:flex;">(0.50)</div></div> 31058000 27304000 103243000 -8812000 119000 113000 413000 -44000 30939000 27191000 102830000 -8768000 17812216 17743538 17800082 17704662 1.74 1.53 5.78 -0.50 31058000 27304000 103243000 -8812000 119000 113000 412000 -44000 30939000 27191000 102831000 -8768000 17812216 17743538 17800082 17704662 58176 57327 59986 0 17870392 17800865 17860068 17704662 1.73 1.53 5.76 -0.50 5531 3722 0 <div id="TextBlockContainer680" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:734px;height:116px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14271" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 13 – Restricted Cash </div><div id="a14281" style="position:absolute;font-family:'Times New Roman';left:28px;top:23px;">Prior to December 2020, the Company had restricted cash recorded in other assets related to proceeds from an inactive subsidiary </div><div id="a14323" style="position:absolute;font-family:'Times New Roman';left:4px;top:39px;">of the Company which previously executed separate settlement and release agreements with two of its insurance carriers for an </div><div id="a14361" style="position:absolute;font-family:'Times New Roman';left:4px;top:54px;">original total value of $35.0 million.</div><div id="a14361_38_98" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:198px;top:54px;"><div style="display:inline-block;width:7px"> </div>The proceeds of both settlements were restricted and could only be used<div style="display:inline-block;width:5px"> </div>to pay claims and costs </div><div id="a14408" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">of defense associated with the subsidiary’s<div style="display:inline-block;width:5px"> </div>asbestos litigation.<div style="display:inline-block;width:7px"> </div>The proceeds of the settlement and release agreements were deposited </div><div id="a14445" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">into interest bearing accounts that earned less than $</div><div id="a14445_54_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:283px;top:85px;">0.1</div><div id="a14445_57_20" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:300px;top:85px;"><div style="display:inline-block;width:3px"> </div>million offset by $</div><div id="a14445_77_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:85px;">0.8</div><div id="a14445_80_54" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:419px;top:85px;"><div style="display:inline-block;width:3px"> </div>million of net payments during the nine months ended </div><div id="a14486" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">September 30, 2020.<div style="display:inline-block;width:7px"> </div>Due to the restricted nature of the proceeds, a corresponding deferred credit was established<div style="display:inline-block;width:5px"> </div>in other non-current<div style="display:inline-block;width:4px"> </div></div></div><div id="TextBlockContainer682" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:723px;height:47px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14543" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">liabilities for an equal and offsetting amount that continued<div style="display:inline-block;width:5px"> </div>until the restrictions lapsed.<div style="display:inline-block;width:7px"> </div>As disclosed in the Company’s 2020<div style="display:inline-block;width:5px"> </div>Form </div><div id="a14585" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">10-K, during December 2020, the restrictions ended on these previously<div style="display:inline-block;width:5px"> </div>received insurance settlements and the Company transferred </div><div id="a14621" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">the cash into an operating account.</div></div><div id="TextBlockContainer684" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:726px;height:31px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14633" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The following table provides a reconciliation of cash, cash equivalents<div style="display:inline-block;width:5px"> </div>and restricted cash as of September 30, 2021 and 2020,<div style="display:inline-block;width:4px"> </div>as </div><div id="a14668" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">well as December 31, 2020 and 2019:</div></div><div id="TextBlockContainer687" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:727px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14680" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:407px;top:0px;">September 30, </div><div id="a14683" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:596px;top:0px;">December 31, </div><div id="a14686" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:387px;top:18px;">2021 </div><div id="a14689" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:482px;top:18px;">2020 </div><div id="a14692" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:575px;top:18px;">2020 </div><div id="a14695" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:668px;top:18px;">2019 </div><div id="a14697" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:35px;">Cash and cash equivalents </div><div id="a14699" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:35px;">$ </div><div id="a14701" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:35px;">141,393</div><div id="a14704" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:35px;">$ </div><div id="a14706" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:35px;">155,750</div><div id="a14709" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:35px;">$ </div><div id="a14711" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:35px;">181,833</div><div id="a14714" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:35px;">$ </div><div id="a14716" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:35px;">123,524</div><div id="a14718" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:53px;">Restricted cash included in other current assets </div><div id="a14721" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:424px;top:53px;">—</div><div id="a14725" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:53px;">82</div><div id="a14729" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:612px;top:53px;">62</div><div id="a14733" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:699px;top:53px;">353</div><div id="a14735" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:70px;">Restricted cash included in other assets </div><div id="a14738" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:424px;top:70px;">—</div><div id="a14742" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:70px;">18,901</div><div id="a14746" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:612px;top:70px;">—</div><div id="a14750" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:70px;">19,678</div><div id="a14752" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:89px;">Cash, cash equivalents and restricted cash </div><div id="a14755" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:89px;">$ </div><div id="a14757" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:89px;">141,393</div><div id="a14760" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:89px;">$ </div><div id="a14762" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:89px;">174,733</div><div id="a14765" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:89px;">$ </div><div id="a14767" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:89px;">181,895</div><div id="a14770" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:89px;">$ </div><div id="a14772" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:89px;">143,555</div></div> Prior to December 2020, the Company had restricted cash recorded in other assets related to proceeds from an inactive subsidiary of the Company which previously executed separate settlement and release agreements with two of its insurance carriers for an original total value of $35.0 million. 35000000.0 100000 800000 <div id="TextBlockContainer688" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:727px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_686_XBRL_TS_017fb2abe70047849a324fdf1864768e" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer687" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:727px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14680" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:407px;top:0px;">September 30, </div><div id="a14683" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:596px;top:0px;">December 31, </div><div id="a14686" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:387px;top:18px;">2021 </div><div id="a14689" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:482px;top:18px;">2020 </div><div id="a14692" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:575px;top:18px;">2020 </div><div id="a14695" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:668px;top:18px;">2019 </div><div id="a14697" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:35px;">Cash and cash equivalents </div><div id="a14699" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:35px;">$ </div><div id="a14701" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:35px;">141,393</div><div id="a14704" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:35px;">$ </div><div id="a14706" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:35px;">155,750</div><div id="a14709" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:35px;">$ </div><div id="a14711" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:35px;">181,833</div><div id="a14714" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:35px;">$ </div><div id="a14716" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:35px;">123,524</div><div id="a14718" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:53px;">Restricted cash included in other current assets </div><div id="a14721" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:424px;top:53px;">—</div><div id="a14725" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:53px;">82</div><div id="a14729" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:612px;top:53px;">62</div><div id="a14733" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:699px;top:53px;">353</div><div id="a14735" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:70px;">Restricted cash included in other assets </div><div id="a14738" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:424px;top:70px;">—</div><div id="a14742" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:70px;">18,901</div><div id="a14746" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:612px;top:70px;">—</div><div id="a14750" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:70px;">19,678</div><div id="a14752" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:89px;">Cash, cash equivalents and restricted cash </div><div id="a14755" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:89px;">$ </div><div id="a14757" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:89px;">141,393</div><div id="a14760" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:89px;">$ </div><div id="a14762" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:89px;">174,733</div><div id="a14765" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:89px;">$ </div><div id="a14767" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:89px;">181,895</div><div id="a14770" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:89px;">$ </div><div id="a14772" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:89px;">143,555</div></div></div></div> 141393000 155750000 181833000 123524000 0 82000 62000 353000 0 18901000 0 19678000 141393000 174733000 181895000 143555000 <div id="TextBlockContainer690" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:617px;height:40px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14774" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 14 – Goodwill and Other Intangible Assets </div><div id="a14779" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">Changes in the carrying amount of goodwill for the nine months ended<div style="display:inline-block;width:5px"> </div>September 30, 2021 were as follows:</div></div><div id="TextBlockContainer693" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:116px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14792" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:569px;top:0px;">Global </div><div id="a14807" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:562px;top:16px;">Specialty </div><div id="a14814" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:278px;top:31px;">Americas </div><div id="a14817" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:380px;top:31px;">EMEA </div><div id="a14820" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:461px;top:31px;">Asia/Pacific </div><div id="a14823" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:558px;top:31px;">Businesses </div><div id="a14826" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:666px;top:31px;">Total </div><div id="a14828" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:48px;">Balance as of December 31, 2020 </div><div id="a14830" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:48px;">$ </div><div id="a14832" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:299px;top:48px;">213,242</div><div id="a14835" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:48px;">$ </div><div id="a14837" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:48px;">140,162</div><div id="a14840" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:48px;">$ </div><div id="a14842" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:48px;">158,090</div><div id="a14846" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:48px;">$ </div><div id="a14848" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:48px;">119,718</div><div id="a14850" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:48px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14852" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:48px;">$ </div><div id="a14854" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:48px;">631,212</div><div id="a14857" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:65px;">Goodwill additions </div><div id="a14860" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:312px;top:65px;">1,208</div><div id="a14864" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:408px;top:65px;">2,626</div><div id="a14868" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:503px;top:65px;">1,308</div><div id="a14872" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:596px;top:65px;">1,951</div><div id="a14876" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:689px;top:65px;">7,093</div><div id="a14879" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:82px;">Currency translation and other adjustments </div><div id="a14881" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14883" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:318px;top:82px;display:flex;">(621)</div><div id="a14887" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:403px;top:82px;display:flex;">(5,530)</div><div id="a14891" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:503px;top:82px;">1,109</div><div id="a14895" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:591px;top:82px;display:flex;">(2,594)</div><div id="a14899" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:684px;top:82px;display:flex;">(7,636)</div><div id="a14901" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">Balance as of September 30, 2021 </div><div id="a14904" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:100px;">$ </div><div id="a14906" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:299px;top:100px;">213,829</div><div id="a14909" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:100px;">$ </div><div id="a14911" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:100px;">137,258</div><div id="a14914" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:100px;">$ </div><div id="a14916" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:100px;">160,507</div><div id="a14919" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:100px;">$ </div><div id="a14921" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:100px;">119,075</div><div id="a14923" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:100px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14925" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:100px;">$ </div><div id="a14927" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:100px;">630,669</div></div><div id="TextBlockContainer696" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:676px;height:32px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14929" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Gross carrying amounts and accumulated amortization for definite-lived<div style="display:inline-block;width:5px"> </div>intangible assets as of September 30, 2021 and </div><div id="a14934" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">December 31, 2020 were as follows:</div></div><div id="TextBlockContainer699" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:728px;height:116px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14940" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:403px;top:0px;">Gross Carrying </div><div id="a14943" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:597px;top:0px;">Accumulated </div><div id="a14947" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:424px;top:15px;">Amount </div><div id="a14950" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:596px;top:15px;">Amortization </div><div id="a14954" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:387px;top:31px;">2021 </div><div id="a14957" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:482px;top:31px;">2020 </div><div id="a14960" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:575px;top:31px;">2021 </div><div id="a14963" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:668px;top:31px;">2020 </div><div id="a14965" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:48px;">Customer lists and rights to sell </div><div id="a14967" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:48px;">$ </div><div id="a14969" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:395px;top:48px;">847,909</div><div id="a14971" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:48px;"><div style="display:inline-block;width:7px"> </div></div><div id="a14973" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:48px;">$ </div><div id="a14975" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:490px;top:48px;">839,551</div><div id="a14977" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:538px;top:48px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14979" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:48px;">$ </div><div id="a14981" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:583px;top:48px;">135,571</div><div id="a14983" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:48px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14985" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:48px;">$ </div><div id="a14987" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:683px;top:48px;">99,806</div><div id="a14989" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:65px;">Trademarks, formulations and product<div style="display:inline-block;width:5px"> </div>technology </div><div id="a14991" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14993" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:395px;top:65px;">167,682</div><div id="a14995" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:65px;"><div style="display:inline-block;width:7px"> </div></div><div id="a14997" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14999" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:490px;top:65px;">166,448</div><div id="a15001" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:538px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15003" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15005" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:590px;top:65px;">36,871</div><div id="a15007" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15009" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15011" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:683px;top:65px;">30,483</div><div id="a15013" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:82px;">Other </div><div id="a15015" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15017" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:82px;">6,325</div><div id="a15019" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:82px;"><div style="display:inline-block;width:7px"> </div></div><div id="a15021" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15023" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:504px;top:82px;">6,372</div><div id="a15025" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:538px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15027" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15029" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:597px;top:82px;">5,886</div><div id="a15031" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15033" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15035" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:690px;top:82px;">5,824</div><div id="a15037" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">Total definite-lived<div style="display:inline-block;width:5px"> </div>intangible assets </div><div id="a15041" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:100px;">$ </div><div id="a15043" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:385px;top:100px;">1,021,916</div><div id="a15045" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:100px;"><div style="display:inline-block;width:7px"> </div></div><div id="a15047" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:100px;">$ </div><div id="a15049" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:480px;top:100px;">1,012,371</div><div id="a15051" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:538px;top:100px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15053" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:100px;">$ </div><div id="a15055" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:583px;top:100px;">178,328</div><div id="a15057" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:100px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15059" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:100px;">$ </div><div id="a15061" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:676px;top:100px;">136,113</div></div><div id="TextBlockContainer702" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:721px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15063" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The Company amortizes definite-lived intangible assets on a straight-line basis over<div style="display:inline-block;width:5px"> </div>their useful lives.<div style="display:inline-block;width:7px"> </div>The Company recorded </div><div id="a15071" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">$</div><div id="a15071_1_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:11px;top:15px;">14.9</div><div id="a15071_5_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:35px;top:15px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a15071_19_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:109px;top:15px;">44.7</div><div id="a15071_23_104" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:132px;top:15px;"><div style="display:inline-block;width:3px"> </div>million of amortization expense for the three and nine months ended September<div style="display:inline-block;width:5px"> </div>30, 2021, respectively.<div style="display:inline-block;width:5px"> </div></div><div id="a15073" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Comparatively,<div style="display:inline-block;width:5px"> </div>the Company recorded $</div><div id="a15073_37_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:222px;top:31px;">14.0</div><div id="a15073_41_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:245px;top:31px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a15073_55_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:31px;">41.7</div><div id="a15073_59_69" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:343px;top:31px;"><div style="display:inline-block;width:3px"> </div>million of amortization expense for the three and nine months ended </div><div id="a15075" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">September 30, 2020, respectively.</div></div><div id="TextBlockContainer704" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:598px;height:16px;display:inline-block;"><div id="a15078" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">Estimated annual aggregate amortization expense for the current year<div style="display:inline-block;width:5px"> </div>and subsequent five years is as follows:</div></div><div id="TextBlockContainer708" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:366px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_706_XBRL_TS_a365e22f30ed407c9cd8c1d17986a8f3" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer707" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:366px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15081" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:1px;">For the year ended December 31, 2021 </div><div id="a15083" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:276px;top:1px;">$ </div><div id="a15085" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:321px;top:0px;">58,852</div><div id="a15089" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:19px;">For the year ended December 31, 2022 </div><div id="a15092" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:321px;top:18px;">59,173</div><div id="a15096" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:36px;">For the year ended December 31, 2023 </div><div id="a15099" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:321px;top:35px;">59,005</div><div id="a15103" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">For the year ended December 31, 2024 </div><div id="a15106" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:321px;top:53px;">58,338</div><div id="a15110" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:72px;">For the year ended December 31, 2025 </div><div id="a15113" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:321px;top:70px;">57,653</div><div id="a15117" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:89px;">For the year ended December 31, 2026 </div><div id="a15120" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:321px;top:88px;">57,346</div></div></div></div><div id="TextBlockContainer712" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:730px;height:101px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15123" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The Company has four indefinite-lived intangible assets totaling $</div><div id="a15123_66_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:0px;">205.1</div><div id="a15123_71_56" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:412px;top:0px;"><div style="display:inline-block;width:3px"> </div>million as of both September 30, 2021 and December 31, </div><div id="a15134" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">2020, including $</div><div id="a15134_17_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:98px;top:15px;">204.0</div><div id="a15134_22_109" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:128px;top:15px;"><div style="display:inline-block;width:3px"> </div>million of indefinite-lived intangible assets for trademarks and tradename associated<div style="display:inline-block;width:5px"> </div>with the Combination. </div><div id="div_710_XBRL_TS_de5984e19ad942cf99354fda61402a5d" style="position:absolute;left:0px;top:39px;float:left;"><div id="TextBlockContainer711" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:714px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15140" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Goodwill and intangible assets that have indefinite lives are not amortized and<div style="display:inline-block;width:5px"> </div>are required to be assessed at least annually for </div><div id="a15143" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">impairment.<div style="display:inline-block;width:7px"> </div>The Company completes its annual goodwill and indefinite-lived intangible asset impairment<div style="display:inline-block;width:5px"> </div>test during the fourth </div><div id="a15147" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">quarter of each year.<div style="display:inline-block;width:8px"> </div>The Company continuously evaluates if triggering events indicate a possible impairment<div style="display:inline-block;width:5px"> </div>in one or more of its </div><div id="a15149" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">reporting units or indefinite-lived or long-lived assets.</div></div></div></div><div id="TextBlockContainer714" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:331px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15172" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The Company previously disclosed in its 2020 Form 10-K that as of March 31, 2020,<div style="display:inline-block;width:5px"> </div>the Company concluded that the impact of </div><div id="a15175" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">COVID-19 did not represent a triggering event with regards to the Company’s<div style="display:inline-block;width:6px"> </div>reporting units or indefinite-lived and long-lived assets, </div><div id="a15183" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">except for the Company’s Houghton<div style="display:inline-block;width:5px"> </div>and Fluidcare trademarks and tradename indefinite-lived intangible assets.<div style="display:inline-block;width:8px"> </div>The determination of </div><div id="a15186" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">estimated fair value of the Houghton and Fluidcare trademarks and tradename<div style="display:inline-block;width:5px"> </div>indefinite-lived assets was based on a relief from </div><div id="a15190" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">royalty valuation method, which requires management’s<div style="display:inline-block;width:5px"> </div>judgment and often involves the use of significant estimates and assumptions, </div><div id="a15192" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">including assumptions with respect to the weighted average cost of capital<div style="display:inline-block;width:5px"> </div>(“WACC”)<div style="display:inline-block;width:5px"> </div>and royalty rates, as well as revenue growth </div><div id="a15194" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:92px;">rates and terminal growth rates.<div style="display:inline-block;width:7px"> </div>In the first quarter of 2020, as a result of the impact of COVID-19 driving<div style="display:inline-block;width:5px"> </div>a decrease in projected </div><div id="a15197" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:107px;">legacy Houghton net sales during that year and the impact of the sales decline on<div style="display:inline-block;width:5px"> </div>projected future legacy Houghton net sales as well as </div><div id="a15199" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:123px;">an increase in the WACC<div style="display:inline-block;width:5px"> </div>assumption utilized in the quantitative impairment assessment, the<div style="display:inline-block;width:5px"> </div>Company concluded that the estimated </div><div id="a15201" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:138px;">fair values of the Houghton and Fluidcare trademarks and tradename<div style="display:inline-block;width:5px"> </div>intangible assets were less than their carrying values.<div style="display:inline-block;width:7px"> </div>As a </div><div id="a15203" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:153px;">result, an impairment charge of $</div><div id="a15203_33_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:182px;top:153px;">38.0</div><div id="a15203_37_94" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:205px;top:153px;"><div style="display:inline-block;width:3px"> </div>million was recorded in the first quarter of 2020 to write down the carrying values of<div style="display:inline-block;width:5px"> </div>these </div><div id="a15205" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:169px;">intangible assets to their estimated fair values. </div><div id="a15207" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:192px;">As of September 30, 2021, the Company continued to evaluate all potential triggering<div style="display:inline-block;width:5px"> </div>events, including the on-going impact of </div><div id="a15249" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:207px;">COVID-19 on the Company’s operations,<div style="display:inline-block;width:5px"> </div>and the volatility and uncertainty in the economic outlook as a result of COVID-19,<div style="display:inline-block;width:5px"> </div>to </div><div id="a15293" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:223px;">determine if this indicated it was more likely than not that the carrying value<div style="display:inline-block;width:5px"> </div>of any of the Company’s reporting<div style="display:inline-block;width:5px"> </div>units or indefinite-</div><div id="a15340" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:238px;">lived or long-lived intangible assets were not recoverable.<div style="display:inline-block;width:8px"> </div>The Company concluded that the impact of COVID-19 did not represent<div style="display:inline-block;width:5px"> </div>a </div><div id="a15385" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:253px;">triggering event as of September 30, 2021.<div style="display:inline-block;width:8px"> </div>While the Company concluded that the impact of COVID-19 did not represent a<div style="display:inline-block;width:5px"> </div>triggering </div><div id="a15430" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:269px;">event as of September 30, 2021, the Company will continue to evaluate the<div style="display:inline-block;width:5px"> </div>impact of COVID-19 on the Company’s<div style="display:inline-block;width:5px"> </div>current and </div><div id="a15475" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:284px;">projected results. If the current economic conditions worsen or projections<div style="display:inline-block;width:5px"> </div>of the timeline for recovery are significantly extended, then </div><div id="a15513" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:299px;">the Company may conclude in the future that the impact from COVID-19<div style="display:inline-block;width:5px"> </div>requires the need to perform further interim quantitative </div><div id="a15556" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:315px;">impairment tests, which could result in additional impairment charges<div style="display:inline-block;width:5px"> </div>in the future.</div></div> <div id="TextBlockContainer694" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:116px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_692_XBRL_TS_52b60c3f2caf4e6da6d400c2e629a373" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer693" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:116px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14792" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:569px;top:0px;">Global </div><div id="a14807" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:562px;top:16px;">Specialty </div><div id="a14814" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:278px;top:31px;">Americas </div><div id="a14817" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:380px;top:31px;">EMEA </div><div id="a14820" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:461px;top:31px;">Asia/Pacific </div><div id="a14823" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:558px;top:31px;">Businesses </div><div id="a14826" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:666px;top:31px;">Total </div><div id="a14828" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:48px;">Balance as of December 31, 2020 </div><div id="a14830" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:48px;">$ </div><div id="a14832" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:299px;top:48px;">213,242</div><div id="a14835" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:48px;">$ </div><div id="a14837" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:48px;">140,162</div><div id="a14840" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:48px;">$ </div><div id="a14842" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:48px;">158,090</div><div id="a14846" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:48px;">$ </div><div id="a14848" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:48px;">119,718</div><div id="a14850" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:48px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14852" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:48px;">$ </div><div id="a14854" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:48px;">631,212</div><div id="a14857" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:65px;">Goodwill additions </div><div id="a14860" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:312px;top:65px;">1,208</div><div id="a14864" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:408px;top:65px;">2,626</div><div id="a14868" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:503px;top:65px;">1,308</div><div id="a14872" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:596px;top:65px;">1,951</div><div id="a14876" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:689px;top:65px;">7,093</div><div id="a14879" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:82px;">Currency translation and other adjustments </div><div id="a14881" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14883" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:318px;top:82px;display:flex;">(621)</div><div id="a14887" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:403px;top:82px;display:flex;">(5,530)</div><div id="a14891" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:503px;top:82px;">1,109</div><div id="a14895" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:591px;top:82px;display:flex;">(2,594)</div><div id="a14899" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:684px;top:82px;display:flex;">(7,636)</div><div id="a14901" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">Balance as of September 30, 2021 </div><div id="a14904" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:264px;top:100px;">$ </div><div id="a14906" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:299px;top:100px;">213,829</div><div id="a14909" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:100px;">$ </div><div id="a14911" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:100px;">137,258</div><div id="a14914" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:100px;">$ </div><div id="a14916" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:100px;">160,507</div><div id="a14919" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:100px;">$ </div><div id="a14921" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:100px;">119,075</div><div id="a14923" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:100px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14925" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:100px;">$ </div><div id="a14927" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:100px;">630,669</div></div></div></div> 213242000 140162000 158090000 119718000 631212000 1208000 2626000 1308000 1951000 7093000 -621000 -5530000 1109000 -2594000 -7636000 213829000 137258000 160507000 119075000 630669000 <div id="TextBlockContainer700" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:728px;height:116px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_698_XBRL_TS_06f89985a76745be86842dc0628bee1a" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer699" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:728px;height:116px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a14940" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:403px;top:0px;">Gross Carrying </div><div id="a14943" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:597px;top:0px;">Accumulated </div><div id="a14947" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:424px;top:15px;">Amount </div><div id="a14950" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:596px;top:15px;">Amortization </div><div id="a14954" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:387px;top:31px;">2021 </div><div id="a14957" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:482px;top:31px;">2020 </div><div id="a14960" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:575px;top:31px;">2021 </div><div id="a14963" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:668px;top:31px;">2020 </div><div id="a14965" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:48px;">Customer lists and rights to sell </div><div id="a14967" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:48px;">$ </div><div id="a14969" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:395px;top:48px;">847,909</div><div id="a14971" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:48px;"><div style="display:inline-block;width:7px"> </div></div><div id="a14973" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:48px;">$ </div><div id="a14975" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:490px;top:48px;">839,551</div><div id="a14977" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:538px;top:48px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14979" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:48px;">$ </div><div id="a14981" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:583px;top:48px;">135,571</div><div id="a14983" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:48px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14985" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:48px;">$ </div><div id="a14987" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:683px;top:48px;">99,806</div><div id="a14989" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:65px;">Trademarks, formulations and product<div style="display:inline-block;width:5px"> </div>technology </div><div id="a14991" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14993" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:395px;top:65px;">167,682</div><div id="a14995" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:65px;"><div style="display:inline-block;width:7px"> </div></div><div id="a14997" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a14999" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:490px;top:65px;">166,448</div><div id="a15001" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:538px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15003" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15005" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:590px;top:65px;">36,871</div><div id="a15007" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15009" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:65px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15011" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:683px;top:65px;">30,483</div><div id="a15013" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:82px;">Other </div><div id="a15015" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15017" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:82px;">6,325</div><div id="a15019" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:82px;"><div style="display:inline-block;width:7px"> </div></div><div id="a15021" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15023" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:504px;top:82px;">6,372</div><div id="a15025" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:538px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15027" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15029" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:597px;top:82px;">5,886</div><div id="a15031" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15033" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:82px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15035" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:690px;top:82px;">5,824</div><div id="a15037" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">Total definite-lived<div style="display:inline-block;width:5px"> </div>intangible assets </div><div id="a15041" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:100px;">$ </div><div id="a15043" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:385px;top:100px;">1,021,916</div><div id="a15045" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:100px;"><div style="display:inline-block;width:7px"> </div></div><div id="a15047" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:100px;">$ </div><div id="a15049" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:480px;top:100px;">1,012,371</div><div id="a15051" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:538px;top:100px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15053" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:100px;">$ </div><div id="a15055" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:583px;top:100px;">178,328</div><div id="a15057" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:632px;top:100px;"><div style="display:inline-block;width:3px"> </div></div><div id="a15059" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:640px;top:100px;">$ </div><div id="a15061" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:676px;top:100px;">136,113</div></div></div></div> 847909000 839551000 135571000 99806000 167682000 166448000 36871000 30483000 6325000 6372000 5886000 5824000 1021916000 1012371000 178328000 136113000 14900000 44700000 14000000.0 41700000 <div id="TextBlockContainer707" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:366px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15081" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:1px;">For the year ended December 31, 2021 </div><div id="a15083" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:276px;top:1px;">$ </div><div id="a15085" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:321px;top:0px;">58,852</div><div id="a15089" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:19px;">For the year ended December 31, 2022 </div><div id="a15092" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:321px;top:18px;">59,173</div><div id="a15096" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:36px;">For the year ended December 31, 2023 </div><div id="a15099" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:321px;top:35px;">59,005</div><div id="a15103" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">For the year ended December 31, 2024 </div><div id="a15106" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:321px;top:53px;">58,338</div><div id="a15110" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:72px;">For the year ended December 31, 2025 </div><div id="a15113" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:321px;top:70px;">57,653</div><div id="a15117" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:89px;">For the year ended December 31, 2026 </div><div id="a15120" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:321px;top:88px;">57,346</div></div> 58852000 59173000 59005000 58338000 57653000 57346000 205100000 205100000 204000000.0 204000000.0 <div id="TextBlockContainer711" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:714px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15140" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Goodwill and intangible assets that have indefinite lives are not amortized and<div style="display:inline-block;width:5px"> </div>are required to be assessed at least annually for </div><div id="a15143" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">impairment.<div style="display:inline-block;width:7px"> </div>The Company completes its annual goodwill and indefinite-lived intangible asset impairment<div style="display:inline-block;width:5px"> </div>test during the fourth </div><div id="a15147" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">quarter of each year.<div style="display:inline-block;width:8px"> </div>The Company continuously evaluates if triggering events indicate a possible impairment<div style="display:inline-block;width:5px"> </div>in one or more of its </div><div id="a15149" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">reporting units or indefinite-lived or long-lived assets.</div></div> 38000000.0 38000000.0 <div id="TextBlockContainer716" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:459px;height:39px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15581" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 15 – Debt<div style="display:inline-block;width:4px"> </div></div><div id="a15586" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">Debt as of September 30, 2021 and December 31, 2020 includes the following:</div></div><div id="TextBlockContainer720" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:685px;height:217px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_718_XBRL_TS_a1ea4a4dd4b147d5bfada4e8581daa8f" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer719" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:685px;height:217px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15610" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:328px;top:0px;">As of September 30, 2021 </div><div id="a15613" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:521px;top:0px;">As of December 31, 2020 </div><div id="a15619" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:317px;top:17px;">Interest </div><div id="a15623" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:402px;top:17px;">Outstanding<div style="display:inline-block;width:4px"> </div></div><div id="a15626" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:514px;top:17px;">Interest </div><div id="a15628" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:588px;top:17px;">Outstanding<div style="display:inline-block;width:4px"> </div></div><div id="a15634" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:326px;top:31px;">Rate </div><div id="a15637" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:415px;top:31px;">Balance </div><div id="a15640" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:523px;top:31px;">Rate </div><div id="a15642" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:601px;top:31px;">Balance </div><div id="a15646" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:47px;">Credit Facilities: </div><div id="a15661" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:65px;">Revolver </div><div id="a15664" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:327px;top:65px;display:flex;">1.58%</div><div id="a15667" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:385px;top:65px;">$ </div><div id="a15669" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:65px;">198,543</div><div id="a15672" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:514px;top:65px;display:flex;">1.65%</div><div id="a15675" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:65px;">$</div><div id="a15677" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:65px;">160,000</div><div id="a15682" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:82px;">U.S. Term Loan </div><div id="a15685" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:327px;top:82px;display:flex;">1.58%</div><div id="a15689" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:82px;">547,500</div><div id="a15692" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:514px;top:82px;display:flex;">1.65%</div><div id="a15696" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:629px;top:82px;">570,000</div><div id="a15701" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:99px;">EURO Term Loan </div><div id="a15704" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:327px;top:99px;display:flex;">1.50%</div><div id="a15708" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:99px;">142,559</div><div id="a15711" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:514px;top:99px;display:flex;">1.50%</div><div id="a15715" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:629px;top:99px;">157,062</div><div id="a15719" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">Industrial development bonds </div><div id="a15722" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:327px;top:116px;display:flex;">5.26%</div><div id="a15726" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:451px;top:116px;">10,000</div><div id="a15729" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:514px;top:116px;display:flex;">5.26%</div><div id="a15733" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:636px;top:116px;">10,000</div><div id="a15737" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:132px;">Bank lines of credit and other debt obligations </div><div id="a15740" style="position:absolute;font-family:'Times New Roman';left:323px;top:133px;">Various</div><div id="a15744" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:133px;">2,060</div><div id="a15747" style="position:absolute;font-family:'Times New Roman';left:510px;top:133px;">Various</div><div id="a15751" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:642px;top:133px;">2,072</div><div id="a15755" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:149px;">Total debt </div><div id="a15760" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:385px;top:150px;">$ </div><div id="a15762" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:150px;">900,662</div><div id="a15767" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:150px;">$</div><div id="a15769" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:629px;top:150px;">899,134</div><div id="a15773" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:166px;">Less: debt issuance costs </div><div id="a15779" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:452px;top:167px;display:flex;">(8,776)</div><div id="a15785" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:631px;top:167px;display:flex;">(11,099)</div><div id="a15789" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:183px;">Less: short-term and current portion of long-term debts </div><div id="a15800" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:446px;top:184px;display:flex;">(52,611)</div><div id="a15806" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:631px;top:184px;display:flex;">(38,967)</div><div id="a15810" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:201px;">Total long-term debt </div><div id="a15817" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:385px;top:202px;">$ </div><div id="a15819" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:202px;">839,275</div><div id="a15824" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:202px;">$</div><div id="a15826" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:202px;">849,068</div></div></div></div><div id="TextBlockContainer722" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:728px;height:254px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15829" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Credit facilities </div><div id="a15833" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The Company’s primary credit facility<div style="display:inline-block;width:5px"> </div>(as amended, the “Credit Facility”) is comprised of a $</div><div id="a15833_93_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:530px;top:23px;">400.0</div><div id="a15833_98_23" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:560px;top:23px;"><div style="display:inline-block;width:3px"> </div>million multicurrency </div><div id="a15867" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">revolver (the “Revolver”), a $</div><div id="a15867_30_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:164px;top:39px;">600.0</div><div id="a15867_35_85" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:194px;top:39px;"><div style="display:inline-block;width:3px"> </div>million term loan (the “U.S. Term<div style="display:inline-block;width:5px"> </div>Loan”), each with the Company as borrower,<div style="display:inline-block;width:5px"> </div>and a $</div><div id="a15867_120_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:665px;top:39px;">150.0</div><div id="a15909" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">million (as of August 1, 2019) Euro equivalent term loan (the “EURO Term<div style="display:inline-block;width:5px"> </div>Loan” and together with the “U.S. Term<div style="display:inline-block;width:5px"> </div>Loan”, the </div><div id="a15954" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">“Term Loans”)<div style="display:inline-block;width:5px"> </div>with Quaker Chemical B.V.,<div style="display:inline-block;width:5px"> </div>a Dutch subsidiary of the Company as borrower, each<div style="display:inline-block;width:5px"> </div>with a </div><div id="a15954_100_9" style="position:absolute;font-family:'Times New Roman';left:571px;top:69px;">five year</div><div id="a15954_109_18" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:69px;"><div style="display:inline-block;width:3px"> </div>term maturing in </div><div id="a15998" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">August 2024.<div style="display:inline-block;width:7px"> </div>Subject to the consent of the administrative agent and certain other conditions, the Company<div style="display:inline-block;width:5px"> </div>may designate additional </div><div id="a16036" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">borrowers.<div style="display:inline-block;width:7px"> </div>The maximum amount available under the Credit Facility can be increased by up<div style="display:inline-block;width:5px"> </div>to $</div><div id="a16036_94_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:524px;top:100px;">300.0</div><div id="a16036_99_26" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:554px;top:100px;"><div style="display:inline-block;width:3px"> </div>million at the Company’s </div><div id="a16076" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">request if there are lenders who agree to accept additional commitments and<div style="display:inline-block;width:5px"> </div>the Company has satisfied certain other conditions.<div style="display:inline-block;width:4px"> </div></div><div id="a16115" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:131px;">Borrowings under the Credit Facility bear interest at a base rate or LIBOR plus an<div style="display:inline-block;width:5px"> </div>applicable margin based upon the Company’s </div><div id="a16157" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:146px;">consolidated net leverage ratio.<div style="display:inline-block;width:7px"> </div>There are LIBOR replacement provisions that contemplate a further amendment<div style="display:inline-block;width:5px"> </div>when LIBOR ceases </div><div id="a16192" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:161px;">to be reported.<div style="display:inline-block;width:7px"> </div>The variable interest rate incurred on the outstanding borrowings under<div style="display:inline-block;width:5px"> </div>the Credit Facility as of and during the nine </div><div id="a16236" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:177px;">months ended September 30, 2021 was approximately </div><div id="a16236_50_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:297px;top:177px;">1.6</div><div id="a16236_53_77" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:177px;">%.<div style="display:inline-block;width:7px"> </div>In addition to paying interest on outstanding principal under the Credit </div><div id="a16273" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:192px;">Facility, the Company<div style="display:inline-block;width:5px"> </div>is required to pay a commitment fee ranging from </div><div id="a16273_71_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:192px;">0.2</div><div id="a16273_74_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:413px;top:192px;">% to </div><div id="a16273_79_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:441px;top:192px;">0.3</div><div id="a16273_82_46" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:458px;top:192px;">% depending on the Company’s consolidated<div style="display:inline-block;width:5px"> </div>net </div><div id="a16316" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:207px;">leverage ratio to the lenders under the Revolver in respect of the unutilized<div style="display:inline-block;width:5px"> </div>commitments thereunder.<div style="display:inline-block;width:8px"> </div>The Company has unused </div><div id="a16354" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:223px;">capacity under the Revolver of approximately $</div><div id="a16354_46_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:259px;top:223px;">197</div><div id="a16354_49_58" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:279px;top:223px;"><div style="display:inline-block;width:3px"> </div>million, net of bank letters of credit of approximately $</div><div id="a16354_107_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:577px;top:223px;">4</div><div id="a16354_108_26" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:583px;top:223px;"><div style="display:inline-block;width:3px"> </div>million, as of September </div><div id="a16396" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:238px;">30, 2021.<div style="display:inline-block;width:7px"> </div></div></div><div id="TextBlockContainer724" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:734px;height:446px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a16417" style="position:absolute;font-family:'Times New Roman';left:28px;top:0px;">The Credit Facility is subject to certain financial and other covenants. The Company’s initial consolidated net debt to </div><div id="a16453" style="position:absolute;font-family:'Times New Roman';left:4px;top:15px;">consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit </div><div id="a16500" style="position:absolute;font-family:'Times New Roman';left:4px;top:31px;">Facility.</div><div id="a16500_9_88" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:48px;top:31px;"><div style="display:inline-block;width:7px"> </div>As of September 30, 2021, the consolidated net debt to adjusted EBITDA<div style="display:inline-block;width:5px"> </div>may not exceed </div><div id="a16500_97_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:539px;top:31px;">4.00</div><div id="a16500_101_22" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:31px;"><div style="display:inline-block;width:3px"> </div>to 1.<div style="display:inline-block;width:7px"> </div>The Company’s </div><div id="a16539" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">consolidated adjusted EBITDA to interest expense ratio cannot be less than </div><div id="a16539_75_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:46px;">3.0</div><div id="a16539_78_50" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:427px;top:46px;"><div style="display:inline-block;width:3px"> </div>to 1 over the term of the agreement.<div style="display:inline-block;width:7px"> </div>The Credit </div><div id="a16583" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">Facility also prohibits the payment of cash dividends if the Company<div style="display:inline-block;width:5px"> </div>is in default or if the amount of the dividend paid annually </div><div id="a16629" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">exceeds the greater of $</div><div id="a16629_24_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:131px;top:77px;">50.0</div><div id="a16629_28_13" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:155px;top:77px;"><div style="display:inline-block;width:3px"> </div>million and </div><div id="a16629_41_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:222px;top:77px;">20</div><div id="a16629_43_79" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:236px;top:77px;">% of consolidated adjusted EBITDA unless the ratio of consolidated net debt<div style="display:inline-block;width:5px"> </div>to </div><div id="a16669" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:92px;">consolidated adjusted EBITDA is less than </div><div id="a16669_42_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:237px;top:92px;">2.0</div><div id="a16669_45_61" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:92px;"><div style="display:inline-block;width:3px"> </div>to 1, in which case there is no such limitation on amount.<div style="display:inline-block;width:8px"> </div></div><div id="a16669_106_25" style="position:absolute;font-family:'Times New Roman';left:569px;top:92px;">As of September 30, 2021 </div><div id="a16713" style="position:absolute;font-family:'Times New Roman';left:4px;top:107px;">and December 31, 2020, the Company was in compliance with all of the Credit Facility covenants.</div><div id="a16713_95_32" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:531px;top:107px;"><div style="display:inline-block;width:7px"> </div>The Term Loans have quarterly </div><div id="a16756" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:123px;">principal amortization during their </div><div id="a16756_36_9" style="position:absolute;font-family:'Times New Roman';left:192px;top:123px;">five year</div><div id="a16756_45_13" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:239px;top:123px;"><div style="display:inline-block;width:3px"> </div>terms, with </div><div id="a16756_58_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:306px;top:123px;">5.0</div><div id="a16756_61_62" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:322px;top:123px;">% amortization of the principal balance due in years 1 and 2, </div><div id="a16756_123_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:123px;">7.5</div><div id="a16756_126_10" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:667px;top:123px;">% in year </div><div id="a16802" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:138px;">3, and </div><div id="a16802_7_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:40px;top:138px;">10.0</div><div id="a16802_11_117" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:64px;top:138px;">% in years 4 and 5, with the remaining principal amount due at maturity.<div style="display:inline-block;width:9px"> </div>During the nine months ended September 30, </div><div id="a16846" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:153px;">2021, the Company made quarterly amortization payments related to the<div style="display:inline-block;width:5px"> </div>Term Loans totaling $</div><div id="a16846_91_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:153px;">28.6</div><div id="a16846_95_34" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:153px;"><div style="display:inline-block;width:3px"> </div>million.<div style="display:inline-block;width:7px"> </div>The Credit Facility is </div><div id="a16885" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:169px;">guaranteed by certain of the Company’s<div style="display:inline-block;width:5px"> </div>domestic subsidiaries and is secured by first priority liens on substantially all of the assets of </div><div id="a16930" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:184px;">the Company and the domestic subsidiary guarantors, subject to certain<div style="display:inline-block;width:5px"> </div>customary exclusions.<div style="display:inline-block;width:7px"> </div>The obligations of the Dutch borrower </div><div id="a16966" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:199px;">are guaranteed only by certain foreign subsidiaries on an unsecured basis. </div><div id="a16989" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:223px;">The Credit Facility required the Company to fix its variable interest rates on at least </div><div id="a16989_88_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:478px;top:223px;">20</div><div id="a16989_90_40" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:492px;top:223px;">% of its total Term Loans.<div style="display:inline-block;width:8px"> </div>In order to </div><div id="a16992" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:238px;">satisfy this requirement as well as to manage the Company’s<div style="display:inline-block;width:5px"> </div>exposure to variable interest rate risk associated with the Credit Facility, </div><div id="a16994" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:253px;">in November 2019, the Company entered into $</div><div id="a16994_44_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:259px;top:253px;">170.0</div><div id="a16994_49_78" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:289px;top:253px;"><div style="display:inline-block;width:3px"> </div>million notional amounts of three year interest rate swaps at a base rate of </div><div id="a16994_127_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:690px;top:253px;">1.64</div><div id="a16994_131_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:713px;top:253px;">% </div><div id="a16996" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:269px;">plus an applicable margin as provided in the Credit Facility,<div style="display:inline-block;width:5px"> </div>based on the Company’s consolidated<div style="display:inline-block;width:5px"> </div>net leverage ratio.<div style="display:inline-block;width:7px"> </div>At the time the </div><div id="a16999" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:284px;">Company entered into the swaps, and as of September 30, 2021, the<div style="display:inline-block;width:5px"> </div>aggregate interest rate on the swaps, including the fixed base rate </div><div id="a17001" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:299px;">plus an applicable margin, was </div><div id="a17001_31_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:172px;top:299px;">3.1</div><div id="a17001_34_73" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:189px;top:299px;">%.<div style="display:inline-block;width:7px"> </div>See Note 18 of Notes to Condensed Consolidated Financial Statements. </div><div id="a17003" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:323px;">The Company capitalized $</div><div id="a17003_25_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:175px;top:323px;">23.7</div><div id="a17003_29_103" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:199px;top:323px;"><div style="display:inline-block;width:3px"> </div>million of certain third-party debt issuance costs in connection with executing<div style="display:inline-block;width:5px"> </div>the Credit Facility.<div style="display:inline-block;width:4px"> </div></div><div id="a17007" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:338px;">Approximately $</div><div id="a17007_15_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:95px;top:338px;">15.5</div><div id="a17007_19_111" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:119px;top:338px;"><div style="display:inline-block;width:3px"> </div>million of the capitalized costs were attributed to the Term<div style="display:inline-block;width:5px"> </div>Loans and recorded as a direct reduction of long-</div><div id="a17010" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:353px;">term debt on the Company’s Condensed<div style="display:inline-block;width:5px"> </div>Consolidated Balance Sheet.<div style="display:inline-block;width:7px"> </div>Approximately $</div><div id="a17010_81_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:473px;top:353px;">8.3</div><div id="a17010_84_39" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:353px;"><div style="display:inline-block;width:3px"> </div>million of the capitalized costs were </div><div id="a17012" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:369px;">attributed to the Revolver and recorded within other assets on the Company’s<div style="display:inline-block;width:5px"> </div>Condensed Consolidated Balance Sheet.<div style="display:inline-block;width:7px"> </div>These </div><div id="a17013" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:384px;">capitalized costs are being amortized into interest expense over the<div style="display:inline-block;width:5px"> </div>five year term of the Credit Facility.<div style="display:inline-block;width:8px"> </div>As of September 30, 2021 </div><div id="a17019" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:399px;">and December 31, 2020, the Company had $</div><div id="a17019_40_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:243px;top:399px;">8.8</div><div id="a17019_43_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:259px;top:399px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a17019_57_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:334px;top:399px;">11.1</div><div id="a17019_61_71" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:357px;top:399px;"><div style="display:inline-block;width:3px"> </div>million, respectively, of debt<div style="display:inline-block;width:5px"> </div>issuance costs recorded as a reduction </div><div id="a17021" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:415px;">of long-term debt.<div style="display:inline-block;width:7px"> </div>As of September 30, 2021 and December 31, 2020, the Company had $</div><div id="a17021_85_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:415px;">4.7</div><div id="a17021_88_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:506px;top:415px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a17021_102_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:580px;top:415px;">5.9</div><div id="a17021_105_24" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:597px;top:415px;"><div style="display:inline-block;width:3px"> </div>million, respectively, </div><div id="a17028" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:430px;">of debt issuance costs recorded within other assets.</div></div><div id="TextBlockContainer726" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:732px;height:240px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a17032" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:0px;">Industrial development bonds </div><div id="a17038" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">As of September 30, 2021 and December 31, 2020, the Company had fixed<div style="display:inline-block;width:5px"> </div>rate, industrial development authority bonds totaling </div><div id="a17072" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">$</div><div id="a17072_1_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:11px;top:39px;">10.0</div><div id="a17072_5_36" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:35px;top:39px;"><div style="display:inline-block;width:3px"> </div>million in principal amount due in </div><div id="a17072_41_4" style="position:absolute;font-family:'Times New Roman';left:224px;top:39px;">2028</div><div id="a17072_45_74" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:251px;top:39px;">.<div style="display:inline-block;width:7px"> </div>These bonds have similar covenants to the Credit Facility noted above. </div><div id="a17113" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:italic;color:#000000;left:4px;top:62px;">Bank lines of credit and other debt obligations </div><div id="a17129" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:85px;">The Company has certain unsecured bank lines of credit and discounting<div style="display:inline-block;width:5px"> </div>facilities in one of its foreign subsidiaries, which are not </div><div id="a17171" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:101px;">collateralized.<div style="display:inline-block;width:7px"> </div>The Company’s other debt obligat<div style="display:inline-block;width:2px"> </div>ions primarily consist of certain domestic and foreign low interest rate or interest-</div><div id="a17208" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:116px;">free municipality-related loans, local credit facilities of certain foreign subsidiaries<div style="display:inline-block;width:5px"> </div>and capital lease obligations.<div style="display:inline-block;width:7px"> </div>Total unused </div><div id="a17243" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:131px;">capacity under these arrangements as of September 30, 2021 was approximately<div style="display:inline-block;width:5px"> </div>$</div><div id="a17243_78_2" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:442px;top:131px;">39</div><div id="a17243_80_10" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:456px;top:131px;"><div style="display:inline-block;width:3px"> </div>million. </div><div id="a17266" style="position:absolute;font-family:'Times New Roman';left:28px;top:155px;">In addition to the bank letters of credit described in the “Credit facilities” subsection above, the Company’s only other off-balance </div><div id="a17309" style="position:absolute;font-family:'Times New Roman';left:4px;top:170px;">sheet arrangements include certain financial and other guarantees. The Company’s total bank letters of credit and guarantees </div><div id="a17343" style="position:absolute;font-family:'Times New Roman';left:4px;top:185px;">outstanding as of September 30, 2021 were approximately $7 million.</div><div id="a17361" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:209px;">The Company incurred the following debt related expenses included<div style="display:inline-block;width:5px"> </div>within Interest expense, net, in the Condensed Consolidated </div><div id="a17397" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:224px;">Statements of Operations:</div></div><div id="TextBlockContainer729" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:722px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a17405" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:384px;top:0px;">Three Months Ended </div><div id="a17408" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:574px;top:0px;">Nine Months Ended </div><div id="a17411" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:404px;top:18px;">September 30, </div><div id="a17414" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:590px;top:18px;">September 30, </div><div id="a17417" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:385px;top:35px;">2021 </div><div id="a17420" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:478px;top:35px;">2020 </div><div id="a17423" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:571px;top:35px;">2021 </div><div id="a17426" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:664px;top:35px;">2020 </div><div id="a17428" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:53px;">Interest expense </div><div id="a17430" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:53px;">$ </div><div id="a17432" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:53px;">4,779</div><div id="a17435" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:451px;top:53px;">$ </div><div id="a17437" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:497px;top:53px;">5,957</div><div id="a17440" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:545px;top:53px;">$</div><div id="a17442" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:583px;top:53px;">14,242</div><div id="a17445" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:638px;top:53px;">$</div><div id="a17447" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:676px;top:53px;">19,621</div><div id="a17449" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:70px;">Amortization of debt issuance costs </div><div id="a17452" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:70px;">1,187</div><div id="a17456" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:497px;top:70px;">1,188</div><div id="a17460" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:590px;top:70px;">3,562</div><div id="a17464" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:683px;top:70px;">3,562</div><div id="a17466" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:89px;">Total </div><div id="a17468" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:89px;">$ </div><div id="a17470" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:89px;">5,966</div><div id="a17473" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:451px;top:89px;">$ </div><div id="a17475" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:497px;top:89px;">7,145</div><div id="a17478" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:545px;top:89px;">$</div><div id="a17480" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:583px;top:89px;">17,804</div><div id="a17483" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:638px;top:89px;">$</div><div id="a17485" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:676px;top:89px;">23,183</div></div><div id="TextBlockContainer732" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:705px;height:32px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a17487" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Based on the variable interest rates associated with the Credit Facility,<div style="display:inline-block;width:5px"> </div>as of September 30, 2021 and December 31, 2020, the </div><div id="a17491" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">amounts at which the Company’s<div style="display:inline-block;width:5px"> </div>total debt were recorded are not materially different from<div style="display:inline-block;width:5px"> </div>their fair market value.</div></div> <div id="TextBlockContainer719" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:685px;height:217px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a15610" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:328px;top:0px;">As of September 30, 2021 </div><div id="a15613" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:521px;top:0px;">As of December 31, 2020 </div><div id="a15619" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:317px;top:17px;">Interest </div><div id="a15623" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:402px;top:17px;">Outstanding<div style="display:inline-block;width:4px"> </div></div><div id="a15626" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:514px;top:17px;">Interest </div><div id="a15628" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:588px;top:17px;">Outstanding<div style="display:inline-block;width:4px"> </div></div><div id="a15634" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:326px;top:31px;">Rate </div><div id="a15637" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:415px;top:31px;">Balance </div><div id="a15640" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:523px;top:31px;">Rate </div><div id="a15642" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:601px;top:31px;">Balance </div><div id="a15646" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:47px;">Credit Facilities: </div><div id="a15661" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:65px;">Revolver </div><div id="a15664" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:327px;top:65px;display:flex;">1.58%</div><div id="a15667" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:385px;top:65px;">$ </div><div id="a15669" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:65px;">198,543</div><div id="a15672" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:514px;top:65px;display:flex;">1.65%</div><div id="a15675" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:65px;">$</div><div id="a15677" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:65px;">160,000</div><div id="a15682" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:82px;">U.S. Term Loan </div><div id="a15685" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:327px;top:82px;display:flex;">1.58%</div><div id="a15689" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:82px;">547,500</div><div id="a15692" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:514px;top:82px;display:flex;">1.65%</div><div id="a15696" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:629px;top:82px;">570,000</div><div id="a15701" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:99px;">EURO Term Loan </div><div id="a15704" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:327px;top:99px;display:flex;">1.50%</div><div id="a15708" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:99px;">142,559</div><div id="a15711" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:514px;top:99px;display:flex;">1.50%</div><div id="a15715" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:629px;top:99px;">157,062</div><div id="a15719" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">Industrial development bonds </div><div id="a15722" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:327px;top:116px;display:flex;">5.26%</div><div id="a15726" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:451px;top:116px;">10,000</div><div id="a15729" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:514px;top:116px;display:flex;">5.26%</div><div id="a15733" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:636px;top:116px;">10,000</div><div id="a15737" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:132px;">Bank lines of credit and other debt obligations </div><div id="a15740" style="position:absolute;font-family:'Times New Roman';left:323px;top:133px;">Various</div><div id="a15744" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:133px;">2,060</div><div id="a15747" style="position:absolute;font-family:'Times New Roman';left:510px;top:133px;">Various</div><div id="a15751" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:642px;top:133px;">2,072</div><div id="a15755" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:149px;">Total debt </div><div id="a15760" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:385px;top:150px;">$ </div><div id="a15762" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:150px;">900,662</div><div id="a15767" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:150px;">$</div><div id="a15769" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:629px;top:150px;">899,134</div><div id="a15773" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:166px;">Less: debt issuance costs </div><div id="a15779" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:452px;top:167px;display:flex;">(8,776)</div><div id="a15785" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:631px;top:167px;display:flex;">(11,099)</div><div id="a15789" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:183px;">Less: short-term and current portion of long-term debts </div><div id="a15800" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:446px;top:184px;display:flex;">(52,611)</div><div id="a15806" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:631px;top:184px;display:flex;">(38,967)</div><div id="a15810" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:201px;">Total long-term debt </div><div id="a15817" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:385px;top:202px;">$ </div><div id="a15819" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:202px;">839,275</div><div id="a15824" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:202px;">$</div><div id="a15826" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:202px;">849,068</div></div> 0.0158 198543000 0.0165 160000000 0.0158 547500000 0.0165 570000000 0.0150 142559000 0.0150 157062000 0.0526 10000000 0.0526 10000000 Various 2060000 Various 2072000 900662000 899134000 8776000 11099000 52611000 38967000 839275000 839275000 849068000 849068000 400000000.0 600000000.0 150000000.0 P5Y 300000000.0 0.016 0.002 0.003 197000000 4000000 The Credit Facility is subject to certain financial and other covenants. The Company’s initial consolidated net debt to consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit Facility. 4.25 4.00 3.0 50000000.0 0.20 2.0 As of September 30, 2021 and December 31, 2020, the Company was in compliance with all of the Credit Facility covenants. P5Y 0.050 0.075 0.100 28600000 0.20 170000000.0 0.0164 0.031 23700000 15500000 8300000 8800000 11100000 4700000 5900000 10000000.0 10000000.0 2028 39000000 In addition to the bank letters of credit described in the “Credit facilities” subsection above, the Company’s only other off-balance sheet arrangements include certain financial and other guarantees. The Company’s total bank letters of credit and guarantees outstanding as of September 30, 2021 were approximately $7 million. 7000000 <div id="TextBlockContainer730" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:722px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_728_XBRL_TS_207f68d821cb4a09ac6e703a54e25dd0" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer729" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:722px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a17405" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:384px;top:0px;">Three Months Ended </div><div id="a17408" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:574px;top:0px;">Nine Months Ended </div><div id="a17411" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:404px;top:18px;">September 30, </div><div id="a17414" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:590px;top:18px;">September 30, </div><div id="a17417" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:385px;top:35px;">2021 </div><div id="a17420" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:478px;top:35px;">2020 </div><div id="a17423" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:571px;top:35px;">2021 </div><div id="a17426" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:664px;top:35px;">2020 </div><div id="a17428" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:53px;">Interest expense </div><div id="a17430" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:53px;">$ </div><div id="a17432" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:53px;">4,779</div><div id="a17435" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:451px;top:53px;">$ </div><div id="a17437" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:497px;top:53px;">5,957</div><div id="a17440" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:545px;top:53px;">$</div><div id="a17442" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:583px;top:53px;">14,242</div><div id="a17445" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:638px;top:53px;">$</div><div id="a17447" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:676px;top:53px;">19,621</div><div id="a17449" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:70px;">Amortization of debt issuance costs </div><div id="a17452" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:70px;">1,187</div><div id="a17456" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:497px;top:70px;">1,188</div><div id="a17460" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:590px;top:70px;">3,562</div><div id="a17464" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:683px;top:70px;">3,562</div><div id="a17466" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:89px;">Total </div><div id="a17468" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:89px;">$ </div><div id="a17470" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:89px;">5,966</div><div id="a17473" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:451px;top:89px;">$ </div><div id="a17475" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:497px;top:89px;">7,145</div><div id="a17478" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:545px;top:89px;">$</div><div id="a17480" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:583px;top:89px;">17,804</div><div id="a17483" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:638px;top:89px;">$</div><div id="a17485" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:676px;top:89px;">23,183</div></div></div></div> 4779000 5957000 14242000 19621000 1187000 1188000 3562000 3562000 5966000 7145000 17804000 23183000 <div id="TextBlockContainer734" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:728px;height:39px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a17510" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 16 – Equity </div><div id="a17515" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The following tables present the changes in equity,<div style="display:inline-block;width:5px"> </div>net of tax, for the three and nine months ended September 30, 2021 and 2020:</div></div><div id="TextBlockContainer737" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:730px;height:352px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a17530" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:464px;top:0px;">Accumulated </div><div id="a17544" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:318px;top:15px;">Capital in </div><div id="a17550" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:485px;top:15px;">Other </div><div id="a17561" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:255px;top:30px;">Common </div><div id="a17564" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:320px;top:30px;">Excess of </div><div id="a17567" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:391px;top:30px;">Retained </div><div id="a17570" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:457px;top:30px;">Comprehensive </div><div id="a17573" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:555px;top:30px;">Noncontrolling </div><div id="a17581" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:265px;top:45px;">Stock </div><div id="a17584" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:317px;top:45px;">Par Value </div><div id="a17587" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:391px;top:45px;">Earnings </div><div id="a17590" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:489px;top:45px;">Loss </div><div id="a17593" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:576px;top:45px;">Interest </div><div id="a17596" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:670px;top:45px;">Total </div><div id="a17598" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:62px;">Balance at June 30, 2021 </div><div id="a17600" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:62px;">$</div><div id="a17602" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:62px;">17,878</div><div id="a17605" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:62px;">$</div><div id="a17607" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:329px;top:62px;">910,862</div><div id="a17610" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:384px;top:62px;">$</div><div id="a17612" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:62px;">482,001</div><div id="a17615" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:62px;">$</div><div id="a17617" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:62px;display:flex;">(35,943)</div><div id="a17620" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:553px;top:62px;">$</div><div id="a17622" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:62px;">603</div><div id="a17625" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:62px;">$</div><div id="a17627" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:62px;">1,375,401</div><div id="a17630" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:79px;">Net income </div><div id="a17633" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:79px;">—</div><div id="a17637" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:79px;">—</div><div id="a17641" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:79px;">31,058</div><div id="a17645" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:529px;top:79px;">—</div><div id="a17649" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:79px;">15</div><div id="a17653" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:680px;top:79px;">31,073</div><div id="a17656" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:96px;">Amounts reported in other comprehensive<div style="display:inline-block;width:4px"> </div></div><div id="a17677" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:113px;">loss </div><div id="a17680" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:113px;">—</div><div id="a17684" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:113px;">—</div><div id="a17688" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:432px;top:113px;">—</div><div id="a17692" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:113px;display:flex;">(18,780)</div><div id="a17696" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:113px;">—</div><div id="a17700" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:113px;display:flex;">(18,780)</div><div id="a17703" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:130px;">Dividends ($</div><div id="a17703_12_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:84px;top:130px;">0.415</div><div id="a17703_17_12" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:114px;top:130px;"><div style="display:inline-block;width:3px"> </div>per share) </div><div id="a17706" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:130px;">—</div><div id="a17710" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:130px;">—</div><div id="a17714" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:411px;top:130px;display:flex;">(7,424)</div><div id="a17718" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:529px;top:130px;">—</div><div id="a17722" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:130px;">—</div><div id="a17726" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:130px;display:flex;">(7,424)</div><div id="a17729" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:147px;">Share issuance and equity-based </div><div id="a17752" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:164px;">compensation plans </div><div id="a17755" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:164px;">11</div><div id="a17759" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:343px;top:164px;">3,415</div><div id="a17763" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:432px;top:164px;">—</div><div id="a17767" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:529px;top:164px;">—</div><div id="a17771" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:164px;">—</div><div id="a17775" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:687px;top:164px;">3,426</div><div id="a17777" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:182px;">Balance at September 30, 2021 </div><div id="a17779" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:182px;">$</div><div id="a17781" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:182px;">17,889</div><div id="a17784" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:182px;">$</div><div id="a17786" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:329px;top:182px;">914,277</div><div id="a17789" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:384px;top:182px;">$</div><div id="a17791" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:182px;">505,635</div><div id="a17794" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:182px;">$</div><div id="a17796" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:182px;display:flex;">(54,723)</div><div id="a17799" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:553px;top:182px;">$</div><div id="a17801" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:182px;">618</div><div id="a17804" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:182px;">$</div><div id="a17806" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:182px;">1,383,696</div><div id="a17828" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:217px;">Balance at June 30, 2020 </div><div id="a17830" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:217px;">$</div><div id="a17832" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:217px;">17,800</div><div id="a17835" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:217px;">$</div><div id="a17837" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:329px;top:217px;">896,108</div><div id="a17840" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:384px;top:217px;">$</div><div id="a17842" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:217px;">362,265</div><div id="a17845" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:217px;">$</div><div id="a17847" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:494px;top:217px;display:flex;">(109,264)</div><div id="a17850" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:553px;top:217px;">$</div><div id="a17852" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:217px;">432</div><div id="a17855" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:217px;">$</div><div id="a17857" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:217px;">1,167,341</div><div id="a17860" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:234px;">Net income </div><div id="a17863" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:234px;">—</div><div id="a17867" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:234px;">—</div><div id="a17871" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:234px;">27,304</div><div id="a17875" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:529px;top:234px;">—</div><div id="a17879" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:234px;">38</div><div id="a17883" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:680px;top:234px;">27,342</div><div id="a17886" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:251px;">Amounts reported in other comprehensive<div style="display:inline-block;width:4px"> </div></div><div id="a17907" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:268px;">income </div><div id="a17910" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:268px;">—</div><div id="a17914" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:268px;">—</div><div id="a17918" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:432px;top:268px;">—</div><div id="a17922" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:506px;top:268px;">34,254</div><div id="a17926" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:268px;">17</div><div id="a17930" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:680px;top:268px;">34,271</div><div id="a17933" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:285px;">Dividends ($</div><div id="a17933_12_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:84px;top:285px;">0.395</div><div id="a17933_17_12" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:114px;top:285px;"><div style="display:inline-block;width:3px"> </div>per share) </div><div id="a17936" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:285px;">—</div><div id="a17940" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:285px;">—</div><div id="a17944" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:411px;top:285px;display:flex;">(7,048)</div><div id="a17948" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:529px;top:285px;">—</div><div id="a17952" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:285px;">—</div><div id="a17956" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:285px;display:flex;">(7,048)</div><div id="a17959" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:302px;">Share issuance and equity-based </div><div id="a17982" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:319px;">compensation plans </div><div id="a17985" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:319px;">31</div><div id="a17989" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:343px;top:319px;">4,494</div><div id="a17993" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:432px;top:319px;">—</div><div id="a17997" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:529px;top:319px;">—</div><div id="a18001" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:319px;">—</div><div id="a18005" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:687px;top:319px;">4,525</div><div id="a18007" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:337px;">Balance at September 30, 2020 </div><div id="a18009" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:337px;">$</div><div id="a18011" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:337px;">17,831</div><div id="a18014" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:336px;">$</div><div id="a18016" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:329px;top:337px;">900,602</div><div id="a18019" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:384px;top:337px;">$</div><div id="a18021" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:337px;">382,521</div><div id="a18024" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:337px;">$</div><div id="a18026" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:337px;display:flex;">(75,010)</div><div id="a18029" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:553px;top:337px;">$</div><div id="a18031" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:337px;">487</div><div id="a18034" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:337px;">$</div><div id="a18036" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:337px;">1,226,431</div></div><div id="TextBlockContainer741" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:742px;height:438px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a18051" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:476px;top:0px;">Accumulated </div><div id="a18065" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:324px;top:15px;">Capital in </div><div id="a18071" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:497px;top:15px;">Other </div><div id="a18082" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:255px;top:30px;">Common </div><div id="a18085" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:326px;top:30px;">Excess of </div><div id="a18088" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:403px;top:30px;">Retained </div><div id="a18091" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:469px;top:30px;">Comprehensive </div><div id="a18094" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:567px;top:30px;">Noncontrolling </div><div id="a18102" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:265px;top:45px;">Stock </div><div id="a18105" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:323px;top:45px;">Par Value </div><div id="a18108" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:403px;top:45px;">Earnings </div><div id="a18111" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:501px;top:45px;">Loss </div><div id="a18114" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:588px;top:45px;">Interest </div><div id="a18117" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:682px;top:45px;">Total </div><div id="a18119" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:62px;">Balance at December 31, 2020 </div><div id="a18121" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:62px;">$</div><div id="a18123" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:62px;">17,851</div><div id="a18126" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:62px;">$</div><div id="a18128" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:341px;top:62px;">905,171</div><div id="a18131" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:62px;">$</div><div id="a18133" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:414px;top:62px;">423,940</div><div id="a18136" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:469px;top:62px;">$</div><div id="a18138" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:62px;display:flex;">(26,598)</div><div id="a18141" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:566px;top:62px;">$</div><div id="a18143" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:631px;top:62px;">550</div><div id="a18146" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:62px;">$</div><div id="a18148" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:62px;">1,320,914</div><div id="a18151" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:79px;">Net income </div><div id="a18154" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:79px;">—</div><div id="a18158" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:371px;top:79px;">—</div><div id="a18162" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:414px;top:79px;">103,243</div><div id="a18166" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:79px;">—</div><div id="a18170" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:637px;top:79px;">62</div><div id="a18174" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:685px;top:79px;">103,305</div><div id="a18177" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:96px;">Amounts reported in other comprehensive<div style="display:inline-block;width:4px"> </div></div><div id="a18198" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:113px;">(loss) income </div><div id="a18201" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:113px;">—</div><div id="a18205" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:371px;top:113px;">—</div><div id="a18209" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:113px;">—</div><div id="a18213" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:113px;display:flex;">(28,125)</div><div id="a18217" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:644px;top:113px;">6</div><div id="a18221" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:687px;top:113px;display:flex;">(28,119)</div><div id="a18224" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:130px;">Dividends ($</div><div id="a18224_12_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:84px;top:130px;">1.205</div><div id="a18224_17_12" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:114px;top:130px;"><div style="display:inline-block;width:3px"> </div>per share) </div><div id="a18227" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:130px;">—</div><div id="a18231" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:371px;top:130px;">—</div><div id="a18235" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:416px;top:130px;display:flex;">(21,548)</div><div id="a18239" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:130px;">—</div><div id="a18243" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:637px;top:130px;">—</div><div id="a18247" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:687px;top:130px;display:flex;">(21,548)</div><div id="a18250" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:147px;">Share issuance and equity-based </div><div id="a18273" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:164px;">compensation plans </div><div id="a18276" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:164px;">38</div><div id="a18280" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:355px;top:164px;">9,106</div><div id="a18284" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:164px;">—</div><div id="a18288" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:164px;">—</div><div id="a18292" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:637px;top:164px;">—</div><div id="a18296" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:699px;top:164px;">9,144</div><div id="a18298" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:182px;">Balance at September 30, 2021 </div><div id="a18300" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:182px;">$</div><div id="a18302" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:182px;">17,889</div><div id="a18305" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:182px;">$</div><div id="a18307" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:341px;top:182px;">914,277</div><div id="a18310" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:182px;">$</div><div id="a18312" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:414px;top:182px;">505,635</div><div id="a18315" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:469px;top:182px;">$</div><div id="a18317" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:182px;display:flex;">(54,723)</div><div id="a18320" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:566px;top:182px;">$</div><div id="a18322" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:631px;top:182px;">618</div><div id="a18325" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:182px;">$</div><div id="a18327" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:182px;">1,383,696</div><div id="a18349" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:217px;">Balance at December 31, 2019 </div><div id="a18351" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:217px;">$</div><div id="a18353" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:217px;">17,735</div><div id="a18356" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:217px;">$</div><div id="a18358" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:341px;top:217px;">888,218</div><div id="a18361" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:217px;">$</div><div id="a18363" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:414px;top:217px;">412,979</div><div id="a18366" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:469px;top:217px;">$</div><div id="a18368" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:217px;display:flex;">(78,170)</div><div id="a18371" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:566px;top:217px;">$</div><div id="a18373" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:621px;top:217px;">1,604</div><div id="a18376" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:217px;">$</div><div id="a18378" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:217px;">1,242,366</div><div id="a18381" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:234px;">Cumulative effect of an accounting change </div><div id="a18384" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:234px;">—</div><div id="a18388" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:371px;top:234px;">—</div><div id="a18392" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:433px;top:234px;display:flex;">(911)</div><div id="a18396" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:234px;">—</div><div id="a18400" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:637px;top:234px;">—</div><div id="a18404" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:704px;top:234px;display:flex;">(911)</div><div id="a18406" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:251px;">Balance at January 1, 2020 </div><div id="a18409" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:251px;">17,735</div><div id="a18413" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:341px;top:251px;">888,218</div><div id="a18417" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:414px;top:251px;">412,068</div><div id="a18421" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:251px;display:flex;">(78,170)</div><div id="a18425" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:621px;top:251px;">1,604</div><div id="a18429" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:251px;">1,241,455</div><div id="a18432" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:268px;">Net (loss) income </div><div id="a18435" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:268px;">—</div><div id="a18439" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:371px;top:268px;">—</div><div id="a18443" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:423px;top:268px;display:flex;">(8,812)</div><div id="a18447" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:268px;">—</div><div id="a18451" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:637px;top:268px;">88</div><div id="a18455" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:694px;top:268px;display:flex;">(8,724)</div><div id="a18458" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:285px;">Amounts reported in other comprehensive<div style="display:inline-block;width:4px"> </div></div><div id="a18479" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:302px;">income (loss) </div><div id="a18482" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:302px;">—</div><div id="a18486" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:371px;top:302px;">—</div><div id="a18490" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:302px;">—</div><div id="a18494" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:302px;">3,160</div><div id="a18498" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:302px;display:flex;">(114)</div><div id="a18502" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:699px;top:302px;">3,046</div><div id="a18505" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:319px;">Dividends ($</div><div id="a18505_12_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:84px;top:319px;">1.165</div><div id="a18505_17_12" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:114px;top:319px;"><div style="display:inline-block;width:3px"> </div>per share) </div><div id="a18508" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:319px;">—</div><div id="a18512" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:371px;top:319px;">—</div><div id="a18516" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:416px;top:319px;display:flex;">(20,735)</div><div id="a18520" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:319px;">—</div><div id="a18524" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:637px;top:319px;">—</div><div id="a18528" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:687px;top:319px;display:flex;">(20,735)</div><div id="a18531" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:336px;">Acquisition of noncontrolling interest </div><div id="a18534" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:336px;">—</div><div id="a18538" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:360px;top:336px;display:flex;">(707)</div><div id="a18542" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:336px;">—</div><div id="a18546" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:336px;">—</div><div id="a18550" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:336px;display:flex;">(340)</div><div id="a18554" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:694px;top:336px;display:flex;">(1,047)</div><div id="a18557" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:353px;">Distributions to noncontrolling affiliate </div><div id="a18578" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:370px;">shareholders </div><div id="a18581" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:370px;">—</div><div id="a18585" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:371px;top:370px;">—</div><div id="a18589" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:370px;">—</div><div id="a18593" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:370px;">—</div><div id="a18597" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:370px;display:flex;">(751)</div><div id="a18601" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:704px;top:370px;display:flex;">(751)</div><div id="a18604" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:387px;">Share issuance and equity-based </div><div id="a18627" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:404px;">compensation plans </div><div id="a18630" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:404px;">96</div><div id="a18634" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:348px;top:404px;">13,091</div><div id="a18638" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:404px;">—</div><div id="a18642" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:404px;">—</div><div id="a18646" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:637px;top:404px;">—</div><div id="a18650" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:692px;top:404px;">13,187</div><div id="a18652" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:422px;">Balance at September 30, 2020 </div><div id="a18654" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:422px;">$</div><div id="a18656" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:422px;">17,831</div><div id="a18659" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:422px;">$</div><div id="a18661" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:341px;top:422px;">900,602</div><div id="a18664" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:422px;">$</div><div id="a18666" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:414px;top:422px;">382,521</div><div id="a18669" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:469px;top:422px;">$</div><div id="a18671" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:422px;display:flex;">(75,010)</div><div id="a18674" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:566px;top:422px;">$</div><div id="a18676" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:631px;top:422px;">487</div><div id="a18679" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:422px;">$</div><div id="a18681" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:422px;">1,226,431</div></div><div id="TextBlockContainer744" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:685px;height:31px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a18700" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The following tables show the reclassifications from and resulting balances<div style="display:inline-block;width:5px"> </div>of AOCI for the three and nine months ended </div><div id="a18703" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">September 30, 2021 and 2020:</div></div><div id="TextBlockContainer747" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:287px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a18714" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:413px;top:0px;">Defined </div><div id="a18717" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:491px;top:0px;">Unrealized </div><div id="a18729" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:325px;top:17px;">Currency </div><div id="a18733" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:415px;top:17px;">Benefit </div><div id="a18736" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:482px;top:17px;">Gain (Loss) in </div><div id="a18748" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:319px;top:34px;">Translation </div><div id="a18751" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:413px;top:34px;">Pension </div><div id="a18754" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:483px;top:34px;">Available-for- </div><div id="a18760" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:580px;top:34px;">Derivative </div><div id="a18769" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:316px;top:51px;">Adjustments </div><div id="a18772" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:420px;top:51px;">Plans </div><div id="a18774" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:481px;top:51px;">Sale Securities </div><div id="a18776" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:575px;top:51px;">Instruments </div><div id="a18779" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:673px;top:51px;">Total </div><div id="a18781" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:68px;">Balance at June 30, 2021 </div><div id="a18784" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:68px;">$</div><div id="a18786" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:68px;display:flex;">(12,177)</div><div id="a18789" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:397px;top:68px;">$</div><div id="a18791" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:68px;display:flex;">(21,778)</div><div id="a18794" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:481px;top:68px;">$</div><div id="a18796" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:68px;">596</div><div id="a18799" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:68px;">$</div><div id="a18801" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:68px;display:flex;">(2,584)</div><div id="a18804" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:68px;">$</div><div id="a18806" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:68px;display:flex;">(35,943)</div><div id="a18809" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:85px;">Other comprehensive (loss) income before<div style="display:inline-block;width:4px"> </div></div><div id="a18829" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:102px;">reclassifications </div><div id="a18833" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:102px;display:flex;">(19,905)</div><div id="a18837" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:102px;">488</div><div id="a18841" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:102px;display:flex;">(85)</div><div id="a18845" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:624px;top:102px;">567</div><div id="a18849" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:102px;display:flex;">(18,935)</div><div id="a18852" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:119px;">Amounts reclassified from AOCI </div><div id="a18856" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:373px;top:119px;">—</div><div id="a18860" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:119px;">709</div><div id="a18864" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:119px;display:flex;">(176)</div><div id="a18868" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:119px;">—</div><div id="a18872" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:699px;top:119px;">533</div><div id="a18875" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:136px;">Related tax amounts </div><div id="a18879" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:373px;top:136px;">—</div><div id="a18883" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:136px;display:flex;">(293)</div><div id="a18887" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:136px;">46</div><div id="a18891" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:136px;display:flex;">(131)</div><div id="a18895" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:694px;top:136px;display:flex;">(378)</div><div id="a18897" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:153px;">Balance at September 30, 2021 </div><div id="a18900" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:153px;">$</div><div id="a18902" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:153px;display:flex;">(32,082)</div><div id="a18905" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:397px;top:153px;">$</div><div id="a18907" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:153px;display:flex;">(20,874)</div><div id="a18910" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:481px;top:153px;">$</div><div id="a18912" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:153px;">381</div><div id="a18915" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:153px;">$</div><div id="a18917" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:153px;display:flex;">(2,148)</div><div id="a18920" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:153px;">$</div><div id="a18922" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:153px;display:flex;">(54,723)</div><div id="a18942" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:187px;">Balance at June 30, 2020 </div><div id="a18946" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:187px;">$</div><div id="a18948" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:187px;display:flex;">(88,637)</div><div id="a18951" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:397px;top:187px;">$</div><div id="a18953" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:187px;display:flex;">(17,363)</div><div id="a18956" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:481px;top:187px;">$</div><div id="a18958" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:531px;top:187px;">1,148</div><div id="a18961" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:187px;">$</div><div id="a18963" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:187px;display:flex;">(4,412)</div><div id="a18966" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:187px;">$</div><div id="a18968" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:187px;display:flex;">(109,264)</div><div id="a18971" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:204px;">Other comprehensive income (loss) before </div><div id="a18990" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:221px;">reclassifications </div><div id="a18994" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:350px;top:221px;">33,601</div><div id="a18998" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:221px;display:flex;">(901)</div><div id="a19002" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:221px;">810</div><div id="a19006" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:624px;top:221px;">460</div><div id="a19010" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:221px;">33,970</div><div id="a19013" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:238px;">Amounts reclassified from AOCI </div><div id="a19017" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:373px;top:238px;">—</div><div id="a19021" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:238px;">584</div><div id="a19025" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:238px;display:flex;">(104)</div><div id="a19029" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:238px;">—</div><div id="a19033" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:699px;top:238px;">480</div><div id="a19036" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:255px;">Related tax amounts </div><div id="a19040" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:373px;top:255px;">—</div><div id="a19044" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:456px;top:255px;">60</div><div id="a19048" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:255px;display:flex;">(150)</div><div id="a19052" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:255px;display:flex;">(106)</div><div id="a19056" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:694px;top:255px;display:flex;">(196)</div><div id="a19058" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:272px;">Balance at September 30, 2020 </div><div id="a19061" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:272px;">$</div><div id="a19063" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:272px;display:flex;">(55,036)</div><div id="a19066" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:397px;top:272px;">$</div><div id="a19068" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:272px;display:flex;">(17,620)</div><div id="a19071" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:481px;top:272px;">$</div><div id="a19073" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:531px;top:272px;">1,704</div><div id="a19076" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:272px;">$</div><div id="a19078" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:272px;display:flex;">(4,058)</div><div id="a19081" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:272px;">$</div><div id="a19083" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:272px;display:flex;">(75,010)</div></div><div id="TextBlockContainer752" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:288px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_750_XBRL_TS_8fcb8910a7f549fb9c5a68afd7060296" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer751" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:288px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19093" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:413px;top:0px;">Defined </div><div id="a19096" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:491px;top:0px;">Unrealized </div><div id="a19107" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:325px;top:17px;">Currency </div><div id="a19110" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:415px;top:17px;">Benefit </div><div id="a19113" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:482px;top:17px;">Gain (Loss) in </div><div id="a19124" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:319px;top:34px;">Translation </div><div id="a19127" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:413px;top:34px;">Pension </div><div id="a19130" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:483px;top:34px;">Available-for- </div><div id="a19136" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:580px;top:34px;">Derivative </div><div id="a19145" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:316px;top:51px;">Adjustments </div><div id="a19148" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:420px;top:51px;">Plans </div><div id="a19150" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:481px;top:51px;">Sale Securities </div><div id="a19152" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:575px;top:51px;">Instruments </div><div id="a19155" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:673px;top:51px;">Total </div><div id="a19157" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:68px;">Balance at December 31, 2020 </div><div id="a19160" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:68px;">$</div><div id="a19162" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:352px;top:68px;display:flex;">(2,875)</div><div id="a19165" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:397px;top:68px;">$</div><div id="a19167" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:68px;display:flex;">(23,467)</div><div id="a19170" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:481px;top:68px;">$</div><div id="a19172" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:531px;top:68px;">3,342</div><div id="a19175" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:68px;">$</div><div id="a19177" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:68px;display:flex;">(3,598)</div><div id="a19180" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:68px;">$</div><div id="a19182" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:68px;display:flex;">(26,598)</div><div id="a19185" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:85px;">Other comprehensive (loss) income before </div><div id="a19204" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:102px;">reclassifications </div><div id="a19208" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:102px;display:flex;">(29,207)</div><div id="a19212" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:440px;top:102px;">1,009</div><div id="a19216" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:102px;display:flex;">(489)</div><div id="a19220" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:614px;top:102px;">1,883</div><div id="a19224" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:102px;display:flex;">(26,804)</div><div id="a19227" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:119px;">Amounts reclassified from AOCI </div><div id="a19231" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:373px;top:119px;">—</div><div id="a19235" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:440px;top:119px;">2,423</div><div id="a19239" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:526px;top:119px;display:flex;">(3,259)</div><div id="a19243" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:119px;">—</div><div id="a19247" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:694px;top:119px;display:flex;">(836)</div><div id="a19250" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:136px;">Related tax amounts </div><div id="a19254" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:373px;top:136px;">—</div><div id="a19258" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:136px;display:flex;">(839)</div><div id="a19262" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:136px;">787</div><div id="a19266" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:136px;display:flex;">(433)</div><div id="a19270" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:694px;top:136px;display:flex;">(485)</div><div id="a19272" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:153px;">Balance at September 30, 2021 </div><div id="a19275" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:153px;">$</div><div id="a19277" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:153px;display:flex;">(32,082)</div><div id="a19280" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:397px;top:153px;">$</div><div id="a19282" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:153px;display:flex;">(20,874)</div><div id="a19285" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:481px;top:153px;">$</div><div id="a19287" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:153px;">381</div><div id="a19290" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:153px;">$</div><div id="a19292" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:153px;display:flex;">(2,148)</div><div id="a19295" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:153px;">$</div><div id="a19297" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:153px;display:flex;">(54,723)</div><div id="a19317" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:187px;">Balance at December 31, 2019 </div><div id="a19321" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:187px;">$</div><div id="a19323" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:187px;display:flex;">(44,568)</div><div id="a19326" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:397px;top:187px;">$</div><div id="a19328" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:187px;display:flex;">(34,533)</div><div id="a19331" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:481px;top:187px;">$</div><div id="a19333" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:531px;top:187px;">1,251</div><div id="a19336" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:187px;">$</div><div id="a19338" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:187px;display:flex;">(320)</div><div id="a19341" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:187px;">$</div><div id="a19343" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:187px;display:flex;">(78,170)</div><div id="a19346" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:204px;">Other comprehensive (loss) income before<div style="display:inline-block;width:4px"> </div></div><div id="a19365" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:221px;">reclassifications </div><div id="a19369" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:221px;display:flex;">(10,468)</div><div id="a19373" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:221px;display:flex;">(409)</div><div id="a19377" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:221px;">802</div><div id="a19381" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:221px;display:flex;">(4,855)</div><div id="a19385" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:221px;display:flex;">(14,930)</div><div id="a19388" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:238px;">Amounts reclassified from AOCI </div><div id="a19392" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:373px;top:238px;">—</div><div id="a19396" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:433px;top:238px;">25,550</div><div id="a19400" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:238px;display:flex;">(229)</div><div id="a19404" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:238px;">—</div><div id="a19408" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:238px;">25,321</div><div id="a19411" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:255px;">Related tax amounts </div><div id="a19415" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:373px;top:255px;">—</div><div id="a19419" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:435px;top:255px;display:flex;">(8,228)</div><div id="a19423" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:255px;display:flex;">(120)</div><div id="a19427" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:614px;top:255px;">1,117</div><div id="a19431" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:684px;top:255px;display:flex;">(7,231)</div><div id="a19433" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:272px;">Balance at September 30, 2020 </div><div id="a19436" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:272px;">$</div><div id="a19438" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:272px;display:flex;">(55,036)</div><div id="a19441" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:397px;top:272px;">$</div><div id="a19443" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:272px;display:flex;">(17,620)</div><div id="a19446" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:481px;top:272px;">$</div><div id="a19448" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:531px;top:272px;">1,704</div><div id="a19451" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:272px;">$</div><div id="a19453" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:272px;display:flex;">(4,058)</div><div id="a19456" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:272px;">$</div><div id="a19458" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:272px;display:flex;">(75,010)</div></div></div></div><div id="TextBlockContainer754" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:712px;height:47px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19460" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">All reclassifications related to unrealized gain (loss) in available-for-sale securities relate<div style="display:inline-block;width:5px"> </div>to the Company’s equity<div style="display:inline-block;width:5px"> </div>interest in a </div><div id="a19466" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">captive insurance company and are recorded in equity in net income<div style="display:inline-block;width:5px"> </div>of associated companies.<div style="display:inline-block;width:7px"> </div>The amounts reported in other </div><div id="a19467" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">comprehensive income for noncontrolling interest are related to currency<div style="display:inline-block;width:5px"> </div>translation adjustments.</div></div> <div id="TextBlockContainer738" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:730px;height:352px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_736_XBRL_TS_3efaa2dc8927451d9e517a9c7c4efd92" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer737" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:730px;height:352px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a17530" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:464px;top:0px;">Accumulated </div><div id="a17544" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:318px;top:15px;">Capital in </div><div id="a17550" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:485px;top:15px;">Other </div><div id="a17561" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:255px;top:30px;">Common </div><div id="a17564" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:320px;top:30px;">Excess of </div><div id="a17567" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:391px;top:30px;">Retained </div><div id="a17570" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:457px;top:30px;">Comprehensive </div><div id="a17573" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:555px;top:30px;">Noncontrolling </div><div id="a17581" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:265px;top:45px;">Stock </div><div id="a17584" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:317px;top:45px;">Par Value </div><div id="a17587" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:391px;top:45px;">Earnings </div><div id="a17590" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:489px;top:45px;">Loss </div><div id="a17593" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:576px;top:45px;">Interest </div><div id="a17596" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:670px;top:45px;">Total </div><div id="a17598" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:62px;">Balance at June 30, 2021 </div><div id="a17600" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:62px;">$</div><div id="a17602" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:62px;">17,878</div><div id="a17605" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:62px;">$</div><div id="a17607" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:329px;top:62px;">910,862</div><div id="a17610" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:384px;top:62px;">$</div><div id="a17612" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:62px;">482,001</div><div id="a17615" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:62px;">$</div><div id="a17617" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:62px;display:flex;">(35,943)</div><div id="a17620" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:553px;top:62px;">$</div><div id="a17622" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:62px;">603</div><div id="a17625" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:62px;">$</div><div id="a17627" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:62px;">1,375,401</div><div id="a17630" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:79px;">Net income </div><div id="a17633" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:79px;">—</div><div id="a17637" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:79px;">—</div><div id="a17641" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:79px;">31,058</div><div id="a17645" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:529px;top:79px;">—</div><div id="a17649" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:79px;">15</div><div id="a17653" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:680px;top:79px;">31,073</div><div id="a17656" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:96px;">Amounts reported in other comprehensive<div style="display:inline-block;width:4px"> </div></div><div id="a17677" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:113px;">loss </div><div id="a17680" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:113px;">—</div><div id="a17684" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:113px;">—</div><div id="a17688" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:432px;top:113px;">—</div><div id="a17692" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:113px;display:flex;">(18,780)</div><div id="a17696" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:113px;">—</div><div id="a17700" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:113px;display:flex;">(18,780)</div><div id="a17703" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:130px;">Dividends ($</div><div id="a17703_12_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:84px;top:130px;">0.415</div><div id="a17703_17_12" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:114px;top:130px;"><div style="display:inline-block;width:3px"> </div>per share) </div><div id="a17706" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:130px;">—</div><div id="a17710" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:130px;">—</div><div id="a17714" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:411px;top:130px;display:flex;">(7,424)</div><div id="a17718" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:529px;top:130px;">—</div><div id="a17722" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:130px;">—</div><div id="a17726" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:130px;display:flex;">(7,424)</div><div id="a17729" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:147px;">Share issuance and equity-based </div><div id="a17752" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:164px;">compensation plans </div><div id="a17755" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:164px;">11</div><div id="a17759" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:343px;top:164px;">3,415</div><div id="a17763" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:432px;top:164px;">—</div><div id="a17767" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:529px;top:164px;">—</div><div id="a17771" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:164px;">—</div><div id="a17775" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:687px;top:164px;">3,426</div><div id="a17777" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:182px;">Balance at September 30, 2021 </div><div id="a17779" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:182px;">$</div><div id="a17781" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:182px;">17,889</div><div id="a17784" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:182px;">$</div><div id="a17786" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:329px;top:182px;">914,277</div><div id="a17789" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:384px;top:182px;">$</div><div id="a17791" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:182px;">505,635</div><div id="a17794" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:182px;">$</div><div id="a17796" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:182px;display:flex;">(54,723)</div><div id="a17799" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:553px;top:182px;">$</div><div id="a17801" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:182px;">618</div><div id="a17804" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:182px;">$</div><div id="a17806" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:182px;">1,383,696</div><div id="a17828" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:217px;">Balance at June 30, 2020 </div><div id="a17830" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:217px;">$</div><div id="a17832" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:217px;">17,800</div><div id="a17835" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:217px;">$</div><div id="a17837" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:329px;top:217px;">896,108</div><div id="a17840" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:384px;top:217px;">$</div><div id="a17842" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:217px;">362,265</div><div id="a17845" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:217px;">$</div><div id="a17847" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:494px;top:217px;display:flex;">(109,264)</div><div id="a17850" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:553px;top:217px;">$</div><div id="a17852" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:217px;">432</div><div id="a17855" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:217px;">$</div><div id="a17857" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:217px;">1,167,341</div><div id="a17860" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:234px;">Net income </div><div id="a17863" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:234px;">—</div><div id="a17867" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:234px;">—</div><div id="a17871" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:234px;">27,304</div><div id="a17875" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:529px;top:234px;">—</div><div id="a17879" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:234px;">38</div><div id="a17883" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:680px;top:234px;">27,342</div><div id="a17886" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:251px;">Amounts reported in other comprehensive<div style="display:inline-block;width:4px"> </div></div><div id="a17907" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:268px;">income </div><div id="a17910" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:268px;">—</div><div id="a17914" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:268px;">—</div><div id="a17918" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:432px;top:268px;">—</div><div id="a17922" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:506px;top:268px;">34,254</div><div id="a17926" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:268px;">17</div><div id="a17930" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:680px;top:268px;">34,271</div><div id="a17933" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:285px;">Dividends ($</div><div id="a17933_12_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:84px;top:285px;">0.395</div><div id="a17933_17_12" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:114px;top:285px;"><div style="display:inline-block;width:3px"> </div>per share) </div><div id="a17936" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:285px;">—</div><div id="a17940" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:359px;top:285px;">—</div><div id="a17944" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:411px;top:285px;display:flex;">(7,048)</div><div id="a17948" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:529px;top:285px;">—</div><div id="a17952" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:285px;">—</div><div id="a17956" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:285px;display:flex;">(7,048)</div><div id="a17959" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:302px;">Share issuance and equity-based </div><div id="a17982" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:319px;">compensation plans </div><div id="a17985" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:319px;">31</div><div id="a17989" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:343px;top:319px;">4,494</div><div id="a17993" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:432px;top:319px;">—</div><div id="a17997" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:529px;top:319px;">—</div><div id="a18001" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:319px;">—</div><div id="a18005" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:687px;top:319px;">4,525</div><div id="a18007" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:337px;">Balance at September 30, 2020 </div><div id="a18009" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:337px;">$</div><div id="a18011" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:337px;">17,831</div><div id="a18014" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:336px;">$</div><div id="a18016" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:329px;top:337px;">900,602</div><div id="a18019" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:384px;top:337px;">$</div><div id="a18021" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:337px;">382,521</div><div id="a18024" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:337px;">$</div><div id="a18026" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:337px;display:flex;">(75,010)</div><div id="a18029" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:553px;top:337px;">$</div><div id="a18031" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:337px;">487</div><div id="a18034" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:337px;">$</div><div id="a18036" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:337px;">1,226,431</div></div></div></div><div id="TextBlockContainer742" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:742px;height:438px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_740_XBRL_TS_3181580e616744a6bfc9c398aebcaeae" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer741" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:742px;height:438px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a18051" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:476px;top:0px;">Accumulated </div><div id="a18065" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:324px;top:15px;">Capital in </div><div id="a18071" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:497px;top:15px;">Other </div><div id="a18082" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:255px;top:30px;">Common </div><div id="a18085" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:326px;top:30px;">Excess of </div><div id="a18088" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:403px;top:30px;">Retained </div><div id="a18091" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:469px;top:30px;">Comprehensive </div><div id="a18094" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:567px;top:30px;">Noncontrolling </div><div id="a18102" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:265px;top:45px;">Stock </div><div id="a18105" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:323px;top:45px;">Par Value </div><div id="a18108" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:403px;top:45px;">Earnings </div><div id="a18111" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:501px;top:45px;">Loss </div><div id="a18114" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:588px;top:45px;">Interest </div><div id="a18117" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:682px;top:45px;">Total </div><div id="a18119" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:62px;">Balance at December 31, 2020 </div><div id="a18121" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:62px;">$</div><div id="a18123" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:62px;">17,851</div><div id="a18126" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:62px;">$</div><div id="a18128" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:341px;top:62px;">905,171</div><div id="a18131" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:62px;">$</div><div id="a18133" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:414px;top:62px;">423,940</div><div id="a18136" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:469px;top:62px;">$</div><div id="a18138" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:62px;display:flex;">(26,598)</div><div id="a18141" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:566px;top:62px;">$</div><div id="a18143" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:631px;top:62px;">550</div><div id="a18146" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:62px;">$</div><div id="a18148" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:62px;">1,320,914</div><div id="a18151" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:79px;">Net income </div><div id="a18154" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:79px;">—</div><div id="a18158" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:371px;top:79px;">—</div><div id="a18162" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:414px;top:79px;">103,243</div><div id="a18166" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:79px;">—</div><div id="a18170" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:637px;top:79px;">62</div><div id="a18174" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:685px;top:79px;">103,305</div><div id="a18177" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:96px;">Amounts reported in other comprehensive<div style="display:inline-block;width:4px"> </div></div><div id="a18198" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:113px;">(loss) income </div><div id="a18201" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:113px;">—</div><div id="a18205" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:371px;top:113px;">—</div><div id="a18209" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:113px;">—</div><div id="a18213" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:113px;display:flex;">(28,125)</div><div id="a18217" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:644px;top:113px;">6</div><div id="a18221" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:687px;top:113px;display:flex;">(28,119)</div><div id="a18224" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:130px;">Dividends ($</div><div id="a18224_12_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:84px;top:130px;">1.205</div><div id="a18224_17_12" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:114px;top:130px;"><div style="display:inline-block;width:3px"> </div>per share) </div><div id="a18227" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:130px;">—</div><div id="a18231" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:371px;top:130px;">—</div><div id="a18235" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:416px;top:130px;display:flex;">(21,548)</div><div id="a18239" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:130px;">—</div><div id="a18243" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:637px;top:130px;">—</div><div id="a18247" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:687px;top:130px;display:flex;">(21,548)</div><div id="a18250" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:147px;">Share issuance and equity-based </div><div id="a18273" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:164px;">compensation plans </div><div id="a18276" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:164px;">38</div><div id="a18280" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:355px;top:164px;">9,106</div><div id="a18284" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:164px;">—</div><div id="a18288" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:164px;">—</div><div id="a18292" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:637px;top:164px;">—</div><div id="a18296" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:699px;top:164px;">9,144</div><div id="a18298" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:182px;">Balance at September 30, 2021 </div><div id="a18300" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:182px;">$</div><div id="a18302" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:182px;">17,889</div><div id="a18305" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:182px;">$</div><div id="a18307" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:341px;top:182px;">914,277</div><div id="a18310" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:182px;">$</div><div id="a18312" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:414px;top:182px;">505,635</div><div id="a18315" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:469px;top:182px;">$</div><div id="a18317" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:182px;display:flex;">(54,723)</div><div id="a18320" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:566px;top:182px;">$</div><div id="a18322" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:631px;top:182px;">618</div><div id="a18325" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:182px;">$</div><div id="a18327" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:182px;">1,383,696</div><div id="a18349" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:217px;">Balance at December 31, 2019 </div><div id="a18351" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:217px;">$</div><div id="a18353" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:217px;">17,735</div><div id="a18356" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:217px;">$</div><div id="a18358" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:341px;top:217px;">888,218</div><div id="a18361" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:217px;">$</div><div id="a18363" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:414px;top:217px;">412,979</div><div id="a18366" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:469px;top:217px;">$</div><div id="a18368" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:217px;display:flex;">(78,170)</div><div id="a18371" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:566px;top:217px;">$</div><div id="a18373" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:621px;top:217px;">1,604</div><div id="a18376" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:217px;">$</div><div id="a18378" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:217px;">1,242,366</div><div id="a18381" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:234px;">Cumulative effect of an accounting change </div><div id="a18384" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:234px;">—</div><div id="a18388" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:371px;top:234px;">—</div><div id="a18392" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:433px;top:234px;display:flex;">(911)</div><div id="a18396" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:234px;">—</div><div id="a18400" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:637px;top:234px;">—</div><div id="a18404" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:704px;top:234px;display:flex;">(911)</div><div id="a18406" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:251px;">Balance at January 1, 2020 </div><div id="a18409" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:251px;">17,735</div><div id="a18413" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:341px;top:251px;">888,218</div><div id="a18417" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:414px;top:251px;">412,068</div><div id="a18421" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:251px;display:flex;">(78,170)</div><div id="a18425" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:621px;top:251px;">1,604</div><div id="a18429" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:251px;">1,241,455</div><div id="a18432" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:268px;">Net (loss) income </div><div id="a18435" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:268px;">—</div><div id="a18439" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:371px;top:268px;">—</div><div id="a18443" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:423px;top:268px;display:flex;">(8,812)</div><div id="a18447" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:268px;">—</div><div id="a18451" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:637px;top:268px;">88</div><div id="a18455" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:694px;top:268px;display:flex;">(8,724)</div><div id="a18458" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:285px;">Amounts reported in other comprehensive<div style="display:inline-block;width:4px"> </div></div><div id="a18479" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:302px;">income (loss) </div><div id="a18482" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:302px;">—</div><div id="a18486" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:371px;top:302px;">—</div><div id="a18490" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:302px;">—</div><div id="a18494" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:302px;">3,160</div><div id="a18498" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:302px;display:flex;">(114)</div><div id="a18502" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:699px;top:302px;">3,046</div><div id="a18505" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:319px;">Dividends ($</div><div id="a18505_12_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:84px;top:319px;">1.165</div><div id="a18505_17_12" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:114px;top:319px;"><div style="display:inline-block;width:3px"> </div>per share) </div><div id="a18508" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:319px;">—</div><div id="a18512" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:371px;top:319px;">—</div><div id="a18516" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:416px;top:319px;display:flex;">(20,735)</div><div id="a18520" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:319px;">—</div><div id="a18524" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:637px;top:319px;">—</div><div id="a18528" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:687px;top:319px;display:flex;">(20,735)</div><div id="a18531" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:336px;">Acquisition of noncontrolling interest </div><div id="a18534" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:336px;">—</div><div id="a18538" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:360px;top:336px;display:flex;">(707)</div><div id="a18542" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:336px;">—</div><div id="a18546" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:336px;">—</div><div id="a18550" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:336px;display:flex;">(340)</div><div id="a18554" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:694px;top:336px;display:flex;">(1,047)</div><div id="a18557" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:353px;">Distributions to noncontrolling affiliate </div><div id="a18578" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:370px;">shareholders </div><div id="a18581" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:370px;">—</div><div id="a18585" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:371px;top:370px;">—</div><div id="a18589" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:370px;">—</div><div id="a18593" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:370px;">—</div><div id="a18597" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:370px;display:flex;">(751)</div><div id="a18601" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:704px;top:370px;display:flex;">(751)</div><div id="a18604" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:387px;">Share issuance and equity-based </div><div id="a18627" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:404px;">compensation plans </div><div id="a18630" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:291px;top:404px;">96</div><div id="a18634" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:348px;top:404px;">13,091</div><div id="a18638" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:404px;">—</div><div id="a18642" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:404px;">—</div><div id="a18646" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:637px;top:404px;">—</div><div id="a18650" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:692px;top:404px;">13,187</div><div id="a18652" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:422px;">Balance at September 30, 2020 </div><div id="a18654" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:422px;">$</div><div id="a18656" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:268px;top:422px;">17,831</div><div id="a18659" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:422px;">$</div><div id="a18661" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:341px;top:422px;">900,602</div><div id="a18664" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:422px;">$</div><div id="a18666" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:414px;top:422px;">382,521</div><div id="a18669" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:469px;top:422px;">$</div><div id="a18671" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:422px;display:flex;">(75,010)</div><div id="a18674" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:566px;top:422px;">$</div><div id="a18676" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:631px;top:422px;">487</div><div id="a18679" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:422px;">$</div><div id="a18681" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:422px;">1,226,431</div></div></div></div> 17878000 910862000 482001000 -35943000 603000 1375401000 0 0 31058000 0 15000 31073000 0 0 0 -18780000 0 -18780000 0.415 0 0 7424000 0 0 7424000 11000 3415000 0 0 0 3426000 17889000 914277000 505635000 -54723000 618000 1383696000 17800000 896108000 362265000 -109264000 432000 1167341000 0 0 27304000 0 38000 27342000 0 0 0 34254000 17000 34271000 0.395 0 0 7048000 0 0 7048000 31000 4494000 0 0 0 4525000 17831000 900602000 382521000 -75010000 487000 1226431000 17851000 905171000 423940000 -26598000 550000 1320914000 0 0 103243000 0 62000 103305000 0 0 0 -28125000 6000 -28119000 1.205 0 0 21548000 0 0 21548000 38000 9106000 0 0 0 9144000 17889000 914277000 505635000 -54723000 618000 1383696000 17735000 888218000 412979000 -78170000 1604000 1242366000 0 0 -911000 0 0 -911000 17735000 888218000 412068000 -78170000 1604000 1241455000 0 0 -8812000 0 88000 -8724000 0 0 0 3160000 -114000 3046000 1.165 0 0 20735000 0 0 20735000 0 707000 0 0 340000 1047000 0 0 0 0 751000 751000 96000 13091000 0 0 0 13187000 17831000 900602000 382521000 -75010000 487000 1226431000 <div id="TextBlockContainer748" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:287px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_746_XBRL_TS_505debe442ea4bc9b875682f085f413f" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer747" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:287px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a18714" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:413px;top:0px;">Defined </div><div id="a18717" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:491px;top:0px;">Unrealized </div><div id="a18729" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:325px;top:17px;">Currency </div><div id="a18733" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:415px;top:17px;">Benefit </div><div id="a18736" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:482px;top:17px;">Gain (Loss) in </div><div id="a18748" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:319px;top:34px;">Translation </div><div id="a18751" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:413px;top:34px;">Pension </div><div id="a18754" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:483px;top:34px;">Available-for- </div><div id="a18760" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:580px;top:34px;">Derivative </div><div id="a18769" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:316px;top:51px;">Adjustments </div><div id="a18772" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:420px;top:51px;">Plans </div><div id="a18774" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:481px;top:51px;">Sale Securities </div><div id="a18776" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:575px;top:51px;">Instruments </div><div id="a18779" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:673px;top:51px;">Total </div><div id="a18781" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:68px;">Balance at June 30, 2021 </div><div id="a18784" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:68px;">$</div><div id="a18786" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:68px;display:flex;">(12,177)</div><div id="a18789" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:397px;top:68px;">$</div><div id="a18791" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:68px;display:flex;">(21,778)</div><div id="a18794" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:481px;top:68px;">$</div><div id="a18796" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:68px;">596</div><div id="a18799" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:68px;">$</div><div id="a18801" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:68px;display:flex;">(2,584)</div><div id="a18804" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:68px;">$</div><div id="a18806" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:68px;display:flex;">(35,943)</div><div id="a18809" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:85px;">Other comprehensive (loss) income before<div style="display:inline-block;width:4px"> </div></div><div id="a18829" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:102px;">reclassifications </div><div id="a18833" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:102px;display:flex;">(19,905)</div><div id="a18837" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:102px;">488</div><div id="a18841" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:102px;display:flex;">(85)</div><div id="a18845" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:624px;top:102px;">567</div><div id="a18849" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:102px;display:flex;">(18,935)</div><div id="a18852" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:119px;">Amounts reclassified from AOCI </div><div id="a18856" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:373px;top:119px;">—</div><div id="a18860" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:119px;">709</div><div id="a18864" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:119px;display:flex;">(176)</div><div id="a18868" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:119px;">—</div><div id="a18872" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:699px;top:119px;">533</div><div id="a18875" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:136px;">Related tax amounts </div><div id="a18879" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:373px;top:136px;">—</div><div id="a18883" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:136px;display:flex;">(293)</div><div id="a18887" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:136px;">46</div><div id="a18891" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:136px;display:flex;">(131)</div><div id="a18895" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:694px;top:136px;display:flex;">(378)</div><div id="a18897" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:153px;">Balance at September 30, 2021 </div><div id="a18900" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:153px;">$</div><div id="a18902" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:153px;display:flex;">(32,082)</div><div id="a18905" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:397px;top:153px;">$</div><div id="a18907" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:153px;display:flex;">(20,874)</div><div id="a18910" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:481px;top:153px;">$</div><div id="a18912" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:153px;">381</div><div id="a18915" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:153px;">$</div><div id="a18917" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:153px;display:flex;">(2,148)</div><div id="a18920" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:153px;">$</div><div id="a18922" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:153px;display:flex;">(54,723)</div><div id="a18942" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:187px;">Balance at June 30, 2020 </div><div id="a18946" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:187px;">$</div><div id="a18948" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:187px;display:flex;">(88,637)</div><div id="a18951" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:397px;top:187px;">$</div><div id="a18953" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:187px;display:flex;">(17,363)</div><div id="a18956" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:481px;top:187px;">$</div><div id="a18958" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:531px;top:187px;">1,148</div><div id="a18961" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:187px;">$</div><div id="a18963" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:187px;display:flex;">(4,412)</div><div id="a18966" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:187px;">$</div><div id="a18968" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:187px;display:flex;">(109,264)</div><div id="a18971" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:204px;">Other comprehensive income (loss) before </div><div id="a18990" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:221px;">reclassifications </div><div id="a18994" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:350px;top:221px;">33,601</div><div id="a18998" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:221px;display:flex;">(901)</div><div id="a19002" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:221px;">810</div><div id="a19006" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:624px;top:221px;">460</div><div id="a19010" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:221px;">33,970</div><div id="a19013" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:238px;">Amounts reclassified from AOCI </div><div id="a19017" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:373px;top:238px;">—</div><div id="a19021" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:238px;">584</div><div id="a19025" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:238px;display:flex;">(104)</div><div id="a19029" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:238px;">—</div><div id="a19033" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:699px;top:238px;">480</div><div id="a19036" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:255px;">Related tax amounts </div><div id="a19040" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:373px;top:255px;">—</div><div id="a19044" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:456px;top:255px;">60</div><div id="a19048" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:255px;display:flex;">(150)</div><div id="a19052" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:255px;display:flex;">(106)</div><div id="a19056" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:694px;top:255px;display:flex;">(196)</div><div id="a19058" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:272px;">Balance at September 30, 2020 </div><div id="a19061" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:272px;">$</div><div id="a19063" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:272px;display:flex;">(55,036)</div><div id="a19066" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:397px;top:272px;">$</div><div id="a19068" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:272px;display:flex;">(17,620)</div><div id="a19071" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:481px;top:272px;">$</div><div id="a19073" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:531px;top:272px;">1,704</div><div id="a19076" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:272px;">$</div><div id="a19078" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:272px;display:flex;">(4,058)</div><div id="a19081" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:272px;">$</div><div id="a19083" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:272px;display:flex;">(75,010)</div></div></div></div><div id="TextBlockContainer751" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:731px;height:288px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19093" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:413px;top:0px;">Defined </div><div id="a19096" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:491px;top:0px;">Unrealized </div><div id="a19107" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:325px;top:17px;">Currency </div><div id="a19110" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:415px;top:17px;">Benefit </div><div id="a19113" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:482px;top:17px;">Gain (Loss) in </div><div id="a19124" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:319px;top:34px;">Translation </div><div id="a19127" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:413px;top:34px;">Pension </div><div id="a19130" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:483px;top:34px;">Available-for- </div><div id="a19136" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:580px;top:34px;">Derivative </div><div id="a19145" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:316px;top:51px;">Adjustments </div><div id="a19148" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:420px;top:51px;">Plans </div><div id="a19150" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:481px;top:51px;">Sale Securities </div><div id="a19152" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:575px;top:51px;">Instruments </div><div id="a19155" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:673px;top:51px;">Total </div><div id="a19157" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:68px;">Balance at December 31, 2020 </div><div id="a19160" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:68px;">$</div><div id="a19162" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:352px;top:68px;display:flex;">(2,875)</div><div id="a19165" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:397px;top:68px;">$</div><div id="a19167" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:68px;display:flex;">(23,467)</div><div id="a19170" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:481px;top:68px;">$</div><div id="a19172" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:531px;top:68px;">3,342</div><div id="a19175" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:68px;">$</div><div id="a19177" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:68px;display:flex;">(3,598)</div><div id="a19180" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:68px;">$</div><div id="a19182" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:68px;display:flex;">(26,598)</div><div id="a19185" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:85px;">Other comprehensive (loss) income before </div><div id="a19204" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:102px;">reclassifications </div><div id="a19208" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:102px;display:flex;">(29,207)</div><div id="a19212" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:440px;top:102px;">1,009</div><div id="a19216" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:102px;display:flex;">(489)</div><div id="a19220" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:614px;top:102px;">1,883</div><div id="a19224" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:102px;display:flex;">(26,804)</div><div id="a19227" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:119px;">Amounts reclassified from AOCI </div><div id="a19231" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:373px;top:119px;">—</div><div id="a19235" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:440px;top:119px;">2,423</div><div id="a19239" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:526px;top:119px;display:flex;">(3,259)</div><div id="a19243" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:119px;">—</div><div id="a19247" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:694px;top:119px;display:flex;">(836)</div><div id="a19250" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:136px;">Related tax amounts </div><div id="a19254" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:373px;top:136px;">—</div><div id="a19258" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:136px;display:flex;">(839)</div><div id="a19262" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:136px;">787</div><div id="a19266" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:136px;display:flex;">(433)</div><div id="a19270" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:694px;top:136px;display:flex;">(485)</div><div id="a19272" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:153px;">Balance at September 30, 2021 </div><div id="a19275" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:153px;">$</div><div id="a19277" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:153px;display:flex;">(32,082)</div><div id="a19280" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:397px;top:153px;">$</div><div id="a19282" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:153px;display:flex;">(20,874)</div><div id="a19285" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:481px;top:153px;">$</div><div id="a19287" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:153px;">381</div><div id="a19290" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:153px;">$</div><div id="a19292" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:153px;display:flex;">(2,148)</div><div id="a19295" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:153px;">$</div><div id="a19297" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:153px;display:flex;">(54,723)</div><div id="a19317" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:187px;">Balance at December 31, 2019 </div><div id="a19321" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:187px;">$</div><div id="a19323" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:187px;display:flex;">(44,568)</div><div id="a19326" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:397px;top:187px;">$</div><div id="a19328" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:187px;display:flex;">(34,533)</div><div id="a19331" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:481px;top:187px;">$</div><div id="a19333" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:531px;top:187px;">1,251</div><div id="a19336" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:187px;">$</div><div id="a19338" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:187px;display:flex;">(320)</div><div id="a19341" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:187px;">$</div><div id="a19343" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:187px;display:flex;">(78,170)</div><div id="a19346" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:204px;">Other comprehensive (loss) income before<div style="display:inline-block;width:4px"> </div></div><div id="a19365" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:221px;">reclassifications </div><div id="a19369" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:221px;display:flex;">(10,468)</div><div id="a19373" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:221px;display:flex;">(409)</div><div id="a19377" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:221px;">802</div><div id="a19381" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:221px;display:flex;">(4,855)</div><div id="a19385" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:221px;display:flex;">(14,930)</div><div id="a19388" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:238px;">Amounts reclassified from AOCI </div><div id="a19392" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:373px;top:238px;">—</div><div id="a19396" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:433px;top:238px;">25,550</div><div id="a19400" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:238px;display:flex;">(229)</div><div id="a19404" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:238px;">—</div><div id="a19408" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:682px;top:238px;">25,321</div><div id="a19411" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:14px;top:255px;">Related tax amounts </div><div id="a19415" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:373px;top:255px;">—</div><div id="a19419" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:435px;top:255px;display:flex;">(8,228)</div><div id="a19423" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:255px;display:flex;">(120)</div><div id="a19427" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:614px;top:255px;">1,117</div><div id="a19431" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:684px;top:255px;display:flex;">(7,231)</div><div id="a19433" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:272px;">Balance at September 30, 2020 </div><div id="a19436" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:272px;">$</div><div id="a19438" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:272px;display:flex;">(55,036)</div><div id="a19441" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:397px;top:272px;">$</div><div id="a19443" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:272px;display:flex;">(17,620)</div><div id="a19446" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:481px;top:272px;">$</div><div id="a19448" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:531px;top:272px;">1,704</div><div id="a19451" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:272px;">$</div><div id="a19453" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:272px;display:flex;">(4,058)</div><div id="a19456" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:272px;">$</div><div id="a19458" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:272px;display:flex;">(75,010)</div></div> -12177000 -21778000 596000 -2584000 -35943000 -19905000 488000 -85000 567000 -18935000 0 709000 -176000 0 533000 0 -293000 46000 -131000 -378000 -32082000 -20874000 381000 -2148000 -54723000 -88637000 -17363000 1148000 -4412000 -109264000 33601000 -901000 810000 460000 33970000 0 584000 -104000 0 480000 0 60000 -150000 -106000 -196000 -55036000 -17620000 1704000 -4058000 -75010000 -2875000 -23467000 3342000 -3598000 -26598000 -29207000 1009000 -489000 1883000 -26804000 0 2423000 -3259000 0 -836000 0 -839000 787000 -433000 -485000 -32082000 -20874000 381000 -2148000 -54723000 -44568000 -34533000 1251000 -320000 -78170000 -10468000 -409000 802000 -4855000 -14930000 0 25550000 -229000 0 25321000 0 -8228000 -120000 1117000 -7231000 -55036000 -17620000 1704000 -4058000 -75010000 <div id="TextBlockContainer756" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:674px;height:55px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19469" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 17 – Fair Value<div style="display:inline-block;width:5px"> </div>Measurements</div><div id="a19474" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The Company has valued its company-owned life insurance policies at fair value.<div style="display:inline-block;width:8px"> </div>These assets are subject to fair value </div><div id="a19478" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">measurement as follows:</div></div><div id="TextBlockContainer759" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:728px;height:80px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19485" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:435px;top:0px;">Fair Value<div style="display:inline-block;width:5px"> </div>Measurements at September 30, 2021 </div><div id="a19490" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:365px;top:15px;">Total </div><div id="a19493" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:499px;top:15px;">Using Fair Value<div style="display:inline-block;width:5px"> </div>Hierarchy </div><div id="a19495" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Assets </div><div id="a19497" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:350px;top:31px;">Fair Value </div><div id="a19500" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:460px;top:31px;">Level 1 </div><div id="a19503" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:558px;top:31px;">Level 2 </div><div id="a19506" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:656px;top:31px;">Level 3 </div><div id="a19508" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">Company-owned life insurance </div><div id="a19512" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:338px;top:46px;">$ </div><div id="a19514" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:393px;top:46px;">2,135</div><div id="a19517" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:46px;">$ </div><div id="a19519" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:510px;top:46px;">—</div><div id="a19522" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:46px;">$</div><div id="a19524" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:591px;top:46px;">2,135</div><div id="a19527" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:634px;top:46px;">$ </div><div id="a19529" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:706px;top:46px;">—</div><div id="a19531" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:64px;">Total </div><div id="a19533" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:338px;top:64px;">$ </div><div id="a19535" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:393px;top:64px;">2,135</div><div id="a19538" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:64px;">$ </div><div id="a19540" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:510px;top:64px;">—</div><div id="a19543" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:64px;">$</div><div id="a19545" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:591px;top:64px;">2,135</div><div id="a19548" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:634px;top:64px;">$ </div><div id="a19550" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:706px;top:64px;">—</div></div><div id="TextBlockContainer763" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:729px;height:80px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19575" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:439px;top:0px;">Fair Value<div style="display:inline-block;width:5px"> </div>Measurements at December 31, 2020 </div><div id="a19580" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:367px;top:15px;">Total </div><div id="a19583" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:501px;top:15px;">Using Fair Value<div style="display:inline-block;width:5px"> </div>Hierarchy </div><div id="a19585" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Assets </div><div id="a19587" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:352px;top:31px;">Fair Value </div><div id="a19591" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:462px;top:31px;">Level 1 </div><div id="a19594" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:560px;top:31px;">Level 2 </div><div id="a19597" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:658px;top:31px;">Level 3 </div><div id="a19599" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">Company-owned life insurance<div style="display:inline-block;width:4px"> </div></div><div id="a19603" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:338px;top:46px;">$ </div><div id="a19605" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:46px;">1,961</div><div id="a19608" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:46px;">$ </div><div id="a19610" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:510px;top:46px;">—</div><div id="a19613" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:46px;">$ </div><div id="a19615" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:592px;top:46px;">1,961</div><div id="a19618" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:634px;top:46px;">$ </div><div id="a19620" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:706px;top:46px;">—</div><div id="a19622" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:64px;">Total </div><div id="a19624" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:338px;top:64px;">$ </div><div id="a19626" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:64px;">1,961</div><div id="a19629" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:64px;">$ </div><div id="a19631" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:510px;top:64px;">—</div><div id="a19634" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:64px;">$ </div><div id="a19636" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:592px;top:64px;">1,961</div><div id="a19639" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:634px;top:64px;">$ </div><div id="a19641" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:706px;top:64px;">—</div></div><div id="TextBlockContainer766" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:721px;height:47px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19643" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The fair values of Company-owned life insurance assets are based on quotes<div style="display:inline-block;width:5px"> </div>for like instruments with similar credit ratings and </div><div id="a19648" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">terms.<div style="display:inline-block;width:7px"> </div>The Company did not hold any Level 3 investments as of September 30,<div style="display:inline-block;width:5px"> </div>2021 or December 31, 2020, respectively,<div style="display:inline-block;width:5px"> </div>so related </div><div id="a19658" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">disclosures have not been included.</div></div> <div id="TextBlockContainer760" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:728px;height:80px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_758_XBRL_TS_006574e538454c048d2a7c64fc5e6b4e" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer759" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:728px;height:80px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19485" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:435px;top:0px;">Fair Value<div style="display:inline-block;width:5px"> </div>Measurements at September 30, 2021 </div><div id="a19490" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:365px;top:15px;">Total </div><div id="a19493" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:499px;top:15px;">Using Fair Value<div style="display:inline-block;width:5px"> </div>Hierarchy </div><div id="a19495" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Assets </div><div id="a19497" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:350px;top:31px;">Fair Value </div><div id="a19500" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:460px;top:31px;">Level 1 </div><div id="a19503" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:558px;top:31px;">Level 2 </div><div id="a19506" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:656px;top:31px;">Level 3 </div><div id="a19508" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">Company-owned life insurance </div><div id="a19512" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:338px;top:46px;">$ </div><div id="a19514" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:393px;top:46px;">2,135</div><div id="a19517" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:46px;">$ </div><div id="a19519" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:510px;top:46px;">—</div><div id="a19522" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:46px;">$</div><div id="a19524" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:591px;top:46px;">2,135</div><div id="a19527" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:634px;top:46px;">$ </div><div id="a19529" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:706px;top:46px;">—</div><div id="a19531" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:64px;">Total </div><div id="a19533" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:338px;top:64px;">$ </div><div id="a19535" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:393px;top:64px;">2,135</div><div id="a19538" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:64px;">$ </div><div id="a19540" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:510px;top:64px;">—</div><div id="a19543" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:64px;">$</div><div id="a19545" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:591px;top:64px;">2,135</div><div id="a19548" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:634px;top:64px;">$ </div><div id="a19550" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:706px;top:64px;">—</div></div></div></div><div id="TextBlockContainer764" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:729px;height:80px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_762_XBRL_TS_dce88a0cef5d4629bfa17876059d510d" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer763" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:729px;height:80px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19575" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:439px;top:0px;">Fair Value<div style="display:inline-block;width:5px"> </div>Measurements at December 31, 2020 </div><div id="a19580" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:367px;top:15px;">Total </div><div id="a19583" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:501px;top:15px;">Using Fair Value<div style="display:inline-block;width:5px"> </div>Hierarchy </div><div id="a19585" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Assets </div><div id="a19587" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:352px;top:31px;">Fair Value </div><div id="a19591" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:462px;top:31px;">Level 1 </div><div id="a19594" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:560px;top:31px;">Level 2 </div><div id="a19597" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:658px;top:31px;">Level 3 </div><div id="a19599" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">Company-owned life insurance<div style="display:inline-block;width:4px"> </div></div><div id="a19603" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:338px;top:46px;">$ </div><div id="a19605" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:46px;">1,961</div><div id="a19608" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:46px;">$ </div><div id="a19610" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:510px;top:46px;">—</div><div id="a19613" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:46px;">$ </div><div id="a19615" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:592px;top:46px;">1,961</div><div id="a19618" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:634px;top:46px;">$ </div><div id="a19620" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:706px;top:46px;">—</div><div id="a19622" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:64px;">Total </div><div id="a19624" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:338px;top:64px;">$ </div><div id="a19626" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:64px;">1,961</div><div id="a19629" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:64px;">$ </div><div id="a19631" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:510px;top:64px;">—</div><div id="a19634" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:64px;">$ </div><div id="a19636" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:592px;top:64px;">1,961</div><div id="a19639" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:634px;top:64px;">$ </div><div id="a19641" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:706px;top:64px;">—</div></div></div></div> 2135000 0 2135000 0 2135000 0 2135000 0 1961000 0 1961000 0 1961000 0 1961000 0 <div id="TextBlockContainer768" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:729px;height:155px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19660" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 18 – Hedging Activities </div><div id="a19667" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">In order to satisfy certain requirements of the Credit Facility as well as to manage<div style="display:inline-block;width:5px"> </div>the Company’s exposure to variable<div style="display:inline-block;width:5px"> </div>interest </div><div id="a19670" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">rate risk associated with the Credit Facility,<div style="display:inline-block;width:5px"> </div>in November 2019, the Company entered into $</div><div id="a19670_91_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:495px;top:39px;">170.0</div><div id="a19670_96_29" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:39px;"><div style="display:inline-block;width:3px"> </div>million notional amounts of </div><div id="a19670_125_6" style="position:absolute;font-family:'Times New Roman';left:680px;top:39px;">three </div><div id="a19673" style="position:absolute;font-family:'Times New Roman';left:4px;top:54px;">year</div><div id="a19673_4_123" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:27px;top:54px;"><div style="display:inline-block;width:3px"> </div>interest rate swaps.<div style="display:inline-block;width:7px"> </div>See Note 15 of Notes to Condensed Consolidated Financial Statements.<div style="display:inline-block;width:8px"> </div>These interest rate swaps are </div><div id="a19698" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">designated as cash flow hedges and, as such, the contracts are marked-to-market<div style="display:inline-block;width:5px"> </div>at each reporting date and any unrealized gains or </div><div id="a19703" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">losses are included in AOCI to the extent effective and reclassified to interest<div style="display:inline-block;width:5px"> </div>expense in the period during which the transaction </div><div id="a19705" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">affects earnings or it becomes probable that the forecasted<div style="display:inline-block;width:5px"> </div>transaction will not occur.<div style="display:inline-block;width:8px"> </div></div><div id="a19709" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:123px;">The balance sheet classification and fair values of the Company’s<div style="display:inline-block;width:5px"> </div>derivative instruments, which are Level 2 measurements, are as </div><div id="a19747" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:139px;">follows:</div></div><div id="TextBlockContainer772" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:709px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_770_XBRL_TS_369daa2b27cf4699a00469a07da0f518" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer771" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:709px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19755" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:568px;top:0px;">Fair Value </div><div id="a19761" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:319px;top:18px;">Condensed Consolidated </div><div id="a19764" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:502px;top:18px;">September 30,<div style="display:inline-block;width:4px"> </div></div><div id="a19767" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:614px;top:18px;">December 31, </div><div id="a19773" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:323px;top:35px;">Balance Sheet Location </div><div id="a19777" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:530px;top:35px;">2021 </div><div id="a19780" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:640px;top:35px;">2020 </div><div id="a19784" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:53px;">Derivatives designated as cash flow hedges: </div><div id="a19797" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:70px;">Interest rate swaps </div><div id="a19799" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:296px;top:70px;">Other non-current liabilities </div><div id="a19804" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:494px;top:70px;">$ </div><div id="a19806" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:560px;top:70px;">2,789</div><div id="a19809" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:604px;top:70px;">$ </div><div id="a19811" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:70px;">4,672</div><div id="a19820" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:494px;top:89px;">$ </div><div id="a19822" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:560px;top:89px;">2,789</div><div id="a19825" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:604px;top:89px;">$ </div><div id="a19827" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:89px;">4,672</div></div></div></div><div id="TextBlockContainer774" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:389px;height:16px;display:inline-block;"><div id="a19830" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">The following table presents the net unrealized loss deferred to AOCI:</div></div><div id="TextBlockContainer778" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:709px;height:85px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_776_XBRL_TS_3dbe44086adb4cc0bd73a1b46021f473" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer777" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:709px;height:85px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19839" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:501px;top:0px;">September 30,<div style="display:inline-block;width:4px"> </div></div><div id="a19842" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:614px;top:0px;">December 31, </div><div id="a19851" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:529px;top:17px;">2021 </div><div id="a19854" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:640px;top:17px;">2020 </div><div id="a19858" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:34px;">Derivatives designated as cash flow hedges: </div><div id="a19871" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:51px;">Interest rate swaps </div><div id="a19874" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:323px;top:51px;">AOCI </div><div id="a19877" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:494px;top:51px;">$ </div><div id="a19879" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:559px;top:51px;">2,148</div><div id="a19882" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:605px;top:51px;">$ </div><div id="a19884" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:51px;">3,598</div><div id="a19893" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:494px;top:69px;">$ </div><div id="a19895" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:559px;top:69px;">2,148</div><div id="a19898" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:605px;top:69px;">$ </div><div id="a19900" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:69px;">3,598</div></div></div></div><div id="TextBlockContainer780" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:424px;height:16px;display:inline-block;"><div id="a19903" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">The following table presents the net loss reclassified from AOCI to earnings:</div></div><div id="TextBlockContainer784" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:717px;height:87px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="div_782_XBRL_TS_4845fb53e79a471baceca67139779eb7" style="position:absolute;left:0px;top:0px;float:left;"><div id="TextBlockContainer783" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:717px;height:87px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19911" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:420px;top:0px;">Three Months Ended </div><div id="a19914" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:578px;top:0px;">Nine Months Ended </div><div id="a19921" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:440px;top:18px;">September 30,<div style="display:inline-block;width:4px"> </div></div><div id="a19924" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:594px;top:18px;">September 30,<div style="display:inline-block;width:4px"> </div></div><div id="a19931" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:429px;top:36px;">2021 </div><div id="a19934" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:506px;top:36px;">2020 </div><div id="a19937" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:583px;top:36px;">2021 </div><div id="a19940" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:660px;top:36px;">2020 </div><div id="a19944" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:53px;">Amount and location of expense reclassified </div><div id="a19962" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:70px;">from AOCI into expense (effective portion) </div><div id="a19965" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:277px;top:70px;">Interest expense, net </div><div id="a19967" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:408px;top:70px;">$ </div><div id="a19969" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:448px;top:70px;display:flex;">(672)</div><div id="a19972" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:485px;top:70px;">$ </div><div id="a19974" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:70px;display:flex;">(640)</div><div id="a19977" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:70px;">$ </div><div id="a19979" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:592px;top:70px;display:flex;">(1,974)</div><div id="a19982" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:639px;top:70px;">$ </div><div id="a19984" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:669px;top:70px;display:flex;">(1,105)</div></div></div></div><div id="TextBlockContainer786" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:709px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19987" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">Interest rate swaps are entered into with a limited number of counterparties,<div style="display:inline-block;width:5px"> </div>each of which allows for net settlement of all </div><div id="a19988" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">contracts through a single payment in a single currency in the event of a default<div style="display:inline-block;width:5px"> </div>on or termination of any one contract.<div style="display:inline-block;width:8px"> </div>As such, in </div><div id="a19990" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">accordance with the Company’s accounting<div style="display:inline-block;width:5px"> </div>policy, these derivative instruments<div style="display:inline-block;width:5px"> </div>are recorded on a net basis within the Condensed </div><div id="a19992" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">Consolidated Balance Sheets.</div></div> 170000000.0 P3Y <div id="TextBlockContainer771" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:709px;height:105px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19755" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:568px;top:0px;">Fair Value </div><div id="a19761" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:319px;top:18px;">Condensed Consolidated </div><div id="a19764" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:502px;top:18px;">September 30,<div style="display:inline-block;width:4px"> </div></div><div id="a19767" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:614px;top:18px;">December 31, </div><div id="a19773" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:323px;top:35px;">Balance Sheet Location </div><div id="a19777" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:530px;top:35px;">2021 </div><div id="a19780" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:640px;top:35px;">2020 </div><div id="a19784" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:53px;">Derivatives designated as cash flow hedges: </div><div id="a19797" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:70px;">Interest rate swaps </div><div id="a19799" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:296px;top:70px;">Other non-current liabilities </div><div id="a19804" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:494px;top:70px;">$ </div><div id="a19806" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:560px;top:70px;">2,789</div><div id="a19809" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:604px;top:70px;">$ </div><div id="a19811" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:70px;">4,672</div><div id="a19820" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:494px;top:89px;">$ </div><div id="a19822" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:560px;top:89px;">2,789</div><div id="a19825" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:604px;top:89px;">$ </div><div id="a19827" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:89px;">4,672</div></div><div id="TextBlockContainer777" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:709px;height:85px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19839" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:501px;top:0px;">September 30,<div style="display:inline-block;width:4px"> </div></div><div id="a19842" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:614px;top:0px;">December 31, </div><div id="a19851" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:529px;top:17px;">2021 </div><div id="a19854" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:640px;top:17px;">2020 </div><div id="a19858" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:34px;">Derivatives designated as cash flow hedges: </div><div id="a19871" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:15px;top:51px;">Interest rate swaps </div><div id="a19874" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:323px;top:51px;">AOCI </div><div id="a19877" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:494px;top:51px;">$ </div><div id="a19879" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:559px;top:51px;">2,148</div><div id="a19882" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:605px;top:51px;">$ </div><div id="a19884" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:51px;">3,598</div><div id="a19893" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:494px;top:69px;">$ </div><div id="a19895" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:559px;top:69px;">2,148</div><div id="a19898" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:605px;top:69px;">$ </div><div id="a19900" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:69px;">3,598</div></div><div id="TextBlockContainer783" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:717px;height:87px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19911" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:420px;top:0px;">Three Months Ended </div><div id="a19914" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:578px;top:0px;">Nine Months Ended </div><div id="a19921" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:440px;top:18px;">September 30,<div style="display:inline-block;width:4px"> </div></div><div id="a19924" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:594px;top:18px;">September 30,<div style="display:inline-block;width:4px"> </div></div><div id="a19931" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:429px;top:36px;">2021 </div><div id="a19934" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:506px;top:36px;">2020 </div><div id="a19937" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:583px;top:36px;">2021 </div><div id="a19940" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:660px;top:36px;">2020 </div><div id="a19944" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:53px;">Amount and location of expense reclassified </div><div id="a19962" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:70px;">from AOCI into expense (effective portion) </div><div id="a19965" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:277px;top:70px;">Interest expense, net </div><div id="a19967" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:408px;top:70px;">$ </div><div id="a19969" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:448px;top:70px;display:flex;">(672)</div><div id="a19972" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:485px;top:70px;">$ </div><div id="a19974" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:70px;display:flex;">(640)</div><div id="a19977" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:70px;">$ </div><div id="a19979" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:592px;top:70px;display:flex;">(1,974)</div><div id="a19982" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:639px;top:70px;">$ </div><div id="a19984" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:669px;top:70px;display:flex;">(1,105)</div></div> 2789000 4672000 2789000 4672000 2148000 3598000 2148000 3598000 -672000 -640000 -1974000 -1105000 <div id="TextBlockContainer788" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:146px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19994" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:0px;">Note 19 – Commitments and Contingencies </div><div id="a20000" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:23px;">The Company previously disclosed in its 2020 Form 10-K that AC Products, Inc.<div style="display:inline-block;width:5px"> </div>(“ACP”), a wholly owned subsidiary,<div style="display:inline-block;width:5px"> </div>has been </div><div id="a20038" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:39px;">operating a groundwater treatment system to hydraulically contain groundwater<div style="display:inline-block;width:5px"> </div>contamination emanating from ACP’s site,<div style="display:inline-block;width:5px"> </div>the </div><div id="a20068" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">principal contaminant of which is perchloroethylene.<div style="display:inline-block;width:8px"> </div>As of September 30, 2021, ACP believes it is close to meeting the conditions<div style="display:inline-block;width:5px"> </div>for </div><div id="a20107" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">closure of the groundwater treatment system, but continues to operate<div style="display:inline-block;width:5px"> </div>this system while in discussions with the relevant authorities.<div style="display:inline-block;width:4px"> </div></div><div id="a20146" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">As of September 30, 2021, the Company believes that the range of potential<div style="display:inline-block;width:1px"> </div>-known liabilities associated with the balance of the ACP </div><div id="a20188" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">water remediation program is approximately $</div><div id="a20188_44_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:252px;top:100px;">0.1</div><div id="a20188_47_13" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:269px;top:100px;"><div style="display:inline-block;width:3px"> </div>million to $</div><div id="a20188_60_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:334px;top:100px;">1.0</div><div id="a20188_63_70" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:351px;top:100px;"><div style="display:inline-block;width:3px"> </div>million.<div style="display:inline-block;width:7px"> </div>The low and high ends of the range are based on the length </div><div id="a20237" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">of operation of the treatment system as determined by groundwater modeling.<div style="display:inline-block;width:8px"> </div>Costs of operation include the operation and </div><div id="a20274" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:131px;">maintenance of the extraction well, groundwater monitoring and<div style="display:inline-block;width:5px"> </div>program management. </div></div><div id="TextBlockContainer790" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:838px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a20312" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:0px;">The Company previously disclosed in its 2020 Form 10-K that an inactive<div style="display:inline-block;width:5px"> </div>subsidiary of the Company that was acquired in 1978 </div><div id="a20353" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">sold certain products containing asbestos, primarily on an installed basis, and<div style="display:inline-block;width:5px"> </div>is among the defendants in numerous lawsuits alleging </div><div id="a20391" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">injury due to exposure to asbestos.<div style="display:inline-block;width:7px"> </div>During the three and nine months ended September 30, 2021, there have been<div style="display:inline-block;width:5px"> </div>no significant </div><div id="a20424" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:46px;">changes to the facts or circumstances of this previously disclosed matter,<div style="display:inline-block;width:5px"> </div>aside from on-going claims and routine payments associated </div><div id="a20464" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">with this litigation.<div style="display:inline-block;width:7px"> </div>Based on a continued analysis of the existing and anticipated future claims against this subsidiary,<div style="display:inline-block;width:6px"> </div>it is currently </div><div id="a20506" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">projected that the subsidiary’s total<div style="display:inline-block;width:5px"> </div>liability over the next 50 years for these claims is approximately $</div><div id="a20506_106_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:548px;top:77px;">0.4</div><div id="a20506_109_29" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:565px;top:77px;"><div style="display:inline-block;width:3px"> </div>million (excluding costs of </div><div id="a20549" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:92px;">defense). </div><div id="a20551" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:115px;">The Company previously disclosed in its 2020 Form 10-K that it is party to certain environmental<div style="display:inline-block;width:5px"> </div>matters related to certain </div><div id="a20593" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:131px;">domestic and foreign properties currently or previously owned by Houghton.<div style="display:inline-block;width:8px"> </div>These environmental matters primarily require the </div><div id="a20625" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:146px;">Company to perform long-term monitoring as well as operating and<div style="display:inline-block;width:5px"> </div>maintenance at each of the applicable sites.<div style="display:inline-block;width:7px"> </div>During the three and </div><div id="a20670" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:161px;">nine months ended September 30, 2021, there have been no significant<div style="display:inline-block;width:5px"> </div>changes to the facts or circumstances of these previously </div><div id="a20701" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:177px;">disclosed matters, aside from on-going monitoring and maintenance<div style="display:inline-block;width:5px"> </div>activities and routine payments associated with each of the sites.<div style="display:inline-block;width:4px"> </div></div><div id="a20739" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:192px;">The Company continually evaluates its obligations related to such matters,<div style="display:inline-block;width:5px"> </div>and based on historical costs incurred and projected costs </div><div id="a20778" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:207px;">to be incurred over the next 28 years, has estimated the present value<div style="display:inline-block;width:5px"> </div>range of costs for all of the Houghton environmental matters,<div style="display:inline-block;width:4px"> </div>on </div><div id="a20827" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:223px;">a discounted basis, to be between approximately $</div><div id="a20827_49_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:273px;top:223px;">5.5</div><div id="a20827_52_14" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:289px;top:223px;"><div style="display:inline-block;width:3px"> </div>million and $</div><div id="a20827_66_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:364px;top:223px;">6.5</div><div id="a20827_69_46" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:380px;top:223px;"><div style="display:inline-block;width:3px"> </div>million as of September 30, 2021, for which $</div><div id="a20827_115_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:223px;">5.7</div><div id="a20827_118_13" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:646px;top:223px;"><div style="display:inline-block;width:3px"> </div>million was </div><div id="a20877" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:238px;">accrued within other accrued liabilities and other non-current liabilities on<div style="display:inline-block;width:5px"> </div>the Company’s Condensed<div style="display:inline-block;width:5px"> </div>Consolidated Balance Sheet as </div><div id="a20914" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:253px;">of September 30, 2021.<div style="display:inline-block;width:7px"> </div>Comparatively, as of December<div style="display:inline-block;width:5px"> </div>31, 2020, the Company had $</div><div id="a20914_81_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:466px;top:253px;">6.0</div><div id="a20914_84_43" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:483px;top:253px;"><div style="display:inline-block;width:3px"> </div>million accrued for with respect to these </div><div id="a20954" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:269px;">matters. </div><div id="a20956" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:292px;">The Company believes, although there can be no assurance regarding the outcome<div style="display:inline-block;width:5px"> </div>of other unrelated environmental matters, that </div><div id="a20958" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:307px;">it has made adequate accruals for costs associated with other environmental<div style="display:inline-block;width:5px"> </div>problems of which it is aware.<div style="display:inline-block;width:7px"> </div>Approximately $</div><div id="a20958_123_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:307px;">0.3</div><div id="a20963" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:323px;">million and $</div><div id="a20963_13_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:76px;top:323px;">0.1</div><div id="a20963_16_115" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:92px;top:323px;"><div style="display:inline-block;width:3px"> </div>million was accrued as of September 30, 2021 and December 31, 2020,<div style="display:inline-block;width:5px"> </div>respectively, to provide for<div style="display:inline-block;width:5px"> </div>such anticipated </div><div id="a20974" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:338px;">future environmental assessments and remediation costs.<div style="display:inline-block;width:8px"> </div></div><div id="a20976" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:361px;">The Company previously disclosed in its 2020 Form 10-K that during the fourth<div style="display:inline-block;width:5px"> </div>quarter of 2020, one of the Company’s </div><div id="a21018" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:377px;">subsidiaries received a notice of inspection from a taxing authority<div style="display:inline-block;width:5px"> </div>in a country where certain of its subsidiaries operate which related </div><div id="a21060" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:392px;">to a non-income (indirect) tax that may be applicable to certain products the<div style="display:inline-block;width:5px"> </div>subsidiary sells.<div style="display:inline-block;width:7px"> </div>During the third quarter of 2021, the </div><div id="a21108" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:407px;">Company’s subsidiary received<div style="display:inline-block;width:5px"> </div>notice from the taxing authority that the inspection was closed, with no tax<div style="display:inline-block;width:5px"> </div>assessment issued.<div style="display:inline-block;width:7px"> </div>Based </div><div id="a21147" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:423px;">on this development, during the third quarter of 2021, the Company reversed<div style="display:inline-block;width:5px"> </div>its previously recorded $</div><div id="a21147_101_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:550px;top:423px;">1.8</div><div id="a21147_104_30" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:567px;top:423px;"><div style="display:inline-block;width:3px"> </div>million liability related to </div><div id="a21187" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:438px;">this matter.<div style="display:inline-block;width:8px"> </div>The Company also reversed the associated $</div><div id="a21187_56_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:308px;top:438px;">1.1</div><div id="a21187_59_75" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:325px;top:438px;"><div style="display:inline-block;width:3px"> </div>million indemnification receivable, as the asserted tax liability in<div style="display:inline-block;width:5px"> </div>part </div><div id="a21226" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:453px;">related to a Houghton entity acquired in the Combination and for<div style="display:inline-block;width:5px"> </div>the periods prior to the Combination, for which the Company would </div><div id="a21270" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:469px;">be indemnified by Houghton’s<div style="display:inline-block;width:5px"> </div>former owners.<div style="display:inline-block;width:7px"> </div>Based on all available information as of the date of this Report, the Company does not </div><div id="a21283" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:484px;">anticipate further tax inspection or liabilities related to this matter to be<div style="display:inline-block;width:5px"> </div>asserted by the taxing authority.<div style="display:inline-block;width:4px"> </div></div><div id="a21292" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:507px;">During the first half of 2021, one of the Company’s<div style="display:inline-block;width:5px"> </div>Brazilian subsidiaries received a notice that it had prevailed on an existing </div><div id="a21336" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:523px;">legal claim in regard to certain non-income (indirect) taxes that had been<div style="display:inline-block;width:5px"> </div>previously charged and paid.<div style="display:inline-block;width:8px"> </div>The matter specifically relates </div><div id="a21379" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:538px;">to companies’ rights to exclude the state tax on goods circulation (a valued-added-tax<div style="display:inline-block;width:5px"> </div>or </div><div id="a21411" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:479px;top:538px;letter-spacing:0.83px;">VAT </div><div id="a21413" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:509px;top:538px;">equivalent, known in Brazil as “ICMS”) </div><div id="a21425" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:553px;">from the calculation of certain additional indirect taxes (specifically the program<div style="display:inline-block;width:5px"> </div>of social integration (“PIS”) and contribution for the </div><div id="a21464" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:569px;">financing of social security (“COFINS”)) levied by the Brazilian States on the sale of<div style="display:inline-block;width:5px"> </div>goods.<div style="display:inline-block;width:7px"> </div>In May 2021, the Brazilian Supreme </div><div id="a21507" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:584px;">Court concluded that ICMS should not be included in the tax base of PIS<div style="display:inline-block;width:5px"> </div>and COFINS, and confirmed the methodology for </div><div id="a21549" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:599px;">calculating the PIS and COFINS tax credit claims to which taxpayers are<div style="display:inline-block;width:5px"> </div>entitled.<div style="display:inline-block;width:7px"> </div>The Company’s Brazilian entities had<div style="display:inline-block;width:5px"> </div>previously </div><div id="a21588" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:615px;">filed legal or administrative disputes on this matter and are entitled to receive<div style="display:inline-block;width:5px"> </div>tax credits and interest dating back to five years </div><div id="a21633" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:630px;">preceding the date of their legal claims.<div style="display:inline-block;width:7px"> </div>As a result of these court rulings, during the second quarter of 2021, the<div style="display:inline-block;width:5px"> </div>Company recognized </div><div id="a21682" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:645px;">non-income tax credits of </div><div id="a21682_26_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:144px;top:645px;">67.0</div><div id="a21682_30_31" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:168px;top:645px;"><div style="display:inline-block;width:3px"> </div>million BRL or approximately $</div><div id="a21682_61_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:344px;top:645px;">13.3</div><div id="a21682_65_40" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:367px;top:645px;"><div style="display:inline-block;width:3px"> </div>million, which included approximately $</div><div id="a21682_105_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:588px;top:645px;">8.4</div><div id="a21682_108_21" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:605px;top:645px;"><div style="display:inline-block;width:3px"> </div>million for the PIS </div><div id="a21728" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:661px;">and COFINS tax credits as well as interest on these tax credits of $</div><div id="a21728_68_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:361px;top:661px;">4.9</div><div id="a21728_71_60" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:378px;top:661px;"><div style="display:inline-block;width:3px"> </div>million.<div style="display:inline-block;width:7px"> </div>The tax credits to which the Company’s Brazilian </div><div id="a21776" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:676px;">subsidiaries are entitled are claimable once registered with the<div style="display:inline-block;width:4px"> </div>Brazilian tax authorities.<div style="display:inline-block;width:7px"> </div>The Company submitted its formal claim for </div><div id="a21818" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:691px;">tax credits in October 2021.<div style="display:inline-block;width:7px"> </div>These tax credits can be used to offset future Brazilian federal taxes and<div style="display:inline-block;width:5px"> </div>the Company currently </div><div id="a21861" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:707px;">anticipates using the full amount of credits during the five year period of<div style="display:inline-block;width:5px"> </div>time permitted.<div style="display:inline-block;width:7px"> </div>During the third quarter of 2021, the </div><div id="a21906" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:722px;">Brazilian Supreme Court ruled that interest income to which companies are<div style="display:inline-block;width:5px"> </div>entitled for matters such as this claim should not be </div><div id="a21948" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:737px;">taxable, which resulted in a reduction to the estimated income tax expense<div style="display:inline-block;width:5px"> </div>associated with the tax credits recorded.<div style="display:inline-block;width:4px"> </div></div><div id="a21986" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:761px;">In connection with obtaining regulatory approvals for the Combination,<div style="display:inline-block;width:5px"> </div>certain steel and aluminum related product lines of </div><div id="a22021" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:776px;">Houghton were divested on August 1, 2019. In July 2021, the entity that acquired<div style="display:inline-block;width:5px"> </div>these divested product lines submitted an </div><div id="a22061" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:791px;">indemnification claim for certain alleged breaches of representation made<div style="display:inline-block;width:5px"> </div>by Houghton in the agreement pursuant to which such assets </div><div id="a22100" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:807px;">had been divested.<div style="display:inline-block;width:7px"> </div>The Company and the acquirer have agreed to extend the period for<div style="display:inline-block;width:5px"> </div>a possible negotiated resolution of this claim </div><div id="a22144" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:822px;">through November 30, 2021 so that both parties can evaluate the other’s<div style="display:inline-block;width:5px"> </div>positions with respect to the subject matters of the claim.<div style="display:inline-block;width:8px"> </div></div></div><div id="TextBlockContainer792" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:733px;height:323px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a22207" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">The Company is evaluating the merits of the alleged losses in the indemnification<div style="display:inline-block;width:5px"> </div>claim received.<div style="display:inline-block;width:7px"> </div>As of the date of this Report, the </div><div id="a22253" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:15px;">Company does not believe it is reasonably possible to determine or quantify<div style="display:inline-block;width:5px"> </div>any possible exposure.<div style="display:inline-block;width:4px"> </div></div><div id="a22286" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:39px;">During the third quarter of 2021, two of the Company’s<div style="display:inline-block;width:5px"> </div>locations suffered property damages as a result of flooding and fire.<div style="display:inline-block;width:5px"> </div>The </div><div id="a22288" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:54px;">Company maintains property insurance for all of its facilities globally.<div style="display:inline-block;width:9px"> </div>In Conshohocken, Pennsylvania, the Company’s<div style="display:inline-block;width:5px"> </div>global </div><div id="a22291" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">headquarters as well as its laboratory experienced property damages<div style="display:inline-block;width:5px"> </div>as a result of flooding from Hurricane Ida.<div style="display:inline-block;width:7px"> </div>Also, one of the </div><div id="a22299" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">Company’s North American<div style="display:inline-block;width:5px"> </div>production facilities in its Global Specialty Businesses segment experienced an<div style="display:inline-block;width:5px"> </div>electrical fire that </div><div id="a22301" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">resulted in damage and the temporary shutdown of production,<div style="display:inline-block;width:4px"> </div>and also required remediation, cleaning and subsequent restoration.<div style="display:inline-block;width:4px"> </div></div><div id="a22312" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">The Company, its insurance<div style="display:inline-block;width:5px"> </div>adjuster and insurance carrier are actively managing the remediation and restoration<div style="display:inline-block;width:5px"> </div>activities associated </div><div id="a22314" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:131px;">with these events and at this time the Company has concluded, based on all available<div style="display:inline-block;width:5px"> </div>information and discussions with its insurance </div><div id="a22316" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:146px;">adjuster and insurance carrier, that the losses incurred<div style="display:inline-block;width:5px"> </div>during the third quarter of 2021 will be covered under the Company’s<div style="display:inline-block;width:5px"> </div>property </div><div id="a22319" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:161px;">insurance coverage, net of an aggregate deductible of $</div><div id="a22319_55_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:299px;top:161px;">2.0</div><div id="a22319_58_74" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:161px;"><div style="display:inline-block;width:3px"> </div>million.<div style="display:inline-block;width:7px"> </div>The Company has received advance payments from its insurers of </div><div id="a22325" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:177px;">$</div><div id="a22325_1_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:11px;top:177px;">1.0</div><div id="a22325_4_126" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:177px;"><div style="display:inline-block;width:3px"> </div>million and has recorded an insurance receivable associated with these events<div style="display:inline-block;width:5px"> </div>(and a gain on insurance recoveries for losses </div><div id="a22327" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:192px;">incurred) of $</div><div id="a22327_14_3" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:78px;top:192px;">1.7</div><div id="a22327_17_118" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:95px;top:192px;"><div style="display:inline-block;width:3px"> </div>million as of September 30, 2021.<div style="display:inline-block;width:7px"> </div>The Company and its insurance carrier are in early stages of reviewing the impact </div><div id="a22330" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:207px;">of the electrical fire on the production facility’s<div style="display:inline-block;width:5px"> </div>operations as it relates to a potential business interruption insurance claim; however, </div><div id="a22335" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:223px;">as of the date of this Report, the Company cannot reasonably estimate any<div style="display:inline-block;width:5px"> </div>probable amount of business interruption insurance claim </div><div id="a22337" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:238px;">recoverable, therefore the Company has not recorded a gain contingency<div style="display:inline-block;width:5px"> </div>for a possible business interruption insurance claim as of </div><div id="a22340" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:253px;">September 30, 2021. </div><div id="a22343" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:277px;">The Company is party to other litigation which management currently<div style="display:inline-block;width:5px"> </div>believes will not have a material adverse effect on the </div><div id="a22344" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:292px;">Company’s results of operations,<div style="display:inline-block;width:5px"> </div>cash flows or financial condition.<div style="display:inline-block;width:7px"> </div>In addition, the Company has an immaterial amount of contractual </div><div id="a22346" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:307px;">purchase obligations.</div></div> 100000 1000000.0 400000 5500000 6500000 5700000 6000000.0 300000 100000 -1800000 -1100000 67000000.0 13300000 -8400000 4900000 2000000.0 1000000.0 1700000 XML 17 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document and Entity Information - shares
 9 Months Ended
Sep. 30, 2021
Oct. 31, 2021
Document and Entity Information [Abstract]    
Document Type 10-Q  
Document Period Focus Q3  
Document quarterly report true  
Document Fiscal Year Focus 2021  
Document period end date Sep. 30, 2021  
Current fiscal year end date --12-31  
Document Transition Report false  
Amendment flag false  
Entity File Number 001-12019  
Entity registrant name QUAKER CHEMICAL CORPORATION  
Entity Incorporation State Country Code PA  
Entity Tax Identification Number 23-0993790  
Entity central index key 0000081362  
Entity Address Address Line 901 E. Hector Street  
Entity Address City Or Town Conshohocken  
Entity Address State Or Province PA  
Entity Address Postal Zip Code 19428 – 2380  
City Area Code 610  
Local Phone Number 832-4000  
Entity current reporting status Yes  
Entity Interactive Data Current Yes  
Entity filer category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Security 12(b) Title Common Stock, $1 par value  
Trading Symbol KWR  
Entity common stock shares outstanding   17,894,480
Security Exchange Name NYSE  
XML 18 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Net sales $ 449,072 $ 367,224 $ 1,314,117 $ 1,031,825
Cost of goods sold (excluding amortization expense - See Note 14) 303,941 227,032 858,341 660,396
Gross profit 145,131 140,192 455,776 371,429
Selling, general and administrative expenses 104,215 97,037 317,204 282,405
Indefinite-lived intangible asset impairment 0 0 0 38,000
Restructuring and related charges (880) 1,383 593 3,585
Combination, integration and other acquisition-related 5,786 6,913 18,259 22,786
Operating income (loss) 36,010 34,859 119,720 24,653
Other income (expense), net 647 (239) 19,344 (22,407)
Interest expense, net (5,637) (6,837) (16,725) (22,109)
Income (loss) before taxes and equity in net income of associated companies 31,020 27,783 122,339 (19,863)
Taxes on income (loss) before equity in net income of associated companies 795 2,245 26,702 (7,603)
Income (loss) before equity in net income of associated companies 30,225 25,538 95,637 (12,260)
Equity in net income of associated companies 848 1,804 7,668 3,536
Net income (loss) 31,073 27,342 103,305 (8,724)
Less: Net income attributable to noncontrolling interest 15 38 62 88
Net income (loss) attributable to Quaker Chemical Corporation $ 31,058 $ 27,304 $ 103,243 $ (8,812)
Per share data:        
Net income (loss) attributable to Quaker Chemical Corporation common shareholders - basic $ 1.74 $ 1.53 $ 5.78 $ (0.50)
Net income (loss) attributable to Quaker Chemical Corporation common shareholders - diluted 1.73 1.53 5.76 (0.50)
Dividends declared $ 0.415 $ 0.395 $ 1.205 $ 1.165
XML 19 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Statement Of Comprehensive Income [Abstract]        
Net income (loss) $ 31,073 $ 27,342 $ 103,305 $ (8,724)
Currency translation adjustments (19,905) 33,618 (29,201) (10,582)
Defined Benefit Plans [Abstract]        
Defined Benefit Retirement Plans 904 (257) 2,593 16,913
Current period change in fair value of derivatives 436 354 1,450 (3,738)
Unrealized (loss) gain on available-for-sale securities (215) 556 (2,961) 453
Other comprehensive (loss) income (18,780) 34,271 (28,119) 3,046
Comprehensive income (loss) 12,293 61,613 75,186 (5,678)
Less: (income) loss attributable to noncontrolling interest (15) (56) (68) 25
Comprehensive income (loss) attributable to Quaker Chemical Corporation $ 12,278 $ 61,557 $ 75,118 $ (5,653)
XML 20 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 141,393 $ 181,833
Accounts receivable, net 433,631 372,974
Inventories    
Raw materials and supplies 121,951 86,148
Work-in-process and finished goods 132,943 101,616
Prepaid expenses and other current assets 63,278 50,156
Total current assets 893,196 792,727
Property, Plant and Equipment, at Cost 423,469 423,253
Less: Accumulated Depreciation (232,636) (219,370)
Property, Plant and Equipment, net 190,833 203,883
Right of use lease assets 34,314 38,507
Goodwill 630,669 631,212
Other intangible assets, net 1,048,688 1,081,358
Investments in associated companies 94,110 95,785
Deferred tax assets 18,409 16,566
Other non-current assets 31,608 31,796
Total assets 2,941,827 2,891,834
Current liabilities    
Short-term borrowings and current portion of long-term debt 52,611 38,967
Accounts and Other Payables 219,601 198,872
Accrued compensation 40,655 43,300
Accrued restructuring 4,050 8,248
Other accrued liabilities 93,042 93,573
Total current liabilities 409,959 382,960
Long-term debt 839,275 849,068
Long-term lease liabilities 24,599 27,070
Deferred tax liabilities 174,405 192,763
Other non-current liabilities 109,893 119,059
Total liabilities 1,558,131 1,570,920
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]    
Common stock, $1 par value; authorized 30,000,000 shares; issued and outstanding 2021 -17,888,577 shares; 2020 - 17,850,616 shares 17,889 17,851
Capital in excess of par value 914,277 905,171
Retained earnings 505,635 423,940
Accumulated other comprehensive loss (54,723) (26,598)
Total Quaker shareholders' equity 1,383,078 1,320,364
Noncontrolling interest 618 550
Total equity 1,383,696 1,320,914
Total liabilities and equity $ 2,941,827 $ 2,891,834
XML 21 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares
Sep. 30, 2021
Dec. 31, 2020
Statement Of Financial Position [Abstract]    
Common Stock Par Value $ 1 $ 1
Common Stock Shares Authorized 30,000,000 30,000,000
Common Stock Shares, Issued 17,888,577 17,850,616
Common stock shares, outstanding 17,888,577 17,850,616
XML 22 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities    
Net income (loss) $ 103,305 $ (8,724)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Amortization of debt issuance costs 3,562 3,562
Depreciation and amortization 65,440 62,818
Equity in undistributed earnings of associated companies, net of dividends (7,563) 1,415
Acquisition-related fair value adjustments related to inventory 801 229
Deferred compensation, deferred taxes and other, net (21,865) (30,657)
Share-based compensation 8,441 17,820
(Gain) loss on disposal of property, plant, equipment and other assets (4,819) 105
Insurance settlement realized 0 (818)
Indefinite-lived intangible asset impairment 0 38,000
Combination and other acquisition-related expenses, net of payments (1,705) 2,498
Restructuring and related charges 593 3,585
Pension And Other Postretirement Benefit Expense (5,638) 16,219
(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions:    
Accounts receivable (68,664) 30,225
Inventories (72,962) 2,137
Prepaid expenses and other current assets (24,512) (113)
Change in restructuring liabilities (4,557) (12,772)
Accounts payable and accrued liabilities 32,652 (13,481)
Net cash provided by operating activities 2,509 112,048
Cash flows from investing activities    
Investments in property, plant and equipment (12,823) (12,184)
Payments related to acquisitions, net of cash acquired (31,975) (3,132)
Proceeds from disposition of assets 14,744 11
Insurance settlement interest earned 0 41
Net cash used in investing activities (30,054) (15,264)
Cash flows from financing activities    
Payments of term loan debt 28,558 28,132
Borrowings (repayments) on revolving credit facilities, net 39,143 (16,485)
Repayments on other debt, net (585) (527)
Dividends paid (21,175) (20,520)
Stock options exercised, other 704 2,385
Purchase of noncontrolling interest in affiliates, net 0 (1,047)
Distributions to noncontrolling affiliate shareholders 0 (751)
Net cash (used in) by financing activities (10,471) (65,077)
Effect of foreign exchange rate changes on cash (2,486) (529)
Net (decrease) increase in cash, cash equivalents and restricted cash (40,502) 31,178
Cash, Cash Equivalents and Restricted Cash at the beginning of the period 181,895 143,555
Cash, Cash Equivalents and Restricted Cash at the end of the period $ 141,393 $ 174,733
XML 23 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Basis of Presentation and Description of Business
 9 Months Ended
Sep. 30, 2021
Basis of Presentation and Description of Business [Abstract]  
Basis of Presentation and Description of Business [Text Block]
Note 1 – Basis of Presentation and Description of Business
 
Basis of Presentation
As used in these Notes to Condensed Consolidated Financial Statements of
 
this Quarterly Report on Form 10-Q for the period
ended September 30, 2021 (the “Report”),
 
the terms “Quaker,”
 
“Quaker Houghton,”
 
the “Company,”
 
“we,” and “our” refer to Quaker
Chemical Corporation (doing business as Quaker Houghton), its subsidiaries, and
 
associated companies, unless the context otherwise
requires.
 
As used in these Notes to Condensed Consolidated Financial Statements,
 
the term Legacy Quaker refers to the Company
prior to the closing of its combination with Houghton International, Inc. (“Houghton”)
 
(herein referred to as the “Combination”).
 
The
condensed consolidated financial statements included herein are
 
unaudited and have been prepared in accordance with generally
accepted accounting principles in the United States (“U.S. GAAP”) for interim
 
financial reporting and the United States Securities and
Exchange Commission (“SEC”) regulations.
 
Certain information and footnote disclosures normally included in financial statements
prepared in accordance with U.S. GAAP have been condensed or omitted
 
pursuant to such rules and regulations.
 
In the opinion of
management, the financial statements reflect all adjustments consisting
 
only of normal recurring adjustments which are necessary for a
fair statement of the financial position, results of operations and cash
 
flows for the interim periods.
 
The results for the nine months
ended September 30, 2021 are not necessarily indicative of the results to be expected
 
for the full year.
 
These financial statements
should be read in conjunction with the Company’s
 
Annual Report filed on Form 10-K for the year ended December
 
31, 2020 (the
“2020 Form 10-K”).
 
During the three months ended September 30, 2020, the Company
 
identified and corrected certain immaterial adjustments relating
to the three months ended March 31, 2020 as well as the three and six months
 
ended June 30, 2020.
 
These adjustments related to the
Company’s over-recognition
 
of cost of goods sold (“COGS”) and corresponding under-recognition
 
of inventory, as well as the
associated tax impact of these adjustments, in the Company’s
 
previously issued interim financial statements for the three months
ended March 31, 2020 and the three and six months ended June 30, 2020.
 
These adjustments impact the Company’s
 
Americas
reportable segment.
 
The cumulative amount of reduction to COGS recorded in the three and nine months ended
 
September 30, 2020
was approximately $
1.7
 
million, with approximately $
0.7
 
million related to the three months ended March 31, 2020 and
approximately $
1.0
 
million related to the three months ended June 30, 2020.
Description of Business
The Company was organized in 1918, incorporated as a Pennsylvania
 
business corporation in 1930, and in August 2019
completed the Combination with Houghton to form Quaker Houghton.
 
Quaker Houghton is the global leader in industrial process
fluids.
 
With a presence around the world, including
 
operations in over
25
 
countries, the Company’s customers
 
include thousands of
the world’s most advanced and specialized
 
steel, aluminum, automotive, aerospace, offshore, can,
 
mining, and metalworking
companies.
 
Quaker Houghton develops, produces, and markets a broad range of formulated
 
chemical specialty products and offers
chemical management services (which the Company refers to as “Fluidcare”)
 
for various heavy industrial and manufacturing
applications throughout its
four
 
segments: Americas; Europe, Middle East and Africa (“EMEA”); Asia/Pacific; and
 
Global Specialty
Businesses.
Hyper-inflationary economies
Based on various indices or index compilations being used to monitor inflation
 
in Argentina as well as economic instability,
effective July 1, 2018, Argentina’s
 
economy was considered hyper-inflationary under U.S. GAAP.
 
As of, and for the three and nine
months ended September 30, 2021, the Company's Argentine
 
subsidiaries represented less than
1
% of the Company’s consolidated
total assets and net sales, respectively.
 
During the three and nine months ended September 30, 2021, the Company
 
recorded less than
$
0.1
 
million and $
0.3
 
million, respectively,
 
of remeasurement losses associated with the applicable currency conversions
 
related to
Argentina.
 
Comparatively, during the
 
three and nine months ended September 30, 2020, the Company recorded $
0.2
 
million and $
0.3
million, respectively,
 
of remeasurement losses associated with the applicable currency conversions
 
related to Argentina.
 
These losses
were recorded within foreign exchange losses, net, which is a component
 
of other income (expense), net, in the Company’s
Condensed Consolidated Statements of Operations.
COVID-19
Management continues to monitor the impact that the COVID-19 pandemic
 
is having on the Company, the overall
 
specialty
chemical industry, and
 
the economies and markets in which the Company operates.
 
The full extent of the COVID-19 pandemic
related business and travel restrictions and changes to business and consumer behavior
 
intended to reduce its spread are uncertain as of
the date of the Report as COVID-19 and the responses of governmental
 
authorities continue to evolve globally.
Further, management continues to evaluate
 
how COVID-19-related circumstances, such as remote work arrangements, affect
financial reporting processes, internal control over financial reporting,
 
and disclosure controls and procedures.
 
While the
circumstances have presented and are expected to continue to present challenges,
 
at this time, Management does not believe that
COVID-19 has had a material impact on financial reporting processes, internal
 
control over financial reporting, and disclosure
controls and procedures.
The Company cannot reasonably estimate the magnitude of the effects
 
these conditions will have on the Company’s
 
operations in
the future as they are subject to significant uncertainties relating to the ultimate
 
geographic spread of the virus, the incidence and
severity of the symptoms, the duration or resurgences
 
of the outbreak including the impact of new variants, the global availability,
acceptance and efficacy of vaccines, the length of the travel restrictions
 
and business closures imposed by governments of impacted
countries, and the economic response by governments of impacted countries,
 
all of which continue to evolve.
To the extent
 
that the Company’s customers and suppliers continue
 
to be significantly and adversely impacted by COVID-19, this
could reduce the availability,
 
or result in delays, of materials or supplies to or from the Company,
 
which in turn could significantly
interrupt the Company’s business operations.
 
Such impacts could grow and become more significant to the Company’s
 
operations
and the Company’s liquidity
 
or financial position.
 
Therefore, given the continuously evolving global developments with respect to
this pandemic, the Company cannot reasonably estimate the magnitude or
 
the full extent to which COVID-19 may impact the
Company’s results of operations,
 
liquidity or financial position.
XML 24 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Business Acquisitions
 9 Months Ended
Sep. 30, 2021
Business Acquisitions [Abstract]  
Business acquisitions disclosure [Text Block]
Note 2 – Business Acquisitions
2021 Acquisitions
In September 2021, the Company acquired the remaining interest in Grindaix-GmbH
 
(“Grindaix”), a Germany-based, high-tech
provider of coolant control and delivery systems for approximately
2.4
 
million EUR or approximately $
2.9
 
million for its Global
Specialty Businesses reportable segment.
 
Previously, in February 2021,
 
the Company acquired a
38
% ownership interest in Grindaix
for approximately
1.4
 
million EUR or approximately $
1.7
 
million.
 
The Company recorded its initial investment as an equity method
investment within the Condensed Consolidated Financial Statements and
 
accounted for the purchase of the remaining interest as a step
acquisition whereby the Company remeasured the previously held
 
equity method investment to its fair value.
In June 2021, the Company acquired certain assets for its chemical maskants
 
product line in the Global Specialty Businesses
reportable segment for
2.3
 
million EUR or approximately $
2.8
 
million.
 
The Company accounted for the acquisition using the asset
acquisition method under ASC 805,
Business Combinations
.
 
In February 2021, the Company acquired a tin-plating solutions business
 
for the steel end market for approximately $
25
 
million.
 
This acquisition is part of each of the Company’s
 
geographic reportable segments.
 
The Company allocated $
19.6
 
million of the
purchase price to intangible assets, comprised of $
18.3
 
million of customer relationships, to be amortized over
19 years
; $
0.9
 
million
of existing product technology to be amortized over
14 years
; and $
0.4
 
million of a licensed trademark to be amortized over
3 years
.
 
In addition, the Company recorded $
5.0
 
million of goodwill related to expected value not allocated to other acquired
 
assets, all of
which is expected to be tax deductible in various jurisdictions in which we
 
operate.
 
As of September 30, 2021, the allocation of the
purchase price has not been finalized and the
one year
 
measurement period has not ended.
 
Further adjustments may be necessary as a
result of the Company’s on-going
 
assessment of additional information related to the fair value of assets acquired
 
and liabilities
assumed.
The results of operations of the acquired assets and businesses subsequent to the
 
respective acquisition dates are included in the
Condensed Consolidated Statements of Operations as of September 30, 2021.
 
Applicable transaction expenses associated with these
acquisitions are included in Combination, integration and other acquisition
 
-related expenses in the Company’s Condensed
Consolidated Statements of Operations.
 
Certain pro forma and other information is not presented, as the operations of the acquired
assets and businesses are not considered material to the overall operations of the
 
Company for the periods presented.
In November 2021, the Company closed two additional acquisitions that expand
 
its strategic product offerings and increase the
Company’s presence in its core metalworking
 
industries.
 
The total initial purchase price for these acquisitions was approximately $
10
million, subject to post-closing adjustments as well as certain earn-out
 
provisions that could total approximately $
4
 
million.
 
Transaction expenses associated with these
 
acquisitions are included in Combination, integration and other acquisition-related
expenses in the Condensed Consolidated Statements of Operations.
 
The results of operations of these two acquisitions are not
included in the Consolidated Statements of Operations because the date of
 
closing for each was subsequent to September 30, 2021.
 
Preliminary purchase price allocation of assets acquired and liabilities assumed
 
have not been presented as that information is not
available as of the date of these Condensed Consolidated Financial Statements.
Previous Acquisitions
In December 2020, the Company completed its acquisition of Coral Chemical
 
Company (“Coral”), a privately held, U.S.-based
provider of metal finishing fluid solutions.
 
The acquisition provides technical expertise and product solutions for pre-treatment,
metalworking and wastewater treatment applications to the beverage
 
cans and general industrial end markets.
 
The original purchase
price was approximately $
54.1
 
million, subject to routine and customary post-closing adjustments related to working
 
capital and net
indebtedness levels.
 
The Company anticipates finalizing its post-closing adjustments for the Coral acquisition
 
during the fourth
quarter of 2021.
The following table presents the preliminary estimated fair values of
 
Coral net assets acquired:
Measurement
December 22,
December 22,
Period
2020
2020 (1)
Adjustments
(as adjusted)
Cash and cash equivalents
$
958
$
—
$
958
Accounts receivable
8,473
—
8,473
Inventories
4,527
—
4,527
Prepaid expenses and other assets
181
—
181
Property, plant and equipment
10,467
652
11,119
Intangible assets
30,300
(500)
29,800
Goodwill
2,814
270
3,084
Total assets purchased
57,720
422
58,142
Long-term debt including current portions and finance leases
183
556
739
Accounts payable, accrued expenses and other accrued liabilities
3,482
—
3,482
Total liabilities assumed
3,665
556
4,221
Total consideration
 
paid for Coral
54,055
(134)
53,921
Less: estimated purchase price settlement
—
(134)
(134)
Less: cash acquired
958
—
958
Net cash paid for Coral
$
53,097
$
—
$
53,097
(1) As previously disclosed in the Company’s
 
2020 Form 10-K
.
Measurement period adjustments recorded during the first nine months of
 
2021 include certain adjustments related to refining
original estimates for assets and liabilities for certain acquired finance
 
leases, as well the adjustment to reflect the expected settlement
of post-closing working capital and net indebtedness true ups to the original purchase
 
price.
 
As of September 30, 2021, the allocation
of the purchase price for Coral has not been finalized and the
one year
 
measurement period has not ended.
 
Further adjustments may
be necessary as a result of the Company’s
 
on-going assessment of additional information related to the fair value of assets acquired
and liabilities assumed.
In May 2020, the Company acquired Tel
 
Nordic ApS (“TEL”), a company that specializes in lubricants and engineering primarily
in high pressure aluminum die casting for its EMEA reportable segment.
 
Consideration paid was in the form of a convertible
promissory note in the amount of
20.0
 
million DKK, or approximately $
2.9
 
million, which was subsequently converted into shares of
the Company’s common stock.
 
An adjustment to the purchase price of approximately
0.4
 
million DKK, or less than $
0.1
 
million, was
made as a result of finalizing a post-closing settlement in the second
 
quarter of 2020.
 
The Company allocated approximately $
2.4
million of the purchase price to intangible assets to be amortized over
17 years
.
 
In addition, the Company recorded approximately
$
0.5
 
million of goodwill, related to expected value not allocated to other acquired
 
assets, none of which will be tax deductible.
 
As of
September 30, 2021, the allocation of the purchase price of TEL was finalized
 
and the
one year
 
measurement period ended.
 
In March 2020, the Company acquired the remaining
49
% ownership interest in one of its South African affiliates, Quaker
Chemical South Africa Limited (“QSA”) for
16.7
 
million ZAR, or approximately $
1.0
 
million, from its joint venture partner PQ
Holdings South Africa.
 
QSA is a part of the Company’s EMEA
 
reportable segment.
 
As this acquisition was a change in an existing
controlling ownership, the Company recorded $
0.7
 
million of excess purchase price over the carrying value of the noncontrolling
interest in Capital in excess of par value.
 
In October 2019, the Company completed its acquisition of the operating
 
divisions of Norman Hay plc (“Norman Hay”), a private
U.K. company that provides specialty chemicals, operating equipment, and
 
services to industrial end markets.
 
The original purchase
price was
80.0
 
million GBP,
 
on a cash-free and debt-free basis, subject to routine and customary post-closing
 
adjustments related to
working capital and net indebtedness levels.
 
The Company finalized its post-closing adjustments for the
 
Norman Hay acquisition and
paid approximately
2.5
 
million GBP during the first quarter of 2020 to settle such adjustments.
XML 25 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Recently Issued Accounting Standards
 9 Months Ended
Sep. 30, 2021
New Accounting Pronouncements And Changes In Accounting Principles [Abstract]  
New Accounting Pronouncements and Changes in Accounting Principles [Text Block]
Note 3 – Recently Issued Accounting Standards
 
Recently Issued Accounting Standards
 
Adopted
The Financial Accounting Standards Board (“FASB”)
 
issued Account Standards Update (“ASU”)
ASU 2019-12
, Income Taxes
(Topic
 
740): Simplifying the Accounting for Income Taxes
 
in December 2019 to simplify the accounting for income taxes.
 
The
guidance within this accounting standard update removes
 
certain exceptions, including the exception to the incremental approach for
certain intra-period tax allocations, to the requirement to recognize
 
or not recognize certain deferred tax liabilities for equity method
investments and foreign subsidiaries, and to the general methodology for
 
calculating income taxes in an interim period when a year-to-
date loss exceeds the anticipated loss for the year.
 
Further, the guidance simplifies the accounting related
 
to franchise taxes, the step
up in tax basis for goodwill, current and deferred tax expense, and codification
 
improvements for income taxes related to employee
stock ownership plans.
 
The guidance is effective for annual and interim periods beginning
 
after December 15, 2020.
 
The Company
adopted this standard on a prospective basis, effective January
 
1, 2021.
 
There was no cumulative effect of adoption recorded within
retained earnings on January 1, 2021.
The FASB issued ASU 2020
 
-04,
Reference Rate Reform (Topic
 
848): Facilitation of the Effects of Reference Rate Reform
 
on
Financial Reporting
 
in March 2020.
 
The FASB subsequently
 
issued ASU 2021-01,
Reference Rate Reform (Topic
 
848): Scope
 
in
January 2021 which clarified the guidance but did not materially change
 
the guidance or its applicability to the Company.
 
The
amendments provide temporary optional expedients and exceptions
 
for applying U.S. GAAP to contract modifications, hedging
relationships and other transactions to ease the potential accounting
 
and financial reporting burden associated with transitioning away
from reference rates that are expected to be discontinued, including
 
the London Interbank Offered Rate (“LIBOR”).
 
ASU 2020-04 is
effective for the Company as of March 12, 2020 and generally can
 
be applied through December 31, 2022.
 
As of September 30, 2021,
the expedients provided in ASU 2020-04 do not presently impact
 
the Company; however, the Company will continue
 
to monitor for
potential impacts on its consolidated financial statements.
XML 26 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Business Segments
 9 Months Ended
Sep. 30, 2021
Business Segment Disclosures [Abstract]  
Segment Reporting Disclosure [Text Block]
Note 4 – Business Segments
The Company’s operating
 
segments, which are consistent with its reportable segments, reflect the structure of the
 
Company’s
internal organization, the method by which the Company’s
 
resources are allocated and the manner by which the chief operating
decision maker assesses the Company’s
 
performance.
 
The Company has
four
 
reportable segments: (i) Americas; (ii) EMEA; (iii)
Asia/Pacific; and (iv) Global Specialty Businesses.
 
The three geographic segments are composed of the net sales and operations in
each respective region, excluding net sales and operations managed globally
 
by the Global Specialty Businesses segment, which
includes the Company’s container,
 
metal finishing, mining, offshore, specialty coatings, specialty grease
 
and Norman Hay businesses.
Segment operating earnings for each of the Company’s
 
reportable segments are comprised of the segment’s
 
net sales less directly
related COGS and selling, general and administrative expenses (“SG&A”).
 
Operating expenses not directly attributable to the net
sales of each respective segment, such as certain corporate and administrative costs, Combination,
 
integration and other acquisition-
related expenses, and Restructuring and related charges,
 
are not included in segment operating earnings.
 
Other items not specifically
identified with the Company’s reportable
 
segments include interest expense, net and other income (expense), net.
The following table presents information about the performance of the Company’s
 
reportable segments for the three and nine
months ended September 30, 2021 and 2020.
Three Months Ended
Nine Months Ended
September 30,
September 30,
2021
2020
2021
2020
Net sales
 
 
 
 
 
 
 
 
 
 
Americas
$
150,799
$
119,540
$
425,343
$
330,012
EMEA
 
122,241
 
94,005
 
365,491
 
276,546
Asia/Pacific
 
98,659
 
84,877
 
286,924
 
226,850
Global Specialty Businesses
 
77,373
 
68,802
 
236,359
 
198,417
Total net sales
$
449,072
$
367,224
$
1,314,117
$
1,031,825
Segment operating earnings
Americas
$
31,273
$
31,099
$
97,155
$
70,590
EMEA
20,153
17,439
68,802
46,269
Asia/Pacific
23,285
27,304
73,990
66,106
Global Specialty Businesses
 
20,663
 
21,161
 
69,041
 
58,114
Total segment operating
 
earnings
 
95,374
 
97,003
 
308,988
 
241,079
Combination, integration and other acquisition-related expenses
(5,786)
(6,913)
(18,259)
(22,786)
Restructuring and related charges
880
(1,383)
(593)
(3,585)
Fair value step up of acquired inventory sold
 
—
—
(801)
(226)
Indefinite-lived intangible asset impairment
—
—
—
(38,000)
Non-operating and administrative expenses
(38,691)
(39,786)
(122,760)
(110,282)
Depreciation
 
of corporate assets and amortization
 
(15,767)
 
(14,062)
 
(46,855)
 
(41,547)
Operating income
36,010
34,859
119,720
24,653
Other income (expense), net
647
(239)
19,344
(22,407)
Interest expense, net
 
(5,637)
 
(6,837)
 
(16,725)
 
(22,109)
Income (loss) before taxes and equity in net income of
associated companies
$
31,020
$
27,783
$
122,339
$
(19,863)
Inter-segment revenues for the three and nine months ended September
 
30, 2021 were $
3.6
 
million and $
9.3
 
million for Americas,
$
6.8
 
million and $
21.9
 
million for EMEA, $
0.8
 
million and $
1.3
 
million for Asia/Pacific, and $
1.8
 
million and $
5.9
 
million for Global
Specialty Businesses, respectively.
 
Inter-segment revenues for the three and nine months ended
 
September 30, 2020 were $
1.7
million and $
7.0
 
million for Americas, $
5.3
 
million and $
16.1
 
million for EMEA, $
0.2
 
million and $
0.5
 
million for Asia/Pacific, and
$
1.1
 
million and $
3.4
 
million for Global Specialty Businesses, respectively.
 
However, all inter-segment
 
transactions have been
eliminated from each reportable operating segment’s
 
net sales and earnings for all periods presented in the above tables.
XML 27 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Net Sales and Revenue Recognition
 9 Months Ended
Sep. 30, 2021
Revenue From Contract With Customer [Abstract]  
Revenue From Contract With Customer [TextBlock]
Note 5 – Net Sales and Revenue Recognition
Business Description
The Company develops, produces, and markets a broad range of formulated
 
chemical specialty products and offers chemical
management services (“Fluidcare”) for various heavy industrial and
 
manufacturing applications throughout its four segments.
 
A
significant portion of the Company’s
 
revenues are realized from the sale of process fluids and services made directly
 
to manufacturers
through its own employees and its Fluidcare programs, with the balance
 
being handled through distributors and agents.
As part of the Company’s Fluidcare
 
business, certain third-party product sales to customers are managed by
 
the Company.
 
Where
the Company acts as a principal, revenues are recognized on a gross reporting
 
basis at the selling price negotiated with its customers.
Where the Company acts as an agent, revenue is recognized on a net reporting
 
basis at the amount of the administrative fee earned by
the Company for ordering the goods.
 
The Company transferred third-party products under arrangements recognized
 
on a net reporting
basis of $
18.9
 
million and $
53.4
 
million for the three and nine months ended September 30, 2021, respectively,
 
and $
11.1
 
million and
$
29.9
 
million for the three and nine months ended September 30, 2020, respectively.
As previously disclosed in the Company’s
 
2020 Form 10-K, during 2020, the Company’s
 
five largest customers (each composed
of multiple subsidiaries or divisions with semiautonomous purchasing
 
authority) accounted for approximately
10
% of consolidated net
sales, with its largest customer accounting for approximately
3
% of consolidated net sales.
Revenue Recognition Model
The Company applies the five-step model in the FASB’s
 
guidance, which requires the Company to: (i) identify the
 
contract with a
customer; (ii) identify the performance obligations in the contract; (iii)
 
determine the transaction price; (iv) allocate the transaction
price to the performance obligations in the contract; and (v) recognize
 
revenue when, or as, the Company satisfies a performance
obligation.
 
Refer to the Company’s 2020 Form 10-K
 
for additional information on the Company’s
 
revenue recognition policies,
including its practical expedients and accounting policy elections.
 
Allowance for Doubtful Accounts
As previously disclosed in the Company’s
 
2020 Form 10-K, during 2020, the Company adopted, as required, an accounting
standard update related to the accounting and disclosure of credit losses effective
 
January 1, 2020.
 
The Company recognizes an
allowance for credit losses, which represents the portion of its trade accounts
 
receivable that the Company does not expect to collect
over the contractual life, considering past events and reasonable and
 
supportable forecasts of future economic conditions.
 
The
Company’s allowance for
 
credit losses on its trade accounts receivables is based on specific collectability facts and circumstances
 
for
each outstanding receivable and customer,
 
the aging of outstanding receivables, and the associated collection risk the
 
Company
estimates for certain past due aging categories, and also, the general risk
 
to all outstanding accounts receivable based on historical
amounts determined to be uncollectible.
 
The Company does not have any off-balance-sheet credit exposure
 
related to its customers.
Contract Assets and Liabilities
The Company recognizes a contract asset or receivable on its Condensed
 
Consolidated Balance Sheet when the Company
performs a service or transfers a good in advance of receiving consideration.
 
A receivable is the Company’s right to
 
consideration that
is unconditional and only the passage of time is required before payment
 
of that consideration is due.
 
A contract asset is the
Company’s right to consideration
 
in exchange for goods or services that the Company has transferred to a customer.
 
The Company
had no material contract assets recorded on its Condensed Consolidated
 
Balance Sheets as of September 30, 2021 or December 31,
2020.
A contract liability is recognized when the Company receives consideration,
 
or if it has the unconditional right to receive
consideration, in advance of performance.
 
A contract liability is the Company’s
 
obligation to transfer goods or services to a customer
for which the Company has received consideration, or a specified amount
 
of consideration is due, from the customer.
 
The Company’s
contract liabilities primarily represent deferred revenue recorded
 
for customer payments received by the Company prior to the
Company satisfying the associated performance obligation.
 
Deferred revenues are presented within other current liabilities in the
Company’s Condensed Consolidated
 
Balance Sheets.
 
The Company had approximately $
4.4
 
million and $
4.0
 
million of deferred
revenue as of September 30, 2021 and December 31, 2020, respectively.
 
For the nine months ended September 30, 2021, the
Company satisfied all of the associated performance obligations
 
and recognized into revenue the advance payments received and
recorded as of December 31, 2020.
Disaggregated Revenue
The following tables disaggregate the Company’s
 
net sales by segment, geographic region, customer industry,
 
and timing of
revenue recognized for the three and nine months ended September 30, 2021
 
and 2020.
Three Months Ended September 30, 2021
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
56,954
$
38,483
$
53,994
$
149,431
Metalworking and other
93,845
83,758
44,665
222,268
150,799
122,241
98,659
371,699
Global Specialty Businesses
46,008
19,253
12,112
77,373
$
196,807
$
141,494
$
110,771
$
449,072
Timing of Revenue Recognized
Product sales at a point in time
$
188,340
$
131,982
$
108,559
$
428,881
Services transferred over time
8,467
9,512
2,212
20,191
$
196,807
$
141,494
$
110,771
$
449,072
Three Months Ended September 30, 2020
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
42,098
$
25,362
$
45,001
$
112,461
Metalworking and other
77,442
68,643
39,876
185,961
119,540
94,005
84,877
298,422
Global Specialty Businesses
39,197
17,429
12,176
68,802
$
158,737
$
111,434
$
97,053
$
367,224
Timing of Revenue Recognized
Product sales at a point in time
$
153,820
$
107,093
$
94,660
$
355,573
Services transferred over time
4,917
4,341
2,393
11,651
$
158,737
$
111,434
$
97,053
$
367,224
Nine Months Ended September 30, 2021
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
155,546
$
108,391
$
151,944
$
415,881
Metalworking and other
269,797
257,100
134,980
661,877
425,343
365,491
286,924
1,077,758
Global Specialty Businesses
137,447
61,203
37,709
236,359
$
562,790
$
426,694
$
324,633
$
1,314,117
Timing of Revenue Recognized
Product sales at a point in time
$
537,161
$
400,982
$
316,222
$
1,254,365
Services transferred over time
25,629
25,712
8,411
59,752
$
562,790
$
426,694
$
324,633
$
1,314,117
Nine Months Ended September 30, 2020
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
121,458
$
80,174
$
122,006
$
323,638
Metalworking and other
208,554
196,372
104,844
509,770
330,012
276,546
226,850
833,408
Global Specialty Businesses
115,722
49,603
33,092
198,417
$
445,734
$
326,149
$
259,942
$
1,031,825
Timing of Revenue Recognized
Product sales at a point in time
$
431,266
$
313,511
$
254,011
$
998,788
Services transferred over time
14,468
12,638
5,931
33,037
$
445,734
$
326,149
$
259,942
$
1,031,825
XML 28 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Leases
 9 Months Ended
Sep. 30, 2021
Leases [Abstract]  
Leases Disclosure [TextBlock]
Note 6 – Leases
The Company determines if an arrangement is a lease at its inception.
 
This determination generally depends on whether the
arrangement conveys the right to control the use of an identified fixed asset explicitly
 
or implicitly for a period of time in exchange for
consideration.
 
Control of an underlying asset is conveyed if the Company obtains the rights to direct the
 
use of, and obtains
substantially all of the economic benefits from the use of, the underlying
 
asset.
 
Lease expense for variable leases and short-term
leases is recognized when the obligation is incurred.
The Company has operating leases for certain facilities, vehicles and machinery
 
and equipment with remaining lease terms up to
10 years
.
 
In addition, the Company has certain land use leases with remaining lease terms up
 
to
94 years
.
 
The lease term for all of the
Company’s leases includes the non
 
-cancellable period of the lease plus any additional periods covered by an option
 
to extend the lease
that the Company is reasonably certain it will exercise.
 
Operating leases are included in right of use lease assets, other current
liabilities and long-term lease liabilities on the Condensed Consolidated
 
Balance Sheet.
 
Right of use lease assets and liabilities are
recognized at each lease’s commencement
 
date based on the present value of its lease payments over its respective lease term.
 
The
Company uses the stated borrowing rate for a lease when readily determinable.
 
When a stated borrowing rate is not available in a
lease agreement, the Company uses its incremental borrowing rate based on
 
information available at the lease’s commencement
 
date
to determine the present value of its lease payments.
 
In determining the incremental borrowing rate used to present value each of its
leases, the Company considers certain information including fully
 
secured borrowing rates readily available to the Company and its
subsidiaries.
 
The Company has immaterial finance leases, which are included in property,
 
plant and equipment, current portion of
long-term debt and long-term debt on the Condensed Consolidated Balance
 
Sheet.
Operating lease expense is recognized on a straight-line basis over the
 
lease term.
 
Operating lease expense for the three and nine
months ended September 30, 2021 was $
3.4
 
million and $
10.6
 
million, respectively.
 
Comparatively, operating
 
lease expense for the
three and nine months ended September 30, 2020 was $
3.7
 
million and $
10.6
 
million, respectively.
 
Short-term lease expense for the
three and nine months ended September 30, 2021 was $
0.2
 
million and $
0.8
 
million, respectively.
 
Comparatively, short-term
 
lease
expense for the three and nine months ended September 30, 2020
 
was $
0.2
 
million and $
1.1
 
million, respectively.
 
The Company has
no
 
material variable lease costs or sublease income for the three or nine months ended September
 
30, 2021 and 2020.
 
Cash paid for operating leases during the nine months ended September 30, 2021
 
and 2020 was $
10.4
 
million and $
10.5
 
million,
respectively.
 
The Company recorded new right of use lease assets and associated lease liabilities of $
5.6
 
million during the nine
months ended September 30, 2021.
 
Supplemental balance sheet information related to the Company’s
 
leases is as follows:
September 30,
December 31,
2021
2020
Right of use lease assets
$
34,314
$
38,507
Other current liabilities
9,356
10,901
Long-term lease liabilities
24,599
27,070
Total operating lease liabilities
$
33,955
$
37,971
Weighted average
 
remaining lease term (years)
5.7
6.0
Weighted average
 
discount rate
4.26%
4.20%
Maturities of operating lease liabilities as of September 30, 2021 were
 
as follows:
September 30,
2021
For the remainder of 2021
$
2,978
For the year ended December 31, 2022
9,695
For the year ended December 31, 2023
7,564
For the year ended December 31, 2024
5,623
For the year ended December 31, 2025
4,340
For the year ended December 31, 2026 and beyond
8,104
Total lease payments
38,304
Less: imputed interest
(4,349)
Present value of lease liabilities
$
33,955
XML 29 R13.htm IDEA: XBRL DOCUMENT v3.21.2
Restructuring and Related Activities
 9 Months Ended
Sep. 30, 2021
Restructuring And Related Activities [Abstract]  
Restructuring And Related Activities Disclosure [Text Block]
Note 7 – Restructuring and Related Activities
The Company’s management approved a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost
synergies associated with the Combination in the third quarter of 2019. The QH Program includes restructuring and associated
severance costs to reduce total headcount by approximately 400 people globally, as well as plans for the closure of certain
manufacturing and non-manufacturing facilities. The exact timing and total costs associated with the QH Program will depend on a
number of factors and is subject to change; however, the Company currently expects reduction in headcount and site closures to
continue to occur throughout 2021 and into 2022 under the QH Program and estimates that anticipated cost synergies realized from the
QH Program will approximate one-times the restructuring costs incurred. Employee separation benefits will vary depending on local
regulations within certain foreign countries and will include severance and other benefits.
All costs incurred to date relate to severance costs to reduce headcount,
 
including customary and routine adjustments to initial
estimates for employee separation costs, as well as costs to close certain facilities and
 
are recorded in Restructuring and related
charges in the Company’s
 
Condensed Statements of Operations.
 
As described in Note 4 of Notes to Condensed Consolidated
Financial Statements, restructuring and related charges
 
are not included in the Company’s calculation of
 
reportable segments’ measure
of operating earnings and therefore these costs are not reviewed by
 
or recorded to reportable segments.
Activity in the Company’s accrual
 
for restructuring under the QH Program for the nine months ended September 30, 2021
 
is as
follows:
QH Program
Accrued restructuring as of December 31, 2020
$
8,248
Restructuring and related charges
593
Cash payments
(4,557)
Currency translation adjustments
 
(234)
Accrued restructuring as of September 30, 2021
$
4,050
XML 30 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Compensation
 9 Months Ended
Sep. 30, 2021
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Note 8 – Share-Based Compensation
The Company recognized the following share-based compensation expense
 
in its Condensed Consolidated Statements of
Operations for the three and nine months ended September 30, 2021
 
and 2020:
Three Months Ended
Nine Months Ended
September 30,
 
September 30,
 
2021
2020
2021
2020
Stock options
$
298
$
353
$
938
$
1,138
Non-vested stock awards and restricted stock units
1,277
1,259
3,963
3,782
Non-elective and elective 401(k) matching contribution in stock
—
910
1,553
2,072
Director stock ownership plan
241
243
660
337
Performance stock units
491
280
1,327
560
Annual incentive plan
—
7,102
—
9,931
Total share-based
 
compensation expense
$
2,307
$
10,147
$
8,441
$
17,820
Share-based compensation expense is recorded in SG&A, except for $
0.2
 
million and $
0.7
 
million for the three and nine months
ended September 30, 2021, respectively,
 
and $
0.4
 
million and $
1.2
 
million for the three and nine months ended September 30, 2020,
respectively, recorded
 
within Combination, integration and other acquisition-related expenses.
Stock Options
During the first nine months of 2021, the Company granted stock options
 
under its long-term incentive plan (“LTIP”)
 
that are
subject only to time-based vesting over a
three
 
year period.
 
For the purposes of determining the fair value of stock option awards,
 
the
Company used a Black-Scholes option pricing model and which primarily used
 
the assumptions set forth in the table below:
Number of options granted
25,250
Dividend yield
0.85
%
Expected volatility
37.33
%
Risk-free interest rate
0.60
%
Expected term (years)
4.0
The fair value of these options is amortized on a straight-line basis over the
 
vesting period.
 
As of September 30, 2021,
unrecognized compensation expense related to all stock options granted was $
2.1
 
million, to be recognized over a weighted average
remaining period of
 
2.1
 
years.
Restricted Stock Awards
 
and Restricted Stock Units
During the nine months ended September 30, 2021, the Company granted
17,692
 
non-vested restricted shares and
2,791
 
non-
vested restricted stock units under its LTIP,
 
which are subject to time-based vesting, generally over a
three year
 
period.
 
The fair value
of these grants is based on the trading price of the Company’s
 
common stock on the date of grant.
 
The Company adjusts the grant
date fair value of these awards for expected forfeitures based on historical experience.
 
As of September 30, 2021, unrecognized
compensation expense related to the non-vested restricted
 
shares was $
5.1
 
million, to be recognized over a weighted average
remaining period of
1.7
 
years, and unrecognized compensation expense related to non-vested restricted
 
stock units was $
0.9
 
million,
to be recognized over a weighted average remaining period of
2.0
 
years.
Performance Stock Units
During the first nine months of 2021, the Company granted performance
 
-dependent stock awards (“PSUs”) as a component of its
LTIP,
 
which will be settled in a certain number of shares subject to market-based and
 
time-based vesting conditions.
 
The number of
fully vested shares that may ultimately be issued as settlement for each award
 
may range from
0
% up to
200
% of the target award,
subject to the achievement of the Company’s
 
total shareholder return (“TSR”) relative to the performance of the Company’s
 
peer
group, the S&P Midcap 400 Materials group.
 
The service period required for the PSUs is three years and the TSR measurement
period for the PSUs is from January 1 of the year of grant through December 31 of the year prior
 
to issuance of the shares upon
settlement.
Compensation expense for PSUs is measured based on their grant date fair value
 
and is recognized on a straight-line basis over
the
three year
 
vesting period.
 
The grant-date fair value of the PSUs granted during the first nine months
 
of 2021 was estimated using
a Monte Carlo simulation on the grant date and using the following assumptions:
 
(i) a risk-free rate of
 
0.29
%; (ii) an expected term of
3.0
 
years; and (iii) a three year daily historical volatility for each of the companies in the peer group,
 
including Quaker Houghton.
 
As of September 30, 2021, the Company estimates that it will issue approximately
23,756
 
fully vested shares as of the applicable
settlement date of all outstanding PSUs awards based on the conditions
 
of the PSUs and performance to date for each award.
 
As of
September 30, 2021, there was approximately $
3.7
 
million of total unrecognized compensation cost related to PSUs, which the
Company expects to recognize over a weighted-average period of
 
2.1
 
years.
Annual Incentive Plan
The Company maintains an Annual Incentive Plan (“AIP”), which may be
 
settled in cash or a certain number of shares subject to
performance-based and time-based vesting conditions.
 
As of September 30, 2020, it had been the Company’s
 
intention to settle the
2020 AIP in shares, and therefore, expense associated with the AIP in 2020
 
was recorded as a component of share-based
compensation expense.
 
In the fourth quarter of 2020, the Company determined that it would settle the 2020
 
AIP in cash.
 
Therefore,
the share-based compensation associated with the AIP during the
 
year ended December 31, 2020 was reclassified from a component
of share-based compensation expense to incentive compensation.
 
This determination and conclusion had no impact on the
classification of AIP expense within the Company’s
 
Condensed Consolidated Statement of Operations for the periods as both are
 
a
component of SG&A.
 
As of September 30, 2021, it is the Company’s
 
intention to settle the 2021 AIP in cash.
Defined Contribution Plan
 
The Company has a 401(k) plan with an employer match covering
 
a majority of its U.S. employees.
 
The Company matches
50
%
of the first
6
% of compensation that is contributed to the plan, with a maximum matching contribution of
3
% of compensation.
 
Additionally,
 
the plan provides for non-elective nondiscretionary contributions on behalf
 
of participants who have completed one year
of service equal to
3
% of the eligible participants’ compensation.
 
Beginning in April 2020 and continuing through March 2021, the
Company matched both non-elective and elective 401(k) contributions
 
in fully vested shares of the Company’s common
 
stock rather
than cash.
 
For the three months ended September 30, 2021, there were
no
 
matching contributions in stock.
 
For the nine months ended
September 30, 2021, total contributions were $
1.5
 
million. Comparatively,
 
total contributions for the three and nine months ended
September 30, 2020 were $
0.9
 
million and $
2.1
 
million, respectively.
XML 31 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Pension and Postretirement Benefits
 9 Months Ended
Sep. 30, 2021
Pension and Other Postretirement Benefits [Abstract]  
Pension And Other Postretirement Benefits Disclosure [Text Block]
Note 9 – Pension and Other Postretirement
 
Benefits
The components of net periodic benefit cost for the three and nine months
 
ended September 30, 2021 and 2020 are as follows:
Three Months Ended September 30,
Nine Months Ended September 30,
Other
Other
Postretirement
Postretirement
Pension Benefits
Benefits
Pension Benefits
Benefits
2021
2020
2021
2020
2021
2020
2021
2020
Service cost
$
289
$
1,227
$
(2)
$
2
$
921
$
3,565
$
1
$
5
Interest cost
1,078
1,527
(1)
25
3,262
4,782
20
77
Expected return on plan assets
(2,075)
(3,526)
—
—
(6,250)
(7,246)
—
—
Settlement charge
—
—
—
—
—
22,667
—
—
Actuarial loss amortization
737
626
(85)
15
2,449
2,288
(85)
46
Prior service cost amortization
3
(42)
—
—
8
(123)
—
—
Net periodic benefit cost
$
32
$
(188)
$
(88)
$
42
$
390
$
25,933
$
(64)
$
128
As disclosed in the Company’s 2020
 
Form 10-K, in the fourth quarter of 2018, the Company began the process of terminating
 
its
legacy Quaker non-contributory U.S. pension plan (“Legacy Quaker
 
U.S. Pension Plan”).
 
During the third quarter of 2019, the
Company received a favorable termination determination letter from the
 
Internal Revenue Service (“I.R.S.”) and completed the
Legacy Quaker U.S. Pension Plan termination during the first quarter of 2020.
 
In order to terminate the Legacy Quaker U.S. Pension
Plan in accordance with I.R.S. and Pension Benefit Guaranty Corporation requirements,
 
the Company was required to fully fund the
Legacy Quaker U.S. Pension Plan on a termination basis and the amount
 
necessary to do so was approximately $
1.8
 
million, subject to
final true up adjustments,
 
which were completed in the third quarter of 2020 resulting in a refund in premium received
 
in the third
quarter of 2020 of approximately $
1.6
 
million.
 
In addition, the Company recorded a non-cash pension settlement charge
 
at plan
termination of approximately $
22.7
 
million.
 
This settlement charge included the immediate recognition into expense
 
of the related
unrecognized losses within accumulated other comprehensive (loss) income
 
(“AOCI”) on the balance sheet as of the plan termination
date.
Employer Contributions
As of September 30, 2021, $
5.7
 
million and $
0.2
 
million of contributions have been made to the Company’s
 
U.S. and foreign
pension plans and its other postretirement benefit plans, respectively
 
.
 
Taking into consideration
 
current minimum cash contribution
requirements, the Company expects to make full year cash contributions
 
of approximately $
6
 
million to its U.S. and foreign pension
plans and less than $
1
 
million to its other postretirement benefit plans in 2021
XML 32 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Other Income (Expense)
 9 Months Ended
Sep. 30, 2021
Other Income and Expenses [Abstract]  
Other Income and Other Expense Disclosure [Text Block]
Note 10 – Other Income (Expense), Net
The components of other income (expense), net, for the three and nine months
 
ended September 30, 2021 and 2020 are as
follows:
Three Months Ended
Nine Months Ended
September 30,
 
September 30,
 
2021
2020
2021
2020
Income from third party license fees
$
314
$
190
$
1,026
$
702
Foreign exchange gains (losses), net
368
(1,897)
(1,948)
(3,080)
(Loss) gain on disposals of property,
 
plant, equipment and other
assets, net
(537)
(24)
4,819
(105)
Non-income tax refunds and other related credits
3
—
14,395
2,131
Pension and postretirement benefit income (costs),
 
non-service components
343
1,375
596
(22,491)
Other non-operating income, net
156
117
456
436
Total other income
 
(expense), net
$
647
$
(239)
$
19,344
$
(22,407)
The (Loss) gain on disposals of property,
 
plant, equipment and other assets, net, during the three months ended
 
September 30,
2021,
 
includes losses related to certain fixed asset disposals resulting from the
 
property damage caused by flooding of the Company’s
Conshohocken, Pennsylvania headquarters, described in Note 19 of Notes
 
to Condensed Consolidated Financial Statements, and
during the nine months ended September 30, 2021, includes the gain on the
 
sale of certain held-for-sale real property assets related to
the Combination.
 
Non-income tax refunds and other related credits during the nine months ended September
 
30, 2021 includes
certain non-income tax credits for the Company’s
 
Brazilian subsidiaries described in Note 19 of Notes to Condensed Consolidated
Financial Statements.
 
Pension and postretirement benefit income (costs), non-service
 
components during both the three and nine
months ended September 30, 2020 includes the refund in premium described
 
in Note 9 of Notes to Condensed Consolidated Financial
Statements.
 
In addition, this line also includes the Legacy Quaker U.S. Pension Plan non
 
-cash settlement charge during the nine
months ended September 30, 2020, also described in Note 9 of Notes to
 
Condensed Consolidated Financial Statements.
XML 33 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Income Taxes and Uncertain Income Tax Positions
 9 Months Ended
Sep. 30, 2021
Income Taxes and Uncertain Tax Positions [Abstract]  
Taxes on Income [Text Block]
Note 11 – Income Taxes
 
and Uncertain Income Tax
 
Positions
The Company’s effective
 
tax rates for the three and nine months ended September 30, 2021 were an expense
 
of
2.6
% and
21.8
%,
respectively, compared
 
to an expense of
8.1
% and a benefit of
38.3
% for the three and nine months ended September 30, 2020,
respectively.
 
The Company’s current year
 
effective tax rates were largely impacted by changes in permanent
 
reinvestment assertions,
changes in foreign tax credit valuation allowances, tax law changes in a foreign
 
jurisdiction, deferred tax benefits related to an
intercompany intangible asset transfer and the income tax impacts of certain
 
non-income tax credits recorded by the Company’s
Brazilian subsidiaries described in Note 19 of Notes to Condensed Consolidated
 
Financial Statements.
 
Comparatively,
 
the prior year
effective tax rates were impacted by the tax effect
 
of certain one-time pre-tax losses as well as certain tax charges and benefits
 
in the
prior year period including those related to changes in tax regulations and
 
other changes in foreign tax credit valuation allowances, tax
law changes in foreign jurisdictions and the tax impacts of the Company’s
 
termination of its Legacy Quaker U.S. Pension Plan.
As of December 31, 2020, the Company had a deferred tax liability of $
5.9
 
million, which primarily represents the Company’s
estimate of non-U.S. taxes it will incur to repatriate certain foreign earnings to
 
the U.S.
 
The balance as of September 30, 2021 was
$
5.8
 
million. As of September 30, 2021, the Company’s
 
cumulative liability for gross unrecognized tax benefits was $
24.0
 
million, an
increase of $
1.9
 
million from the cumulative liability accrued as of December 31, 2020.
 
The Company continues to recognize interest and penalties associated with uncertain
 
tax positions as a component of taxes on
income (loss) before equity in net income of associated companies
 
in its Condensed Consolidated Statements of Operations.
 
The
Company recognized an expense for interest of approximately $
0.2
 
million and $
0.4
 
million and a benefit of less than $
0.1
 
million and
$
0.2
 
million for penalties in its Condensed Consolidated Statement of Operations for the
 
three and nine months ended September 30,
2021, respectively,
 
and recognized a credit for interest of $
0.2
 
million and an expense of $
0.4
 
million and an expense for penalties of
less than $
0.1
 
million and $
0.5
 
million in its Condensed Consolidated Statement of Operations for the
 
three and nine months ended
September 30, 2020, respectively.
 
As of September 30, 2021, the Company had accrued $
3.3
 
million for cumulative interest and $
3.5
million for cumulative penalties in its Condensed Consolidated
 
Balance Sheets, compared to $
3.0
 
million for cumulative interest and
$
3.9
 
million for cumulative penalties accrued at December 31, 2020.
 
During the nine months ended September 30, 2021 and 2020,
the Company recognized decreases of $
1.2
 
million and $
1.9
 
million, respectively,
 
in its cumulative liability for gross unrecognized tax
benefits due to the expiration of the applicable statutes of limitations for
 
certain tax years.
The Company estimates that during the year ending December 31, 2021
 
it will reduce its cumulative liability for gross
unrecognized tax benefits by approximately $
1.5
 
million due to the expiration of the statute of limitations with regard to certain tax
positions.
 
This estimated reduction in the cumulative liability for unrecognized tax
 
benefits does not consider any increase in liability
for unrecognized tax benefits with regard to existing tax positions or any increase
 
in cumulative liability for unrecognized tax benefits
with regard to new tax positions for the year ending December 31, 2021.
The Company and its subsidiaries are subject to U.S. Federal income tax,
 
as well as the income tax of various state and foreign
tax jurisdictions.
 
Tax years that remain subject
 
to examination by major tax jurisdictions include Italy from
2006
, Brazil from
2011
,
the Netherlands and China from
2015
, Mexico, Spain, Germany and the United Kingdom from
2016
, Canada and the U.S. from
2018
,
India from fiscal year beginning April 1, 2018 and ending March 31,
2019
, and various U.S. state tax jurisdictions from
2011
.
 
As previously reported, the Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia
S.r.l., relating to the tax years 2007 through 2015. The Company has filed for competent authority relief from these assessments under
the Mutual Agreement Procedures (“MAP”) of the Organization for Economic Co-Operation and Development for all years except
2007. In 2020, the respective tax authorities in Italy, Spain and the Netherlands reached agreement with respect to the MAP
proceedings which the Company has accepted.
 
As of September 30, 2021, the Company has received $
1.6
 
million in refunds from the
Netherlands and Spain and currently expects to pay $
2.6
 
million due to Italy in the fourth quarter of 2021.
 
As of September 30, 2021,
the Company believes it has adequate reserves for the remaining uncertain
 
tax positions related to 2007.
Houghton Italia, S.r.l is also involved
 
in a corporate income tax audit with the Italian tax authorities covering tax years
2014
through
2018
.
 
As of September 30, 2021, the Company has a $
6.0
 
million reserve for uncertain tax positions relating to matters
related to this audit.
 
Because the reserve relates to the tax periods prior to August 1, 2019, the tax liability was established
 
through
purchase accounting related to the Combination.
 
The Company has also submitted an indemnification claim against funds held in
escrow by Houghton’s former
 
owners and as a result, a corresponding $
5.4
 
million indemnification receivable has also been
established through purchase accounting.
 
In October 2021, the Company settled a portion of the Houghton Italia
 
S.r.l corporate
income tax audit with the Italian tax authorities for the tax year 2015.
 
The Company remains under audit for tax years 2014 and 2016
through 2018 and believes it has adequate reserves for the remaining uncertain
 
tax positions.
Houghton Deutschland GmbH is also under audit by the German tax authorities for
 
the tax years
2015
 
through
2017
.
 
Based on
preliminary audit findings, primarily related to transfer pricing,
 
the Company has recorded reserves for $
0.9
 
million as of September
30, 2021.
 
Of this amount, $
0.8
 
million relates to tax periods prior to the Combination and therefore
 
the Company has submitted an
indemnification claim with Houghton’s
 
former owners for any tax liabilities arising pre-Combination.
 
As a result, a corresponding
$
0.8
 
million indemnification receivable has also been established to offset
 
the $
0.8
 
million tax liability.
 
In October 2021 the
Company received a settlement proposal from the German
 
tax authorities and is currently reviewing the proposal with Houghton’s
former owners.
XML 34 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings Per Share
 9 Months Ended
Sep. 30, 2021
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]
Note 12 – Earnings Per Share
The following table summarizes earnings per share calculations for
 
the three and nine months ended September 30, 2021 and
2020:
Three Months Ended
 
Nine Months Ended
September 30,
September 30,
2021
2020
2021
2020
Basic earnings (loss) per common share
 
 
 
Net income (loss) attributable to Quaker Chemical Corporation
$
31,058
$
27,304
$
103,243
$
(8,812)
Less: (income) loss allocated to participating securities
 
(119)
 
(113)
 
(413)
 
44
Net income (loss) available to common shareholders
$
30,939
$
27,191
$
102,830
$
(8,768)
Basic weighted average common shares outstanding
17,812,216
17,743,538
17,800,082
17,704,662
Basic earnings (loss) per common share
$
1.74
$
1.53
$
5.78
$
(0.50)
Diluted earnings (loss) per common share
Net income (loss) attributable to Quaker Chemical Corporation
$
31,058
$
27,304
$
103,243
$
(8,812)
Less: (income) loss allocated to participating securities
(119)
 
(113)
 
(412)
 
44
Net income (loss) available to common shareholders
$
30,939
$
27,191
$
102,831
$
(8,768)
Basic weighted average common shares outstanding
17,812,216
17,743,538
17,800,082
17,704,662
Effect of dilutive securities
58,176
57,327
59,986
—
Diluted weighted average common shares outstanding
17,870,392
17,800,865
17,860,068
17,704,662
Diluted earnings (loss) per common share
$
1.73
$
1.53
$
5.76
$
(0.50)
Certain stock options and restricted stock units are not included in the diluted
 
earnings (loss) per share calculation when the effect
would have been anti-dilutive.
 
The calculated amount of anti-diluted shares not included was
5,531
 
and
3,722
 
for the three and nine
months ended September 30, 2021,
 
respectively.
 
All of the Company’s potentially
 
dilutive shares for the nine months ended
September 30, 2020 are anti-dilutive and not included in the dilutive loss per
 
share calculations because of the Company’s net
 
loss
during the period.
 
There were
no
 
anti-dilutive shares excluded from the diluted earnings per share calculation for the three months
ended September 30, 2020.
XML 35 R19.htm IDEA: XBRL DOCUMENT v3.21.2
Restricted Cash
 9 Months Ended
Sep. 30, 2021
Restricted Cash Abstract]  
Cash And Cash Equivalents Disclosure [Text Block]
Note 13 – Restricted Cash
Prior to December 2020, the Company had restricted cash recorded in other assets related to proceeds from an inactive subsidiary
of the Company which previously executed separate settlement and release agreements with two of its insurance carriers for an
original total value of $35.0 million.
 
The proceeds of both settlements were restricted and could only be used
 
to pay claims and costs
of defense associated with the subsidiary’s
 
asbestos litigation.
 
The proceeds of the settlement and release agreements were deposited
into interest bearing accounts that earned less than $
0.1
 
million offset by $
0.8
 
million of net payments during the nine months ended
September 30, 2020.
 
Due to the restricted nature of the proceeds, a corresponding deferred credit was established
 
in other non-current
 
liabilities for an equal and offsetting amount that continued
 
until the restrictions lapsed.
 
As disclosed in the Company’s 2020
 
Form
10-K, during December 2020, the restrictions ended on these previously
 
received insurance settlements and the Company transferred
the cash into an operating account.
The following table provides a reconciliation of cash, cash equivalents
 
and restricted cash as of September 30, 2021 and 2020,
 
as
well as December 31, 2020 and 2019:
September 30,
December 31,
2021
2020
2020
2019
Cash and cash equivalents
$
141,393
$
155,750
$
181,833
$
123,524
Restricted cash included in other current assets
—
82
62
353
Restricted cash included in other assets
—
18,901
—
19,678
Cash, cash equivalents and restricted cash
$
141,393
$
174,733
$
181,895
$
143,555
XML 36 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Goodwill and Intangible Assets
 9 Months Ended
Sep. 30, 2021
Goodwill And Intangible Assets Disclosure [Abstract]  
Goodwill And Intangible Assets Disclosure [Text Block]
Note 14 – Goodwill and Other Intangible Assets
Changes in the carrying amount of goodwill for the nine months ended
 
September 30, 2021 were as follows:
Global
Specialty
Americas
EMEA
Asia/Pacific
Businesses
Total
Balance as of December 31, 2020
$
213,242
$
140,162
$
158,090
$
119,718
 
$
631,212
Goodwill additions
1,208
2,626
1,308
1,951
7,093
Currency translation and other adjustments
 
(621)
(5,530)
1,109
(2,594)
(7,636)
Balance as of September 30, 2021
$
213,829
$
137,258
$
160,507
$
119,075
 
$
630,669
Gross carrying amounts and accumulated amortization for definite-lived
 
intangible assets as of September 30, 2021 and
December 31, 2020 were as follows:
Gross Carrying
Accumulated
Amount
Amortization
2021
2020
2021
2020
Customer lists and rights to sell
$
847,909
 
$
839,551
 
$
135,571
 
$
99,806
Trademarks, formulations and product
 
technology
 
167,682
 
 
166,448
 
 
36,871
 
 
30,483
Other
 
6,325
 
 
6,372
 
 
5,886
 
 
5,824
Total definite-lived
 
intangible assets
$
1,021,916
 
$
1,012,371
 
$
178,328
 
$
136,113
The Company amortizes definite-lived intangible assets on a straight-line basis over
 
their useful lives.
 
The Company recorded
$
14.9
 
million and $
44.7
 
million of amortization expense for the three and nine months ended September
 
30, 2021, respectively.
 
Comparatively,
 
the Company recorded $
14.0
 
million and $
41.7
 
million of amortization expense for the three and nine months ended
September 30, 2020, respectively.
Estimated annual aggregate amortization expense for the current year
 
and subsequent five years is as follows:
For the year ended December 31, 2021
$
58,852
For the year ended December 31, 2022
59,173
For the year ended December 31, 2023
59,005
For the year ended December 31, 2024
58,338
For the year ended December 31, 2025
57,653
For the year ended December 31, 2026
57,346
The Company has four indefinite-lived intangible assets totaling $
205.1
 
million as of both September 30, 2021 and December 31,
2020, including $
204.0
 
million of indefinite-lived intangible assets for trademarks and tradename associated
 
with the Combination.
Goodwill and intangible assets that have indefinite lives are not amortized and
 
are required to be assessed at least annually for
impairment.
 
The Company completes its annual goodwill and indefinite-lived intangible asset impairment
 
test during the fourth
quarter of each year.
 
The Company continuously evaluates if triggering events indicate a possible impairment
 
in one or more of its
reporting units or indefinite-lived or long-lived assets.
The Company previously disclosed in its 2020 Form 10-K that as of March 31, 2020,
 
the Company concluded that the impact of
COVID-19 did not represent a triggering event with regards to the Company’s
 
reporting units or indefinite-lived and long-lived assets,
except for the Company’s Houghton
 
and Fluidcare trademarks and tradename indefinite-lived intangible assets.
 
The determination of
estimated fair value of the Houghton and Fluidcare trademarks and tradename
 
indefinite-lived assets was based on a relief from
royalty valuation method, which requires management’s
 
judgment and often involves the use of significant estimates and assumptions,
including assumptions with respect to the weighted average cost of capital
 
(“WACC”)
 
and royalty rates, as well as revenue growth
rates and terminal growth rates.
 
In the first quarter of 2020, as a result of the impact of COVID-19 driving
 
a decrease in projected
legacy Houghton net sales during that year and the impact of the sales decline on
 
projected future legacy Houghton net sales as well as
an increase in the WACC
 
assumption utilized in the quantitative impairment assessment, the
 
Company concluded that the estimated
fair values of the Houghton and Fluidcare trademarks and tradename
 
intangible assets were less than their carrying values.
 
As a
result, an impairment charge of $
38.0
 
million was recorded in the first quarter of 2020 to write down the carrying values of
 
these
intangible assets to their estimated fair values.
As of September 30, 2021, the Company continued to evaluate all potential triggering
 
events, including the on-going impact of
COVID-19 on the Company’s operations,
 
and the volatility and uncertainty in the economic outlook as a result of COVID-19,
 
to
determine if this indicated it was more likely than not that the carrying value
 
of any of the Company’s reporting
 
units or indefinite-
lived or long-lived intangible assets were not recoverable.
 
The Company concluded that the impact of COVID-19 did not represent
 
a
triggering event as of September 30, 2021.
 
While the Company concluded that the impact of COVID-19 did not represent a
 
triggering
event as of September 30, 2021, the Company will continue to evaluate the
 
impact of COVID-19 on the Company’s
 
current and
projected results. If the current economic conditions worsen or projections
 
of the timeline for recovery are significantly extended, then
the Company may conclude in the future that the impact from COVID-19
 
requires the need to perform further interim quantitative
impairment tests, which could result in additional impairment charges
 
in the future.
XML 37 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Debt
 9 Months Ended
Sep. 30, 2021
Debt [Abstract]  
Debt [Text Block]
Note 15 – Debt
 
Debt as of September 30, 2021 and December 31, 2020 includes the following:
As of September 30, 2021
As of December 31, 2020
Interest
Outstanding
 
Interest
Outstanding
 
Rate
Balance
Rate
Balance
Credit Facilities:
Revolver
1.58%
$
198,543
1.65%
$
160,000
U.S. Term Loan
1.58%
547,500
1.65%
570,000
EURO Term Loan
1.50%
142,559
1.50%
157,062
Industrial development bonds
5.26%
10,000
5.26%
10,000
Bank lines of credit and other debt obligations
Various
2,060
Various
2,072
Total debt
$
900,662
$
899,134
Less: debt issuance costs
(8,776)
(11,099)
Less: short-term and current portion of long-term debts
(52,611)
(38,967)
Total long-term debt
$
839,275
$
849,068
Credit facilities
The Company’s primary credit facility
 
(as amended, the “Credit Facility”) is comprised of a $
400.0
 
million multicurrency
revolver (the “Revolver”), a $
600.0
 
million term loan (the “U.S. Term
 
Loan”), each with the Company as borrower,
 
and a $
150.0
million (as of August 1, 2019) Euro equivalent term loan (the “EURO Term
 
Loan” and together with the “U.S. Term
 
Loan”, the
“Term Loans”)
 
with Quaker Chemical B.V.,
 
a Dutch subsidiary of the Company as borrower, each
 
with a
five year
 
term maturing in
August 2024.
 
Subject to the consent of the administrative agent and certain other conditions, the Company
 
may designate additional
borrowers.
 
The maximum amount available under the Credit Facility can be increased by up
 
to $
300.0
 
million at the Company’s
request if there are lenders who agree to accept additional commitments and
 
the Company has satisfied certain other conditions.
 
Borrowings under the Credit Facility bear interest at a base rate or LIBOR plus an
 
applicable margin based upon the Company’s
consolidated net leverage ratio.
 
There are LIBOR replacement provisions that contemplate a further amendment
 
when LIBOR ceases
to be reported.
 
The variable interest rate incurred on the outstanding borrowings under
 
the Credit Facility as of and during the nine
months ended September 30, 2021 was approximately
1.6
%.
 
In addition to paying interest on outstanding principal under the Credit
Facility, the Company
 
is required to pay a commitment fee ranging from
0.2
% to
0.3
% depending on the Company’s consolidated
 
net
leverage ratio to the lenders under the Revolver in respect of the unutilized
 
commitments thereunder.
 
The Company has unused
capacity under the Revolver of approximately $
197
 
million, net of bank letters of credit of approximately $
4
 
million, as of September
30, 2021.
 
The Credit Facility is subject to certain financial and other covenants. The Company’s initial consolidated net debt to
consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit
Facility.
 
As of September 30, 2021, the consolidated net debt to adjusted EBITDA
 
may not exceed
4.00
 
to 1.
 
The Company’s
consolidated adjusted EBITDA to interest expense ratio cannot be less than
3.0
 
to 1 over the term of the agreement.
 
The Credit
Facility also prohibits the payment of cash dividends if the Company
 
is in default or if the amount of the dividend paid annually
exceeds the greater of $
50.0
 
million and
20
% of consolidated adjusted EBITDA unless the ratio of consolidated net debt
 
to
consolidated adjusted EBITDA is less than
2.0
 
to 1, in which case there is no such limitation on amount.
 
As of September 30, 2021
and December 31, 2020, the Company was in compliance with all of the Credit Facility covenants.
 
The Term Loans have quarterly
principal amortization during their
five year
 
terms, with
5.0
% amortization of the principal balance due in years 1 and 2,
7.5
% in year
3, and
10.0
% in years 4 and 5, with the remaining principal amount due at maturity.
 
During the nine months ended September 30,
2021, the Company made quarterly amortization payments related to the
 
Term Loans totaling $
28.6
 
million.
 
The Credit Facility is
guaranteed by certain of the Company’s
 
domestic subsidiaries and is secured by first priority liens on substantially all of the assets of
the Company and the domestic subsidiary guarantors, subject to certain
 
customary exclusions.
 
The obligations of the Dutch borrower
are guaranteed only by certain foreign subsidiaries on an unsecured basis.
The Credit Facility required the Company to fix its variable interest rates on at least
20
% of its total Term Loans.
 
In order to
satisfy this requirement as well as to manage the Company’s
 
exposure to variable interest rate risk associated with the Credit Facility,
in November 2019, the Company entered into $
170.0
 
million notional amounts of three year interest rate swaps at a base rate of
1.64
%
plus an applicable margin as provided in the Credit Facility,
 
based on the Company’s consolidated
 
net leverage ratio.
 
At the time the
Company entered into the swaps, and as of September 30, 2021, the
 
aggregate interest rate on the swaps, including the fixed base rate
plus an applicable margin, was
3.1
%.
 
See Note 18 of Notes to Condensed Consolidated Financial Statements.
The Company capitalized $
23.7
 
million of certain third-party debt issuance costs in connection with executing
 
the Credit Facility.
 
Approximately $
15.5
 
million of the capitalized costs were attributed to the Term
 
Loans and recorded as a direct reduction of long-
term debt on the Company’s Condensed
 
Consolidated Balance Sheet.
 
Approximately $
8.3
 
million of the capitalized costs were
attributed to the Revolver and recorded within other assets on the Company’s
 
Condensed Consolidated Balance Sheet.
 
These
capitalized costs are being amortized into interest expense over the
 
five year term of the Credit Facility.
 
As of September 30, 2021
and December 31, 2020, the Company had $
8.8
 
million and $
11.1
 
million, respectively, of debt
 
issuance costs recorded as a reduction
of long-term debt.
 
As of September 30, 2021 and December 31, 2020, the Company had $
4.7
 
million and $
5.9
 
million, respectively,
of debt issuance costs recorded within other assets.
Industrial development bonds
As of September 30, 2021 and December 31, 2020, the Company had fixed
 
rate, industrial development authority bonds totaling
$
10.0
 
million in principal amount due in
2028
.
 
These bonds have similar covenants to the Credit Facility noted above.
Bank lines of credit and other debt obligations
The Company has certain unsecured bank lines of credit and discounting
 
facilities in one of its foreign subsidiaries, which are not
collateralized.
 
The Company’s other debt obligat
 
ions primarily consist of certain domestic and foreign low interest rate or interest-
free municipality-related loans, local credit facilities of certain foreign subsidiaries
 
and capital lease obligations.
 
Total unused
capacity under these arrangements as of September 30, 2021 was approximately
 
$
39
 
million.
In addition to the bank letters of credit described in the “Credit facilities” subsection above, the Company’s only other off-balance
sheet arrangements include certain financial and other guarantees. The Company’s total bank letters of credit and guarantees
outstanding as of September 30, 2021 were approximately $7 million.
The Company incurred the following debt related expenses included
 
within Interest expense, net, in the Condensed Consolidated
Statements of Operations:
Three Months Ended
Nine Months Ended
September 30,
September 30,
2021
2020
2021
2020
Interest expense
$
4,779
$
5,957
$
14,242
$
19,621
Amortization of debt issuance costs
1,187
1,188
3,562
3,562
Total
$
5,966
$
7,145
$
17,804
$
23,183
Based on the variable interest rates associated with the Credit Facility,
 
as of September 30, 2021 and December 31, 2020, the
amounts at which the Company’s
 
total debt were recorded are not materially different from
 
their fair market value.
XML 38 R22.htm IDEA: XBRL DOCUMENT v3.21.2
Equity
 9 Months Ended
Sep. 30, 2021
Equity [Abstract]  
Equity [Text Block]
Note 16 – Equity
The following tables present the changes in equity,
 
net of tax, for the three and nine months ended September 30, 2021 and 2020:
Accumulated
Capital in
Other
Common
Excess of
Retained
Comprehensive
Noncontrolling
Stock
Par Value
Earnings
Loss
Interest
Total
Balance at June 30, 2021
$
17,878
$
910,862
$
482,001
$
(35,943)
$
603
$
1,375,401
Net income
—
—
31,058
—
15
31,073
Amounts reported in other comprehensive
 
loss
—
—
—
(18,780)
—
(18,780)
Dividends ($
0.415
 
per share)
—
—
(7,424)
—
—
(7,424)
Share issuance and equity-based
compensation plans
11
3,415
—
—
—
3,426
Balance at September 30, 2021
$
17,889
$
914,277
$
505,635
$
(54,723)
$
618
$
1,383,696
Balance at June 30, 2020
$
17,800
$
896,108
$
362,265
$
(109,264)
$
432
$
1,167,341
Net income
—
—
27,304
—
38
27,342
Amounts reported in other comprehensive
 
income
—
—
—
34,254
17
34,271
Dividends ($
0.395
 
per share)
—
—
(7,048)
—
—
(7,048)
Share issuance and equity-based
compensation plans
31
4,494
—
—
—
4,525
Balance at September 30, 2020
$
17,831
$
900,602
$
382,521
$
(75,010)
$
487
$
1,226,431
Accumulated
Capital in
Other
Common
Excess of
Retained
Comprehensive
Noncontrolling
Stock
Par Value
Earnings
Loss
Interest
Total
Balance at December 31, 2020
$
17,851
$
905,171
$
423,940
$
(26,598)
$
550
$
1,320,914
Net income
—
—
103,243
—
62
103,305
Amounts reported in other comprehensive
 
(loss) income
—
—
—
(28,125)
6
(28,119)
Dividends ($
1.205
 
per share)
—
—
(21,548)
—
—
(21,548)
Share issuance and equity-based
compensation plans
38
9,106
—
—
—
9,144
Balance at September 30, 2021
$
17,889
$
914,277
$
505,635
$
(54,723)
$
618
$
1,383,696
Balance at December 31, 2019
$
17,735
$
888,218
$
412,979
$
(78,170)
$
1,604
$
1,242,366
Cumulative effect of an accounting change
—
—
(911)
—
—
(911)
Balance at January 1, 2020
17,735
888,218
412,068
(78,170)
1,604
1,241,455
Net (loss) income
—
—
(8,812)
—
88
(8,724)
Amounts reported in other comprehensive
 
income (loss)
—
—
—
3,160
(114)
3,046
Dividends ($
1.165
 
per share)
—
—
(20,735)
—
—
(20,735)
Acquisition of noncontrolling interest
—
(707)
—
—
(340)
(1,047)
Distributions to noncontrolling affiliate
shareholders
—
—
—
—
(751)
(751)
Share issuance and equity-based
compensation plans
96
13,091
—
—
—
13,187
Balance at September 30, 2020
$
17,831
$
900,602
$
382,521
$
(75,010)
$
487
$
1,226,431
The following tables show the reclassifications from and resulting balances
 
of AOCI for the three and nine months ended
September 30, 2021 and 2020:
Defined
Unrealized
Currency
Benefit
Gain (Loss) in
Translation
Pension
Available-for-
Derivative
Adjustments
Plans
Sale Securities
Instruments
Total
Balance at June 30, 2021
$
(12,177)
$
(21,778)
$
596
$
(2,584)
$
(35,943)
Other comprehensive (loss) income before
 
reclassifications
(19,905)
488
(85)
567
(18,935)
Amounts reclassified from AOCI
—
709
(176)
—
533
Related tax amounts
—
(293)
46
(131)
(378)
Balance at September 30, 2021
$
(32,082)
$
(20,874)
$
381
$
(2,148)
$
(54,723)
Balance at June 30, 2020
$
(88,637)
$
(17,363)
$
1,148
$
(4,412)
$
(109,264)
Other comprehensive income (loss) before
reclassifications
33,601
(901)
810
460
33,970
Amounts reclassified from AOCI
—
584
(104)
—
480
Related tax amounts
—
60
(150)
(106)
(196)
Balance at September 30, 2020
$
(55,036)
$
(17,620)
$
1,704
$
(4,058)
$
(75,010)
Defined
Unrealized
Currency
Benefit
Gain (Loss) in
Translation
Pension
Available-for-
Derivative
Adjustments
Plans
Sale Securities
Instruments
Total
Balance at December 31, 2020
$
(2,875)
$
(23,467)
$
3,342
$
(3,598)
$
(26,598)
Other comprehensive (loss) income before
reclassifications
(29,207)
1,009
(489)
1,883
(26,804)
Amounts reclassified from AOCI
—
2,423
(3,259)
—
(836)
Related tax amounts
—
(839)
787
(433)
(485)
Balance at September 30, 2021
$
(32,082)
$
(20,874)
$
381
$
(2,148)
$
(54,723)
Balance at December 31, 2019
$
(44,568)
$
(34,533)
$
1,251
$
(320)
$
(78,170)
Other comprehensive (loss) income before
 
reclassifications
(10,468)
(409)
802
(4,855)
(14,930)
Amounts reclassified from AOCI
—
25,550
(229)
—
25,321
Related tax amounts
—
(8,228)
(120)
1,117
(7,231)
Balance at September 30, 2020
$
(55,036)
$
(17,620)
$
1,704
$
(4,058)
$
(75,010)
All reclassifications related to unrealized gain (loss) in available-for-sale securities relate
 
to the Company’s equity
 
interest in a
captive insurance company and are recorded in equity in net income
 
of associated companies.
 
The amounts reported in other
comprehensive income for noncontrolling interest are related to currency
 
translation adjustments.
XML 39 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements
 9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Fair Value Disclosures [Text Block]
Note 17 – Fair Value
 
Measurements
The Company has valued its company-owned life insurance policies at fair value.
 
These assets are subject to fair value
measurement as follows:
Fair Value
 
Measurements at September 30, 2021
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
$
2,135
$
—
$
2,135
$
—
Total
$
2,135
$
—
$
2,135
$
—
Fair Value
 
Measurements at December 31, 2020
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
 
$
1,961
$
—
$
1,961
$
—
Total
$
1,961
$
—
$
1,961
$
—
The fair values of Company-owned life insurance assets are based on quotes
 
for like instruments with similar credit ratings and
terms.
 
The Company did not hold any Level 3 investments as of September 30,
 
2021 or December 31, 2020, respectively,
 
so related
disclosures have not been included.
XML 40 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Hedging Activities
 9 Months Ended
Sep. 30, 2021
General Discussion Of Derivative Instruments And Hedging Activities [Abstract]  
Derivative Instruments And Hedging Activities Disclosure [Text Block]
Note 18 – Hedging Activities
In order to satisfy certain requirements of the Credit Facility as well as to manage
 
the Company’s exposure to variable
 
interest
rate risk associated with the Credit Facility,
 
in November 2019, the Company entered into $
170.0
 
million notional amounts of
three
year
 
interest rate swaps.
 
See Note 15 of Notes to Condensed Consolidated Financial Statements.
 
These interest rate swaps are
designated as cash flow hedges and, as such, the contracts are marked-to-market
 
at each reporting date and any unrealized gains or
losses are included in AOCI to the extent effective and reclassified to interest
 
expense in the period during which the transaction
affects earnings or it becomes probable that the forecasted
 
transaction will not occur.
 
The balance sheet classification and fair values of the Company’s
 
derivative instruments, which are Level 2 measurements, are as
follows:
Fair Value
Condensed Consolidated
September 30,
 
December 31,
Balance Sheet Location
2021
2020
Derivatives designated as cash flow hedges:
Interest rate swaps
Other non-current liabilities
$
2,789
$
4,672
$
2,789
$
4,672
The following table presents the net unrealized loss deferred to AOCI:
September 30,
 
December 31,
2021
2020
Derivatives designated as cash flow hedges:
Interest rate swaps
AOCI
$
2,148
$
3,598
$
2,148
$
3,598
The following table presents the net loss reclassified from AOCI to earnings:
Three Months Ended
Nine Months Ended
September 30,
 
September 30,
 
2021
2020
2021
2020
Amount and location of expense reclassified
from AOCI into expense (effective portion)
Interest expense, net
$
(672)
$
(640)
$
(1,974)
$
(1,105)
Interest rate swaps are entered into with a limited number of counterparties,
 
each of which allows for net settlement of all
contracts through a single payment in a single currency in the event of a default
 
on or termination of any one contract.
 
As such, in
accordance with the Company’s accounting
 
policy, these derivative instruments
 
are recorded on a net basis within the Condensed
Consolidated Balance Sheets.
XML 41 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies
 9 Months Ended
Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]  
Commitments And Contingencies Disclosure [Text Block]
Note 19 – Commitments and Contingencies
The Company previously disclosed in its 2020 Form 10-K that AC Products, Inc.
 
(“ACP”), a wholly owned subsidiary,
 
has been
operating a groundwater treatment system to hydraulically contain groundwater
 
contamination emanating from ACP’s site,
 
the
principal contaminant of which is perchloroethylene.
 
As of September 30, 2021, ACP believes it is close to meeting the conditions
 
for
closure of the groundwater treatment system, but continues to operate
 
this system while in discussions with the relevant authorities.
 
As of September 30, 2021, the Company believes that the range of potential
 
-known liabilities associated with the balance of the ACP
water remediation program is approximately $
0.1
 
million to $
1.0
 
million.
 
The low and high ends of the range are based on the length
of operation of the treatment system as determined by groundwater modeling.
 
Costs of operation include the operation and
maintenance of the extraction well, groundwater monitoring and
 
program management.
The Company previously disclosed in its 2020 Form 10-K that an inactive
 
subsidiary of the Company that was acquired in 1978
sold certain products containing asbestos, primarily on an installed basis, and
 
is among the defendants in numerous lawsuits alleging
injury due to exposure to asbestos.
 
During the three and nine months ended September 30, 2021, there have been
 
no significant
changes to the facts or circumstances of this previously disclosed matter,
 
aside from on-going claims and routine payments associated
with this litigation.
 
Based on a continued analysis of the existing and anticipated future claims against this subsidiary,
 
it is currently
projected that the subsidiary’s total
 
liability over the next 50 years for these claims is approximately $
0.4
 
million (excluding costs of
defense).
The Company previously disclosed in its 2020 Form 10-K that it is party to certain environmental
 
matters related to certain
domestic and foreign properties currently or previously owned by Houghton.
 
These environmental matters primarily require the
Company to perform long-term monitoring as well as operating and
 
maintenance at each of the applicable sites.
 
During the three and
nine months ended September 30, 2021, there have been no significant
 
changes to the facts or circumstances of these previously
disclosed matters, aside from on-going monitoring and maintenance
 
activities and routine payments associated with each of the sites.
 
The Company continually evaluates its obligations related to such matters,
 
and based on historical costs incurred and projected costs
to be incurred over the next 28 years, has estimated the present value
 
range of costs for all of the Houghton environmental matters,
 
on
a discounted basis, to be between approximately $
5.5
 
million and $
6.5
 
million as of September 30, 2021, for which $
5.7
 
million was
accrued within other accrued liabilities and other non-current liabilities on
 
the Company’s Condensed
 
Consolidated Balance Sheet as
of September 30, 2021.
 
Comparatively, as of December
 
31, 2020, the Company had $
6.0
 
million accrued for with respect to these
matters.
The Company believes, although there can be no assurance regarding the outcome
 
of other unrelated environmental matters, that
it has made adequate accruals for costs associated with other environmental
 
problems of which it is aware.
 
Approximately $
0.3
million and $
0.1
 
million was accrued as of September 30, 2021 and December 31, 2020,
 
respectively, to provide for
 
such anticipated
future environmental assessments and remediation costs.
 
The Company previously disclosed in its 2020 Form 10-K that during the fourth
 
quarter of 2020, one of the Company’s
subsidiaries received a notice of inspection from a taxing authority
 
in a country where certain of its subsidiaries operate which related
to a non-income (indirect) tax that may be applicable to certain products the
 
subsidiary sells.
 
During the third quarter of 2021, the
Company’s subsidiary received
 
notice from the taxing authority that the inspection was closed, with no tax
 
assessment issued.
 
Based
on this development, during the third quarter of 2021, the Company reversed
 
its previously recorded $
1.8
 
million liability related to
this matter.
 
The Company also reversed the associated $
1.1
 
million indemnification receivable, as the asserted tax liability in
 
part
related to a Houghton entity acquired in the Combination and for
 
the periods prior to the Combination, for which the Company would
be indemnified by Houghton’s
 
former owners.
 
Based on all available information as of the date of this Report, the Company does not
anticipate further tax inspection or liabilities related to this matter to be
 
asserted by the taxing authority.
 
During the first half of 2021, one of the Company’s
 
Brazilian subsidiaries received a notice that it had prevailed on an existing
legal claim in regard to certain non-income (indirect) taxes that had been
 
previously charged and paid.
 
The matter specifically relates
to companies’ rights to exclude the state tax on goods circulation (a valued-added-tax
 
or
VAT
equivalent, known in Brazil as “ICMS”)
from the calculation of certain additional indirect taxes (specifically the program
 
of social integration (“PIS”) and contribution for the
financing of social security (“COFINS”)) levied by the Brazilian States on the sale of
 
goods.
 
In May 2021, the Brazilian Supreme
Court concluded that ICMS should not be included in the tax base of PIS
 
and COFINS, and confirmed the methodology for
calculating the PIS and COFINS tax credit claims to which taxpayers are
 
entitled.
 
The Company’s Brazilian entities had
 
previously
filed legal or administrative disputes on this matter and are entitled to receive
 
tax credits and interest dating back to five years
preceding the date of their legal claims.
 
As a result of these court rulings, during the second quarter of 2021, the
 
Company recognized
non-income tax credits of
67.0
 
million BRL or approximately $
13.3
 
million, which included approximately $
8.4
 
million for the PIS
and COFINS tax credits as well as interest on these tax credits of $
4.9
 
million.
 
The tax credits to which the Company’s Brazilian
subsidiaries are entitled are claimable once registered with the
 
Brazilian tax authorities.
 
The Company submitted its formal claim for
tax credits in October 2021.
 
These tax credits can be used to offset future Brazilian federal taxes and
 
the Company currently
anticipates using the full amount of credits during the five year period of
 
time permitted.
 
During the third quarter of 2021, the
Brazilian Supreme Court ruled that interest income to which companies are
 
entitled for matters such as this claim should not be
taxable, which resulted in a reduction to the estimated income tax expense
 
associated with the tax credits recorded.
 
In connection with obtaining regulatory approvals for the Combination,
 
certain steel and aluminum related product lines of
Houghton were divested on August 1, 2019. In July 2021, the entity that acquired
 
these divested product lines submitted an
indemnification claim for certain alleged breaches of representation made
 
by Houghton in the agreement pursuant to which such assets
had been divested.
 
The Company and the acquirer have agreed to extend the period for
 
a possible negotiated resolution of this claim
through November 30, 2021 so that both parties can evaluate the other’s
 
positions with respect to the subject matters of the claim.
 
The Company is evaluating the merits of the alleged losses in the indemnification
 
claim received.
 
As of the date of this Report, the
Company does not believe it is reasonably possible to determine or quantify
 
any possible exposure.
 
During the third quarter of 2021, two of the Company’s
 
locations suffered property damages as a result of flooding and fire.
 
The
Company maintains property insurance for all of its facilities globally.
 
In Conshohocken, Pennsylvania, the Company’s
 
global
headquarters as well as its laboratory experienced property damages
 
as a result of flooding from Hurricane Ida.
 
Also, one of the
Company’s North American
 
production facilities in its Global Specialty Businesses segment experienced an
 
electrical fire that
resulted in damage and the temporary shutdown of production,
 
and also required remediation, cleaning and subsequent restoration.
 
The Company, its insurance
 
adjuster and insurance carrier are actively managing the remediation and restoration
 
activities associated
with these events and at this time the Company has concluded, based on all available
 
information and discussions with its insurance
adjuster and insurance carrier, that the losses incurred
 
during the third quarter of 2021 will be covered under the Company’s
 
property
insurance coverage, net of an aggregate deductible of $
2.0
 
million.
 
The Company has received advance payments from its insurers of
$
1.0
 
million and has recorded an insurance receivable associated with these events
 
(and a gain on insurance recoveries for losses
incurred) of $
1.7
 
million as of September 30, 2021.
 
The Company and its insurance carrier are in early stages of reviewing the impact
of the electrical fire on the production facility’s
 
operations as it relates to a potential business interruption insurance claim; however,
as of the date of this Report, the Company cannot reasonably estimate any
 
probable amount of business interruption insurance claim
recoverable, therefore the Company has not recorded a gain contingency
 
for a possible business interruption insurance claim as of
September 30, 2021.
The Company is party to other litigation which management currently
 
believes will not have a material adverse effect on the
Company’s results of operations,
 
cash flows or financial condition.
 
In addition, the Company has an immaterial amount of contractual
purchase obligations.
XML 42 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Basis of Presentation and Description of Business (Policies)
 9 Months Ended
Sep. 30, 2021
Basis of Presentation and Description of Business [Abstract]  
Basis Of Accounting Policy [Policy Text Block]
Basis of Presentation
As used in these Notes to Condensed Consolidated Financial Statements of
 
this Quarterly Report on Form 10-Q for the period
ended September 30, 2021 (the “Report”),
 
the terms “Quaker,”
 
“Quaker Houghton,”
 
the “Company,”
 
“we,” and “our” refer to Quaker
Chemical Corporation (doing business as Quaker Houghton), its subsidiaries, and
 
associated companies, unless the context otherwise
requires.
 
As used in these Notes to Condensed Consolidated Financial Statements,
 
the term Legacy Quaker refers to the Company
prior to the closing of its combination with Houghton International, Inc. (“Houghton”)
 
(herein referred to as the “Combination”).
 
The
condensed consolidated financial statements included herein are
 
unaudited and have been prepared in accordance with generally
accepted accounting principles in the United States (“U.S. GAAP”) for interim
 
financial reporting and the United States Securities and
Exchange Commission (“SEC”) regulations.
 
Certain information and footnote disclosures normally included in financial statements
prepared in accordance with U.S. GAAP have been condensed or omitted
 
pursuant to such rules and regulations.
 
In the opinion of
management, the financial statements reflect all adjustments consisting
 
only of normal recurring adjustments which are necessary for a
fair statement of the financial position, results of operations and cash
 
flows for the interim periods.
 
The results for the nine months
ended September 30, 2021 are not necessarily indicative of the results to be expected
 
for the full year.
 
These financial statements
should be read in conjunction with the Company’s
 
Annual Report filed on Form 10-K for the year ended December
 
31, 2020 (the
“2020 Form 10-K”).
During the three months ended September 30, 2020, the Company
 
identified and corrected certain immaterial adjustments relating
to the three months ended March 31, 2020 as well as the three and six months
 
ended June 30, 2020.
 
These adjustments related to the
Company’s over-recognition
 
of cost of goods sold (“COGS”) and corresponding under-recognition
 
of inventory, as well as the
associated tax impact of these adjustments, in the Company’s
 
previously issued interim financial statements for the three months
ended March 31, 2020 and the three and six months ended June 30, 2020.
 
These adjustments impact the Company’s
 
Americas
reportable segment.
 
The cumulative amount of reduction to COGS recorded in the three and nine months ended
 
September 30, 2020
was approximately $
1.7
 
million, with approximately $
0.7
 
million related to the three months ended March 31, 2020 and
approximately $
1.0
 
million related to the three months ended June 30, 2020.
Segments [Policy Text Block]
The Company’s operating
 
segments, which are consistent with its reportable segments, reflect the structure of the
 
Company’s
internal organization, the method by which the Company’s
 
resources are allocated and the manner by which the chief operating
decision maker assesses the Company’s
 
performance.
 
The Company has
four
 
reportable segments: (i) Americas; (ii) EMEA; (iii)
Asia/Pacific; and (iv) Global Specialty Businesses.
 
The three geographic segments are composed of the net sales and operations in
each respective region, excluding net sales and operations managed globally
 
by the Global Specialty Businesses segment, which
includes the Company’s container,
 
metal finishing, mining, offshore, specialty coatings, specialty grease
 
and Norman Hay businesses.
Revenue Recognition [Policy Text Block]
The Company applies the five-step model in the FASB’s
 
guidance, which requires the Company to: (i) identify the
 
contract with a
customer; (ii) identify the performance obligations in the contract; (iii)
 
determine the transaction price; (iv) allocate the transaction
price to the performance obligations in the contract; and (v) recognize
 
revenue when, or as, the Company satisfies a performance
obligation.
 
Refer to the Company’s 2020 Form 10-K
 
for additional information on the Company’s
 
revenue recognition policies,
including its practical expedients and accounting policy elections.
The Company recognizes a contract asset or receivable on its Condensed
 
Consolidated Balance Sheet when the Company
performs a service or transfers a good in advance of receiving consideration.
 
A receivable is the Company’s right to
 
consideration that
is unconditional and only the passage of time is required before payment
 
of that consideration is due.
 
A contract asset is the
Company’s right to consideration
 
in exchange for goods or services that the Company has transferred to a customer.
A contract liability is recognized when the Company receives consideration,
 
or if it has the unconditional right to receive
consideration, in advance of performance.
 
A contract liability is the Company’s
 
obligation to transfer goods or services to a customer
for which the Company has received consideration, or a specified amount
 
of consideration is due, from the customer.
 
The Company’s
contract liabilities primarily represent deferred revenue recorded
 
for customer payments received by the Company prior to the
Company satisfying the associated performance obligation.
 
Deferred revenues are presented within other current liabilities in the
Company’s Condensed Consolidated
 
Balance Sheets.
Revenue From Contract With Customer [Policy Text Block]
As part of the Company’s Fluidcare
 
business, certain third-party product sales to customers are managed by
 
the Company.
 
Where
the Company acts as a principal, revenues are recognized on a gross reporting
 
basis at the selling price negotiated with its customers.
Where the Company acts as an agent, revenue is recognized on a net reporting
 
basis at the amount of the administrative fee earned by
the Company for ordering the goods.
Goodwill And Intangible Assets, Goodwill, Policy [Policy Text Block]
Goodwill and intangible assets that have indefinite lives are not amortized and
 
are required to be assessed at least annually for
impairment.
 
The Company completes its annual goodwill and indefinite-lived intangible asset impairment
 
test during the fourth
quarter of each year.
 
The Company continuously evaluates if triggering events indicate a possible impairment
 
in one or more of its
reporting units or indefinite-lived or long-lived assets.
Lessee Leases [Policy Text Block]
The Company determines if an arrangement is a lease at its inception.
 
This determination generally depends on whether the
arrangement conveys the right to control the use of an identified fixed asset explicitly
 
or implicitly for a period of time in exchange for
consideration.
 
Control of an underlying asset is conveyed if the Company obtains the rights to direct the
 
use of, and obtains
substantially all of the economic benefits from the use of, the underlying
 
asset.
 
Lease expense for variable leases and short-term
leases is recognized when the obligation is incurred.
Credit Loss Financial Instrument [Policy Text Block]
The Company recognizes an
allowance for credit losses, which represents the portion of its trade accounts
 
receivable that the Company does not expect to collect
over the contractual life, considering past events and reasonable and
 
supportable forecasts of future economic conditions.
 
The
Company’s allowance for
 
credit losses on its trade accounts receivables is based on specific collectability facts and circumstances
 
for
each outstanding receivable and customer,
 
the aging of outstanding receivables, and the associated collection risk the
 
Company
estimates for certain past due aging categories, and also, the general risk
 
to all outstanding accounts receivable based on historical
amounts determined to be uncollectible.
 
The Company does not have any off-balance-sheet credit exposure
 
related to its customers.
XML 43 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Business Acquisitions (Tables)
 9 Months Ended
Sep. 30, 2021
Business Acquisition [Line Items]  
Schedule of estimated fair values of net assets acquired [Table Text Block]
Measurement
December 22,
December 22,
Period
2020
2020 (1)
Adjustments
(as adjusted)
Cash and cash equivalents
$
958
$
—
$
958
Accounts receivable
8,473
—
8,473
Inventories
4,527
—
4,527
Prepaid expenses and other assets
181
—
181
Property, plant and equipment
10,467
652
11,119
Intangible assets
30,300
(500)
29,800
Goodwill
2,814
270
3,084
Total assets purchased
57,720
422
58,142
Long-term debt including current portions and finance leases
183
556
739
Accounts payable, accrued expenses and other accrued liabilities
3,482
—
3,482
Total liabilities assumed
3,665
556
4,221
Total consideration
 
paid for Coral
54,055
(134)
53,921
Less: estimated purchase price settlement
—
(134)
(134)
Less: cash acquired
958
—
958
Net cash paid for Coral
$
53,097
$
—
$
53,097
(1) As previously disclosed in the Company’s
 
2020 Form 10-K
XML 44 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Business Segments (Tables)
 9 Months Ended
Sep. 30, 2021
Business Segment Disclosures [Abstract]  
Schedule of information about the performance of the Company's reportable segments, sales and total assets [Table Text Block]
Three Months Ended
Nine Months Ended
September 30,
September 30,
2021
2020
2021
2020
Net sales
 
 
 
 
 
 
 
 
 
 
Americas
$
150,799
$
119,540
$
425,343
$
330,012
EMEA
 
122,241
 
94,005
 
365,491
 
276,546
Asia/Pacific
 
98,659
 
84,877
 
286,924
 
226,850
Global Specialty Businesses
 
77,373
 
68,802
 
236,359
 
198,417
Total net sales
$
449,072
$
367,224
$
1,314,117
$
1,031,825
Segment operating earnings
Americas
$
31,273
$
31,099
$
97,155
$
70,590
EMEA
20,153
17,439
68,802
46,269
Asia/Pacific
23,285
27,304
73,990
66,106
Global Specialty Businesses
 
20,663
 
21,161
 
69,041
 
58,114
Total segment operating
 
earnings
 
95,374
 
97,003
 
308,988
 
241,079
Combination, integration and other acquisition-related expenses
(5,786)
(6,913)
(18,259)
(22,786)
Restructuring and related charges
880
(1,383)
(593)
(3,585)
Fair value step up of acquired inventory sold
 
—
—
(801)
(226)
Indefinite-lived intangible asset impairment
—
—
—
(38,000)
Non-operating and administrative expenses
(38,691)
(39,786)
(122,760)
(110,282)
Depreciation
 
of corporate assets and amortization
 
(15,767)
 
(14,062)
 
(46,855)
 
(41,547)
Operating income
36,010
34,859
119,720
24,653
Other income (expense), net
647
(239)
19,344
(22,407)
Interest expense, net
 
(5,637)
 
(6,837)
 
(16,725)
 
(22,109)
Income (loss) before taxes and equity in net income of
associated companies
$
31,020
$
27,783
$
122,339
$
(19,863)
XML 45 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Net Sales and Revenue Recognition (Tables)
 9 Months Ended
Sep. 30, 2021
Disaggregation Of Revenue [Abstract]  
Disaggregation Of Revenue [Table Text Block]
Three Months Ended September 30, 2021
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
56,954
$
38,483
$
53,994
$
149,431
Metalworking and other
93,845
83,758
44,665
222,268
150,799
122,241
98,659
371,699
Global Specialty Businesses
46,008
19,253
12,112
77,373
$
196,807
$
141,494
$
110,771
$
449,072
Timing of Revenue Recognized
Product sales at a point in time
$
188,340
$
131,982
$
108,559
$
428,881
Services transferred over time
8,467
9,512
2,212
20,191
$
196,807
$
141,494
$
110,771
$
449,072
Three Months Ended September 30, 2020
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
42,098
$
25,362
$
45,001
$
112,461
Metalworking and other
77,442
68,643
39,876
185,961
119,540
94,005
84,877
298,422
Global Specialty Businesses
39,197
17,429
12,176
68,802
$
158,737
$
111,434
$
97,053
$
367,224
Timing of Revenue Recognized
Product sales at a point in time
$
153,820
$
107,093
$
94,660
$
355,573
Services transferred over time
4,917
4,341
2,393
11,651
$
158,737
$
111,434
$
97,053
$
367,224
Nine Months Ended September 30, 2021
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
155,546
$
108,391
$
151,944
$
415,881
Metalworking and other
269,797
257,100
134,980
661,877
425,343
365,491
286,924
1,077,758
Global Specialty Businesses
137,447
61,203
37,709
236,359
$
562,790
$
426,694
$
324,633
$
1,314,117
Timing of Revenue Recognized
Product sales at a point in time
$
537,161
$
400,982
$
316,222
$
1,254,365
Services transferred over time
25,629
25,712
8,411
59,752
$
562,790
$
426,694
$
324,633
$
1,314,117
Nine Months Ended September 30, 2020
Consolidated
Americas
EMEA
Asia/Pacific
Total
Customer Industries
Metals
$
121,458
$
80,174
$
122,006
$
323,638
Metalworking and other
208,554
196,372
104,844
509,770
330,012
276,546
226,850
833,408
Global Specialty Businesses
115,722
49,603
33,092
198,417
$
445,734
$
326,149
$
259,942
$
1,031,825
Timing of Revenue Recognized
Product sales at a point in time
$
431,266
$
313,511
$
254,011
$
998,788
Services transferred over time
14,468
12,638
5,931
33,037
$
445,734
$
326,149
$
259,942
$
1,031,825
XML 46 R30.htm IDEA: XBRL DOCUMENT v3.21.2
Leases (Tables)
 9 Months Ended
Sep. 30, 2021
Leases [Abstract]  
Schedule of Maturities of operating lease liabilities [Table Text Block]
September 30,
December 31,
2021
2020
Right of use lease assets
$
34,314
$
38,507
Other current liabilities
9,356
10,901
Long-term lease liabilities
24,599
27,070
Total operating lease liabilities
$
33,955
$
37,971
Weighted average
 
remaining lease term (years)
5.7
6.0
Weighted average
 
discount rate
4.26%
4.20%
Schedule of Company's future minimum rental commitments under operating leases [Table Text Block]
September 30,
2021
For the remainder of 2021
$
2,978
For the year ended December 31, 2022
9,695
For the year ended December 31, 2023
7,564
For the year ended December 31, 2024
5,623
For the year ended December 31, 2025
4,340
For the year ended December 31, 2026 and beyond
8,104
Total lease payments
38,304
Less: imputed interest
(4,349)
Present value of lease liabilities
$
33,955
XML 47 R31.htm IDEA: XBRL DOCUMENT v3.21.2
Restructuring and Related Activities (Tables)
 9 Months Ended
Sep. 30, 2021
Restructuring And Related Activities [Abstract]  
Restructuring and Related Costs [Table Text Block]
QH Program
Accrued restructuring as of December 31, 2020
$
8,248
Restructuring and related charges
593
Cash payments
(4,557)
Currency translation adjustments
 
(234)
Accrued restructuring as of September 30, 2021
$
4,050
XML 48 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Share Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2021
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of share-based compensation expense in its Consolidated Statements of Income [Table Text Block]
Three Months Ended
Nine Months Ended
September 30,
 
September 30,
 
2021
2020
2021
2020
Stock options
$
298
$
353
$
938
$
1,138
Non-vested stock awards and restricted stock units
1,277
1,259
3,963
3,782
Non-elective and elective 401(k) matching contribution in stock
—
910
1,553
2,072
Director stock ownership plan
241
243
660
337
Performance stock units
491
280
1,327
560
Annual incentive plan
—
7,102
—
9,931
Total share-based
 
compensation expense
$
2,307
$
10,147
$
8,441
$
17,820
Schedule of Black-Scholes option pricing model and the assumptions [Table Text Block]
Number of options granted
25,250
Dividend yield
0.85
%
Expected volatility
37.33
%
Risk-free interest rate
0.60
%
Expected term (years)
4.0
XML 49 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Pension and Other Post Retirement Benefits (Tables)
 9 Months Ended
Sep. 30, 2021
Pension Plans, Defined Benefit [Member]  
Defined Benefit Plan Disclosure [Line Items]  
Schedule of components of net periodic benefit costs - pension plans [Table Text Block]
Three Months Ended September 30,
Nine Months Ended September 30,
Other
Other
Postretirement
Postretirement
Pension Benefits
Benefits
Pension Benefits
Benefits
2021
2020
2021
2020
2021
2020
2021
2020
Service cost
$
289
$
1,227
$
(2)
$
2
$
921
$
3,565
$
1
$
5
Interest cost
1,078
1,527
(1)
25
3,262
4,782
20
77
Expected return on plan assets
(2,075)
(3,526)
—
—
(6,250)
(7,246)
—
—
Settlement charge
—
—
—
—
—
22,667
—
—
Actuarial loss amortization
737
626
(85)
15
2,449
2,288
(85)
46
Prior service cost amortization
3
(42)
—
—
8
(123)
—
—
Net periodic benefit cost
$
32
$
(188)
$
(88)
$
42
$
390
$
25,933
$
(64)
$
128
XML 50 R34.htm IDEA: XBRL DOCUMENT v3.21.2
Other Income (Expense) (Tables)
 9 Months Ended
Sep. 30, 2021
Other Income and Expenses [Abstract]  
Schedule of other expense, net [Table Text Block]
Three Months Ended
Nine Months Ended
September 30,
 
September 30,
 
2021
2020
2021
2020
Income from third party license fees
$
314
$
190
$
1,026
$
702
Foreign exchange gains (losses), net
368
(1,897)
(1,948)
(3,080)
(Loss) gain on disposals of property,
 
plant, equipment and other
assets, net
(537)
(24)
4,819
(105)
Non-income tax refunds and other related credits
3
—
14,395
2,131
Pension and postretirement benefit income (costs),
 
non-service components
343
1,375
596
(22,491)
Other non-operating income, net
156
117
456
436
Total other income
 
(expense), net
$
647
$
(239)
$
19,344
$
(22,407)
XML 51 R35.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings Per Share (Tables)
 9 Months Ended
Sep. 30, 2021
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Three Months Ended
 
Nine Months Ended
September 30,
September 30,
2021
2020
2021
2020
Basic earnings (loss) per common share
 
 
 
Net income (loss) attributable to Quaker Chemical Corporation
$
31,058
$
27,304
$
103,243
$
(8,812)
Less: (income) loss allocated to participating securities
 
(119)
 
(113)
 
(413)
 
44
Net income (loss) available to common shareholders
$
30,939
$
27,191
$
102,830
$
(8,768)
Basic weighted average common shares outstanding
17,812,216
17,743,538
17,800,082
17,704,662
Basic earnings (loss) per common share
$
1.74
$
1.53
$
5.78
$
(0.50)
Diluted earnings (loss) per common share
Net income (loss) attributable to Quaker Chemical Corporation
$
31,058
$
27,304
$
103,243
$
(8,812)
Less: (income) loss allocated to participating securities
(119)
 
(113)
 
(412)
 
44
Net income (loss) available to common shareholders
$
30,939
$
27,191
$
102,831
$
(8,768)
Basic weighted average common shares outstanding
17,812,216
17,743,538
17,800,082
17,704,662
Effect of dilutive securities
58,176
57,327
59,986
—
Diluted weighted average common shares outstanding
17,870,392
17,800,865
17,860,068
17,704,662
Diluted earnings (loss) per common share
$
1.73
$
1.53
$
5.76
$
(0.50)
XML 52 R36.htm IDEA: XBRL DOCUMENT v3.21.2
Restricted Cash (Tables)
 9 Months Ended
Sep. 30, 2021
Restricted Cash Abstract]  
Schedule Of Cash And Cash Equivalents [Table Text Block]
September 30,
December 31,
2021
2020
2020
2019
Cash and cash equivalents
$
141,393
$
155,750
$
181,833
$
123,524
Restricted cash included in other current assets
—
82
62
353
Restricted cash included in other assets
—
18,901
—
19,678
Cash, cash equivalents and restricted cash
$
141,393
$
174,733
$
181,895
$
143,555
XML 53 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Goodwill and Intangible Assets (Tables)
 9 Months Ended
Sep. 30, 2021
Goodwill And Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill [Table Text Block]
Global
Specialty
Americas
EMEA
Asia/Pacific
Businesses
Total
Balance as of December 31, 2020
$
213,242
$
140,162
$
158,090
$
119,718
 
$
631,212
Goodwill additions
1,208
2,626
1,308
1,951
7,093
Currency translation and other adjustments
 
(621)
(5,530)
1,109
(2,594)
(7,636)
Balance as of September 30, 2021
$
213,829
$
137,258
$
160,507
$
119,075
 
$
630,669
Schedule of Finite-Lived Intangible Assets [Table Text Block]
Gross Carrying
Accumulated
Amount
Amortization
2021
2020
2021
2020
Customer lists and rights to sell
$
847,909
 
$
839,551
 
$
135,571
 
$
99,806
Trademarks, formulations and product
 
technology
 
167,682
 
 
166,448
 
 
36,871
 
 
30,483
Other
 
6,325
 
 
6,372
 
 
5,886
 
 
5,824
Total definite-lived
 
intangible assets
$
1,021,916
 
$
1,012,371
 
$
178,328
 
$
136,113
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
For the year ended December 31, 2021
$
58,852
For the year ended December 31, 2022
59,173
For the year ended December 31, 2023
59,005
For the year ended December 31, 2024
58,338
For the year ended December 31, 2025
57,653
For the year ended December 31, 2026
57,346
XML 54 R38.htm IDEA: XBRL DOCUMENT v3.21.2
Debt (Tables)
 9 Months Ended
Sep. 30, 2021
Debt [Abstract]  
Schedule of Debt [Table Text Block]
As of September 30, 2021
As of December 31, 2020
Interest
Outstanding
 
Interest
Outstanding
 
Rate
Balance
Rate
Balance
Credit Facilities:
Revolver
1.58%
$
198,543
1.65%
$
160,000
U.S. Term Loan
1.58%
547,500
1.65%
570,000
EURO Term Loan
1.50%
142,559
1.50%
157,062
Industrial development bonds
5.26%
10,000
5.26%
10,000
Bank lines of credit and other debt obligations
Various
2,060
Various
2,072
Total debt
$
900,662
$
899,134
Less: debt issuance costs
(8,776)
(11,099)
Less: short-term and current portion of long-term debts
(52,611)
(38,967)
Total long-term debt
$
839,275
$
849,068
Interest Income And Interest Expense Disclosure [Table Text Block]
Three Months Ended
Nine Months Ended
September 30,
September 30,
2021
2020
2021
2020
Interest expense
$
4,779
$
5,957
$
14,242
$
19,621
Amortization of debt issuance costs
1,187
1,188
3,562
3,562
Total
$
5,966
$
7,145
$
17,804
$
23,183
XML 55 R39.htm IDEA: XBRL DOCUMENT v3.21.2
Equity (Tables)
 9 Months Ended
Sep. 30, 2021
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]
Defined
Unrealized
Currency
Benefit
Gain (Loss) in
Translation
Pension
Available-for-
Derivative
Adjustments
Plans
Sale Securities
Instruments
Total
Balance at June 30, 2021
$
(12,177)
$
(21,778)
$
596
$
(2,584)
$
(35,943)
Other comprehensive (loss) income before
 
reclassifications
(19,905)
488
(85)
567
(18,935)
Amounts reclassified from AOCI
—
709
(176)
—
533
Related tax amounts
—
(293)
46
(131)
(378)
Balance at September 30, 2021
$
(32,082)
$
(20,874)
$
381
$
(2,148)
$
(54,723)
Balance at June 30, 2020
$
(88,637)
$
(17,363)
$
1,148
$
(4,412)
$
(109,264)
Other comprehensive income (loss) before
reclassifications
33,601
(901)
810
460
33,970
Amounts reclassified from AOCI
—
584
(104)
—
480
Related tax amounts
—
60
(150)
(106)
(196)
Balance at September 30, 2020
$
(55,036)
$
(17,620)
$
1,704
$
(4,058)
$
(75,010)
Defined
Unrealized
Currency
Benefit
Gain (Loss) in
Translation
Pension
Available-for-
Derivative
Adjustments
Plans
Sale Securities
Instruments
Total
Balance at December 31, 2020
$
(2,875)
$
(23,467)
$
3,342
$
(3,598)
$
(26,598)
Other comprehensive (loss) income before
reclassifications
(29,207)
1,009
(489)
1,883
(26,804)
Amounts reclassified from AOCI
—
2,423
(3,259)
—
(836)
Related tax amounts
—
(839)
787
(433)
(485)
Balance at September 30, 2021
$
(32,082)
$
(20,874)
$
381
$
(2,148)
$
(54,723)
Balance at December 31, 2019
$
(44,568)
$
(34,533)
$
1,251
$
(320)
$
(78,170)
Other comprehensive (loss) income before
 
reclassifications
(10,468)
(409)
802
(4,855)
(14,930)
Amounts reclassified from AOCI
—
25,550
(229)
—
25,321
Related tax amounts
—
(8,228)
(120)
1,117
(7,231)
Balance at September 30, 2020
$
(55,036)
$
(17,620)
$
1,704
$
(4,058)
$
(75,010)
Schedule of Stockholders Equity [Table Text Block]
Accumulated
Capital in
Other
Common
Excess of
Retained
Comprehensive
Noncontrolling
Stock
Par Value
Earnings
Loss
Interest
Total
Balance at June 30, 2021
$
17,878
$
910,862
$
482,001
$
(35,943)
$
603
$
1,375,401
Net income
—
—
31,058
—
15
31,073
Amounts reported in other comprehensive
 
loss
—
—
—
(18,780)
—
(18,780)
Dividends ($
0.415
 
per share)
—
—
(7,424)
—
—
(7,424)
Share issuance and equity-based
compensation plans
11
3,415
—
—
—
3,426
Balance at September 30, 2021
$
17,889
$
914,277
$
505,635
$
(54,723)
$
618
$
1,383,696
Balance at June 30, 2020
$
17,800
$
896,108
$
362,265
$
(109,264)
$
432
$
1,167,341
Net income
—
—
27,304
—
38
27,342
Amounts reported in other comprehensive
 
income
—
—
—
34,254
17
34,271
Dividends ($
0.395
 
per share)
—
—
(7,048)
—
—
(7,048)
Share issuance and equity-based
compensation plans
31
4,494
—
—
—
4,525
Balance at September 30, 2020
$
17,831
$
900,602
$
382,521
$
(75,010)
$
487
$
1,226,431
Accumulated
Capital in
Other
Common
Excess of
Retained
Comprehensive
Noncontrolling
Stock
Par Value
Earnings
Loss
Interest
Total
Balance at December 31, 2020
$
17,851
$
905,171
$
423,940
$
(26,598)
$
550
$
1,320,914
Net income
—
—
103,243
—
62
103,305
Amounts reported in other comprehensive
 
(loss) income
—
—
—
(28,125)
6
(28,119)
Dividends ($
1.205
 
per share)
—
—
(21,548)
—
—
(21,548)
Share issuance and equity-based
compensation plans
38
9,106
—
—
—
9,144
Balance at September 30, 2021
$
17,889
$
914,277
$
505,635
$
(54,723)
$
618
$
1,383,696
Balance at December 31, 2019
$
17,735
$
888,218
$
412,979
$
(78,170)
$
1,604
$
1,242,366
Cumulative effect of an accounting change
—
—
(911)
—
—
(911)
Balance at January 1, 2020
17,735
888,218
412,068
(78,170)
1,604
1,241,455
Net (loss) income
—
—
(8,812)
—
88
(8,724)
Amounts reported in other comprehensive
 
income (loss)
—
—
—
3,160
(114)
3,046
Dividends ($
1.165
 
per share)
—
—
(20,735)
—
—
(20,735)
Acquisition of noncontrolling interest
—
(707)
—
—
(340)
(1,047)
Distributions to noncontrolling affiliate
shareholders
—
—
—
—
(751)
(751)
Share issuance and equity-based
compensation plans
96
13,091
—
—
—
13,187
Balance at September 30, 2020
$
17,831
$
900,602
$
382,521
$
(75,010)
$
487
$
1,226,431
XML 56 R40.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Table)
 9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
Fair Value
 
Measurements at September 30, 2021
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
$
2,135
$
—
$
2,135
$
—
Total
$
2,135
$
—
$
2,135
$
—
Fair Value
 
Measurements at December 31, 2020
Total
Using Fair Value
 
Hierarchy
Assets
Fair Value
Level 1
Level 2
Level 3
Company-owned life insurance
 
$
1,961
$
—
$
1,961
$
—
Total
$
1,961
$
—
$
1,961
$
—
XML 57 R41.htm IDEA: XBRL DOCUMENT v3.21.2
Hedging Activities (Tables)
 9 Months Ended
Sep. 30, 2021
General Discussion Of Derivative Instruments And Hedging Activities [Abstract]  
Scheudule of fair values of the Company''s derivative instruments, Level 2 measurements [Table Text Block]
Fair Value
Condensed Consolidated
September 30,
 
December 31,
Balance Sheet Location
2021
2020
Derivatives designated as cash flow hedges:
Interest rate swaps
Other non-current liabilities
$
2,789
$
4,672
$
2,789
$
4,672
September 30,
 
December 31,
2021
2020
Derivatives designated as cash flow hedges:
Interest rate swaps
AOCI
$
2,148
$
3,598
$
2,148
$
3,598
Three Months Ended
Nine Months Ended
September 30,
 
September 30,
 
2021
2020
2021
2020
Amount and location of expense reclassified
from AOCI into expense (effective portion)
Interest expense, net
$
(672)
$
(640)
$
(1,974)
$
(1,105)
XML 58 R42.htm IDEA: XBRL DOCUMENT v3.21.2
Basis of Presentation and Description of Business (Details)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
USD ($)
Countries
Sep. 30, 2020
USD ($)
Jun. 30, 2020
USD ($)
Mar. 31, 2020
USD ($)
Sep. 30, 2021
USD ($)
Segments
Countries
Sep. 30, 2020
USD ($)
Basis of Presentation and Description of Business [Abstract]            
Number Of Countries In Which Entity Operates | Countries 25       25  
Number Of Reportable Segments | Segments         4  
Cost of goods sold $ 303,941 $ 227,032     $ 858,341 $ 660,396
Error Correction Other [Member]            
Cost of goods sold   1,700 $ 1,000 $ 700   1,700
Subsidiaries [Member] | Geographic Concentration Risk [Member]            
Currency conversion impacts of hyper-inflationary accounting         $ 300  
Subsidiaries [Member] | Argentina [Member]            
Currency conversion impacts of hyper-inflationary accounting $ 100 $ 200       $ 300
Assets Total [Member] | Subsidiaries [Member] | Argentina [Member] | Geographic Concentration Risk [Member]            
Concentration Risk, Percentage 1.00% 1.00%     1.00% 1.00%
Sales Revenue Net [Member] | Subsidiaries [Member] | Argentina [Member] | Geographic Concentration Risk [Member]            
Concentration Risk, Percentage 1.00% 1.00%     1.00% 1.00%
XML 59 R43.htm IDEA: XBRL DOCUMENT v3.21.2
Business Acquisitions - Narrative (Details)
$ in Thousands, € in Millions, £ in Millions, kr in Millions, R in Millions
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Dec. 22, 2020
USD ($)
Nov. 30, 2021
USD ($)
Sep. 30, 2021
EUR (€)
Sep. 30, 2021
USD ($)
Feb. 28, 2021
EUR (€)
Feb. 28, 2021
USD ($)
May 31, 2020
DKK (kr)
May 31, 2020
USD ($)
Mar. 31, 2020
USD ($)
Mar. 31, 2020
ZAR (R)
Oct. 31, 2019
GBP (£)
Sep. 30, 2020
DKK (kr)
Mar. 31, 2020
GBP (£)
Sep. 30, 2021
EUR (€)
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
Business Acquisition [Line Items]                                  
Payments related to acquisitions, net of cash acquired                             $ 31,975 $ 3,132  
Goodwill, Acquired During Period                             $ 7,093    
Tin Plating Solutions [Member]                                  
Business Acquisition [Line Items]                                  
Intangible assets           $ 19,600                      
Payments related to acquisitions, net of cash acquired           25,000                      
Goodwill, Acquired During Period           5,000                      
Business Combination, Measurement Period                           1 year 1 year    
Tin Plating Solutions [Member] | Customer lists and rights to sell [Member]                                  
Business Acquisition [Line Items]                                  
Intangible assets           $ 18,300                      
Intangible Assets, Amortizable Life         19 years 19 years                      
Tin Plating Solutions [Member] | Licensed Trademark [Member]                                  
Business Acquisition [Line Items]                                  
Intangible assets           $ 400                      
Intangible Assets, Amortizable Life         3 years 3 years                      
Tin Plating Solutions [Member] | Product technology [Member]                                  
Business Acquisition [Line Items]                                  
Intangible assets           $ 900                      
Intangible Assets, Amortizable Life         14 years 14 years                      
Grindaix GmbH [Member] | Global Specialty Businesses [Member]                                  
Business Acquisition [Line Items]                                  
Business Acquisition, Percentage of Voting Interests Acquired           38.00%                      
Cash Paid for Acquisitions     € 2.4 $ 2,900 € 1.4 $ 1,700                      
Coral Chemical Company (Coral) [Member]                                  
Business Acquisition [Line Items]                                  
Intangible assets $ 29,800                                
Payments related to acquisitions, net of cash acquired                                 $ 54,100
Cash Paid for Acquisitions 53,921                                
Total Assets Purchased 58,142                                
Business Combination, Measurement Period                           1 year 1 year    
Post Closing Adjustment $ (134)                                
Tel Nordic ApS[Member]                                  
Business Acquisition [Line Items]                                  
Intangible assets                               $ 2,400  
Intangible Assets, Amortizable Life             17 years 17 years                  
Payments related to acquisitions, net of cash acquired             kr 20.0 $ 2,900                  
Goodwill, Acquired During Period               500                  
Business Combination, Measurement Period                           1 year 1 year    
Post Closing Adjustment               $ 100       kr 0.4          
South Africa Equity Affiliate [Member]                                  
Business Acquisition [Line Items]                                  
Payments related to acquisitions, net of cash acquired                 $ 1,000 R 16.7              
Business Acquisition, Percentage of Voting Interests Acquired                 49.00% 49.00%     49.00%        
Adjustments To Additional Paid In Capital Other                 $ 700                
Norman Hay [Member]                                  
Business Acquisition [Line Items]                                  
Payments related to acquisitions, net of cash acquired | £                     £ 80.0            
Post Closing Adjustment | £                         £ 2.5        
2021 Acquisitions [Member] | Subsequent Event [Member]                                  
Business Acquisition [Line Items]                                  
Cash Paid for Acquisitions   $ 10,000                              
Earn-out provisions   $ 4,000                              
Chemical maskants product line [Member] | Global Specialty Businesses [Member]                                  
Business Acquisition [Line Items]                                  
Asset Acquisition, Consideration Transferred                           € 2.3 $ 2,800    
XML 60 R44.htm IDEA: XBRL DOCUMENT v3.21.2
Business Acquisitions - Preliminary Estimated Fair Values of Coral Net Assets Acquired (Details) - USD ($)
$ in Thousands
Dec. 22, 2020
Sep. 30, 2021
Dec. 31, 2020
Business Acquisition [Line Items]      
Goodwill   $ 630,669 $ 631,212
Coral Chemical Company (Coral) [Member]      
Business Acquisition [Line Items]      
Cash and cash equivalents $ 958    
Accounts receivable, net 8,473    
Inventories 4,527    
Prepaid expenses and other assets 181    
Propery, plant & equipment 11,119    
Intangible assets 29,800    
Goodwill 3,084    
Total Assets Purchased 58,142    
Long-term debt including current portions and finance leases 739    
Accounts payable, accrued expenses and other accrued liabilities 3,482    
Total Liabilities Assumed 4,221    
Total consideration paid for Coral 53,921    
Less: estimated purchase price settlement (134)    
Less: cash Acquired 958    
Net cash paid for Coral 53,097    
Coral Chemical Company (Coral) [Member] | As initially Reported [Member]      
Business Acquisition [Line Items]      
Cash and cash equivalents 958    
Accounts receivable, net 8,473    
Inventories 4,527    
Prepaid expenses and other assets 181    
Propery, plant & equipment 10,467    
Intangible assets 30,300    
Goodwill 2,814    
Total Assets Purchased 57,720    
Long-term debt including current portions and finance leases 183    
Accounts payable, accrued expenses and other accrued liabilities 3,482    
Total Liabilities Assumed 3,665    
Total consideration paid for Coral 54,055    
Less: estimated purchase price settlement 0    
Less: cash Acquired 958    
Net cash paid for Coral 53,097    
Coral Chemical Company (Coral) [Member] | Measurement period adjustments [Member]      
Business Acquisition [Line Items]      
Cash and cash equivalents 0    
Accounts receivable, net 0    
Inventories 0    
Prepaid expenses and other assets 0    
Propery, plant & equipment 652    
Intangible assets (500)    
Goodwill 270    
Total Assets Purchased 422    
Long-term debt including current portions and finance leases 556    
Accounts payable, accrued expenses and other accrued liabilities 0    
Total Liabilities Assumed 556    
Total consideration paid for Coral (134)    
Less: estimated purchase price settlement (134)    
Less: cash Acquired 0    
Net cash paid for Coral $ 0    
XML 61 R45.htm IDEA: XBRL DOCUMENT v3.21.2
Business Acquisitions - Coral - Narrative (Details)
 9 Months Ended
Sep. 30, 2021
Coral Chemical Company (Coral) [Member]  
Business Acquisition [Line Items]  
Measurement period 1 year
XML 62 R46.htm IDEA: XBRL DOCUMENT v3.21.2
Business Segments - Narrative (Details)
 9 Months Ended
Sep. 30, 2021
Segments
Business Segment Disclosures [Abstract]  
Number of reportable segments 4
XML 63 R47.htm IDEA: XBRL DOCUMENT v3.21.2
Business Segments - Performance of reportable segments (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Mar. 31, 2020
Sep. 30, 2021
Sep. 30, 2020
Segment Reporting Information [Line Items]          
Net sales $ 449,072 $ 367,224   $ 1,314,117 $ 1,031,825
Combination, integration and other acquisition-related expenses (5,786) (6,913)   (18,259) (22,786)
Restructuring charges 880 (1,383)   (593) (3,585)
Fair value step up of acquired inventory sold 0 0   (801) (226)
Indefinite-lived intangible asset impairment 0 0 $ (38,000) 0 (38,000)
Non-operating and administrative expenses (38,691) (39,786)   (122,760) (110,282)
Depreciation of corporate assets and amortization (15,767) (14,062)   (46,855) (41,547)
Operating income 36,010 34,859   119,720 24,653
Other income (expense), net 647 (239)   19,344 (22,407)
Interest expense, net (5,637) (6,837)   (16,725) (22,109)
Income (loss) before taxes and equity in net income of associated companies 31,020 27,783   122,339 (19,863)
Americas [Member]          
Segment Reporting Information [Line Items]          
Net sales 196,807 158,737   562,790 445,734
EMEA [Member]          
Segment Reporting Information [Line Items]          
Net sales 141,494 111,434   426,694 326,149
Asia Pacific [Member]          
Segment Reporting Information [Line Items]          
Net sales 110,771 97,053   324,633 259,942
Operating Segments [Member]          
Segment Reporting Information [Line Items]          
Net sales 371,699 298,422   1,077,758 833,408
Segment operating earnings 95,374 97,003   308,988 241,079
Operating Segments [Member] | Global Specialty Businesses [Member]          
Segment Reporting Information [Line Items]          
Net sales 77,373 68,802   236,359 198,417
Segment operating earnings 20,663 21,161   69,041 58,114
Operating Segments [Member] | Americas [Member]          
Segment Reporting Information [Line Items]          
Net sales 150,799 119,540   425,343 330,012
Segment operating earnings 31,273 31,099   97,155 70,590
Operating Segments [Member] | Americas [Member] | Global Specialty Businesses [Member]          
Segment Reporting Information [Line Items]          
Net sales 46,008 39,197   137,447 115,722
Operating Segments [Member] | EMEA [Member]          
Segment Reporting Information [Line Items]          
Net sales 122,241 94,005   365,491 276,546
Segment operating earnings 20,153 17,439   68,802 46,269
Operating Segments [Member] | EMEA [Member] | Global Specialty Businesses [Member]          
Segment Reporting Information [Line Items]          
Net sales 19,253 17,429   61,203 49,603
Operating Segments [Member] | Asia Pacific [Member]          
Segment Reporting Information [Line Items]          
Net sales 98,659 84,877   286,924 226,850
Segment operating earnings 23,285 27,304   73,990 66,106
Operating Segments [Member] | Asia Pacific [Member] | Global Specialty Businesses [Member]          
Segment Reporting Information [Line Items]          
Net sales 12,112 12,176   37,709 33,092
Intersegment Elimination [Member] | Global Specialty Businesses [Member]          
Segment Reporting Information [Line Items]          
Net sales 1,800 1,100   5,900 3,400
Intersegment Elimination [Member] | Americas [Member]          
Segment Reporting Information [Line Items]          
Net sales 3,600 1,700   9,300 7,000
Intersegment Elimination [Member] | EMEA [Member]          
Segment Reporting Information [Line Items]          
Net sales 6,800 5,300   21,900 16,100
Intersegment Elimination [Member] | Asia Pacific [Member]          
Segment Reporting Information [Line Items]          
Net sales $ 800 $ 200   $ 1,300 $ 500
XML 64 R48.htm IDEA: XBRL DOCUMENT v3.21.2
Net Sales and Revenue Recognition - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Revenues [Abstract]          
Net Reporting Amount $ 18.9 $ 11.1 $ 53.4 $ 29.9  
Deferred Revenue $ 4.4   $ 4.4   $ 4.0
Customer Concentration Risk [Member] | Sales Revenue Net [Member] | Top Five Customers [Member]          
Concentration Risk [Line Items]          
Concentration Risk, Percentage         10.00%
Customer Concentration Risk [Member] | Sales Revenue Net [Member] | Largest customer [Member]          
Concentration Risk [Line Items]          
Concentration Risk, Percentage         3.00%
XML 65 R49.htm IDEA: XBRL DOCUMENT v3.21.2
Net Sales and Revenue Recognition (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Product Information [Line Items]        
Net sales $ 449,072 $ 367,224 $ 1,314,117 $ 1,031,825
Product sales at a point in time [Member]        
Product Information [Line Items]        
Net sales 428,881 355,573 1,254,365 998,788
Services transferred over time [Member]        
Product Information [Line Items]        
Net sales 20,191 11,651 59,752 33,037
Americas [Member]        
Product Information [Line Items]        
Net sales 196,807 158,737 562,790 445,734
Americas [Member] | Product sales at a point in time [Member]        
Product Information [Line Items]        
Net sales 188,340 153,820 537,161 431,266
Americas [Member] | Services transferred over time [Member]        
Product Information [Line Items]        
Net sales 8,467 4,917 25,629 14,468
EMEA [Member]        
Product Information [Line Items]        
Net sales 141,494 111,434 426,694 326,149
EMEA [Member] | Product sales at a point in time [Member]        
Product Information [Line Items]        
Net sales 131,982 107,093 400,982 313,511
EMEA [Member] | Services transferred over time [Member]        
Product Information [Line Items]        
Net sales 9,512 4,341 25,712 12,638
Asia Pacific [Member]        
Product Information [Line Items]        
Net sales 110,771 97,053 324,633 259,942
Asia Pacific [Member] | Product sales at a point in time [Member]        
Product Information [Line Items]        
Net sales 108,559 94,660 316,222 254,011
Asia Pacific [Member] | Services transferred over time [Member]        
Product Information [Line Items]        
Net sales 2,212 2,393 8,411 5,931
Operating Segments [Member]        
Product Information [Line Items]        
Net sales 371,699 298,422 1,077,758 833,408
Operating Segments [Member] | Metals [Member]        
Product Information [Line Items]        
Net sales 149,431 112,461 415,881 323,638
Operating Segments [Member] | Metalworking and other [Member]        
Product Information [Line Items]        
Net sales 222,268 185,961 661,877 509,770
Operating Segments [Member] | Global Specialty Businesses [Member]        
Product Information [Line Items]        
Net sales 77,373 68,802 236,359 198,417
Operating Segments [Member] | Americas [Member]        
Product Information [Line Items]        
Net sales 150,799 119,540 425,343 330,012
Operating Segments [Member] | Americas [Member] | Metals [Member]        
Product Information [Line Items]        
Net sales 56,954 42,098 155,546 121,458
Operating Segments [Member] | Americas [Member] | Metalworking and other [Member]        
Product Information [Line Items]        
Net sales 93,845 77,442 269,797 208,554
Operating Segments [Member] | Americas [Member] | Global Specialty Businesses [Member]        
Product Information [Line Items]        
Net sales 46,008 39,197 137,447 115,722
Operating Segments [Member] | EMEA [Member]        
Product Information [Line Items]        
Net sales 122,241 94,005 365,491 276,546
Operating Segments [Member] | EMEA [Member] | Metals [Member]        
Product Information [Line Items]        
Net sales 38,483 25,362 108,391 80,174
Operating Segments [Member] | EMEA [Member] | Metalworking and other [Member]        
Product Information [Line Items]        
Net sales 83,758 68,643 257,100 196,372
Operating Segments [Member] | EMEA [Member] | Global Specialty Businesses [Member]        
Product Information [Line Items]        
Net sales 19,253 17,429 61,203 49,603
Operating Segments [Member] | Asia Pacific [Member]        
Product Information [Line Items]        
Net sales 98,659 84,877 286,924 226,850
Operating Segments [Member] | Asia Pacific [Member] | Metals [Member]        
Product Information [Line Items]        
Net sales 53,994 45,001 151,944 122,006
Operating Segments [Member] | Asia Pacific [Member] | Metalworking and other [Member]        
Product Information [Line Items]        
Net sales 44,665 39,876 134,980 104,844
Operating Segments [Member] | Asia Pacific [Member] | Global Specialty Businesses [Member]        
Product Information [Line Items]        
Net sales $ 12,112 $ 12,176 $ 37,709 $ 33,092
XML 66 R50.htm IDEA: XBRL DOCUMENT v3.21.2
Leases - Narrative (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Lessee, Lease, Description [Line Items]        
Operating Lease Cost $ 3,400,000 $ 3,700,000 $ 10,600,000 $ 10,600,000
Short Term Lease Cost 200,000 200,000 800,000 1,100,000
Variable Lease Cost 0 0 0 0
Sublease Income $ 0 $ 0 0 0
Operating Lease Payments     10,400,000 $ 10,500,000
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability     $ 5,600,000  
Land [Member] | Maximum [Member]        
Lessee, Lease, Description [Line Items]        
Lessee Operating Lease Term Of Contract 94 years   94 years  
Facilities vehicles and machinery and equipment [Member] | Maximum [Member]        
Lessee, Lease, Description [Line Items]        
Lessee Operating Lease Term Of Contract 10 years   10 years  
XML 67 R51.htm IDEA: XBRL DOCUMENT v3.21.2
Leases - Supplemental Balance Sheet Information (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Lessee, Lease, Description [Abstract]    
Right of use lease assets $ 34,314 $ 38,507
Other current liabilities 9,356 10,901
Long-term lease liabilities 24,599 27,070
Total operating lease liabilities $ 33,955 $ 37,971
Weighted average remaining lease term (years) 5 years 8 months 12 days 6 years
Weighted average discount rate 4.26% 4.20%
XML 68 R52.htm IDEA: XBRL DOCUMENT v3.21.2
Leases - Maturities of Operating Lease Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Operating Lease Liabilities Payments Due [Abstract]    
For the remainder of 2021 $ 2,978  
For the year ended December 31, 2022 9,695  
For the year ended December 31, 2023 7,564  
For the year ended December 31, 2024 5,623  
For the year ended December 31, 2025 4,340  
For the year ended December 31, 2026 and beyond 8,104  
Total lease payments 38,304  
Less: imputed interest (4,349)  
Present value of lease liabilities $ 33,955 $ 37,971
XML 69 R53.htm IDEA: XBRL DOCUMENT v3.21.2
Restructuring and Related Activities - Narrative (Details)
 9 Months Ended
Sep. 30, 2021
People
Restructuring Cost and Reserve [Abstract]  
Restructuring And Related Cost Description The Company’s management approved a global restructuring plan (the “QH Program”) as part of its plan to realize certain cost synergies associated with the Combination in the third quarter of 2019. The QH Program includes restructuring and associated severance costs to reduce total headcount by approximately 400 people globally, as well as plans for the closure of certain manufacturing and non-manufacturing facilities. The exact timing and total costs associated with the QH Program will depend on a number of factors and is subject to change; however, the Company currently expects reduction in headcount and site closures to continue to occur throughout 2021 and into 2022 under the QH Program and estimates that anticipated cost synergies realized from the QH Program will approximate one-times the restructuring costs incurred. Employee separation benefits will vary depending on local regulations within certain foreign countries and will include severance and other benefits.
Restructuring And Related Cost Expected Number Of Positions Eliminated 400
XML 70 R54.htm IDEA: XBRL DOCUMENT v3.21.2
Restructuring and Related Activities (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Restructuring Reserve [Roll Forward]        
Restructuring and related charges $ (880) $ 1,383 $ 593 $ 3,585
QH Program [Member]        
Restructuring Reserve [Roll Forward]        
Accrued Restructuring, Beginning Balance     8,248  
Restructuring and related charges     593  
Cash Payments     (4,557)  
Currency Translation Adjustments     (234)  
Accrued Restructuring, Ending Balance $ 4,050   $ 4,050  
XML 71 R55.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Compensation - Narrative (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Share Based Compensation [Line Items]        
Share-based Compensation Expense $ 2,307,000 $ 10,147,000 $ 8,441,000 $ 17,820,000
Option Award Vesting Period     3 years  
Risk-free Interest Rate     60.00%  
Expected Term (Years)     4 years  
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross     25,250  
Employee Stock Option [Member]        
Share Based Compensation [Line Items]        
Unrecognized Compensation Expense, Options 2,100,000   $ 2,100,000  
Weighted Average Remaining Life, Nonvested Stock Awards     2 years 1 month 6 days  
Restricted Stock LTIP [Member]        
Share Based Compensation [Line Items]        
Option Award Vesting Period     3 years  
Nonvested Stock Awards Granted     17,692  
Unrecognized Share-based Compensation Expense, Nonvested Stock Award 5,100,000   $ 5,100,000  
Weighted Average Remaining Life, Nonvested Stock Awards     1 year 8 months 12 days  
Annual Incentive Plan [Member]        
Share Based Compensation [Line Items]        
Share-based Compensation Expense 0 7,102,000 $ 0 9,931,000
Restricted Stock Units (RSUs) LTIP Plan [Member]        
Share Based Compensation [Line Items]        
Nonvested Stock Awards Granted     2,791  
Unrecognized Share-based Compensation Expense, Nonvested Stock Award 900,000   $ 900,000  
Weighted Average Remaining Life, Nonvested Stock Awards     2 years  
Combination And Other Acquisition-Related [Member]        
Share Based Compensation [Line Items]        
Share-based Compensation Expense 200,000 400,000 $ 700,000 1,200,000
Performance Stock Units [Member]        
Share Based Compensation [Line Items]        
Share-based Compensation Expense 491,000 280,000 $ 1,327,000 560,000
Option Award Vesting Period     3 years  
Vesting Shares Target Lower Percent     0.00%  
Vesting Shares Target Upper Percent     200.00%  
Risk-free Interest Rate     0.29%  
Expected Term (Years)     3 years  
Unrecognized Share-based Compensation Expense, Nonvested Stock Award 3,700,000   $ 3,700,000  
Weighted Average Remaining Life, Nonvested Stock Awards     2 years 1 month 6 days  
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross     23,756  
Defined Contribution Plan [Member]        
Share Based Compensation [Line Items]        
Defined Contribution Plan Employer Matching Contribution Percent Of Match     50.00%  
Defined Contribution Plan, Employer Matching Contribution, Percent     6.00%  
Defined contribution plan employer matching contribution percent maximum     3.00%  
Defined contribution plan employer non-elective nondiscretionary contributions percent     3.00%  
Defined Contribution Plan Employer Discretionary Contribution Amount $ 0 $ 900,000 $ 1,500,000 $ 2,100,000
XML 72 R56.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Compensation - Share-based Compensation Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total share-based compensation expense $ 2,307 $ 10,147 $ 8,441 $ 17,820
Stock Options [Member]        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total share-based compensation expense 298 353 938 1,138
Non-vested stock awards and restricted stock units [Member]        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total share-based compensation expense 1,277 1,259 3,963 3,782
Non-elective and elective 401(k) matching contribution in stock [Member]        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total share-based compensation expense 0 910 1,553 2,072
Director stock ownership plan [Member]        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total share-based compensation expense 241 243 660 337
Performance Stock Units [Member]        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total share-based compensation expense 491 280 1,327 560
Annual Incentive Plan [Member]        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Total share-based compensation expense $ 0 $ 7,102 $ 0 $ 9,931
XML 73 R57.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Compensation - Black-Scholes Option Pricing Model (Details)
 9 Months Ended
Sep. 30, 2021
shares
Black-Scholes option pricing model  
Number of options granted 25,250
Dividend Yield 0.85%
Expected Volatility 37.33%
Risk-free Interest Rate 60.00%
Expected Term (Years) 4 years
XML 74 R58.htm IDEA: XBRL DOCUMENT v3.21.2
Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Pension Benefit [Member]        
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]        
Service Cost $ 289 $ 1,227 $ 921 $ 3,565
Interest Cost 1,078 1,527 3,262 4,782
Expected Return on Plan Assets (2,075) (3,526) (6,250) (7,246)
Settlement Loss 0 0 0 22,667
Actuarial Loss Amortization 737 626 2,449 2,288
Prior service cost amortization 3 (42) 8 (123)
Net Periodic Benefit Cost 32 (188) 390 25,933
Postretirement Benefits [Member]        
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]        
Service Cost (2) 2 1 5
Interest Cost (1) 25 20 77
Expected Return on Plan Assets 0 0 0 0
Settlement Loss 0 0 0 0
Actuarial Loss Amortization (85) 15 (85) 46
Prior service cost amortization 0 0 0 0
Net Periodic Benefit Cost $ (88) $ 42 $ (64) $ 128
XML 75 R59.htm IDEA: XBRL DOCUMENT v3.21.2
Pension and Other Postretirement Benefits - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Pension Plans, Defined Benefit [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit Plan, Contributions by Employer   $ 5.7  
Defined Benefit Plan, Estimated Future Employer Contributions in Current Fiscal Year   6.0  
Other Postretirement Benefit Plans Defined Benefit [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit Plan, Contributions by Employer   0.2  
Defined Benefit Plan, Estimated Future Employer Contributions in Current Fiscal Year   $ 1.0  
Defined benefit plan settlement [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Defined Benefit Plan, Contributions by Employer $ 1.8    
Defined Benefit Plan Premium Refund $ 1.6    
Defined Benefit Plan Effect Of Settlements And Curtailments On Accumulated Benefit Obligation     $ 22.7
XML 76 R60.htm IDEA: XBRL DOCUMENT v3.21.2
Other Income (Expense) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Other Income and Expenses [Abstract]        
Income from third party license fees $ 314 $ 190 $ 1,026 $ 702
Foreign exchange gains (losses), net 368 (1,897) (1,948) (3,080)
Gain (loss) on fixed asset disposals, net (537) (24) 4,819 (105)
Non-income tax refunds and other related credits 3 0 14,395 2,131
Pension and post retirement benefit costs, non-service components 343 1,375 596 (22,491)
Other Operating Income Expense Net 156 117 456 436
Total other income (expense), net $ 647 $ (239) $ 19,344 $ (22,407)
XML 77 R61.htm IDEA: XBRL DOCUMENT v3.21.2
Income Taxes and Uncertain Income Tax Positions - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Defered Tax Liabilties, Net $ 5.8   $ 5.8   $ 5.9
Unrecognized Tax Benefits 24.0   24.0    
Unrecognized Tax Benefits, Income Tax Penalties Accrued 3.5   3.5   3.9
Unrecognized Tax Benefits, Interest on Income Taxes Accrued 3.3   3.3   $ 3.0
Unrecognized Tax Benefits, Income Tax Penalties Expense (0.1) $ 0.1 0.2 $ 0.5  
Unrecognized Tax Benefits, Interest on Income Taxes Expense $ 0.2 $ 0.2 0.4 0.4  
Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations     $ 1.2 $ 1.9  
XML 78 R62.htm IDEA: XBRL DOCUMENT v3.21.2
Income Taxes and Uncertain Income Tax Positions 2 - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Income Taxes and Uncertain Tax Positions [Abstract]            
Effective Income Tax Rate, Continuing Operations 2.60% 8.10% 21.80% (38.30%)    
Unrecognized Tax Benefits, Interest on Income Taxes Expense $ 0.2 $ 0.2 $ 0.4 $ 0.4    
Accrued Interest 3.3   3.3     $ 3.0
Accrued Penalties 3.5   3.5     3.9
Unrecognized Tax Benefits, Income Tax Penalties Expense (0.1) $ 0.1 0.2 0.5    
Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations     1.2 $ 1.9    
Unrecognized Tax Benefits 24.0   24.0      
Income Tax Examination [Line Items]            
Deferred Tax Liabilities 5.8   5.8     $ 5.9
Unrecognized Tax Benefits Period Increase     $ 1.9      
Forecast [Member]            
Income Tax Examination [Line Items]            
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Upper Bound         $ 1.5  
Italy [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination Description     As previously reported, the Italian tax authorities have assessed additional tax due from the Company’s subsidiary, Quaker Italia S.r.l., relating to the tax years 2007 through 2015. The Company has filed for competent authority relief from these assessments under the Mutual Agreement Procedures (“MAP”) of the Organization for Economic Co-Operation and Development for all years except 2007. In 2020, the respective tax authorities in Italy, Spain and the Netherlands reached agreement with respect to the MAP proceedings which the Company has accepted.      
Germany [Member]            
Income Tax Examination [Line Items]            
Unrecognized Tax Benefits Reserve 0.9   $ 0.9      
Liability For Uncertain Tax Positions Noncurrent 0.8   0.8      
Germany [Member] | Houghton [Member]            
Income Tax Examination [Line Items]            
Indemnification assets 0.8   $ 0.8      
Internal Revenue Service (IRS) [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2018      
Foreign Tax Authority [Member] | The Netherlands [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2015      
Foreign Tax Authority [Member] | United Kingdom [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2016      
Foreign Tax Authority [Member] | Brazil [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2011      
Foreign Tax Authority [Member] | China [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2015      
Foreign Tax Authority [Member] | Italy [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2006      
Income Tax Examination Liability Refund Adjustment from Settlement with Taxing Authority 2.6   $ 2.6      
Foreign Tax Authority [Member] | Italy [Member] | Maximum [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2015      
Foreign Tax Authority [Member] | Italy [Member] | Minimum [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2007      
Foreign Tax Authority [Member] | Italy [Member] | Houghton [Member]            
Income Tax Examination [Line Items]            
Unrecognized Tax Benefits Reserve 6.0   $ 6.0      
Indemnification assets 5.4   $ 5.4      
Foreign Tax Authority [Member] | Italy [Member] | Houghton [Member] | Maximum [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2018      
Foreign Tax Authority [Member] | Italy [Member] | Houghton [Member] | Minimum [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2014      
Foreign Tax Authority [Member] | Mexico [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2016      
Foreign Tax Authority [Member] | India [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2019      
Foreign Tax Authority [Member] | Germany [Member] | Houghton [Member] | Maximum [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2017      
Foreign Tax Authority [Member] | Germany [Member] | Houghton [Member] | Minimum [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2015      
Foreign Tax Authority [Member] | Netherlands and Spain [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination Liability Refund Adjustment from Settlement with Taxing Authority $ (1.6)   $ (1.6)      
State and Local Jurisdiction [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2011      
State and Local Jurisdiction [Member] | Canada [Member]            
Income Tax Examination [Line Items]            
Income Tax Examination, Year under Examination     2018      
XML 79 R63.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings Per Share - Earnings per Share Calculations Basic (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Earnings Per Share [Abstract]        
Net income (loss) attributable to Quaker Chemical Corporation $ 31,058 $ 27,304 $ 103,243 $ (8,812)
Less: (income) loss allocated to participating securities (119) (113) (413) 44
Net income (loss) available to common shareholders $ 30,939 $ 27,191 $ 102,830 $ (8,768)
Basic weighted average common shares outstanding 17,812,216 17,743,538 17,800,082 17,704,662
Basic earnings (loss) per common share $ 1.74 $ 1.53 $ 5.78 $ (0.50)
XML 80 R64.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings Per Share - Earnings per Share Calculations Diluted (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Earnings Per Share [Abstract]        
Net income (loss) attributable to Quaker Chemical Corporation $ 31,058 $ 27,304 $ 103,243 $ (8,812)
Less: income allocated to participating securities (119) (113) (412) 44
Net income (loss) available to common shareholders $ 30,939 $ 27,191 $ 102,831 $ (8,768)
Basic weighted average common shares outstanding 17,812,216 17,743,538 17,800,082 17,704,662
Effect of Dilutive Securities 58,176 57,327 59,986 0
Diluted weighted average common shares outstanding 17,870,392 17,800,865 17,860,068 17,704,662
Diluted earnings (loss) per common share $ 1.73 $ 1.53 $ 5.76 $ (0.50)
XML 81 R65.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings Per Share - Earnings per Share Calculations Antidilutive Shares (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Business Acquisition [Line Items]      
Antidilutive Shares 5,531 0 3,722
XML 82 R66.htm IDEA: XBRL DOCUMENT v3.21.2
Restricted Cash (Details) - USD ($)
$ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Restricted Cash Abstract]        
Cash and cash equivalents $ 141,393 $ 155,750 $ 181,833 $ 123,524
Restricted cash included in other current assets 0 82 62 353
Restricted cash included in other assets 0 18,901 0 19,678
Cash cash equivalents restricted cash and restricted cash equivalents $ 141,393 174,733 181,895 $ 143,555
Loss Contingency, Settlement Agreement, Terms Prior to December 2020, the Company had restricted cash recorded in other assets related to proceeds from an inactive subsidiary of the Company which previously executed separate settlement and release agreements with two of its insurance carriers for an original total value of $35.0 million.      
Proceeds Of Settlement And Release Agreements     $ 35,000  
Payments Of Settlement and Release Agreements   800    
Interest Income Other   $ 100    
XML 83 R67.htm IDEA: XBRL DOCUMENT v3.21.2
Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
USD ($)
Goodwill Roll Forward  
Goodwill, Beginning Balance $ 631,212
Goodwill Additions 7,093
Currency translation and other adjustments (7,636)
Goodwill, Ending Balance 630,669
Operating Segments [Member] | Global Specialty Businesses [Member]  
Goodwill Roll Forward  
Goodwill, Beginning Balance 119,718
Goodwill Additions 1,951
Currency translation and other adjustments (2,594)
Goodwill, Ending Balance 119,075
Operating Segments [Member] | Americas [Member]  
Goodwill Roll Forward  
Goodwill, Beginning Balance 213,242
Goodwill Additions 1,208
Currency translation and other adjustments (621)
Goodwill, Ending Balance 213,829
Operating Segments [Member] | EMEA [Member]  
Goodwill Roll Forward  
Goodwill, Beginning Balance 140,162
Goodwill Additions 2,626
Currency translation and other adjustments (5,530)
Goodwill, Ending Balance 137,258
Operating Segments [Member] | Asia Pacific [Member]  
Goodwill Roll Forward  
Goodwill, Beginning Balance 158,090
Goodwill Additions 1,308
Currency translation and other adjustments 1,109
Goodwill, Ending Balance $ 160,507
XML 84 R68.htm IDEA: XBRL DOCUMENT v3.21.2
Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Finite Lived Intangible Assets Gross [Abstract]          
Amortization $ 14,900 $ 14,000 $ 44,700 $ 41,700  
Finite-Lived Intangible Assets [Line Items]          
Gross Carrying Amount 1,021,916   1,021,916   $ 1,012,371
Accumumlated Amortization 178,328   178,328   136,113
Customer lists and rights to sell [Member]          
Finite-Lived Intangible Assets [Line Items]          
Gross Carrying Amount 847,909   847,909   839,551
Accumumlated Amortization 135,571   135,571   99,806
Trademarks Formulations And Product Technology [Member]          
Finite-Lived Intangible Assets [Line Items]          
Gross Carrying Amount 167,682   167,682   166,448
Accumumlated Amortization 36,871   36,871   30,483
Other Intangible Assets [Member]          
Finite-Lived Intangible Assets [Line Items]          
Gross Carrying Amount 6,325   6,325   6,372
Accumumlated Amortization $ 5,886   $ 5,886   $ 5,824
XML 85 R69.htm IDEA: XBRL DOCUMENT v3.21.2
Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details)
$ in Thousands
Sep. 30, 2021
USD ($)
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]  
For the year ended December 31, 2021 $ 58,852
For the Year ended December 31, 2022 59,173
For the Year ended December 31, 2023 59,005
For the Year ended December 31, 2024 58,338
For the Year ended December 31, 2025 57,653
For the Year ended December 31, 2026 $ 57,346
XML 86 R70.htm IDEA: XBRL DOCUMENT v3.21.2
Intangible Assets - Indefinite Lived (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Mar. 31, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]              
Indefinite lived intangible assets $ 205,100       $ 205,100   $ 205,100
Indefinite-lived intangible asset impairment 0   $ 0 $ 38,000 0 $ 38,000  
Houghton Combination [Member]              
Finite-Lived Intangible Assets [Line Items]              
Indefinite Lived Trademarks $ 204,000       $ 204,000   $ 204,000
Indefinite-lived intangible asset impairment   $ 38,000          
XML 87 R71.htm IDEA: XBRL DOCUMENT v3.21.2
Debt - Table (Details) - USD ($)
$ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Debt Instrument [Line Items]    
Total debt $ 900,662 $ 899,134
Less: debt issuance costs (8,776) (11,099)
Less: short-term and current portion of long-term debts (52,611) (38,967)
Total long-term debt $ 839,275 $ 849,068
Revolver [Member]    
Debt Instrument [Line Items]    
Interest Rate 1.58% 1.65%
Total debt $ 198,543 $ 160,000
U.S. Term Loan [Member]    
Debt Instrument [Line Items]    
Interest Rate 1.58% 1.65%
Total debt $ 547,500 $ 570,000
EURO Term Loan [Member]    
Debt Instrument [Line Items]    
Interest Rate 1.50% 1.50%
Total debt $ 142,559 $ 157,062
Industrial development bonds [Member]    
Debt Instrument [Line Items]    
Interest Rate 5.26% 5.26%
Total debt $ 10,000 $ 10,000
Bank lines of credit and other debt obligations [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Interest Rate Terms Various Various
Total debt $ 2,060 $ 2,072
XML 88 R72.htm IDEA: XBRL DOCUMENT v3.21.2
Debt - Debt related expenses included within Interest expense (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Debt related expenses included within Interest expense:        
Interest Expense, Debt $ 4,779 $ 5,957 $ 14,242 $ 19,621
Amortization of debt issuance costs 1,187 1,188 3,562 3,562
Total $ 5,966 $ 7,145 $ 17,804 $ 23,183
XML 89 R73.htm IDEA: XBRL DOCUMENT v3.21.2
Debt - Narrative (Details) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Nov. 30, 2019
Debt Instrument [Line Items]      
Letters Of Credit Outstanding Amount $ 4.0    
Initial consolidated net debt to consolidated EBITDA ratio 4.25    
Consolidated adjusted EBITDA to interest expense ratio 3.0    
Maximum annual cash dividends restriction based on covenants $ 50.0    
Percentage of cash dividends of consolidated adjusted EBITDA 20.00%    
Debt Issuance Costs, Current, Net $ 8.8 $ 11.1  
Deferred Finance Costs Noncurrent Gross 23.7    
Line of Credit Facility, Remaining Borrowing Capacity $ 300.0    
Line of Credit Facility, Covenant Compliance As of September 30, 2021 and December 31, 2020, the Company was in compliance with all of the Credit Facility covenants.    
Line of Credit Facility, Covenant Terms The Credit Facility is subject to certain financial and other covenants. The Company’s initial consolidated net debt to consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit Facility.    
Other off balance sheet arrangements In addition to the bank letters of credit described in the “Credit facilities” subsection above, the Company’s only other off-balance sheet arrangements include certain financial and other guarantees. The Company’s total bank letters of credit and guarantees outstanding as of September 30, 2021 were approximately $7 million.    
Other Assets [Member]      
Debt Instrument [Line Items]      
Debt Issuance Costs, Current, Net $ 4.7 5.9  
Maximum [Member]      
Debt Instrument [Line Items]      
Net debt to consolidated adjusted EBITDA ratio 4.00    
Minimum [Member]      
Debt Instrument [Line Items]      
Net debt to consolidated adjusted EBITDA ratio 2.0    
Interest Rate Swap [Member]      
Debt Instrument [Line Items]      
Derivative Liability Notional Amount     $ 170.0
New Credit facility [Member]      
Debt Instrument [Line Items]      
Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate 1.60%    
U.S. Term Loan [Member]      
Debt Instrument [Line Items]      
Line of Credit Facility, Current Borrowing Capacity $ 600.0    
EURO Term Loan [Member]      
Debt Instrument [Line Items]      
Line of Credit Facility, Current Borrowing Capacity $ 150.0    
Term loan [Member]      
Debt Instrument [Line Items]      
Percentage of term loan principal amortization year one and two 5.00%    
Percentage of term loan principal amortization year three 7.50%    
Percentage of term loan principal amortization year four and five 10.00%    
Percentage of term loan borrowings 20.00%    
Derivative Liability Notional Amount     $ 170.0
Derivative Fixed Interest Rate 3.10%    
Derivative, Basis Spread on Variable Rate     1.64%
Payments of long-term debt $ 28.6    
Deferred Finance Costs Noncurrent Gross $ 15.5    
Long Term Debt Term 5 years    
The Revolver [Member]      
Debt Instrument [Line Items]      
Debt Instrument, Unused Borrowing Capacity, Amount $ 197.0    
Deferred Finance Costs Noncurrent Gross 8.3    
Line of Credit Facility, Current Borrowing Capacity $ 400.0    
Long Term Debt Term 5 years    
The Revolver [Member] | Maximum [Member]      
Debt Instrument [Line Items]      
Line of Credit Facility, Commitment Fee Percentage 0.30%    
The Revolver [Member] | Minimum [Member]      
Debt Instrument [Line Items]      
Line of Credit Facility, Commitment Fee Percentage 0.20%    
Industrial Development Bond Due 2028 [Member]      
Debt Instrument [Line Items]      
Debt Instrument Maturity Date Description 2028    
Industrial Development Revenue Bond $ 10.0 $ 10.0  
Bank lines of credit and other debt obligations [Member]      
Debt Instrument [Line Items]      
Letters Of Credit Outstanding Amount 7.0    
Line of Credit Facility, Remaining Borrowing Capacity $ 39.0    
XML 90 R74.htm IDEA: XBRL DOCUMENT v3.21.2
Equity - Changes in Equity (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Beginning Balance $ 1,375,401 $ 1,167,341 $ 1,320,914 $ 1,242,366
Net income (loss) 31,073 27,342 103,305 (8,724)
Amounts reported in other comprehensive income (loss) (18,780) 34,271 (28,119) 3,046
Dividends (7,424) (7,048) (21,548) (20,735)
Acquisition of noncontrolling interest       (1,047)
Distributions to noncontrolling affiliate shareholders       (751)
Share issuance and equity-based compensation plans 3,426 4,525 9,144 13,187
Ending Balance 1,383,696 1,226,431 1,383,696 1,226,431
Cumulative Effect, Period of Adoption, Adjustment [Member]        
Beginning Balance       (911)
Adjusted Balance [Member]        
Beginning Balance       1,241,455
Common Stock [Member]        
Beginning Balance 17,878 17,800 17,851 17,735
Net income (loss) 0 0 0 0
Amounts reported in other comprehensive income (loss) 0 0 0 0
Dividends 0 0 0 0
Acquisition of noncontrolling interest       0
Distributions to noncontrolling affiliate shareholders       0
Share issuance and equity-based compensation plans 11 31 38 96
Ending Balance 17,889 17,831 17,889 17,831
Common Stock [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]        
Beginning Balance       0
Common Stock [Member] | Adjusted Balance [Member]        
Beginning Balance       17,735
Capital in Excess of Par Value [Member]        
Beginning Balance 910,862 896,108 905,171 888,218
Net income (loss) 0 0 0 0
Amounts reported in other comprehensive income (loss) 0 0 0 0
Dividends 0 0 0 0
Acquisition of noncontrolling interest       (707)
Distributions to noncontrolling affiliate shareholders       0
Share issuance and equity-based compensation plans 3,415 4,494 9,106 13,091
Ending Balance 914,277 900,602 914,277 900,602
Capital in Excess of Par Value [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]        
Beginning Balance       0
Capital in Excess of Par Value [Member] | Adjusted Balance [Member]        
Beginning Balance       888,218
Retained Earnings [Member]        
Beginning Balance 482,001 362,265 423,940 412,979
Net income (loss) 31,058 27,304 103,243 (8,812)
Amounts reported in other comprehensive income (loss) 0 0 0 0
Dividends (7,424) (7,048) (21,548) (20,735)
Acquisition of noncontrolling interest       0
Distributions to noncontrolling affiliate shareholders       0
Share issuance and equity-based compensation plans 0 0 0 0
Ending Balance 505,635 382,521 505,635 382,521
Retained Earnings [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]        
Beginning Balance       (911)
Retained Earnings [Member] | Adjusted Balance [Member]        
Beginning Balance       412,068
Accumulated Other Comprehensive Income (Loss) [Member]        
Beginning Balance (35,943) (109,264) (26,598) (78,170)
Net income (loss) 0 0 0 0
Amounts reported in other comprehensive income (loss) (18,780) 34,254 (28,125) 3,160
Dividends 0 0 0 0
Acquisition of noncontrolling interest       0
Distributions to noncontrolling affiliate shareholders       0
Share issuance and equity-based compensation plans 0 0 0 0
Ending Balance (54,723) (75,010) (54,723) (75,010)
Accumulated Other Comprehensive Income (Loss) [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]        
Beginning Balance       0
Accumulated Other Comprehensive Income (Loss) [Member] | Adjusted Balance [Member]        
Beginning Balance       (78,170)
Noncontrolling Interest [Member]        
Beginning Balance 603 432 550 1,604
Net income (loss) 15 38 62 88
Amounts reported in other comprehensive income (loss) 0 17 6 (114)
Dividends 0 0 0 0
Acquisition of noncontrolling interest       (340)
Distributions to noncontrolling affiliate shareholders       (751)
Share issuance and equity-based compensation plans 0 0 0 0
Ending Balance $ 618 $ 487 $ 618 487
Noncontrolling Interest [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]        
Beginning Balance       0
Noncontrolling Interest [Member] | Adjusted Balance [Member]        
Beginning Balance       $ 1,604
XML 91 R75.htm IDEA: XBRL DOCUMENT v3.21.2
Equity - Changes in Equity (Parentheticals) (Details) - $ / shares
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Consolidated Statement Of Changes In Equity Parentheticals [Abstract]        
Dividends declared $ 0.415 $ 0.395 $ 1.205 $ 1.165
XML 92 R76.htm IDEA: XBRL DOCUMENT v3.21.2
Equity - AOCI Reclassifications (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Beginning Balance $ (35,943) $ (109,264) $ (26,598) $ (78,170)
Other Comprehensive (Loss) Income, before reclassifications (18,935) 33,970 (26,804) (14,930)
Amounts Reclassed from AOCI 533 480 (836) 25,321
Related Tax Amounts (378) (196) (485) (7,231)
Ending Balance (54,723) (75,010) (54,723) (75,010)
Currency Translation Adjustments [Member]        
Beginning Balance (12,177) (88,637) (2,875) (44,568)
Other Comprehensive (Loss) Income, before reclassifications (19,905) 33,601 (29,207) (10,468)
Amounts Reclassed from AOCI 0 0 0 0
Related Tax Amounts 0 0 0 0
Ending Balance (32,082) (55,036) (32,082) (55,036)
Defined Benefit Pension Plans [Member]        
Beginning Balance (21,778) (17,363) (23,467) (34,533)
Other Comprehensive (Loss) Income, before reclassifications 488 (901) 1,009 (409)
Amounts Reclassed from AOCI 709 584 2,423 25,550
Related Tax Amounts (293) 60 (839) (8,228)
Ending Balance (20,874) (17,620) (20,874) (17,620)
Unrealized Gain (Loss) in Available-for-Sale Securities [Member]        
Beginning Balance 596 1,148 3,342 1,251
Other Comprehensive (Loss) Income, before reclassifications (85) 810 (489) 802
Amounts Reclassed from AOCI (176) (104) (3,259) (229)
Related Tax Amounts 46 (150) 787 (120)
Ending Balance 381 1,704 381 1,704
Derivative Instruments        
Beginning Balance (2,584) (4,412) (3,598) (320)
Other Comprehensive (Loss) Income, before reclassifications 567 460 1,883 (4,855)
Amounts Reclassed from AOCI 0 0 0 0
Related Tax Amounts (131) (106) (433) 1,117
Ending Balance $ (2,148) $ (4,058) $ (2,148) $ (4,058)
XML 93 R77.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements - Assets Subject to Fair Value Measurement (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Company Owned Life Insurance $ 2,135 $ 1,961
Assets Fair Value Disclosure 2,135 1,961
Level 1 [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Company Owned Life Insurance 0 0
Assets Fair Value Disclosure 0 0
Level 2 [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Company Owned Life Insurance 2,135 1,961
Assets Fair Value Disclosure 2,135 1,961
Level 3 [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Company Owned Life Insurance 0 0
Assets Fair Value Disclosure $ 0 $ 0
XML 94 R78.htm IDEA: XBRL DOCUMENT v3.21.2
Hedging Activities - Narrative (Details) - Interest Rate Swap [Member] - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2021
Nov. 30, 2019
Derivatives, Fair Value [Line Items]    
Derivative Liability Notional Amount   $ 170
Derivative, Term of Contract 3 years  
XML 95 R79.htm IDEA: XBRL DOCUMENT v3.21.2
Hedging Activities - Balance Sheet Classification and Fair Values (Details) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Derivative Instruments Gain Loss [Line Items]          
Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net     $ 2,148,000   $ 3,598,000
Interest Rate Cash Flow Hedge Liability At Fair Value $ 2,789,000   2,789,000   4,672,000
Interest Expense [Member]          
Derivative Instruments Gain Loss [Line Items]          
Amount and location of expense reclassified from AOCI into expense (effective portion) (672,000) $ (640,000) (1,974,000) $ (1,105,000)  
Other Noncurrent Liabilities [Member]          
Derivative Instruments Gain Loss [Line Items]          
Interest Rate Cash Flow Hedge Liability At Fair Value $ 2,789,000   2,789,000   4,672,000
Interest Rate Swap [Member]          
Derivative Instruments Gain Loss [Line Items]          
Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net     $ 2,148,000   $ 3,598,000
XML 96 R80.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies - Narrative (Details)
$ in Thousands, R$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2021
BRL (R$)
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
Loss Contingencies [Line Items]            
Loss Contingency Accrual At Carrying Value $ 300     $ 300   $ 100
Interest Income Other         $ 100  
Income Tax Expense (Benefit) 795 $ 2,245   26,702 $ (7,603)  
ACP [Member] | Maximum [Member]            
Loss Contingencies [Line Items]            
Loss Contingency, Estimate of Possible Loss 1,000     1,000    
ACP [Member] | Minimum [Member]            
Loss Contingencies [Line Items]            
Loss Contingency, Estimate of Possible Loss 100     100    
SB Decking [Member]            
Loss Contingencies [Line Items]            
Loss Contingency, Estimate of Possible Loss 400     400    
Houghton Combination [Member]            
Loss Contingencies [Line Items]            
Loss Contingency, Estimate of Possible Loss 5,700     5,700   $ 6,000
Houghton environmental matters [Member] | Maximum [Member]            
Loss Contingencies [Line Items]            
Loss Contingency, Estimate of Possible Loss 6,500     6,500    
Houghton environmental matters [Member] | Minimum [Member]            
Loss Contingencies [Line Items]            
Loss Contingency, Estimate of Possible Loss 5,500     5,500    
Foreign Consumption Tax [Member]            
Loss Contingencies [Line Items]            
(Reversal) of previously recorded liability of best estimate of indirect tax owed (1,800)          
(Reversal) of indemnification receivable (1,100)          
Brazilian Indirect Taxes [Member]            
Loss Contingencies [Line Items]            
Gain (Loss) Related To Litigation Settlement     R$ 67 13,300    
Interest Income Other       4,900    
Income Tax Expense (Benefit)       (8,400)    
Insurance claim [Member]            
Loss Contingencies [Line Items]            
Gain (Loss) Related To Litigation Settlement       1,000    
Proceeds from Insurance Settlement, Operating Activities       1,700    
Insurance Settlements Receivable $ 2,000     $ 2,000    
EXCEL 97 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 99 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 100 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 435 429 1 false 103 0 false 12 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 000200 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations Statements 2 false false R3.htm 000300 - Statement - Condensed Consolidated Statements of Comprehensive Income Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome Condensed Consolidated Statements of Comprehensive Income Statements 3 false false R4.htm 000400 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 4 false false R5.htm 000450 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 5 false false R6.htm 000500 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 010110 - Disclosure - Basis of Presentation and Description of Business Sheet http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusiness Basis of Presentation and Description of Business Notes 7 false false R8.htm 010210 - Disclosure - Business Acquisitions Sheet http://www.quakerchem.com/role/BusinessAcquisitions Business Acquisitions Notes 8 false false R9.htm 010310 - Disclosure - Recently Issued Accounting Standards Sheet http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards Recently Issued Accounting Standards Notes 9 false false R10.htm 010409 - Disclosure - Business Segments Sheet http://www.quakerchem.com/role/BusinessSegments Business Segments Notes 10 false false R11.htm 010410 - Disclosure - Net Sales and Revenue Recognition Sheet http://www.quakerchem.com/role/NetSalesAndRevenueRecognition Net Sales and Revenue Recognition Notes 11 false false R12.htm 010508 - Disclosure - Leases Sheet http://www.quakerchem.com/role/Leases Leases Notes 12 false false R13.htm 010640 - Disclosure - Restructuring and Related Activities Sheet http://www.quakerchem.com/role/RestructuringAndRelatedActivities Restructuring and Related Activities Notes 13 false false R14.htm 010710 - Disclosure - Share-Based Compensation Sheet http://www.quakerchem.com/role/ShareBasedCompensation Share-Based Compensation Notes 14 false false R15.htm 010750 - Disclosure - Pension and Postretirement Benefits Sheet http://www.quakerchem.com/role/PensionAndPostretirementBenefits Pension and Postretirement Benefits Notes 15 false false R16.htm 010810 - Disclosure - Other Income (Expense) Sheet http://www.quakerchem.com/role/OtherIncomeExpense Other Income (Expense) Notes 16 false false R17.htm 010910 - Disclosure - Income Taxes and Uncertain Income Tax Positions Sheet http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions Income Taxes and Uncertain Income Tax Positions Notes 17 false false R18.htm 011010 - Disclosure - Earnings Per Share Sheet http://www.quakerchem.com/role/EarningsPerShare Earnings Per Share Notes 18 false false R19.htm 011118 - Disclosure - Restricted Cash Sheet http://www.quakerchem.com/role/RestrictedCash Restricted Cash Notes 19 false false R20.htm 011510 - Disclosure - Goodwill and Intangible Assets Sheet http://www.quakerchem.com/role/GoodwillAndIntangibleAssets Goodwill and Intangible Assets Notes 20 false false R21.htm 011910 - Disclosure - Debt Sheet http://www.quakerchem.com/role/Debt Debt Notes 21 false false R22.htm 012210 - Disclosure - Equity Sheet http://www.quakerchem.com/role/Equity Equity Notes 22 false false R23.htm 012410 - Disclosure - Fair Value Measurements Sheet http://www.quakerchem.com/role/FairValueMeasurements Fair Value Measurements Notes 23 false false R24.htm 012415 - Disclosure - Hedging Activities Sheet http://www.quakerchem.com/role/HedgingActivities Hedging Activities Notes 24 false false R25.htm 012510 - Disclosure - Commitments and Contingencies Sheet http://www.quakerchem.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 25 false false R26.htm 020001 - Disclosure - Basis of Presentation and Description of Business (Policies) Sheet http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies Basis of Presentation and Description of Business (Policies) Policies http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards 26 false false R27.htm 030303 - Disclosure - Business Acquisitions (Tables) Sheet http://www.quakerchem.com/role/BusinessAcquisitionsTables Business Acquisitions (Tables) Tables http://www.quakerchem.com/role/BusinessAcquisitions 27 false false R28.htm 030410 - Disclosure - Business Segments (Tables) Sheet http://www.quakerchem.com/role/BusinessSegmentsTables Business Segments (Tables) Tables http://www.quakerchem.com/role/BusinessSegments 28 false false R29.htm 030510 - Disclosure - Net Sales and Revenue Recognition (Tables) Sheet http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionTables Net Sales and Revenue Recognition (Tables) Tables http://www.quakerchem.com/role/NetSalesAndRevenueRecognition 29 false false R30.htm 030609 - Disclosure - Leases (Tables) Sheet http://www.quakerchem.com/role/LeasesTables Leases (Tables) Tables http://www.quakerchem.com/role/Leases 30 false false R31.htm 030610 - Disclosure - Restructuring and Related Activities (Tables) Sheet http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesTables Restructuring and Related Activities (Tables) Tables http://www.quakerchem.com/role/RestructuringAndRelatedActivities 31 false false R32.htm 030710 - Disclosure - Share Based Compensation (Tables) Sheet http://www.quakerchem.com/role/ShareBasedCompensationTables Share Based Compensation (Tables) Tables 32 false false R33.htm 030750 - Disclosure - Pension and Other Post Retirement Benefits (Tables) Sheet http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables Pension and Other Post Retirement Benefits (Tables) Tables 33 false false R34.htm 030810 - Disclosure - Other Income (Expense) (Tables) Sheet http://www.quakerchem.com/role/OtherIncomeExpenseTables Other Income (Expense) (Tables) Tables http://www.quakerchem.com/role/OtherIncomeExpense 34 false false R35.htm 031010 - Disclosure - Earnings Per Share (Tables) Sheet http://www.quakerchem.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.quakerchem.com/role/EarningsPerShare 35 false false R36.htm 031110 - Disclosure - Restricted Cash (Tables) Sheet http://www.quakerchem.com/role/RestrictedCashTables Restricted Cash (Tables) Tables http://www.quakerchem.com/role/RestrictedCash 36 false false R37.htm 031510 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.quakerchem.com/role/GoodwillAndIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://www.quakerchem.com/role/GoodwillAndIntangibleAssets 37 false false R38.htm 031750 - Disclosure - Debt (Tables) Sheet http://www.quakerchem.com/role/DebtTables Debt (Tables) Tables http://www.quakerchem.com/role/Debt 38 false false R39.htm 032211 - Disclosure - Equity (Tables) Sheet http://www.quakerchem.com/role/EquityTables Equity (Tables) Tables http://www.quakerchem.com/role/Equity 39 false false R40.htm 032410 - Disclosure - Fair Value Measurements (Table) Sheet http://www.quakerchem.com/role/FairValueMeasurementsTable Fair Value Measurements (Table) Tables http://www.quakerchem.com/role/FairValueMeasurements 40 false false R41.htm 032411 - Disclosure - Hedging Activities (Tables) Sheet http://www.quakerchem.com/role/HedgingActivitiesTables Hedging Activities (Tables) Tables http://www.quakerchem.com/role/HedgingActivities 41 false false R42.htm 040010 - Disclosure - Basis of Presentation and Description of Business (Details) Sheet http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails Basis of Presentation and Description of Business (Details) Details http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies 42 false false R43.htm 040214 - Disclosure - Business Acquisitions - Narrative (Details) Sheet http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails Business Acquisitions - Narrative (Details) Details 43 false false R44.htm 040215 - Disclosure - Business Acquisitions - Preliminary Estimated Fair Values of Coral Net Assets Acquired (Details) Sheet http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails Business Acquisitions - Preliminary Estimated Fair Values of Coral Net Assets Acquired (Details) Details 44 false false R45.htm 040216 - Disclosure - Business Acquisitions - Coral - Narrative (Details) Sheet http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails Business Acquisitions - Coral - Narrative (Details) Details 45 false false R46.htm 040314 - Disclosure - Business Segments - Narrative (Details) Sheet http://www.quakerchem.com/role/BusinessSegmentsNarrativeDetails Business Segments - Narrative (Details) Details 46 false false R47.htm 040315 - Disclosure - Business Segments - Performance of reportable segments (Details) Sheet http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails Business Segments - Performance of reportable segments (Details) Details 47 false false R48.htm 040410 - Disclosure - Net Sales and Revenue Recognition - Narrative (Details) Sheet http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails Net Sales and Revenue Recognition - Narrative (Details) Details 48 false false R49.htm 040412 - Disclosure - Net Sales and Revenue Recognition (Details) Sheet http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails Net Sales and Revenue Recognition (Details) Details http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionTables 49 false false R50.htm 040415 - Disclosure - Leases - Narrative (Details) Sheet http://www.quakerchem.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 50 false false R51.htm 040416 - Disclosure - Leases - Supplemental Balance Sheet Information (Details) Sheet http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails Leases - Supplemental Balance Sheet Information (Details) Details 51 false false R52.htm 040417 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details) Sheet http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails Leases - Maturities of Operating Lease Liabilities (Details) Details 52 false false R53.htm 040640 - Disclosure - Restructuring and Related Activities - Narrative (Details) Sheet http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails Restructuring and Related Activities - Narrative (Details) Details 53 false false R54.htm 040650 - Disclosure - Restructuring and Related Activities (Details) Sheet http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails Restructuring and Related Activities (Details) Details http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesTables 54 false false R55.htm 040710 - Disclosure - Share-Based Compensation - Narrative (Details) Sheet http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails Share-Based Compensation - Narrative (Details) Details 55 false false R56.htm 040720 - Disclosure - Share-Based Compensation - Share-based Compensation Expense (Details) Sheet http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails Share-Based Compensation - Share-based Compensation Expense (Details) Details 56 false false R57.htm 040760 - Disclosure - Share-Based Compensation - Black-Scholes Option Pricing Model (Details) Sheet http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails Share-Based Compensation - Black-Scholes Option Pricing Model (Details) Details 57 false false R58.htm 040815 - Disclosure - Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details) Sheet http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details) Details 58 false false R59.htm 040860 - Disclosure - Pension and Other Postretirement Benefits - Narrative (Details) Sheet http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails Pension and Other Postretirement Benefits - Narrative (Details) Details 59 false false R60.htm 040900 - Disclosure - Other Income (Expense) (Details) Sheet http://www.quakerchem.com/role/OtherIncomeExpenseDetails Other Income (Expense) (Details) Details http://www.quakerchem.com/role/OtherIncomeExpenseTables 60 false false R61.htm 040960 - Disclosure - Income Taxes and Uncertain Income Tax Positions - Narrative (Details) Sheet http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails Income Taxes and Uncertain Income Tax Positions - Narrative (Details) Details 61 false false R62.htm 040970 - Disclosure - Income Taxes and Uncertain Income Tax Positions 2 - Narrative (Details) Sheet http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails Income Taxes and Uncertain Income Tax Positions 2 - Narrative (Details) Details 62 false false R63.htm 041010 - Disclosure - Earnings Per Share - Earnings per Share Calculations Basic (Details) Sheet http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails Earnings Per Share - Earnings per Share Calculations Basic (Details) Details 63 false false R64.htm 041020 - Disclosure - Earnings Per Share - Earnings per Share Calculations Diluted (Details) Sheet http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails Earnings Per Share - Earnings per Share Calculations Diluted (Details) Details 64 false false R65.htm 041030 - Disclosure - Earnings Per Share - Earnings per Share Calculations Antidilutive Shares (Details) Sheet http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsAntidilutiveSharesDetails Earnings Per Share - Earnings per Share Calculations Antidilutive Shares (Details) Details 65 false false R66.htm 041110 - Disclosure - Restricted Cash (Details) Sheet http://www.quakerchem.com/role/RestrictedCashDetails Restricted Cash (Details) Details http://www.quakerchem.com/role/RestrictedCashTables 66 false false R67.htm 041510 - Disclosure - Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details) Sheet http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details) Details 67 false false R68.htm 041520 - Disclosure - Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details) Sheet http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details) Details 68 false false R69.htm 041540 - Disclosure - Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details) Sheet http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details) Details 69 false false R70.htm 041550 - Disclosure - Intangible Assets - Indefinite Lived (Details) Sheet http://www.quakerchem.com/role/IntangibleAssetsIndefiniteLivedDetails Intangible Assets - Indefinite Lived (Details) Details 70 false false R71.htm 041910 - Disclosure - Debt - Table (Details) Sheet http://www.quakerchem.com/role/DebtTableDetails Debt - Table (Details) Details 71 false false R72.htm 041950 - Disclosure - Debt - Debt related expenses included within Interest expense (Details) Sheet http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails Debt - Debt related expenses included within Interest expense (Details) Details 72 false false R73.htm 041960 - Disclosure - Debt - Narrative (Details) Sheet http://www.quakerchem.com/role/DebtNarrativeDetails Debt - Narrative (Details) Details 73 false false R74.htm 042211 - Disclosure - Equity - Changes in Equity (Details) Sheet http://www.quakerchem.com/role/EquityChangesInEquityDetails Equity - Changes in Equity (Details) Details 74 false false R75.htm 042212 - Disclosure - Equity - Changes in Equity (Parentheticals) (Details) Sheet http://www.quakerchem.com/role/EquityChangesInEquityParentheticalsDetails Equity - Changes in Equity (Parentheticals) (Details) Details 75 false false R76.htm 042220 - Disclosure - Equity - AOCI Reclassifications (Details) Sheet http://www.quakerchem.com/role/EquityAOCIReclassificationsDetails Equity - AOCI Reclassifications (Details) Details 76 false false R77.htm 042410 - Disclosure - Fair Value Measurements - Assets Subject to Fair Value Measurement (Details) Sheet http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails Fair Value Measurements - Assets Subject to Fair Value Measurement (Details) Details 77 false false R78.htm 042504 - Disclosure - Hedging Activities - Narrative (Details) Sheet http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails Hedging Activities - Narrative (Details) Details 78 false false R79.htm 042505 - Disclosure - Hedging Activities - Balance Sheet Classification and Fair Values (Details) Sheet http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails Hedging Activities - Balance Sheet Classification and Fair Values (Details) Details 79 false false R80.htm 042510 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 80 false false All Reports Book All Reports kwr20210930.htm exhibit101.htm exhibit102.htm exhibit103.htm exhibit311.htm exhibit312.htm exhibit321.htm exhibit322.htm kwr-20210930.xsd kwr-20210930_cal.xml kwr-20210930_def.xml kwr-20210930_lab.xml kwr-20210930_pre.xml http://fasb.org/srt/2021-01-31 http://xbrl.sec.gov/country/2021 http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021 true true JSON 103 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "kwr20210930.htm": { "axisCustom": 0, "axisStandard": 29, "contextCount": 435, "dts": { "calculationLink": { "local": [ "kwr-20210930_cal.xml" ] }, "definitionLink": { "local": [ "kwr-20210930_def.xml" ] }, "inline": { "local": [ "kwr20210930.htm" ] }, "labelLink": { "local": [ "kwr-20210930_lab.xml" ] }, "presentationLink": { "local": [ "kwr-20210930_pre.xml" ] }, "schema": { "local": [ "kwr-20210930.xsd" ], "remote": [ "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd" ] } }, "elementCount": 958, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 5, "http://xbrl.sec.gov/dei/2021": 6, "total": 11 }, "keyCustom": 29, "keyStandard": 400, "memberCustom": 34, "memberStandard": 68, "nsprefix": "kwr", "nsuri": "http://www.quakerchem.com/20210930", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010409 - Disclosure - Business Segments", "role": "http://www.quakerchem.com/role/BusinessSegments", "shortName": "Business Segments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010410 - Disclosure - Net Sales and Revenue Recognition", "role": "http://www.quakerchem.com/role/NetSalesAndRevenueRecognition", "shortName": "Net Sales and Revenue Recognition", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010508 - Disclosure - Leases", "role": "http://www.quakerchem.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010640 - Disclosure - Restructuring and Related Activities", "role": "http://www.quakerchem.com/role/RestructuringAndRelatedActivities", "shortName": "Restructuring and Related Activities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010710 - Disclosure - Share-Based Compensation", "role": "http://www.quakerchem.com/role/ShareBasedCompensation", "shortName": "Share-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010750 - Disclosure - Pension and Postretirement Benefits", "role": "http://www.quakerchem.com/role/PensionAndPostretirementBenefits", "shortName": "Pension and Postretirement Benefits", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010810 - Disclosure - Other Income (Expense)", "role": "http://www.quakerchem.com/role/OtherIncomeExpense", "shortName": "Other Income (Expense)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010910 - Disclosure - Income Taxes and Uncertain Income Tax Positions", "role": "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions", "shortName": "Income Taxes and Uncertain Income Tax Positions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011010 - Disclosure - Earnings Per Share", "role": "http://www.quakerchem.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011118 - Disclosure - Restricted Cash", "role": "http://www.quakerchem.com/role/RestrictedCash", "shortName": "Restricted Cash", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000200 - Statement - Condensed Consolidated Statements of Operations", "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "shortName": "Condensed Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011510 - Disclosure - Goodwill and Intangible Assets", "role": "http://www.quakerchem.com/role/GoodwillAndIntangibleAssets", "shortName": "Goodwill and Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011910 - Disclosure - Debt", "role": "http://www.quakerchem.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012210 - Disclosure - Equity", "role": "http://www.quakerchem.com/role/Equity", "shortName": "Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012410 - Disclosure - Fair Value Measurements", "role": "http://www.quakerchem.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012415 - Disclosure - Hedging Activities", "role": "http://www.quakerchem.com/role/HedgingActivities", "shortName": "Hedging Activities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012510 - Disclosure - Commitments and Contingencies", "role": "http://www.quakerchem.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020001 - Disclosure - Basis of Presentation and Description of Business (Policies)", "role": "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies", "shortName": "Basis of Presentation and Description of Business (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030303 - Disclosure - Business Acquisitions (Tables)", "role": "http://www.quakerchem.com/role/BusinessAcquisitionsTables", "shortName": "Business Acquisitions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030410 - Disclosure - Business Segments (Tables)", "role": "http://www.quakerchem.com/role/BusinessSegmentsTables", "shortName": "Business Segments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030510 - Disclosure - Net Sales and Revenue Recognition (Tables)", "role": "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionTables", "shortName": "Net Sales and Revenue Recognition (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000300 - Statement - Condensed Consolidated Statements of Comprehensive Income", "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome", "shortName": "Condensed Consolidated Statements of Comprehensive Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030609 - Disclosure - Leases (Tables)", "role": "http://www.quakerchem.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030610 - Disclosure - Restructuring and Related Activities (Tables)", "role": "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesTables", "shortName": "Restructuring and Related Activities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030710 - Disclosure - Share Based Compensation (Tables)", "role": "http://www.quakerchem.com/role/ShareBasedCompensationTables", "shortName": "Share Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030750 - Disclosure - Pension and Other Post Retirement Benefits (Tables)", "role": "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables", "shortName": "Pension and Other Post Retirement Benefits (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030810 - Disclosure - Other Income (Expense) (Tables)", "role": "http://www.quakerchem.com/role/OtherIncomeExpenseTables", "shortName": "Other Income (Expense) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031010 - Disclosure - Earnings Per Share (Tables)", "role": "http://www.quakerchem.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031110 - Disclosure - Restricted Cash (Tables)", "role": "http://www.quakerchem.com/role/RestrictedCashTables", "shortName": "Restricted Cash (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031510 - Disclosure - Goodwill and Intangible Assets (Tables)", "role": "http://www.quakerchem.com/role/GoodwillAndIntangibleAssetsTables", "shortName": "Goodwill and Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031750 - Disclosure - Debt (Tables)", "role": "http://www.quakerchem.com/role/DebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032211 - Disclosure - Equity (Tables)", "role": "http://www.quakerchem.com/role/EquityTables", "shortName": "Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000400 - Statement - Condensed Consolidated Balance Sheets", "role": "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032410 - Disclosure - Fair Value Measurements (Table)", "role": "http://www.quakerchem.com/role/FairValueMeasurementsTable", "shortName": "Fair Value Measurements (Table)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032411 - Disclosure - Hedging Activities (Tables)", "role": "http://www.quakerchem.com/role/HedgingActivitiesTables", "shortName": "Hedging Activities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfCountriesInWhichEntityOperates", "reportCount": 1, "unitRef": "Countries", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040010 - Disclosure - Basis of Presentation and Description of Business (Details)", "role": "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "shortName": "Basis of Presentation and Description of Business (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2020_TO_Sep30_2020_Entity_0000081362_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_us-gaap_ErrorCorrectionOtherMember", "decimals": "-5", "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040214 - Disclosure - Business Acquisitions - Narrative (Details)", "role": "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "shortName": "Business Acquisitions - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Feb28_2021_Entity_0000081362_us-gaap_BusinessAcquisitionAxis_kwr_TinplatingsolutionsMember", "decimals": "-5", "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040215 - Disclosure - Business Acquisitions - Preliminary Estimated Fair Values of Coral Net Assets Acquired (Details)", "role": "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails", "shortName": "Business Acquisitions - Preliminary Estimated Fair Values of Coral Net Assets Acquired (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Dec22_2020_Entity_0000081362_us-gaap_BusinessAcquisitionAxis_kwr_CoralChemicalCompanyMember", "decimals": "-3", "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362_us-gaap_BusinessAcquisitionAxis_kwr_CoralChemicalCompanyMember", "decimals": null, "first": true, "lang": "en-US", "name": "kwr:BusinessCombinationMeasurementPeriod", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040216 - Disclosure - Business Acquisitions - Coral - Narrative (Details)", "role": "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "shortName": "Business Acquisitions - Coral - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R46": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unitRef": "Segments", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040314 - Disclosure - Business Segments - Narrative (Details)", "role": "http://www.quakerchem.com/role/BusinessSegmentsNarrativeDetails", "shortName": "Business Segments - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R47": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040315 - Disclosure - Business Segments - Performance of reportable segments (Details)", "role": "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "shortName": "Business Segments - Performance of reportable segments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "kwr:FairValueStepUpOfInventorySold", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "kwr:Netreportingamount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040410 - Disclosure - Net Sales and Revenue Recognition - Narrative (Details)", "role": "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails", "shortName": "Net Sales and Revenue Recognition - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "kwr:Netreportingamount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040412 - Disclosure - Net Sales and Revenue Recognition (Details)", "role": "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails", "shortName": "Net Sales and Revenue Recognition (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362_us-gaap_TimingOfTransferOfGoodOrServiceAxis_us-gaap_TransferredAtPointInTimeMember", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "myUSDPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000450 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)", "role": "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "shortName": "Condensed Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "myUSDPerShare", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040415 - Disclosure - Leases - Narrative (Details)", "role": "http://www.quakerchem.com/role/LeasesNarrativeDetails", "shortName": "Leases - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040416 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)", "role": "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails", "shortName": "Leases - Supplemental Balance Sheet Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:LeaseCostTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OperatingLeaseLiabilityCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040417 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)", "role": "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails", "shortName": "Leases - Maturities of Operating Lease Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedCostDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040640 - Disclosure - Restructuring and Related Activities - Narrative (Details)", "role": "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails", "shortName": "Restructuring and Related Activities - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedCostDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040650 - Disclosure - Restructuring and Related Activities (Details)", "role": "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails", "shortName": "Restructuring and Related Activities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Dec31_2020_Entity_0000081362_us-gaap_RestructuringPlanAxis_kwr_QhProgramMember", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040710 - Disclosure - Share-Based Compensation - Narrative (Details)", "role": "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "shortName": "Share-Based Compensation - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember", "decimals": null, "lang": "en-US", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040720 - Disclosure - Share-Based Compensation - Share-based Compensation Expense (Details)", "role": "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails", "shortName": "Share-Based Compensation - Share-based Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362_us-gaap_AwardTypeAxis_kwr_StockOptionsCompensationExpenseMember", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040760 - Disclosure - Share-Based Compensation - Black-Scholes Option Pricing Model (Details)", "role": "http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails", "shortName": "Share-Based Compensation - Black-Scholes Option Pricing Model (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "4", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040815 - Disclosure - Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details)", "role": "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails", "shortName": "Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040860 - Disclosure - Pension and Other Postretirement Benefits - Narrative (Details)", "role": "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "shortName": "Pension and Other Postretirement Benefits - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000500 - Statement - Condensed Consolidated Statements of Cash Flows", "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040900 - Disclosure - Other Income (Expense) (Details)", "role": "http://www.quakerchem.com/role/OtherIncomeExpenseDetails", "shortName": "Other Income (Expense) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxLiabilities", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040960 - Disclosure - Income Taxes and Uncertain Income Tax Positions - Narrative (Details)", "role": "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails", "shortName": "Income Taxes and Uncertain Income Tax Positions - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R62": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "5", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040970 - Disclosure - Income Taxes and Uncertain Income Tax Positions 2 - Narrative (Details)", "role": "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "shortName": "Income Taxes and Uncertain Income Tax Positions 2 - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "5", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041010 - Disclosure - Earnings Per Share - Earnings per Share Calculations Basic (Details)", "role": "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails", "shortName": "Earnings Per Share - Earnings per Share Calculations Basic (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041020 - Disclosure - Earnings Per Share - Earnings per Share Calculations Diluted (Details)", "role": "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails", "shortName": "Earnings Per Share - Earnings per Share Calculations Diluted (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041030 - Disclosure - Earnings Per Share - Earnings per Share Calculations Antidilutive Shares (Details)", "role": "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsAntidilutiveSharesDetails", "shortName": "Earnings Per Share - Earnings per Share Calculations Antidilutive Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041110 - Disclosure - Restricted Cash (Details)", "role": "http://www.quakerchem.com/role/RestrictedCashDetails", "shortName": "Restricted Cash (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2020_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Dec31_2020_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041510 - Disclosure - Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details)", "role": "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "shortName": "Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "lang": "en-US", "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AdjustmentForAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041520 - Disclosure - Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details)", "role": "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails", "shortName": "Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AdjustmentForAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041540 - Disclosure - Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details)", "role": "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails", "shortName": "Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010110 - Disclosure - Basis of Presentation and Description of Business", "role": "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusiness", "shortName": "Basis of Presentation and Description of Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041550 - Disclosure - Intangible Assets - Indefinite Lived (Details)", "role": "http://www.quakerchem.com/role/IntangibleAssetsIndefiniteLivedDetails", "shortName": "Intangible Assets - Indefinite Lived (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Dec31_2020_Entity_0000081362", "decimals": "-5", "lang": "en-US", "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtAndCapitalLeaseObligations", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041910 - Disclosure - Debt - Table (Details)", "role": "http://www.quakerchem.com/role/DebtTableDetails", "shortName": "Debt - Table (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtAndCapitalLeaseObligations", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebt", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041950 - Disclosure - Debt - Debt related expenses included within Interest expense (Details)", "role": "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails", "shortName": "Debt - Debt related expenses included within Interest expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebt", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LettersOfCreditOutstandingAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041960 - Disclosure - Debt - Narrative (Details)", "role": "http://www.quakerchem.com/role/DebtNarrativeDetails", "shortName": "Debt - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LettersOfCreditOutstandingAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042211 - Disclosure - Equity - Changes in Equity (Details)", "role": "http://www.quakerchem.com/role/EquityChangesInEquityDetails", "shortName": "Equity - Changes in Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jul01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unitRef": "myUSDPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042212 - Disclosure - Equity - Changes in Equity (Parentheticals) (Details)", "role": "http://www.quakerchem.com/role/EquityChangesInEquityParentheticalsDetails", "shortName": "Equity - Changes in Equity (Parentheticals) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R76": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042220 - Disclosure - Equity - AOCI Reclassifications (Details)", "role": "http://www.quakerchem.com/role/EquityAOCIReclassificationsDetails", "shortName": "Equity - AOCI Reclassifications (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Jun30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashSurrenderValueFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042410 - Disclosure - Fair Value Measurements - Assets Subject to Fair Value Measurement (Details)", "role": "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails", "shortName": "Fair Value Measurements - Assets Subject to Fair Value Measurement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashSurrenderValueFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Nov30_2019_Entity_0000081362_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeLiabilityNotionalAmount", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042504 - Disclosure - Hedging Activities - Narrative (Details)", "role": "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails", "shortName": "Hedging Activities - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember", "decimals": null, "lang": "en-US", "name": "us-gaap:DerivativeTermOfContract", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042505 - Disclosure - Hedging Activities - Balance Sheet Classification and Fair Values (Details)", "role": "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails", "shortName": "Hedging Activities - Balance Sheet Classification and Fair Values (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010210 - Disclosure - Business Acquisitions", "role": "http://www.quakerchem.com/role/BusinessAcquisitions", "shortName": "Business Acquisitions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Sep30_2021_Entity_0000081362", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyAccrualAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042510 - Disclosure - Commitments and Contingencies - Narrative (Details)", "role": "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "shortName": "Commitments and Contingencies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "AS_OF_Dec31_2020_Entity_0000081362", "decimals": "-5", "lang": "en-US", "name": "us-gaap:LossContingencyAccrualAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010310 - Disclosure - Recently Issued Accounting Standards", "role": "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards", "shortName": "Recently Issued Accounting Standards", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "kwr20210930.htm", "contextRef": "FROM_Jan01_2021_TO_Sep30_2021_Entity_0000081362", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 103, "tag": { "country_AR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Argentina [Member]" } } }, "localname": "AR", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "domainItemType" }, "country_BR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BR", "terseLabel": "Brazil [Member]" } } }, "localname": "BR", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_CA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ca", "terseLabel": "Canada [Member]" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_CN": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CN", "terseLabel": "China [Member]" } } }, "localname": "CN", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_DE": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DE", "terseLabel": "Germany [Member]" } } }, "localname": "DE", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_ES": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ES", "terseLabel": "Spain [Member]" } } }, "localname": "ES", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_FR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FR", "terseLabel": "France [Member]" } } }, "localname": "FR", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_GB": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "GB", "terseLabel": "United Kingdom [Member]" } } }, "localname": "GB", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_IN": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IN", "terseLabel": "India [Member]" } } }, "localname": "IN", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_IT": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IT", "terseLabel": "Italy [Member]" } } }, "localname": "IT", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_MX": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MX", "terseLabel": "Mexico [Member]" } } }, "localname": "MX", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_NL": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NL", "terseLabel": "The Netherlands [Member]" } } }, "localname": "NL", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "United States [Member]", "terseLabel": "Domestic plan [Member]", "verboseLabel": "U.S. [Member]" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current fiscal year end date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r951", "r953", "r954" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document period end date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r952" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document quarterly report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r955" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r949" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated By Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r956" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity central index key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity common stock shares outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity current reporting status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r956" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r956" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity filer category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r957" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity public float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r956" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity registrant name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r956" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r956" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r956" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity voluntary filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity well known seasoned issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r948" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12(b) Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r950" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.quakerchem.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "kwr_AcpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AC Products, Inc. Subsidiary involved in groundwater contamination litigation", "label": "Acp [Member]", "terseLabel": "ACP [Member]" } } }, "localname": "AcpMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_AcquisitionRelatedFairValueAdjustments": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non-cash adjustments to the fair value of acquisition-related contingent consideration liabilities or non-cash gains from the revaluation of an existing equity interest as the result of a business combination .", "label": "Acquisition-related fair value adjustments related to inventory", "negatedLabel": "Acquisition-related fair value adjustments related to inventory" } } }, "localname": "AcquisitionRelatedFairValueAdjustments", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_AsbestosClaimsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Numerous lawsuits alleging injury due to exposure to asbestos.", "label": "Asbestos claims [Member]" } } }, "localname": "AsbestosClaimsMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_AvailableForSaleSecuritiesAssetsFixedIncomeRegisteredInvestmentCompaniesFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of mutual funds which are invested in fixed income common stock.", "label": "Available For Sale Securities Assets Fixed Income Registered Investment Companies Fair Value Disclosure", "terseLabel": "Fixed Income Registered Investment Companies" } } }, "localname": "AvailableForSaleSecuritiesAssetsFixedIncomeRegisteredInvestmentCompaniesFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "kwr_AvailableForSaleSecuritiesAssetsInternationalDevelopedAndEmergingMarketsRegisteredInvestmentCompaniesFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of mutual funds which are invested in international developed and emerging markets common stock.", "label": "Available For Sale Securities Assets International Developed And Emerging Markets Registered Investment Companies Fair Value Disclosure", "terseLabel": "International Developed And Emerging Markets Registered Investment Companies" } } }, "localname": "AvailableForSaleSecuritiesAssetsInternationalDevelopedAndEmergingMarketsRegisteredInvestmentCompaniesFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "kwr_AvailableForSaleSecuritiesAssetsLargeCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of mutual funds which are invested in large capitalization common stock.", "label": "Available For Sale Securities Assets Large Capitalization Registered Investment Companies Fair Value Disclosure", "terseLabel": "Large Capitalization Registered Investment Companies" } } }, "localname": "AvailableForSaleSecuritiesAssetsLargeCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "kwr_AvailableForSaleSecuritiesAssetsMidCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of mutual funds which are invested in mid capitalization common stock.", "label": "Available For Sale Securities Assets Mid Capitalization Registered Investment Companies Fair Value Disclosure", "terseLabel": "Mid Capitalization Registered Investment Companies" } } }, "localname": "AvailableForSaleSecuritiesAssetsMidCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "kwr_AvailableForSaleSecuritiesAssetsSmallCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of mutual funds which are invested in small capitalization common stock.", "label": "Available For Sale Securities Assets Small Capitalization Registered Investment Companies Fair Value Disclosure", "terseLabel": "Small Capitalization Registered Investment Companies" } } }, "localname": "AvailableForSaleSecuritiesAssetsSmallCapitalizationRegisteredInvestmentCompaniesFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "kwr_BankLinesOfCreditAndOtherDebtObligationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bank lines of credit and other debt obligations.", "label": "Bank lines of credit and other debt obligations [Member]" } } }, "localname": "BankLinesOfCreditAndOtherDebtObligationsMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "domainItemType" }, "kwr_BrazilianIndirectTaxesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legal claim in regards to certain Brazilian non-income (indirect) taxes.", "label": "Brazilian Indirect Taxes [Member]" } } }, "localname": "BrazilianIndirectTaxesMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_BusinessAcquisitionAcquireeIndiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Quaker Chemical India Private Limited business combination completed during the year.", "label": "Business Acquisition Acquiree India [Member]", "terseLabel": "India [Member]" } } }, "localname": "BusinessAcquisitionAcquireeIndiaMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfCompanyInSharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of equity interest issued or issuable of the total company shares issued in business acquisition.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Percentage Of Company in Shares Issued" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfCompanyInSharesIssued", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsAntidilutiveSharesDetails" ], "xbrltype": "percentItemType" }, "kwr_BusinessCombinationMeasurementPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The measurement period post acquisition during which the company may record adjustments to the estimated fair value of asset acquired and liabilities assumed.", "label": "Business Combination, Measurement Period", "terseLabel": "Measurement period" } } }, "localname": "BusinessCombinationMeasurementPeriod", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "durationItemType" }, "kwr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherAccruedLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, accrued expenses and other accrued liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts payable, accrued expenses and other accrued liabilities", "terseLabel": "Accounts payable, accrued expenses and other accrued liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedExpensesAndOtherAccruedLiabilities", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "kwr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebtIncludedCurrentPortions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Long-term debt included current portions", "terseLabel": "Long-term debt including current portions and finance leases" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebtIncludedCurrentPortions", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Businesscombinationindemnificationassetsrelatedtoformerownership": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Indemnification assets associated with business combinations", "label": "Business Combination Indemnification Assets Related to Former Ownership" } } }, "localname": "Businesscombinationindemnificationassetsrelatedtoformerownership", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_CapitalExpendituresReductionInAccrualButNoCashImpact": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of reduction in capital expenditure accruals which did not have any impact on cash.", "label": "Capital Expenditures Reduction In Accrual But No Cash Impact", "negatedLabel": "Change in accrued purchases of property, plant and equipment, net" } } }, "localname": "CapitalExpendituresReductionInAccrualButNoCashImpact", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_CashSurrenderValueCompanyOwnedLifeInsuranceDeferredCompensationAssetsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of company owned life insurance in deferred compensation assets.", "label": "Cash Surrender Value Company Owned Life Insurance Deferred Compensation Assets Fair Value Disclosure", "terseLabel": "Company Owned Life Insurance - Deferred Compensation Assets" } } }, "localname": "CashSurrenderValueCompanyOwnedLifeInsuranceDeferredCompensationAssetsFairValueDisclosure", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "kwr_CeoTransitionCosts": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expense recognized for the Company's former CEO's supplemental retirement plan, which relates to the former CEO's retirement.", "label": "CEO transition costs", "negatedTerseLabel": "CEO transition charges" } } }, "localname": "CeoTransitionCosts", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kwr_ChemicalMaskantsProductLineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2021 acquisition Chemical maskants product line.", "label": "Chemical maskants product line [Member]" } } }, "localname": "ChemicalMaskantsProductLineMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_CombinationAndNormanHayMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Combination and Norman Hay business acquisition that was completed during the period.", "label": "Combination And Norman Hay [Member]" } } }, "localname": "CombinationAndNormanHayMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_CombinationAndOtherAcquisitionRelatedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Combination And Other Acquisition-Related [Member]" } } }, "localname": "CombinationAndOtherAcquisitionRelatedMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_CombinationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The August 1, 2019 business acquisition and Combination with Houghton International", "label": "Combination [Member]" } } }, "localname": "CombinationMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsAntidilutiveSharesDetails", "http://www.quakerchem.com/role/EquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Combinationrelatedexpensesnetofpayements": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities, net of payments.", "label": "Combination and other acquisition-related expenses, net of payments" } } }, "localname": "Combinationrelatedexpensesnetofpayements", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_CommingledFundsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This category includes information about pooled institutional investments, including primarily investment trusts", "label": "Commingled funds measured at NAV [Member]" } } }, "localname": "CommingledFundsMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_CompanyStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Describes amounts and percentages of the Entity's common stock as part of the Entity's Pension and Postretirement Benefit Plans.", "label": "Company Stock [Member]" } } }, "localname": "CompanyStockMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ConsolidatedAdjustedEbitdaToInterestExpenseRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Company's consolidated adjusted EBITDA to interest expense ratio as part of debt convenants.", "label": "Consolidated adjusted EBITDA to interest expense ratio" } } }, "localname": "ConsolidatedAdjustedEbitdaToInterestExpenseRatio", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "pureItemType" }, "kwr_ConsolidatedStatementOfChangesInEquityParentheticalsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Statement Of Changes In Equity Parentheticals [Abstract]" } } }, "localname": "ConsolidatedStatementOfChangesInEquityParentheticalsAbstract", "nsuri": "http://www.quakerchem.com/20210930", "xbrltype": "stringItemType" }, "kwr_CoralChemicalCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business acquisition of Coral, a privately held, U.S.-based provider of metal finishing fluid solutions.", "label": "Coral Chemical Company (Coral) [Member]" } } }, "localname": "CoralChemicalCompanyMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsTables" ], "xbrltype": "domainItemType" }, "kwr_Debtinstrumentmaturityyear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Year that debt instrument matures and is to be fully repaid.", "label": "Debt Instrument Maturity Year" } } }, "localname": "Debtinstrumentmaturityyear", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "gYearItemType" }, "kwr_DeferredTaxAssetsAcquiredDisallowedInterest": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Acquired Disallowed Interest.", "label": "Deferred Tax Assets, Acquired Disallowed Interest" } } }, "localname": "DeferredTaxAssetsAcquiredDisallowedInterest", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DeferredTaxAssetsOperatingLossCarryforwardsForeignExpirationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Operating Loss Carryforwards Foreign Expiration Period.", "label": "Deferred Tax Assets Operating Loss Carryforwards Foreign Expiration Period" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeignExpirationPeriod", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "durationItemType" }, "kwr_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocalBasedOnReversalOfDeferredTaxLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Operating Loss Carryforwards State And Local Based On Reversal Of Deferred Tax Liabilities.", "label": "Deferred Tax Assets Operating Loss Carryforwards State And Local Based On Reversal Of Deferred Tax Liabilities" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocalBasedOnReversalOfDeferredTaxLiabilities", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocalExpirationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Operating Loss Carryforwards State And Local Expiration Period.", "label": "Deferred Tax Assets Operating Loss Carryforwards State And Local Expiration Period" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocalExpirationPeriod", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "durationItemType" }, "kwr_DeferredTaxAssetsPartialValuationAllowanceNetExpectedFutureBenefit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Partial Valuation Allowance, Net Expected Future Benefit.", "label": "Deferred Tax Assets, Partial Valuation Allowance, Net Expected Future Benefit" } } }, "localname": "DeferredTaxAssetsPartialValuationAllowanceNetExpectedFutureBenefit", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DeferredTaxAssetsTaxCreditCarryforwardsForeignExpectedToExpire": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Tax Credit Carryforwards Foreign Expected To Expire.", "label": "Deferred Tax Assets Tax Credit Carryforwards Foreign Expected To Expire" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeignExpectedToExpire", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DeferredTaxAssetsTaxCreditCarryforwardsForeignExpectedToExpireNextFiveYears": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Tax Credit Carryforwards Foreign Expected To Expire Next Five Years.", "label": "Deferred Tax Assets Tax Credit Carryforwards Foreign Expected To Expire Next Five Years" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeignExpectedToExpireNextFiveYears", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DefinedBenefitPlanAmortizationOfGainsLossesWithSettlementLoss": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 15.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amortization of actuarial loss including plan settlement losses", "label": "Defined Benefit Plan, Amortization of Gains (Losses) with Settlement Loss", "terseLabel": "Actuarial Loss" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLossesWithSettlementLoss", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DefinedBenefitPlanForeignCurrencyExchangeRateChangesOtherComprehensiveIncomeLoss": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 18.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from foreign currency exchange rate changes for an obligation of a foreign operation whose functional currency is not the reporting currency.", "label": "Defined Benefit Plan Foreign Currency Exchange Rate Changes, Other Comprehensive Income Loss", "negatedLabel": "Foreign Currency Exchange Rate Changes", "terseLabel": "Effect of exchange rates on amounts Included in AOCI" } } }, "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesOtherComprehensiveIncomeLoss", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DefinedContributionPlanEmployerNonElectiveNondiscretionaryContributionsPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nonelective contributions funds the entity choose to direct toward their eligible workers defined contribution plan if employees make their own contributions, after employees have completed one year of service.", "label": "Defined contribution plan employer non-elective nondiscretionary contributions percent" } } }, "localname": "DefinedContributionPlanEmployerNonElectiveNondiscretionaryContributionsPercent", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_DefinedContributionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Contribution Plan [Member]" } } }, "localname": "DefinedContributionPlanMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Definedbenefitplanpremiumrefund": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Refund Related to Overpayment of Premium Refund", "label": "Defined Benefit Plan Premium Refund" } } }, "localname": "Definedbenefitplanpremiumrefund", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DefinedbenefitplansettlementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined benefit plan settlement [Member]" } } }, "localname": "DefinedbenefitplansettlementMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Definedcontributionplanemployermatchingcontributionpercentmaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of emplyee compensation that is contributed to the plan, with a maximum matching contribution made by the employer.", "label": "Defined contribution plan employer matching contribution percent maximum" } } }, "localname": "Definedcontributionplanemployermatchingcontributionpercentmaximum", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_DirectorRetainerAnnualFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total annual director retainer fee.", "label": "Director Retainer Annual Fee", "terseLabel": "Total annual director retainer fee" } } }, "localname": "DirectorRetainerAnnualFee", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_DirectorStockOwnershipCashRetainer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the director retainer fee in company stock and cash.", "label": "Director Stock Ownership Cash Retainer", "terseLabel": "Director Stock Ownership Plan Terms" } } }, "localname": "DirectorStockOwnershipCashRetainer", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_DirectorStockOwnershipPercentageThreshold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Director Stock ownership percentage threshold", "label": "Director Stock ownership Percentage Threshold" } } }, "localname": "DirectorStockOwnershipPercentageThreshold", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_DirectorsStockOwnershipPlanCompensationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for the company's board of director's stock plan.", "label": "Directors Stock Ownership Plan Compensation Expense [Member]", "terseLabel": "Director stock ownership plan [Member]" } } }, "localname": "DirectorsStockOwnershipPlanCompensationExpenseMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "kwr_Directorstockownershipplanpercentagecash": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Director Stock Ownership Plan paid in Cash", "label": "Director Stock Ownership Plan Percentage Cash" } } }, "localname": "Directorstockownershipplanpercentagecash", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_Directorstockownershipplanpercentagestock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Director Stock Ownership Plan paid in Cash", "label": "Director Stock Ownership Plan Percentage Stock" } } }, "localname": "Directorstockownershipplanpercentagestock", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_Directorstockownershipplanpercentagetotal": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Director Stock Ownership Plan paid in Total", "label": "Director Stock Ownership Plan Percentage Total" } } }, "localname": "Directorstockownershipplanpercentagetotal", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_DiversifiedInvestmentFundRegisteredInvestmentCompaniesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments held in diversified investment funds or registered investments measured at NAV.", "label": "Diversified investment fund - registered investment companies measured at NAV [Member]" } } }, "localname": "DiversifiedInvestmentFundRegisteredInvestmentCompaniesMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_DocumentAndEntityInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Document and Entity Information [Abstract]" } } }, "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.quakerchem.com/20210930", "xbrltype": "stringItemType" }, "kwr_EffectOfTaxRateChange": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Effect on EPS of tax rate change in current period.", "label": "Effect Of Tax Rate Change" } } }, "localname": "EffectOfTaxRateChange", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_EffectofpriorservicecostChargeperdilutedshare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reflects the effect on diluted earnings per share due to a prior service cost related to pension during the period.", "label": "Effect Of Prior Service Cost Charge Per Diluted Share" } } }, "localname": "EffectofpriorservicecostChargeperdilutedshare", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "kwr_Effectofrestructuringcostsperdilutedshare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reflects the effect on diluted earnings per share due to restructuring costs during the period.", "label": "Effect Of Restructuring Costs Per Diluted Share" } } }, "localname": "Effectofrestructuringcostsperdilutedshare", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "perShareItemType" }, "kwr_EmployeeStockPurchasePlanCompensationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of equity basedcompensation cost recognized during the period in selling, general and administrative expense for the employee stock purchase plan.", "label": "Employee Stock Purchase Plan Compensation Expense [Member]" } } }, "localname": "EmployeeStockPurchasePlanCompensationExpenseMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInNextYearMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of Tax Loss Carryforward Expiring in Next Year", "label": "Expiration In Next Year [Member]" } } }, "localname": "ExpirationInNextYearMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within eight years of the balance sheet date.", "label": "Expiration In Year Eight [Member]" } } }, "localname": "ExpirationInYearEightMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within five years of the balance sheet date.", "label": "Expiration In Year Five [Member]" } } }, "localname": "ExpirationInYearFiveMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within four years of the balance sheet date.", "label": "Expiration In Year Four [Member]" } } }, "localname": "ExpirationInYearFourMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within nine years of the balance sheet date.", "label": "Expiration In Year Nine [Member]" } } }, "localname": "ExpirationInYearNineMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within seven years of the balance sheet date.", "label": "Expiration In Year Seven [Member]" } } }, "localname": "ExpirationInYearSevenMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within six years of the balance sheet date.", "label": "Expiration In Year Six [Member]" } } }, "localname": "ExpirationInYearSixMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearTenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within ten years of the balance sheet date.", "label": "Expiration In Year Ten [Member]" } } }, "localname": "ExpirationInYearTenMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expiration In Year Three [Member]" } } }, "localname": "ExpirationInYearThreeMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationInYearTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within two years of the balance sheet date.", "label": "Expiration In Year Two [Member]" } } }, "localname": "ExpirationInYearTwoMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationinfifteenyearsmemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within Fifteen years of the balance sheet date.", "label": "Expiration In Fifteen Years [Member]" } } }, "localname": "ExpirationinfifteenyearsmemberMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ExpirationintwentyyearsmemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of tax loss carryforward expiring within twenty years of the balance sheet date.", "label": "Expiration In Twenty Years [Member]" } } }, "localname": "ExpirationintwentyyearsmemberMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_FacilitiesVehiclesAndMachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating leases for certain facilities, vehicles and machinery and equipment.", "label": "Facilities vehicles and machinery and equipment [Member]" } } }, "localname": "FacilitiesVehiclesAndMachineryAndEquipmentMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_FairValueStepUpOfInventorySold": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value step up of inventory sold relates to expenses associated with selling inventory from acquired businesses which was adjusted to fair value as part of purchase accounting.", "label": "Fair value step up of acquired inventory sold", "negatedLabel": "Fair value step up of acquired inventory sold" } } }, "localname": "FairValueStepUpOfInventorySold", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_FederalIncomeTaxExpenseForeign": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of federal income tax expense payable to non-domestic authorities.", "label": "Fededral income tax expense foreign" } } }, "localname": "FederalIncomeTaxExpenseForeign", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite Lived Intangible Assets Accumulated Amortization [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "kwr_FiniteLivedTrademarksFormulationsAndProductTechnologyGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date for the trademarks formulations and product technology.", "label": "Finite Lived Trademarks Formulations And Product Technology Gross", "terseLabel": "Trademarks, Formulations And Product Technology" } } }, "localname": "FiniteLivedTrademarksFormulationsAndProductTechnologyGross", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_ForeignconsumptiontaxMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Consumption Tax Matter", "label": "Foreign Consumption Tax [Member]" } } }, "localname": "ForeignconsumptiontaxMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_GainOnDispositionOfAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.", "label": "Gain (loss) on disposition of assets" } } }, "localname": "GainOnDispositionOfAssets", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "kwr_GlobalSpecialtyBusinessesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Global Specialty Businesses.", "label": "Global Specialty Businesses [Member]" } } }, "localname": "GlobalSpecialtyBusinessesMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "kwr_GrindaixGmbhMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acqusition of Grindaix-GmbH, a privately held, German-based, high-tech provider of coolant control and delivery systems.", "label": "Grindaix GmbH [Member]" } } }, "localname": "GrindaixGmbhMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_HoughtonCombinationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hougton, a business combination.", "label": "Houghton Combination [Member]", "terseLabel": "Houghton Combination [Member]" } } }, "localname": "HoughtonCombinationMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/IntangibleAssetsIndefiniteLivedDetails" ], "xbrltype": "domainItemType" }, "kwr_HoughtonEnvironmentalMattersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Houghton environmental matters.", "label": "Houghton environmental matters [Member]" } } }, "localname": "HoughtonEnvironmentalMattersMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_HoughtonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business combination of Houghton.", "label": "Houghton [Member]" } } }, "localname": "HoughtonMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsTables", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_IncludingGlobalSpecialtyBusinessesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Segment including Global Specialty Businesses.", "label": "Including Global Specialty Businesses [Member]" } } }, "localname": "IncludingGlobalSpecialtyBusinessesMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "kwr_IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 15.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Income Loss From Continuing Operations Before Noncontrolling Interests and Income Loss From Equity Method Investments", "label": "Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments", "totalLabel": "Income (loss) before equity in net income of associated companies" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kwr_IncreaseDecreaseInDeferredCompensationAndOtherNet": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future and other certain items.", "label": "Increase Decrease In Deferred Compensation And Other Net", "terseLabel": "Deferred compensation, deferred taxes and other, net" } } }, "localname": "IncreaseDecreaseInDeferredCompensationAndOtherNet", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_Increasedecreaseinaccruednoncurrentincometaxespayable": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Increase decrease in accrued non current income taxes payable", "negatedTerseLabel": "Non-current income taxes payable" } } }, "localname": "Increasedecreaseinaccruednoncurrentincometaxespayable", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_IndustrialDevelopmentBondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Industrial development bonds.", "label": "Industrial development bonds [Member]" } } }, "localname": "IndustrialDevelopmentBondsMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "domainItemType" }, "kwr_Industrialdevelopmentrevenuebond": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents an Industrial Development Revenue Bond used to fund the expansion of the company's Middletown, Ohio manufacturing facility.", "label": "Industrial Development Revenue Bond" } } }, "localname": "Industrialdevelopmentrevenuebond", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_InitialConsolidatedNetDebtToConsolidatedEbitdaRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Company's initial consolidated net debt to consolidated adjusted EBITDA ratio range.", "label": "Initial consolidated net debt to consolidated EBITDA ratio" } } }, "localname": "InitialConsolidatedNetDebtToConsolidatedEbitdaRatio", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "pureItemType" }, "kwr_Insurancesolvencyrecovery": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Income associated with a cash receipt from an insolvent insurance carrier for previously submitted claims by an inative subsiary of the Company.", "label": "Insurance solvency recovery" } } }, "localname": "Insurancesolvencyrecovery", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "kwr_KoreaHoughtonCoporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Korea Houghton company business combinations that was completed during the period.", "label": "Korea Houghton Coporation [Member]" } } }, "localname": "KoreaHoughtonCoporationMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Kwr_lineofcreditremainingborrowingcapacity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of Credit Remaining borrowing Capacity, net of letters of credit", "label": "Line of Credit Remaining borrowing Capacity, net of letters of credit" } } }, "localname": "Kwr_lineofcreditremainingborrowingcapacity", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_LargestCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from the entity's largest customer is to net revenues.", "label": "Largest customer [Member]" } } }, "localname": "LargestCustomerMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_LegacyQuakerUsPensionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Legacy Quaker U.S. Pension Plan [Member]" } } }, "localname": "LegacyQuakerUsPensionPlanMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Lineofcreditfacilityinitiationdatedescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line Of Credit Facility Initiation Date Description.", "label": "Line Of Credit Facility Initiation Date Description" } } }, "localname": "Lineofcreditfacilityinitiationdatedescription", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_LossCarryforwardExpirationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about the expirations of tax loss carryforwards.", "label": "Loss Carryforward Expiration [Axis]" } } }, "localname": "LossCarryforwardExpirationAxis", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_LossCarryforwardExpirationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identifies the period in which available tax loss carryforwards expire.", "label": "Loss Carryforward Expiration [Domain]" } } }, "localname": "LossCarryforwardExpirationDomain", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_LossContingencyRangeOfOperationWellP2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated range of time that Well P-2 will operate", "label": "Loss Contingency Range Of Operation Well P 2", "terseLabel": "P-2 well operation range estimate" } } }, "localname": "LossContingencyRangeOfOperationWellP2", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_LossContingencyRangeOfOperationWellP3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated range of time that Well P-3 will operate", "label": "Loss Contingency Range Of Operation Well P 3", "terseLabel": "P-3 well operation range estimate" } } }, "localname": "LossContingencyRangeOfOperationWellP3", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_LossOnDispositionOfAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.", "label": "Loss on Disposition of Assets" } } }, "localname": "LossOnDispositionOfAssets", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "kwr_MatchingStockContribution401KPlanCompensationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for the non-elective and elective 401 (k) match stock contribution plan.", "label": "Matching Stock Contribution 401 K Plan Compensation Expense [Member]", "terseLabel": "Non-elective and elective 401(k) matching contribution in stock [Member]" } } }, "localname": "MatchingStockContribution401KPlanCompensationExpenseMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "kwr_MaximumAnnualCashDividendsRestrictionBasedOnCovenants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of maximum cash dividends that can be paid annually per convenants.", "label": "Maximum annual cash dividends restriction based on covenants" } } }, "localname": "MaximumAnnualCashDividendsRestrictionBasedOnCovenants", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_MetalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Metals product line.", "label": "Metals [Member]" } } }, "localname": "MetalsMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "kwr_MetalworkingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Metals product line.", "label": "Metalworking and other [Member]" } } }, "localname": "MetalworkingMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "kwr_MetalworkingnorthamericamemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Metalworking North America business combination completed during the year.", "label": "Metalworking North America [Member]" } } }, "localname": "MetalworkingnorthamericamemberMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_MiningNorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Minining North America business combination completed during the year.", "label": "Mining North America [Member]" } } }, "localname": "MiningNorthAmericaMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_MiningnorthamericatrademarksformulationsandproducttechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mining North America Trademarks Formulations And Product Technology [Member]" } } }, "localname": "MiningnorthamericatrademarksformulationsandproducttechnologyMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_NarrativeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Narrative [Abstract]" } } }, "localname": "NarrativeAbstract", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "stringItemType" }, "kwr_NetDebtToConsolidatedAdjustedEbitdaRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Company's consolidated net debt to consolidated adjusted EBITDA ratio range.", "label": "Net debt to consolidated adjusted EBITDA ratio" } } }, "localname": "NetDebtToConsolidatedAdjustedEbitdaRatio", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "pureItemType" }, "kwr_NetherlandsAndSpainMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Netherlands and Spain [Member]" } } }, "localname": "NetherlandsAndSpainMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Netreportingamount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as revenue under net reporting arrangements", "label": "Net Reporting Amount", "terseLabel": "Revenue Recognized Under Net Reporting Arrangements" } } }, "localname": "Netreportingamount", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_NonoperatingCharges": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of non-operating charges recurring against earnings in the period, which are not directly related to or being allocated to a specific segment.", "label": "Nonoperating Charges", "negatedTerseLabel": "Non-operating and administrative expenses" } } }, "localname": "NonoperatingCharges", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_NonvestedStockAwardsCompensationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for nonvested stock and restricted stock unit awards.", "label": "Nonvested Stock Awards Compensation Expense [Member]", "terseLabel": "Non-vested stock awards and restricted stock units [Member]" } } }, "localname": "NonvestedStockAwardsCompensationExpenseMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "kwr_NormanHayMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business acquisition of Norman Hay.", "label": "Norman Hay [Member]" } } }, "localname": "NormanHayMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsTables", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_OffsetInTaxLiabilitiesThroughPurchaseAccounting": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Offset In Tax Liabilities Through Purchase Accounting.", "label": "Offset In Tax Liabilities Through Purchase Accounting" } } }, "localname": "OffsetInTaxLiabilitiesThroughPurchaseAccounting", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_OldCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Syndicated multicurrency, unsecured revolving credit facility with a group of lenders.", "label": "Previous Credit Facility [Member]", "terseLabel": "Previous Credit Facility [Member]" } } }, "localname": "OldCreditFacilityMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_OneJurisdictionExposurePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of exposure represented by one jurisdiction relating to possible contingency related to unasserted claims.", "label": "One Jurisdiction Exposure Percentage", "terseLabel": "Percentage of potential exposure represented by one jurisdiction" } } }, "localname": "OneJurisdictionExposurePercentage", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_OperatingIncomeLossSegmentReporting": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues before amortization and non-operating charges.", "label": "Operating Income Loss Segment Reporting", "terseLabel": "Operating Earnings, Excluding Indirect Operating Expenses", "verboseLabel": "Segment operating earnings" } } }, "localname": "OperatingIncomeLossSegmentReporting", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "kwr_OperatingLossCarryforwardsForeignPartialValuationAllowance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating Loss Carryforwards, Foreign, Partial Valuation Allowance.", "label": "Operating Loss Carryforwards, Foreign, Partial Valuation Allowance" } } }, "localname": "OperatingLossCarryforwardsForeignPartialValuationAllowance", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_OperatingLossCarryforwardsStatePartialValuationAllowance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating Loss Carryforwards, State, Partial Valuation Allowance.", "label": "Operating Loss Carryforwards, State, Partial Valuation Allowance" } } }, "localname": "OperatingLossCarryforwardsStatePartialValuationAllowance", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_OtherLiabilitiesCurrentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line item in the statement of financial position in which the fair value amounts of the derivative instruments are included.", "label": "Other Liabilities Current [Member]" } } }, "localname": "OtherLiabilitiesCurrentMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Othercomprehensiveincomelossplancurtailments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Other Comprehensive Income Loss Plan Curtailments" } } }, "localname": "Othercomprehensiveincomelossplancurtailments", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Othercomprehensiveincomelossplansettlement": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Other comprehensive income loss plan settlement" } } }, "localname": "Othercomprehensiveincomelossplansettlement", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Pensionandpostretirementbenefitcostsnonservicecomponents": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other income related to non-service pension cost components", "label": "Pension and post retirement benefit costs, non-service components", "negatedTerseLabel": "Pension and post retirement benefit costs nonservice components" } } }, "localname": "Pensionandpostretirementbenefitcostsnonservicecomponents", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "kwr_PercentageOfCashDividendsOfConsolidatedAdjustedEbitda": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of cash dividends of consolidated adjusted EBITDA.", "label": "Percentage of cash dividends of consolidated adjusted EBITDA" } } }, "localname": "PercentageOfCashDividendsOfConsolidatedAdjustedEbitda", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PercentageOfDefenseAndIndemnityCosts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of defense and indemnity costs incurred by or on behalf of the subsidiary.", "label": "Percentage of defense and indemnity costs" } } }, "localname": "PercentageOfDefenseAndIndemnityCosts", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PercentageOfTermLoanBorrowings": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of term loan borrowings.", "label": "Percentage of term loan borrowings" } } }, "localname": "PercentageOfTermLoanBorrowings", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PercentageOfTermLoanPrincipalAmortizationYearFourAndFive": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of term loans quarterly principal amortization during their respective five-year maturities, for years four and five.", "label": "Percentage of term loan principal amortization year four and five" } } }, "localname": "PercentageOfTermLoanPrincipalAmortizationYearFourAndFive", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PercentageOfTermLoanPrincipalAmortizationYearOneAndTwo": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of term loans quarterly principal amortization during their respective five-year maturities, for year one and two.", "label": "Percentage of term loan principal amortization year one and two" } } }, "localname": "PercentageOfTermLoanPrincipalAmortizationYearOneAndTwo", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PercentageOfTermLoanPrincipalAmortizationYearThree": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of term loans quarterly principal amortization during their respective five-year maturities, for year three.", "label": "Percentage of term loan principal amortization year three" } } }, "localname": "PercentageOfTermLoanPrincipalAmortizationYearThree", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PercentageOfTermLoanPrincipalAmortizationYearTwo": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of term loans quarterly principal amortization during their respective five-year maturities, for year two.", "label": "Percentage of term loan principal amortization year two" } } }, "localname": "PercentageOfTermLoanPrincipalAmortizationYearTwo", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_PeriodOfProjectedClaimsOfSubusidiary": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of total projected claims liability of the subsidiary.", "label": "Period Of Projected Claims Of Subusidiary" } } }, "localname": "PeriodOfProjectedClaimsOfSubusidiary", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "kwr_PooledSeparateAccountPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pooled Separate account Description", "label": "Pooled Separate account percentage" } } }, "localname": "PooledSeparateAccountPercentage", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_PriorPeriodReclassifications": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of balance sheet reclassifications made to prior period financial statements in order to conform to current year presentation.", "label": "Prior Period Reclassifications" } } }, "localname": "PriorPeriodReclassifications", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_ProceedsFromNonIncomeTaxRefunds": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash received during the period as refunds for the overpayment of non-income taxes.", "label": "Proceeds From Non Income Tax Refunds", "terseLabel": "Non-income tax refunds and other related credits" } } }, "localname": "ProceedsFromNonIncomeTaxRefunds", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "kwr_PublicOfferingDollarAmountSecurities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate dollar amount of securities that may be sold in a public offering.", "label": "Public Offering Dollar Amount Securities" } } }, "localname": "PublicOfferingDollarAmountSecurities", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_QhProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Companys management approved and the Company initiated a global restructuring plan (the QH Program) as part of its plan to realize certain cost synergies associated with the Combination.", "label": "QH Program [Member]" } } }, "localname": "QhProgramMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "domainItemType" }, "kwr_SbDeckingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inactive Subsidiary involved in asbestos litigation", "label": "Sb Decking [Member]", "terseLabel": "SB Decking [Member]" } } }, "localname": "SbDeckingMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_ScheduleOfDeferredTaxAssetsAndLiabilitiesBalanceSheetClassificationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the classification on the balance sheet of deferred income tax assets and liabilities", "label": "Schedule Of Deferred Tax Assets And Liabilities Balance Sheet Classification [Table Text Block]" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesBalanceSheetClassificationTableTextBlock", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/TaxesOnIncomeAndUncertainPositionsTables" ], "xbrltype": "textBlockItemType" }, "kwr_ShareBasedCompensationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share Based Compensation [Line Items]" } } }, "localname": "ShareBasedCompensationLineItems", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuanceExpectedTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Estimated period over which the equity-based payment award remains in effect once approved.", "label": "Share Based Goods And Nonemployee Services Transaction Shares Approved For Issuance Expected Term", "terseLabel": "Director Stock Ownership Plan Life" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuanceExpectedTerm", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_ShareRepurchaseProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share repurchase program authorized by the Board of Directors of the Company. Shares may be purchased from the open market or in private negotiated transactions.", "label": "Share Repurchase Program [Member]", "terseLabel": "2015 Share Repurchase [Member]" } } }, "localname": "ShareRepurchaseProgramMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumNumberOfSharesPercentagePerEmployee": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the maximum number of shares to be held per employee as a percentage of outstanding common stock.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Maximum Number Of Shares Percentage Per Employee", "terseLabel": "ESPP: Maximum Ownership of Outstanding Shares" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumNumberOfSharesPercentagePerEmployee", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_SignificanceThresholdInPercentageForReportingDispositionsOfABusiness": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of significance threshold for reporting dispositions of a business, as required by significance test in SEC Regulation.", "label": "Significance threshold in percentage for reporting dispositions of a business" } } }, "localname": "SignificanceThresholdInPercentageForReportingDispositionsOfABusiness", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_SouthAfricaEquityAffiliateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "South Africa Equity Affiliate [Member]" } } }, "localname": "SouthAfricaEquityAffiliateMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_StockOptionsCompensationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for the stock options plan.", "label": "Stock Options Compensation Expense [Member]", "terseLabel": "Stock Options [Member]" } } }, "localname": "StockOptionsCompensationExpenseMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "kwr_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityInstallmentsPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax installment paid related to accumulated foreign earnings liabilities, US Tax reforms.", "label": "Tax Cuts And Jobs Act Of 2017 Transition Tax For Accumulated Foreign Earnings Liability Installments Paid" } } }, "localname": "TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityInstallmentsPaid", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityRemainingInstallments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax installment remining to be paid, related to accumulated foreign earnings liabilities, US Tax reforms.", "label": "Tax Cuts And Jobs Act Of 2017 Transition Tax For Accumulated Foreign Earnings Liability Remaining Installments" } } }, "localname": "TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityRemainingInstallments", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Taxcutsandjobsactof2017accountingearningsofforeignsubsidiary": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Tax Cuts And Jobs Act Of 2017 Accounting Earnings Of Foreign Subsidiary" } } }, "localname": "Taxcutsandjobsactof2017accountingearningsofforeignsubsidiary", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_TelnordicMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tel Nordic ApS[Member]" } } }, "localname": "TelnordicMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_TermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A type of credit facility.", "label": "Term loan [Member]" } } }, "localname": "TermLoanMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_TinplatingsolutionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquisition of a tin-plating solutions business for the steel end market.", "label": "Tin Plating Solutions [Member]" } } }, "localname": "TinplatingsolutionsMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_TopFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from the entity's top five customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk Top Five [Member]", "terseLabel": "Top Five Customers [Member]" } } }, "localname": "TopFiveMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_TotalRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveLossOrIncome": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total recognized in net periodic benefit cost and other comprehensive loss or income", "label": "Total Recognized In Net Periodic Benefit Cost And Other Comprehensive Loss Or Income", "totalLabel": "Total Recognized In Net Periodic Benefit Cost And Other Comprehensive Loss Or (Income)" } } }, "localname": "TotalRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveLossOrIncome", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "kwr_TrademarksFormulationsandproducttechnologymemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trademarks Formulations And Product Technology [Member]" } } }, "localname": "TrademarksFormulationsandproducttechnologymemberMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "kwr_TrademarksandformulationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trademarks and Formulations [Member]" } } }, "localname": "TrademarksandformulationsMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_TwentyTwentyOneAcquisitionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Twenty Twenty One Acquisition.", "label": "Twenty Twenty One Acquisition [Member]", "terseLabel": "2021 Acquisitions [Member]" } } }, "localname": "TwentyTwentyOneAcquisitionMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_USTaxReformAct": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A decription of the Tax Cuts and Jobs Act (U.S. Tax Reform) tax legislation as enacted by the U.S. government on December 22,2017 and its effetcs on the Company's earnings.", "label": "U.S. Tax Reform Act" } } }, "localname": "USTaxReformAct", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "kwr_UncertainTaxPositions": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non-cash adjustment for the non-deferred portion of the change in liability for uncertain tax positions", "label": "Uncertain Tax Positions", "terseLabel": "Uncertain tax positions (non-deferred portion)" } } }, "localname": "UncertainTaxPositions", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kwr_UnrecognizedTaxBenefitsIfRecognized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of potential unrecognized tax benefits.", "label": "Unrecognized Tax Benefits If Recognized" } } }, "localname": "UnrecognizedTaxBenefitsIfRecognized", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_UnrecognizedTaxBenefitsIncomeTaxPenaltiesIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of Income for penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits Tax Penalties Income" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesIncome", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_UnrecognizedTaxBenefitsInterestIncomeOnIncomeTaxes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income for an overpayment of income taxes.", "label": "Unrecognized Tax Benefits Interest Income On Income Taxes" } } }, "localname": "UnrecognizedTaxBenefitsInterestIncomeOnIncomeTaxes", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_UnrecognizedTaxBenefitsReserve": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount unrecognized tax benefit reserve.", "label": "Unrecognized Tax Benefits Reserve" } } }, "localname": "UnrecognizedTaxBenefitsReserve", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_ValuationAllowanceAmountRelatedToBusinessCombination": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Valuation Allowance, Amount Related To Business Combination", "label": "Valuation Allowance, Amount Related To Business Combination", "terseLabel": "Valuation allowance, amount Related To Business Combination" } } }, "localname": "ValuationAllowanceAmountRelatedToBusinessCombination", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Valuationallowanceamountotherforeigndeferredtaxasset": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Valuation allowance amount Other Foreign Deferred Tax Asset" } } }, "localname": "Valuationallowanceamountotherforeigndeferredtaxasset", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_Valuationallowanceamountstatedeferredtaxasset": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Valuation Allowance Amount State Deferred tax asset" } } }, "localname": "Valuationallowanceamountstatedeferredtaxasset", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "kwr_VatAssessmentThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assessment amount for VAT related matters", "label": "Vat Assessment Three [Member]", "terseLabel": "VAT Assessment Three [Member]" } } }, "localname": "VatAssessmentThreeMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_VatSettlementOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Charge taken for settlement with two jurisdictions related to VAT disputes", "label": "Vat Settlement One [Member]", "terseLabel": "VAT Settlement One [Member]" } } }, "localname": "VatSettlementOneMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_VatSettlementTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Charge taken for settlement with third jurisdictions related to VAT disputes", "label": "Vat Settlement Two [Member]", "terseLabel": "VAT Settlement Two [Member]" } } }, "localname": "VatSettlementTwoMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_VatTotalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total charge taken for VAT related matters.", "label": "Vat Total [Member]", "terseLabel": "VAT, Total [Member]" } } }, "localname": "VatTotalMember", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "kwr_Vestingsharestargetlowerpercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vesting Shares Target Lower Percent" } } }, "localname": "Vestingsharestargetlowerpercent", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "kwr_Vestingsharestargetupperpercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vesting Shares Target Upper Percent" } } }, "localname": "Vestingsharestargetupperpercent", "nsuri": "http://www.quakerchem.com/20210930", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "srt_AmericasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Americas [Member]" } } }, "localname": "AmericasMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asia Pacific [Member]" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails", "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r153", "r372", "r377", "r385", "r713", "r714", "r721", "r722", "r837", "r945" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r153", "r372", "r377", "r385", "r713", "r714", "r721", "r722", "r837", "r945" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r153", "r220", "r239", "r240", "r241", "r242", "r244", "r246", "r250", "r372", "r373", "r374", "r375", "r376", "r377", "r379", "r380", "r382", "r384", "r385" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r153", "r220", "r239", "r240", "r241", "r242", "r244", "r246", "r250", "r372", "r373", "r374", "r375", "r376", "r377", "r379", "r380", "r382", "r384", "r385" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Operating Lease Maturities [Table Text Block]" } } }, "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": { "auth_ref": [ "r2", "r157", "r169", "r275", "r607", "r608", "r609", "r655", "r656", "r753", "r759", "r760", "r960" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]", "terseLabel": "Adjusted Balance [Member]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r2", "r157", "r169", "r177", "r275", "r607", "r608", "r609", "r655", "r656", "r753", "r756", "r759", "r760", "r960" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityChangesInEquityDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r2", "r157", "r169", "r177", "r275", "r607", "r608", "r609", "r655", "r656", "r753", "r756", "r759", "r760", "r960" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityChangesInEquityDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r2", "r157", "r169", "r177", "r275", "r607", "r608", "r609", "r655", "r656", "r753", "r756", "r759", "r760", "r960" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityChangesInEquityDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r257", "r464", "r468", "r914" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r390", "r423", "r570", "r580", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r911", "r915", "r946", "r947" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/LeasesNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r390", "r423", "r570", "r580", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r911", "r915", "r946", "r947" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r257", "r464", "r468", "r914" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "North America [Member]" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r252", "r464", "r466", "r854", "r910", "r912" ], "lang": { "en-us": { "role": { "label": "Products and Services [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r252", "r464", "r466", "r854", "r910", "r912" ], "lang": { "en-us": { "role": { "label": "Products and Services [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r390", "r423", "r504", "r570", "r580", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r911", "r915", "r946", "r947" ], "lang": { "en-us": { "role": { "label": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/LeasesNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r390", "r423", "r504", "r570", "r580", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r911", "r915", "r946", "r947" ], "lang": { "en-us": { "role": { "label": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/LeasesNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAdjustmentMember": { "auth_ref": [ "r154", "r155", "r156", "r160", "r161", "r166", "r167", "r169", "r171", "r172", "r174", "r175", "r203", "r759", "r760" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period, Adjustment [Member]", "terseLabel": "Measurement period adjustments [Member]" } } }, "localname": "RestatementAdjustmentMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r3", "r154", "r155", "r156", "r160", "r161", "r166", "r167", "r168", "r169", "r171", "r172", "r173", "r174", "r175", "r177", "r203", "r278", "r279", "r611", "r656", "r754", "r759", "r760", "r761", "r918", "r919", "r920", "r921", "r922", "r923", "r924", "r925", "r926", "r927", "r961", "r962" ], "lang": { "en-us": { "role": { "label": "Restatement [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r3", "r154", "r155", "r156", "r160", "r161", "r166", "r167", "r168", "r169", "r171", "r172", "r173", "r174", "r175", "r177", "r203", "r278", "r279", "r611", "r656", "r754", "r759", "r760", "r761", "r918", "r919", "r920", "r921", "r922", "r923", "r924", "r925", "r926", "r927", "r961", "r962" ], "lang": { "en-us": { "role": { "label": "Restatement [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r170", "r575" ], "lang": { "en-us": { "role": { "label": "Forecast [Member]" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioPreviouslyReportedMember": { "auth_ref": [ "r3", "r154", "r156", "r160", "r161", "r166", "r167", "r168", "r169", "r171", "r172", "r174", "r175", "r203", "r278", "r279", "r611", "r656", "r754", "r759", "r760", "r761", "r918", "r919", "r920", "r921", "r922", "r923", "r924", "r925", "r926", "r927", "r961", "r962" ], "lang": { "en-us": { "role": { "label": "As initially Reported [Member]" } } }, "localname": "ScenarioPreviouslyReportedMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r170", "r177", "r575" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r253", "r254", "r464", "r467", "r913", "r936", "r937", "r938", "r939", "r940", "r941", "r942", "r943", "r944" ], "lang": { "en-us": { "role": { "label": "Segment Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails", "http://www.quakerchem.com/role/IntangibleAssetsIndefiniteLivedDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails", "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "domainItemType" }, "srt_SouthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "South America [Member]" } } }, "localname": "SouthAmericaMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r253", "r254", "r464", "r467", "r913", "r931", "r936", "r937", "r938", "r939", "r940", "r941", "r942", "r943", "r944" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails", "http://www.quakerchem.com/role/IntangibleAssetsIndefiniteLivedDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails", "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r170", "r177", "r356", "r575", "r843" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_SubsidiariesMember": { "auth_ref": [ "r533", "r834", "r835", "r836" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [Member]", "terseLabel": "Argentina [Member]" } } }, "localname": "SubsidiariesMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdate201613Member": { "auth_ref": [ "r271" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.", "label": "Accounting Standards Update 2016-13 [Member]", "terseLabel": "ASU 2016-13 [Member]" } } }, "localname": "AccountingStandardsUpdate201613Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdate201811Member": { "auth_ref": [ "r812" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2018-11 Leases (Topic 842): Targeted Improvements.", "label": "Accounting Standards Update 2018-11 [Member]" } } }, "localname": "AccountingStandardsUpdate201811Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdateExtensibleList": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r160", "r161", "r162", "r164", "r263", "r264", "r272", "r273", "r274", "r275", "r278", "r279", "r371", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r611", "r655", "r656", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r758", "r759", "r760", "r761", "r775", "r776", "r777", "r778", "r779", "r780", "r784", "r785", "r832", "r916", "r917", "r918", "r919", "r920", "r921", "r922", "r923", "r924", "r925", "r926", "r927", "r958", "r959", "r960", "r961", "r962" ], "lang": { "en-us": { "role": { "documentation": "Indicates amendment to accounting standards.", "label": "Accounting Standards Update [Extensible Enumeration]" } } }, "localname": "AccountingStandardsUpdateExtensibleList", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r49", "r840" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 25.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable", "terseLabel": "Accounts and Other Payables" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r15", "r34", "r259", "r260" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r872", "r900" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.", "label": "Accrued Liabilities" } } }, "localname": "AccruedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalariesCurrent": { "auth_ref": [ "r19", "r20", "r54" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 27.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued compensation" } } }, "localname": "AccruedSalariesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r80", "r85", "r94", "r95", "r96", "r720" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment [Member]", "terseLabel": "Defined Benefit Pension Plans [Member]" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAOCIReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r47", "r327" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation Depletion And Amortization Property Plant And Equipment", "negatedTerseLabel": "Less: Accumulated Depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": { "auth_ref": [ "r75", "r85", "r719" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.", "label": "Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]", "terseLabel": "Derivative Instruments" } } }, "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAOCIReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "auth_ref": [ "r76", "r77", "r78", "r85", "r94", "r95", "r96" ], "lang": { "en-us": { "role": { "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.", "label": "Accumulated Net Unrealized Investment Gain (Loss) [Member]", "terseLabel": "Unrealized Gain (Loss) in Available-for-Sale Securities [Member]" } } }, "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAOCIReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r37", "r83", "r84", "r85", "r893", "r923", "r927" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 44.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated other comprehensive loss", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/EquityAOCIReclassificationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r94", "r95", "r792", "r793", "r794", "r795", "r796", "r798" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAOCIReclassificationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r82", "r85", "r94", "r95", "r96", "r154", "r155", "r156", "r720", "r918", "r919", "r962" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive Income (Loss) [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r73", "r85", "r94", "r95", "r96", "r720", "r793", "r794", "r795", "r796", "r798" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Translation Adjustment [Member]", "terseLabel": "Currency Translation Adjustments [Member]" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAOCIReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Intangible Assets, Amortizable Life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r35" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 42.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Capital in excess of par value" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r154", "r155", "r156", "r607", "r608", "r609", "r759" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Capital in Excess of Par Value [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r136", "r316" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsForErrorCorrectionDomain": { "auth_ref": [ "r166", "r167", "r168", "r171", "r172", "r174", "r175" ], "lang": { "en-us": { "role": { "documentation": "Type of error correction.", "label": "Error Correction, Type [Domain]" } } }, "localname": "AdjustmentsForErrorCorrectionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r160", "r161", "r162", "r164", "r177", "r263", "r264", "r272", "r273", "r274", "r275", "r278", "r279", "r371", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r611", "r653", "r654", "r655", "r656", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r758", "r759", "r760", "r761", "r775", "r776", "r777", "r778", "r779", "r780", "r784", "r785", "r832", "r856", "r857", "r858", "r916", "r917", "r918", "r919", "r920", "r921", "r922", "r923", "r924", "r925", "r926", "r927", "r958", "r959", "r960", "r961", "r962" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Adjustments For New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).", "label": "Adjustments To Additional Paid In Capital Other" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation": { "auth_ref": [ "r435", "r440", "r615" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from a tax benefit associated with share-based compensation plan other than an employee stock ownership plan (ESOP). Includes, but is not limited to, excess tax benefit.", "label": "Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation", "terseLabel": "Excess tax benefit from stock option exercises" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income (loss) to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r583", "r600", "r613" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Allocated Share Based Compensation Expense", "terseLabel": "Share-based Compensation Expense", "verboseLabel": "Total share-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r261", "r283", "r286", "r287" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Allowance For Doubtful Accounts Receivable", "periodEndLabel": "Balance at End of Period", "periodStartLabel": "Balance at Beginning of Period", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r106", "r136", "r410", "r804" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_InterestAndDebtExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of debt issuance costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmountRecognizedInIncomeDueToInflationaryAccounting": { "auth_ref": [ "r800" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount that will be recognized through the income statement (as well as the impact on the other financial statements) as part of highly inflationary accounting.", "label": "Amount Recognized In Income Due To Inflationary Accounting", "verboseLabel": "Currency conversion impacts of hyper-inflationary accounting" } } }, "localname": "AmountRecognizedInIncomeDueToInflationaryAccounting", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r200" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "terseLabel": "Antidilutive Shares" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsAntidilutiveSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AssetAcquisitionConsiderationTransferred": { "auth_ref": [ "r701", "r702", "r703", "r704" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.", "label": "Asset Acquisition, Consideration Transferred" } } }, "localname": "AssetAcquisitionConsiderationTransferred", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r149", "r228", "r241", "r248", "r270", "r372", "r373", "r374", "r376", "r377", "r378", "r379", "r381", "r383", "r385", "r386", "r713", "r721", "r774", "r838", "r840", "r865", "r889" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total assets", "terseLabel": "Segment assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsAndLiabilitiesLesseeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Abstract]" } } }, "localname": "AssetsAndLiabilitiesLesseeAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r16", "r17", "r68", "r149", "r270", "r372", "r373", "r374", "r376", "r377", "r378", "r379", "r381", "r383", "r385", "r386", "r713", "r721", "r774", "r838", "r840" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total current assets", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r763" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets Fair Value Disclosure" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsTotalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total assets, when it serves as a benchmark in a concentration of risk calculation, representing the sum of all reported assets as of the balance sheet date.", "label": "Assets Total [Member]", "terseLabel": "Assets Total [Member]" } } }, "localname": "AssetsTotalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r584", "r602" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r731", "r734" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis Of Accounting Policy [Policy Text Block]" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r563", "r576" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsTables", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsAntidilutiveSharesDetails", "http://www.quakerchem.com/role/EquityNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r563", "r576", "r679", "r680" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsTables", "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsAntidilutiveSharesDetails", "http://www.quakerchem.com/role/EquityNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails", "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date when the business acquisition agreement was executed, in YYYY-MM-DD format.", "label": "Business Acquisition, Date of Acquisition Agreement" } } }, "localname": "BusinessAcquisitionDateOfAcquisitionAgreement1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r698" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsAntidilutiveSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsTables", "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsAntidilutiveSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionNameOfAcquiredEntity": { "auth_ref": [ "r674" ], "lang": { "en-us": { "role": { "documentation": "Name of the acquired entity.", "label": "Business Acquisition Name Of Acquired Entity" } } }, "localname": "BusinessAcquisitionNameOfAcquiredEntity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r675" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Percentage of Voting Interests Acquired" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r677", "r678" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Schedule of unaudited Pro Forma [Text Block]" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r673" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 9.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination Acquisition Related Costs", "negatedLabel": "Combination, integration and other acquisition-related expenses", "negatedTerseLabel": "Combination-related expenses", "terseLabel": "Combination, integration and other acquisition-related" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r693", "r694", "r696" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Total consideration paid", "terseLabel": "Purchase price", "totalLabel": "Total fair value of consideration transferred", "verboseLabel": "Total fair value of consideration transferred", "zeroTerseLabel": "Total consideration paid for Coral", "zeroVerboseLabel": "Cash Paid for Acquisitions" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": { "auth_ref": [ "r693", "r694" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.", "label": "Fair value of common stock issued as consideration", "terseLabel": "Shares issued related to the Combination", "verboseLabel": "Less: Fair value of common stock issued as consideration" } } }, "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "auth_ref": [ "r135", "r700" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.", "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "negatedTerseLabel": "Change in Fair Value Estimate", "terseLabel": "Change in Fair Value Estimate" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationAsset": { "auth_ref": [ "r692", "r695", "r699" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset recognized arising from contingent consideration in a business combination.", "label": "Contingent consideration", "terseLabel": "Earn-out provisions" } } }, "localname": "BusinessCombinationContingentConsiderationAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r705" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business acquisitions disclosure [Text Block]" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitions" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate": { "auth_ref": [ "r683" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of indemnification assets (amounts to be reimbursed if and when certain assumed liabilities are paid) recognized at the acquisition date of a business combination.", "label": "Business Combination Indemnification Assets Amount As Of Acquisition Date", "terseLabel": "Indemnification assets" } } }, "localname": "BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationIndemnificationAssetsDescription": { "auth_ref": [ "r682" ], "lang": { "en-us": { "role": { "documentation": "For indemnification assets recognized in connection with a business combination, this element represents a description of such assets.", "label": "Business Combination Indemnification Assets Description" } } }, "localname": "BusinessCombinationIndemnificationAssetsDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationIndemnificationAssetsRangeOfOutcomesValueHigh": { "auth_ref": [ "r684" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "For indemnification assets recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the indemnification benefit which may be realized.", "label": "Business Combination Indemnification Assets Range Of Outcomes Value High" } } }, "localname": "BusinessCombinationIndemnificationAssetsRangeOfOutcomesValueHigh", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationIndemnificationAssetsRangeOfOutcomesValueLow": { "auth_ref": [ "r684" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "For indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the indemnification benefit which may be realized.", "label": "Business Combination Indemnification Assets Range Of Outcomes Value Low" } } }, "localname": "BusinessCombinationIndemnificationAssetsRangeOfOutcomesValueLow", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred": { "auth_ref": [ "r687" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred", "terseLabel": "Post Closing Adjustment", "verboseLabel": "Less: estimated purchase price settlement" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r685" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "totalLabel": "Total Assets Purchased" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r685" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "negatedTerseLabel": "Cash Acquired", "terseLabel": "Cash Acquired", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [ "r685" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets", "terseLabel": "Prepaid expenses and other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r685" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables", "terseLabel": "Accounts receivable, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r685" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "terseLabel": "Deferred tax liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r685" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r681", "r685" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventories, net", "verboseLabel": "Inventories" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r685" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Acquisition, Purchase Price Allocation, Liabilities Assumed", "negatedTotalLabel": "Total Liabilities Assumed", "terseLabel": "Total Liabilities Assumed", "totalLabel": "Total Liabilities Assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r681", "r685" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Net", "terseLabel": "Cash Paid for Acquisitions", "totalLabel": "Business Acquisition, Cost of Acquired Entity, Purchase Price" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r681", "r685" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Propery, plant & equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": { "auth_ref": [ "r676" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.", "label": "Equity Method Investment Realized Gain (Loss) On Revaluation", "negatedLabel": "Non cash gain from purchase of equity affiliate", "terseLabel": "Gain on Revaluation of Existing Equity Interest in Step Purchase" } } }, "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Acquisitions [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r140", "r141", "r142" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred but Not yet Paid", "terseLabel": "Change in accrued purchases of property, plant and equipment, net" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAcquiredFromAcquisition": { "auth_ref": [ "r114" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).", "label": "Cash Acquired From Acquisition", "negatedTerseLabel": "Cash Acquired", "terseLabel": "Less: cash Acquired", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAcquiredFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r13", "r44", "r138" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.quakerchem.com/role/RestrictedCashDetails": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at begining of period" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.", "label": "Cash And Cash Equivalents Disclosure [Text Block]" } } }, "localname": "CashAndCashEquivalentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCash" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r130", "r138", "r143" ], "calculation": { "http://www.quakerchem.com/role/RestrictedCashDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash cash equivalents restricted cash and restricted cash equivalents", "periodEndLabel": "Cash, Cash Equivalents and Restricted Cash at the end of the period", "periodStartLabel": "Cash, Cash Equivalents and Restricted Cash at the beginning of the period", "totalLabel": "Cash cash equivalents restricted cash and restricted cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted Cash Abstract]" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r130", "r790" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash And Cash Equivalents Period Increase Decrease", "terseLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash", "totalLabel": "Net (decrease) increase in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashSurrenderValueFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).", "label": "Cash Surrender Value Fair Value Disclosure", "terseLabel": "Company Owned Life Insurance" } } }, "localname": "CashSurrenderValueFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfTreasuryStockTable": { "auth_ref": [ "r442", "r443", "r444", "r445" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table]" } } }, "localname": "ClassOfTreasuryStockTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r61", "r355", "r873", "r898" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 39.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r352", "r353", "r354", "r366", "r935" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments And Contingencies Disclosure [Text Block]" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r440" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Dividends declared" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/EquityChangesInEquityParentheticalsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r154", "r155", "r759" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock Par Value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r33", "r435" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock shares, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r33", "r840" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 41.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $1 par value; authorized 30,000,000 shares; issued and outstanding 2021 -17,888,577 shares; 2020 - 17,850,616 shares", "terseLabel": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockVotingRights": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Common Stock Voting Rights" } } }, "localname": "CommonStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r90", "r92", "r93", "r103", "r879", "r907" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive income attributable to Quaker Chemical Corporation", "totalLabel": "Comprehensive income (loss) attributable to Quaker Chemical Corporation" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r90", "r92", "r102", "r709", "r710", "r725", "r878", "r906" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 13.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest", "negatedLabel": "Less: (income) loss attributable to noncontrolling interest", "terseLabel": "Less: comprehensive income attributable to noncontrolling interest" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r90", "r92", "r101", "r708", "r725", "r877", "r905" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 12.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive income", "totalLabel": "Comprehensive income (loss)" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive income (loss) [Policy Text Block]" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r212", "r213", "r257", "r771", "r772", "r934" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/EquityNarrativeDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r212", "r213", "r257", "r771", "r772", "r930", "r934" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk By Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/EquityNarrativeDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r212", "r213", "r257", "r771", "r772", "r930", "r934" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentsOffBalanceSheetRisk": { "auth_ref": [ "r773", "r887" ], "lang": { "en-us": { "role": { "documentation": "Description of financial instruments, excluding certain derivatives, with off-balance sheet credit risk (for example, standby letters of credit or financial guarantees), including (1) information about the (shared) activity, region or economic characteristic that identifies the concentration, (2) the face or contract amount of the instrument, (3) the nature and terms of the instrument, including the market risk, cash requirements and accounting policies for it, (4) the maximum amount of loss due to credit risk that would be incurred if the counterparties failed completely to perform according to the terms of the contracts, and any security or collateral that proved to be of no value, (5) the entity's policy of requiring collateral or other security to support financial instruments subject to credit risk, information about access to collateral or other security, and a brief description of the security supporting those financial instruments, and (6) the policy of entering into and a brief description of master netting arrangements to mitigate the credit risk, and the extent to which such arrangements would reduce the maximum amount of loss due to credit risk.", "label": "Concentration Risk Credit Risk Financial Instruments Off Balance Sheet Risk", "terseLabel": "Other off balance sheet arrangements" } } }, "localname": "ConcentrationRiskCreditRiskFinancialInstrumentsOffBalanceSheetRisk", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r212", "r213", "r257", "r771", "r772" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Reclassification Percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/EquityNarrativeDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r209", "r212", "r213", "r214", "r771", "r773", "r934" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r212", "r213", "r257", "r771", "r772", "r934" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateBondSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).", "label": "Industrial Development Bond Due 2028 [Member]" } } }, "localname": "CorporateBondSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r108", "r854" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of goods sold", "terseLabel": "Cost of goods sold (excluding amortization expense - See Note 14)" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditLossFinancialInstrumentPolicyTextBlock": { "auth_ref": [ "r280", "r281", "r282", "r284", "r285", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r301" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security. Includes, but is not limited to, methodology used to estimate allowance for credit loss, how writeoff of uncollectible amount is recognized, and determination of past due status and nonaccrual status.", "label": "Credit Loss Financial Instrument [Policy Text Block]" } } }, "localname": "CreditLossFinancialInstrumentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r210", "r257" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerListsMember": { "auth_ref": [ "r689" ], "lang": { "en-us": { "role": { "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information.", "label": "Customer lists and rights to sell [Member]" } } }, "localname": "CustomerListsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r690" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtAndCapitalLeaseObligations": { "auth_ref": [ "r871", "r901" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term and long-term debt and lease obligation.", "label": "Debt and Capital Lease Obligations", "terseLabel": "Total debt", "totalLabel": "Debt And Capital Lease Obligations", "verboseLabel": "Credit facilities" } } }, "localname": "DebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r52" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 24.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.", "label": "Short-term borrowings and current portion of long-term debt", "negatedTerseLabel": "Current portion of long-term debt" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r146", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r404", "r411", "r412", "r414", "r420" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt [Text Block]" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentDescriptionOfVariableRateBasis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of reference rate used for variable rate of debt instrument.", "label": "Debt Instrument, Description of Variable Rate Basis" } } }, "localname": "DebtInstrumentDescriptionOfVariableRateBasis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r56", "r407", "r803" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Debt Instrument, Interest Rate During Period" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r56", "r388" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument Interest Rate Stated Percentage", "terseLabel": "Interest Rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateTerms": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.", "label": "Debt Instrument, Interest Rate Terms" } } }, "localname": "DebtInstrumentInterestRateTerms", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r57", "r390", "r767" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt Instrument, Maturity Date", "terseLabel": "Line Of Credit Maturity Date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Debt Instrument Maturity Date Description" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r59", "r148", "r153", "r387", "r388", "r389", "r390", "r391", "r392", "r394", "r400", "r401", "r402", "r403", "r405", "r406", "r407", "r408", "r409", "r410", "r413", "r416", "r417", "r418", "r419", "r436", "r437", "r438", "r439", "r802", "r803", "r805", "r806", "r885" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Debt Instrument [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount": { "auth_ref": [ "r58" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.", "label": "Debt Instrument, Unused Borrowing Capacity, Amount" } } }, "localname": "DebtInstrumentUnusedBorrowingCapacityAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of debt outstanding.", "label": "Debt, Weighted Average Interest Rate" } } }, "localname": "DebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": { "auth_ref": [ "r632" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.", "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Upper Bound" } } }, "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsCurrentNet": { "auth_ref": [ "r67", "r804" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Current, Net" } } }, "localname": "DeferredFinanceCostsCurrentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r48", "r400", "r804" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Cost Capitalized to Term loans and Long Term Debt", "negatedLabel": "Less: debt issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNoncurrentGross": { "auth_ref": [ "r48", "r804" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Deferred Finance Costs Noncurrent Gross" } } }, "localname": "DeferredFinanceCostsNoncurrentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r623", "r625" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 19.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Tax Assets Net Noncurrent", "terseLabel": "Deferred tax assets" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r136", "r150", "r650", "r662", "r663", "r664" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred income taxes", "negatedTerseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r30", "r31", "r641", "r867", "r888" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r623", "r625" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 35.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities Net", "terseLabel": "Deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r41" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred Revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueRevenueRecognized1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue.", "label": "Deferred Revenue Revenue Recognized 1", "negativeTerseLabel": "Deferred Revenue Revenue Recognized" } } }, "localname": "DeferredRevenueRevenueRecognized1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r644" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "terseLabel": "Deferred Tax Assets, Net", "totalLabel": "Total deferred tax assets, net" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetCurrent": { "auth_ref": [ "r623", "r624", "r625", "r626", "r642" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards classified as current.", "label": "Current deferred tax assets" } } }, "localname": "DeferredTaxAssetsNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": { "auth_ref": [ "r648", "r649" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": { "auth_ref": [ "r648", "r649" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax": { "auth_ref": [ "r646", "r648", "r649" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible alternative minimum tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax", "terseLabel": "Alternative minimum tax carryforward" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign": { "auth_ref": [ "r646", "r648", "r649" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards, Foreign", "terseLabel": "Foreign tax credit and other credits" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeign", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r625", "r644" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities", "terseLabel": "Defered Tax Liabilties, Net", "totalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesCurrent": { "auth_ref": [ "r623", "r625", "r626", "r648", "r649" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 30.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as current.", "label": "Current deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": { "auth_ref": [ "r513" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.", "label": "Defined Benefit Plan, Accumulated Benefit Obligation", "terseLabel": "Accumulated Benefit Obligation" } } }, "localname": "DefinedBenefitPlanAccumulatedBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligationIncreaseDecreaseForSettlementAndCurtailment": { "auth_ref": [ "r537" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of (increase) decrease in accumulated benefit obligation of defined benefit plan from effects of settlement and curtailment.", "label": "Defined Benefit Plan Effect Of Settlements And Curtailments On Accumulated Benefit Obligation" } } }, "localname": "DefinedBenefitPlanAccumulatedBenefitObligationIncreaseDecreaseForSettlementAndCurtailment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": { "auth_ref": [ "r81", "r85", "r525" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Pension and Other Postretirement Benefit Plans, Accumulated Other Comprehensive Income (Loss), before Tax", "negatedTotalLabel": "Accumulated Other Comprehensive Loss", "terseLabel": "Gross AOCI", "totalLabel": "Accumulated Other Comprehensive Loss (\"AOCI\")" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "auth_ref": [ "r480", "r520", "r551", "r557", "r558" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 8.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Gains (Losses)", "negatedLabel": "Actuarial Loss Amortization", "terseLabel": "Actuarial Loss Amortization" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "auth_ref": [ "r480", "r521", "r552", "r557", "r558" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 9.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "negatedLabel": "Prior Service (Credit) Cost Amortization", "terseLabel": "Prior service cost amortization" } } }, "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfTransitionAssetObligation": { "auth_ref": [ "r480", "r522", "r553" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 13.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transition asset (obligation) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Transition Obligations (Assets)", "terseLabel": "Transition Asset Amortization" } } }, "localname": "DefinedBenefitPlanAmortizationOfTransitionAssetObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmountOfEmployerAndRelatedPartySecuritiesIncludedInPlanAssets": { "auth_ref": [ "r533", "r557" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of employer security in which defined benefit plan asset is invested. Includes, but is not limited to, security issued or managed by related party of employer.", "label": "Defined Benefit Plan, Amount of Employer and Related Party Securities Included in Plan Assets", "terseLabel": "Value of Employer Securities Included in Plan Assets" } } }, "localname": "DefinedBenefitPlanAmountOfEmployerAndRelatedPartySecuritiesIncludedInPlanAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]" } } }, "localname": "DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForRemeasurementDueToSettlement": { "auth_ref": [ "r484" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from remeasurement due to settlement. Excludes decrease to benefit obligation for settlement payment.", "label": "Defined Benefit Plan Benefit Obligation Increase Decrease For Remeasurement Due To Settlement", "terseLabel": "Pension Settlement Charge" } } }, "localname": "DefinedBenefitPlanBenefitObligationIncreaseDecreaseForRemeasurementDueToSettlement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement": { "auth_ref": [ "r484" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment, which decreases benefit obligation of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract. Excludes decreases to benefit obligation for remeasurement due to settlement.", "label": "Defined Benefit Plan Benefit Obligation Payment For Settlement" } } }, "localname": "DefinedBenefitPlanBenefitObligationPaymentForSettlement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationPeriodIncreaseDecrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan Benefit Obligation Period Increase (Decrease)" } } }, "localname": "DefinedBenefitPlanBenefitObligationPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": { "auth_ref": [ "r504", "r505", "r507", "r508", "r509", "r510", "r511", "r512", "r533", "r557" ], "lang": { "en-us": { "role": { "documentation": "Information by defined benefit plan asset investment.", "label": "Defined Benefit Plan, Asset Categories [Axis]" } } }, "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [ "r496", "r505", "r507", "r555", "r557", "r558" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.", "label": "Defined Benefit Plan, Contributions by Employer", "terseLabel": "Employer Contributions" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod": { "auth_ref": [ "r536" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost of providing special or contractual termination benefits payable from defined benefit plan.", "label": "Defined Benefit Plan Cost Of Providing Special Or Contractual Termination Benefit Recognized During Period", "terseLabel": "Defined Benefit Plan, Termination" } } }, "localname": "DefinedBenefitPlanCostOfProvidingSpecialOrContractualTerminationBenefitRecognizedDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDescriptionOfNatureOfEventResultingInSpecialOrContractualTerminationBenefitsRecognizedDuringPeriod": { "auth_ref": [ "r536" ], "lang": { "en-us": { "role": { "documentation": "Description of nature of event resulting in defined benefit plan providing special or contractual termination benefits.", "label": "Defined Benefit Plan Description Of Nature Of Event Resulting In Special Or Contractual Termination Benefits Recognized During Period" } } }, "localname": "DefinedBenefitPlanDescriptionOfNatureOfEventResultingInSpecialOrContractualTerminationBenefitsRecognizedDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": { "auth_ref": [ "r505", "r557" ], "lang": { "en-us": { "role": { "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.", "label": "Defined Benefit Plan Equity Securities [Member]" } } }, "localname": "DefinedBenefitPlanEquitySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear": { "auth_ref": [ "r555", "r558" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.", "label": "Defined Benefit Plan, Estimated Future Employer Contributions in Current Fiscal Year" } } }, "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r480", "r519", "r550", "r557", "r558" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 5.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return on Plan Assets", "negatedLabel": "Expected Return on Plan Assets", "terseLabel": "Expected Return on Plan Assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExplanationOfSignificantChangeInBenefitObligationOrPlanAssetsNotApparentFromOtherRequiredDisclosures": { "auth_ref": [ "r537", "r560" ], "lang": { "en-us": { "role": { "documentation": "Description of reason for changes in benefit obligation and plan assets of defined benefit plan.", "label": "Defined Benefit Plan Explanation Of Significant Change In Benefit Obligation Or Plan Assets Not Apparent From Other Required Disclosures" } } }, "localname": "DefinedBenefitPlanExplanationOfSignificantChangeInBenefitObligationOrPlanAssetsNotApparentFromOtherRequiredDisclosures", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r480", "r485", "r518", "r549", "r557", "r558" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 4.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost", "terseLabel": "Interest Cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r516", "r547", "r557", "r558" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 10.0, "parentTag": "kwr_TotalRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveLossOrIncome", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost", "terseLabel": "Net Periodic Benefit Cost", "totalLabel": "Net Periodic Benefit Cost", "verboseLabel": "Pension and postretirement benefit costs, non-service components" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanOtherCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of defined benefit plan cost (credit), classified as other.", "label": "Defined Benefit Plan Other Costs", "terseLabel": "Prior Service Cost Charge" } } }, "localname": "DefinedBenefitPlanOtherCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryPercentage": { "auth_ref": [ "r505", "r557" ], "lang": { "en-us": { "role": { "documentation": "Percentage of investment to total investment within defined benefit plan asset category.", "label": "Defined Benefit Plan Additional Disclosures About Plan Assets" } } }, "localname": "DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments": { "auth_ref": [ "r481", "r523", "r554" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 7.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.", "label": "Defined Benefit Plan, Recognized Net Gain (Loss) Due to Curtailments", "terseLabel": "Curtailment Charge" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": { "auth_ref": [ "r481", "r523", "r554" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 6.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.", "label": "Defined Benefit Plan, Recognized Net Gain (Loss) Due to Settlements", "negatedTerseLabel": "Settlement Loss" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r483", "r517", "r548", "r557", "r558" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "terseLabel": "Service Cost" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlansGeneralInformation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of defined benefit pension and other postretirement plans.", "label": "Defined Benefit Plans General Information", "terseLabel": "Defined Benefit Plans Investment Description" } } }, "localname": "DefinedBenefitPlansGeneralInformation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedContributionPlanCostRecognized": { "auth_ref": [ "r561" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for defined contribution plan.", "label": "Defined Contribution Plan, Cost Recognized", "terseLabel": "Total Contribution Amount" } } }, "localname": "DefinedContributionPlanCostRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.", "label": "Defined Contribution Plan Employer Discretionary Contribution Amount" } } }, "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.", "label": "Defined Contribution Plan, Employer Matching Contribution, Percent", "terseLabel": "Non-elective Match Percentage" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage employer matches of the employee's percentage contribution matched.", "label": "Defined Contribution Plan Employer Matching Contribution Percent Of Match" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeAmountOfHedgedItem": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of hedged item in hedging relationship. Excludes hedged asset or liability.", "label": "Derivative Amount Of Hedged Item" } } }, "localname": "DerivativeAmountOfHedgedItem", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeBasisSpreadOnVariableRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.", "label": "Derivative, Basis Spread on Variable Rate" } } }, "localname": "DerivativeBasisSpreadOnVariableRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract Type [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral": { "auth_ref": [ "r69", "r70", "r72", "r745" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Fair Value, Amount Not Offset Against Collateral", "terseLabel": "Interest Rate Swaps, Liability" } } }, "localname": "DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fixed interest rate related to the interest rate derivative.", "label": "Derivative Fixed Interest Rate" } } }, "localname": "DerivativeFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r71", "r732", "r733", "r739", "r742" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument Risk [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r749", "r762" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments And Hedging Activities Disclosure [Text Block]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r730", "r732", "r739", "r742", "r743", "r746", "r748" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments Gain Loss By Hedging Relationship By Income Statement Location By Derivative Instrument Risk [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments Gain Loss [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": { "auth_ref": [ "r737", "r741" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.", "label": "Derivative Instruments Gain Loss Reclassified From Accumulated OCI Into Income Effective Portion Net", "terseLabel": "Amount and location of expense reclassified from AOCI into expense (effective portion)" } } }, "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet": { "auth_ref": [ "r738", "r747" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments representing (a) the amount of the hedge ineffectiveness and (b) the amount, if any, excluded from the assessment of hedge effectiveness.", "label": "Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net" } } }, "localname": "DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityNotionalAmount": { "auth_ref": [ "r727", "r728", "r729" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payments on the derivative liability.", "label": "Derivative Liability Notional Amount" } } }, "localname": "DerivativeLiabilityNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeRemainingMaturity1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period remaining until the derivative contract matures, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Derivative Remaining Maturity 1" } } }, "localname": "DerivativeRemainingMaturity1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DerivativeTermOfContract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Derivative, Term of Contract" } } }, "localname": "DerivativeTermOfContract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DerivativeVariableInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.", "label": "Derivative Variable Interest Rate" } } }, "localname": "DerivativeVariableInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of defined contribution pension and other postretirement plans.", "label": "Description of Defined Contribution Pension and Other Postretirement Plans", "terseLabel": "Description of Defined Contribution Plan" } } }, "localname": "DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases": { "auth_ref": [ "r807", "r808" ], "lang": { "en-us": { "role": { "documentation": "A general description of the nature of the existing leasing arrangements of a lessee for all operating leases including, but not limited to: (1) rental escalation clauses; (2) renewal or purchase options; (3) guarantees or indemnities, if any, (4) restrictions imposed by lease arrangements; (5) unusual provisions or conditions; (6) contingent rentals, if any; and (7) lease expiration dates.", "label": "Operating Lease Terms" } } }, "localname": "DescriptionOfLesseeLeasingArrangementsOperatingLeases", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disaggregation Of Revenue [Abstract]" } } }, "localname": "DisaggregationOfRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation Of Revenue [Table Text Block]" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r616" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Disclosure of Compensation Related Costs, Share-based Payments [Text Block]" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationChangesToPlanOfSale": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Description of the facts and circumstances leading to the decision to change the plan to sell the disposal group, including discontinued operation, and its effect on the results of operations of the period and any prior periods presented.", "label": "Disposal Group Including Discontinued Operation Changes To Plan Of Sale" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationChangesToPlanOfSale", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent": { "auth_ref": [ "r6", "r7", "r10", "r324", "r332" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Current", "terseLabel": "Intangible Assets Reclassified as Held for Sale" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsCash": { "auth_ref": [ "r440", "r884" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.", "label": "Cash dividends" } } }, "localname": "DividendsCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsCommonStock": { "auth_ref": [ "r440", "r884" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends Common Stock", "negatedLabel": "Dividends common stock", "negatedTerseLabel": "Dividends" } } }, "localname": "DividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableCurrent": { "auth_ref": [ "r20", "r54" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 26.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Dividends payable" } } }, "localname": "DividendsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Country [Member]" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DomesticLineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, inside the reporting entity's home country.", "label": "Domestic Line of Credit [Member]", "terseLabel": "U.S. Term Loan [Member]" } } }, "localname": "DomesticLineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EMEAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Regions of Europe, Middle East and Africa.", "label": "EMEA [Member]" } } }, "localname": "EMEAMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails", "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Per share data:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r104", "r166", "r167", "r169", "r170", "r171", "r180", "r183", "r195", "r198", "r199", "r203", "r204", "r760", "r761", "r880", "r908" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Net income (loss) attributable to Quaker Chemical Corporation common shareholders - basic", "terseLabel": "Basic earnings (loss) per common share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r104", "r166", "r167", "r169", "r170", "r171", "r183", "r195", "r198", "r199", "r203", "r204", "r760", "r761", "r880", "r908" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Net income (loss) attributable to Quaker Chemical Corporation common shareholders - diluted", "terseLabel": "Diluted earnings (loss) per common share" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r200", "r201", "r202", "r205" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": { "auth_ref": [ "r790" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 45.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.", "label": "Effect of foreign exchange rate changes on cash" } } }, "localname": "EffectOfExchangeRateOnCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r628" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate, Continuing Operations" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r151", "r628", "r665" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r628", "r665" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.", "label": "Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r601" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1", "terseLabel": "Weighted Average Remaining Life, Nonvested Stock Awards" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [ "r601" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options", "terseLabel": "Unrecognized Share-based Compensation Expense, Nonvested Stock Award" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r601" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options", "terseLabel": "Unrecognized Compensation Expense, Options" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r598" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Employee Stock Option [Member]", "terseLabel": "Stock Options [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Equity Class Of Treasury Stock [Line Items]" } } }, "localname": "EquityClassOfTreasuryStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r2", "r94", "r95", "r96", "r154", "r155", "r156", "r161", "r172", "r175", "r208", "r275", "r435", "r440", "r607", "r608", "r609", "r655", "r656", "r759", "r792", "r793", "r794", "r795", "r796", "r798", "r918", "r919", "r920", "r962" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAOCIReclassificationsDetails", "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment Ownership Percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r45", "r229", "r268" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 18.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Investments in associated companies", "terseLabel": "Equity Method Investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ErrorCorrectionOtherMember": { "auth_ref": [ "r166", "r167", "r168", "r171", "r172", "r174", "r175" ], "lang": { "en-us": { "role": { "documentation": "Error correction to previously issued financial statement classified as other.", "label": "Error Correction Other [Member]" } } }, "localname": "ErrorCorrectionOtherMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": { "auth_ref": [ "r166", "r167", "r168", "r171", "r172", "r174", "r175" ], "lang": { "en-us": { "role": { "documentation": "Information by type of error correction.", "label": "Error Corrections And Prior Period Adjustments Restatement By Restatement Period And Amount Axis" } } }, "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r763", "r764", "r765", "r770" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r766" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [TableTextBlock]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsTable" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r763", "r764" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsTable" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r402", "r416", "r417", "r505", "r507", "r508", "r509", "r510", "r511", "r512", "r557", "r764", "r844", "r845", "r846" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value By Fair Value Hierarchy Level [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r769" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r402", "r505", "r507", "r512", "r557", "r764", "r844" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r402", "r416", "r417", "r505", "r507", "r512", "r557", "r764", "r845" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r402", "r416", "r417", "r505", "r507", "r508", "r509", "r510", "r511", "r512", "r557", "r764", "r846" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r763", "r764" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.", "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsTable" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r768", "r770" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsTable" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r402", "r416", "r417", "r505", "r507", "r508", "r509", "r510", "r511", "r512", "r557", "r844", "r845", "r846" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Measurements Fair Value Hierarchy [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsAssetsSubjectToFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r731", "r735", "r746" ], "lang": { "en-us": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives Balance Sheet Location By Derivative Contract Type By Hedging Designation [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r814" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Finance Lease Liability Current" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r814" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Long-term lease liabilities" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedCustomerListsGross": { "auth_ref": [ "r315" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date of an asset comprised of customer information, acquired in a business combination or other transaction, having a finite beneficial life.", "label": "Finite Lived Customer Lists, Gross" } } }, "localname": "FiniteLivedCustomerListsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r315" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets Accumulated Amortization", "terseLabel": "Accumumlated Amortization", "totalLabel": "Total" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r317" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Next Twelve Months", "terseLabel": "For the Year ended December 31, 2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "terseLabel": "For the year ended December 31, 2021" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r317" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Five", "terseLabel": "For the Year ended December 31, 2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r317" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Four", "terseLabel": "For the Year ended December 31, 2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r317" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Three", "terseLabel": "For the Year ended December 31, 2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r317" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Two", "terseLabel": "For the Year ended December 31, 2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r310", "r312", "r315", "r319", "r855", "r862" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r315", "r862" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets Gross", "terseLabel": "Gross Carrying Amount", "totalLabel": "Gross Carrying Amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGrossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite Lived Intangible Assets Gross [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsGrossAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails", "http://www.quakerchem.com/role/IntangibleAssetsIndefiniteLivedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r310", "r314" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedTrademarksGross": { "auth_ref": [ "r315" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a specified period of time.", "label": "Finite Lived Trademarks, Gross" } } }, "localname": "FiniteLivedTrademarksGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FixedIncomeSecuritiesMember": { "auth_ref": [ "r505", "r557" ], "lang": { "en-us": { "role": { "documentation": "Investment that provides a return in the form of fixed periodic payments and eventual return of principal at maturity.", "label": "Fixed Income Securities [Member]" } } }, "localname": "FixedIncomeSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionGainBeforeTax": { "auth_ref": [ "r788", "r789" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain recognized in the income statement.", "label": "Foreign Currency Transaction Gain, before Tax" } } }, "localname": "ForeignCurrencyTransactionGainBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossRealized": { "auth_ref": [ "r788", "r789" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), Realized", "terseLabel": "Foreign exchange gains (losses), net" } } }, "localname": "ForeignCurrencyTransactionGainLossRealized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionLossBeforeTax": { "auth_ref": [ "r788", "r789" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized loss recognized in the income statement.", "label": "Foreign Currency Transaction Loss Before Tax" } } }, "localname": "ForeignCurrencyTransactionLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of transaction giving rise to foreign currency transaction gain (loss), including but not limited to, nature of the transaction, the foreign currency involved, the accounting for the transaction.", "label": "Foreign Currency Transactions Description" } } }, "localname": "ForeignCurrencyTransactionsDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ForeignLineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars, outside the reporting entity's home country.", "label": "Foreign Line of Credit [Member]", "terseLabel": "EURO Term Loan [Member]" } } }, "localname": "ForeignLineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignPlanMember": { "auth_ref": [ "r562", "r566", "r579" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Foreign Plan [Member]", "terseLabel": "Foreign [Member]" } } }, "localname": "ForeignPlanMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets": { "auth_ref": [ "r136", "r323", "r330" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Assets", "terseLabel": "Gain (loss) on fixed asset disposals, net" } } }, "localname": "GainLossOnDispositionOfAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfOtherAssets": { "auth_ref": [ "r136" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of other assets.", "label": "Gain Loss On Sale Of Other Assets" } } }, "localname": "GainLossOnSaleOfOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r136" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain on disposal of property, plant and equipment", "negatedLabel": "(Gain) loss on disposal of property, plant, equipment and other assets" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossRelatedToLitigationSettlement": { "auth_ref": [ "r355" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.", "label": "Gain (Loss) Related To Litigation Settlement" } } }, "localname": "GainLossRelatedToLitigationSettlement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralDiscussionOfDerivativeInstrumentsAndHedgingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "General Discussion Of Derivative Instruments And Hedging Activities [Abstract]" } } }, "localname": "GeneralDiscussionOfDerivativeInstrumentsAndHedgingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Pension and Other Postretirement Benefits [Abstract]" } } }, "localname": "GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_GeographicConcentrationRiskMember": { "auth_ref": [ "r211", "r934" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).", "label": "Geographic Concentration Risk [Member]" } } }, "localname": "GeographicConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r302", "r303", "r840", "r864" ], "calculation": { "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails": { "order": 8.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Goodwill, Ending Balance", "periodStartLabel": "Goodwill, Beginning Balance", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails", "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r304" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Goodwill Additions" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill And Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill And Intangible Assets Disclosure [Text Block]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "Goodwill And Intangible Assets, Goodwill, Policy [Policy Text Block]" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r305" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Currency translation and other adjustments" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillPeriodIncreaseDecrease": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill Period Increase Decrease" } } }, "localname": "GoodwillPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "auth_ref": [ "r306", "r672" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill Purchase Accounting Adjustments", "terseLabel": "Goodwill Reductions" } } }, "localname": "GoodwillPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill Roll Forward" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r107", "r149", "r228", "r240", "r244", "r247", "r250", "r270", "r372", "r373", "r374", "r377", "r378", "r379", "r381", "r383", "r385", "r386", "r774" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": { "auth_ref": [ "r136", "r320" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.", "label": "Indefinite-lived intangible asset impairment", "negatedLabel": "Indefinite-lived intangible asset impairment" } } }, "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/IntangibleAssetsIndefiniteLivedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "auth_ref": [ "r136", "r322", "r329" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).", "label": "Impairment of Long-Lived Assets Held-for-use", "negatedTerseLabel": "Impairment of Long-Lived Assets Held-for-use" } } }, "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r228", "r240", "r244", "r247", "r250" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 13.0, "parentTag": "kwr_IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (loss) before taxes and equity in net income of associated companies", "totalLabel": "Income (loss) before taxes and equity in net income of associated companies" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r98", "r136", "r225", "r268", "r874", "r902" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 16.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Equity in net income of associated companies", "verboseLabel": "Total equity in net income of associated companies" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": { "auth_ref": [ "r136" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.", "label": "Equity in net (income) loss of associated companies, net of dividends", "negatedLabel": "Equity in undistributed earnings of associated companies, net of dividends" } } }, "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r331", "r338" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r633" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxCreditsAndAdjustments": { "auth_ref": [ "r137" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A credit or adjustment for government or taxing authority authorized decrease in taxes owed as a result of meeting certain tax policy conditions.", "label": "Income Tax Credits and Adjustments", "terseLabel": "Certain indirect tax credits" } } }, "localname": "IncomeTaxCreditsAndAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r151", "r629", "r640", "r645", "r660", "r666", "r668", "r669", "r671" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Taxes on Income [Text Block]" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationDescription": { "auth_ref": [ "r631" ], "lang": { "en-us": { "role": { "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.", "label": "Income Tax Examination Description" } } }, "localname": "IncomeTaxExaminationDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the additional liability or refund received or expected based on a final settlement with a taxing authority.", "label": "Income Tax Examination Liability Refund Adjustment from Settlement with Taxing Authority" } } }, "localname": "IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExaminationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Tax Examination [Line Items]" } } }, "localname": "IncomeTaxExaminationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationTable": { "auth_ref": [ "r634" ], "lang": { "en-us": { "role": { "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued.", "label": "Income Tax Examination [Table]" } } }, "localname": "IncomeTaxExaminationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationYearUnderExamination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax year being audited in the income tax examination, in YYYY format.", "label": "Income Tax Examination, Year under Examination" } } }, "localname": "IncomeTaxExaminationYearUnderExamination", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "gYearListItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r152", "r174", "r175", "r226", "r627", "r661", "r667", "r909" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 14.0, "parentTag": "kwr_IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Taxes on income (loss) before equity in net income of associated companies", "terseLabel": "Income Tax Expense (Benefit)", "totalLabel": "Income Tax Expense (Benefit), Total" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r622", "r628" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.", "label": "Income Tax Reconciliation Change In Enacted Tax Rate", "terseLabel": "Transition Tax", "verboseLabel": "U.S. Tax Reform Charges" } } }, "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxSettlementsForeign": { "auth_ref": [ "r628" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax settlement.", "label": "Income Tax Reconciliation Tax Settlements Foreign" } } }, "localname": "IncomeTaxReconciliationTaxSettlementsForeign", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes and Uncertain Tax Positions [Abstract]" } } }, "localname": "IncomeTaxUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r132", "r139" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Income taxes, net of refunds" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r135" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 26.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Accounts payable and accrued liabilities", "negatedLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r135" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Accounts receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r135" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 27.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Estimated taxes on income" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r135" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase Decrease In Inventories", "negatedLabel": "Inventories", "terseLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r135" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 24.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "negatedLabel": "Prepaid expenses and other current assets", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInRestrictedCash": { "auth_ref": [ "r116", "r119" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 34.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or outflow for the increase (decrease) associated with funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as investing activities.", "label": "Change in restricted cash, net", "negatedLabel": "Change in restricted cash, net" } } }, "localname": "IncreaseDecreaseInRestrictedCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInRestructuringReserve": { "auth_ref": [ "r135" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 25.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the carrying amount (including both current and noncurrent portions of the accrual) of the liability pertaining to the exit from or disposal of business activities or restructuring pursuant to a duly authorized plan, excluding costs or losses pertaining to an entity newly acquired in a business combination and to asset retirement obligations.", "label": "Change in restructuring liabilities" } } }, "localname": "IncreaseDecreaseInRestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": { "auth_ref": [ "r632" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase reasonably possible in the next twelve months for the unrecognized tax benefit.", "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Lower Bound" } } }, "localname": "IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r184", "r185", "r186", "r199" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails": { "order": 5.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Effect of Dilutive Securities" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r318" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite Lived Intangible Assets Excluding Goodwill", "terseLabel": "Indefinite lived intangible assets" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsIndefiniteLivedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Indefinite Lived Intangible Assets Excluding Goodwill [Abstract]" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedTrademarks": { "auth_ref": [ "r318" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite period of benefit.", "label": "Indefinite Lived Trademarks" } } }, "localname": "IndefiniteLivedTrademarks", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IntangibleAssetsIndefiniteLivedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InsuranceClaimsMember": { "auth_ref": [ "r362", "r928" ], "lang": { "en-us": { "role": { "documentation": "A demand for payment of a policy benefit because of the occurrence of an insured event, such as the death or disability of the insured; the maturity of an endowment; the incurrence of hospital or medical bills; the destruction or damage of property and related deaths or injuries; defects in, liens on, or challenges to the title to real estate; or the occurrence of a surety loss; and the costs to process claims.", "label": "Insurance claim [Member]" } } }, "localname": "InsuranceClaimsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InsuranceSettlementsReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy.", "label": "Insurance Settlements Receivable" } } }, "localname": "InsuranceSettlementsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r309", "r313" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 17.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Other intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndDebtExpense": { "auth_ref": [ "r801" ], "calculation": { "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity.", "label": "Interest and Debt Expense", "totalLabel": "Total" } } }, "localname": "InterestAndDebtExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndDebtExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "InterestAndDebtExpenseAbstract", "terseLabel": "Debt related expenses included within Interest expense:" } } }, "localname": "InterestAndDebtExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r112", "r408", "r415", "r418", "r419" ], "calculation": { "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_InterestAndDebtExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedWithinInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseMember": { "auth_ref": [ "r741" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing interest expense.", "label": "Interest Expense [Member]" } } }, "localname": "InterestExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.", "label": "Interest Income And Interest Expense Disclosure [Table Text Block]" } } }, "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r881" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 12.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income Expense Net", "negatedLabel": "Interest Income Expense Net", "terseLabel": "Interest expense, net", "verboseLabel": "Interest Income Expense Net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income earned from interest bearing assets classified as other.", "label": "Interest Income Other" } } }, "localname": "InterestIncomeOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r126", "r131", "r139" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue": { "auth_ref": [ "r733" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of all interest rate derivative liabilities designated as cash flow hedging instruments.", "label": "Interest Rate Cash Flow Hedge Liability At Fair Value" } } }, "localname": "InterestRateCashFlowHedgeLiabilityAtFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r740" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InternalRevenueServiceIRSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.", "label": "Internal Revenue Service (IRS) [Member]" } } }, "localname": "InternalRevenueServiceIRSMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntersegmentEliminationMember": { "auth_ref": [ "r220", "r239", "r240", "r241", "r242", "r244", "r246", "r250" ], "lang": { "en-us": { "role": { "documentation": "Eliminating entries used in operating segment consolidation.", "label": "Intersegment Elimination [Member]", "terseLabel": "Intersegment Sales Elimination [Member]" } } }, "localname": "IntersegmentEliminationMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryFinishedGoodsAndWorkInProcess": { "auth_ref": [ "r64" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.", "label": "Work-in-process and finished goods" } } }, "localname": "InventoryFinishedGoodsAndWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r14", "r66", "r840" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventories, net", "totalLabel": "Inventories, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventories" } } }, "localname": "InventoryNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryRawMaterialsAndSupplies": { "auth_ref": [ "r65" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.", "label": "Raw materials and supplies" } } }, "localname": "InventoryRawMaterialsAndSupplies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseAndRentalExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "Operating Leases, Rent Expense" } } }, "localname": "LeaseAndRentalExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r828" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Schedule of Maturities of operating lease liabilities [Table Text Block]" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r819" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r817" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee Leases [Policy Text Block]" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r829" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Schedule of Company's future minimum rental commitments under operating leases [Table Text Block]" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r829" ], "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee Operating Lease Liability Payments Due", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r829" ], "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due After Year Five", "terseLabel": "For the year ended December 31, 2026 and beyond" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r829" ], "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Next Twelve Months", "terseLabel": "For the year ended December 31, 2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r829" ], "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Five", "terseLabel": "For the year ended December 31, 2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r829" ], "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Four", "terseLabel": "For the year ended December 31, 2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r829" ], "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Three", "terseLabel": "For the year ended December 31, 2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r829" ], "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Two", "terseLabel": "For the year ended December 31, 2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r829" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee Operating Lease Liability Payments Remainder Of Fiscal Year", "terseLabel": "For the remainder of 2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r829" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee Operating Lease Liability Undiscounted Excess Amount", "negatedLabel": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "auth_ref": [ "r818" ], "lang": { "en-us": { "role": { "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee Operating Lease Term Of Contract" } } }, "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r831" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Leases Disclosure [TextBlock]" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter of Credit [Member]" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters Of Credit Outstanding Amount" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r53", "r149", "r242", "r270", "r372", "r373", "r374", "r377", "r378", "r379", "r381", "r383", "r385", "r386", "r714", "r721", "r722", "r774", "r838", "r839" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 38.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Total liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r40", "r149", "r270", "r774", "r840", "r870", "r896" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Total liabilities and equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r55", "r149", "r270", "r372", "r373", "r374", "r377", "r378", "r379", "r381", "r383", "r385", "r386", "r714", "r721", "r722", "r774", "r838", "r839", "r840" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 32.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Total current liabilities", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": { "auth_ref": [ "r60" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.", "label": "Liability For Uncertain Tax Positions Noncurrent", "terseLabel": "Uncertain Tax Positions (Includes Interest and Penalties)" } } }, "localname": "LiabilityForUncertainTaxPositionsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityCovenantCompliance": { "auth_ref": [ "r25", "r27" ], "lang": { "en-us": { "role": { "documentation": "Identification of whether the entity has been in compliance with any credit facility debt covenants during the period.", "label": "Line of Credit Facility, Covenant Compliance" } } }, "localname": "LineOfCreditFacilityCovenantCompliance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityCovenantTerms": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Description of the conditions for borrowing under the credit facility including the nature of any restrictions.", "label": "Line of Credit Facility, Covenant Terms" } } }, "localname": "LineOfCreditFacilityCovenantTerms", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": { "auth_ref": [ "r50" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Current Borrowing Capacity" } } }, "localname": "LineOfCreditFacilityCurrentBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": { "auth_ref": [ "r148" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of the credit facility.", "label": "Line of Credit Facility, Increase (Decrease), Net" } } }, "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityInitiationDate1": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Date the credit facility first became available, in YYYY-MM-DD format.", "label": "Line Of Credit Facility Initiation Date 1" } } }, "localname": "LineOfCreditFacilityInitiationDate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_LineOfCreditFacilityInterestRateDescription": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Description of interest rate for borrowing under credit facility. Includes, but is not limited to, terms and method for determining interest rate.", "label": "Line Of Credit Facility Interest Rate Description" } } }, "localname": "LineOfCreditFacilityInterestRateDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r50" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line Of Credit Facility Maximum Borrowing Capacity", "terseLabel": "Total debt", "totalLabel": "Debt And Capital Lease Obligations", "verboseLabel": "Credit facilities" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r50" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line of Credit Facility, Remaining Borrowing Capacity" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Revolver [Member]", "terseLabel": "Line of Credit, Current Facility [Member]", "verboseLabel": "New Credit facility [Member]" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": { "auth_ref": [ "r255" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.", "label": "Long-lived Assets by Geographic Areas [Table Text Block]", "verboseLabel": "Schedule of reportable segments' long-lived assets, including certain identifiable assets [Table Text Block]" } } }, "localname": "LongLivedAssetsByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "auth_ref": [ "r28" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.", "label": "Long-term Debt and Capital Lease Obligations", "terseLabel": "Total long-term debt", "totalLabel": "Long Term Debt And Capital Lease Obligations" } } }, "localname": "LongTermDebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtByMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long Term Debt By Maturity Abstract" } } }, "localname": "LongTermDebtByMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r153", "r369", "r406" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Next Twelve Months", "terseLabel": "2021" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "auth_ref": [ "r153", "r369", "r406" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Five", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r153", "r369", "r406" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Four", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r153", "r369", "r406" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Three", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r153", "r369", "r406" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Two", "terseLabel": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtMaturitySchedulesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r59" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 33.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtPercentageBearingVariableInterestRate": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time.", "label": "Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate" } } }, "localname": "LongTermDebtPercentageBearingVariableInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LongTermDebtTerm": { "auth_ref": [ "r767" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Long Term Debt Term" } } }, "localname": "LongTermDebtTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r59", "r370" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r355", "r356", "r357", "r360", "r361", "r362", "r365", "r367", "r368" ], "lang": { "en-us": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingencies by Nature of Contingency [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r355", "r356", "r357", "r360", "r361", "r362", "r365", "r367", "r368" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyAccrualAtCarryingValue": { "auth_ref": [ "r355" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability.", "label": "Loss Contingency Accrual At Carrying Value", "terseLabel": "Unrelated Environmental Liability Accruals" } } }, "localname": "LossContingencyAccrualAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in loss contingency liability.", "label": "Loss Contingency Accrual, Period Increase (Decrease)", "verboseLabel": "(Reversal) of previously recorded liability of best estimate of indirect tax owed" } } }, "localname": "LossContingencyAccrualCarryingValuePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualPayments": { "auth_ref": [ "r355" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow reducing loss contingency liability.", "label": "Payments Of Settlement and Release Agreements" } } }, "localname": "LossContingencyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyEstimateOfPossibleLoss": { "auth_ref": [ "r359", "r364", "r367" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.", "label": "Loss Contingency, Estimate of Possible Loss" } } }, "localname": "LossContingencyEstimateOfPossibleLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyLossInPeriod": { "auth_ref": [ "r355" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.", "label": "Non-Income Tax Contingency Charge", "negatedTerseLabel": "Non-income tax contingency charge" } } }, "localname": "LossContingencyLossInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyManagementsAssessmentAndProcess": { "auth_ref": [ "r359", "r364" ], "lang": { "en-us": { "role": { "documentation": "Describes management's process to evaluate the contingency matter and to estimate the impact on the financial statements and ongoing operations, such as added credit risk or loss of customers, including pertinent information to adequately disclose the matter and significant assumptions underlying the estimates.", "label": "Loss Contingency Actions Taken By Defendant" } } }, "localname": "LossContingencyManagementsAssessmentAndProcess", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r355", "r356", "r357", "r360", "r361", "r362", "r365", "r367", "r368" ], "lang": { "en-us": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingencyReceivableProceeds": { "auth_ref": [ "r127", "r368" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from the collection of receivables related to a loss contingency.", "label": "Proceeds Of Settlement And Release Agreements" } } }, "localname": "LossContingencyReceivableProceeds", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyRelatedReceivableCarryingValuePeriodIncreaseDecrease": { "auth_ref": [ "r368" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of receivables pertaining to a loss contingency.", "label": "Loss Contingency, Receivable, Period Increase (Decrease)", "verboseLabel": "(Reversal) of indemnification receivable" } } }, "localname": "LossContingencyRelatedReceivableCarryingValuePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencySettlementAgreementTerms": { "auth_ref": [ "r355", "r358", "r363" ], "lang": { "en-us": { "role": { "documentation": "Description of the terms of a settlement agreement which resolved the legal matter, including the nature of the consideration, timing of payment, and the nature of rights obtained or lost (for example, but not limited to, patent, trademark, copyright, license and franchise rights).", "label": "Loss Contingency, Settlement Agreement, Terms" } } }, "localname": "LossContingencySettlementAgreementTerms", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r63", "r149", "r270", "r372", "r377", "r378", "r379", "r385", "r386", "r774", "r869", "r895" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 46.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Noncontrolling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "auth_ref": [ "r440" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "negatedLabel": "Distributions to noncontrolling affiliate shareholders" } } }, "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDecreaseFromRedemptions": { "auth_ref": [ "r440", "r711", "r712" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).", "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests", "negatedLabel": "Acquisition of noncontrolling interest", "terseLabel": "Acquisition of noncontrolling interest" } } }, "localname": "MinorityInterestDecreaseFromRedemptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r130" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 44.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net cash provided (used in) by financing activities", "totalLabel": "Net cash (used in) by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r130" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 35.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net cash (used in) provided by investing activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r130", "r134", "r137" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 28.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net cash provided by operating activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r11", "r88", "r91", "r96", "r99", "r137", "r149", "r160", "r166", "r167", "r169", "r170", "r174", "r175", "r192", "r228", "r240", "r244", "r247", "r250", "r270", "r372", "r373", "r374", "r377", "r378", "r379", "r381", "r383", "r385", "r386", "r761", "r774", "r875", "r903" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 }, "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net income (loss) attributable to Quaker Chemical Corporation", "terseLabel": "Net income", "totalLabel": "Net income (loss) attributable to Quaker Chemical Corporation" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails", "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r88", "r91", "r96", "r174", "r175", "r716", "r724" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 18.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Less: Net income attributable to noncontrolling interest" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r166", "r167", "r169", "r170", "r180", "r181", "r194", "r199", "r228", "r240", "r244", "r247", "r250" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "NetIncomeLossAvailableToCommonStockholdersBasic", "totalLabel": "Net income (loss) available to common shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r182", "r187", "r188", "r189", "r190", "r194", "r199" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "NetIncomeLossAvailableToCommonStockholdersDiluted", "totalLabel": "Net income (loss) available to common shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleDescription": { "auth_ref": [ "r158", "r169", "r176", "r178", "r206", "r207" ], "lang": { "en-us": { "role": { "documentation": "Disclosure related to a new accounting pronouncement or a change in accounting principle, including the nature and reason for the change and the effect of the change on prior periods and the current period.", "label": "New Accounting Pronouncement Or Change In Accounting Principle Description" } } }, "localname": "NewAccountingPronouncementOrChangeInAccountingPrincipleDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements And Changes In Accounting Principles [Abstract]" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r5", "r158", "r159", "r162", "r163", "r177", "r178", "r179", "r265", "r266", "r276", "r277", "r470", "r471", "r472", "r473", "r610", "r657", "r658", "r659", "r757", "r781", "r782", "r783", "r833", "r859", "r860", "r861", "r922", "r923", "r924", "r925", "r927", "r963" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.", "label": "New Accounting Pronouncements and Changes in Accounting Principles [Text Block]" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards" ], "xbrltype": "textBlockItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "New Accounting Pronouncements Or Change In Accounting Principle [Line Items]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r157", "r160", "r161", "r162", "r164", "r165", "r169", "r177", "r203", "r263", "r264", "r272", "r273", "r274", "r275", "r278", "r279", "r371", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r611", "r653", "r654", "r655", "r656", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r758", "r759", "r760", "r761", "r775", "r776", "r777", "r778", "r779", "r780", "r784", "r785", "r832", "r856", "r857", "r858", "r916", "r917", "r918", "r919", "r920", "r921", "r922", "r923", "r924", "r925", "r926", "r927", "r958", "r959", "r960", "r961", "r962" ], "lang": { "en-us": { "role": { "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NonUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Countries excluding the United States of America (US).", "label": "Non Domestic [Member]" } } }, "localname": "NonUsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation": { "auth_ref": [ "r441", "r718" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of the reduction or elimination during the period of a noncontrolling interest resulting from the parent's loss of control and deconsolidation of the entity in which one or more outside parties had a noncontrolling interest.", "label": "Noncontrolling Interest Decrease From Deconsolidation", "negatedLabel": "Disposition of noncontrolling interest", "terseLabel": "Disposition of Noncontrolling Interest" } } }, "localname": "NoncontrollingInterestDecreaseFromDeconsolidation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r154", "r155", "r156", "r440", "r706" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r111" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 11.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Other income (expense), net", "negatedLabel": "Other expense, net", "terseLabel": "Total other income (expense), net", "totalLabel": "Other Income (Expense), Net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfCountriesInWhichEntityOperates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of countries in which the entity operates as of balance sheet date.", "label": "Number Of Countries In Which Entity Operates" } } }, "localname": "NumberOfCountriesInWhichEntityOperates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number Of Reportable Segments", "terseLabel": "Number of reportable segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/BusinessSegmentsNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpenseMember": { "auth_ref": [ "r741" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing expenses associated with normal operations.", "label": "Operating Expense [Member]" } } }, "localname": "OperatingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r228", "r240", "r244", "r247", "r250" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 10.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating income (loss)", "terseLabel": "Operating income for reportable segments", "totalLabel": "Operating income (loss)", "verboseLabel": "Operating income" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r820", "r830" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease Cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease Liabilities Payments Due [Abstract]" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r814" ], "calculation": { "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating lease liabilities", "terseLabel": "Present value of lease liabilities", "totalLabel": "Total operating lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails", "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r814" ], "calculation": { "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails": { "order": 3.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease Liability Current", "terseLabel": "Short-term lease liabilities", "verboseLabel": "Other current liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r814" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 34.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails": { "order": 4.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease liaiblity noncurrent", "terseLabel": "Long-term lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r815" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes operating lease liability.", "label": "Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r816", "r824" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease Payments" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r813" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right of use lease assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r815" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.", "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]" } } }, "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r827", "r830" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease Weighted Average Discount Rate Percent", "terseLabel": "Weighted average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r826", "r830" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term (years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r809", "r810" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Future Operating Lease Minimum Payments, Due Next Year", "terseLabel": "For the year ended 2019" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": { "auth_ref": [ "r809", "r810" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Future Operating Lease Minimum Payments, Due in Five Years", "terseLabel": "For the year ended 2023" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": { "auth_ref": [ "r809", "r810" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Future Operating Lease Minimum Payments, Due in Four Years", "terseLabel": "For the year ended 2022" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": { "auth_ref": [ "r809", "r810" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Future Operating Lease Minimum Payments, Due in Three Years", "terseLabel": "For the year ended 2021" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r809", "r810" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Future Operating Lease Minimum Payments, Due in Two Years", "terseLabel": "For the year ended 2020" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": { "auth_ref": [ "r809", "r810" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Future Operating Lease Minimum Payments, Due Therafter", "terseLabel": "For the year ended 2024 and beyond" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r646" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLimitationsOnUse": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.", "label": "Operating Loss Carryforwards, Limitations on Use" } } }, "localname": "OperatingLossCarryforwardsLimitationsOnUse", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r647" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsValuationAllowance": { "auth_ref": [ "r643" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.", "label": "Operating Loss Carryforwards, Valuation Allowance" } } }, "localname": "OperatingLossCarryforwardsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r239", "r240", "r241", "r242", "r244", "r250" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basis of Presentation and Description of Business [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r12", "r726" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Basis of Presentation and Description of Business [Text Block]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r731", "r746" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsMiscellaneousCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.", "label": "Other Assets Miscellaneous Current" } } }, "localname": "OtherAssetsMiscellaneousCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r48" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 20.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other non-current assets", "totalLabel": "Total other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plans [Abstract]" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r79", "r83", "r524" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Net gain (loss) arising during the period, other", "negatedLabel": "Net gain (loss) arising during the period, other" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r74", "r83", "r786", "r787", "r791" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "terseLabel": "Currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": { "auth_ref": [ "r83", "r86", "r87", "r524" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 14.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax", "terseLabel": "Prior service credit (cost)", "totalLabel": "Total Recognized in Other Comprehensive (Income) Loss", "verboseLabel": "Recognition of amortization in net periodic benefit cost Prior service credit (cost)" } } }, "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax": { "auth_ref": [ "r83", "r86", "r87", "r524" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 6.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.", "label": "Other Comprehensive Income (Loss), Amortization Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Prior Service (Cost) Credit, Net of Tax", "negatedTerseLabel": "Amortization of prior service cost", "terseLabel": "Amortization of prior service gain" } } }, "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "auth_ref": [ "r85", "r94", "r95", "r792", "r794", "r798" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive (Loss) Income, before reclassifications" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAOCIReclassificationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "auth_ref": [ "r75", "r83" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 9.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Current period change in fair value of derivatives" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r89", "r92", "r94", "r95", "r97", "r100", "r435", "r792", "r797", "r798", "r876", "r904" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 11.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Amounts reported in other comprehensive income (loss)", "totalLabel": "Other comprehensive (loss) income" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome", "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r81", "r83" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 8.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Defined Benefit Retirement Plans", "negatedLabel": "Defined benefit retirement plans" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": { "auth_ref": [ "r79", "r83", "r524" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 12.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net Unamortized Gain (Loss) Arising During Period, before Tax", "negatedLabel": "Net Loss (Gain) Arising During The Period", "terseLabel": "Net Loss (Gain) Arising During The Period" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax": { "auth_ref": [ "r83", "r86", "r87", "r524" ], "calculation": { "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "order": 19.0, "parentTag": "kwr_TotalRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveLossOrIncome", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net period benefit cost (credit) of defined benefit plan.", "label": "Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, before Tax", "terseLabel": "Total Recognized in Other Comprehensive Income (Loss)", "totalLabel": "Total Recognized in Other Comprehensive (Income) Loss" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": { "auth_ref": [ "r83", "r86", "r87", "r524" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 5.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net (Gain) Loss, Net of Tax", "negatedTerseLabel": "Amortization of actuarial loss", "terseLabel": "Amortization of actuarial loss" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax": { "auth_ref": [ "r83", "r86", "r87", "r524" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 7.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for transition asset (obligation) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Transition (Asset) Obligation, Net of Tax", "terseLabel": "Amortization of Initial Net Asset" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": { "auth_ref": [ "r708", "r709", "r719" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent", "terseLabel": "Related Tax Amounts" } } }, "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAOCIReclassificationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r76", "r83" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 10.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "Unrealized (loss) gain on available-for-sale securities" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherDebtSecuritiesMember": { "auth_ref": [ "r267", "r300", "r505", "r769" ], "lang": { "en-us": { "role": { "documentation": "Investments in debt securities classified as other.", "label": "Other Debt Securities [Member]" } } }, "localname": "OtherDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherDepreciationAndAmortization": { "auth_ref": [ "r109", "r136", "r325" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.", "label": "Other Depreciation And Amortization", "negatedLabel": "Depreciation of corporate assets and amortization", "terseLabel": "Depreciation" } } }, "localname": "OtherDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherFiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r315" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of finite-lived intangible assets classified as other.", "label": "Other Finite Lived Intangible Assets, Gross" } } }, "localname": "OtherFiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income and Expenses [Abstract]" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": { "auth_ref": [ "r475", "r617" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.", "label": "Other Income and Other Expense Disclosure [Text Block]" } } }, "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpense" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherIncomeMember": { "auth_ref": [ "r744" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other revenue.", "label": "Other Income [Member]" } } }, "localname": "OtherIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r18", "r19", "r54", "r840" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 31.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other accrued liabilities", "terseLabel": "Other Current Liabilities", "totalLabel": "Accrued Liabilities, Current, Total" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r60" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 37.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other non-current liabilities", "totalLabel": "Total" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermDebt": { "auth_ref": [ "r28", "r868", "r891" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt classified as other.", "label": "Other Long Term Debt", "terseLabel": "Other debt obligations (including capital leases)" } } }, "localname": "OtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncome": { "auth_ref": [ "r137" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income or gain included in net income that result in no cash inflow (outflow), classified as other.", "label": "OtherNoncashIncome", "negatedLabel": "Gain on inactive subsidiary litigation and settlement reserve", "terseLabel": "Gain on inactive subsidiary litigation and settlement reserve" } } }, "localname": "OtherNoncashIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Noncash Investing And Financing Items [Abstract]" } } }, "localname": "OtherNoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingExpense": { "auth_ref": [ "r113" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense related to nonoperating activities, classified as other.", "label": "Other Nonoperating Expense", "negatedLabel": "Other non-operating expense" } } }, "localname": "OtherNonoperatingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r105" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Other non-operating income" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income Expense Net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "auth_ref": [ "r477", "r478", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r504", "r505", "r507", "r508", "r509", "r510", "r511", "r512", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r527", "r529", "r530", "r533", "r536", "r542", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r561", "r562", "r563", "r564", "r565", "r566" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.", "label": "Other Postretirement Benefit Plans Defined Benefit [Member]", "terseLabel": "Domestic Other Postretirement Benefits [Member]", "verboseLabel": "Postretirement Benefits [Member]" } } }, "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherRestrictedAssetsCurrent": { "auth_ref": [ "r67", "r932", "r933" ], "calculation": { "http://www.quakerchem.com/role/RestrictedCashDetails": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets that are pledged or subject to withdrawal restrictions, classified as other.", "label": "OtherRestrictedAssetsCurrent", "terseLabel": "Restricted cash included in other current assets" } } }, "localname": "OtherRestrictedAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r110" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of selling, general and administrative expense classified as other.", "label": "Other Selling General And Administrative Expense" } } }, "localname": "OtherSellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PatentedTechnologyMember": { "auth_ref": [ "r691" ], "lang": { "en-us": { "role": { "documentation": "Exclusive legal right granted by the government to the owner of the patented technology to exploit the technology for a period of time specified by law.", "label": "Product technology [Member]" } } }, "localname": "PatentedTechnologyMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForLegalSettlements": { "auth_ref": [ "r133" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.", "label": "Insurance settlement realized", "negatedLabel": "Insurance settlement realized", "terseLabel": "Payments Made, Restricted Cash" } } }, "localname": "PaymentsForLegalSettlements", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r121" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments For Repurchase Of Common Stock", "negatedLabel": "Payments for repurchase of common stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": { "auth_ref": [ "r121" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 42.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests.", "label": "Payments To Acquire Additional Interest In Subsidiaries", "negatedLabel": "Purchase of noncontrolling interest in affiliates, net" } } }, "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r127", "r337" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Cash Payments", "negatedLabel": "Cash Payments", "terseLabel": "Restructuring, Cash Payments" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails", "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r124" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Financing-related debt issuance costs", "negatedLabel": "Financing-related debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r121" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 40.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Dividends paid", "negatedLabel": "Dividends paid" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsMinorityInterest": { "auth_ref": [ "r121" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 43.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.", "label": "Distributions to noncontrolling shareholders", "negatedTerseLabel": "Distributions to noncontrolling affiliate shareholders" } } }, "localname": "PaymentsOfDividendsMinorityInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r117", "r697" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments To Acquire Businesses Gross", "negatedTerseLabel": "Gross Cash Paid for Acquisition", "terseLabel": "Cash transferred to Houghton shareholders", "totalLabel": "Net cash paid", "verboseLabel": "Net cash paid for Coral" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r117" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 31.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments related to acquisitions, net of cash acquired", "negatedLabel": "Payments related to acquisitions, net of cash acquired", "terseLabel": "Net cash paid for Coral", "totalLabel": "Net cash paid for Coral", "verboseLabel": "Net cash paid for Coral" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r118" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 30.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Investments in property, plant and equipment", "negatedLabel": "Investments in property, plant and equipment", "terseLabel": "Capital Expenditures" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitContributions": { "auth_ref": [ "r133" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for pension and other postretirement benefits. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree.", "label": "Pension and other postretirement benefits contributions", "negatedLabel": "Pension and other postretirement benefits" } } }, "localname": "PensionAndOtherPostretirementBenefitContributions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitExpense": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost (reversal of cost) for pension and other postretirement benefits.", "label": "Pension And Other Postretirement Benefit Expense", "negatedLabel": "Pension And Other Postretirement Benefit Expense" } } }, "localname": "PensionAndOtherPostretirementBenefitExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r504", "r506", "r512", "r531", "r534", "r535", "r536", "r538", "r539", "r557", "r559", "r560", "r561", "r581" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for retirement benefits.", "label": "Pension And Other Postretirement Benefits Disclosure [Text Block]" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndPostretirementBenefits" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": { "auth_ref": [ "r26", "r478", "r479", "r502", "r557" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 29.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.", "label": "Accrued pension and postretirement benefits", "negatedLabel": "Current Liabilities", "terseLabel": "Current Liabilities" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": { "auth_ref": [ "r29", "r478", "r479", "r502", "r557" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 36.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.", "label": "Accrued Pension and Postretirement Benefits, Non-current", "negatedLabel": "Non-current Liabilities", "terseLabel": "Non-current accrued pension and post-retirment benefits" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r476", "r478", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r504", "r505", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r527", "r529", "r530", "r533", "r536", "r542", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r561", "r562", "r576", "r577", "r578", "r579" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plans, Defined Benefit [Member]", "terseLabel": "Total Pension Plans [Member]", "verboseLabel": "Pension Benefit [Member]" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Stock Units [Member]", "terseLabel": "Performance Stock Units [Member]" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanAssetCategoriesDomain": { "auth_ref": [ "r504", "r505", "r507", "r508", "r509", "r510", "r511", "r512", "r533", "r557" ], "lang": { "en-us": { "role": { "documentation": "Defined benefit plan asset investment.", "label": "Plan Asset Categories [Domain]" } } }, "localname": "PlanAssetCategoriesDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r32", "r421" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock Par Or Stated Value Per Share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r16", "r42", "r43" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromInsuranceSettlementInvestingActivities": { "auth_ref": [ "r116", "r129" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 33.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow for proceeds from settlement of insurance claim, classified as investing activities. Excludes insurance settlement classified as operating activities.", "label": "Insurance settlement interest earned" } } }, "localname": "ProceedsFromInsuranceSettlementInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromInsuranceSettlementOperatingActivities": { "auth_ref": [ "r125", "r129" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow for proceeds from settlement of insurance claim, classified as operating activities. Excludes insurance settlement classified as investing activities.", "label": "Proceeds from Insurance Settlement, Operating Activities" } } }, "localname": "ProceedsFromInsuranceSettlementOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r120" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "auth_ref": [ "r120" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 41.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.", "label": "Stock options exercised, other" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 38.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).", "label": "Borrowings (repayments) on revolving credit facilities, net" } } }, "localname": "ProceedsFromRepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfOtherDebt": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 39.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) for debt classified as other.", "label": "Repayments on other debt, net" } } }, "localname": "ProceedsFromRepaymentsOfOtherDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r115" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 32.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from disposition of assets" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r11", "r88", "r91", "r96", "r128", "r149", "r160", "r174", "r175", "r228", "r240", "r244", "r247", "r250", "r270", "r372", "r373", "r374", "r377", "r378", "r379", "r381", "r383", "r385", "r386", "r708", "r715", "r717", "r724", "r725", "r761", "r774", "r882" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 17.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income (loss)", "totalLabel": "Net income (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAdditionalDisclosures": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional information disclosed pertaining to property, plant and equipment.", "label": "Property Plant And Equipment Additional Disclosures" } } }, "localname": "PropertyPlantAndEquipmentAdditionalDisclosures", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r47", "r328" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r46", "r326" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property, Plant and Equipment, at Cost", "totalLabel": "Property, Plant and Equipment, Gross, Total" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r22", "r23", "r328", "r840", "r883", "r897" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Net property, plant and equipment", "terseLabel": "Property, plant and equipment, net", "totalLabel": "Property, Plant and Equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r22", "r326" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RealEstateHeldforsale": { "auth_ref": [ "r899" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of investments in land and buildings held for sale, excluding real estate considered to be inventory of the entity.", "label": "Real Estate Held for sale" } } }, "localname": "RealEstateHeldforsale", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "auth_ref": [ "r85", "r94", "r95", "r792", "r796", "r798" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "terseLabel": "Amounts Reclassed from AOCI" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAOCIReclassificationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": { "auth_ref": [ "r240", "r244" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.", "label": "Schedule of information about the performance of the Company's reportable segments, operating earnings [Table Text Block]" } } }, "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock": { "auth_ref": [ "r242", "r244" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.", "label": "Reconciliation of capital expenditures and depreciation for identifiable assets [Table Text Block]" } } }, "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r123" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 37.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "RepaymentsOfLongTermDebt", "terseLabel": "Payments of term loan debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": { "auth_ref": [ "r122" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.", "label": "Payments of long-term debt", "negatedLabel": "Payments of long-term debt" } } }, "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r143", "r863", "r892" ], "calculation": { "http://www.quakerchem.com/role/RestrictedCashDetails": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash", "terseLabel": "Restricted cash included in other assets" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r200" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock LTIP [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) LTIP Plan [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring And Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesCompletionDate": { "auth_ref": [ "r335", "r346" ], "lang": { "en-us": { "role": { "documentation": "Date the exit and disposal activities were completed or are expected to be completed, in YYYY-MM-DD format.", "label": "Restructuring and Related Activities, Completion Date" } } }, "localname": "RestructuringAndRelatedActivitiesCompletionDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDescription": { "auth_ref": [ "r335", "r346" ], "lang": { "en-us": { "role": { "documentation": "Description of a specific restructuring plan and related activities including the facts and circumstances leading to the restructuring or decision to exit an activity, and the expected completion date. This concept and related items would be utilized for each plan if multiple exit plans have been implemented in the period.", "label": "Restructuring and Related Activities, Description" } } }, "localname": "RestructuringAndRelatedActivitiesDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r335", "r337", "r340", "r350", "r351" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring And Related Activities Disclosure [Text Block]" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivities" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringAndRelatedActivitiesInitiationDate": { "auth_ref": [ "r335", "r346" ], "lang": { "en-us": { "role": { "documentation": "Date the restructuring activities were initiated or are expected to be initiated, in YYYY-MM-DD format.", "label": "Restructuring and Related Activities, Initiation Date" } } }, "localname": "RestructuringAndRelatedActivitiesInitiationDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_RestructuringAndRelatedCostDescription": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "Information pertinent to an understanding of the specified type of restructuring cost, including the facts and circumstances leading to the expected activity, discussion of the level and quantity of personnel to be terminated, and the expected completion date.", "label": "Restructuring And Related Cost Description" } } }, "localname": "RestructuringAndRelatedCostDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expected cost remaining for the specified restructuring cost.", "label": "Restructuring And Related Cost Expected Cost Remaining" } } }, "localname": "RestructuringAndRelatedCostExpectedCostRemaining1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The expected number of positions to be eliminated as a result of restructuring activities.", "label": "Restructuring And Related Cost Expected Number Of Positions Eliminated" } } }, "localname": "RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r136", "r334", "r343", "r347" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 8.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring and related charges", "negatedLabel": "Restructuring and related charges", "negatedTerseLabel": "Restructuring charges", "verboseLabel": "Restructuring Charges (Credits)" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring Cost and Reserve [Abstract]" } } }, "localname": "RestructuringCostsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r337", "r344" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Accrued restructuring", "periodEndLabel": "Accrued Restructuring, Ending Balance", "periodStartLabel": "Accrued Restructuring, Beginning Balance", "terseLabel": "Accrued Restructuring" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveCurrent": { "auth_ref": [ "r26", "r337", "r348" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 28.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Current", "periodEndLabel": "Accrued Restructuring, Ending Balance", "periodStartLabel": "Accrued Restructuring, Beginning Balance", "terseLabel": "Accrued restructuring" } } }, "localname": "RestructuringReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Restructuring Reserve [Roll Forward]" } } }, "localname": "RestructuringReserveRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserveTranslationAdjustment": { "auth_ref": [ "r337", "r348" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.", "label": "Currency Translation Adjustments", "negatedLabel": "Currency Translation Adjustments" } } }, "localname": "RestructuringReserveTranslationAdjustment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion": { "auth_ref": [], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Depreciation, depletion, amortization, and accretion related to oil and gas producing activities.", "label": "Results of Operations, Depreciation, Depletion, Amortization and Accretion", "terseLabel": "Depreciation and amortization" } } }, "localname": "ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r36", "r440", "r611", "r840", "r894", "r922", "r927" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 43.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained earnings", "terseLabel": "Adjustment to prior period earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r2", "r154", "r155", "r156", "r161", "r172", "r175", "r275", "r607", "r608", "r609", "r655", "r656", "r759", "r918", "r920" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanNameAxis": { "auth_ref": [ "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r504", "r505", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r527", "r528", "r529", "r530", "r533", "r536", "r542", "r543", "r544", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r580" ], "lang": { "en-us": { "role": { "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.", "label": "Retirement Plan Name [Axis]" } } }, "localname": "RetirementPlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanNameDomain": { "auth_ref": [ "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r504", "r505", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r527", "r528", "r529", "r530", "r533", "r536", "r542", "r543", "r544", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r580" ], "lang": { "en-us": { "role": { "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.", "label": "Retirement Plan Name [Domain]" } } }, "localname": "RetirementPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanSponsorLocationAxis": { "auth_ref": [ "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r504", "r505", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r527", "r528", "r529", "r530", "r533", "r536", "r543", "r544", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r562", "r566", "r579" ], "lang": { "en-us": { "role": { "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Axis]" } } }, "localname": "RetirementPlanSponsorLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanSponsorLocationDomain": { "auth_ref": [ "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r504", "r505", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r527", "r528", "r529", "r530", "r533", "r536", "r543", "r544", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r562", "r566", "r579" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Domain]" } } }, "localname": "RetirementPlanSponsorLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r476", "r477", "r478", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r504", "r505", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r527", "r529", "r530", "r533", "r536", "r542", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r561", "r562", "r563", "r564", "r565", "r566", "r576", "r577", "r578", "r579" ], "lang": { "en-us": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r476", "r477", "r478", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r504", "r505", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r527", "r529", "r530", "r533", "r536", "r542", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r561", "r562", "r563", "r564", "r565", "r566", "r576", "r577", "r578", "r579" ], "lang": { "en-us": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue From Contract With Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r219", "r220", "r239", "r245", "r246", "r252", "r253", "r257", "r463", "r464", "r854" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue From Contract With Customer Excluding Assessed Tax", "terseLabel": "Net sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r219", "r220", "r239", "r245", "r246", "r252", "r253", "r257", "r463", "r464", "r854" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue From Contract With Customer Including Assessed Tax", "terseLabel": "Income from third party license fees" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r144", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r474" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue recognition [Policy Text Block]", "terseLabel": "Revenue From Contract With Customer [Policy Text Block]" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r465", "r474" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue From Contract With Customer [TextBlock]" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognition" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r144", "r145" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition [Policy Text Block]" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "The Revolver [Member]" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r825", "r830" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r212", "r257" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Sales Revenue Net [Member]", "terseLabel": "Sales Revenue Net [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": { "auth_ref": [ "r543", "r544", "r557" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets.", "label": "Schedule of Information for pension plans with an accumulated benefit obligation in excess of plan assets [Table Text Block]" } } }, "localname": "ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r85", "r797", "r798" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.", "label": "Schedule of compan's pension plan target asset allocation and pension plan investments measured at fair value on a recurring basis [Table Text Block]" } } }, "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAmountsInAccumulatedOtherComprehensiveIncomeLossToBeRecognizedOverNextFiscalYearTableTextBlock": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts related to pension plans and/or other employee benefit plans in accumulated other comprehensive income (loss) expected to be recognized as components of net periodic benefit cost over the next fiscal year, including the net gain (loss), net prior service cost or credit, and net transition asset or obligation.", "label": "Schedule of Amounts in Accumulated Other Comprehensive Income (Loss) to be Recognized over Next Fiscal Year [Table Text Block]" } } }, "localname": "ScheduleOfAmountsInAccumulatedOtherComprehensiveIncomeLossToBeRecognizedOverNextFiscalYearTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock": { "auth_ref": [ "r502" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.", "label": "Scheudule of funded status of Company'ds plans' reconciled with amounts reported in the Consolidated Balance Sheets [Table Text Block]" } } }, "localname": "ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.", "label": "Schedule of other changes recognized in other comprehensive income - pension plans [Table Text Block]" } } }, "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.", "label": "Schedule of Weighted-average assumptions used to determine benefit obligations [Table Text Block]" } } }, "localname": "ScheduleOfAssumptionsUsedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": { "auth_ref": [ "r543", "r557" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.", "label": "Schedule of Benefit Obligations in Excess of Fair Value of Plan Assets [Table Text Block]" } } }, "localname": "ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r679", "r680" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsCoralNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsPreliminaryEstimatedFairValuesOfCoralNetAssetsAcquiredDetails", "http://www.quakerchem.com/role/BusinessAcquisitionsTables", "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsAntidilutiveSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r679", "r680" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "Schedule of fair value of consideration transferred in the Combination [Table Text Block]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "Schedule Of Cash And Cash Equivalents [Table Text Block]" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestrictedCashTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r736" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.", "label": "Scheudule of fair values of the Company''s derivative instruments, Level 2 measurements [Table Text Block]" } } }, "localname": "ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "auth_ref": [ "r599" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.", "label": "Schedule of share-based compensation expense in its Consolidated Statements of Income [Table Text Block]" } } }, "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r651" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schecule of taxes on income before equity in net income of associated companies [Table Text Block]" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/TaxesOnIncomeAndUncertainPositionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt [Table Text Block]" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r644" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of total deferred tax assets and liabilities [Table Text Block]" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/TaxesOnIncomeAndUncertainPositionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r541", "r542", "r545", "r546", "r557" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r199" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesTableTextBlock": { "auth_ref": [ "r532" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effect of a one-percentage-point increase and the effect of a one-percentage-point decrease in the assumed health care cost trend rates on the aggregate of the service and interest cost components of net periodic postretirement health care benefit costs and the accumulated postretirement benefit obligation for health care benefits.", "label": "Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates [Table Text Block]" } } }, "localname": "ScheduleOfEffectOfOnePercentagePointChangeInAssumedHealthCareCostTrendRatesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock": { "auth_ref": [ "r508" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effect of fair value measurements using significant unobservable inputs (Level 3) on changes in plan assets of pension plans and/or other employee benefit plans for the period.", "label": "Schedule of changes in the fair value of the plans' Level 3 investments [Table Text Block]" } } }, "localname": "ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r628" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/TaxesOnIncomeAndUncertainPositionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r583", "r599", "r613" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r583", "r599", "r613" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Schedule of The compensation expense recorded on each award during the year [Table Text Block]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.", "label": "Schedule of Expected Benefit Payments [Table Text Block]" } } }, "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r310", "r314", "r855" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails", "http://www.quakerchem.com/role/IntangibleAssetsIndefiniteLivedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r310", "r314" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": { "auth_ref": [ "r811" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.", "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]" } } }, "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r307", "r308" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r307", "r308" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfHealthCareCostTrendRatesTableTextBlock": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the assumed health care cost trend rates for the next year used to measure the expected cost of benefits covered by the plans, including the ultimate trend rate(s) and when that rate is expected to be achieved.", "label": "Schedule of Assumed health care cost trend rates [Table Text Block]" } } }, "localname": "ScheduleOfHealthCareCostTrendRatesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r150" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of components of earnings before income taxes [Table Text Block]" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/TaxesOnIncomeAndUncertainPositionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule of Maturities of Long-term Debt [Table Text Block]" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.", "label": "Schedule of components of net periodic benefit costs - pension plans [Table Text Block]" } } }, "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostRetirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.", "label": "Schedule of other expense, net [Table Text Block]" } } }, "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/OtherIncomeExpenseTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfProductInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of product information that are included in the discussion of the nature of an entity's operations.", "label": "Schedule of Product Information [Table Text Block]" } } }, "localname": "ScheduleOfProductInformationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r686" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of estimated fair values of net assets acquired [Table Text Block]" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r336", "r337", "r338", "r339", "r347", "r348", "r349" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "auth_ref": [ "r341", "r342", "r345" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.", "label": "Restructuring and Related Costs [Table Text Block]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RestructuringAndRelatedActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r228", "r231", "r243", "r307" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r228", "r231", "r243", "r307" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of information about the performance of the Company's reportable segments, sales and total assets [Table Text Block]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r588" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Schedule of activity of nonvested restricted stock units granted under the Company's LTIP plan [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r602" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Schedule of summary of the Company's outstanding stock options [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r588", "r590", "r592" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule of Stock option activity under all plans [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Black-Scholes option pricing model and the assumptions [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Schedule of activity of nonvested restricted stock awards granted under the Company's LTIP plan [Table Text Block]" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": { "auth_ref": [ "r435" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.", "label": "Schedule of Stockholders Equity [Table Text Block]" } } }, "localname": "ScheduleOfStockholdersEquityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [ "r639", "r652" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits.", "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/TaxesOnIncomeAndUncertainPositionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r215", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r239", "r240", "r241", "r242", "r244", "r245", "r246", "r247", "r248", "r250", "r257", "r339", "r349", "r910" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segment Domain" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r215", "r217", "r218", "r228", "r232", "r244", "r248", "r249", "r250", "r251", "r252", "r256", "r257", "r258" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegments" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingMeasurementDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Segment Disclosures [Abstract]" } } }, "localname": "SegmentReportingMeasurementDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r233", "r234", "r235", "r236", "r237", "r238", "r253" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segments [Policy Text Block]" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r110" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": { "auth_ref": [ "r680" ], "lang": { "en-us": { "role": { "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.", "label": "Other Acquisitions [Member]" } } }, "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r135" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation [Abstract]" } } }, "localname": "ShareBasedCompensationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "auth_ref": [ "r585" ], "lang": { "en-us": { "role": { "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period 1", "terseLabel": "Option Award Vesting Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r585" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Equity Award Vesting Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate": { "auth_ref": [ "r602" ], "lang": { "en-us": { "role": { "documentation": "Discount rate from fair value on purchase date that participants pay for shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Purchase Date", "terseLabel": "ESPP: Discount from Market Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r589" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period", "terseLabel": "Nonvested Stock Awards Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement By Share-Based Payment Award Fair Value Assumptions And Methodology [Abstract]", "terseLabel": "Black-Scholes option pricing model" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate", "terseLabel": "Dividend Yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r595" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate", "terseLabel": "Expected Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r597" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate", "terseLabel": "Risk-free Interest Rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r591" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share Based Compensation Arrangement By Share Based PaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "terseLabel": "Exercised Options, Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross", "terseLabel": "Number of options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r582", "r587" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance": { "auth_ref": [ "r586" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of shares (or other type of equity) that have been approved for issuance in the equity-based payment transaction.", "label": "Share Based Goods And Nonemployee Services Transaction Shares Approved For Issuance", "terseLabel": "Director Stock Ownership Plan Maximum Number of Shares Authorized Under Plan" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareRepurchaseProgramAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by share repurchase program.", "label": "Share Repurchase program [Axis]" } } }, "localname": "ShareRepurchaseProgramAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareRepurchaseProgramDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the share repurchase program.", "label": "Share Repurchase Program [Domain]" } } }, "localname": "ShareRepurchaseProgramDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r594", "r612" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1", "terseLabel": "Expected Term (Years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationBlackScholesOptionPricingModelDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent", "terseLabel": "ESPP: Purchase Price Percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r435" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares Issued" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermBorrowings": { "auth_ref": [ "r24", "r840", "r866", "r890" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.", "label": "Short Term Borrowings", "negatedLabel": "Less: short-term and current portion of long-term debts", "terseLabel": "Short-term Debt (including capital leases)" } } }, "localname": "ShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtTableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r821", "r830" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short Term Lease Cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State and Local Jurisdiction [Member]" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r8", "r215", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r239", "r240", "r241", "r242", "r244", "r245", "r246", "r247", "r248", "r250", "r257", "r307", "r333", "r339", "r349", "r910" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Statement, Business Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/BusinessSegmentsPerformanceOfReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails", "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r2", "r62", "r94", "r95", "r96", "r154", "r155", "r156", "r161", "r172", "r175", "r208", "r275", "r435", "r440", "r607", "r608", "r609", "r655", "r656", "r759", "r792", "r793", "r794", "r795", "r796", "r798", "r918", "r919", "r920", "r962" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Statement, Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityAOCIReclassificationsDetails", "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/EquityAOCIReclassificationsDetails", "http://www.quakerchem.com/role/EquityChangesInEquityDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Changes in Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r154", "r155", "r156", "r208", "r854" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BasisOfPresentationAndDescriptionOfBusinessDetails", "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockCompensationPlanMember": { "auth_ref": [ "r200" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.", "label": "Annual Incentive Plan [Member]" } } }, "localname": "StockCompensationPlanMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Share based compensation plans", "verboseLabel": "Share issuance and equity-based compensation plans" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan": { "auth_ref": [ "r32", "r33", "r435", "r440", "r614" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.", "label": "Stock Issued During Period Shares Employee Stock Ownership Plan", "terseLabel": "Shares issued for ESPP" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period Shares Other", "terseLabel": "Shares issued for Options exercise and Other activity" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r32", "r33", "r435", "r440" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Stock Issued During Period Shares Share Based Compensation", "terseLabel": "Shares issued for equity based comp plans" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan": { "auth_ref": [ "r32", "r33", "r435", "r440", "r614" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock issued during the period as a result of employee stock ownership plan (ESOP).", "label": "Shares issued for employee stock purchase plan" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r32", "r33", "r435", "r440" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock offering, net of related expenses" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r62", "r435", "r440" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Shares issued upon exercise of stock options and other" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program Authorized Amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount remaining of a stock repurchase plan authorized.", "label": "Stock Repurchase Program Remaining Authorize" } } }, "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r32", "r33", "r435", "r440" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Stock Repurchased And Retired During Period Shares" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "auth_ref": [ "r32", "r33", "r435", "r440" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).", "label": "Repurchases of common stock", "negatedLabel": "Repurchases of common stock" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r33", "r38", "r39", "r149", "r262", "r270", "r774", "r840" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 45.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Total Quaker shareholders equity", "totalLabel": "Total Quaker shareholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r2", "r3", "r95", "r149", "r154", "r155", "r156", "r161", "r172", "r270", "r275", "r440", "r607", "r608", "r609", "r655", "r656", "r706", "r707", "r723", "r759", "r774", "r792", "r793", "r798", "r919", "r920", "r962" ], "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "order": 47.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Total equity", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/EquityChangesInEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r147", "r422", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r440", "r446" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Equity [Text Block]" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/Equity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubleaseIncome": { "auth_ref": [ "r823", "r830" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sublease income excluding finance and operating lease expense.", "label": "Sublease Income" } } }, "localname": "SubleaseIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventDescription": { "auth_ref": [ "r841" ], "lang": { "en-us": { "role": { "documentation": "Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.", "label": "Subsequent Event Description" } } }, "localname": "SubsequentEventDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r799", "r842" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r799", "r842" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r799", "r842" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsDate": { "auth_ref": [ "r841" ], "lang": { "en-us": { "role": { "documentation": "Date the event occurred after the balance sheet date but before financial statements are issues or available to be issued, in YYYY-MM-DD format.", "label": "Subsequent Events Date" } } }, "localname": "SubsequentEventsDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "xbrltype": "dateItemType" }, "us-gaap_SummaryOfValuationAllowanceTextBlock": { "auth_ref": [ "r643" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.", "label": "Schedule of changes in the Company's deferred tax asset valuation allowance [Table Text Block]" } } }, "localname": "SummaryOfValuationAllowanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/TaxesOnIncomeAndUncertainPositionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalEmployeeRetirementPlanDefinedBenefitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide limited group of employees with supplemental retirement benefits, in addition to other pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Supplemental Employee Retirement Plans, Defined Benefit [Member]", "terseLabel": "Supplemental Retirement Benefits Plan [Member]" } } }, "localname": "SupplementalEmployeeRetirementPlanDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/PensionAndOtherPostretirementBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions": { "auth_ref": [ "r618", "r620" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.", "label": "Tax Adjustments, Settlements, and Unusual Provisions" } } }, "localname": "TaxAdjustmentsSettlementsAndUnusualProvisions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCreditCarryforwardDescription": { "auth_ref": [ "r647" ], "lang": { "en-us": { "role": { "documentation": "A description of the origin, nature, and characteristics of the tax credit carryforward.", "label": "TaxCreditCarryforwardDescription" } } }, "localname": "TaxCreditCarryforwardDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability": { "auth_ref": [ "r671" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax liability from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.", "label": "Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Liability" } } }, "localname": "TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceAxis": { "auth_ref": [ "r464", "r469" ], "lang": { "en-us": { "role": { "documentation": "Information by timing of transfer of good or service to customer.", "label": "Timing Of Transfer Of Good Or Service [Axis]" } } }, "localname": "TimingOfTransferOfGoodOrServiceAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceDomain": { "auth_ref": [ "r464", "r469" ], "lang": { "en-us": { "role": { "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.", "label": "Timing Of Transfer Of Good Or Service Domain" } } }, "localname": "TimingOfTransferOfGoodOrServiceDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r688" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks [Member]", "verboseLabel": "Licensed Trademark [Member]" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsNarrativeDetails", "http://www.quakerchem.com/role/GoodwillAndOtherIntangibleAssetsGrossCarryingAmountsAndAccumulatedAmortizationForDefinitelivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferredAtPointInTimeMember": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred at point in time.", "label": "Transferred At Point In Time [Member]", "terseLabel": "Product sales at a point in time [Member]" } } }, "localname": "TransferredAtPointInTimeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferredOverTimeMember": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred over time.", "label": "Transferred Over Time [Member]", "terseLabel": "Services transferred over time [Member]" } } }, "localname": "TransferredOverTimeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/NetSalesAndRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r160", "r161", "r162", "r164", "r177", "r263", "r264", "r272", "r273", "r274", "r275", "r278", "r279", "r371", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r611", "r653", "r654", "r655", "r656", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r758", "r759", "r760", "r761", "r775", "r776", "r777", "r778", "r779", "r780", "r784", "r785", "r832", "r856", "r857", "r858", "r916", "r917", "r918", "r919", "r920", "r921", "r922", "r923", "r924", "r925", "r926", "r927", "r958", "r959", "r960", "r961", "r962" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Type Of Adoption [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandardsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": { "auth_ref": [ "r193", "r196", "r197" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.", "label": "UndistributedEarningsAllocatedToParticipatingSecurities", "negatedLabel": "Less: (income) loss allocated to participating securities" } } }, "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted": { "auth_ref": [ "r191", "r193", "r196", "r197" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.", "label": "Undistributed Earnings Allocated To Participating Securities Diluted", "negatedLabel": "Less: income allocated to participating securities" } } }, "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UndistributedEarningsOfForeignSubsidiaries": { "auth_ref": [ "r619", "r670", "r886", "r929" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.", "label": "Undistributed Earnings of Foreign Subsidiaries" } } }, "localname": "UndistributedEarningsOfForeignSubsidiaries", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss": { "auth_ref": [ "r736" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) related to the increase or decrease in fair value of interest rate derivatives designated as cash flow hedging instruments, which was recorded in accumulated other comprehensive income to the extent that the cash flow hedge was determined to be effective.", "label": "Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net" } } }, "localname": "UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationAndFairValuesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r621", "r635" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Unrecognized Tax Benefits, Ending Balance", "periodStartLabel": "Unrecognized Tax Benefits, Beginning Balance" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": { "auth_ref": [ "r636" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.", "label": "Unrecognized Tax Benefits, Decreases Resulting from Settlements with Taxing Authorities", "terseLabel": "Decrease in Unrecognized Tax Benefits Due to Settlements" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued": { "auth_ref": [ "r630" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of statutory penalties accrued for a tax position claimed or expected to be claimed by the entity, in its tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties Accrued", "terseLabel": "Accrued Penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense": { "auth_ref": [ "r630" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties Expense" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued": { "auth_ref": [ "r630" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense accrued for an underpayment of income taxes.", "label": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued", "terseLabel": "Accrued Interest" } } }, "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense": { "auth_ref": [ "r630" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense for an underpayment of income taxes.", "label": "Unrecognized Tax Benefits, Interest on Income Taxes Expense" } } }, "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": { "auth_ref": [ "r635" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.", "label": "Unrecognized Tax Benefits Period Increase" } } }, "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [ "r637" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.", "label": "Unrecognized Tax Benefits, Reductions Resulting from Lapse of Applicable Statute of Limitations", "negatedTerseLabel": "Decrease in Unrecognized Tax Benefits Due to Lapse of Statute of Limitations" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails", "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "auth_ref": [ "r638" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate" } } }, "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesAndUncertainIncomeTaxPositions2NarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableLeaseCost": { "auth_ref": [ "r822", "r830" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.", "label": "Variable Lease Cost" } } }, "localname": "VariableLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r182", "r199" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "WeightedAverageNumberOfDilutedSharesOutstanding", "totalLabel": "Diluted weighted average common shares outstanding" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r180", "r199" ], "calculation": { "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails": { "order": 4.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "WeightedAverageNumberOfSharesOutstandingBasic", "terseLabel": "Basic weighted average common shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsBasicDetails", "http://www.quakerchem.com/role/EarningsPerShareEarningsPerShareCalculationsDilutedDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 12 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r12": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3337-108585" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "21B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080549-108585" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693" }, "r179": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "60", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2740-109256" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "65", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2793-109256" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "66", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2814-109256" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r205": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e725-108305" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e765-108305" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "b", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r258": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)(1)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)(2)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL82887624-210437" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "30", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124256539&loc=SL120269210-210444" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "30", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124256539&loc=SL120254536-210444" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "8A", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124266218&loc=SL120267834-210445" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL120267845-210446" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919260-210447" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919272-210447" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "3C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL120267966-210447" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "3D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL120267969-210447" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 6.M.Q4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122651532&loc=SL122037091-237805" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124268681&loc=SL120267897-210452" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "13A", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=125515542&loc=SL120267917-210453" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=125515542&loc=SL120269220-210453" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL120267853-210455" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "3C", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL120267859-210455" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "3D", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL120267862-210455" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r321": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2473-110228" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(a))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(e))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r351": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "http://asc.fasb.org/topic&trid=2175745" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r354": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r366": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S65", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r446": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048" }, "r474": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r475": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "610", "URI": "http://asc.fasb.org/topic&trid=49130413" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(m)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(o)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(p)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(s)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r581": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "40", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109244457&loc=d3e16649-113920" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "740", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121829988&loc=d3e23524-113945" }, "r616": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r617": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "720", "URI": "http://asc.fasb.org/topic&trid=2122503" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123452999&loc=d3e28511-109314" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123452999&loc=d3e28200-109314" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123452999&loc=d3e28446-109314" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32059-109318" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31928-109318" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31958-109318" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1),(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(4),(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r671": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=SL65897772-128472" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6411-128476" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123385561&loc=d3e9135-128495" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9212-128498" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9215-128498" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6829253&loc=SL6831962-166255" }, "r705": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569655-111683" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4616395-111683" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226006-175313" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r726": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a-c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "4F", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Subparagraph": "(a)(1),(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r762": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123389372&loc=d3e36991-112694" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 1)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123341672&loc=SL77916155-209984" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r831": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "848", "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(1)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(2)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(3)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r863": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r864": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r865": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r866": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r867": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r868": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r869": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580" }, "r870": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r871": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.13,16)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r872": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r873": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r874": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r875": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r876": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r877": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r878": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r879": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r880": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r881": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r882": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r883": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r884": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r885": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r886": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838" }, "r887": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788" }, "r888": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r889": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r890": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r891": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r892": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r893": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r894": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r895": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r896": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r897": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r898": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r899": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(f))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r900": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r901": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.16)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r902": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r903": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r904": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r905": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r906": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r907": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r908": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r909": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r910": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r911": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r912": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r913": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r914": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r915": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r916": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r917": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r918": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r919": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r920": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r921": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r922": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r923": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r924": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r925": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r926": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r927": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r928": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "40", "Subparagraph": "(SAB Topic 5.W)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=27015833&loc=d3e570705-122907" }, "r929": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r930": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r931": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r932": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580" }, "r933": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413209&loc=SL6242269-115581" }, "r934": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594" }, "r935": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r936": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r937": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r938": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r939": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r940": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r941": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r942": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r943": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r944": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r945": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r946": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r947": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r948": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r949": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r950": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r951": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r952": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r953": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r954": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r955": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r956": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r957": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r958": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848" }, "r959": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r960": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848" }, "r961": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848" }, "r962": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r963": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "848" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" } }, "version": "2.1" } ZIP 104 0000081362-21-000016-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000081362-21-000016-xbrl.zip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Ú?97KV28CV5[<6Y:B'KP8%0H$@09!B@?FRM=UAW(K+6;^E?N]C S%OZ. MAE(O\_E4J1>7?AFBQ%(_LZM?/FLGXJVQ:1U:QG W6MM[2]WG4N=&6 Y0]#U? M\D.I>J"K*N^D4M>K0_W%EM[A=,JJ-80['NXEG=7E 0HE;[UHXZ1;5)*NXRTL MW--]:"K*9[,*$0X]UJ-JCLK95)/V.0_B />B?B@E@,'>,C+(XDA^CX[^-5T:BG=6UNNH%D#] MCJ]#J &*21<+A6+.8&5E]ANWERS)=(:HZ( MWXF@09YE"Y_=WI,!BD.7D61N=T5G)T,4A^I':F?U!0Z#JX-9MR+2ZF,V"JRM M5G$*!,?>&2"+NYQ*;GEJEP1/YH7=)G[:8KYJ-SLT0S^KRU$@&9*LQJ"M)+!# M.O^1Y^5QX94_FTZ_0AU%KPH-V$]V.XP:X6*5#&M@@_]. MLJ8_8:R#:XD\<;I!7P(+-SI$_(D+E]2=/>"RLC^<9ZQNS%EB'X> M>_9BU@<>/8F&>'8XF[1!RLZ'SR?/ DA+/3$H<6A(N9PV1CD<.]35 'SW"A'L MN!-T/KM&/I^J)OS"ILB0T>KB_X97X_%E0+%LU=MM1VX[\7?Q7HT(T*AI'&YZ M8H>0_A-*BE/4,!N#5IL_K61/6(M!RVPCW6G/V O8,*Y=>9;)Q'\F0M.3TETD M04*.Y2=N$'*6;8#^VW!01=:7@<=5$&%; M]H!V,W;8SFM9+&ALQ&=;J*V$N)Y*P32*)$L%AK$>CCP8KH)*JO3>,2,#X.9C MF2ANS0AZU'?8_E 0 NOQ6XL)AN2K,JD3M>TMD>Q6<2#* (!W!31^=@G [6.[ MM]O93TX DIFAK=X",!N@R3:4V9X*?V3Z#G!R%SEM&[UZI+TZ9'.@/&=;#LJT M^NT4U3T(YA\K".Z&4$[M1HGLZYHJ&I*ON/5R)VA<=3)<+I>M$);P+&"GH Z_ M3V3G;= +MCH&E=M-.@['$ MD=Z>#)#>AND2:L8%&B$,*ZN: ]]HJ%QP-;!X6]+*;"3'[+:31*3F[K(P7[>O M,W-QMH3^>I)K"96A) %]'3TB6^SQ##]G6U'TP)@J:,_,@;&:VT0;E7I%>5OS M8DOFCW?; %5/;:K?DYG.B[5[9QK L+:@,BPG-SLF=QIN7SG$&P!^K.P=U'$[ M @PK'JH.MX\SMN J"X.9DO7:0=)L4H),\LW.,:(NV?S'&B)E[Y@#PN:N$N@& MV(!92Z2:_V9<,&!OJZ&!NLKP,6%G%)4T &=I MDSX7WCE&\L2IO?QQH6KQE%6$[@5?9']%A!,O::HS^+Y8,?>&L8WOB[Q4NIW! M]^DAP/;&'+:_*8S& S G*I#NL]U4C 7E7-:1;-R#;6\9/'/3!M44AT.3"PNF M@Y"EHHZ6-WCZ<$?C 9@6%: 7N=K2-7'EID0$AHTG"_QWPS(XT^B, M(KQW2W2?//BT0YI)\8/4*,,5FR=1ZQ MMOWAF$#_!W-F](04(3PX7UER/])^C4%Y^ ,#JRK) M$)V).0Y4MYC-R+#PHQ $S(*LED)L5&##Z9>%";5IW,5;T0!-BF=S26)K&GO* M.NSM2_38VG^ "3570+9PYM 17M(@9W2$'L)U5:6[7)'%?,\M:Y]E)Y$_GE(] M_GCV2&E$Y*]^T$"@JD?>MO4(-A^4J$J+OH30DBU&'9IOR03>,5- M>Y:6O'"1APU*=N3 ($+5]#:B>JA'?\R@ZB@O'L7<1=,!J+GU(Y^S_E9(306R MT7=!E$2S1M@61H =\O@_S0L%GZ-<#RD8DWMYI(ZQ3I>(^I!F5:6;E,JTV^=8 M<<-W^;+XU[L$\Y_@72CDG-%K1%2LJLO_C7)R1\%>]HJ@D$]>B-$>E*)JK7:' MBZ-W0-)J@>U4V],!-,!2$JJ?4=M\'Q//]AWU5!!SYV9\$_P66!-E3Y=#,/]1 M_67(^=1-XWRDSA.,JCGP&J85^L+Z@+7@G6::9MV[#TV?^'+DK]120XUC62?E MBB]'LP%:INI'WEHE_L)ID%ED,;T7,F/)NTR9':?(6('I7^\3Q+,>6+G#@^>0 MQ/\-OYQ-=!D%83YE&ZE'C\4E@1JX-8*;!1S%.J60A-$G1[>FY(P0L/DP+]O& M/#P/':LWT9_H6(6.O6IQV3J1FN$R' (F.IF$9Q\]F?. O6\"W_CJ_+.GD_$0 M#+Z+L ==]&PR&T+N<+SL 0N>1^%S"*.%OIE[M4Y3T(C M35B:IK#%2'DN0(CBTD+=CX%V)#[- [CTL3L8>'M@#I>"NXL'S=T\)M$ >7V- MK^61;'?[Y)J )97A311YL)5<%T%A!"6B"@CI2QJV@S< M3*=2MN5)5:++R(KZXJ@"5=K<[G7SC\[32%EM$,$ZH$5ZPDC EILX7F36\1I! M\\*M?"8JJ=&TX=P1E?32B?I,5%(/X4XV64WQT+T A M.VF-'7E:Z@=3-J>9%$^293KF8@A J]$ENL7-J<&0V%,5 M8$ZC792T^@E0T$AE624KN^ H)D7DD&X 1&$4J8:R;4Y6 4D])#46GCV-%W1^ MY=3.G=("DEZTVS7[[W8-V--%;?$ ^)IH*O&#%?491BW+5_GT1CRU,SA$CC?W M#)(#;_#F8L!U2#8 _?!,P@);Q*&\0&73M"#;LM_6Z%1CC[E#C\6A-\- P]3& ML=1CCL1&[(^EV4"0JD>:$3X\T>6=*+BD8!%.7I.GR.E8\@ 8KG!7&9C)OTZZ MSQ9G &KF>")Q?JU5;R$[NS69(,7[!KXP^,RJHBF1X ;-(,Q9LDZ.0QW.[XN$ MLVP[I!H" RH;U[RC0"JFB2Y@>U+FJ,BH+&E=,GS4I=FO#Y:F1:J;'&%S@P6% M\ UU%@2>B@:*Z>CD:Z>6R"&B_W"^[+GUS7?Q>'D-M_A%V*41>A,89 B=?6>V M2\T4SD\J(9&MH(8TQLUD"S9 1]MX/E?E%0K"QZ%X%K>[PM?KRE+7(/^ +E-3 MI17"I6V8QEXJ,\]1+EM:4LV"9I)N(W*35' M%X$:ZJ]*%%59JAVXA-[(7X^ASL5&=3)V''" MO92NGD.=B@%\(=-SE69IW;O&)[:[T=A"^ ."&*!3F1!]]B&WBQT[A[AL\Y6Y MPSKM4A0J/;]+LG3CY"B*IP/T_589U28W\4WH!W,3$JOD)#7 (4DI-M.6D/'!R'.[$X!9D52V=F2.J@%HV6]10;7LR!B"]GL\D9WJ6W+N:"%"S M%]Y9D;?U&\%UGF)>+0?74K?U*PV&_N#QIEP.P?P7%LP7$K8K\H9D9G2AMU1D M*QE1X5UFWTBKR!#3/ (10^^D ISR^?"Q0G9MU"ZJ8VK\1U468XD"-HJ/A(%) M.3L3'EAB+U"XU='=;/O1(V'(&;6E!(?&EQGGHD!,VJD2K'CNWP%=3"0$N.OK MBV*E*]UH4'6ZL/8$G )^H'&_BMRJXPAP5)1Y"&P9_14H:QEC@> N@W69'JCB MVSAZFF@#VWQT7%-,'FWN).])K9I.X+Z5)"NUZ(JG8*Y4MW5TN1L#9-46L['0 M1YVATT;C08V:HG: M/27"%@I1H:\' TWO$JY'N7[%DE7,"-H!%*,K[Y/IN6(B+>)K4ZF ^3X%.+MP\?@UP^W'V^^? E^?7_S^>;3#R/+N):0]KKH;8I9 M7ARF=%%9[CG2"#1IFT 8E%93[XLR_5W0^&-9)$;N'=,Q /Y?L5;*C(5*(;2K M5W$R!%DCO%QQMBV#U5F%K$7>(4]DR2?_7=RDSDSU=(#\GH;(8=U:_[* \Q[^=("N MOZ%B".GK/4>.^F-[J/Y*MJ/YD@XEC58Q.I_M)2+=G54[^MO@U^3M?[A&7!#U?!]TE9.@"34W]%N>8PHK%* MV?[/S=M_W'[X[QO7L_U-O/GLR_4))2RN,I(+%'."!4G0;(7."!?RT=GY%?IXCNX)+RG+ M)\AS!_X@Z/=/7APO19;*#X*3DV-!14I.R..2SJAP'?_X;?WDQ?%;]<*+XQE+ M5FBVB%G*^+NCER24?X]0*58I>7( M)D ?21)/\4K5HD^S5.:DW[#F#65"2T+> 5FRPF,/GX+HT_64YRSV%V_.L/Q MW8*S*D_Z]:)?/KS_V?.='FI^O)FJ199/B&Y(TK,4.$EHOIB@4?&X3>TU7I#O MK14$L(S^\69:L)(**4).4BSH/9EFF"]HWD_)7$QP)5CS@"MZU!,&0O\F=TVR!2AZ_.]KH6.%29_!'L3A".!7M7S1L M;#:/9T!U)?ZX1.%G;$TJ2D*H^$@T#2Y0V=0[_[BOQ\OWU_>(M<9^&A'Z?"P V+4 MVD-GJ#8NUQZ/P:[4VJZQ8-C9@E&STR#03#ZM%E4ID NZXCF>N?:X^[6C4'/Y M5T;0>\+_K&@IMFVP,7H-"K.4Q7=:5WPY].CD]4LW=*::UAV*7;=SDCW''42* MY']7^(YP])%5H$8L-]CE=J<? 3' "'"L1 5G&9-KR._$DJ"+ M_USWT-F2DCFZ$4 "6:S0Y_FY\./F-9@?/5ZY>1YXZFMEP(32Z4M9W0^'"1%)PR_DQA@'4>SDD B&0?41BK MVXNB9?LUH!Q._1J)#B>A@3 3A8+N40@"C]JWE60A8^^>-=VC%BRQ'FP T0-- M[;EN .#,7N+&V#4&I?:3&#YC'_@Q]KX__!CK[Z/S!@<.A1]CHL5^QF,P(B-\ M0>P9:6C@:YP5T\.7Q[$,1O?SQ88D((R)P7B?0<4>X&D,9GR!<_I5Q6KVIFPX MI'TQV. "A!4F?(TZAR_?&>N\Z8SQ@DGG9TESU +=D IAFF,5C-CB=V3Z'S(' M-!"E+?LCTX[V!826S=C'=9'I@?8-(UJFL-?B%@ZR@G"EPM9@TL(!7( IXGAY M^![L0;UE#V55@$+^[X1H$$#SN:QQ[8%F+9,($B]SEC)(O8Q"2/\-=;(+ MQ',,:EC%HN+$UI14+&/H(9)@!$-RE3621Q)7*LT$]J"$+H#R&B]E'58#GQIR MN6$@NEWSX1F8N(7-MLFIV[(E0Q#=5VG\(-#I_^_V.MB2V,B:MJI^PG#,!4H M5A3?ZXQ?4XO@_S>D$"2;06H_KFM1@]UM!C^N#.A'JK*TLW5KI3/PVR#=[TI" M_MA1U#VE]#>"9B2E!/@LRRDQMK7XH1E#9?@.I$47.9U3F$B@&.CC=*9LID0T MKV7'64J4/8F^ >=@_N0[>I_.Z!*2U!?@ZKX#RO<$J_$OM0V3#2LMXY MM0_5C0#A5> X/0?^69N;$;!#L"A#/;#BG#S:US0-+D(22P7@I.SNEO8;:HG?T&G! MJ0FNH^[+_4._1@/0 ,\^V#*$R,D\;;1YCB"(5P%4'H-;DLT+I5_F=KIH<'T/ M[T)/.X]3A1P0V\40FDA"KU-K;^F;8&1LIOM8;#@:Z6Z=O8&U^'5E8-*7T[PB MLL520$!&8UK(D QT32J^Z@&V<@C]?'IY_:8'WEXLD8JDU4LSEE1C\0WXH*YI)[UF#[,&MF%OIY7=Y'/T 'J_[KU2&.'%:E5J)I:.?5\ ZQ1N] M[6W-EM&LVN^37L8*86G^AXM+1C$SU2F#^%C/?T_E[P?PM24R-SJ]7=26OV.% M@3=4//[$($R[)3RS)M_(@7:TT]A-]Z6FP!]O4J+#^:[]'%J[JW9+E"PZ7'DD M;PT#_G0+%GQX:PD+A!M+O\=II:S#=9RUP1\NS ,T>F3.\HM**TG[00;7Z?Y< M0! ,M5,I['U(R_:E;[2/V@S!R(R/DYB I&VCX;"E7H<6'._1RC44&V#J"G/K M2.5O5@GKXY)ACT6&D,5$FK%/70.&8GHTQ/6I>(6Y?]" M2L%I+/9@J(&Y-P*^WLN(?H1,30WNK/2TP;UPK /25_)L)6B0]%J?8\%D JK@ M%YR:S@7JP@F5I1*BPB7.,O5,<4H>^KFGR7,V337N2#>T3P)K.DT@:J,(:$N> MLCXI@#$Z(#-YW'U?/HB:VMZZQG8/M$E&XSAF/%&QIXK&)3.E;W]&![Q*[8]+ MC;\?2[I>]]6CT*UK1U)* L*;$NW3)S6<)B1"-6R4>X8O+7.1K$C92IWHYB3# M(")J7\IIZQZ"V?00>8Q)80LE;0E$B4IY%D56<=-TA4IB/YDA8=G0A+QOQN[) M,PI$N\G5!$Z9EE!\K+NQ2.0QP,!,X9/K#)Q=>;B<-Q31ML# ,4Q) ]Z208, MX=H^0*\WFFF675R_^S)2&+K:,_Q&9 )\N,*!]E.)PJ!RE3"+_?8UOK9X&P)F M>?A8,BQE[$[.)ML%SVAS,=5W 60&DY4]"$4P>00)@V]3O1);'3>C)#"\'<-Y M1I)T*F\ M)Q;_@& /1II#[:N7L#[JJ(BA2D# ONRN6'X]3%BU:>J.S#2) '4 MYQ0R7[5@+0SE)NN.D*BX.EJ<:;^)X?UB)9]\ ?.]Y;B:'0Y$ M@H1,%G?2OGS*XI%3']V[H;!+3M)5KV79[F.3D=^<7'Y;OD57-%YBDJ)?!N@] MYBVM)#>(NBW:MO&:C<,F M^1D[+KH8H(\0K3$N;R@0TI)_A=W6,)X0-8S6IQ:BT%L?A,O+)5L"6A&(.JY/ MD3L>>E'?\R/'I&[4K2IN4S=RPHWNC9J"Q^T$2:6,?&\PE(FC25&W^O:$7]%8 M*96B*&KNF?VIU&O9N%:(R[:3FA?-QY9G^+M+@AN0_W^X)+C-%$-82#?-'-7# MGZ)FN/Q_#:KJT,44U9?O/(5.R&!;@;B\LC/_XS5]<:VUVO MH?5&H-=B))V!RK>;-6&HW<6%2B((D7>O (=/-W&505?4?9$]\O3]A$L=T2G/ MNJX H.U$OA(R5$OJ/-6\)N=&G<5"0;#&-M=M+E/*:.A75I)BB>RC]8* MXLV'O!NOKLJK*_5_ 5!+ P04 " "FAF13C:SR4PP+ '.@ #@ &5X M:&EB:70S,3$N:'1MO5MM<^(X$OX^OT*7J=I*JH#Q*QC(IBI#R(2JG60VPUSM M?12V %6,Q"$XN3@O:)&2"_*\I#-:^*Y[_DE=^7#^2=[PX7S&D@V:+6*6,O[[R4?2 M%?^?H+S8I.3WDSG+BO8[;"V5!^)N\;9(RO<*JOT'_( MP/4[7K1^5E>>"%TLB]V;"DZ*>%E=D]8''QWYW_ $W$KH(Z().$"?2=).\8:5 M19MF*D)_9"D,PH_^<#=N/VHA:H_X GXWIY!J#VT\;P@?(#3)[S)A^H1 MD=N%Z=2@N$XHWNV#4@T%S\"'LB!#I+[K!0[K],3[PJV'O3= MJ!.*-P9J55B@DXO?/KI=9ZCFMT8=UY";/C0C^#<,GP_WXEA='$J/ B>0'DF' M^A## MS9>P+P$0KKA.7_LR&M]/)]>3T>5TC-&H[NOWRYO__-J$^&^B6\_[K__ MN+R=HND=NO_QQQBY/FZ[P2D^JTSL0^DZ[X:E%X6=J +3"R64WV'D]Y/I9/P= M4!C=7-Y^&:/+T51XY_;]P'3/1MBI.-^Z$BJW3BXF+?25QDM,4G3=>27H,EEV M0?^,.=^T4 SK%)UO4+'$Q< <2&A_(#U7#N.5GON=8-]SPTD;B;7G9-3M^(I2 M.B8H?5OV>IYA;X*6^)$@3AXI>0(I 2M"COXN,:@)GF[@^IKQ K$,7<-ZAURG M_2=B<_1GB1\(1Z,E6=$8I\='Q8AQ,(#%F(;&P+W .M">4PW<7CQX7?MN@FQ3 MK.J9\>!%UN*A)_AWS^)GG$,8[X1_JP@%0"=QLASN)8 9 !,*MA>9(RX(:8<]"G0E D! M>E!\-GZ&0B5;$'0)J\Y]F<*39&T7GI(SZ:<;)NJ=>@N($)[]@H U)D*C@,2: MUJ IE8X"^I<\W(M1+"#=3*W;1X17*Z$/$N MU>G/*:,EY'V,R_Q_?.4-I<0N/8$6G1'(2.VB@8PUMMI!QJLDL53]B)4<1@KB MX9'F4LN 5R23 Q:-D;JV:>@]I!K!0"E*3A]/XG6"BQI%J$'Q5 I2"M"676)\ M2,GTK"F9'6C\GBX\\W*6TX1B3D5(4%5%2:FSQHH[$(65.IX1X1B( M31@H24RUUWL'NNM&UM5>SW[')'2ZNE]IT4U[+.G43=X@\O4R=SHSF3FRT6G6 M$>36$;2UN'T!'+FH&-1?JI ML0G=0(M(R8B2?-2*M.-:HPLEZX]G/<_KDL-SP9!H*,0QXXE$2C#X\4O8@F10 M\:?I1CR2K,5R)9Y=9A(; Q=KM+B#BU>5>VM8+V*Z!G5M4G+T#EP7A%I-V..Z MR!K7U6Y"(6)[[Z5OCQZ!DKN5IUU'+QZGL4G)?:M99=H9STDL M]OLSDN?(Z$)5O817[W[Z1Y3PZFW5T=IM,4E.-""RFF!=(X# 49"IN6KPS5A9 MO S5*\J-8SNG>&N$B-;L_(6FM@&.M=[6#CA0+?N:E>O)F55-9KF\$Q59)24VN8ZV] MZP;.5J+61J]4-IDL(';\="=+?O(6CGJ#1!3%,HOCDHOOT;7H<)GW7>0="C0+[A.K:.[U7^=ES' U2 M>."CS!T>O4 ?($9<)+1A7VE(\7%Z L:]6M"@(>;-R/P#RC&$N=6="8>JD M]5/@/E"@N1#&\"J:Q57KTL3[/7;N>[Y2Z.3ODD(/#!6'0IYTR&07Z8U MS^+RW@ 'A:W"@[E""+> CQF&1D55V MGK>@_ERM,*?_D,,:Q-X9QAV0^KYN&.@JY>#!J1=DD6^MM;3-^,AU[P08VMYY=WU[55=C]R3R>GJ*#^V>N+Z]K?1&I[@EE[YS#6M^"["-2N0'3 MR*.6FI):JCJBV2-+'XFH6#*\T =BN1)[Q_,16:U3MB'PV*MW?B**J'V?.UCK^"F1Z@6W!H-0.? M@A;R',_\^8UK[^1?G:A1U+'=7W/M'1$,O6@K#/N."HI/^:?&[T>0_!G( :RL M*8H=']R^YM]7>& M.78\\*O">+2D9([&SR0N1EBK3DI'_9?Q&\PY4\R MY4\W_PM02P,$% @ IH9D4Y\ Z"H""P $3H X !E>&AI8FET,S$R M+FAT;;U;:W/:R!+]GE\QUZE*V55 ]$0"O*YR,(ZI2NRLX]3N_3A( TQ9:%@] M;+._?GL>>L#8&P?S6W1U]_4+BEE4KDA: MH"@CN" QFFW0F&0%/S2^^(JN+M #R7+*TB%R[)[;\[O=LW>GRV*5\!>"X[/3 M@A8).2-/2SJCA6L[IQ_ED7>G'\4)[TYG+-Z@V2)B"3'$9<&J YGP1QQAL.[SA#T.ES2.23J:L2PFF5J+G"4TK@X] MTKA8#HLEK4]J/+$'80=5?\ 3\+T[@U"[[^)Y0;(A3A[Q)A_)2X1V'Y93@6); M/G^W"TIU*W@&/I0%&2'Y7<>SX&Q4?9G_6]R=[P2]@+\KV'HXL,.>S]]HJ%5A M@8[./KRW^]9(KF^#.FX@UWUH1_ '#)^/=N)8'AP)CSS+$QX)AP80P^(N;;03 M4=@U8+"=&C.6Q-*#?N@)&+@'?5[9RA7; M&BA?QI/;N^GE='Q^-[VY;B]_E80J26<)B^Y5\/C\.MNK=W.)QE?3R26ZG%Z? M7X^GYU_0S25<=G(+K^CN:H+&-U^_G5___]4F^KLFOOVX_?[C_/H.W=V@VQ]? M)LAV<=?VCO%)96(72ML[&)9.Z/?""DS'%U!^GXQ_W$[OII/O:/+G^.K\^O,$ MG8_ON'?VP/5T]P)C<5Z[XDNWCLZF'?1]B5."KEA>D ((H(,BJ#9TOD'%$A=# MS1W',N].8 MG7KGH;L_;773-2<>\DV&_YTIBZ.F@F @A82\(F^RK+4[1$C\0 ME)$'2AY!$@"SY^BO$H,JR)(-'%^SK$ L19=0MY!M=7]';(Y^+_$]R=!X258T MPLDKT154N(WNF&5@ /.[&NFW;H*)MJ%VK.K&S46$:SYL'9!?DAT=/2)<8Q$8 M!'5$-!8_X1SB %9\M4'W*7M,2+P@'1D8*AQB!E=,&0A)L(9IBG"Z065:9"4! MST!:"I7)YJ^.BW 78XQ6<)F,X@3-<037RA!;T0(*NS2 =D_00#*7-BV07 E1 M2B*2YSC;<']6D J 3NO.A,."V%KP->H)[V1^AQ M2:,ERDO^IS'\2#*BK//U6=$\ 54.RA*44['44>H? B7?X4D#.&4D7Y-(K!J_ M_S6L%XLA:$!MRNZC%51Z^KL#\WD%;LI2Z>IYY1E3?6TP:HLOYA5!>P#RQ MDT3'R818U7 :.+V!P*G.:Q4]^0Y$P#FQ,-KA9Y0)G #YQ2"XQ-WE K<(YTO$ M.YI\?\A4UF9D0:&[Q (YJ;DP@":G590YQ5H@*J&UR&2S+5D-3\ZVUY$/8T\ M\U74=3SC5=0W7T5==]"3;:6G9[MOKHKV>[K%NZW(^? ^=.Q@E*M\5C(8:'E_ M_F?S.87KB&"<(IP1D2\0_W26$!Z>B "9S!*:+SG]\]-64*IYN?X5NX-=NW!V ME+"\!(.\^F0E#$!>I!\-GF*H.E8$'0. M=>>V3.!*HDOSC\F)\-/V8_E.O@5$2);^ K-J"Z%00+RJM6A*IB.'_B4/-9B, MU;LV3(&EA@X:(/,M0.8 "(^:7-4HECH?L3*#.X4Q,,#S866 :](*FZ8 M#T>:[J8MW.1(%RA%"NK]$6D2O*/4(+\J!2D%:(MY+WY.R03^0:!Q ]5ZYN4L MIS'%&>4A064?)<1RRF^YS'G/($IH+OH9(7U83@"Y KSA7UIC(-VH3# (V?WQ M@4 1,#=-"YB2'5>[#Z9ZK0N,L>(61'ZECF>$.P9B$VZ4Q+K:"PY =_W0N-H+ MS:L]W^JKR:-!-\VQI-6,:[W0567N>*8SW410;7.;FRO]@WXF8W8I M>O_D>K5)Q=0:0 93K 700"9871=>YFFH)0\TYC()YRS%7&_C'*B;SW6X=L)9 M_":)+2580O&,)K38\/;V.71X6=.P,3;1;V/CVYX2D8(1!?G(BK3E6FL.)?J/ M)[7.ZS*#ZX(A/E"((I;%'*G]&W,QREJ0%#K^)-GP2Y(U+U?\VF4JL-%P,::M MMW!QJG9O#?4BHFM0USHE#\SM)M9/ M%EZ^K29:VR,FP8D:1$83K*\%$#@*,C67 [X9*XN7H7I%N_%:[+1.HC9"^'!V M_L)86]MGM*YVU_<%YO@%2W.@9=!%VT;4NNROM2)@$TYTF&_RIF4-_(F$78?9F-C9 M@KGN?YD\2M4.[<_ZK^5]_S.@%\'\6K3I. M!J=,+9SJ5KU.CQ=HWS8FHQI"#3WSA'J 1Y0"RU(@^?JVD&V;F\(WNW6-R?]X M7T@\W!-7_-UIQ '7<&UN:G3"6TS_>AXXA]AT#VQ?311;XPOU$,(SX.,RI@7+ MWCAAYA<75X)[7ZUH41#R9O'^#"'/&,Z$](PI+!UW&QT#]X$(S;DVAE<^+ZZF MESK>A]B\#UPITLE?)84X$K6N3".Q'7^B[QS9CGGR";Q J16#Y.,<@'R"@7H> MQ*2?YIJOUO91T'=ZU1[K,ZK3-5CIFTEW8_0\21 ?Q5'@,[X3R;=0(TJ 1U1_ M6F^1/!)\SQM .6$2+: 8XHFGQJKG0M[T',@OTYI[D$VD '(NW.8UM2LA]_^? MT3XXYC_I(+7T>>LP07LHNAI2@BW@(Y9!D1&-=IYWH -=K7!&_R;/:Q!SS^AM M@31PU8>B*LS/K1M\[+(-;_-$P*&IC??09L>8@,E= *U MQ,]MH$ P'&+8VQ@]A[9WGD&M[T#V$:'<@&G$\Y:*DCJR.Z+I TL>".]84KQ0 M3\5F4NSMST=DM4[8AL!E'Y=,*CR\Q91 4'5#KH-CD)E:X'C-,Y\_;8[>0,4O MS ">T?&>,8T1A,UM!J[2\1>PTD-T#0ZM9N"3UT&.Y>B_Z[$]\Q(B#,.>\0&; M9TQ"^$[S.X.!)8/B8_Y1_1CDCU[S>Q =+7,/Y6UY80\4 U<^[*_T_\UY8^5L MRWFWZJK'2TKFZ+*._AO5Z;57]-WN"_\UIOAQIO@1YS]02P,$% @ IH9D M4V^'B89D! )1 X !E>&AI8FET,S(Q+FAT;;67T4[C.!2&[WF*LT5" M()$0)TUIDTXE*# @+3!3BK2W;N(T%F[<<5Q*Y^GWV&E*:2]@M1F0TM9V[._\ M_SEVTO_+<:ZOOE^,X'9\_S>D,EG,6*$A48QJEL)D!4.FM&D:7MW#[16\,E5R M643@$S=P0\<9'/1S/1/F@]%TT-=<"S9@;SF?L6_IM%)'#][ORM:EDR/LWUQT%:,9WD=9M=/3KT[%_<0JR4OP)/$8"_L=01 M="47VN&%X 5S:F$VE"DOYS@$9RL8WMT_P[L'FRFN9$(V0R9DJN2A2IUIT M]/WRV ^\4Z@O)[%=)/\ 72.M9YG3-.7%-(+S^=LV[0\Z99^M%8:XS/IR$L]E MR;6Q4#%!-7]E\8RJ*2\ZCS2.=\,>BXIU!! MG9RB00,+;A?'1(JT(NATVVZX)N@$%J8UN/[G]N[R;@R![^ZS=/X82[M;2]&V M/K4&P^O1^.[F;G@QOGM\V':_KL%UC4Z$3%[6N1.ZQ)3)MG4_GD=/SQ,Y/^+F@N!,KL8(1FTNEORB%3:Z/4LC,3/;"% QS M-N,)%3"4"N>D)D8X-NL>'79]WXN'CZ!C OL6'*=6\HGEBP4PN!:M$CA^BW) M:3%E7U:NMZL@)H(PF/TQ/3LZ/4?U:INZO21:+-O*07M*WNFV3F168. M-\N18'R4F^3GA>VL1(2,T"(Q[6@0;'HY:B$IDB0EJPRO_5W6:U=:5Y^XIX3=?:KY'UKO^ M%[$#4YD?L?]PGI5G<,]Q,V ";ERXI$KMUV7@-6]S$#2L4]!!ZNZK21QB-<19QY1RO_[&#J&42+>]NRQ(@=C.^)EW M9FS#\#?+NKG^0 NL3W;MZS1T3!5RTQ_,!J/AHJKC(W8:\KG7'FN.[RH6HZ&%V; T7 NX@W, M%Y'(A/S4.68]_>Y J389^]1)1*ZLA"YYM@EF?,E*>&!KF(@ES4/39\8%N9!+ MFFU;^%\L()[M]HO7JF7-^")5[P(P!_9;&5 MT8U8*8OG&<^950NSHXQY6> 0M)8S?'IX@4^/=B:N141V0^EY(LLYYU!?SD(S2?H.ND;:6BEH'/-\$$R+P+@GF5@'*8]CEH=S(6,FM[$H M1<;CNFG-8Y4&*N6[06\D9- _A_J"),ANS3'5GBV:*"8#FJWII@PK$WW2PW!N M12&.K^\.1:E=H7-D6"D60O6LY[OV ,=#_;C^;OSKDDO;TW=*%('K$5N;A89N M=6) 9W1R3'I.6$7X37?Z)GJ38C^'3RCVAP>97#6&%9'3M3&HH08:##"+C9\$ M#G**>BU,N%\<?[V?@N;;;8.G],I9NOY:B M:^+4&8UO)K/[V_OQU>S^\6$_^G4-;FMTGHGH>9L[ODUTF>R'[MO39/IT]3"# MV2.0/CS94WMLP_1FK,T"\7RGX>6@M1#73A'7-S[-4@:8;'HM7>2XSJ9,,EQK M(UQK><+1C$JIP@N#6UP-@#C6=_B^HK@2RVP#$U8(J3XHA4FN]U*(1!M[9A+& M*5ORB&8P%A)M4NTCG.IY3X[[KNN$8[$L:+XQ=R0\@T1(@W4H%7';UZKKV%VC MUH^=YP637,3 4+H8IJQ0;#E'-\PZZK@$$IYAQYJKU%!.6;22"(-ST3R&F]2E^6A2E5 WD1:9<@:H729GGJ'TQ#-;U\TW[?[1C3)?JRX M9'K7*@$CCEJ8Z!+OE)X!AI'XI_&9[CE0ZE^KU#]4Z2I2VBX9>%VC^RZ9>9[H MS6XZ*Q$AH5Q'NJ'5+RC&2V*4*B0KM4KGFH1F&2 AYAE6!784 M*!OV:,"$YS2/=#NRQP;!N(>C5EDELL $->Z5_ZLZ]6S;RK,;2KCMEYKKD.VJ M_T%L3U?F>^P&9K=]3%)!7NNS:0 />"@QY=^MJO_#[(V$;;"WL;]M-_>^WHK> MX;>H<;\U3CP671YP7I07,,6E@,$?-MR)4C&%==$\E[1W$MH%VO-:5LIKX_34 MC*AG#AKMDK:W*>S'=$=:1_2_+^__D J7[:>"[]A^VQ*WMY?L)P.2]EHF[;97 M6_O)L",=IYPE<+O;V!Z3A.,A%'YR0MR'/3K\T#_OS:]]\Z_ WU!+ P04 M" "FAF13OH5'QZ\< "56@$ $ &MW<^Q]X_;3WP?%'DMTF9[,]CC^R;FU+M91M[U,/1$(2-A2A J1M]==W!B!% MB 1)Z,NA]K(];61B,,!@!H/!8##X^<\OL]![HD(R'GTZ.GMS>N31R.+RB):>"-%MXE%3%^NKRZ MSU!]],[/WKQ]\]Y+)&#R;I+?62P3[S:*H3PF$^K]X^\D"KSC8T0N_2F=$2\F M8D+C!S*CAA3[ M<\/%[(J.21+&GXX .&1C1H,C#\B+Y JFY[=ON)@ AM.SDW_E(LMD\Q-ZK;U-!QY^.8/"/ MLQ'^YUS0-]#!#$+PD-8,!Q:?0!4)HJ#Z=Y>WFZ$@PB]A*;$+D/ YR#.CTN#) MR6YI\TFX+FU0Q4_"]I,6T/&ZI$$5%K'64Q:2T;J4014:O@91B&T(9'CXX^OC M;9T.4SV[2M5X]N]%%%Q',8L7MS"1Q4S)V9''@D]'UW>/MU?_=((O="WO7L[A M7TY![9Z>>L=>ALG\B2N"1NL9>'\^*2*I:B>1-.A%OZC?16608DE!7#"LRN7Z M]0M3M@Y!6I:Q<3<\ON110"-H#GY('K( U^L!C(A:,&5OW /Q4MV3)JN7$.O4 M=V3]N6+]$@?\7C;BF:WD(-+C8R]OJ).%'V=EL*K^L2%/M=1)P&82<$.8^(V$";VG1"9"#^V*?<>D M'W(LLH,Z/D9IS\E083%DTN_)@],=P;V+E8 M!G/FX/LB!U-<7HZL8]YFS!M,84'[3)1.G M*XR>B;)CYF;,O"8B@FDA^U2HH;6SL03EQL"STS(#,U0>X-+<[%BW&>L^HU>: M2CF@DYJ5L 3E./?>G7XHLBY#Y66X.LYMQKDOG ?/+ POHN 6!B*:L%%(+Z2D M54RLJ^ X%=^7IV*&57FL1MPQ=S/F]F%)@K:!57TN8P';/FTL?J814%;% MX<9:KDOF^Q*;4]2*RZO(O0Q[Q^M-]Z2S&8N5+@3.P>8OAJ6-1GZE15M7P=&V MM4QD ZOB\@K>CK>;\?8V@I]T2%XHLNIKY%,1$Q8M/\-48B6WLWLEQ_G\H%![4N!JS!W,N_?9#BKWS[^Z2M:N^ M-=U*$'YLJE.#O8H!VG 8#2Y MHT1:U8F38[$"C:MTE->D)NE8-NCI%CLAV59(G-V*=:ICAWZL=#;H.QB,^VJ!R7*?>8 M/2C1S7MI^U[,*V [0=I6D$H1?'6:IB;P;V/;]O1="Q0N\DQXD8$(/C M?O!M^?9&*?18Q34N&\4S5K%LUI,94"'[R0S[30/X*&+V;T7"#1=7>D!H".M%*6)^ Y'<3P=47]7M MHNAJ?YK1=<_LNP^V>\ M^CHJ?KU^P9_NPN"$Q55 RDJG1D!TT:A!]1F?&V#QE5TRGNX&M%131^G;7NZ<2]MW5/-=[*SK>Q8SV"4QVN- M[ D:WDD&WJYS'/.#0MSQ=E?N=C6TX7'1TUO&V M:1JY85 ML^ST[-BY&W9>^/]*6!H[Y,)2"[PC6^&_E6PUL7:LW9*U-2DRZCC<7,UQC5T[ MOT;'\2TYKH(#>VD@HAF:N P++#/>N8[C]+8$%.B81;X,5%R-7LQ#%COV;\?^ M/&.*H[&7=2+[[F$W.L_WZTB44TSZ9JA<):A\ M9K*6!'4'M+M-0W/1N[Q]I/Y*B'=U^IE::#<).#^WW/W/TLX@?J_40,?KW?"Z MPD#494[<.SL_MQB$"D''FFU84VO!FQ".%EUU2J_.=-L%O^I6T@H(5_58-<&Z MU6^7;$RC']%QE8;NV">?!/E MS,Y.P^Z1>CMU;HN^8O"F38?>>^'@?,9I<1,$CU1<'&M[ M::[FR.X?RY'=0KUOSEO6;>=TOY=LQONDE6_/LF 890\P;6!M?3W)&ZB<_9^_):X7CES/9- M=V?UFEDG:%L*6ED&4HKH'5[:J]T;.-9U%9:RKK%+1M:(IUKI1&!;$6A<-.K< M<>M7=EUZ-K,S.S_>J^XHZT5CWFO<<\?% M+70_\T&'XKO2-:Z#',:-<_"?/UGUMT*D7K'N>+89SQYH/""A2J/Z2)]HE "' M?#[1)-E96%_%<2Y:KI9@R)%"G*[&"K5GX.YXO(MY67?R8H5T<^W '+7;6/D< M[;PX6S*R=N;5\=6EHJ,'SQ* VCAQ.\9OR?C5>5FU=X?RH-\=,1F=?G&T MF-^?EO9 &D''D&T84F?K"SJ3."=L(OMXL1%;#.RK)T=R;E8:<1 M=\[003*?A^KV" G-7/JWD6X\)=#Q>Z\SO ^:ELU81,3B6L9LAEHW?ZVI-[[D@H0/--:Q0JJFL(8P M[1ZYL^ZH?I*BH#N,_GC+#JT\#06FBNJ4\@JE\5%9OSH!W(< :AE82_,T5W<6 MG=+>IDITM%1TZFB7TD D R70-P;B(H+9+WW!5*[IWCCC1H4\K(' T;MH.0-2 MK:!B,-M1OF*C)2S/VNKD8>_R8%M_UJ_MJ"4L&:76EHE.6[RB=/1YR/S"K:U- MJCO)Q_DI",@.Y"-K]?^W@/Q\0N9S%HUY^@W^CB*NR1B)\P\7D!/CR]H1%,D:GY)$G49K('=<)6FJJX%_'6;UC_'1\=G[\]NS- MBPR.O)/&3IC8WJN_@MBY^:P"MOO>M<4BD@]ZPD1T@N:M6]NA$"NUL ,?D/"S M'UV[,29RI' E\GA"R!RZTAI@,T1,=6=B!D M+7,A#\G+,AMR3EE%\8$0!Y-8@HT5X/(V (M"E?7&RRBLE#WYME?%X_(FN6A)X_^3L.P?YZ3 MZ@B^$][5TKYS(M^N1^3;UA'9B^A?$L%DP'R$NWZ9I_D^!5Y-(Q.:$^@ JHD# MX^I8&5/8%2S[KA1>^/-[.AM1D5-B?"KV.. S4+_?4V<,1K":?\/GYPJ]+A6T MK^^_D7@(>\FPV/7B]U;V?$#C6'\#2;=08"UO.27#9UY+B5'>/DKP0L @ 6LV M"J@^T4*KED2+WG-$@SLV!GL7-!"N9E:S5Z>#R$[#186OLK85VF&S:RQ)7 MZ\8GPA3B&RXP0GM _32D2)-V1\2$7I(Y@[F;)J]XI!,F<2MF;+;TH$&MVL%^ ME<;^&.-^SX+7&O4=-/7'&//!C(3A:XWZ3AK[8XR[$6?:,CG-$"G MV8P*?%[SGHAO +<_9NRO!W\,#MVP%YHZW?;'A*T:.8QQ5DXX(R[W4ED><=% M:P!KGYWVP".>11]?3G$5-UQ:UL)V\*N1L)L\+=10D(#.0 ](D-]9>@J'-^?Z M@@>)'P^I/XUXR"<+Z+$TZ-\&1SN&J4FL#0J+N;4N?#]1A((Z-1*@E9U^V^!H ME\NOGXQ"YO?&L%N GEQQ0"@NE'LOUW@YW6[0AR$']N=][UA$L:\&T8V [>*H MZNZHV-T+(=##I]Z_6>0@?;)09W[/1 3WY(7-DME#@HJ[-U9 ,G>7P:_KV3SD M"TH+8[/OQEKF@\SE ?,LHD*$18.FO1U0\<1\*M6)#U&>1TW;Q7PN..@+T*68 M/@N%%R]*8"J!(14SF[CM%'W+!O&*">@5D'+Z(H(>&-.75J0 Y$@2IVJ,@E:<[^]/Y/R1_L!MY*>Q'->CS> PJ4 M]G*A=\UJ[:,[4\"J__U$^%-02GV0&@?B-ZG;OA&X)[$_51V 9'^T8D4UIR51<[CL5FM=LW"@-_2H,DI+UQYF8?DI?4_(\"8R]L MWKB^7'D13N4\&-*7^',(0V%HR=VC+HY?G!5]UQ52';"E257^C=LH^^N>63 0 MRH>@4WQG\4G%4O72!U/RH=L=QG:LOPY'QG%W*6WZ2+X/2G%L+G"'PCY M*H*!"+$8E9:K[?:4TH N% M&63[=&C>1YRH+_'_42)*5D0-3+LIPIY:#K-K0 Z GJF@94.O#JC]--WPI%;J MBC '0!&L9HT4&3#MIVC 7IH(,D .@![,*-=(D0G4?IJNV61:.AFJ!6H_30^L M'%=5!]-^BH;-!>/!NDV M!C?,-UQ0-HGT::N_N'[Q5<3Y(YCU:>QY>9>3CX2Q)]\YYD,9TS1V3ODBBM/" M5M:^^? ;49DRI%2QD3;SK!JB?=3T!?,6(;05MX]S]D@!$@5S'2D0+R,%9HJ&(J&;UF_?2%R/Q^CA M' OS%24?[WP!FH"%20QRBP=VQ@KL7J5(+P"HT[_OZLC++0@6C=DXIC1:@"$A M[:QV@VXA8XU^Q\_P?>%(9"5P^VA4L@3&479<(_A$D%GI'*\6JGU49?-K#G6$ MU.?G.+UT=%?CM'2LULJI6;;MS)"DWO@+L$:BT48EIG#,[UDTF8AKH3F4U?AK M)):'!V!-I.3*[":W-C-ZN;E!5V["KE^W)>/2=,Q?25I*2I]&),03J>)YS-H5 M6S(@#H8JJ 1]LO1(_96SMQ4KM0YJ@T.'?6J*[&9^D-[,9Q'Q?4 61#SR=4 O M4UR*47;G9('ME2_VKUG]0 Z:^OJ@!^U16 $C9E0Q2,MT\MF]VP MD1PQ?6,DS:.]WL. AB7/P.K7 MEO;ZF0O;O7!;6?LH^)4GDVG,2_[RXO?V]?P!DS9%OY)%.2"Q4-"^OG\)._92GKP* &RZ,.T[I8=$U M$1'HW1 \4A09=N&VK'?G=?XYV?7&G/Y?8#6\9HCF!FD7SO8Q)7TK+E<1?# M5(FK_0.$=H72!14$Z7NG7)%&:P9G33P'.O?6HA+CW-$EA<%X=7IM&Z0'.H[+ M]X 8:&A8 57R!76^5C-.=94.8QRJSM'&^5VGYD.W%> #,1HJ:'FD>$[2?-"X MA#L,-O?&8XGOLJX:',.I0/]!=H46=FJ8;6,UT'7=BHAD4(&4"-J?.UP!MY=DO\"$T%7]ZFV9WT*#Y .P#MR6"Y;LGP\U]9Y6R M4 /2/IFXC8($SP.7>=M4BA1NB?ULAFP?=9])] W3XN!#?DKI9RYK?,&U-PK9 M1$<_%&E=MUX+*4_GHR&$QD7D ,,?QHP8.:*T3;)ZHQO*DAD-TOQI9H'6W;*O MXR8N=&A%]@AO?BZ@/EMWQ6WMWX$8(J;VQ&PZ=YQ$?<$BG\U):,;"I7,MAT!'3=@Q\#O#(*RX]U:!]Y/A*R."K-WP@^C>3FU+T3N%[^PR#7AAH MD^:&^.HZ<4,*OJD%-I3"=$^:BQ;J'0^4;"]68DV M5_CV4?JW:<5-CE)!^_J^?%VYG(/54F2JL^^?B!.O1?2B*R;GZ=-8O;'6VT88 M4S5(2U2S4Y::!BIK0-KABFHFDDZ(O_B;>H7VJTRCN?$B3'%*-0*V;XJE:?W5 M=@V$(!%4/E*\=8FG3I':M9'P3N;KSY_ME'M0Q'N"SFB,N;R,B1L M5O);V$O;QV'3!,?S$=B5JV?RN$7 GIM(N\R5CW WL;LU'-##K0>WC&N7\ MHMM@:=]T-Z]*1+BK(GI79;]U[@;=/BJU=P(Z[1S][UZC?=2FEZG-3, V0[(! MK(UTC6)47T(](CXCF,="YSTPB:J&,172!#V@W_D^;';\%N3';P)SLB5TQ*/ M=E!7!7D@:\M?@9@09(Z/-0Z117R/,F^M3\!Z!X89%QS6J',@PW!GD#-.?7+X MV@M3 J.>>:;2%VR^:G:L6:UER^\E%R2\G-(9/D^=Q@>4@RZJ8=JGCAYHC-IF MR,WWN7668QIY:U1OX6&5WL;UQGW!?UIH.!J!L(O,*#0R M&.T$6PME(<^C1J)@;*12JTZX5@'8/H4^I"%L:@+FEP\!"P7MZ_N )_'T8HR; M,1VF=S$>@X4 &J:47*L1LGW4Z5,_<\<9+\5KW)#/SWZ"N!VN]HW0D$7S4%T" M@94EL<_(:I#VT9-N3M/L-=#O: Z6/TMF0F7@+.UBJP%;LBEPI=@WMN-(3?HL MFYBEC_RLE.OU8*8?NBN-R3:HVNA\MS_2EJ^IRX6VZ5TW:Y4V4RRQ^SSKOA+R M)0D^V):6]X\::QPJO:IL/8+3*H=*<8RO#JU'<5JEC13_!NS -4C=#(@QTV6, M=Z9$VC?CF*4)\$"H2^9S-^I6 5M)77;R1;*3+Z).OF2LO$_Z7EQ,7@C&7E@. MS-RJM63%;MH*55'%,11]K&])KC\F];4/9&B&Y,5/8C2A?^#- ]>:B,I%U'T@S#H' M,@R9U\[/8SZ8#FC*4O(J%2[37)>@R[B84;&TW\HQ-9MC.A#5]T4 782]?)F- MIJ7L>Y:R]JF!](EY_:[VBI/_$9]:8"I&,=X;(=M'77I9C%'Y&YTR/U2W MK.\).HZI6,!O/#R:VW8IZ]=L'_6?!?DW'HI%>/$*W6WJ08W2A:U:J/91=4,# M*DBX?!XCC;U(]UX&!QO@#L0DSR*)[HG\AI937Q_GW5D>W70 ;2$[LZ?5!S&= M?YWWQAAY',5<+ 8KAR!-< ?"SCMTDLKX,I$QB&4I-KFB^#NS[><3Z8-LD5_^ M U!+ P04 " "FAF13*G"HU7<< 4V@$ % &MW&UL[5U9<]LXMGZ_5?<_^&:>'=N2UZ[.3,FRG7&5$[MD9WKNDXHF(0D3 MBE2#E)?^]7- $K)D$1M%"8=6NCJ)+1'@^2(LH7'TY=/! MY_U/.R3RXX!&PR^??CQ<[9Y^^L??__=_?O^_W=U_G_=N=H+8GXY)E.[XC'@I M"78>7W>ZA*7\H^[%-]'5;SNM@\_MST<[TP1ZVKF:_H>FR73G.DKA^]0;DIU_ M_^%%P<[N+N\\I-'/1R\A.T!,E/SVDM OGT9I.OEM;^_Y^?GS<_MSS(9[K?W] M@[U_?[NY]T=D[.W2"#J*?/)I!Y[_+62AZ*"])YKM2)_@ MO\UZW^4?[1ZT=ML'GU^2X%-.HJ)_@>63 /?4@-Z9L_S#LK@'YR=G>UEWWX" MGNW ?[^S."0],MCA__[H72^T^G/J_22,<^6S'X_W^"-[YUP:)$DZ_I]3FE#. MJ>2.D9".:>2QU\LDI6,NU"N/LG]YX90DMX-NS+SP.TD[24+2O"4CP05)/1HF M0#0GZ+?T=4*^?$KH>!(2\=F(D<&73S^?&;"P=;!_UM[G#/S;Y4WO^J*_!DKV MJG*E&TV5 M,5]Z+()Y++DC['[D,?+^]ZX7^M,P9^VYEU!_5<#57[@1C!^'\1',= M#6(VSEA9GS':O[(RNCL^(,=1)PINTQ%A=W&2,I+" H"_]YQ$9 +3%@<@.I0 M6+WZQ4==>&Y5O'6\NC+N'@QCC/J@^7RJ716*I+<9=?Z;P=U 9PNO(2^PR(GBVH!U[RF*V3I\GNT/,F>QS^ M'@G31'R2,61W_Z!8RO^M^+C_G:LJG^=OXF3&VM![).&73S?Y>_NES_8/#D[> MF+=QNN]8#&IF0/3;@T#QZ3N*YT3>88O$>\P7/<./2_)>]&.*)_:2Z3BW^5T* M0A;M!RP>&W&S>'^L1Q&S@#!P64^XS_I,Z'"4PF^-D\=9%8J7S!L^Z+^Q\@JX M#08'\\P4IIHW$SLG,"*3;S2*83YZ%:LD&-@6FUZ"9Y6^?B/I*(9OGN"1S%@E MJ#;QZOY!:Q^1WKX7X++2;HXIP@R.5C:#+50JE\.%*;S\N0?O!5:2]3+9 27 M\Q8"0]Z<>LGGLXUS78P4;2P3YK9:0-LASV<.J/&2MZ0%8#A$8,7.I"$/5&?)/=Q&&@@R!OV#]J8/.XE M7LLU48>I4+C6O,+M?H"9N.T2PST)H=/A5Q(!92'PO1.,:423E-/Y1(I$G :6 M62> %(,+J96%7$-MOCAM-6E$\1)R-V$(8G\5_[K=92G;S18%"T!$R:G M2,IUN5YJP17*>/3AE+&2$U,:+^V2^(%Y45[2Q*8; MQA./,A['O1U<1ZD7#>EC2/)RXNLH( -8A*5#ZSN(&T'>#!Y))M7))RB]6P M3 1ET41EM]4<76;7!+D+^O&=Z,+BLF: !I-KNW$YJBI!5!P3MMCZ5>!ESW>7 M#OI,7R$:QWJ\&5BBO-(+Z^]Z[+4.;W4FTN)7:E6;F@0Z-NN4/]5M. M1_:_) M"_F4UTF['F.O,(YDAS;HJH],^@" I, M[A&? ,-AAH.ISQ"&HBF@PN!^*3BN& :UN,J*C)JJ?"ZGUPLR($ '+V[-R3+6 M/47+?NL$W]2[P&^YZFEAE>4Y&ZIY)VZ##&3B47$.1D @Z?^UYS]_ 66/4"[.*;'Y<"-76*NF: SI,N;T2 MSJO"1R;8RG+B355$MWFL@MM7O,AZ1 *Q-^"/F/V\CNY8[!-M),RL$T"*V%DY MT62AS!&6%72Z5TW#"(S3*":P<4)8^GH7>A'/B'"_<,+#Q?K$JJHIH,(W->>L M5LW).D"EV9P/*;Y3E*BR;5=5<66- 1DFQ=0+H8*ZS@&M+UF/7F%=KBT[OC\= M3[.BV0LR8<2GQ3%SDY"D^5EMG7',4OI7]KD4B3XB5,MK@%N8UJIZP2J#236R MI/1($J?9>KN5A$L;,*Q,GM79MHXPZ> \"^7:MD@\NE2ZG;(XKN5;J,H&2[.\:5<]QUMT.?B3Y&D2G6ZJV M@ OC0O_8[-P\.:+Z#KJM.Z]@LB?F[=%^Z\3MKH1UI^4P+[C2\G-W6W";2B-_9^C. 0:D]P1TLA6UQQ MNXRG+!.4WT $,]@=CWZ"8JV^0Z&>EP"G,,5DS 0KMXDZF2+J'M$83:/4Z@P7 MIZQ1 P),SEB=8K$QGYP-PA30K*[K$;#3+1+Q>!Q'&5E&NR'>/0[48QJW9>R5 MJUHY(*%H:';@U*-H3O<\!$%VC)07WGDTN(ZZWH2F7CC'?UU 1-L!(,3DULE$ MH,A;&T(4ZHFF@*,>]73IZ_7X-7,1"<3MC@LE! /J:X]$T'?0;^]C\O%D(I"K MIRE$H9YH]HG5H9[M?:8X\\XU(4)QLRS?/":K- M':357P <0NJ5+(A0KM)UL4"H/YK2^7K4WZTS,SL9RAJ,LBW@PN[PJ&]W-D G MG<9??UZ*-+%R@;(*QA2%H!%NQ.D/HV9R4NH7UH*CCJT3ZW*?*Y*^S@%\*> M##TA1F[LT[S$)C<,8XK32.#R;V@5=K^:*IVL/^)"&)'/.*_3/#)I00XS9 M[355A;E<%?#Z?YH?Q,,OZLCNLAN2R-<;G:)EOW6&= 97B$"NN5JD0F=EX7'' MET3=I_!W1O[M@%_%+M98OJ'3N_CS(FX'D>@VJFZW0;N(,'9"'=#(\)CH(P$VC-7C/H G)BR,;8" M,EO^:-"CVT+M1M^=.K$2:64I7U[155'79^T!7U-=6?4%]8;(=0F>+=%QE\[L MPB@T5ZRH+0\N;P9HFNJXJB^[5P,N+?)PNCK9ZNR!TYM8)3J77\U3PQA2TA$@ MQN0RN!"W=?9 RD9T5;%.%.H80^CI(>[XH!F,5+UHT[RC_N%) P)14E'IO6Y3 M%I3N <3H:*]7_T\<7ZX[6S[GL?'*!F#>$V#&-(G8"LO,&3'B ;HSIMQ8@--0 MT_M1ZWR:\!A)0O(C/[-51/Y-8#L'*+H"U T(/$G%93$+:)E0NAMW"^0'HC_XNU55? !QJ M0%Q**EKE!KUFRG%Q*//$;.O6114AIT MY8T 20-"25(1R =R%5RAPEN^QG$9+OKJT8C/LK=12?;'-)%FU@D@;4#H2"HB MN8K;P!BS8U+,0J7Q MQ$2=J+33F]F5I\ 5Q[_Q0V1,/5/K_@!_4QU1]=WM%3DAC.)LRXW"98!^V;$2 M]PSUB$_H$]]699T.6^X"4#;5*55?H6D.7L0JT6] 6[.VNW1&EZ7%(V41O$X/ M4MD6<#75-3U3NJ8&J(5B;_ER_0Q71<,=(Q./!B),=OG"XPI$3-&=)"':E7RU M3H$3375ASRRK'\S947HWY!;:B$N75CY5%Y?:@>"*N\;,C[BMUFG_:+^ICO"9 MTA%>A1WHKA%T82)'^XZSN= -*&^L1'ZJO7;>"CN[G8C! MJ6D-V!KJ&!^I+V8RPEUH]U973QY5N]ZIM+#F1^03EGHT G[?Q0E5A>FESP-% M#750C\KO;-(@+900^QDI:U9"-+&VJQE37I'Z&Z@,F6_?*Q5 Y6I(BV M>P1U>EF327*OF/MJ2)@6/0'FIOJ$ZMN>K'D@%LAHKE1V8P'U%^<&A7="(R_W MRJ/9C4)3<,^_E M0\J51]F_O'!*.L%_IL5^+<6 ;-9!_ZC55"_QH-1+M(5>Z.UVC\4MIVG$\02D MPT5R.[B.4B\:4I[ZS>HAKJ. 7[@,BA/2)UXS4>QE_QK'P3,-0UUJ986N@2M- M=2I;ZD3CRDP1"YCM3L.TG%Y1G.UQA06)!OW,=V0'(\!W8C'3Y](,4 ZO)W[/2W9.0L/WHM&G14M M^\=.=X(H*)L=.'3'50G4*,VW\O#XW4-2AR;N_X(*SAES'4PWR7I1699U "B4O;<$HVZ:)_ M@JI@?RTRU+A?1AQ"=^#.YO0#(\JKF($,HFZ6?/5?'Y@7)9Y?> +9;[D"B],Y M.HPFH!<762%.?OCDBDRJD0+@,:;PG;E:V!M6[5S#=E#BYLS2>4A/0B*/ ER% M\?,_23 D,SD.8$#N$3_TDH0.J"^<]M6X8?LJX!HF9\I,%3BR0HZE;Y66Z<2;"^A64=KP:N8@J+F"N" MO?G5QRYL94&;LT"L<8ZE9VTV*ODLCI"5U&650K>/(1UF/6,T>RVQ M(+GF18?4>X4P,KBLN')+!@:LD:2% H]5U> .%GSLGK GZA->"]YE)*!I#8S< M()4@J^;%K\JW5:'D;-E](=LQ!& ,?7$2C87\IA\U,&:%MP(OFQ?X*M\MMA%. ME1TDXO9*Q355P+FT, 5EZZV[,,S18[(8K10K5;B9,T)[1\3F*E_=]]>F)Q["?4O2.K1,'%6O0K1[ 5J;9 !W9ABQ96X+K?)$JC8JN1<:ZW+Z.^/*!#7]I% MC"\9Y6'V6A(\Q'<>> $^G63;"-Y2:B;,6+7[_DD;4PRVDFSEME$/=\HJN/C @2=)X(\X;D^W3\2!B_[C@C M.IO-DMMIFJ1>Q$N.-(IDV1OPQ.6:4$+M$IDF"T"KOOHG1YA6>Y6D)K>5"JS M5A'CV"J.G-]@P..G7E@,EQF!BX&EM_MVBXL;.XQYT=#H>LO57P 7Z9S+\EMCG&L+P$XPK02I&F8.X\'UO#-NN7LP+#$KRA& M&].P8DA9+>BVF8G+[(J-^+I3?D-4:!+EJMHM9P>F5(JE&.LQDQ*&H-LVX6GK&.!^CJES>O_Z>XX"Y*K'S;QXJF M4-XI9T5#'>M32\?:@AVU'2?S$5('&(^ZJ'G3Y3D9Q(R@V60[(X>S'\,";@TJ M);=<1TP6*9$S-+/B+^4_W>)=OG6(99-D$;'V=(=Y[]& *<"K^]R5HN0]A\T';UE0A4[\E;N%R"> M84H@.!+QLDW7Q5ETUU[^LNFS^J+>RQKR[EZ%RQ=_Q+<=]+R4=+.?$A5B*S-? M[56<$9B2)(X4P=3R:V&V& Q.G6\YZ1&^6Y.7I_&["5QOON47Q#O4<:TO15-_:6M^JWW9[4*2'+<#Y1 M-N;0,,TH:@DHY@H3E-BV+]:NI$XKR:KJ*G;^TY0$SS@%H.UJJZ!%2S M*7'3@_XW+RT.2;H=E$/@YR$;?->"1A=-N^FW3UHN!Q!3 M.K^#W!^>2?A$OL51.M*M-*MVR]F!*8QG*4:YR:[($&SSC@,K<1FX,J7S_XG' M'I[CFE 7O7'PF()9ED);W286^8!MI[T#4W#I25@)#=Y<%^Y9?YP!F/P-2\'5 M9 YSG- <_(560VHT")=>BXW8KN(IJ]$>>'<&-$V3;Z[;*&=A/@=@8I836;Q$*?G!$- M]:O;M?C59=PHVV/O)#QV01Y3_J='0GZV.#]J*4I(X5C;S(A\&,;PS4!5I533DL3($C)?/E*FD $4UV^WR:T BFI([_ MYY3FFR.2.T9".@:RV>MEDM(Q'^*O/,JRLJSD=M"-F1=^)VE>G9*U9.YO$!)( MNO'X$6CG2.9.%@A@6J4#R@\G7R0;9#N7S('OIF-1=Z/1Y/I?V&^?.3UL]6L< M!\\T##7 Q6.<7$PSR-H$(C?U=ZS0+-!^V40U$;BV ,@'&4)<9J#J1'3'X@EAZ2O?$\/7I;S. MBHA T?Q)\NHE'1:1. M[-/;.)>-:>*"P)0E7)NJ;68HL>4[MA3]!QE:7"8ZZUW,/L'S,=/5;:_EG(MG2TBYDC@;/[P\4CU"=4; M9#.V"N\/,DY\E%AGL2O4?*_O>E_.6?OAHYGJLV(WPF!-TKTLL?G['B?YT4O( MW_\+4$L#!!0 ( *:&9%/F0'=)2'@ %=L" 4 :W=R+3(P,C$P.3,P M7V1E9BYX;6SMO5M7Y+BR+OI^QCC_H4_MY^XB@8+,.6;O/9);-7M7 1OHGFL] M,8RM!'?_]^OO_[7R>V7 M7X+$+^8DSG_Q4^+E)/CE\>V74Y+F\*O3LZ]U5__X97_TV\%OGWXI,MK3+Q?% MWV&>%;]^X]D5_^ZU]>'/SRZZ_0>13&WQZ]C/Q"A8FS?[QFX>\?GO-\ M\8^/'[]___[;]X/?DO3IX_[>WNCC?WW]G8"MB59=D9R+XPR*A4(]X_\;4%^_Y"%\T5$ZM\]IV3V^X=OWU.JSOW1 MWN1@#Y3Y/\Z_W%Z>/31YU(Q!4>O5%!*$LJ_9%\ MFF4DKUJF)+ !M*4D1K5R[SU&Q!8EZ\Y;2WQ'GN#3D-V0=):DW9)&D M.;RB_K,I8^F^KC&^TV0^#_.R,SHQG29Q3K]I]"L9$G-#3>L=C9&?_SJ1?Y151^LJC9\C (HP*T4?ZQ M-=$-O;TY>CI'Y&_3Z]/+6^)'7I:%L[!:7[6'IM!U2[E/GSTZ@K++N/K1C,2\ M3EO*:FQ,\KIK+-_JB_>5>/ !J6:H\I-W5SS^3?S\/F$]TQ9(Z__J<D9F81SF=$7U0H+WO=E6F"5I&VOW M#Q(\@20^':)T"4:R$R^"U\TAMN!M*;RCL?R7 M,?TGN?=>"1#G3ZHSNL8,X]6O;Y+E6GK?&+ VK[2/LWN81E%NC^C+.%@.^"\P MX,U14O5%C9%\H1\^*X.)UW%C2:FC?.=%I9%OR0N)"]K:3Y[BTKAMY5;KW([L MQI2O^9;&:&Y(G%4S?/FQI ,L3TD>5LNG$Q)3AN8V*-7PO99QDIQZ4V$2A/[R M5Z?TN;:@3;S:).[;G9<;VU#2>EMC3'0DT.ZBM\LL*P@LW& -1S_V=W1^#;PT M,,?7!F]J@8KRHO#S(H5U"PS[:C&Z6L&T!Z/Z@L88RKV&$_JQ"$Z3^8*2P3,Z M*:IV;UC^\K>/[W][_@K_M(1)[94KG%[JUU"7_]Q$NPH%A7'^,0CG'Y?/?/2B M2"XW)U95QY0@)/:IQ%/VUE8D^N]J#OF5+HZ\(LH-"LCHVZ"XR9RN5.U(N^RZ MM;!E/[_.R?R1I"8EW>ZWK9C/5*+4+Q[)KRL5&!26V?M*Y.6*G/[R"^U[ZZWD M-2=TQ1[4[P59VVT^+E]:OCA*_*VW11"[3M)=D%FMNIF7/98PLS3_"!/+1Q+E M&?Q43C._[HV64>K_07_U<%IM;M!9\GPV(_YRL7$]FP9)&56=OH:K.2SR'DGT M^XIL:U VP%5U0)&-WR%;$V6:;F.D-*Y?N&1T\VED MEB;SIH98RI0T!YRD 4F7:2"HS&J"K$<'0R7KT4%G9-W^1#=D:VF)5FPM$:-E MJ[%):#)"AFP:_%UDU(58[AQ_W5I8-!F8K/XH[GV[?&8MB_2YO&FE9FP6P%^2 M>W^XY!Y/D"&KK $;%X9XO>Z*VO2]'5%3&FS3AM+OD=N8JHOLUR?/6VS8??F; M][9?_OKA+O?R597,9^5$"V M[@U$,*GZ\SP-'XLR ^H^N4IB/XESRA JRU.9?4NR7(K:Q$NHIHY<,UYFQUV& MV] !$N[WB3D&%^K:FF+L^?ZY""B!SF$[((-HWI=0J@K%7BA6RTMWG5%BSGK\ MD:6E&"1#Q\1GP^!B1QO!39K,POQ+DLDD7S_X<#1ROF"1Z9-/LOG;OO4HPJ71!43KW_V0VX'-/'>&2 ME0<#8.6!ZZ7-+5D4J?\,\;,RT)F7AS'*P&?EH92I;"KK%[6>*.9#U!P]D"YO M=8 NJ7HX *JZ]-_.PIP6E"OT14N>4/]ZD79S.2TN%>K_.KM7NVS'J) _@'K/(E MT V^B>H,D2?$MBB?T\85L1P*1P,8"BX]GZ]AG*0;ZCXC<&X](Q?4[KSV_)'M5W3 M@K\ZKZ':0NV8[0L=,[-:6(Z \0!&@$OGC:WI+=,0^D"61&%0?DDE +7[H_A1 M.W+[0D>N(=PE>2<#(*_S<%RU@-OQFZ_(]_(O&_ M-P!FNG0!12HO_W9=K>;.7TGJA]DZQ[4!2YG]4?RHW;E]H3O7$&[-W@'$J_9= M>FTB]9_/%U'R1I9F^![3!=ESN+B)/-G*H%FG#T<'J'VZ?:%/UP9S3>8!!,T. M7/IXI7X_IQY=FS$F$^:IG[)@@0J=&W1+M8':ASL0^G#M4->4'D#$[<"ET[;. M\:.^\C0(2NYXT8T7!E"59!'F7G3OO58)@N"$L(^\R5)HS+R%Z@JU@W<@=/", M*J'F/Y(PWO*H%!4SBI_&@VO 0*YC.-@VAP+'.:J#BDQ3MB6XD*S>250O&C5*$6'(B76)!-= M;EC=POG^F 1UA58E"K(;/1SMH=EP$JB:SST1+!09KP:71GLN-Y8VZE?R-%M' H,(ID4]I"B27DVR%5^@7XF@HJ84%9K='8':=2/XF^ &DQ7[ MZ=AM2'0IT+U"8NOVPU1RN^O!C;)Y1D)/C]0Y["\8E^6F_L]GB*M>W.L=VI3U"62\+2#;TK M,)0/#H6[W(YZ!K=AT%12^C2VNSG3GGC,O1D]?"P'^9\?M\O%62LB9^3F#]?G M3S8N&5)=-8B:/AP?N?3QM_1,_"(M*ZB>O\(1>1) Z UFL**ZP.QZ]MYDU;T# M,E?,Q#L>CH_1["#([2GPULPI \5WQ-JP.':Y"\$0C7G"Z3JM#SA=%<";ZUDU M655_U"\G9=17:#9)Y';;)?[-K6"8E?:VACXY#23EZYK@R(BZRM< M-V^>/'G;^$G)N]+LCBXQ["Z%I!LW.<+2XWBAA"*FP1<5I1 M+-@VAQI90VL5M :.=<'?RJ N,WI84E57'A.ED)2T/<7769Z90M*CT IZI&3 M'"(]CP=.SV-4:9!",[3BYS%F?IJ>K-I^+QP*?B<7=3<8N5PKCM3#S^@6;B<;/4$.9,_$=2 M/#WG"M/P]H-4AA[-P6-V]@H MC!@.9S'TQ@YX[XCNE@J:JN[ZQJ:OU)#S8BZ5ZSJCYZKVJ<6+S.2JG\P-,3-5Q.+$K.XJ5!Q3-WEJRJ\9$^ T?QD[/SN\( MIK*3S6Y$D=C]%$FC&S(M\Y>_(D0]CF"8M:[+=.D=H4[>KKR\2,M0:OWK-P4O M5;TCBMCN=U0[9B&RC :W)8AQSK1=V/O096QZ6]"ED$K^K*#EP_B3Y>0[KU/M'99!L\1$TRTB6E2JD#RK-3%R:"CNJ[)%*7/K[FGV2+(\R4XC+YR+ MJYCQ'J?R]&.US4[D%L-"<>F3+1J9S\ ZCU_"-(EA1-*UIY?G))632MZ8RMJ/ M!3D_3U85)(J+FFP1SMPB_2))2?@$A;2RHKJG,/=>I4P3M'H8XZFA(%4BFV)2 M=#CN6K)$KF8U$=@GOU/O/V$4>O%E'(0I\?-[[Y7(YS%1,RI?/Q;P[$($:O!P MW(9DBU\NQP/;NA?PCI M(NZ+_%I6I3XH3J0QDEUK*--4!!5AKHDIPIJ+FKS39^F$7L^NJ?M1?I?^1:+H M9E^PX:C4GDJ,-':RJU?VQJ,&3(19*:9H9RYVHJ+/@Y:T.W@83WKA[XRYX10- MF CS5PS1;N+2Q7EG@:GOIX473?-3+TW?Z"_+.\#U/L_L/BC.7K@X$Z&+HP$5 M87:,*<*:2[>ZCLG_+M(P"T*_K#S\NDBR(MVH,2R8(Z5MJ:2]<%S8ESUK0$28 M06.*:N;2L#;K5I^1&8DS,HV#RS@@\[B\*2?+>9*J-J?R]L(%8=^RJX<281*- M*;EL@=BZ_X<)GOM[ M95:4AR-;J@%C"I"943!Q>O6OJGEJ+[7(X6[;K%SR?TF^&QH#G-ZI;OK@/DW$ M=P4;40+2[",C_,=P54(3X_P1/CU;' #0/=5.'[RYB?AF8C-:J(? \()5DSUS M'E^M:W^MZW!;UUZIZ[2*5^?)+$GG)$V^QR3-GL.%* ^Y9=<49Q\\Q=(:[%6[ M&0W41!Y>$&NRY[* T77^3-)J)OD:9CZ)(B\F29&=%FDJSUF1M*;8^N!REA;@ MS\1*(&M^#B_:-=ESZ7&6RK^C.J>2?29T2O"B:1Q,@SEE4997]P>*L#N.;P\$)GDY%+?_$RAJ79O?=Z2_R$2A:%7G7/UNLZ MVRU;'AB38-3IBJ+NA2\"-MDY#(Y<#4++#]8)_1[-@MERU-.*XJE%S[52)@ * 17 M\W!X4;?)R%S4[8($L"IZKTGQIUC>D,K8"[=GQ(VTJ>"K,_.'%V.;C!"=BUIF M#FWE#56!4&J=E'@9.2/5?QLE7RGT^S#9[X4W--(Y+:4+OV;[ &-I^XC2"I>U+Y.2F)S1=1C88!QM7V7#E9Y4I,$V04U_*JH MPD;1QRK;.7Z:^GGX0KE'9$CU.Z0:Z(5[MB]TSYKBKHD]P&C9OEOO;<<&V7K> MD3IQHL8462]\N7V)+R?'6)-S*P+6U36^*T^ P#6^?U))TYRJ9?7KFZ1*/K)V MJ:]2J92[ZEJJSR1Y2KW%<^A[D;#6D+#-PVADX&J1C/B_/24O'WW(U$K?*@S+ M'TH(I?#+7SS\><>1=/T B.7G_N:'3@W$M3 M41-[PX$)!L79?[/URY4P?G#\*[9F5P-J2J4S3L5G,ZNJK[+O9R\7UA(JB)RV\!2I.M[K(TO M.2V[O4J?614M[Y)-!1J*"6[EWDZ+_#E)PUSE[DIV(Q@_;I,WWDNE-$7SF@$< MRQN%6NL\H=(58NAL>,,CX;[39&/C)-RWG5^L=U&J4.M-6+B_A\7'L#!_N-R1 M/H.S,GGHGU9;4DHUO)EM B:#6B)MOD,%$$;*OU<3H3+1!H=]K&: SG>\&* MNN:33X ,Q0[@:H&K&H?;;4#A-+MZS-0IBCKB68:H(,X_2]+O7AHHU3&7M 9P M=M>"7A2)N\?LLJ56?\]2C(2 M_/XA3Z$@UF!M[K1XN%G/S'(U<.TB]FK*UUE0;@!%\3VW30-04AD=R>HJ96]>:@$MMWGO&/K-"NTHRFD*HU^\1N!<,Y#7QI:9/-&BJ]_C#%7=753.: 8E4O3N6U -.?) MQ1HZE/.%!:_3-8X1NIC[3.WH1NE:=$$K$,_Y[JJ&'A4ILP.PW94B+DAC[A#F M>^U<)(7>5VF[$0CG?$]40XMJE-G!U^Y.#Q>,,>=.[2@G?-&?9=:-J'#NR[UH M:%&1,>_QM;N.PP%CFM5L46+,72B_GYS;!D3KR[J775M%!5Z[:S1LO>. MO!!YGJ"@%8C7EZ4ON_*)&L!V5UFX((V]Q>]Y^/2<:Y-FHQ6(UY?%+[M4B1K M=I=2N""-O<7O51CK+V76C4"XOBQ^^=5'I/C:72GA@C'V%K_W#;Y,]QO3MOO: M'AHZ5/2OW\%K>1N$ [XT*\DAX4L8S\)93DC\1G6451;1H Z_.0C+V9;',KD.A!Q3'-076,S(,YK^Y.#&T M9_EN:QO9&DQRJN!$<<6U=4:Z3$ W?JS@;*OX2>H]A MI%*_C-T(H#A?'THUK<2V753#.?$P.G!ZP.O]D*;_.*4_A_G6QV@:Y22-RX)5 M7RF!YL6O>"AT7"671U'R'WF$^MQ+8VJQ MK'8K>%?&FW\1J RW3W8H],F,:Z)=)@RNL6 N1\:BJ*R4?..% 0>8 MW9>"$:$.;RF:AJ?:I[+P[^IKKW_#PI=>_Y9;5P**6_U'$RFU5*SXK' M+ Q"+^4M;]IV2P%^PNUJ'G)SH0S@;IDNA8JHGU!%U_@^52D\G7\ 5"0!VK1; M4 =NC_237I1.#W?+I"U&F"'JFO,F)>.?JVT!89MV"X*?N)Y@2\PU.8<0 MT/MDSM'C:W7I.YBEIZQ3 (?;/?O$=<]:HZXI.H2XWR=SKE?3!=6)EY'@.KXE M+R3-O.AZII7JJ4?$$**+1^8.RS15_CK9O[HWU0+U MW[\"@./VYHZX1VT,ZZ F\Q "C\W*!+H@AQN6.+WMOR M)L_@+,P\V-\DP66.(*/ZP0U)?2JB]T2N9W\E>9EB6,UH*X,I#A2]3D$5N!W#8Z%C MV IU3>@A! Z=WM?U9YRN9APZ=2S36V0X.*TH&,LW=K6FI/ HH!A6S;DAA.:: M7<-EEW.KR]%N2.Q%Y:?-]]-".GWJ=@?P<7MY[-N\6N*MZ3N$8)S)FF7FZ%M] MJJ[CE25:,YC?(R@!MU/(+G+6'G+-XR%$YIQ6.E.>1V"S*)96#-#M#N#C=M[$ MA= :XJWI.X28W-BE*Z8S@[1D,+]'4 )N)VPL=,*:0ZYY/(00W1BA!W9+@L(O M:X_WH0;RU.'5[-K"#&ZB;D8 M'7$K*;3$()O$V3!M\LX(/,XG-$O1LF6*J0S MA]/?TXQ^3-;;X&<4C7YL3:]_4!!N[VNB&SIKI(":\4.(C$T,'I*;S:CV+N/M M:.+]H_>QF9KFH7"&94S9X !FZ':L(_#M<(:LW (82R)N9R'7?/ M#%9#^9:4=5[N$\8,(*!AD^[@9GK<3LV$F]?8 F]-R '$N?;WS'DL*XUZM4:] M4J,9O#=89E_DWJL'WQT5)JKT Q!0>S&EAB44U !:-T*7"&3^FY_,/Y8:V8R!Q<&?5.XTIRI:AQB2:CV;[5]Y M:5I6=3\C](DH^]#IA4[DZ?V51<*KT81M'D8'!JH29\3_[2EY^5BNM=*W"L/R MAQ)"*?SR%P]77SB2KA\ L9Q/Q"J*VQT!.R!L7)WBABCMTP#TB/+Y1$*4SR<@ MEO-Y4D5Q?**L0-BX\\0-4=KO!>D1Y>160I236Q#+^0Z,BN+X1%F!L'%UB!NB MM(]HZQ'E_$Y"E/,[$,OYEHB*XOA$68&P<<^'&Z*T#QGK$>7T2D*4TRLJEOOR MJ"J*XQ-E!<+&)1M.B&*@T*D>42[O)42YO >QT"]FV35'=T#8N-O"#5&Z7LQ> MR-8H%_!Y=U_D4T5Q?**L0-BX^,$-4;I>S'[]+PE1OOX7B(5^,RQ>R4BN6^5*2*X@2+ MV1J$E<+]3IC2K*1C"Z:@+_BZ90I&B(O;!D1#OZ3E%SB4X<)1D9YQMGOZ&JH6C'C7BB+;=YF@ MSQ*K.HU.A"-$N3T%>&#Y4Q=2JF6TLU^#+8G9T56Q'79YJ0O41OP)IU7-99_\ M 3ED>2*?^+8?!"&^9C G(4R;[WXB0CFM*UG8&XV.(.I"RADR[NG MJ)"VJ_@IS4(LS>TR@BV\6SKH:MO@(78E(;]26\Z+N53,K>= 4!3KI5WEL5G! MDMY9(+L1+PS6YE#CA?>JQHO-YT!0YU\6MO(XO&!([RX3IDY@VUS^2SXGW#8 MQN!A%R?NHNTZ;LJ?'IF6V>2204.QY%WE#9Z_>O-ESO<7Q0Q785L*E?3_ M_4-6<7K]]RC)2/#[ASPMR-",[7)_8278M,B?DS3,WQ3V2MB-P$6WNX9_IBU3 MOW@DOZZF5'T>;ZI=@<,LB+@F5".6.W!9U&I7*J5=$%XS@&/9:]#:TA(J78>" M6_"0DK"UY5R>G"Y+S\1>!/>EQ06Y(^E+Z)/+VSNA>Z+8&L Y3U-0M("(E2H@ MATI.EPO-9?7\TRILI\1(5A. X3P)0E'7?!H*D-G8;\' /9?+Q*T+]_YWD899 M$):UB91H*&D-B;G.LRT4+Q=JWNZ%HU'?9YVXT MRA#BFAQ-\L^E V,\Y<"N^V*6BT(G1HQQN+-AYUOB];B_\TGLI6&B.A-N/@^" MV_50S#*/OR,N0.?N%)@A$YF\455-\.7[_XRS!?'#64@">;B%UP8 H NW,#3, M(98$EON87CMR'3:K68.'7(>V*]:LR45F7A'EVNPZ9!>M4<'ECEVF9P"#^RA: M &#;P/>R7)INP&X HCO?.U%1KIA?3%"XMNQ,KL6Z)IMN>MZ^74J977-QR?4> MD8U#U*BR#IS>!<<2#NY/_3.F6M_X70.,K&X KO.)3\%\-B-^?CVC+[NE4\/I,^PH"184S.>I2'@N@U-1'GL=(<)F MHY@8*DXUN^K-_&2Y<9&*^J2XT0B@],:/8M\(IP301M$R7(2T<)N"RZME#O#< M)*>B>O84V0*ZC>)IN CKT@%;;1W2I=#JWHC-&R.NDM@OZ&P2\^X):= 3@.Z- M4R6^7DX?M94:;[@(C?"V[QN2ADE )4^)EY$S4OU7 E2K+P#>&^^)?3==&]Q6 M"M+AHK7+X%NM[8_1&)Y\LE"=B-.H3TIMZX[.QK[TS@9]9 M/J^KZYXNO#"%%17Y2L4KTC*XEU7[''?%X]_4&;U/6,\8OO-)F\1,N5>__",D M*>7 L]KI*ZV^J-&<;G.OY+J,%T6>?2$O)!JIG0KDMP10:%913GQ5H9]]AOS>7]M630+J";FT./S-FH4&1A.^>QR=<6RST%C/A^L+(MG M=[N).?3XO(T:19;&2LQE8#,.-O9#EXH(KN-; AXZI$7% 777T_K'$R\+,U7O MP>B[J!*=IOJ9 *.2"F[L/KR!/0*R,G; M[A>@G,L5#D2K=0)0D9V/-FU&A3&JHB)<#DTGS' :.G:YUK4=:-:J>*9E+@6R M:^C@Q^/\I]$/ROE/(Q1G?1O9RQCI2R7@(GT//2.G\?)3+WN^*^.YU(HEJA6\ MLS"#%3%%(U&(4A\ %-_NKD$3\D>5CGY^CJ:VIFBTC\Q,E]JUVVDR7WCQV_7W MF% Q9^0RIN)!]D^=H@8/T'E[(_MM$&3L].T+*L3UR9W'P>K MN03NZ8L71N#&7B3IG1>1.WAI*56_(49CFA(E_& M+Z0Z85KQ@[;2&[<=O)TNM_ D*M@@ GL(=Z?9GUO\[8SXJ5G]ID:C^6L8.!O+ MK=\-JD*3FF^#!,U&LBF]HCCAVNMQ;.[$@ZG1:%[>SP#6]J(SV'5,%B2@ I[/2?I$A?OJI=\(5"3H M;(C;$@D4.]3MK)(RS<:]976C.-']Z@#T_%#ECFY'NE97U4J4%70!,?.ZAU"R:&0)LT*Q09EOI1#^E=<&]RG*HNW7WW5NHW_VZTPB@H(DR*>B< MSTDA/A1L//$BR"&Y>R8D+Z4/U2YAXS0#:$ZOE&/(I32T^ T!$J9[L26JYY-1 M"A$M(0U8T%PHX3I_)NF&JWU:U102SG?2=B BFDUYJ2;9VW$J %%0;#VEKSM&28^3JIA< M8=O!EFJ&<%YT6'S%X2J:]H _V745FY\>M65#%5>3JRD4'[IACJ]/+MU<\_[2 M)[NN+JYQ]4GH+DNTA.+0@LW%XR>7KO-:N)5LU[/U+U?E5:MRP5=)?CV;922? M/E&_(,M/DPCJ!Z=>I*R#=J\!=:&)3ZD85N5S8D0E*#X]5H>)RV.G#+M0BY19 M8Y5]E,%QV@- -%L!*J90(;88Z_ G=AP!SK^\-(0/\>:VM#(R5F. AB;Q3,4( M*EP5 $5QT,HJ47'XKLO,O08LW6E)01VAR=E24;_2.H&#$L4!(IO\/#)W4.^& MND74;_>>Z&+KGJ3S+XD7GR1IFGRGK@M/3GE#$!)A\)*O3O9FOA)(%"=U3ZV,J;M9@"G-P[3D:+#Q(3(.FOA+'UO[?$$*%-F6@G%;#B9QZ@C/\7P%G?,Y*<2'@HW& M P%'S0ZO8TZ[.;)]P-Q0XM01^[BX,D2TA#1@09=[K65&T?K:MJWS30J3I*PY MP$.STRJU I^?BCA1L)2U4LD^4Y1?DDSYE*):)W3AX_0J"Z&4JR!I>>\F7$_X M'"Y.WJK3JGS!XZQ0Z_8*3R4:WYT@L-9T7/Q?BQMZ*1Y6==;C-*X?E.@X M]H:,N^O(+@GHW*9Z<\([S>'_Q@YW/+I1?=1W6(C-T)SCNYC"7E8G7%<[M35T:;S5[A M@6A%X+;:4"!X"H2IJ%P>@6/A&SP;G=X-5F[G5Q*JASDVGP< :,+ *JJ6A#88 MV/#[>*9C&4I[Q?S M LZF!*49H=YF2I[ALPI@P:;0D40_%M\,2D68$:? _Z L:\N%)-_QT,/QX$C MAI2WQ%_F%)+@@O)JTY2GE]3P266_\]F,0$HBN4E2(/<544\C-?M:4">:H+L6 M QH&"]OKZD?\V.$X,,4V9_(4PP1[&5>&NXS).]--XZ ZWW;^ZD=%4-E]9=^8 M9-D]G8[#^*G],#0J"R@>X7$N!:XT'YLV%(ABT[/C 8O!?]]9X*R/3N>K5'N- MS%II7[ [@\;?U[*5W/'740#KW%E7)R[.R&->1BO<'Z%XS->:5Q]AS%94L<=N M5YV;8FVE8X,K'ZS/AVGA$W4$D!&M#$5F$7UN-.$B<:<,4]?M\HUG C@MI@=J MIS6 0[1$$AF@"4DW,2)Q.PPSTVU&\&-.EY/+V^6^$"\CUX]1^%0%ZA4P\1M3 M:&-$*Q&1^L6\E$)$LK@V2\NQRX!#?8'X11A#7M5IDN69BF?*; 5@T 0?Q H7 M$5&$#4F5!<,,=!E>N'NFOC9\>Z0%& 0M 2B[7R1HOG,X^-"4FS!,.M<^CA? MDO@)5-WJLZS6"4#M@6\S%OHV6E!17'AIFJZ.ZWAMBJ66^[O3 D XKZO;/$TR8&&8K/'H+5< MKAG?RZ24^,5N!% P52H0J%N==EO04!*OI<7,70A]&0<%'>/AZN)O&.PG21R( MZPRH- 5!T>P7"G6YRRP-?"CV"@WSRZEK0E=%U[/3E 2A^&8A?@. @,;E$&I9 M,*?Q4.&8SXP8Z=CIUE\RA^0%7QL*OR% 0K,!R-6XP,V0(1L2]YQ>9)VD)'R* MM9%PVP$@-!N 7'WSF2<#-L2/;*-P'',1=^+%WT!U6:V[:5RE,\-+-_:GI$LZ MO8[ -F@";T(]LQ=XC="R8G!=YON@N1/]KGC,RFOH\_,7V"!0"*:U3F6TH$#S74/05"=C9K"3Z@+,WMDH,MO%LZZ&K;X"2C).17 M:LMY,9>*N?4<%?3 ^23"5AZ;%2SI;7BS]GAA<%VNQ@OO58T7F\^!H,Z##6SE M<7C!D![% L9PXLC8:4$)0SD&8\M%)9HGCHS%123X:'XFCHR=EI4PEHHPMES( MP4SBR%A!.GFPA& MB3>QO8V@MYTET+<^\R:VMA%M#?L!YJ:JZRC0()6@!8B%9_(2:8X]@8EAX?C.F261 MRQGM-$D72>KE!(Z"W!&_2-6OY12V!6!X9C21[OFSF@I ')]6LX0<0"[O^-!Y M7%U)S^PYL!%:%-]78]$LITF+=>T.C7UJ9AL @N[Z-YZZ^?.@"!N*#[))@QTZ M34]\+Y1:MB6[%23_=19;4,G:%FA<@WQ;X%!LN!FDW\3MP0&S])MT=VA *5-; MH/(&_)O@.3%@>M9P&M4G.5TMZ6T4,9H ##2A!K&J!3$N/C 4Q#.VVL-V2X"1 M*[C'EFOPFUK[:9?=?P<1A0MLSXJ?<-P/?YK$>>KYZO.[J"G PE0H1\$$*A3E M D4R6UJSI4MO>:LV^G=OH77KXG8C@()F[UI!YWQ."O$A8:.A;S>BXWRJOA?W M^+#E2T!,?;%UCO2]0S>H74*3ER+;.9G8AS*(8_:UQBPL"&L7MV"/RX7=B1=! M1?*[9T)T+@GG-0,XO3@YL2].$G#AU>:T0L+,/OTRPCN5IR MS,[S !-!K)4SWP&\H"A()[IX]YH:L>NDN&J@_:K2T5.O07]2_ZFD4HKZPI@ M(]J$$9E&$#G1!SQ, KN,K+",'?AF&.$WF\S ',2\(4;Y)5:,G"AI/45*Q8?0H+,:+ M)*)HEKU.ZX/?>&_E-=+7LU+ +"M6]^%) E: B@T.19BQ?/9*<>'<,O< !L; M.5/,)._U\+V>US3H$ M4&@<++'B=]G8&C;"G7D#)#5WODI+N0;IN;10#QPJ]GWH+0"CV*TW3DESMQ7I MJ95VQ%M8-NL,P/3 /6+?@-X*\I*8Q\,BIKE36UJ*O4B*E'Z)+L(78_3@&@"^I.AX459M=DJY,5>G=T_*&(&0//!OVY>?*\);DF@R+7#C2 M=;^$WF.YTW&5 &7*L5[$LBU.:7L V ,G1WPWNBK*>D=^;U@$=1E36JO^(GPE MP6::JC(U=UH"J!XX..)+T>7X:CH.*T(TQG'VYL3+PNQND1(ON([_\M(0\L6T M:,GM 4#VP-$9*Y[#D>&L:3JLV,_89>QG6RRN 49:Z/C=4+B3'C@]8V'41Q-L MS=IAQ7PF>*X+.".9GX8+8-#U;-,"I6FT$(J[ M@]\)TF&E<-* &N&3RL.-'$ M::GC\OSSJ@K.=9%GN1<'U(55\J9DS0%>#YRIB;@.LAK(FIW#"A!-W/I2FV+] M&1<9"7:2RQ3=?N6> '0/?*V)Q-?2Q5O3=UC!I D.WZO2]/7L#Q(\4<^7"J?L M=.TV!5@]\+8FBMX6%V#-R&%%D29XW*S-'9BS(J4S0Y7DJ(6-U\G#:++7 Q=K MHN%B2:#6?!U4*&FRY]+!NB6+5?(85'FL*_Q,XX!^Q,+%#QJLF>N42\2V" %YTF<99$84#G <@(+VM.)9N_/'\,\\"[ MA;"S($+:H#> @]^A*E7.#ILVQUPGW \J5C79,Y> Q]3C-/B[R)09J=H%"([? M1RJ5RZ:A)M":>X,*3$WVS&7:\=5XG]3+IO/7!8DS(N.@;E< !+\[5"J;S<6& M@&M.#BH*-=DSEV2W/(TXC>."?G"\[/DL? D#$@?9+=5H&OK CQ,O(\%U?)J\ MD-B+N6>#OLFZO;HJXI.JB8TL3I5=4K]8,M9! VGP7!>^#N#?B.R74,-;4'%389^*XW/6,I"D) M+L)X==#UM*"_B7-Y"09Q8X#6 U]'5O!: 6+-RT$%?R9.2[FR]'Z5Q'ZE^L]I MDLF!27N@("V7>#7#4$G81Q5G3=-AQ7Q,5GW53TEB%+.X)6#S,'XR49:)WQE M[X$GQ*XFVPIRS>-A17Z /; L3K0=JQ8*&N"#BND=& NBPY>$JY> M,E]^DMZ(QROY+6X$PO7 XSG@YL1)H=6,&E;\Z,!\,&5;-M6*&33TY# M)QN:7I]#.2$>E(>H"YEI9*9K]P<*Z('7\TD<6FF(NB;T5JCEGQ_7^*D(W^I? M;_]V2RWD-2=Q0%;[Q%N*^?[]^V__+KQO5*YG,O_-3^8?2[V<%!D%F&5WY*DL MLT %GR7I'$*5U[-;LDC2',2N_WQ& Y]+Q+>$BML\["_]\EE.M)5$O^I=C7LQI,@M//5K8I:^8-C%XV-^[*< M\,GD0D$)P'1.4BJ!F$:[#X+>G2\*5)2YRR(N&!NWL;J9E%Q^_\^_GD^5YJ3U M@R"R\R^VBE+Y4](.&!NWH;HAD\%M2+49*0N]&^HMSD)?/BF]?Q8$=KZ%J*)2 MSKS$P8/B=M(E)"&;F,\""'-[,9^CY-&+[A;$#[TH?ZL7G43\"5-H"6*BV6]A M*9"]RZ*&"L55XW$C?EM'.?@VV MI./03D'+_*\@"]K@B>>T('0;XMDNZKPF'IEY192W8YZXO#,+F[OU? UE\^LO M8)JP#01Y9=1:4I3D7+[%69#)HSHJV+^5#PY<:BA&7L!@##H,O8 M4'0IPWA-0'S+[J,RP80*9K-+ FL Y#)YH8<#EG^\A_"P#+5^CQ *LNN!>%&DM)VG8BN!D]L8 M^I+ROY:5I9 ZOQ:=Y< M"3@6+IV1_]C<)1(K]_\R]JF2OR2KR64EA"!+1*$UB.L\8:V!?G=IJ@<8Q^JC M.TJZW-*K/XNGR?QQN6TZ]?]=A%G)L5L2P?&ILA"S!*QZ1P#9^<9? QOQ9U]M M[#_8BN/89=RDO"ZI\//RXMC39R]]4KBS=+<)P' >)6F@=]&:@8O2QD$'S/PT MES9ZX87I7UY4D+N<+/Y<7,\N8[HRHVW?[I)(5 ]+W!"$Q)8TJJ)5]E) ">N2 M@VYKKW7(09=>V>5\04T"8H(M IUCV3- 5[? MG*VQ..M"#?&2PV[+QW7(89):$USO]=T#]_)?ES$L#&4):7 7LI_SN3!)3>-S=P(JPK MT;WRZE&Z[Z*"5+VC0F4NO8GW.S'4&XZI-WP9GWII^@9A\WE2P)9-W7 -:5& M_:D!-$)? VBD7@-H-*0:0*/^U0 :H:\!-%*O 30:4@V@4=]J (W0UP ::=4 M&@VA!M"H6:W$KFL C=Q71Q0ID!TQ4$.%(Z/07M[TR.D9S#9#P_9Y2Y,U@$;B MLY@G%Z<_3ZN$HMDM3 M&W5>^'U&[:I3SJDED&$1R64BXBI+!HXRIR0X*P^*WI T3%31L)I26'B*;_#5 M+B>< !R*M9PI$C8KF6$8Q$V1^L]>1J:^#ZE8D),5_%VHI08J]0% G3NVG$6E7L3GZG1%4[$J'<$D)TG MGLA-(F>J,E04Y0B,T16#$U)]K2YC/R5TJC@CU7]5YU%F8X"&SC795;W"!"J" MQSI]C25M^7-*A\QVRG(&AR-]OY@790V:S7.25"UGF^?-W_=F.,=9FZH7I6A? M6**=O'WU_D[2T\C+5/9R-'IZV-_?=SD^!:*N!;WRYD0I_T>S-P#?V65-"AE" M^G;C#^YFJD#A3+H:"$XKNKL>")8KN6O>6J9O.),CX=!2(+9WI'":+E77\OP2 M9HHA7$8+ (%FMZ^9 ?C,YN/]R5Z8%IR7.=D15"D1@=\20*'QA)L91)"G(,6- MPBUVSFIS]:'N4R\@+- D*/\^)_QPG4?+T5O%!>@JD M68< "LU.9#.#[+*ZM3I0;%FZ)ON^RR7YVGQ*\_;[Q\&.:.(^S53/GZPY8%'$ M@01859,I5+H R$BW3LJ-L>80R^8 #\WVIH8]&CF"FXBQKYU-<]BECR>0D;.+ MVQPTIT-001\\Q/KFHLH[@H^[XOD8-R_#YK8UX M$ ?+.J6)RYT39W$PM ?7%"W6Z(O 401K$=15V/?NV4O)B9?!%2)S*'97?J.N MO!2.L;P0UW':M5W.YXLH>2/DCJ0OH4_8Z#7XSH?] Z>?P"ED*=S3UR@,Y:UGJ>"6/V0M!JMY _''-4LK*-R75J9U MF7[),1>=>N*G&_RN1+"&$0"6HT?*6JE9F \O& M@@6>/8WT?G0XK7XZG-%ANYZI7KH#R\B=#X\)EN$Q')8Y]:-6"Y$\\;]=+P"0 M6O%(7CL A";Z;-%B_)$G4\W/X6/6&,ZO40S]G 2EM96&#K,- $$32+%H*?ZP M$:D%Q9[S@(:,V[O.M^S\)V5X=GOW9Y.AL]V6 L,32K=H.>4AQ%0/BO2HX0PE M@XE6F_34F71/NR\*WU%X;A[=3A#QUQ)ZO+(%H@7 MT_GOL0#QX'72P2)L!R(.?4G&SH5150V.&S&',R!<;@31B/4TADY MK0#,T#11: B@T^686K2;8OY8JIUWN M.W,=P48JRRA3: E!6AQ5Q0>0CN"HHKFZF56RTLSKQ$4"6^>CR&DBHV B M7,Z#C^_GP;KZT$U*37T]HZWG25S.<-26?F40Z7?3RHM!I"/U7O6B0 M0;7[=E"7\WUC=;.R][>ZTU//_)1FM\I(Q(0B75!UZRJ)R?;"-RL+W'D^B%'I MO,(:QU3]*Y$CB#[P.5.-_+4C>=@.V6--,NHM@] MOUWFBQBS@_(JJ.5[0&'.@R#JAE59\IC12+M@8/>L;^0WLX-M84JG@"2M\MN^ MQR3-GL/%J9<]W\*AFU@<<9,V!F%[XI&R+Y'0@MDN$M ]C1IYE4(:U0J9QG'A M11?"Q2VW#17M4T\\LT.F9Z:"KEVXM7.N?#+G4K&'TWK1?4_;9L])Q*L]K-4' MB-X3]^83U[W11;ODUK@OW#+GI-2:RD!32:VI1>3%BY6V?#IQ*U!+U@4(WA-7 MXA/7E= $NR36I"_$P]_K M"QM=1KN4(I34B7HA&52*@;VQ[#[)O6CS[Q"EO$KR_R;Y.GZY<3!&=K"Q$QE MT3WQ.-BWL[O05CV4^A(/,WF;L?90XB13+NV5?O5R_SF,G[;^7GU,KV?E'R7# MI'7_5$&V[TLV-@2$D2U3FJCIW9?XE=.[E)LKW1JO024]<>+$%S.W5D'-Y+[$ MGXX,NG:5[OP-W8"?LMSU3>=+W6W]O=+=O KRR8\.-.\;H/;$&3SB.X.&M%"3 MM"]!I&9WYNJ<7:D'.%VNG4?4X0Y?"/UG$&9^2N 9+WW;;)*))U3S+P(E],2! M9-^^:TTE-9?[$AIR>B^OQ )G/)U7%WFU6SY(.@?5],0M%-\%;$0--:O[$JER M>DEPX_RZ\G]N274,M?;CJWSOD83L5MY)%>G^6F)U@ZN$_\UKIQX:?0G,-;NZ MN''PI/Q;R^A)^3<0O2<^'?M2XB9H:W+U)3+7[-[AQN3*8?NR);G*/D#TGKAC M['N$FZ"MR=67Z)S36X(;?T+.Z<XVK&YC$"&@HK%HB%]-EM2,<<]\6*. MN=F!:AAK^O0E;C5&7:F8]V6X\,+T+R\JX'J$8EY]#&[#[-M%2LAEG!.PT*W% MLXJJ[P<%]\1C&K>K9FQ(4_7PZ4NP;.RR9%#C(W0LHVP>+%+:ZK+R8E!I3[S ML;#^D'45U2.E+Q&[L4O7T5YBUJJGJM%[#\59>IU$+C!(3YS+L="Y=*W!>ACV M)=@X'F1&:[4!< %'=\I?P7.RCUBWPH#J>^)!C]WDN(K45H^RO@0_Q[T,?C)W MU51N*;;P1JK$24^V#,9V I]2W=2#8BOLZ?;Z/_:J=WD&Q/65@&8JOLDF"$MO M>]@_'#D-O@RG@.'AR.[*5WJ_KAUJ"*8@BWH_KPBM/TK08V6 PAMK@@]='%%Z"&:*T('1#*#1>G].<[>6\I<7N#6AN7CX\\I% M\Z9P&@RV<^7BX="O^SUD7_>KKAP4%_[V/8_"Z15VG9:8/71_M9Q=,PHBJCHJ M8NV1=Y5(=5)D%%263?VJQ 7LZ9=!8W>)4@R15$>KJ.G#_B=051D[CLP$]L-0R6!&Q%49-_S#>U-(=MUZ M$L3 [%4QE<8F$QL9UOT$\VPR=P+A-$F]Z/29S$._*CO@Q7)B\1N!<&@B^ZJJ M9'-,"I+EA7<5";FIU@/3."AKK=PD67Y+DMM#Z)+E^\$+8"X!%$XO6,8_*9JT*75K$*CT!< M[O%(HW>Z1A(A?WJJ <1PW- &)=.[>X262'0PVX$4.PZ ML"UB=^JFX(\)(6P4BR/#UG3IS1IWSH_V+/NE6C$ZH=)U*+@%SV5N-F-'/CSCB/W^H&'_6,\*W=U->X.D1U(*);F#-@:-8#'2X_W:\YW+O>E=(]L)_^DA-Z?F\VQ*; M=D?AC]"L:74,QF=^0Q6@F,\1L,'E^F17WN6Y;A!2&^M&6P"&9F72T"HZC-^% M_I/>E2)=+F]VY:VOJFS$[\W& W-HJ6A770(SL".=-W2.<-=;D7OREO?,4D7 MLD4:7Y=N57664QLZORN C2:5JJ'-=-@OU02*4Z\(QH++K;Y=>==I$53RSY1/ MD -Q5I#[Y([D>17WS63W"S;M%M2!9N.PH2UUQHB65E 4-44P7G!YPGP3GA8I MQ,%*&QH<+YO=4G7@J3C2T)9FQ@M#*RC*E;H?+T[+ENS*.YTG:1[^9UGI#&R8 M@1&)_A#A]@2@^^Q(BTN0Z"L"1?E1! ,!EUN];;4;*GFZL2-RFI(@U%>"2J>@ MBCZ[X>*"):UT@J+&*(*1@LL]9\MK"#; [;-;+BY.HJF%)?_'R/AO+ZSFM)() M/0W> MYF>BH5Z0;NHB)I-+%UYTUD57) NI>*&@-/01J3])(DG3C3 M--(0)]ZYHEFEG8Z\MON4NR^2%)P@YCZ B<]UEV*" MN1#OY30G8+/OMP/5(XUB(YY>S-TBK;$5_J\P?U['5.%W'+BM^P6(B#>4FAMM M=TB:TA72R#;B,63N(NGR;?[FV\+R;1$USP(FPY7!! -&O1,0'O%64G-SL$>' MMF*0!JT1#P5S17UEQO+E"1VZW5 AX/;?SG@%@UNH!JDP6N\ ^+0X&7-.R(M M#\*>%FE*8O_M_-5_AELA;[V">#;RKV-]*P6I!N_-DK >DT:N^R MHI_E"+FQ$I#BN'<3U#]+0#92G=-[#83UCK3K!S+: \">%X847WJ@J@$4N1P= MF/L84>5(:R77CA'7D^1;I2&)MT#_,#0^=+F Z8K&GRQO)Z]I3&9>$>7M>7PH M7+:HHT;!8Z?+#CS3=-M:Q98OG;&_P- L^[L!&T6^FE%K'N^Y/&5AH?P@IMMA MA4K7H> 6/!1SJ5D2'@Z+A(>=D5#_._].ZXU8>,AA(:[ZYUZ:TH7("\%5\OS* MFS?AU[K9P_ZX61$RYI;W%_+D^6__MU3RG]E&Z5KIQ:22EB FFHB/1)?L/6DU M@ AG8VL.S-A ;3 +5?7'>&IWJ:MQEW,[D'XL:O6\JOX83W$L=87SO_X\A$@] MH)8KMK'3PE76J^J/\12BDMB 3TA%E CG3!/\=%HH"DE5_3&>PE$22_%9W!SX M0"=>IX6?[HK%H@J5>]'Y?!$E;X1LR]J V\TZ!54@=9=V["7(8VB#'472C@6& MF\M/@[0G+WZ[RQ/_F]0_WWT8A$'J*>UHC.V2/8KS6N:9VZP,#>\+.P_CIX@$ MH%DY)9G/@TA]<%78M5UDL&R<.\K2?(- ]*?WY*&_>KB%DU&"*./6,R"L0==" M74 A9=X]!4):7O0KQ:M9FMLE!EMX&QLN]K1M, M'2U7BQ^1P(ZGR-S58>AQ<,Z5'L8W5X-&?QY:+)Y@ZFC-FET1H@_KGT9QFJG,9Y.@@R7ULN>J![-A99./N\LF;W&D8=PTF7S,2R;_L>927!IEY.G) U)IC D M-7JBH"T?A[0_ZVK>D"C3!8H$"&=D<.G\,<12FK6Y[0"0Y1"0UK2M;PL^L66@ M44SFSFCLTN>S0N/._#N5LVSZQFC(8RP.GA63XKI"\/S?19B_W1&_2"FM)'D@ MNMT 7.>Q-%6CZ"PFA'"'2UVGIX3"5\BQ@3ISFFP5M 10SH-ZJJKG$U2.$,5& M@Q5..K\Q[XP\YIJ,Y+:C@([0),K)U,[GHPP?"E_+Y8[#$9Y@&YS'UM[OJQL! ME)Z'U8XTPFKO8"/,>V]M33Q1,Q.U&H[PQL?>*5V'@EOP4*PV#9,03VS+" D[ MJY^H7Y#FG=:;L1"+S^/TB]YU$J-N0O:173_'_G>:F^CX'B6*(T)=)CD>X8I? M37V_F!<1=1KJW[:Y_E?0&85^C,9;TC&6SE:3@@)03+Y=$OX8U]77*TGAG28Q MJ#\M9Z_;,/NVML=(@D_4%&"AJ=^@8P@^RQ7@HMA%ZY2ZN$)GR\MP,NZ=ERI- M 1::$)F.(70FZ!VX*';..J6NN5H2Y[,9\?-DMH!;V+/J%G8?;F%_]M(G0KVP M((P*NEK,Z,^BR["T^@$(: )E.DK?I6E3[#^<6WF,RZT\(YF?AHOJ\O0K+Z?2 M7L_.7^@W\99D192'\=-E?+<@?NA%UW2VB]6 MY7[T,P)5>@5E],X1'FLZPCJ:0'J#L<6QX-+Q5;%5.5-=QGY*O(RJ_!D8# MLU]02.]PF35["@'ZYU3[XAE9R!M\-BNV= M1S_6].C-ZVLY^B8_SNASF4TKC#/Q+D]7O=^^7>>@FMYM-8R%^;E&%%)'^?9^ MG!&":P.BG-O"QP)HF)V\+4LLZY^5X/1# 4]ZY^J/-5U],?::XC].)'MBKGKF M\I4;)73IC#(/BSEM4L2\)9%"2Q"S=Z[SA%M>4PUM3<4?)S#L]&YVO;R7]P[< MUO[&- Y.BQ1NG6NTFV3HO:#0WOG7XMO?;>NJ'G(_3D#;Z;W$C%.-K]2-RZ'L M,&S!U]_FK4_V+0'243M=SRXH)"_Z;^(U."W:\$6@LMZYUN(;CXTKIQY%6['U MKNX&K<[%3J]/+ZFO'WD95$SWR^D@L91P>:$5>@,H*/9^A091XFXZH!1G(HQ2F"7FYL;)K@B^9]Q2KP(HN#KTTJ? MJ92P>-.EL%)W !_-5J3(0$HDUH&,XH2,41J[=+:VC5 K_(*:^8QDX5-<>B;I M_RVH:69O8?QTZF7/%U'R_0\2/"D61C+Q"E 3FDU"D2%5Z=Y*#2A.VIC9>VMV MAJ;;#19JKNN9/$-&LS< CR8EAFN;UGMQ[^"B6$4;HJ[S*G4+0^)=R=O5VT-2231A-P(H M=K?OI-E&4CWS)SD.GD[(;'_//?2;PK+#UES@(BMD7,9,/[4:CH M->S>SBF6Z1O=WGB*U-4H0?8_'"Z &4(I[1[ MP6L'@!R?AU-7NX"D$GQ]WJVR8/)#EQR^@SK$MV11I/ZSEY&;-'E*O;G*$2AN M0X!DE\7Z^U02]?.Y+(6)8KJU8T6GM_*R)5-:<8N: BQ,L4ZI 72IN05SP.1T M6L++'CEM%^K2VW*26J Q.R=88J86YQEST7?VFZ2!>%$S*B">"Z$5-,D.QRL@ M1,$R*^M&EQN8QC.L[&YFFETQ"O!RQLC* M_SVA,T8 *9>4$"IW2#;H$92 )@U;W6B"SWIC':"8ASMCOLNY66BC9=DO4CYT M_3TF:?8<+N#(=AOV\WL%9: )5*D;K^$(D.KAQYK_W59P$MBIS+9O0_BR X"( M)MZE;I*&W-Z$C.(H36L9U33]P)TE4>2ETWE2Q/D=\>DJ+0\)3V;5YB!P MSYPT=EDG3< HKBKLC)).O;'R,U>Y%BIAE>6C(';//"QQ 28&.!2W W9&0I>^ MU$V:^(0$9;TK,($7^^1ZMN%#2+_RDO8 L&?^E;B^DBIB%'?L=<9AIZD'(,UN M2'[E/U1?.EFNK&(O$.7OF>\E+JVDAQO'Q7A=T=IIH:5WA@FF<7!+\C!E;43J M<5O8%<#NF4.X6*\S'CN/K>U\1JO+H^@DL_Z>KI]ILRY1Z1A4TC-/47PU=FM5,&^]ZZH@ MV"W)\K3P\_*C4WZ$RKI]4S\/7\H=&,,EPK(TWZ O_>D]=>FO'NZJ0R6?":AR M\1SZ7B1,]!2V>3@8F;S84@G 59+FS],Y_8;[GC#[D_TPB.S\VZ"BU-U1(01D M([7(#:$,>I9J ))"G5"[#S\<[.\Y]P]5E,HF%!>0C<"Q&T*Y7"6 M-1IX6,S7Z_SZK MEL)X]R2(X7R?44U5N]SAX\''%YL^^_X>FMEL*=QM$D472?K=2V5)SI+6 ,[Y MYF4#:RA.=%S ^ ALP[(N\T=9XC5 !!\HYY$_/97K<7,)\(<@Y B-FWSZ[*5/ MT@Q/5A. @2:34TWEBH3F!"2* MLA#6R>DR4L02[S[UXBPJ:RU-@[^++%\&+G1A,OL!P#@]):YQ]#[T(M0NKU2] MC',O?@H?(S+-,I)GE_'R#731_4*" >1/[C\R36N:>2VP9$ M<^Y]J2B/O3<@PX5B37NQIO)[IJON$JAT 9"='M=;!4H$TNH%OF0=4 MP=@N;6DD!Y!=SU(%V@^V4G!:K_+=^IZZ)0&!V\IDV+CM ! :STW# OP5@0SJ MCT97E^&O=[9X+^?YJQ\5 ?6R/R=)\#U<+QC56"SM#N [=]$:V$N9W*H:0+$? MW"'G73ISE_.%%Z;PQ;R>\;=G(L"@S?\675.UX*F0J6%'P5AHKPW65G1WAY_A M3L;HK2KS-?5].)9-1:2+M#CPTB"[\E*XPO&%&-[%TV;T/7W#]6P:) OICIFH MR%O M?APJF2N??96D&=1I4;:[OH\\E=JRWDA/FBR\QP5 M])/SG1FV\MBL8$GO=IK0Y477-6J^>J]JO-A\#@1U[J.QEI$E,_^F7@=#L.CU]!GB7\>838>R'BTCY)%+K_JFR]EUF,S<%H))LTJIO M4(S=Y94T3 $5A'TFK+P!N]\NCG31E MPI""S<0&VD'Q97-)D4\N#X29V_#_A*%"6QL;\&DM0/S#L[?9W6OHV&O[1C:] M\A9-C*!-WV,L.8>H%RY=;WWH;M<=("NU9D+A@DVT#=0HHI&8N7O@/HA3O7>D!Q\A0 MI19<.532V)%N5P#7>9:JMG4:3KML[+WV(KL,3AFLP4#[3]+*/K?$A\O/X/:* MLOZ \()Z03,0T'F@U+2Z=XFNJ(:?I%;5LLL$6CX H?QG)//3L)S3&FM(]054 M199+1'0]K(29NL84UNO]G2X'H,G*$MH*N@ACN*?^"_$R*I3W&$9P&6>1IO*R M6**F M-KWIT^EP.#XVF!0EJ,X8D6\YNTSA0'AYJG0!4YPZY:<,)+3. MP/G7\ZE2.O/Z01#9^4I>1:G\1<@.&&>G88V3J>LTXFD6>C>>#U\K^:3T_EDJ ML/N(E8I*.?,2!X^-'70E8]"%2%#X.7QP[TCZ$OHDD[*)VP; N SX+ 53FIVV MG@7!G2\4553+GZ!8>%#D";0RBKGR+U_IXC$2KX+>/P8"H(EIL%3#=@48$/I/ M!'-WQ9;J^9ZDWZ@CI$:'K8=!&.<+8Y&:!*1@ 4&1RK#\F"J5C=IZ%D T6K\P MJ7$9US5DH^31B^X6Q ^]*'^K'60BGS]4NZ""X]G#8ZF432-->/TGE[FLR.:< MDNL:3YR$I4 VE=10H?ARW8=S2OGK67E%W(RDUS,H,GV=+I=H2LQ2Z@.&C=,C M]TOA4A),\YN$\N RIH*+BR^I-09HSI?838S!7W(K ?[Q".STU/W:)-UV B-#Z!C B7:,K'B^&C7]QC5WX7EAT6E3H2P+04Y=CG%MEF-C#'5,5'1 M,I^$+&A#N<[L\+CK((_I/>%C+#5,95IF[[+*H V&:..N]^Y-$VW260%X46T; M%37K,VUBJ>:[VJG3),Z2* S*S 0R8KBNI[DHB/_W+:0+B6W:- MU4]RBQ3,9I<$%B)RM;*0RQ2]ZP6!&YCBIWKUHN0N<%K!5.%\4T]!V_QEF1@8 M"E]VN>=]&<^@F/TR]4@I@4[0D@)L=FN%*:]@=6'PKI!ZUSUSV@- N]Z#M,JN M7/T"=T$17X]KY'9"@+]=DC)76[*D.+8&.R"ERY7I#9W/BU?0F*'K\(%JPIB%,?3N^"MR7+=.MF# MJPB$9"IE/0YB(ZN?J:IJ]BPJ .FL'J 9.XV[KO=G.CEUC*6JGT#!0E)Q43G; M"C+#K(FCB9D^]@"#>M3:X(E@:&3KZ?3Q 5Q:%]A[:?0 X!$5J=7 MU3#\%: Z;A05)KHR]-AE294N\XW&&&+5^K9I3.@MX"@FYZXH/4$\01NE] 35 MC2_JQFG/Z0FRPRK&HTQCET=WET?J+ZB93Y,X3ST__U>8/Y\669[,27K^NDSN MGT(:=D:">^]5 K9!CZ $-.GJ#CX9/+MQGRPNJ%:D)S6VG@,1G!-=14F[%.=A<;;-8)P; MY@Z-??'2)Y+E]2ND'&$^3T5R?QQ,16ELKH@PH8@:T0D:ZN"DY11_&V;?5+_F M_(84GM.4D1W)5/9!V(T BN/D$*F>^=]A(:8>)X28-;#3JUQWI#IYNZ 8G")[)F19<^T:[)Z"N5O'E!2P"%(>]87?\ZT^M[F(,F MI]/CC+;(B>M*8;D!FK(3S3W"UF89EYE*]7)_1T2E''I):_ WG'M$ZD80,%0) M)U*6MEIQHIHY3]Y.2.P_S[WT6[-OPE9S@(+R0NA MW 28,&0E"=7+)I,,D[,(8'M.=5Z5Q32GNJO*(DLRYNI7GU2VZK$@"1$Z+>>W M(]GZ.I"1+JB-I@ +32D_J?8U_(==C"XS=\VQ)\]=X9U]@[7IT/7Y[D9TZ"Q0)_NJOE>=$A]< M9F4U4G?7)J_AO)A+Q=QZC@IZX#SZP%8>SPGRAR)H": <9V.IJ9V_LI*CZW%>EC6CN]S O4F3!4GS MMYO(*Z]G/O]W$2[*N@JJ:10*/0!(9%$SN4GX+%='C&(F[LS$+D\>R,S"A<('W#M&8SEN3%S@SM,EWLBQ<'2H'A M]8-4Y$/G;IB^B@4+X_?0?BCZ-3LOPSQU=>'YRRO@_R+/H5\=:/SJ^<_41TG? M-B60'LC2[0J H-G^5E?\+BE;@$>1#F;+$3OLNLZ5[K[J8:^$I@EZI_N23I7PBCK!*"BN2A3S2RR#2U%R"B^Z=9I M[-(QVC;$:9+E$CR[#0""\]/Y>NKFTY,+[\>849V6ZWU.TAP&ORH5=QM0")8+ M\YJEHK@@+P\>BBJ\MJGH])3U7UX:PII+E8D[SP, -)Z-FK+Y1.2ALU&$%Q\/ MG1X&**C:J6R7L9_,I94YMQX&T=&D_ZNI63 5LJ"A*$)IG7XN?9SMQ="-]U;6 M@]=:(-:- $J/?!CV&0$EB$M:'@V;EDZ+[X5/S_GU[,^,0$&X_/HQIX8GP65\ M_NH_PT;(19)NF^@+_7[!YMR;!'B+GD$I/?*"Q)4JVNMA.0J.AST*4-RW5VVA M;%ML=9G']>PBC+W8#[WH)LE*+IY#"G46PH(NU'3W&[^%*@M/#0(UPZI._VUU MLAPIXT&/%*>GP3DSE:4QTJ!_4%"/O$7Q67)3VEB.BXF+ R/U%4A3_]]%6,EH M[?B(OE/8_-[[<;.,,F;<^'.4/'K1W8* )?.W6F5$?.^K0DL0$XVKP%(@._ZK MA@I%1(-!;]6I7M240G0:DJL=L?NDE"XE:QMVQW&G.9!G\765[//T%02D?7B%X87,:GWB+,O>@Z?Y;F/"KW M X#1K+H5+,/GM"YD%%N4%FGL2/R=4^2^DLLOU]YBDV7.X6,\U M$HS*_0#@OBP_Q-OJNI!1[)Q8I+'+M0=<*O0]C*+Z WA6I/2[2$T0)K(5AJ@I MP.K+.D*\1:Z DK6#,21^NMS]KF4[3>:/85S5':ENW_D/"2X#.D^$LS)IH=R4 M7:WCIG%0[TB%)*-_*^8DH+Z-HB8,O8TJ#\]NN(*5Y:MILXJI-TGV!CIR3-9D MTU]G@R4V!#M-XBP,2%6[I[Y53NY'JG8#83CE;ABFMIC^]BWH#\'U9Q+!O)6L'O&;V4+=!G%Y&9?*+>DF]I?@I M7#U<[@'ZEE63E6G*[!L7_QL\5F@!JA1I,=;=#^0 M?1%NTN0ES,JXR\8=V)= -2^:^GY2Q%5DT4_FBXCD9!VT:>B!=R,$J+HO7P[Q M%1*=ZJM>C[D]+VIM^!T[O_D;>,GE1H6NMT!?+M#0EI6 M4L$Z_('0$&^/"TVZ)\S8Z7BI.[L?E:%ZI(J6A80D0$-Q;8/@MG594#MKGC,R+\+:IKSEV6Y M,)41QVX%8)!=I-70'@(B"Z&C\%L-VW3LM/@I0RRUN937#@!ANI1=K'TSH_VX*IW7#):@.[9FBV]V3J5F;A%C8<#'3^?3_&D&NP(9?"MX#3 M"L#8G3J[^+X?ZQZQV(".@M*F;3K&1M J[*7VI9"V!X"8OO=B.^@1DP44+46- M6]7I.H"D(%%T=OE?$Y=Y#3T(M9/S[+:SSL/ S"H DDM]0HFZ)^O2_R7SAQ6]2CO(;@7!H#BVTU#";JU+L* H[(.1L(T>/O0 @44RU'/KR MS_[VDR &FO,'+77)^=@S >.(LN*C9",GCDG)NZ3(GZ>SE$X*U6'LZ6P61B&5 M0LI16=.'@_$>&O>JI;;9I%74 ([X%C86C_?,>597D,@7_^')5P#OG@0Q!N!% ME;ID4FKPD(-@ _JM0NFZ02Y"@. M:B!DJSEO2K#["(+)N:O6 0@] "^KU#R;R5IZ0%'.!B&OS7E<7TGN1=^3]!N= M7F*87KQJ>JGX(9^1%9J#P /PS4JM-O:AJH:?PS#O=.L>9\ MR7K7_JN7??/B/+NIYI4O].7RD(>L+8@Z!.]RQ/4N556 XP0G@MQ+ESE"%T \ M\B5\V:V$?2GF!FKT!>,N;-%JYG_IV:S0(!*I D6GDG!,N$YY/BRQ/J+<% MMP6IK=P8+0 $FIV:9@;@,YN/]R=[01%.+^Z#$FX[@JJP6-"2@MI'L]/2S"!\ M-LMQ8U^<=,+J?8-;):M-K O))I;BWGFS#@$4FFV59@;A[*:T40>*U#SG9'=9 MD6)M/J5Y^_WC(#Z:399FJN=/UARP*)+WG)/6[?5X.8ES$MRK18!DS0 .FNA] M,U/P22P!C2.'S_G6X-A@H>PLS3>@TY_>PZ:_>KB%N\<%FSM;SX" =A>@U(>SIULMO+8K&!)WRM>''3]A?GJO:KQ8O,Y$-2YF\I6'H<7 M#.E1;*%8K'_NTE^LJ] +EJG_(N'3,UUQ3E](ZCV1/S,R*Z(OX4RV;&O3-:@% MC1^J8#_^>MV %@;._R-SFX.,0MI?B9<5:5G;4GA'I&IS$-CYC*JA6?8NGP92 M9M[4/S^N,=,W?JM_O?W;+5605^JX!NO:\5O*^/[]^V__+KQOU&EY)O/?_&3^ ML=0%RQFY24D4SJG4Z=MYEH>0=!-<>&'ZEQ<5D)-3'B"^(OGV-1MG)/?"*/LP MN/$S:7;*$N$--*=>]DS_ $<47[P(JL\J*L;.RQ\.]_"<"U7@ /\;U(F>4(1O M;8TR"G$H5Z^=%FE*&U1/TEX(M2-MV>E8XX@ :N['M[7B0TT.RV4EK0[ 41\NF1?JRA\$^4\U!A**XD46.#66? MP=4][E2%?=EA8!_!MJX;%&64+(X@\V6^3)C@2Q(_W9-T?D8>\\O8CXI@Y6W> M)&D94=0+"=N4!-38E\T!]@E6=TI#4=/)XO R5VW,PL;-YA^JV\FS&^^M[,/W MTX+4FSG9:C>G^O5&NXY&H3F!P2A]V3Y@'\I%KUL)L1N@D&8STAPFW M*X#=EST']LGC%JAQ5,.R2&AD&Q,W:?(2POD@+[J,H9!D^=M+X)H7+3_W8?Q$ MU^K)?!&1G$R#OXLLAP "SY3Z0\&"$*#JOFQ@B,\Y=ZJO>O@--6G"Z<'H,MFR M/D! B;(AHP25H"6 ZLL>@_@LM!QDS3(Y=D=5Z38')DE\S>.D39Z C!D9#" M#?$N*?UKZ6V"Z$'^#S^)<_*:GT?E6:/?/V3D:9D0M/Q[E&0D^/U#GA;DAR:, MR:O;U:4(JS^4LS@YJCV/+K:(I.7CN&W A#.MQU%ZI6OB-B(4)Q+1+"(QW#H:D,N MA0L(.*T C-U]PTX6^4I'FMC0L1YQ;V73"3:"5EMD:H5.I>T!(*9+(L1VT",F M"RA:BAJWJKETN+)@3'WYTFDR7WBQ_ I"?B,0#O.^-5.5N\Q3 LFBF\O:0%7M M'R^%:.4+&6K-G\.]3RXG;=>+*@K?[I3>;BN]LH[!K?0*[\^M]#8*Q'">VLR* MC8+I^U9[90_]57@%'>T2IY5-,20"VUNO'>X=8=C&5[-#FU5X!10M18U;U5SM M3M.K<"J<\PU;755JK\(KD"CHYOXC?^0R4];-_9\4M-W-XRX6 T?";%9]=:#8 M>7;&AQ_W/E@*'M-6G[[=&@T"@2I0?!><,9JCF\U,P>>S!#3VM4HG9#ZV<3VL%P>S MC1M,->Z!9;8$,='XD\U4S/8NU7"C*(WKWL4\[CS?2.L&.RI@_]W!8W[2T3N@ M/;E7D IKT"FS=*,9%1*#\\32G( ,6\+WZ/XX*G#7ASN:W2M(!77N:K"5QV8% M2_I^\:+S^R8;W2MXN#=VOF1G*X_#"X;T*-;>]G)$3-Z!; +6&?6$KF>;(9"G ME)2)"ZJU4-0Z ^AH5NH*-M(*-\IQH]@>LYJHW MO$AZ ;#.3P9H6$6+QP+ 0Y^6709H5M4RD%WW2M72EY(DX@,$!K2 8JO%(O^M MUC$U?MTK%=BY Z2A6?8>GP92UL4ZG65T>UF87<]N4I)1L4HQIW%P1C(_#1?P MTWH7R7!JM]KQTBJ[]C-)GE)O\0S9.-)#B]PV#XTI>/I8%O-*W M"L/RAQ)"*?SR%P_36XZDZP= +.=\5U'<+M%W0*!8":]/1V8727J>IDEZFJ0I M\ MG:U]M)'EO+A&N]DC=J8;6_@^[5J.3&:=V=RU'-G.$&NP:SEBIW[QI$?Q53M- M8I_.AE51T-LP^W;R=D]?JI#-*&@)GVV77[$=T4 PI4^TH"58#=/1![G^^9\P M.4R1X .-]*T=2V8&.; ^]'H:++A>F=%Y'LEKR0N"!71%QN3-@&5GAH-E44 MMTVH'"<7G6QDD@I=OVYA>N5DB@,J!Q5&A1+O":@/C8"G2R],O^T$I0 M.5O0F370IZYK8K-DD:[G^(T @N5=0N4%G43-ZC3;@N8L[F:6:)V?+S%/--LG M3]3+^$OTW(!I3L^E6)@3NDX)N"L>LS (O91*(2_NO_,PB.P\MUI)JQROE(=H M"$NPKF,>(==+_UU\_H.[2[LVY/HD+NJ?P]C21>W-VFVI(O+';%WR:K9- YNTC!) MJZ,"&^FP&_? G+QM_+!\, ZF&,+Y.%,=".+]M%-=2VO#JP9-L! M-L:2;&PF]-ZL IXIQG\S)64'ND\MX5M6#\]*WJ5^> ML0OC)QG9]7L$):!)/^;:2$#;QI"'1&-447PZ^\ OO"RBPU%Q0U##'2;[9[EU[//21+ I_*.I"^A3[*[).)5(9 W!$C.CZQ)-2YB MGP09:T>946_@GQ_A%8]>1O[G_P]02P,$% @ IH9D4XM+VQ/< P$ E+T- M !0 !K=W(M,C R,3 Y,S!?;&%B+GAM;.R];6_C.I;O^_X"]SOP[G-Q3A60 MZBX_V_O,G(,\U>X J223I+JG4;@X4&PZ46]97LDIC5/^TNG9 MUZ*I7TF_]Z?!GT9DD["6R)?-/_PTV9"+,&7OI]XC)?_Y-R]..!'_[^ MX"64L"\3)K^^)/Z___*4INM?__SG'S]^_.G'X$]1_/CG_N?/O3__Y]?+N_D3 M77F?_) U%,[I+X25_S41+UY&T,$WECX&^8W-?]FW MWS/@_[YD36]]*'UAO\P%710?RQNN@5%\KHQ8UG0TWVHTX+^R*(9=25BCHL&E MESR(5C?)IT?/6[/6^[T_TR!-BE<^\5<^?>[EOZO_EK_\?XY_>/'BGGW,\8N? M%)\@^L8Z$U ^]/2J7E<]W_J",4VB33RG;^J+__1:F2)WXRI@;? 1D8:?OMW] M0OQ%WMK_47[O_Y,5^U_B1<)?)=_YZ__?OV4M@F]_'&];V(OGQ==D?^[XIGF) M/\\C-HRLTT^!S-XRCE:RY?)/B2IK_-F:J^?S:!.F;'ZX8R/@@IDJ^;9>,+;[ MGWO37N\K73W06(U 'X5 WQ "3?I3HE$6)F5IDA4GO/RG7H]\SZK8IJ8/J 'F M=X2:<6]01\T 1VK*_C2D9ORI-W"%F@&@!IC_,*@9HJ@9MJ$FE5=F*G1$ M@3W1N?OF&B)#@ BPM0N(G/,U5.(_!/323U(U)",4)*..AY;M'C497+Y75=.!-WPD9)V] M;=GW8^![8%-'?3]!^7YB?D;9!0!7;J[3)QJ3O&!BF84)8 '8V (+MW1._6=N MGRN:UA(Q11$Q-3L:J+H!D(C+0D[-.DEH09 MBH29,1(4'9 8X.^2>;1:LS6"6!A8]O\,^!_8M7O_7_K>@Q_X:67!XW!QQ?I2 MQT/O,T[M^FR4B!U=>DN(5-RV$O89$ (MW2TBF]4FX,*NF%A/V6\IID]\R?U, M+T+VTZ*749+<\P%6 PI2%C6EB[;HF(1+42=?9FS5(EDU\H%7_$B^B[JVGT1Z M"FW5LKA:V/ ^]L(D$,/R\>(?FR3EW[=.\>CAY-6>.7VU09=4$$G%257>%1FD M!P56Z(%#00>GL?9:B:SM'VY:\)/-9_-7#3R),_1 H14ZP0X][''A6QA3+_#_ M11<7X3/-3/>;YX=\Z*[E"*>Z]EK)KGL-08TZIQJ,6$52U2155<+KEK.:(W1! MC1:ZYO#HPLFUO59Z[?ZC5"O$)*1DCMA?Q\^>'_ UTJ=E%']B#W&4W%&V0A?K M<&= @U(N])(=T,[HT@_IXH2&[(_TAODO:3@9XD3>GCF5MT775$-87HWD]8BH MZ.+*"FK$T">'!A5./>X9EH_W( O0Q!_SV&(KH\H5E*#$##UA;2(LIH0O["N? MT<1_#,4#=_P?&S8E+%_]\/'42YZ^!-&/O]#%(ZV?''%B=,^<&HWNL&XY)D^8 MW.ND:I)$,:D:);Q5PILE6;O.X D5;^C'GP-/G$+>:R61H]9N.$;/:.P_LZ=. MH7U$3U<1)[WYS$WJ9OJK$M$N+I?$L\ M#5@=VQL*H?@.?7!P%.'T]WXK_7W-!H=H<9=Z<5HW.DG%L%B=T$<_#/D4>.(% M_+R";8:@W@X]<' ,(?,SC.P\5N@E@A+#^L"8?@46QI=D1QU]FT=C<\ M3G3OF]O9W*Q7>\;]W%AY]Z'^#OUA2V-@QIO[(G3!_@ZHB'>$B^-5%*?^O\3K M-W'$?N/I*W_8YL'[\W]N_/5*NQVAC]/E^\UT^9KS:BKLKJ1R:BT"88<"SDN: M)+^2;16L:M8VA%"FAY[Z>2#$R?=]<]NMWY4X'6ND;)&P:D1NDQ2-"O$L%>^7 M[=IF%"K\T)&=,LH,$]/%%S_T4WK))IC%19@R%_--[L=)0M/D;]1_?&+F/WZF ML?=(OR5TN0DN_:5F"TX?I_?WC>G]^W>T8C%K@V2-? IX*Z1JAF3M')&B)9(W M1;*V"&_,-H P&@ ]=M@ XF(#?;.Q 3R%"MZ*T8^_Y@)C,$P G=(E8XN%SR<& M+[CQ?&;P4V_MIU[ UM6K*+Q+H_GO&I)P08"^J2# SNZ4VW>R=WC\F[[,V=J- M1$NR]F+R[ 4;ZY1 M1X:W#XEM<^<.!F^;VJG>EU/RLFL+$1XJ4^,D0(75QXJ MHXV( .ZKA?E$"*]9IL J(1#JUHA(+F/;BGO@"^.CDF[_2,> M^63/JL_^@BY.7ME*C_T*K]?B5''X>#Q/_6>Q.^WX(4EC;Z[1 08XN7Q@:I^Z M 0-44U>U 3F-^*F[K'5^YHZ-5)D^&@A]E+W-7YSS'0OK_)-XMJZH^!3BE1_S MJVV&H2 /G6N+80\CJ/X-(K93U:H@M'*\W63(DYD'YC:_+Z[/V6TC[])JG>/\B18 M62GK:R:HED.3.S;:W'LOY\LELR;?373WY,7TQ&.3QJETYE8#$TXL'QC=Z_X^ M'2^IRY;IJ?="'O*]I&(W7\*% 3;O"86F ME/'WY>_-XNSM=%G)#$=%*)LU3DYD5,4'?.+Y0Q?DU)WS] ,HG4.76IM:K^B/ M*G<16U2'[,^Y^-Z)/HOD *>5#UIIY?M.LCMZI@*/U2*L&I&R.6U7=",5Y0 * MY= C71(5B-;I0OT3/W_A?VK"+@.<6#XP)98WZE+)4%$Z&X/("1B#2%[#-CE0 M/(<..!1R<"KZP.AF]E;XZ"8N5Z"!@CJT_8% ,\0IZ\-6ROHSC1^B>FSR(GN" M(Y)NDT3"1\XCQ);K+N SA"H[]$+'^/S@&VG9;'\6;1[2Y2: Z;HT^. D]Z$I MR;U1E^392I06ZYVB?+'H24A5PS8Y4)V'#C@4G['7%HA5*^)9UX M*:D..?!0GVC9-CY0&(=>.!1\<*KXL)4JON_IAGW188VX PT4PJ'M#P4:9/IM MH_FW]YRREFS*6A13EI=7L,V,(AFW54U<"K!?+[_X(;,ORXM=*!M-0@U.FAZ:4Z?;]DV!B+Y"J+H_3YGHSJ\X#N7(#DE!H MFS$H,D/O'"1C.*EYV$IJWN>!?7_8RBQYS+WYU6_$7ZV]>2JVRSVQSL6??!DW MSQG5A*TX MAVA4^3;%919:L;Z6 M@UHX]$:7E/&C/.)X4"+BY:=1F/B+_(89D7UU2=DLLU"#-,*IX2-3V5L:=JK$ MA)>QGNYR^%V5MQ_E'4/^&=N\<%@T0.'U[U$K?3N4[;95S M$B_PAHKMH)DG7K/M8*A00SNZXF"< CTRM2_;6=]"(1F:T!7?XH3BD5&A>,O! M=_11),EUP\50]X66['XRKY^XD;_FW?G]G6TO*RY*M"K?"E-] M\?Q8'*8\\Y-Y$"6;6!,$&N%$VI$ID5;7BZU%?4)XB?S4:%7&-A%0;(56[IR( MVJO11C@9==0NN\4^R[,W%Z-E,WE^%Y8CPST4/:%9'7,[3KPD#1CA]<&0JO\3;;_]FJ,\ <"0WP @*?="L[KE^C%/TQD8S1QR2 M_\=0J(.VM378UR_QQSAM;FQ4FWO3@^U8J"/#_ACJ;M"F'?H^WRIW]T1I>LD_ M9\<9Z#%.BQL;RNV@[\;;/8&B""G*N'+T>0S5.FAIRUCHS^R-;AW@%$7)]_R_O X1E:S3 ]5#Z(0NZ=DD?DB3Y#1:/?BA^)E)VYH6 M[!O[2]\K$TX6.2FW@VWLOHDO&:-/,&%>B:F M0CT=&*1NU=%813M6JVBDB$?FY:6/M8T^#$)!!OX8Z.,"6I-6 2V;@MH._LN\ M37'YWA'/7F\;5!@<@QZS *IT3.R,S60\ME2^<7/ARG^\&J9P(;!)=R&PNKZ5J\;JB7TN M%[)-#@Q 0;L?'#FXB-*DXXA2$WSX>C%'&<:;-PSAMI?-<@>B65ZPKD;$!UC\XI#.1 G_VT M=.("-]-6IUPLSNV'Q",,RT O_;0\XB(QTW8)<.S)T8?$(XR50"]95WV4JPI_\#_T";^GN)#(M..0R+Z=W[HW)Q')GMDC>$P#<053 M&I'TB MAX4++H(S;9=R'ZTV[L0EDVR6;]:(\NF[B[&?Q MD\F_B*@FOHH;>[MG,&P"23G07\Q%F#+X_+*P,/O]DQ?^%D6+'WX0:'XIN C* MS-"5%YU:QK!.77U^7N_C7B9_K*W0B%3S3PX6(N,T.WD>S7 MQ1VG',H&N*:5-4'*-ES),CB#<1KHHT.%#1>QF9F\)!E'W(&P!:,VT"5VV;KR M5D62!+ZQBLTOZ:L:IMYG7,1&U.]H[%+UJFZP(KQ"EC0]7_5E=2SS(YFL!$CA M!KO+M[N4KB53;N_-NPASB]);UB./7US'._:;]MZ.WF=,0)':])&]2#@"9%WL96##&Q7M$6^Y9 L\^YG')!-+5#H6 M!WIO*G%Q(E&_H^=I+(Q9!?*5ID\1>S0.GUDU<=_L+?4"\;C,2Y,/EU&2?"37 M7&OB@4L7ML]*9I;(="RL]-YDXL).HGZ7C[-8/ 5\T19U?(P\?_$3L0C,\2U: MY,D;^4>69ZZM(PHC5@H?VD5TQ_W)O<^XT)*HW]%H".Y35BW_$O*]*&;[1AS) M-A(?+H1_Y$1JVANV>I]Q$1I1OZ.'A*TKME0/!4YB&=A3/#^1< MQ\5YG*L-O\[R>ID=5LS>U?&#BUN(^AWQLT>GZP6SMU-75H=$,2G:/")9JWS& MR]JU3B>,+RA\:)?.2_;"14I7VC$+%Q 0]3MBKNQ*_<#%BQ%1SO[P!<5\A<'M MKGWZ6[O1X$U39?0T MN[_B."E%M1S-,Q?T"RCY*[SW,R")T_]%_2Z?#??C\BV"3L0P)=M)D#DF_AQM^Q=F6]E_D07FT#H\IO0VRQ\GF^%U22B*OGNSN6ZDNDD MHAS3Z1&[6YY9^2C612M[2,6^=P#7@I0V,+[3+?\ M#QEAZ+6*,%C,>GI%:X-6_%;1)"WOJ:DV+;W-+VV=4T4 SKQY^,4&\Q9LJ8$H6-1E#,_F0<1 MW[.S4Q-"ADIZW85*%)T"(YXG[R19E!7,/&1?I'<6!KGFT6@+?VRRC>6Z[#,Z:I$!I;[A@))9H]2/WM('$ND3 MN8(O/I-4'TJJ3STBU>=R54%.&G7O3/(QR7'2S\"Q<%:'/P-D?*O?\64K!G\+ M-UP'.V6+;HYU5J3-.Q6J3D+;UY)1&.LBZ4 M]A7!)NB+@R()&4?J=WP9R@ZMBL:(:(VPYJS#J(BY0,\="(Q_\1^?-#0.D.&407=7FK3J[GOBR-NS MS>- $4Z!ONN0QU-O[:=>()(K+_QTPX^+AW.>@7EQLDFOHO3O-.6[4G3<(0,B M T,!D:;=JG;?B/)$KD"*&N1ADQ)6A[S25&S1L4Z1(AH!/7% %"'C"0.3\836 M*#V)\<=GZ[7Y/-Y(^FK"-\RNRST*6;R7+^K*:*\3)PP&BM@!]%"G="5/_'\\ M=/[L!>P[)KBRESP1G-_LO^'6P6?OAX M_C(7_KIE:^CSY9)J\PX-D#&$0;L3,.VV?G=KH3)U(!L./RSR\A\9\=E?''V> M4? HRRM(JT\2L,?E]Q#O6Z==$6. OO[#T8X,3PP,A2?L@"[VYO)]XN(/J462 M-4F*-DG1J'6J%4$-Z-,_'-7(P,B@W?&=MNL,6V-X.7!O#>:'-(8K B_0UQW3 MSMSUQDG--ZD/D'&7@:'S.XW[M7OD/'-SK_I $6R!WCB4@5.'%S+^,C"4= S5 MURWDP*CU9L12C6)R>>L8*@(UT&N'CB$R=C-H=11G+:;(N]2+T[I)62KV_EP> MP7&0@UC5S=[W4I(^4?) '_TPY!L+HZ5X(?MNUME4!'B@*P^=361X9] JO),Y M]CRLC2R6A6QS27DZ, #)W*(#/$,VYV8Z5" ^JEF[J$BP@-==R@L M[DC&/D2&?X;&PC_OT.<"R[>CH#/IVH>*,!#TB/7'WN/TU(OC5[:.$7%8'4K( M&-#04,ZT1GW:&L'X .7'+[O$HT#^).#& MFFNHB)M QQP*42SU=89T,A[$-CN\T&4LH?FCQ"T0"0[+#@7,;$ M.A4*C1Z:V6TJD K\L+L3$&T'$>MT**1S:&ZWZ4 *X\-6PO@>YY6;,N'DHY!" MOH8&[YB/.[Z?,%S06"SBOGA^]D<5)-61@I2IAX9.(33JTQ8J9>E\MS8OG_]9 MU;#.CD)HABXX$'9&2$%Y9#(%4SN HM7:"U_)]8^0\M1@2THN0E; "^UGH!TI M]&!H^2Z1";PDN5[>Q^*.T]>[-)K_?L^36>DP06J\(U,:KZX?)16\ '_.+8H0 M489\%Z6LJ[X 9:.(J3(.S*UIUW?$]U(-)<+64=#(>!"6W>,!K_LG?UN MSOQG?\'6D'R#M+BT]HS. T^?*6R$5')'II3D>#LRM0_[[?>7!XHH+!:ZV7OVYPZ%7@LM:\?]#:X%'R&UVI&I MW=+J7BA1R H+F(Y]ZDZ/I='HTFDS*\NR-S^03X>^,/A^->^/\'=ND MC172+/2B)=(B_H!WZS\^:3>$CY'"[-B4,*ONA7*ZR0J0K(1U'A2*+#2RS77J MW?*QC^D3#Q'^F(DL\O:+I]?+>>SE.T]A_V*0\#'8? M7;'.16'*.AJ(?/)LQ4@377QGC-10Q\TTU/W3;2*[O;WK[8,O&OA(@HA?M2;5 M)VE$PJT61*9.WH1U$A5R+'3;X9.(5&K'YI3:]P#P6N1YW6HLNS6'D@^7C,:/ MXGY2$=WV7H[(311G*1#?,+K](>3"%485@C!TZ.$SBI2/QT;W_K[G2#G? C4; M-@]FP%3(T]!S=F&\B0)__IK]_UW1\C%2KQZ;TZL;=4O>U068^L"GXH_D>U:' M.!0A'RM$;>@*-\:T,C%4/F]@QCBD #XV)X"_9^_KH+1.GD(JAV[Y^&7CXG6*53H]M!%;E"H(6J"E/ GYB1\74]JP7B[ /N/C?<[?ZIX MHBM_[@7L\2)>1]GE$K;IF2BT>.@.M^E!ZO&35GK\^XU'3=9;AT220L6'KNF4 M)/:=V8B>W2/M)[^?QG3AI_RO+W[HA7.?7_&8I/%&;/"[7BY/O( ?7;A[HE04 MTP&'%/LGQL1^;(M$:DYPMHC>8-$M"@*6\=2$4" #OPI ML$2&&2;M,J6W53W>B\U,H8L8; \Y;(F S8MCGFIWY<)9QXDB*@'=8Q.ZNI-' M$V2P86)LP[:J$S5CEB,GCB:*R "TL54:V$>>12O/UYV,GB!5_XDQU5_;DQHN M>"'R/2MFGPZ%)@_-;9..&QKS%[Q'VM/A@13<)\;V:^N[HN?CB%3%K-.A$,FA MM1VG RF,3UH)X]B%B0*16WZ>(TFJ&\\9IP82*8*'1A:OE-:,HVM'W;;(T$^T)=\XP3Q5GSKQ+^R"8CR MFWD32CZ1.TKY/21E'=G&+Z50A MPD*?=,D46]]%*QI?^DFZ8U1!:J]34YN280]*0O*W2,#?R^X=$N=4^0:8A :! M.V.-0GR%!K? !7BBK&<$J;U.36FO];T!O*AD%%=(42BOT.SNDX)47Z=&DVS\ M1+@HQ%AH>PNXW-) F"MY\M?U$\\,J<;.3*FQ^IX 0K;*. /'3"''0FMW",>9 MGWB/CS$_$;.#&V%57=BBQ"'!A*%) L-VS$"?Z-<4Z"+ MXV<:>X^T./#'?S(Z%I "[&Q-LV7=-./5(U'@K8FGFR>U_ MQBFTHK[Y1V"HR8IG8'>$5\D.$@96A=>M!X": \&L/A(!4V(K[('F2<61H\"2 M)20(W-%4+^N/6/0_XR144=\\")=OSU< &"Z=.5PAF40BPK8^6MGJJY?R/>:O M9^R!7GK8U_&!DTM%??-\:/JDHZ4H3GAY6?&PC@[4514>L(:.+$)FU^!4QV9U M_. D5E'?/#]U'=-!M"6SDJR6.\>()<-)*+DCO.Z#$DYV%?6-/N"VX\DEF5ZR MC42+;4U5/;[KZ,#IJ:)^MQ.55H+?FIZLDP$E5(6MG28#)Y^*^AV-&RH\Q,KV M>EFD:W,+#JB<*LQM#8YOX2:ABY,HCJ,??OAXZJV].3/=\2K:A)K] ?W/.!E5 MU#<_CM3V3#NP9+5(68T4]8Y(5M,Z3U!V53C$B47+&?L5AH]L6OK8YJ>G$&:A%YS@YY[&6E&FAQ1H>P8%VIK>-"1& ME+5.BD*[A6;OF)3331Q3[M>R\G-*1+/TTNDEOV?A1Z#\'K M390DOCX0U$/JNSUC^NX>?2R''Y\5YZG]&%:G3SR',/%#(C?$[_HB15/$3TC5 M&"E:.R+G2>JOA*YW*QIA:&;-L:7T>DUCMI+>A/87/0K1&+JU4SZ7E/VF%UER M?&;I2]][R$/W5U0[BB&5XEXKI;CU8WIMEZJ53U:,I ROH"IB'1&%& SM[3XB M2 6X9VSC;3LZ\NL'^1@DE>37$%H'1:$#0ZM; "4_3%7^IQC(-4>#^CVD'-PS M)@?OZ ^ I3A&5OVWG,1ZUG%1B,/0\H> "U(C[K72B,42VG^F.]?06P6-,&2= M((6"#)UAF1^F5[VH&Z;CKY"XX7V=F0MJ^,#*?#VC0F\^JZX_HS35RBZ MT,X6N,ARHE&>7"_)Q:Z:D0,I\O:-B;QUG=E6_I-D(VYQ$H6.2%[LR(7GF[Y" MW84FMPQ)#1U(I;=O;+>NLA=Z+(K#8.(Q)HU$3(@$D1=F48++*'S,7CMS0 #N M*P1@Z EWH4%*O/UF$N]V>*!!9* I/91GK7"B$5VALFRN1 M\RRA;RYTZ_A "J_]9L+K^X2/:CL(EBCYU:MLI>+ ^D2AP4+3NT\+4H/M=Z7! M'A(:"M45VMGV!%,^ ?X61XGVR0:IN_8-ZZXU/0*(Y&6S=:ST!$Q$<>O0*+17 M:'U[VJL.$*32VC>6S&#KV^LD5.M>5^BET*06O"Z+2?7;5?I(P;1O;(>MMB=O M]ZHLW!--^PK1%%K:,A@:(@9(N71@6"YM*)0*A2-+FA1LLC20QT$0_>"3B&T\ M!@K5%)K=43R0:NF@E5K:.E62GI$BGPD8+(Y(:%\+&R@$4VAJ1Y% RJ2#5C+I MGD&W-L.&=1@4PB@TLDT8V!_9$:A3+XY?EU'\PXL7R7' ;!^*(/E7/_17FQ4K MIX,&J9X.#*NG^W2UEBO^=WYL;*NE(R*U1?+&>&GK%"J45NBU Z<0*<<.3%XG M]AXHRFRM76K .FD*ZA8YQ#[0O44S]1UVRC@%2R1T82[;0IG-[#FEY M;>MD*61>Z)>#(PNI^@[,YE[8!Z_\G]G0E!'%0X]1^D3C_ 7K#_4#A3 ,76$3 MINLUY=?MA(_\^KCU[ M@-2S!^;U;-B76D7;H5U] X6L#0UNG1 -&D.DL#TT+VS7[?!\PL"T@5>]B1BJT 0J%C.S1$#!4Z-C2VLU@@E>QA1TJV;IS8&B;XNT[(V4.% MG TMW2T3?D@7^6ZD&V;W\W]N_/3UCLYY.B^__BKY_A I70_-2=>-NB4AP\N3 MO +A-4A6A51U7+F84S*;A)%E/?J-O?G_LC7_1?A,DY1_[[_YZ9-?O7/*GBP? MH_AU9X;-(5*:'AI+!O$NO:Z%\'BQ\'G(GDUT50[ZA!P_1)NBA!/[/(8*Y1KZ MS2J2Q_/Y9K4)^/;=_-7J4H>+,,OK4>3W8 ^B=S1-L\[QJR V<>KYP4K_N#5$ MBMQ#,'?J:>= MTI&2^M#<1NIWZG@=N')RG:Q=4C1,MEKFF7L*D2)KFO"VK?.J4.:A1ZWR6AWR M9PORWYA[N!!XMJ'WD314Z!(B#)'*_-"<,K]7-^M9E')J\"U\O!7R@;?SD;"6 M^ $UJ2WKZ"FD>>BN T8/*= /FPGT[W0>"45C]9I0Z:V3I9#CH3>Z)TN>$,2$ ME,\47[UT_L33'\OO9\O]ZZ5X4X<84K(?FI/L4HH!U)!7Z/_2>U<&NR=J>K8_87VR5PSOU9CC0,#I"Q@Y&K6('[87!=[9" M0>X-#1,.HC0TGCYYL?T+54:*Z /TT4])(C)R,3*7K<00A,I';?C03(KF2=$^ M#ZR3K4\0"\A[>0%I'61%O 2ZV*Z"M.+)@/_E99>7W\<>&Q/XWT*"J^ROXQ49 M4AF9RZ&R7S_K'U[D1OCIHZH9^9)E\B'3+S]:QT\1FH$>.V3\D+&:4:M8#7KB M;LF@1)>I%-0T<9,B8RZBPF4G6E=A03Q;($(M;Y4$0LH+T=YP,9 ME1BUBDJ@EU80DIO8%Y-7_.R7F?#<4#<4005H;7=FL1HI5,<.,JPP,K?O?\^. M[IR]CG:HO4>%W&N=/D7@ ?KKH.E#1AQ&AK.$(Q&\BL)/K*OS[$ Y+^_05=@C M10P!^L/JS,=G@NOE31P]^PMFZ;LUG?M><)UMLO#FZ<8+>#I4/Q1/0GG%*M;8 MX#+*,3*<,#9W%,&<+6K79F+VO5Z2\I-(_E'D.M^#DGT8D3ZM;$':,>#4#9AC M190"NOYG9QT9L!BW.VJ!729V!/R1#+)U3A5!".@VVRHP>ZQ/*D-?% OZU3JF M3SQ.^4RS=*/'#XGPE(Y'9$!BW&5 HFV?=P8G>(/R>.E7C\52H\6E6/FVJ^]% M\];/ (P5\0KH4-ND2A(^WW64<"MJSQR-D1&*<6>G2;0]:Q<2$Q4SM*C]"-A8 M$:6 +CDLHI"1B;'AI$9ML3KFLV[,UX+B]+Q+,:ZQ(MX S7]8]""#"^-],M#7 M\:.XH>!G(D@1*8 N]YXL7SZF3W4!)L%?XRJ3JSJ M.$/&)\9FXQ/OU?LFCXM\R5Y&+GA*K+QY(MJ7#XH7G\ ?*ATZI#M6Q#.@?W\^ MA)%!CG$'08[WYICG>J=;P!X GHJ "/2=*Q.U3H ZH.NZ4WX[(@_@\%W)"3Q01#>C:@X<5 M&;*8&,X.]0[$[B)0/"=_^.7X^O3B%^L:W401GX ^.GCJD(&)2;/ Q)NCMKO@ MNY+*66#0.GJ*@ -TU,&CAXQ!3#H^);$';.*:.,+',^M(*2(.T &VGT);.6X<2,O@PZ>""VSUZJ]XS^B%[\V.V?<4E67FB"$Q UQPL9,@8 MQ:35 8AWCG U 2S) >-7*Q//):X4X0KHC8/E"AFVF'07MFB!5+.PO&(W?#&\ M68=.$2W" M31K2I\C@Q[3#XQ[*?M6O)+=3A#Z\EM$WVR!-%=$*Z(M# @D9F)AV?9:BEB9U MCEGKT"B"#=#N5J&YHFDV4OOS_%7^N*9C!AE6F'9VWD'=K?JQAV>(+2J5;_%J MUC%2! Z@*PX((V2(8-IMB*">)7>I4<0&H.4/B!ID-&#:[B@"-I)^J-0HQ'YH M^0.B!BGO3UO)^\\T?HCJ1YN\R-[DR/N#UML[@QYRCKC2GQR1, H_5>+_:AV% M+F0YGRI4?^@D)RZ$N*7LZ3B\WKT_=7_D N[;C4H>\'LDJDLBI?8]3 MA:@/?7)@3"&U_6FWQQ-V@^4X0@IE'[K@P!!"BOG3?2YV%Z^L3<12]@8.4ZKKQP%:7'Z[7';^WYPCHNMDS= MTG]NV!)D(5VOI@,2*=-/.Y/INS!2_?U?U1<0EX!57X%DWX$K](KXU74L_QP( M^RJD^"Z$?YE\=V3Q=>0[\:S_=A1:/23&P4>/'5E"9DC)?M:99%_?O3W5,X=2 M?LP4(C[TCE7"+D*VTJ))W2/M#*G$Z18 M/S-\ 74#5MRB0J'"0QL[>CV;?&FHCA>D*C_K5I5OUM>").DU1Q+SSA3R/'3! M >.$E.MGG=UIT(ZD?2^:E-NRSIY"Y(?^LLJ>M -9!QA2V9]UNW%?ZE!U2V2U M0=HZ$@I9'EK8=220.ORL,QU>08-Z8'&*$87,#DUNE9'D-_9W[ 47X3**5W7I M?V9(?7W6V=YY19_JF$E(7IY(%:RCHY#7H0<.!1VDKCYKM4D>/?.TYNL(*:1UZ F[9R]>2Q'XU$OI8Q3[-#E^\;5K9*0>/NM,#]?V;,?! M,'&37%6#?.=U[.N "J49^L+^M11\TJ^>+-00#3[CY&51WR!$]7UJ<-6)T)"K M&I;9DO;Y-,)/%B5TR._6>/7^C"3_)< M+XNS/3I$<#*RJ&]F>%%WHQI1BO>S^Q'XN>2BC'4FH)2LL+,5)F[IRO-#/WS\ MRH^&^>EK3\<%3BX6]$!I6&%N*WA-(@-C5;PN+7?K>@Q^PG]%5).Y4 M#>INGQU\QFFXHKY92C3]4:!2EB1%45=6(%#:51C>\G"2'(>+O]#%(QN)C_EM M%!%M MV1^RH':L<)H5"(MTP=R8=,$3C>@@PTG&HKY9R&!7%!#EN;BOER0K)G*K6.<# M"L0*>UOAXXOGQR(;]/52,2]DUF1#_O5RF=#T^)%?&9*>1@'/*1A[@8XEG(8L MZAM\\GZ?OH-]/+?L=7+WPULG1]5\:1T]*"PKW/,3H8=3G45]L\/8^U"G6IL= M$=XV$8V7MQ+P3=)96R1OC%2M6:<3:M4*#]JATW_AN?.SWS;_:6N ZR$5ZIXQ MA5K;$P5#H@S9&LILL]%3:-'0V%;8./$2/[E;Q]1;7(=_Y1=F/02TCA&D$MTS MMJEY9X]4BJ,H3++2_(A24=X-;!22-+2_%6P*.S4959#"=,^X,*WJC&)@*=EP M:VQ1:-30Y+95@V*[YF5]ILQ!#ZE6]XRKU76=VJ$$B-VFXI8%AW)E2B:3 ')- MQ2YM+=^,G*5]OPCI'K;*#P.%]F*\?PEN_Z''Z@[+PJ%-$GNV:_7 M#Q^OJ$[P["%E\5Z'LK@QVS3&6=I5?1$6-]E(GTWR#Q=:6+Z8+SX_.^VX]0U( M_A7X%FWKOPZ%A _AL/+K***D]^PSSR(>'M/!C%3O>\;5>]@5!7M%(<)+D>]9 M.?O#IT*UAP9W:/@,O"3QEW[VRY>OU3B]8 N;*/OUGK\9-FI&2J2BW^M2T7\' M,[09%,O/R :YKS@.?S M-,]?)5R:WQE 7]8T3"B)9;R7 F_.M,^9+LI\J%8 ZZQ]V]FY)9=(2+L1OU"X M\>0UCQR*>S%YJM0G?WWRFOGN+F7NY,4O<_>J>42%GZ5?N0LR2,[+%3I-/9OJ%5'*+1 MH-1'AD+ZQD(AV Y7O%4W#+!I7;VQ?]<=MZ)%VU3V%=$5Z+^?@DID\*5O]AA MIVBR"M;!4\1GH(ML@7=)DX322^HE? -;'/-D9&)!<[VFL+@?1\9V^J?@.KK?OA:-#&Y+[ MB@ ,]%ZW0*ZCQ M^BZ/-FCWV!YL%FU"XQ=GZQ \W=)'/,A'/E<;<[;,'_"S- MY^DFY@D^=4PBPS1]4V$:=(/=X 2H;4=PO(3\A08+LN0WYGJ!]7T_?45L M!GK*3?ZRS,C)?<2?XJZ7W)PZ]I 1F+ZIHQRHSJK'PYW#89Y1.B'W498\FB>< M=@%%14P%.JY3%)_]!0T7"5OYK*+P+JU9""*C'WU3T0]%%RIL\O=(]B81[UJG M0!%"@-9UE )DY*#?+'* N(&A$0[S#(?$"1P4L0)H9C=Q&"#5_T$S]7\;A_M= M"Y\KJ5P[,&RS,% H]-#&-EA@C[P\_EJ_ !X@9?>!J3,/ZE[ <6&=O6\= X5> M#FUK94CPDB>=\Y$Z^,"4#BY_]S)]-ON;+)SYV2N$;6C.+OT=K?C.XODIW]D4 MOWZEJP?=OGN M3UGNM@Z02NG T%[XZHN7M_.Q5]QQM$+*A*;L MTM%>S%/-)3.O55#I%XY-+1;6=>-NNG'F9U00X5H M"0WM,!1(U7)H2J9 M<.X'OK1WZB(\#]G:@"[R,CJXD"KLT-#^V?T[NHU:=GQ83(?L_2Q'ZW8K^08Q MGH0G;Z@L:1T_A9@+'>88?L?I%[K@R47YL>X-^R:O6X5U'")5X*$I%1C?X]9 M'J3G<'T1 IA0]-2>&=&J=D.O_4\L[@3/D2 M'[Q]5JO\:))]-BEN3Y/*B&OW>&9L]@7D1'S95R#L.Q#Y2UC_@2AT>(C''^X' M@A3XAT8%?BN_DK^Q1ZHG@?XS&]P?Y1O +OTE&_^K'X?8])K_1*SSK0@E0._: MX)L;Z5J!T4^P.OEV\% MM_?MUWM5V_QH'US,B?:=R@@V4L0QH'M=(WB?Q4K54E9))#&Z?_+"?++1L8Z, ME(P,;2.W9J=NGX+D1O/:62(S_HV*=8+U'Y$BT@.Y^2/_B)!AHU&KL)$KCT=- M?TG?PO@-\'D^EZU?R'F6DU?SW&3])Z"(3D&O_Q0_@6JIJL4=&<@:F0ID=6&3 MCN<'^7G1^H] $2.#+/Q1?@3(*-K(9-:93G\)6^.[>DQW!6!%) WZL4N _[GQ MTU=NLRAD7[#VEI01,F@V,A4T4_6A'"7%FZ1\UYEK44:*0!BT<.@23MW^E>:/D6+"S$:\^]Y_2-DH_F3O[ZAS)%A MZCWJMG*,D'&9D:&,\HW[]0:5K :IJI"R#JDJ6<=($4.!GK".D6[E,D9&4,:F M3F.H>U'EORM?(GY(O"2)YKY(%3IGLXL7^M3Z^F*LB*- :[L+!C**,C9Z(J.> M#MT 8I\)10P%&KK[-2?/''F]O(^IEVSB5[&NWQ47&2/C(F-3<9'=/7J['N5E M>0RC*)T_:+L4NA@K0A?0 UV"$\=1?!K%,=_Q%H5"[JN-RHZ1L86QJ=B"MB,E M)KP$J8KDHKPK<=FQ0I"'QK:'1G(<+FYB/XJSN.#QXA^;?#2^9<-R?@/5R:OT MC[Q@2_UF4KNZY MY9]CG6>%N@[]W"'/Y3586:9E9JY+WWOP S]EJ\RO8LJ@B^OPELXW<?QJQ/3Z^7])F9IF9X1L4V5N6/M%8BG"!# M#A-#!S>:=&D71-4PY8IN.%'$(J '+)/S):9L]1'.=PQ#R%C$Q% LHD&/ZKDA M96EW!AQ%) +:W_+CZ:ZGA@DR&#$Q%(RH[337ON+&D4ZCLTKV4:^O4T("7WB6G)'?9DFX:^.S0H MA'1H7LLT#.II0.KH$],Z.NS)-@T#=VA0J.;0O#9HJ)?+Q,S[+8P>$AH_\^E7 MF'P[<]G.90M2))^8%LG?T02JI8U2.X3KFR,B?P@1G_(V1YR#2R"%$ X=[BC8 M.\E%BMX3TZ)WFSXBT'21.X6@#=UE@[ODC,;^L\:T*\,1\/*I[S[[>R>M?Z.*17XU-$_\QS,:5FHC,%*E^3TVKW^]N"$AP0J3/ M(/F'$/$II/@8ONVB*D6*3R+\H_A[^8<1Z=-?UBG6D]E+8*5)9GYI2UNM[4ZXEH_#Q4\KO? MX21)4@Z9U0!0J.K2V;4#J MKPR>(N7SJ2GYO*8KY4B4E2&B4#F;OI*\F'4\%&HY-'>W>/@IL^8S79QNDC1: MT?C23]+DMSA*=-L ITBU?&I*+:_KBP0(*T1$*5(4(Z+<$1$EK3.B$,NAR>TP M5@8;,?FORE2))^:$LD;=DM)3E6C$,I%'8>V!4X54CATA1L8 M':^B./7_)99Z>5Z(OU,O_L*@T$&%5,FG)F^MW:^G)6=13-(G2OCKA(8+1ML9 MG0O5C QZ1X29=V0=+H6R#EURL' A1?>I*=$=QU7]^"6W4"1GR1CDC5@'3B'> M0SP$WK(X^I,@_-27RXWN\C>(G-8I'@CYQ 8S<[A$I MF^3W%F6-"D"MLZD()4 G_AQL(B,'TU:1 Z/3;CV@^1S\JI^#K=]&,%4(_= _ MSF+'S7W_(]*!AA3ZIR8O%=BKHRV6=P/K:"FT?.B1 T5KAI3I9Z9D>A15^R[N M6!NV:9LI1'7H)$=HF\\WJTW 4PO)-M6AAM399^9T]I8=;,I957N+.>N(*61Y MZ)R#1 PIUL]:B?4ISP-:.U'R N_ F4@X:IT:A5H/[7V0U" E_)G).Y#WIR9[ M>^7@^*/0]*$/W"#IJ_>/*!9)L*Z\%:T]:#-#2ONS[J5]5>\:R1+)$1%U\_Q@ MO+8SAW!F"JT?^L8-O"YWI+Z9(97]F:G][PVZU PDIS+4S!1*/G2!&^CH'H/8 MY^OV9,V04O[,9";V/;O:0DD86L=+H=M#GQPN7DBM?N:$5@_)VEM-X*U89TZA MQT-'N<';+L.RAM04NK/_8J:0YZ'7W*!0 M%SUF977\(?7YF:F-^'MU$A\B9S6L Z<0[:&;#A2XX6><:B_J.[20VZ)N]SIN M;!DNR7PE7 J7N %7S=[5X6><(B_JVY!+M_:P9EL-3[TX?A6)KD2R7NN$0(E= M8>T#( 0GJ(OZ'<]L^@W.FFVJUEF!PKK"[@? "DY&%_5M3$H',)I P5QA;3<( M44SQ5_0EO?]!@V?Z-0K3)RT_./U_BG[;66UUH<=R^S^]9A@VJ\PC5NP';R6L72]$GCAY]Q"KRHW_$8][9G M#<,Z#Z];$4(GTL=+YI.(_UBRR4$V!5QHUS MAI)=)#+LRN0O_+[R+-HZ/,A#3_C5'!1WPP:VIY4;+R(0827(54A M5_(C2::1Z+ J7TFA3%B5R>2!6LPP.E:(4+NH?GT@_I]?(TI@L_K1U8>DBUN6=JC[BN M'V\1X27X,:FLC#.C2D\A(T-;NPP&4C_NF;P&=2<=Y]]NK\D]3YQR&7FA.U0H MI&-H:"?FFM\\/SRA2_;^O?>B8P2I(/=,*M5DMB&\QA%Y$'4(JV0=(86B M#/W@!$*7;.V_$R&DL-PSE6*E6:\:(<1KD!-W"%(HSM -W1-TPUQ2/R4A1>2> M*1'Y[?=_2P5_QYTY2"'S0LNZZ'ZDH'_+[K0<8'477NF=-?&'6N\$"$?>+6//$-$5M,Z30K1%?KCH&A"BK"]5B+L M?J/,'DC1E_D3:YN21U8P(1\"5I9RDD)J/03>4^BST T6(.+[ ^+7^DD)*4'BQ!S35^BQT/Q6>+GS GJ]O$Z?:%Q/"U*1[1O*L5'3 MDRU,A QR'1)>BEPOB2CGR'#25PBST-X6\;B)HS6-TU?^@)F>_W/CKU?:O-;# M/E*7[3?396<9*2%]Y&D(ZD:6JZR(%AEU[PIZ/O#B'PD?9?@@4PPL?#):YQ6/ MR)I7/2*TJ$R\<$$B@9CG!F(*X18ZZF 00^JV?4.Z;3NRQ+A4CY3@J*3*.D0* M[1:ZP@)$MU3D(KF/+MDZX5'L4KRC:9I];1U#2#VW;TC/;=0GU6(YKT#N(U)5 M(54=Z_0HI%_HA"[IH2&-O8#?YKI)$K&^K.Y+N0B3--Z(6Z2/PT5^5\KQG+TE M-A#5GQL>]I%J<=]0=HWWZ'+)7M86J1KCZRKIQAFI/<(:+"^*2JZQ)Y"QX9^ZI2]Z#'VUD_^_)1_>WYQ%)],;OWD]UH]LH^4K_N& M]A#O[$\UIA4%R59)PHLZ(U+V%9(U-'V7O$31XH2\Q\\!!#5=.E&^0E&TID696_G%:IR=)Q78Z_(BM-]BB-\RN%!77 M--IF8* 0HZ&='6( J3P/6BG/F7//PUI%L2S4P/^LE$O.5TC-T, ..1\I)@_: MY5UN&:1R=)0?*,1>:$@WUH?%6S=1X,]?=10@]=Z!*;VW:;^:K0J/2#5L9/7( M]_R_#JT1!PH5&#K( ETW8E2^".S_GN)*YP+OZQ25(A4^I80:JY U-J;I,^063R MTJ0J3J3RULE1"+'0 8="#E)M'9C,B[P?/K=TLF]O:^_?[ ]PY=\2)907*_"]*JZMQ6X,GGMG1<(,77H:$,"\T[5@!3 MGFE,JS+R'EUW'G^'"NT6^J%+BG@2M9LX6OJZ]>H0JW;H;O8PQA==C_S;G0?^R@_% ML%B[P6N(5$*'AI30VKX4-,B%B%3*F7U=0X7T"2WN.B)(R7-H4O)LSPD_R)&X M28M"_H3&[Y*6U=KS8_[=KI=O!:*+<$&7(D]KP-.TGK_,@PW?%[$C_#]$ZJ1# M0SHIIJL59D6Y3Z(@\2MU+#O$ZI>?8ITUAD9(M7;43*W='ION=ZVMKJ1R/S]0(X6\ M"_W2Z>J<9S6_]U[.7[QB=DW'%%+U'1E2?9MVJYK21')WGD]( M>O\H]B=CJ+5IZO10[D4(#AB:WSTC-=30CI"8\,J0)U_2D 1].7#4S4NC& MT-PVYJ$RG5L=&$@)>61HWZVZ$XHY1LI9YP8."ET9&KES''CT[0O[HCSK2?KZ ME3*C+2["9YJ'V:XH6QZ>^<_^@H:+Y#H^\Y,T]A\V(I"O0PS7V1\H-][-H+?9IE.^-O+HH/ ML(ZG0M.&COPI\$0*WR-#F15,4,DI^^"+AHO46 <#I$(VAZZS!N1IQ'=@;]B/ M_'I-L^0#><+_NON/13M2YQ\9VE[]7Z"C0%<$"Z"G M75MGZ!!%!@M&IH(%;> Z/R1Z%,$"Z(0#H6>,#!:,6VWM?J;Q0U0?)\B+[(?1 M/5\-'-10-%8$"J!/[,EW.XX?C9%Q@;'1N #HA5:V<^<\T5BA^4,K6XXK^B'_6Q(?)=%++/A4+GAZ:VJN36AH'&2)%_;%3DA]VH5W,= M"?Z,%?(^-+0-*+*K3GENV-T'W\=(F7]L6N97=D8!2%Y./ \YE"5AK%#]H] M5"?83) 2\*25!+P'+$WZIAA@MJN1K!ZCBN0ULT*LKFVJ)@H-&#KET*A"*L.3 M5LKPOH]K;= 2*2.RRT79.]:A4>C$T.:'!@U2.YZTTH[WCD:U!.?;G^[^E(]( MRRA>\9$H?K0?>IHH%&7H #NKX34-$YK?OJ-C!2DH3TP+RMN] ,L;7[6?XI!" MEQ.%^ R=XBX_2-5Y8C(_R0Z(MAZC1 'R(2_R\8B(*+AU.A2B,S2YNW0@U>9) M)VIS>SJL8Z&0F:&M[2];V N5FI7DR<-TK" UYXEIS;E!UW8_/_&7I'HDKV@= M*(4>#1UB ZAO[+N+>$^#.T G2'UY8EI?5G8&0I-O!BU+"VINHNRQR:5K%"<* M*1@ZP08V-+GQ?%TFU@E2_)V8%G^S;Z\$@[]AW>T*<1?:U#VW(_7<22L]=]_5 MB-+W8H=X>;(G%H$C^X\N"AT7VKA;#+;N;KD(;RF_$'F>BFS&[!\T?M:I)E.D M@#LU)^ VZ%2Y.2+39]F<$@]!*]L&DY\_;[-*5*PG9K;RMN^CP54=VR%ZB_]N1>FI ), M;DBL4,I[GOV$5(V1HK4CB$3:49M\*C1A MZ%:KPUI^;PQSV9SZSS7;B*=(*7AJ;AOQSBX5]!7OL!&M>,LZ(@K1%YKZ0!!! M*L#39@HPZHS_0;.B$'BAS6VS$F_H8FL)^EJ'#%+TG9K;:MRT9^61N7)*2K=# M"M:Q42B_T.ZVL1$_MMRD?+=N9N[+:K&I(P@I#$^-9;7>IY-@]%EGA86*XV7% MG5J!*^1CZ)ZLI)$^;"^"&9>\E3=IIE+@2^1+PHK@1+LZSW68BS>$E:MY11#H]?19C'/'^US>!, M(5I#+UIE\":F:\]?G-$E949=Y)M6V%KRFM^XEJ7WUO&(5*UGAK<9[]'3 M"\ M+*%9H42Z@VZ;1^N$*61GZ)>#)0PI1,\Z$Z+;P+5?;>ND*=1KZ)^#)0VI9\^Z MU[-_SO%,H7M#W]C?'>#SLP:G;+VBXPDI=L\Z$[NWNZ/9$2#>%^LSL="R3HE" MYH86/P!*D(+VK(-,V3\#+@KE&IJ^:USX5_."TVBUBL*[)X\9[CC-P)[TS/]BD_C,E M=Y3-84ZHUS.%>@U=TBEHQ35RXKJFM[?1-;UR;X84M&?&MDBWZQZ\78]DUUA5 M-8L;K?<1*ZJ._"1 9/ M >TQH;ES)$BR:\F=PE>=ICS[C='!1WPQ4BCY4Q.1O MDCE_UY7;TB5C2"38%;1S0TD','=MCQU]Q@G7HKY1))2=@6S(ATYO7=D<*UE' M8L2N%+T]7E_1M.'J=_09)SR+^F9(V=VE@A:3^2]ZWJPNK;+;KX1FG HOZW0T)\!&Y MKI1U0J"XJ["W\X3@I%Q1WZ"4VP03,6G$-!"GN\KM$G[(E[[L%9Y;VP^KE4A> MPO9.0\ER$C]VU5QY_2>>$'30X'1<4=_\"E;T0+0D>%QK4V#.2VNJ):$)!2:L^8E*KN MAFY *!Y0K^P+(#V%H K-[# 22"FUUTI*W7--L9,+6HP2#DAB/85\"JWL,!%( MR;1G?J_NX8X6"KD4VMMA-I!R:*^5'+I7%O/#94,A:$)[6V"#)WSGNU&_!-&/ MO]#%(RUO2SI.OWA^_%D14E.Z0.DX) MKTM$9>M8*:11Z!4+6/&,BC4C#5(3[1G;:KOU[=^B8=W;"BD4FM+2('+WPUO7 M;O7H(270GF$)=+L3ZF&!O^_,=H^>0O>$1K8G6M33@)0[>\8R.BCZH!,NW$%! M(6%""W>-0N@%M_29AAMZ1^-G?TXO;N_JH4#*F3V3T?*>P9)DO7K_XH9\\T07?),/O(OY;%/_.#VM&DKY%%H>QO4W'H_OK+).?:] M@-OW;K->!]I$,:,^4B;M&Y-)Z[M3D,+>)JOB?<%)DI>P3HA"+876MD&(_DFD MCU1(^\8VFU9?79$@R DMM*_00J$]'?,W4O_LM]HRVGHWS@$X72%R0J-:93RVSW$Y"D-)DWY T6=^9"A)! MQ];>[J*,?4 4\B4TMV5 ;NG*8\]=^;_N:;S2@8*4,_N&Y,QFG7HSJI3%L_&% M\"+D>DE.H]")+9Y]A=0)'6 9G3)&E*?@2,XV](K]^NY_T."9?F6F?-(^E"+5 MT+XA-73?;N[ JXJF%6T0U@CAK9"L&9*U8YT[A:X*?77 W"$%U[[)K+E8^+Y$ M,4F?*'FE7DQHR+<@G]&YT&#)H'=$F(G[U@%3:+'0*0X"=KQDSOH[L^P77W?! MVVB E&8'AJ39O?JXWY FFB"\#<(;L8W;0"'B0B\=*FY(97=@,J[SB_]+1@Y2N M!X:DZ[WZV'@\DAL@60LD:\(Z; HM'/KH4&%#JN0#TZEUT=3]2OS5>I-FN06= MV-LY4*CGT ^N "5-";L6Y4@]?="AGE[7O?T>_]QY\%-H[] U!X@74H4?M%+A M#3WS[?.X9QTHA2(/G>$J4 P('5!()7Y@68DONH<9KUAUZW@IA'?HF@/$"RFX M#UP0W-\RUF"\&ED'2B&T0V>X!E06N%W0^'KYA2UJO8";7H/6$*FV#VVJ[^<(VL?!*Y9Y^L6]D/D:+[T++H7O8/L1(3]:T3IA#BH7,.D3"D(C]LI\B; M6XMM8=9@,3:TCI1"JH?>< 6IKU[*[TAZ;913>(@4ZHI'2E6Y?\A"IP@^-JO#:WC3A MA!AZR,?2 4&C0TTJC>L^URA3D*C MNN5SI!(Y,J5$'H*[%?HBM*<==_/,FBE;!3U%P8+&R?D_-_Q:@!U3/U)G')G2 M&1MVJYP3+HY/+BXO[B_.[\CQU1DY_X]O%_=_MTZ+0F&$%G>(%@TE8Z3:.&ZE M-NX_2RC[I!U+1'H!*LK8!F6LT!^AT0\ %*02.3:E1/X,C"@D26AO.XR<;F*^ M6TI'!5*:'+>[LVWOX2/OQ38,\^Q%EQ8A8X5F"6WL) E(P7)L2K \0 @40B4T MKU4(=JP]QTBM^_E)DI\ MOFTDN6*=JA\LD++DV)0LV;QGY>-)N:.3[\@K*Q%6BY352%7/.DT*21.ZX[!H M0BJ=8Z/;.]LCI8/HPT5V.7U2W4K/U[ W-/0"/E!]M,Z60B6%SNF4K9 V$LO' M2+%T;&J;)^A >;,*?8Z"9QH[(Y&/%7(I-*N3SD>JIN-6JFGK\4-' '^G"I4< MD6+I\L6;9Q.2,V0HE%5HL$V/]G\?1+%^%I%QK/;$AU M>&),'6[>M5T@Y?5[#^R*;1@Z(8#PPBI$D^,YN_= Z,L!+Y@,%G'1:$>0W,?&"Y( M77G22E=&JH=-D=G6%!T(CT\4ZC*TO/6%\SS.\C!D__T2Q>S1PX\6^LN_)TCM M>6)L_VZ[[NU\)"LJDP]%]8]'Y,K^Y>$3A4H-G6(=K"P2?,N>1J3,'1JFIDB] M>MJA7JWIV>XGM#PTSNO)R4QLXS15:-C0'Y9Q*N_>;3K'39%:]K1#+5O?N9UC M5%G5P0>VJ4+ M(4)#LW;L^DO_F2Z.DX2FRMI*F][GF6POR.0L"S%=1W$J M<$KHHT@?^3](4%'HB8:/B"]V$_*9K-ANZ"]887_IB[I9,1?!5$C>T*V6YKOC M<)%+FC- M3Y4V3.QM=IGR$U]9E!3;UU']]AJ'+@EON90F"';CI4WI Z^ZR5SFY\J)*@<^%^ MZ)E" H<6=QD=_65=,Z0@/C.U^WN/+N('*@'CIHKF6=( M07S6@2#>O)/O,%>Y< 'X3"&B0T<=+')(]7S62CTW/E_)W+EP8>E,(7Q#DUN" MISJK?,)LYX>/?V7_GV_.D7=*J[D9?\:)W:*^Z:&J4?]T5XQ5E4E>FQ35RRWA M6Z5X8Y9QDZQ:XJ;P5*>X)6@X?SV>S^.-%YQZ#W9[]K/!+$B*U0/(F!&*LGNI0BW7:H#2N<- ATX:3QT7]YK3M MM;<3B=V'6\K:3+S@(]_HN8[ILQ]MDN"5Q'0>Q?P.\*!,1\H*//!S,.Q__HJ? MA6$O^.'"9T53DGHO)/I!%]:9A)J[PHW6F&3+EY/7*[Z4X8=)),]IKV\=?\8) M[:*^^2&OKF.:,8X_ 3R\DJR2."0C#7].W/4JV4ZBR:ZBKOK!'Z=;/WD=2#@% M7=0WN-1OT+$JGVU, S8"+>%B"AE?UZ"0KC"V/:&E5LZI_XS?U:^B:,YI0LM(3A-7-3O8$B! M_2E *?[-!'14X 5O4[VY14G2F'#ZD^(E;,^GO04XC.T MMST\OGJA]YC]DOA1Z"3A?[*)6DSAB6Y\Z2$5YUXWBO..SM4\_617P=Q[O].0 M'V(ZHTL:+CSK]PI)AI-P=M#%'ZZ".?1 MBHH[@V1D3I^\V'IZ8\DV$A[N"+V-\$ JN[UFRNXLPR.DCUPRN]^ERUU)Y=H2 MXV?$\&# 7")F[@8Q"C$7NL >,>=Y7.5Z>\-DC B^@8PA9 +?6!3<1&">"54[!_U["%EWEXW,N\^/=:#5S7CW MI=6_5$C:(5DT3#@'9*MIDD9$4X_DS5O'5:&10Y?^1+@BU?1>,S5]^Y&TP=.H M,6X!D.$VD-YRZ0<^?R))V$,L?7($2X42#UWG"):WE*UGUC79PL9]I"K?-Z3* M-^Q5RS%0JDFBF-RP;CWQ-]G2KZAB';"^0LN'7CH5((Z] 3]GFZ7M/82QL-3TAMO=\N ?B[S'2*WNG' M*#8R145YETA2Z.O0%P=%$E)![QM2T']FB!2J-W2#?8@NPF=^&+G-](;4M_N& M=HNW[Z!N>O.+*B[QI)"KH2?L\Z3X[>[@:8!4K@>&E.OV'=3QY.+X-%"HT] 3 M]GE2_'QU'"$%ZD$[@?I=EDN*WH&9+G^0F[)4A(>EB7GW7@@5>6!R8'FY3JCC8-D#+RP)R,W*Y_$F;M*EI'2R$I0Z\<(EI(97E@6%G> MFZ^WPUA1FX]AA'()D4Z?^:8F#]<0J54/#65$0?6U8NX'JQO,R"O2R O=$!>NI.V\/?H1*[O#W=<,ES(?++ MRD6K]O%4"/K0C8>!YXY]"T-D&&!H+ R [G$S.(\E.#5#)X.S:-,^FHI@ O2A M$VC63F]G-)G'OCB+I",3&8$8&MO7CNUP$S ;3.A2B]:I5(0OH/^ZI#(*OR5? MZ>J!:FX\'P^1@8FAJA M0$K^PU:2?UOUK!D9>;;.#^A&"'%]E$[L;WEKKE=0-SST85$[DXG(X6*#DW>)1\;OO:Z7M[2=12+ MJ.D=?:R[E&"$E,A'IB1R;4?*1:I1*[FZ M[**CL05.A3J,K2W!3I.^4-\['/AZF]/_OSIG#W2IZ_961SM7OX1 M4C\>F=*/&W4*#B=E>2YLB!HDJT**.M;Y4M2\BU^1V9>MX*21 MC[$S/UE'588L#7+6H5(HL- ?AP@54J<=-=-I4<_=[P*6HWLO1PJ=%_K$.EBU M6O\(*?6.S$F]VJ[LFN)'?)1'VR_Y[Z^\"?IT$\?L^^H(0>J^ M(T-;O>L[4RI[Y=%\44RZ_CHO:!T2A?H+3>X\)$@)>-1JOW;+]4TS4NZ>V,/Z M)U9S1;)+)8.\H /GID<*-1B:W'5(QDA)>-Q*$M[CNI*&0XI0A>?9BRY1,E9H MPM#F]BFY2]DJ4>P*6>:YZ;S@)E_NG;^D-,PNP?*UIX_&2.EX;$@Z1O=7,VL= M5=/6$2E;XROCLCU2-$B^5TV2\W"SHMDQ7NNKH;%"F(:.M$;GWZC_^,0>7H[9 MH. ]4O8$(O85W3)CWU &DGY40\K58T.[J]MV3[=B*FJ2O"HIZA)>F>2UK=.E M$+:A9PZ0+J3$/3:9?&1?Q$JDO!RI18$4%[FMHZ30N*$;[$^C_/&W?KV%U+3' M[3)IO\NBO.I4=757^.CHLGRLD*NAT0^!%*0\/3:TH;@Q)-6D54+"%D#\,3\L MRUJG1:%#0\-;IX7]KFZ\5Q&M/MO0'6FQHJW";KNV2BG@\MJA&6#V' MCCR,%0HT=(DUI JKZ>!!:L]C0]JSNA,Z3(KWK;.@4)NAA:VQ<,N7?-?+;PD] M3A*J'4^08O.X$['Y35\*,L3+_*E\PV<@ 8?'W[>/AD)CAI:VAL9II%=ZD+KR MV% >$-@!W?# W[/N?X5\#"WKRL/Q+5UY?EB\R6_D[6GHF" %Y8FAS-)MN]=8 M>BGKY@5X;=MP312J,W3, <*%%)DG)N]#W)M#^\4B]./EHG M2Z$80Z]8?V!ZU0&$%(8GG0C#92]J'J5=T5LF"I$76ME=()!:[J0[+1=0<<.^ M&8\Y/7O!1ES#ZQX<"MD66MQ=.)!B[<3DM8<[X,A/2SD\<"B$6FAP&VP4IT=J M-^E-D/+LQ+0\N]T+.),4[SNS-6^BT&*AE5T12] ;)B9(F7;2B4R[=Z^UVR9$ MBY^BY2?6)A&-MML_P1NWSZI"Y(4.M<%J?FBV?NQ"BKP3TR+O5B<@2?G;[HQ< M"ID7VMC:R)5\V:2;F'YESY2KS4J*MM1O#9P@==]))[KOKLX5]&3%R%LY)Z]7 M1@R.1#3IBB=W^SM[X+9.ED(EAGXY.+*0"O*DNYW)C?&*8I(^4<)5&D)#?M]3 M_W-O9IT?A\>/_=/-*;>,M5.85.DS#SM1&9NT+^]QB=>7=2VS==4(31# MUQPB7TBE>=J=TMP&,M4HU1^*E*Q M8HI4GJ>=*,\-^K?7@.6'A-472RKKPM-4H5A#[QPB8D@M>]J=EMV&,^68]=DZ M10II&SK 18J^^,^T%B.DZCTUE':C?0?W':IX XZ,50J1'/KG("E#ZN=3D]DW M$*@I1ZN!=8X4VCKT@(L#( M>*40V*%_#I(RI,@^=4!D5Z&F'*WZUCE2".W0 S8XVGEW^@PII<],7L&HZ :, M!V]=MFB;A)E"$H'+^R'] /+UXD M?_6"C/=75/L6V25R%:M(U+6(V5%ZT II&+H M$"> JKNE>8;4A6?&TUXH>],$&UO.C&>\>-N1)JQ8YT*A MWD)+=\E%_.B%_K_$C^=4SF]^'"[R@W3BG]+!AO)40L+SIK'GRDU,=UV?/4-J MNS-3VNX[=[]@\,1+_(2?VI ;$?O)I/M>^?LGF\0/:>+6S=DSA?H+/7@HE.[( M"S5#"L(S4WD[WJ//"!Z=R1PU4VC(T&E=TLBS*I]&JW5,G_CQJV=:/5>?>LG3 M%_;H\Q>Z>*2_>7[(7SSFFTUOZ3SPDL1?^O/"C??>BQK*R6><^"SJ&X'R';M> ML)D?&2!LVO:C!9EG]V7[(5EZ?ER=XEZPMY]9]6?K9W0EZY9$*CSF")' ^(M_ M;)*4]X/?:G)\?7IQPZL(KXAV;B+VPZ>I'XO.GM"0+OWTAH&1?(GB*YK>Q^Q/ M<0!1'%.\?@C\1]$R>^]Z6<,T3D87];MFNGOC;:=NW_I:Y$/VQ3Z*A>T1>?OE M2/7M" >6\.]W1/)O*$;[K-7M+TGR;TG$USP2 C'[-J3ZJN2#^+(?2?5UQ77$ M_&?)OK+UGR.,*BA@^Z^?XYN?(RZ@(>J;"V@X9<'B-WF\BN(T7Y)Q]B]"5LL+ MQ$]!5+7^2X!!%(6?'?DER-9$^_"&K1WB.QH_^W.1X^XTI@L_W?43P 5N1/VN M9Z0.K58W%177T_.O]/&(;/TRWG<:$M^1Y%^2?.!?\R/)OJA3DQ ,7"GX^J^? M7F$N7$Q,U&_PT]N^$/!^UR1T)95S]=?X=A):B]]'DO\^YO9S>$J^D7X*5D-N M;GA0]U/ A?9$?2L+,>?@?_1\V_<"2]Z0X+<:1;3KP1/*)G):0S\N1BGJ_X1K ML-)L+?2 ,]9R2!=;"ZFC-^LG_@EL$24^@ZW;'L3'.+%^@A%3!1O_];LI[86+ MSXKZ/^NL 7X\-]MK)%&(?.!K)=M;8B4_2-Q;C0@[XCL=][A(LJC?G/M]-ELZ M8K_RJ@=L.LAF#O[+("[_:&" 6@'&?_UH2GOA M8MRB?HO)HN59%D=LMYTB./_9_(NMI]BO9.?JR_HO @;)%5YWY!?QC@K^+O)[ MR$!ZST(@W81Y6FBY;87:ZNNY]#S14\3H(0Q_P!\$,@K?:Y?![?VF I._BH,< M\GN*L#?T[A^0<&1@N_<3!+;W)GQK+K!.N"*<#;W;->'5E:[2M9MUB<4G/62< MN6U%0U5PZ[Y11[*-2T:28'$U -OXA\P>6[Z%^3,[792[*F,_\^UBD2':\_4 M(40[4C*X'H:8A,K;,'B=K#.6O1)3[\342SFU;$9\MSIT_KQ?$=%7V[/EJ^W@ M4P+F1[AWED=T-S#HC*^7\X;XMS MQ*6J*]<1G"LQO]T"[=_L$=V@/5/'5 E#;73YJW6$ZJQ8.,1O^[(./<2KJ:O* M$>B=/* \MR9[ K]Z1%=FS]2A6)NRU;/<"33N(;Y/'4E_]D^+Z/#L M&1U#3L"^7W()#H9^[:15 4UKCH!]Z&&Z+CKFZH% MU1HPC7RR.TO)/N)?TY7P3L!#]+'UC59Y:H$@,4MMH?ZXRM&J/+418H9<2NQ; MD5X%2:XZWX2P[V E(%84:1K[3UN9"?:=U5"*N'5U5/RXJ MB5Z?_F%>'\LNROWPS,_K5,CLC1/P1-P_NLZZAN>;-/B?OF^$)KB0;1W*B/Z9 MODG_3.U@=A=U93+<;$&7-81=J'64()X,7>9=H^0F3(7X?;$\D2F=FB,[^T0_ M0]]4\M#ZD>SBHVRC,EBY$\_91UP NKB[1P=\1<)V9]_1GNRRDP&1HQ^8/']4 M.YBW&)&6 _RG>4-WTL-6)%3B1)=ZUSC)OC@_F?- J()'VR3+Q.OF$4?L@/:'FRI74D((R\+F!7D4#D MV@?MN/8C8ACJX*#.>BJ?H2- 0$AT7;X.3&'74SKR"\;0/681AUW7WYX LD6T? M='S&P@!:#_"09T]E!; KSY7<2>7)AYP)=2=,:("P^3HF'/@4?@UC[@6PO/Y; M%"R$,',-WX8/7$R2\L#Z$?@G^@$&'9_3H(HA!WW93[[UD-L0@/.+YP?@P?^P MC.(/B2?K2.<]6XHU\!@270I#DRZ%AN&\14G9D(F6.R4D;$-E MB/@4=+&_ Z@0G0K#=G'X1VPV#L!+M8EU8"!.!%W([P 81$? L!-'0$MPP')Y M'L6;*!9=9E3$&9.W6 A2>;R,==H@D_; 52=\2.]7W MW\4'7&%P26Z6K&L?8>=UP;JH?2*7/C3.I==#8 &[Y*@H-9FPG_QP'FR!KF%S M;^.#"R?@7L+M'^X:(E2X+OK.\5'FH-SKRQL2&>RA208;'4B]:S5J$07-@9=#(MLZ-,FVZJ/8-0S> M?!YOQ8;%):. T*RZC)V%PXC(KHY:L:M$B_ &$^<9&BHMSO+PVS/FA+$8( ('J,[#Q;4?>N$< MSERE?+WOY,>(2+&.3&8S.7AP>@IX<1LK[I.>F^).)F]UZ&S(""%;=;U80%:T M>WJO#D)$>G5DN&[ FU'H>Y:B@2/9DD8(?ZH+N6L\U)\ W@TC;PP:&!%9U)%) M%K7="'=QU)2L4RMYZTJLP0@A5'4-O4^@$2G7D?$<),>A[4K8)S&GS1MSQ+H3 MS3)"2%M=->\3841:=]2*UCVVQ.MQ*',>5@C7J^O#YHHI4T=P0;"/6KR[MK;#SP M(("H9V%;8R^ P*'%V@]]V).F_@O? Q[$JC/VY^&)5*% S03@FTL=CD\&Y-4/9P4M-&]O8&".\L2YK MQ[%!)(_'QLGC/0 I+S-) ZJ(A9T4M4Z=/QXCQ+*N!#OA?TSD MP 8.>*=>TC#*PN5R>U3R18Q\8)5A0"OV1G0_T0SCR+746R?4K\ MA>_%KPS\S"NO. DMS$2J!LO$2'C\8A\M")NJZ\%)M!#)TG$GU3I_0,0@1*FN M"P<.Q2.IJ/3$P@W)V?>$.8R)A.NXX^00IQ)'7:9PY9=T)P1BC-"WNLXZQ.F= ML ZA+! V?PZC(%J]-J^%B?3MV%#RA;IA%(Z>.%ILYRE+B^ON+(P1UE870 M>)4Y?ZZC^)YOA"J?O83?+N_Y@O,U?'PP?41A*@88R&@3L2;A2:U%(C*X8T,, M[I&C+ "5W(W8^_]?6CSD[7RQ\,%1>P/+FXA_L(9]''0CN&R.DKJZA=PNV M"9'OG1Q3@['-\HN*NNP..%L=[K04R[8,<6(5YRV7?N"+!R=G++2?67Z"L,6Z MINR [K-04/!0K&?KCE9/B&3QQ% ^Z(:1Y)BY"9-M[ DE[2[;52HAZ]! .&%= MUFY#@\@.3UJQPRT)@@/P4A5?A4NP1K0,$88UUB;L-$")_/#F, M/S[)I/0^C0A"+>M"M[^H$?O?=10^I/7)%R9$JGEBB&K>/R#-FHBFK&S+;I=, MM6:RN77(('RT+OQW 1DB/STYC)\^^9*W"3M+@9VXQ(Y,)"2QDSB!'82=UK5@ M 3NWRRO_Q5_P<)%\\<,H]M/7??LE(ET],51/\( 1%8P?!$X!+2C3-J31VWU1 M\NS%_#D*%F)=9!TY"$NMJ^!]((=(-$^.J?GWN&_Q^[72S@28BHVU6[!"2&5= M/W9@Q9_2FR39PM+Q,DKJU\A$7GEBC%>N'4F.F>*\Y8SE.9)[L&*%,B"3PU M%/1;-XRB!@,$<>:-;(-@BG"VNF =!@&1L)T>1MB>:%OD/!H0FE:7L,-H('*T MTXXX6A0).S^>,;> @="SNK#M[FCVT!6@\1ED(Q\4V\4.>)+PQS_:42+E. M#:6YW3>5)?R.T &D2R= MMDN3>]QN9A\RI/V0U2:7/([Y MCVOT7;U7,*?CZ'V/4I0IWJ&G@'J"'RI]-6 M@;A'Y/$YRJ;(V>875G48&9&I%)G7<73'C)& M;?F;<_#"\GCE^D7%S,J@ P"9E]UM&UXSA)#5U?/.X$4D:6>&HVK_!*A"B%U= M*^\,542R=]:.[#W9PKD66HY.>#.$^]5E_\ZP0V2"9ZV8X-,MK=\==A"66)?] M.\,.D3.>M0K>/>T"^]WA!Z&2=?G;Q,]=#/D!TUAXM/XM<--*E##Y%4 MGG5%*M<.K#PK .GHU6+(#]DF:W_&-G"'3"# \WNLXPBAF75-O"L<$0GGF>D, M%#\XH!#V65?)NP(4D8>>M>.AB4NBO6"ZS*KYR2R;"S_=QO9/9<\08EH7>Y>@ M@1P=4=@V5?B,2$S/3$7Q[AE.L8=7[536D#-GRQG,$$9:%_T[@ N1D9ZU8J3; M6I8#,2/K>+$=Y+@#%(22UH7N/%"F'VDTM+S?[,ZJI8%QS*)4!%0 !1%Z]T#) M*WWOUFE DD9EJ7$K9=3JH$2CG.7]!J!]D]VZM\72&'5':CX)&&ODN[W=J"CX8D2[- MQ#H%CRC&%<1ETFXL@S7]2./@Y?V=S[>[(WM+@4#AJ\:2LFZ4P:J(KH(F![AY M"IIH-+V\WYZ5^D%@I7/XB%X<@]4EI,+)T^/4@8M&ZLO[;9FJG?&]11:LL519 MK1HVC,QZ<:19AM;/<1=H*O%,6PE5WXR#Z)D M&_-'_CV]"&I/?T][1"=!SX:3H&&8;2?)A)6=L-^A&R;[L>ZGZB$. UU9G0(O M7D;Q&I(W/<"9M<9*T0O0,U1(L&84)6R*RRI[*_LU=*A*>D4L%538I?A; MH8+(V_>,QIR_0M*S->BC7#*H*:(%?1VO/#.G 0F?:>*::] M;AP%,D0#58.2E4W8[ZJ1?5P@'+DNZBYQ(3J3YZ#E5Z0^M?-M^BS$]N^Z$P?3 M'I'\[IF*&6\<3%F3*6N560[5CI4-K8,$H:YUD5L#R9T7W\8/*>P]?O."+1>V M6(JP#BQ$;KIG*M?S08.J XUHSVYCINY@\A8F[E%@L@X@A(G6U= M@. <3\:! MY?N( ZJE3WM$!KIGBH'>/Z(*=.0A)J[:)I5]ME.%TBNRJL#&*N4<1W/.%\FU M>,U[(<0\]=AG.#UVN[P4GZ-?"QPBV=PS%1-^R)ARZ%Q$<1Q]\\-5PGZ*B\8_ M0[G4F+]$P0LD!Y_+6]C2FV>.,!>*;U7D5P&35:*Y1O#RPX7,R75 (A++/5/$ M\K[QE'D\\XN &V5X(/VS&S!!Z&)=XI9@4E0?*BL3J3-AXK,[AV+%36%Q?2)? MW#>5#KKU !N+,17U_[@7A_;7SGV$(M8UX0Z>;C<\]@[#$Y$<[ILBAUL/L%(< M5][)0(6L1%=Y\QDK;F?E_=8QAK#!NG9L82S+Z2]V,U[ ;Y=P$#%]K<,4D1CN MFR*&]PXHQY#:C44;53F%?^?QW$_XXDS-<]:1@C#$NLQM(V5_M:]IG\@5]TUE MJMXWGAI;DQ>^B)PJ#U<14P4O5FGCBGS5Y]?R&/>T3R22^Z:(Y,-'AF-HX2>; M2"79 ABYL87O(_RRKH%N ;38SIN/6?:)='+?&)U<>?<*".!'9SQ-?80LU@7: MO<9O0NF@@\\#J(V;E*]K5[9$AKAOC"&N'+ MCJ6??JY-%SOM$PG?OM'TT\7;5_-4^>$\6G/V4R!^_]FZQA$25Y>I4QHG,K5] MHVFEWX'&$:95EZE3&B=2JGUSE"JB[)M,V?#[SV?P9[!= "-Q%\72X)^G*J;2 M>PHXI%_]NEN\,R_V:1TG"-6J:Z);G. +[HO71_'P\^]^'8 &1&YU8(Y;W3>B MRLHARR9V5V03*YJ?,6C.?H<;K*\A!@BEJBO !=R T!JCF@9$#G5@CD/=-Z)6 MN'$DVFF $*6Z"EQ CK#S=9 A4J0#HQDT&L:C P9)6^B$#W" L*2ZV!V'"9$@ M'9@C2/WK BG A#+M&AK@!!YT$$K'K3]OK:%'4$G'A?L"$)^ZF)W M 2;GBX4DCKV@//!2N]8ELJ,#<^QHB\&]15$&HO,JB%AY9^4@D'5.?8 PK+I2 M7(!50QFFZ8!(L@[,D:P-@SG0^+A0.K(BH0I.+'.M1^"$R+\.C*9=/@58O)1= M1O;IF %"U.K"=QXN1/)VT(Z\/=&RIK5M$1MKZ-DZ9A"J5]= AYBY]U?/Z>WR MUX3+T/?;I]2#5#XWX:?O\V>A''X=Q44(UV?NB8\]2]A3%Y(T('+# T/<,&&D M12 N=/$A6GX0G61'U/)NH+Y WI&L=E+&O>.A(=X8'4,9OPUE ^15!ING>R\SAV/_6AQ MP85X^:/WO0Y"1 IY:(A"/NG82^CM=JHBGRK=9ND<=CK.'&9G+,^6JCH_8T^R M>R;ZMXYQZ/-GOM@&,JK8KP2$>4_1-F4"P6Q325LA&L%/ &HO?/T+%'#=1+$*(DBR M!YZQJ%@'POD:>1+P]T?9QJ'T.$.$G]=5;A/,8#X>_%4H[4N8%M?#E8S3(R"; M2.L/#84W&Y! 95%0Z5J5%E:UK7BEMI7<1B^X,-CSK"$L6_V%>(!X!8E@%3+M M(IX11X*NZ$[Q7#DH'(6K1QZO&XZL#HDN@Z$AET'=,/23JKO7K>,!\0#H,G88 M#T3N?]B*^V^]\FL&15'@'"9,<8T%D1?* \S688$0_KJH'8#%>;C(R@\^\/DV M;CIE.B32_T-#^3;:# U#3B#N^2#AXP1R$.Y?E_P[0P[1$S TG=WY!X,0X@K0 M5= IA)(T]N="XE#/NPXD1'9_:(K=WWGYA]&?*OO#0J?XH;ISU'" &OB]L*(.1QZL93GR,BD3XR1J0C M8T"0H3(/?'Z\N7/F+.@(H;5U,=O#@\S1>O_P:S,NB#3UR%!.BL:QU.)#I:7] M231,?E9@D0E*G4$,0D/K"N@:,=MY*M9AX4JLS.ZYY/_+Y"_ EP8<"*4K<:$. M0T2^>62,;VXUNAU4Y;=)8BV[L9(4YXR5]S*XV3JT$%)8UXLM:,%7V'A4:$0D M=D?&B%UT%#A4E*UQY#30"&%5=2G; @2$!,HO,N'Q"_^\)V7!B,BPCHPQK/N' MA$,%&F>F139W*HW!""%@=16X-$V=/XD&WKR.D1T1&=F1H6CL@\>%@^@XCY+]6FEW!$(%3V,BG%(U. !G1BTMX07A870%NXX5(QXY-)LIH@9.XVM0Z+A Z M5A>T95S4 8)(QXX-59S#AN V"!#F51>NHR @,J_C5LSKB1X(%1B,RK",!(5UU"=OG MTX"2O.+)//9E3;,Z;! )V$D7!&SMH/8'CTABMG*'=?0@;*RN S?0 S6IY]F_ M[SF$_HDFO3H@$?G82;=\;/WX#L14?K/ZJ[C=.KX02E97C7U\E:SV 3:*R-%. MNN!H]PRM'<_ODL%">%Q=(?8!5?V@OV[A3,3M\BXKJY=\"ORU'T*S.H@1J=Y) M%V&XK0?;UI2IKMCMDA6=L;(WZTA$J&%=;S;/ 304FID02>%)%W&Z^1B:S@ X M44EF@K"^NH3M&Z7*5%"D(=^7"&A"I(,G743G'CC$5L'=Y?WL=X=R^$P0)EG7 MD>6=_V/LA4D@(P/.%__<)NFZWM\P(=++DP[I971<.:J4'V+^RBJM6-G,>B#? M!*&?=>&_)^00.>G)89STB>+$?P@((<2TKH5N(;0-(/%)EN%0+!&O*KG9Q+_5 MR='S-=0T_+<2>[@ )H\W;/&F1!)[:CBW VG,.=BJ-\FMGU>YP3;2I@C!K6OE M!T :D0R?F@M+/@G(LGX@SU#9$S *95_R+]7;&:OV)T%9]&@=D0C1KFNO4T2J M'/N?L@2JC=DGID1B?6J,6,<&4:(G*R/PJ4@2ZTB"B2E"G.LRMHB&2I+I*[[T MYW[=*FI*9,JGQICR?0/24)*G$K8.#H3UUL7\+L!!Y+JG[:K[M5T('8J0<@D- M=:PWL1_%3$4%N(,9A-C6I=\M9OQ8OALP;8^O>TH03XF4]=0898T/HV(\LNN* M4806SJ06F2(T=4!Y6L,<)!QJ9M47%)L1.=F9,4ZV]0A+4,E;&=S+\IL9W,WRVUEQ/\L[<*&D MW0RA774%O4^<$3G9F=G"=4>#396P4S7ITF<_7K"-%Z>O+/#G/$S$!6X_J\T, MX6]U?;@#JSV)2V9$$G=FC,0]:%1MS)0[J4QF",VK*\(=#-U%X@M\W1?P-2-2 MOC-CXM..'33G![\-1H MH1S$%T(DZ]IQ!U^?OA^^BB(2RS-CQ'+K$;8!67&_6ZMUA'G6%?0^<4:DI6=F M\V(<#;:O/&6)%SBP)$=H:EWH[F!G[^Q')*YGQHCKPX;5:LHK[K(_U2'TMJZ* M[F%T7ZY #UP]$7GNF3&>>\]XW@+GWO&U-T)]Z[+O'C![DI7./M*8;GF_07P@ M*4K5[^[LX"LB*%2/B+5;U4?!"R1YE5G!KSVH1YZ^-H5VSC[2Z&IYOR$SB ME56:98]A\CD,'L3DDUCE4>4Y=ODPZP#7R6I$Y3\TP&G$MKS?V ;>/,IWX,A^ M^A_NQ=:+CE1D6D&E3=[[:#W<"=P\BQ_O8G_.;Y?B[G44REJI=UP@JNX0Z^PC MC2.7]SME=O<*XE1F-W\0DT^"-"'J65F%VNQIUA&N,^^(SG]HA-,(>GF_>W;W M8)A_>KB[^X^W8,W:>"O["U^=L49FWVD4;ER_N-V-P3#KVPLEF?< )7 M]?I!=LO*?IGJ^(RIKG?/X&:=L]]E]P[Q=A4M5)!KTU_P %Z4C.7ZRM-FTH;F M')#W&X$@-H8"2W"1Y;0N.(Z<86QTTA\1L:M8H!']\GYS$^0[!81.ZB-RMC"M MW2[E>N+B[7I"+AUNU?X-]G-J'5+NZ0Z:V'I$ET#/D$O@M(/'IK:+P)O_\4'\ M$@$B(WD;'/2=0X3$.EH(*4 VB?29,Z_"T;@WJ_40EX2N5LO K:Z5J[K+TJ>] M'@96HM^B9\AO01\P!E"U*OWB0 M60N2]=TN/T?A"HBM*_Z4'H8^HK>D9\I;TG)X&-;*.^$ON/=#"J0?W.TBQ!#? MBZX>*Q#+0A?^+;9A"_&J_M+G"[5;.I__:^O'XJ]P\=GWGL"U*>0MYRP(KSH$ M@42'2\^4P^6TH\< RI/47\N$FTOPG;P ?RVQ&HHEI">?(&RD>H2+@$5\*;HV MK0#V5JQPXJ]1&*ED6^%*N5?;L",]HI^D9^@ P'&#Q. 7P?V,J^9G$G0.@@QQ MC>BJL0(RL=&[X"%?^JFL17P8JHA^CIXI/\=AH\)@)#"WB4+(RYF;+I53R)^S M)]61:")Z8A\8($WN2%Q=Y2%>"EUC]G8=&D,O4ZOZX,^4"VN9 'KGEU]#/VVY M'R'Z*7J&#A*8% 4&ZV)S J".PA?165Y)3_;)$KF5\6#CGK!5[(7PH]K)P/X: MWLT+7_^2L,^/-W<2\BXB'O%[Z BP@OB[.%ILY^E-N(SBM53Q8?@E>C5ZAKT: M^P>&H3&[AU5N@B.BQZ MIAP61P\40UNU#SA/Q?)>&'3#LGYK/Q1Y0+%6XOSILY] G^D+ZQGTA1XUV/V>3)W]F3[)G MYJO,1:GWG;O(TO011XFN.RMP_+1<\GEZN[P->1G;>!?Y87KY#*&4-V'F'/@; M]X+T^5(LBH!E>XQYN+CW4GX8B=@GNDSZQETF)Y8#!F'U"%E1(^0?RJ=\D(]A MZCD"RBQ[$E./8O L56%1/HW)Q[F("LJO^)+'L=Q>9GZP'?_781@F MNE?ZQMTKK4:)(32-4B]@BZP;,*>%4T_@+BB[9<[U M@S!-=./TC;MQ.I01]@TDT,4'=:)J7CUXE3G$8>D G-$EY!T._(6,TWA(Q?_6 M^;HYR_#IX)>!>'5T0-CY,KSD64RD\#_8[[YX 4CS,$@3/3M]XYZ=0P:G81%. M[(D;9 %>^8_*K2YB"_'QZ)JQN/OR7\J],2SN(7PKA*0;A_L0^T0O3]^XEZ?] M4.OW4**7W)2!KPA/SZ;"TV:=LX6YJZ]S4,$'^4C@4[=$+]&>/#($UT3 V,.Z8.'F'[P](N M0@UQ5NDZGZL.IK>O!7H;_TYUZ8_AI& M3PF/7T!T-^%FFR;*#9+>'QL0/0C#8S[ MD5J-$MVEY^YYT8/* W7&9"?2CY1UXR+R$!^2KBXKR".YWP=$=]' N+OH>*]Z M[BQ_5L[R.3C+X?0.2Z6S/';463Y 7$&ZFBPYRP\\BCT@>FP&QCTVAQV[=O1X M]0#QB>@BMP*1\W6T%8N'F_!\/M^NMP&06_)P)Q ,7^&4W,YT_LY2I+'Z(*7 MAY)O7WC\5!9H^>,)@>:O=M%!;B(T0IFW!(6^*'_+B0'?T%/@KS]7D40/$ M]Z+KS@KLLH_VMI3?3?CI^YPGX%3(:ZRS#8J5/ MF+A5KY)A+!/2PVD=.-KE+&L]1!PDNE;M6,H#5U\' 97H+!D:=Y8<-5IT+=EJ M >D@(A$_BJX^F_NE2EZFD(Y,HI-E:-S)0AIU??Z?G.VNG/@65C2[MH/8+ ;# M_30N0\1IH^O7%>A>> &$#SP\&V M%P*&EK%$7\[0N"_G="+ #'+U(#F?L MHA=Q$.D8L+-/VR9BOYNH#(\JEBNY>*W\M1?+1"?1T+B3Z/ A8EC=]8H+92?^ M0IX8$A!,8X'7[-1;88373W[H:C#Q$'$?Z0IT%(@-D4-#HDMI:-RE=-CPT.U_ M=B>KWGK&GEZK/[@21C1$G$^ZA73 X.KR(WCA7Y*= M*9BE7KS*,_-"MO*L:QF&L=.P&A&41>8NF)?N&$UQ&RQAMW$,ARR?O,1WV3)M;!S^B&VEH MW(UT0AE@QQWS[EG6OPIJ8Q=($<32R(K[*OYU]1B9Q\,=4"-N)UW7[QG4>]8# M(Z(;:F3<#75B.6 V&$JYH^?)@:^*@=2"W[SYLTH=S!9;N0" 3=*KFS$B(\0W MI:O:"JY_B:+%-S\(FLSMB.AS&AGW.>V, L-4WL 52S="?$.ZF.TB8I^M(OI[ M1L;]/=I(#D"&4V8#\<+H4G;87:T2'S/$#>-KF9+Q9K@?/ \E>L*609!^@H.6\$1/3 CXQZ8@T:7PVZGL:1ILN8[ M&P>G<(6X1'2EV#&:? 6O>"_=J_)H?.&MNGC-+C:NPX@>D9%QC\C!(T13^:KK MK+B[ZLZ3O'3>PI5%'.+TT'7D+M3VF3*B[V-DOHY-FU%BD/,K_F+O24R?ZG1J MF9)"GV-5<(2T>HEZ0G+&$EF_6!:&E2DKG748CQ WBJYG]V;=)JM(]*&,C/M0 M]HX,@^9A,Z]]0"'N#5TC70)*?917T=KSPSK($-T7(U/NB^J[%Z#()CWUJW5] M(WX'79S=ZQN; S[[(;])^3JI@P'1C3 RY48X8$AOT8$NFMCOT)[)&^Q;"H3< MUS5@$3E?R@Q0%8??^9.PP]X\K<'0F,C8CTTQ]JT&EZ.I" DIC$[5\YFWM@ZE M,<*GZXJP"*52;/L6V6,BMSXVQ:WO'U&]"2H;BV6*.XO?,4*ZZ_*W")N[*/#G MK^J_>X%#I-_'INCW0\;T!CK"MJ@&+FV5Q@C[K@N]4[0$HM/5+SSDL1>(?<3Y M8NV'/MAD2&N890VM@PN101^;8M /&E2)%]GZC*U4>[DO\G;NR+W%B77\( 2W MKH5.\1/[7.:97?@O_F+K!<'KS5JL%,7O7H#%D7[AZR<>UR&*R'2/33'=1PXS MQY@Z:EB]SGY7+>R;)(3;UM70):3P\(^RYL#%JUZ10):GA/_\!E6WQ PAXT)Z M=3 CDMYC4Z3W"8=>F+=*187=**ZR6\F#5]IE73/9[9GZ'\NZSX*\K,,6XO.Z$S.X8498]@ZF'L)LP#Y:5 MS[&.9H1QU]7\8Z*9R-N/6_'V71G5_9#^NH7EI\PXD$$SJ\-M'8N(-T!7TGO M(E!6A'$K+T)7H#Q 'L7,_W!W M]Q\LOX$!0IBZA"3OB HL'W]%MLL?R"# M)]I&^@3QB^B:MX_T9I?:A.@2F9ARB30.9N\>WAWWV03Q@^A"MP^3 _>C]UQ1 M=?F9I.:-^83H-YF8\IN8D,'I3*#Z;_&8XN!AMC/J6<7=00>!3;[5(Z36L8 X;G0) M=XV%>[[)5J]W<;2*O75CT.2$Z(B9F'3$U QE=_XK&[&L%?M=M;._)$-<)+K MK0/D_+M?Q\U-B Z/B:G3 K4#J07')@<'M+(/#<1[H0O;^CQRP(1>)/6K)%G/ MD_%?@:\^J[)3AS"B+V/BFB_C4'F<;A5?2>A=>699$2%_JBQA;1WXB*-#Q\"? M ?A$M\?$2;='6_07V/P?GP?V5_>(YT/7TWL%YWFX^,+3YV@1!='J=1]?1W2 M3$P=HS OD=U]QX&6^4,+RRP>RRK/=8E$1+PJ.A+^%!_ E.A& ;M%/$0:)K[SV 5H5;W925[&78 MZN.S%Z+A!'7();I:IMVZ6DXNEM.MK+/PM\J3LYHE\.S:B"+KWP/B"=(Q\2?Z M'HC.H6DKYU!7EOS(C^)K))/P"JC+C$4*Z!F&[8<>31&'CZZ^]P!=;**]]Y,_ MKF/.;X2H!>+2AMWAE.C\F9HZV6-:'L9I$7@H@Z>R_+%.\")3Q+&D@^#/@'RB MCVK:RD=E<]W=!'^X]F'I'DH1EY>NL/>*TIRH^BT*1#>!F%Z;<$KTG$U=.\)T MN$2ZHZ[+Y[H!?\2AI^/@SP%_HF=PZN11J/;? )5ZRA%?(NZNMX#2F]S#:A, MJL5FYA'RL8F),?;#Q)]+A=7!E.A>G+KF7FPADA.8Z;:/M Y]Q+NH0^!/ GVB M@W'JI(/Q"/SG;8LS@&>L:,C<@"WB=]35YQ)LD\;XSD?Q@N?A A)A?_76O#$" M;4IT-$YM.1J/$$&.2+7XA2;.Q*I-$<^?KAHK$(1D_N"D^AJ%?+=02?(()16] M>24K^V831R]\<1W%-V()!]E>:W W(_KW9L8/3Q''C4W_LDOI?ZYTFH?])ZS2 MK5H-B+99QTSTS/*N;8-UAGC\='W^2& ENO1FK5QZ1\_E)T+LE1^+/97 FW)1 MW'X+Q?.>_8TLW,:^>-_]]7;-RO/3.52+B@Q,EF20S:U#%7'&Z=KL&JH)B)S7 M.$T,^9PTD90JEY<8G"-E1>M0P#QX^BR=1,"1,_+S*SGI1D''U+ P15_2ME/ M?C@/MK)>SMS;^)"Z/^!B>DI^M@X.Q'VB2]U-E,FN$90O#J\%=Y'*SMQ\-J/W\2.-O%4=&$/, MGD'MP$8Z7V^7K&C-\N;N' NJBJL #Z8$.^BY">?1&CY3<-3$_)F'B?_"LU_W M 8E&K*H.# /ID/&AF-IIS]0-3J%*YT8QC=A 59Y1/J]E4;_3$6],HTM5!T8Q MA(U&0\P9>ULH*'%CZU,54!4H5HG57&H-10S%*])(5=6!463L5BHLC(<;=0BK MXZ\JWBJ=FLOH*FA#09?5XA63#9S:C6ATZ68T&V@1)W5@^58%.Y= M3="(4]6!49A@HT%6$]GAV;*=,ZL)G4G%Q&['G,B0A^

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�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

SH6(;P\<[F1-H;\67# M#SS"^OOY+4-8+-O!Z_7X<^Q#L"VP?WWB!\"_CU!CX) M0N6P[XAY,538%B<1\?OG/CS^\\S)0,=AG7JZ-QL\-:9F9 MFCB2EBQ8V.&HL^^T5%E'QBA,H!$UYA5=6PH0N$A:"&?#!QBH\O\&^#K['V<$<"8ZP;D!AY\XDJ)6H0W49? M<^VO'QTS-U]!:C+$X&AY?YI6M\ U2,'WZ,FBD,@C:XP^SMX^;'Q7/Y$^IYS2 M)TAO?4$L&OTF,KFCDN;[S WH]8H/D9/Z1Q5DZIMRZ.- :0:^.HY676L,\L#- M;)F.(4NS2<-;NYRM4&'$E.(?/>Y!4Y#A>9ZUK]&*#[Q;C]NX*RQ%^S92]1U:N.=9+W-C(DCA?9\ECL6\539*)0@\VK).%F>V.5EE536W(U4A-G MY*!KK('E9W00B)2!6EJ%-M&+35S_S^_?_XJE\^@!M$.I08--(%+B0 K (84" M@PE;/0HQS0-"%@59_)(.7L0*Y(1BW=FS-<>'[S[^\<-[(J;CN!."X?&@X(5P M4! 8#''H4C;V:/755W%PFTV*!@V#0<1T+.\I]IB)6RKM'!GN8:M3#UA<@0P< MLTC4D$8F0YU[-/)YK3I+:)$@*(WPECP4U),U% V*QF5FV^D\G$-"+:SAB@8' MV 7U65/E&AX4TE#& )JY1YF0!H)$NRJWZNO#/5SAD.H2FWJMA<9&5 MR ^/S\--R/4-5D?#J/$XG]4'J(*#3?%GWR&/BH&,HZBQ//QG[34-F:?1&G M@Z2?:$YJV4R*HS,FW:11-?=L.EO,&<3^O_*D_I& )&:VS9"JL36MD+ X>-]^ MZGB$O1,FO1.:>!9:@3H_%590]^AG;OW]!*J8%)&U;, #;W[3T#2QY=4FOBN+ MLN\*D.@K5=<3 WE^>2&:TPPA2 Z%GV=+#V1*!P-:ED$[OY%^4[Z8\HT^6?'( M.KX'62E(3IBU_*C<;.,:' M'(NNL+9_BP<0NO/#3Q^$WOP6CHC;>]^6^?_S:TZRW;3,^Z9\_&: $CB7!!)< M4!9[MB4<"APS8H+QXN'\R"]%0ZC,&JGZ5 AW)?/2L^4H$$>$S&H3 M":T-2-&4IQB(1JY!T2^2ENUI34K7=(V^09K8BL2E3-\=]9OIH[.JM8R[29M;:1E,7("9.R1UHW]WE5KKLU!O-S1*3M MN"!!RJ)EF7-R- 8V,7 05I3/J'R8_>[K?O2+YYY49T5#6FO5["F+KO?*P]]X 0,);^_SO^&8)[IDJ8,+"EUKM6MIS) <2;B& MID+^X_;W6V=#IF[00E@*=::DS.<_ZC/E#29]2-1H*O1A9V$YF4SA1&-%=Q.A M-2&0LM(:!GHL+481WQ:UJKT(VJCJGE]=Q#4^F]B@"WAV(QU"G&AHE-JRE]), MX,NH+U@!;,E'A?I$6L0CBD@PT]B]<,-B?KD#E3RT!'E8LH(!P2%M3;"8>FW& M'DWN=(*.RJOG95ZOB S.CB>3@"(QPJ6E<^RVD>ES0KF._SQKVB1C ?9>=%)$ MVZB:)>R@0LSG5><)C<3PYD=+N\G$?AU>M66:1][ED$:^M2ARQD+M%!*8KZAH M/;TTZ978TQCY#A[UKJ5PYL*$X-0VB"ZKER/ATVD\,7_$2]%0*+)51)E%E(OV M/'*E5-B1VIFB/<"3(@3C/H8(@Y _YV!FR-W_BV%FA+XIQJUES S8D,7V2>N8 M&; ]4TX?8F:D.C)80SS(ABA,&._(*=*U4-@"[(>6'MU&_3SRMFQ !& +[OP& M0]*YJ^@CU5#3;&=(%GO5"![+F8LC>YY_ZRY\Z/FA?;R^3=%5#KK+ZRFX;D4] M2Z1JR)I:ZY!F5@"8:;E:3X")T.J>;%UT9^8'[&D>6.M2G&5(]9RF\-=O#7$OS"#4X6QQU\SU8>TC;RK$E9ENWXK6CK M4[/69")IRFPLG15&UKIF/:8(?T&DRMU.'PTAGM-<\O9+:(FO)?U2EN1IJ(8$-$98F5!\KPQ?J<>(FO/XFJ%K54-5@9%D? MTH-J4*5'S+(8*,"YX4D4U1.5M;[ KWL1W.RXFTHEDWG#D]L?PSBD:QQ8HRM3 MN]QK5 )C)$7#8XMH,MF/5ZFF4('8XJ* 1E?,]G)E9!A;ZUODR",\=C!;6?\7 MJ<^7S4TCB?U\F%NE/4NFI^(H"O,-8"4)V6U%57$9'!5@H0=^H"&0M9)3G^7V-0 +I $2 MIXO)]D3^&LW>HE+B*YGAY:>H46EFH5L-7:WICH!E^,T-[^$N4].N'@6_A&JX M]]VFPEU=?Q;P=#BA3\X(+NF<2[S$3FFP0>Z57RHNB$/1N'U")+;4B!J6T)#& M6E=/H/B&'?M)=%UA&@?QG^YQ+AX=028@2$J;J58!0<8+XN#Z1BN,4>.40S>D>@(@5_S;?J M1!+C0 Q&?,%P%2(#]OU#6;&ISCS@\(*GDID"UDG2<'W#/!61DE/\)@92-Q\N MB[Q9I&I+QT?@[ X'JQ@V+4M^J^OM \MKVAW'3/A:(03S24E50:7P'//*?7>R\485UO'+;5#AA( MJUB[ENU'YHUTVW-HB'FMS0Q&%AO76>5S6<&'$'L0)&]^A&=U.DC3;I??Z[IM M>*!7=<- M<\G#[,(1 )9$[N*/-/QAJ]! @V9;OR%XZ_QUF2E%E.S18-Y,EVC MCD,V_"'E>WTZDMQD9P\/'?=:QK\PAD- ]HB^>$)<7J.6;?9:-G4A%;!!.:2B M_C54-!@:HT=GZ([->6*>M()7+NA95(\E2$-B^H#A,5M;(+YI3K,N-/-U@@LI MOAR+2C25B_ND([1W)NU$ OY;1TU;TC1B 4KN *HV/S.13B E&H3O)(=ZK/$U M[QC&Y9%/,C)A1)6.L"PU!,3M[7/^!&P&^+8GG)2G):TMU1^)=EHM$K1V7 QB M- EZ&W1WP\<(5L0'H@AU3'+2PJN"1CN&\-2,QB96GH:PD;4N>>8!@L!I"^Y! M$%>PQ.24Q%XU063X0=:-58W2&FN.8&14+$K#R9WB)AT]K1 MR)#CH2G>B2=(_592TBWR;T6[;LH[1=RRK-5LIOU)&6JENJW[&JP9"H\NY0"; M"Z^CBC7T$.8K#I%-$'R7EGEU.S=FNT7D%=*<&P>4/F)4@U4#<;=+QB<)>@J/ M0O(\1D$7]X MGX,V."),.GM774O&A K\A=:T(Y%JV5$-R*(A.B)90R5@[F)^1R:%4G6!:Y=* M6*JEYDZ+ GR/F#3,F54FQ)$1SR0QPXPA-7@S6U/"4KMR"YK8J/SCT-3H=F/S MGXJ^I".K+>D8!Y$P;II[$IDQ:(7KF,X*+B[Z04_.8PZ.9-4S3D%3P+I&D2@% M,5H-Q&&33?[\[EB_@__@]="L_3ESW%J'0LR1)^4S0?N7I7^!ZS16AM,W%^#' MV,.C8$KS [Q_U"P?1FUSKG8MV>#R]8UPJSUD"-:F)(W$7FZC:Q]3- PR]=). M_0FW(594/J_KTPZ9;G-B,+3Y8U[NF(2:S=)UH_#)!GS/9YR.H55!J34QP+J. M>+2'2'5&92)4T6HJ1L3NQ8EYMC;95#Q\^2@-31;-C62V MPB,QAQ C/F!% UW"I31@KZZ-PT9X,%"5%S0]O:KA,^-/S$8%B8ZFMBS7A/4V MB6Z*N=?_(_6>5IT)OJJS4SSFNQ.\I=DUKO63B)R\8_$G9UTVZ].^/6)I"8B$ M]@2O*, .D6^M8S3Q&2CC;D8J\NT6V53F MGHBGT^1@N'=U,YU-S" K9\=^1-R%]GW2EE(RPZ7@4RU:1%%948%2T0C-$:RL MD2%'D3T\SX0%-S2;I"$WK'S=U5BZP#?5\E;8-6B45U0T#$=&"?30#LM0JHLA M:U0]-H7#H8<=I5; H-Q 1U5;KE+">J;8(91:2TI4" M!719B:[!*>_0>#OLZF=*M_8$K+\N"R80-XT8N"AVZ-R1SD4-/#<0R%9F/$DH MV]6B(E1&O8C5AX/+X",ZHHMD#G!D.!LB3M4!ES^S95C>LO8;F4,2&+*ZMZNA MB[7J; ZQ(N3#4":T5"AH'VS=Z-ZKB=/R^F?^@VUC*X*' VA0JV/-MP8, +?B0Y"$: M],ZJH6:MWK06I$UY[S"1T;PU DV&BO"6L%*9)":5%;6S+W#T!=\BNPJ0=(6) M5ZA:@JKU\"_4P#HZ#P1R^X$V^Q<;IDCAP&UYQ_-I0^($ M@37B,!U(N9[86S615W!05/3D*_"73=Y@#9TH%S,!;M*8<)0".;J(:]IA5E0/ M;'GX/K: /#S?@T9$DP/INN9*6D.FJDBAT2-W2M$9E#O4/+:+Z<.H/0%'B\8K.^<'I7JRP M,K,J690!- I)(4(I+D*]) MV15F9%/\S#?-8-J=6##T1*2O:I4! %KOD1W@_:-;,UX5]X@RN#E@(3CKU%C@F(R"%%JQ;H&B3H MDYEJ&]+0W>I@CO/1*!-7<#2T"I5VV'77) M\A7UCLUX)]#ZY&=G!_YPC/:S6F]*&[;J)])5H/;%B#H'#75"VT M2BVOS@JC MBFW'4:KA!BL'L9,'41=I@\_.@.)*.%X< X[Z*CTKREU#56L&-L=V.=;U9QYV M<5C\A"AH!JB&:#P(;%TTJ*<1&(3> TF:TS9#,<=U]HNLL(&6*=Y.[0QU2B6X MF]I2,:1.:FVJ*T=:H1 -!3Y*%BA24=[:>E",P?/APM8 \M%0_7ROKA$%_9S; MTQ)6U!;'TJ0S.]\\@D0F25$-?:U%3KU4#J$G_5P,_H*U3]$ ' EI$@^\UQU, M#.J))QS@A? V%]9G7SA_(>FNZ:7$(R@+I+"&RQ4PVRH10E X!P7UD*Z9M2B- MSVHT,0B\K9MUL>K3C@JXCL*@5:K%EW6!CXY!'=-?(S\].Y2@DZ(KFOPDL0[I M&!T?0"IOL=-%0QUKNL!GP19>5:ZH 8J^)1'/^F,EZ59)>=SLPAZ>\D4!3V'Q M^83P#G,3&T?3O1:[WOQ>D5=WKW%P%CU"E42/TFS3M']:9/=\-E'S_='Y'=S6 M8G\'EQ:X*X9!T&V/()8S2 ["=05L^C'?%=PGY@'U^54+'ABJ'0( M)]C2P+R C5G!=:IT@YUT?D=#H,A6#4S@=2J+>OLBBK^+:MJ;=:*",%/I:Q R MZX]&<)09![/'5/2'+&(I2^=$0_+:*VSCD"W\2C'R6&YH<:*2HQ$DURD4>W48 M 2LD_QEM7XZJV+ZX*3;Q=HAM.[_6CJ/#.CUL6[7;;(@LJZ&--0#M(.8ELBIZ MK?.V,+0MU5UNII"Z T4[E^(2UT^++CLD;&"MB"Q@:FV(8&M$3?44*OH[SXR1 MO(YL?Z!"GLK3W-GES7T'-'Y^B<< ''<(@:PCKST!SC3<>9!HW3YI+4Q.N0\! M&>HG TKT,FH8.Q3 (L3IDA,%Q&8T=+$&Z14RQ28//&AXINTR&W4:U.C+G_WP MI'KL:\Y.(LP.W)*V;RZV5UX0,G4VUN[<&THA4)HU;X*2U\!8X&RNXF JS5ME MBW>J!XG4D"BUQG=*M1G='H&2[I)#5NCUF\>)"0KO"",2X/BO/QM4%7=B7 QD M:P!BS;M!<&Y42_K97KPW*04[4SAK1S'+L0_?B8[(PF'D:M< ML0*R(6U2:^/D.:P*9;""QN;0?R!&'>.LAV*W>0>W_HY\ Z&/D3!@?&+4>\AU M5)W=E55NA$##8^FD3!DL##)FYSX]P@_YM M.CYUY[RL]F_]V3G.:2O.%[]#4F:F?5M"H<;G%:HN!LH4:B<^N]1@I\XEQ=% MA6O8++,6_XH75*C#V-=4ZF,X+ IO8TZ)V34RNGE.N<;725S7&FQ'R+M'Y-GO MZJ:IG\B 3W:GG7C5J=H4C0'HYK#WAN<-L32%L%[8K)9*C(9$U M:R/FA2UTQJ7NDC1S(/HC@*@A;(C5/;@+"69&2A_LN:8:@EH;(Q9S?#+F_A[R M<@/&FG?K#[)+TILY%_\R#-"L,'WD*K8&<%7P]="\EIL94L>S-KLN3H>8=EUN MGVTF_ C2"RRWE9Z85A2$VXUL$+GYE:>8X5C!G9_CXV0E"\AGZ#8);@=U;W0K]#M,,*>M;FYZ?N2/["/)5[UOOW%*FDAJRI8,ET%Y M'KJN(G7VI]VQY!E[,SL%V/A&KR$#:Q4A"=.0[-B_L87Y>8G"BCL')$6;NQJL M195>_W'[^ZWS!WQK[I'_"I\H5R6CM$B 5)7QV&Y(+$8RAGX^=FR. 3KU3#=DWSH=34RLU0"/D)3]EB;RL4O*^(.6$@L@V M;Y"J9K9W_$P'O]GR^YU?VG_4!%Z2(+,5E$J9\NZW,'UW^Y^WL]$X'$\X7 M:$]W;;DI46!U.ZX[?#V7-O+%Y""J'PO6R8FT!PU(K3"0Y(S]0&Z'L\V-WUFG MX/ F0FM])2F?8%%S\-I6@9#/-WNPY, (H1GD_)Z$@;#QA@7'Z( /6:QJ!=$- M429INP%:&PKX$;\\L\82#3D36V(^#6@SX#X'@^BT=_(]EAPXLDE,<;6[F@^Q M>A&02#J06$[0T2=ZI BPUO]^ D-DM@N[I;C[I.5^2%GC>; *8@@M M(@/AO2%EZ0\U\&-3%*S.I#@<558!XV%?'O>BVK.7\)Z=$8"'T&[+8OP%S+9- MOY,Q&LDD&HI:"[VE#(BTSXAW*-"D@7K$6@+T[4@_!/@>?_WXW2^_.8<=:3%6 MP%/8A)G9%?"$Z6M]&PO*)>SE-9EA@0' '6ESU)6>);$UV+R4 9&2MD5#7P6? M%25X4\"OKOG0M!H!803J);H6V&5$Y*7 Q<_A9SC M&L5F-3<06!/#K#J-]C1@+(U=NV!KPLP$=J:17 ?.. $=0ATN0Z:SI?"HJ&?! MFKN:F81:ET]#'VLS9#.&C$:+F:H- X@?]E&0X&@WB>?=QE_;*!LC<:/\N>,- M8Z1.N0-P_RH<@+<;JLTA=1)KJB9C.0E^7YT V&Q%255MR6=:Y%@3*[64LRU0 MPM*N1I(9=6_]K_$GW=O@:X1I+"A-YBV MN&*75\V=9%X[5JR%87JJ3D>XFW\8M.PH!@*Q8,BZ(L9"_IP#>2&#QO]BD!=) M8M N@3D!6QHOCY9'O(B25W3!,, \B)P-61(35.+(D;(M.H?&I6&0W
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